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FOREWORD 
This book about transplantation of the liver recounts and details experience 
with the first attempts at  this kind of operation in humans. A number of the 
patients have been helped by these efforts. Furthermore, progress toward the 
ultimate goal of general applicability is amply documented. However, the text 
is more than a summary and progress report. In clear relief against the back- 
ground of clinical experience is shown the confluence of modern biology and 
medicine ranging from old and new anatomy to genetics, immunology, phar- 
macology. chemistry. microbiology, and more. As such, we have an outstanding 
example of what surgery is about and where it is going. 
The most distinct impression left with the reader is that of the intertwining 
of an  extensive laboratory program with the clinical endeavor. At first, the 
results with the latter trials were totally disheartening. Instead of causing defeat 
and retreat, the consequence of the early failures was to stimulate the re- 
examination of the apparent problems in more detail and to evolve solutions. 
The course has been back and forth from the clinic to the laboratory with 
complete dissolution of the artificial barrier between "basic" and "clinical" 
sciences. 
In this work can be discerned a model that deserves study of how to advance 
medicine and surgery against the grudging opposition posed by the unknown. 
Central to the effort has been the attitude that laboratories are to help people and, 
more specifically. patients. In relating the fascinating story of liver trans- 
plantation. Dr. Starzl has written about a small group of ,~atients, a larger 
number of participating researchers. and the accomplishments of a vigorous 
segment of the scientific community. 
LF'ILLIA~I R. LJ'ADDELL, M.D. 
Professor and Chairman. 
Department of Surgei'r 
Unir  ersitx of Colorado School of Medicine 

PREFACE 
Five years ago a monograph entitled Exper ience  i n  Renal  Transp lan ta -  
tion,l published by the W. B. Saunders Company described an extensive clinical 
trial with that form of treatment at the University of Colorado. It n7as conceded 
that kidney transplantation was still an experimental undertaking, but it was also 
evident that the majority of the patients in the reported series had received real 
benefit. In the ensuing yetrs renal transplantation has become increasingly 
accepted as a service even though it has continued to provide a fertile area for 
clinical investigation. 
In the foregoing publication a chapter was devoted to speculation about the 
effect that such research would have in promoting the transplantation of other 
vital organs. It was suggested that improvements achieved with the kidney in 
surgical technique. organ storage, histocompatibility typing, and immuno- 
suppression could be generally applied. Furthermore, there was no reason to 
think that several important phenomena seen in the early postoperative period 
after renal homotransplantation would not also pertain with other organs. These 
included the reversibility of rejection and an adaptive change in the host-graft 
relationship which often permitted a late relaxation in the requisite intensity 
of chronic immunosuppression. 
Now there are clear signs that homotransplantation of the liver will be a 
valuable means in the future of treating patients who have an otherwise hope- 
less prognosis from hepatic disease. As with the kidney, the early efforts to pro- 
vide patients with new liver tissue were beset with difficulties and tragedies. 
Problems were encountered which were not anticipated from previous animal 
studies. often necessitating a return to the laboratory for long intervals. 
Eventually a much more complete view emerged of the requirements for 
clinical hepatic transplantation, as can be appreciated from the fact that four 
patients in our series have lived for at least one year after complete removal and 
replacement of their diseased livers. In reviewing this progress, the usual prac- 
tice of devoting a section to historical background will be omitted. The first 
description of transplantation of the whole canine liver by \t1elch2 was published 
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only 14 years ago. This and almost all other articles on the subject are still of 
current interest and will be frequently alluded to in subsequent chapters. 
A comment ma>- be in order concerning the organization and focus of the 
text. Tliere are tn-o general approaches to transplantation of the liver which pro- 
vide the basis for division of the book into several of its component p s. With 
the first method. the host liver is removed and replaced n-ith a homogra !% (ortho- 1 
topic hoinotraiisplantation). The alternative technique is the insertion of an extra 
liver (auxiliary homotransplantation) at an ectopic site. 
Both procedures were developed in dogs. and much of the most incisive 
information about them was obtained from animal experimentation. However, 
this book was not designed to recapitulate such laboratory research except as a 
means of better understanding the small but pathfinding experience with 
human liver transplantation. Instead, the primary objective was to system- 
atically develop a clinical point of view about liver trarisplantation. 
The number of cases with which to do this is still small, and individual 
patients are alluded to repeatedly in different parts of the book. In order to 
facilitate their identification. they have been designated with sequential code 
numbers. Those who received orthotopic and auxiliary liver homografts are 
referred to as OT and AT. respectively. A summary table of the salient features 
of each case is in the up-to-date appendix to which the reader can refer from time 
to time for purposes of continuity. 
The emphasis on the clinical material is in no way a denigration of the 
importance of past or future investigations in animals. In our own laboratories, 
research on liver transplantation has occupied our almost continuous attention 
for more than 10 years. first in Chicago and later in Denver. It is doubtful if 
even a small fraction of the work actually carried out would have been possible 
without the continuous, unselfish, and imaginative efforts during most of this 
time of Mr. Paul Taylor, the present administrative chief of our research 
laboratories. 
The program was also sustained by many other gifted collaborators, among 
whom were several surgeons whose contributions were so noteworthy as to 
require special mention. The first was Dr. Harry A. Kaupp, Jr., who was a 
resident in surgery at Northwestern University in Chicago from 1959 to 1962 
and who is now practicing in Allentown, Pennsylvania. Next was Dr. Thomas 
L. Marchioro at the University of Colorado. He is currently an Associate 
Professor of Surgery at the IJiiiversity of Washington. Seattle. In the summer of 
1966, Dr. Lawrence Brettschneider, a Commander in the United States Navy, 
was placed on detached service at the University of Colorado, where he made his 
major research objective the development of a technique of long-term liver 
preservation. Dr. Carl-Gustav Groth, a fellow from the Serafimerlasarettet 
Hospital, Stockholm. cared for the first five patients who achieved extended 
survival in 1967 and esrly 1968: his uncanny clinical judgment made possible 
the diagnosis and treatment of a number of life threatening complications. 
Since September. 1967. Dr. Israel Penn. an Associate Professor of Surgery, 
has shouldered a heavy responsibility in the program, as have many fellows in- 
cluding Drs. Herye Blanchard (Montreal). Peter Bell (Glasgow). Robert McGuire 
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(New York City). John Homatas (Athens), Reginald0 Picache (-Manila), and 
Geoffrey Giles (Leeds). 
Finally, no undertaking of the magnitude of the establishment of an organ 
transplantation center could succeed without broad institutional. federal. and 
community support. This has been given to us from the beginning by the 
Veterans Administration. the University of Colorado, and the United States 
Public Health Senice,  and by the practicing physicians of Denver. 
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Note About Liver Chemistries 
The liver function tests depicted in the graphs and described in the text 
were not all done in the same laboratory. For example, the bloods from the small 
children were examined with micro-techniques, whereas larger aliquots of the 
specimens from the adults were usually submitted to standard analysis. The 
results of most of the determinations were not markedly different with the 
variant methods. However, the alkaline phosphatase values were expressed in 
several ways which are summarized below. 
- 
Units 
Bessey-Lowry 
Bodansky 
International (micro) 
N o ~ . m n l  Range 
1 to 3 
3 to 5 
55 to 260'* 
'6Range slightly variable according to exact age. 
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MEMORIAM 
AKDRES ZAHLER ~ I A Y A S Z .  M.D. 
(1 943- 1968) 
On October 16, 1968, two anesthesiologists, Dr. Antonio Aldrete and Dr. 
Andres Zahler, were driving from Denver to Leadville. Colorado, to carry out 
some studies in high altitude respiratory physiology. En route, the car went out 
of control and fell into a mountain pass. Dr. Zahler suffered a lethal brain injury 
from which he died on October 24. 1968. His parents, Mr. and Mrs. Jorge Zahler, 
who are both lawyers. had been told by their son that he wished to be an organ 
donor in the unlikely eventuality of such a circumstance. Accordingly, his liver 
and a kidney were removed after death and transplanted. 
"Andy" Zahler was born in Chile on March 20, 1943. He received his early 
education and medical school training in Santiago and then came to Denver for 
an internship and a residency in anesthesiology. He was happy in Colorado. In 
addition to his general duties in patient care, he became involved in clinical 
and laboratory research and with the activities of the transplantation team. He 
was a shy and modest young man who distinguislied himself by his industry 
and intelligence. but above all by his kindness and gentleness. 
It is doubtful if anlone who knew Andy Zahler could or would ever want to 
forget him. He was convinced of the goodness of people and he understood their 
pain in a way not common in 25 year old men. The act of trying to help others at  
the time of his death was perfectly consistent with his beliefs about life. 
PART I 
DEMAND, SUPPLY, 
AND SELECTION 

Chapter One 
CANDIDACY 
The potential usefulness of liver transplantation can be appreciated from the 
survey compiled from the Vital Statistics for the United States3" by Couch.' An 
estimated 15,000 persons between the ages of five and 60 died of liver disease 
in 1963; the diagnosis was cirrhosis in more than 90 per cent. Deaths from liver 
disease. excluding those caused by biliary atresia, ivere also studied in England 
and Wales by Terblanche and Riddell.47 The incidence per capita was almost the 
same as in the United States, although alcoholic cirrhosis was less frequently 
recorded. 
Admittedly, only a fraction of these patients could ha\-e been considered for 
treatment with liver transplantation since acceptance for this kind of therapy 
requires fulfillment of several criteria. As with renal transplantation. a highly 
desirable feature is freedom from disease in organs other than that to be trans- 
planted. Thus, patients with extrahepatic metastases from hepatomas or those 
with secondary involvement of the liver from an uncontrolled primary malignant 
lesion would be excluded. 
There are a number of additional potential contraindications. For example, 
children with biliary atresia often have other severe congenital anomalies." In 
adults, the presence of atherosclerosis in coronary, cerebral. or other vessels 
may be a factor. particularly in older patients, although the incidence and 
severity of occlusive vascular disease may be lower in people with chronic liver 
disease than in the general population." Ii Many of the alcoholic cirrhotics seen 
by us have also had pulmonary disease as a result of years of self-abuse and 
excessive smoking. In addition, the behavior of the alcoholic may be so un- 
reliable that the necessarily strict postoperative medical regimen could not 
be enforced. 
The extent of metabolic derangement already present in patients with 
chronic liver failure will be an important consideration. at least for the time 
being. The patient with terminal renal disease can be rescued from a moribund 
state with intensive dialysis and kept in good condition for weeks or months (or 
el-en years) until the arrival of a satisfactory renal homograft. For the victim 
of end stage liver disease. such delaying maneuvers are usually impossible since 
effective means of resuscitation and interval maintenance are not yet available. 
3 
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A host of deri1-ative complications such as gastrointestinal ulceration, bleeding 
diathesis, renal failure, coma. and hypoglycemia may cause death before the only 
operation ~vhich might hold any hope of survival can be attempted. 
Finally, existing extrahepatic infection is a contraindication to operation. 
Even under optimal circumstances, there is considerable risk of sepsis with the 
immunosuppressive drugs currently used to pre1-ent homograft rejection. If a 
focus of infection cannot be eradicated prior to institution of therapy n-it11 these 
agents. there is little hope that this can be acliie\-ed aftern-ard. This is a par- 
ticularly limiting factor in patients dying of hepatic cirrhosis. In many such 
cases. ind\velling urinary catheters. which were placed with the development of 
the hepatorenal syndrome, has-e already caused urinary tract sepsis by the time of 
the first evaluation for transplantation. Moreover, the majority of such potential 
recipients who have bled or passed into coma are found to have radiographic or 
clinical evidence of hypostatic or aspiration pneumonitis. 
HEPATIC MALIGNANCY 
In the non-neoplastic disorders, the objective of transplantation is to provide 
more adequate liver function. Removal of the patient's diseased organ is not, at  
least in concept, an obligatory component of the operation. 
Primary Liver Carcinoma 
Consequently. the unequivocal indication for the operation of liver replace- 
ment (orthotopic homotransplantation) was originally considered to be primary 
hepatic malignancy which could not be treated with conventional techniques of 
subtotal liver resection. Eleven patients with this diagnosis were in the series at  
the [Tniversity of C o l ~ r a d o ~ j - ~ ~ ,  41-4'  and three others have been reported by 
Calne.' " 
Of our 11 patients with hepatoma. there were four who had pre-existing 
cirrhosis (OT 2 , 4 , 5 ,  and 15) and seven who did not (OT 3,6.8,14.17.23.  and 25). 
In every case, the diagnosis of malignancy had been made by biopsy at another 
hospital. There were 10 hepatic cell carcinomas and one cholangiocarcinoma. 
Useful information about the extent of the lesions and the effect upon them of 
prior irradiation or chemotherapy was obtained lvith liver scans (Figs. 1 and 2). 
Tumor metastasis as a contraindication to transplantation was investigated 
with chest x-rays, bone surveys. and bone marrom examinations: these studies 
were usually carried out by the referring physician, as outlined in Chapter Four. 
A final decision for or against hepatic replacement was not made until a cada- 
veric l i ~  er became available and definitil e exploration was carried out. In many 
cases. the effort was abandoned when tumor n as found outside the l i ~  er. In spite 
of these precautions. one of our patients (OT4) n a s  found at autopsy. one week 
after operation, to have a metastasis in a lumbar ~e r t eb ra .  Others have devel- 
oped recurrent tumor long after transplantation (Chapter Ses enteen). 
There were t n o  male patients n ho benefited from consideration of hepatic 
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l i i i l i ~ (  1 Groif-t11 of' ii hepiitomr in piitiel~t OT 8. 1 Lii,er scan in  F e b r ~ ~ a r -  1967  usin< ' * A u .  The  
child !!.as then 13 months o ld  l o s t  of the trli11or r w s  in  the left lobe but smaller grori-ths in  the  right 
lobe ~ r e c l u d e d  resection. B -1 repeat s tud>  three morrtl~s later shoxi-in? o n 1  a small remnant  of func- 
tional liver t i ssue The excised organ iieigiled 1183 gin (RI- permission of i n n  Surq. 168:392. 1968.) 
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F i g u r e  2.  Liver scan wit11 ""' technetium of a 16 year old girl \\-hose diagnosis xvas hepatoma. Note 
the central location of the piincipal mass. The determination of inoperability for subtotal hepatic 
resection n-as made in October. 1967. in another city: a feeding gastrostolny 17-as performed because 
of severe anorexia. The lix-er scan xvas obtained on January 5. 1968. Orthotopic homotrallsplantation 
\?-as carried out on 1Iarch 1;. 1968. at xthich time there xvas tumor inr.asion of the nlaiil hepatic 
veins below the line of suprahepatic vena caval transection. A,  posterioanterior scan; B ,  lateral scan. 
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although the procedure was not performed. In one, a small 
cholangiocarcinoma was located at the bifurcation of the common hepatic duct. 
illthough a cadaveric liver was available, it was decided to attempt a Longmire 
procedure2' as has been described by Waddell" for the treatment of a central 
hilar malignancy. There was a prompt fall of serum bilirubin from 38 mg per cent 
to normal (Fig. 3). This case was reported with a two and a half year follo\v-up 
since it then represented the longest knon-n surxikal after such a palliative 
 pera at ion.^^ The patient is still alive after more than four years. 
The other man was found at operation to ha1 e a liver cell carcinoma ivhich 
could be remo\-ed by resection of two and a half liver segments as n-ell as a por- 
tion of the abdominal wall. He recovered promptly but died with widespread 
~netastases 27 months later. 
It remains to be determined whether orthotopic lik er transplantation will be 
an effective method for treating primary carcinoma of either the liver cells 
(hepatoma) or intrahepatic bile ducts (cholangiocarcinoma). The natural history 
of both diseases is grim if partial hepatectomy cannot be carried out. the average 
sur1ival being only about three to four months in large collected series.> 
Total hepatectomy with liver replacement extends the criteria of local resecta- 
- 
Fiq i i r r  3.  Course of a patient xvho was explored on October 13. 1964. for consideration of orthotopic 
liver transplantation. ,although a potential cadaveric donor was near death in the same hospital, it 
\\-as decided to perform apalliatix e Longmire procedurei~lstead 'intrahepatic cl~olangiojejunostomy). 
The 111-perbilirubinemia xvas promptll- reliex-ed. There has been ilow gron-th of the original sclerosing 
adenocarcinoma at the junction of the right and left common ducts. Ho~ve\-er. the patient is still 
ah\-e more than four years later. He now has carcinomatosis. (By permission of Amer. J .  Surg. 114: 
7 2 2 .  1967.) 
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bility but it does not insure against extrahepatic spread and, in fact. immuno- 
suppressis-e therapy could concei\~ably accelerate metastatic growth (see Chap- 
ter Seventeen). 
Liver Metastases 
The differentiation of primary hepatoma from liver metastases can be ex- 
tremely difficult. even with adequate biopsy material for histologic examination. 
A potentially discriminating biochemical test was reported by Tatarinov4%nd 
several later investigators2 " '; 4" who found an unusual protein of the alpha, 
globulin class in the serum of 50 to 80 per cent of patients with liver cell car- 
cinoma. It mas speculated that the undifferentiated hepatoma cells synthesized 
this primitive serum protein. which is not normally found except in the fetus or 
newborn. False positive tests with hepatic metastases have been documented in  
only a few patients, of whom all were infants or children with embryonal prim- 
ary malignant lesions." 
There have only been two examples of liver transplantation for metastatic 
liver disease. The diagnosis was known in Demirleau's case," but in Moore's 
the preoperative impressioii of hepatoma had to be revised when a small primary 
carcinoma of the sigmoid colon was found at autopsy 11 days after transplanta- 
tion." 
It is possible that occasional patients with metastatic liver disease could be 
benefited by orthotopic liver transplantation although. for reasons to be dis- 
cussed in  Chapter Seventeen, this is unlikely. Presumably. the conditions would 
be the development of isolated hepatic metastases long after resection of the 
primary neoplasm. We have seen patients die with tumor detectable only in the 
liver, years after resection of a melanoma of the eye. or after complete local 
control of carcinomas or carcinoids of the intestinal tract. 
NON-NEOPLASTIC DISEASE 
The central issues in transplantations in  patients with non-neoplastic liver 
disease are if and when to proceed, whether to use an auxiliary or an orthotopic 
homograft, and what the life expectancy might be without this heroic form of 
treatment. 
Congenital Biliary Atresia 
The decisions are relatively easy if the diagnosis is extrahepatic biliary 
atresia, a disease described by PottsLX as having been responsible for the "darkest 
chapter in pediatric surgery." The course is inexorable if. as is usually the case, 
there are no ducts available for biliary reconstruction. Under these circum- 
stances, survival is uncommon for more than two and essentially unheard of 
for as long as four or five years.Iq Noreover. the last months of life are an agony 
CANDIDACY / 9 
to both parents and child because of itching, ascites, hemorrhages. recurrent 
respiratory infections, and. finally (in the event of a merciful pro\ idence), coma. 
It is not hard to justify the decision for transplantation once serious deterioration 
has begun (Fig. 4). In our series there have been 11 children n-ith this diagnosis 
treated with orthotopic transplantation (OT 1. 7. 9. 10. 11. 12. 13. 16. 18. 21. 24) 
and one more (AT 3 )  in whom an auxiliary procedure was attempted. 
In considering the proper form of treatment. there are factors  fa^ oring the 
orthotopic in preference to the auxiliary operation aside from the fact that the 
latter procedure has special physiologic disads-antages, as will be discussed in 
detail in Chapter Twenty-one. There are hepato- and splenomegaly. which may 
be so marked as to cause respiratory embarrassment in the later stages of the 
disease. This mechanical handicap is eliminated by the removal of both organs 
in the course of orthotopic homotransplantation. The livers in the patients with 
biliary atresia treated by us h a ~ e  weighed 415 to 885 gm (compared to an ex- 
pected normal of 200 to 250 gm) and the spleens were 93 to 415 gm (normal at  
age two, approximately 35 gm.) 
IVith the alternative procedure of auxiliary transplantation, there is little 
room in the overcrowded abdomen for an additional large organ. This was 
illustrated in Absolon's recipient1 by the necessity for performing splenectomy 
and left nephrectomy before the incision could be closed, and by one of our 
pediatric  patient^".^" in whom the vascular supply of the graft was compressed 
when the abdominal wall was reapproximated (AT 3), leading to loss of the 
organ (see Chapter Twenty-two). 
If the diagnosis is intraizeputic n tres~cl ,  a distinction that can usually be 
made with biopsy, a doubly cautious attitude is necessary in recominendiilg 
transplantation. Most children with this intrahepatic defect are dead by the age 
of five years. but survival for 10 years or longer has been recorded.18 2 L . 4 i  Only 
one of our patients had intrahepatic atresia (OT 19). 
Post-necrotic and Alcoholic Cirrhosis 
Until now, there have been few reported attempts at liver transplantation 
in cases of cirrhosis; our experience for this indication has been limited to one 
orthotopic (OT 22) and three auxiliary procedures (AT 1, 2, and 4). There were 
probably two reasons for the paucity of cases. At least in the past, death was 
imminent, usually as the consequence of recent or ongoing variceal hemorrhage, 
when most such candidates were first considered. Cadaveric donors seldom be- 
come available on such short notice. and many prospective recipients have died 
in our institutions and elsewhere while awaiting a hepatic homograft. 
Secondly, the fate of better risk patients with less advanced disease cannot 
be predicted with the absolute certainty which is possible with the diagnosis of 
liver carcinoma or extrahepatic biliary atresia. Most physicians with experience 
in liver disease can recall one or more deeply jaundiced, ascitic. and semicoma- 
tose cirrhotics who unexpectedly recovered completely enough to be discharged 
from the hospital. The possibility of a remission. however remote. has been 
responsible for many retrospectively regretted decisions against transplantation. 
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F i g z ~ ~ e  4. One of the  patients (OT 12)  11-ith biliary atresia who receix-ed a n  orthotopic liver homo- 
graft. A .  The infant xras 16 lnonths old and  xras admitted to the hospital in a moribund state. T h e  
pad on the lox\-er abdomen COT-ers a peritoneal fistula. which had dex-eloped solne weeks previously 
after a paracentesis. B.  The  early conr-alesceilce after transplantation TI-as ver!- rapid. This picture 
was taken one rnoilth postoperatix-ely. The child died three and a half months  post-transplantation of 
septic infarction of the  right lobe of the homograft (Chapter Fifteen). 
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The foregoing factors of both predictably high operative risk in cirrhotic patients 
and uncertainty about the natural course of the disease ha\-e also influenced 
judgment about the choice of procedure in the direction of auxiliary transplanta- 
tion. hich could be a potentially less difficult operation and one which does not 
involve the sacrifice of any residual host lis-er function. Whether these are suf- 
ficient reasons to select a method of therapy n hich has yielded inferior results in 
experimental animals as ~i ell as in patients (Chapters Twenty-one and Twenty- 
two) is open to the kind of serious question ivhich can be answered only with 
more experience. 
Now that the possibility of obtaining extended survival after liver trans- 
plantation has been pro1 ed, it may become possible to relax the indications for 
intervention. particularly in cases of postnecrotic cirrhosis in which the maxi- 
mum value of abstinence from alcohol has usually already been realized. An 
ideal prospect might be someone whose physical condition is relentlessly deter- 
iorating; who has progressive jaundice, hypoproteinemia, prothrombin depres- 
sion. and other worsening indices of liver malfunction; and whose mental 
competence is failing. Such a patient is known to has e little chance of surviving 
even if continuously hospitalized.'? 
Having made a decision for transplantation, it would probably be best to 
make the final choice of procedure contingent upon the circumstances of organ 
supply. For example, if a histocompatible (Chapter Three) liver of an infant or 
child became available. it could be placed as an auxiliary organ by one of the 
techniques described in Chapter Twenty-two: the problem of adding a cumber- 
some intra-abdominal mass would be minimized. On the other hand, an adult 
liver might be placed orthotopically if it were thought that the operation could 
be tolerated. If not, an attempt at auxiliary transplantation might be justifiable 
in spite of its drawbacks. 
Other Chronic Diseases 
Cirrhosis and liver failure resulting from less common diseases should also 
be amenable to treatment under the same guidelines as in the preceding section. 
Examples might include primary biliary (Hanot's) cirrhosis, Wilson's hepato- 
lenticular degeneration. irreparable biliary duct injury, and hemachromatosis. 
To our knowledge. liver transplantation for these diseases has not yet been per- 
formed. One of our recipients of an orthotopic homograft (OT 20) had an unusual 
disorder. She apparently had neonatal hepatitis and later postnecrotic cirrhosis. 
At the time of transplantation, she was eight years old. The biliary drainage sys- 
tem was patent but the intrahepatic ducts had marked cystic changes (Fig. 5). 
Acute Liver Failure 
The role, if any. of transplantation in the treatment of fulminating viral or 
toxic hepatitis will eventually have to be defined by clinical trial. There seems 
little doubt that patients dying of acute hepatic failure can be helped with the 
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F i t  5. 4 c ~ l ~ o l a ~ i q i o q r a t ~ ~  o f t h e  l i \er  yenlo\ ed from p,ltiellt 0 T  20. Xote the \ \ ide ipread  s:~ccular 
cholangiectasis. 
kind of extracorporeal liver,"'. '" :3" exchange transfusion,:"'.4x or cross circula- 
t i on~ ,  I.-). :U procedures that are used for only a few hours. The improvement is. of 
course, ordinarily too short-lived to influence the ultimate outcome. 
What is needed is assistance for intervals long enough to permit healing and 
regeneration of the gravely damaged host liver. Auxiliary homografts might 
permit this, subject to several potentially iinportant reservations. First, in in- 
fectious hepatitis it m-ill ha\-e to be established that the vireinia which may be 
present. but which has not been consistently or convincingly denlollstrated dur- 
ing the period of rapidly developing jaundice."" will not lead to acute destruction 
of the homograft. Second. the use of immunosuppressi~-e agents to protect the 
homograft would be predicted to adversely affect the host's immunologic de- 
fense against the invading microorganisms (see Chapter Seventeen). 
\17it11 either infectious hepatitis or the more favorable situation of acute 
yellow atrophy resulting from drugs or other toxic agents, another factor may 
conceivably defeat the ultimate purpose of el-entually re-establishing de- 
pendence upon the acutely diseased organ. It is highly likely for reasons dis- 
cussed in Chapter Tn-entp-one that a well functioning auxiliary hoinograft will 
inhibit to some extent the recovery of the injured host liver. 
Metabolic Diseases 
Several recent studies'" ? '  " have provided strong evidence that liver homo- 
grafts retain their metabolic specificity after transfer to a new host (Chapter 
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Eighteen). A practical implication of these demonstrations is that certain liver- 
based metabolic disorders might become treatable wit11 such a procedure or 
even with auxiliary transplantation. The concept has been conclusis ely tested 
by Kuster et al.?" Using mongrel canine donors, they were able to cure the gout 
naturally present in Dalmatian recipients. Con\ ersely, the transplantation of 
Dalmatian livers conferred the defect in uric acid metabolism upon mongrel 
recipients. 
Clinical l i ~ e r  transplantation has not vet been performed for this kind of 
objectis-e, and if it is attempted in the future it will be for extremely limited 
indications. Lists have been compiled of many liler-based inborn errors of 
metabolism which hypothetically should be curable by hepatic transplanta- 
tion.'; However. most of the resulting diseases cause neither serious morbidity 
nor mortality. In others. the crippling or lethal complications can be controlled 
or prevented by dietary restriction. enzyme replacement, specific medication, or 
other forms of consen ative therapy. None of these disorders could be considered 
at present to be sufficiently grave and untreatable to warrant recommendation 
of hepatic transplantation with its high early risk and unknown long term 
dangers. 
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Chapter Two 
THE LIVER DONOR 
Some of the practical problems of cadaveric organ supply have often intro- 
duced a regrettable but unavoidable impersonal note into the preoperative 
relationship of the transplant physicians and surgeons to the prospective recipi- 
ents. Someone in need of a liver homograft may be entered on a candidacy list 
for hepatic transplantation, but this is no a s s u r a ~ ~ c e  that treatment will ever be- 
come a reality or even that the patient will be seen by the staff at the transplanta- 
tion center. Whether the undertaking will become possible depends upon the 
procurement of a lil er ~vhich is of the proper size and antigenic structure and 
which has not been so badly damaged that it cannot support life in its new host. 
Only after the arrival and study of a potential donor can a designation be made of 
the appropriate recipient. 
The go\ erning role of unpredictable donor availability in determining which 
recipient can be treated. and at what time. ~vill  continue to be a major barrier 
to the full utilization of cadal eric organs of all \ arieties until techniques of organ 
banking can be perfected. Then, as now, however, a vital factor will be the 
procurement of organs TX hich ha1 e not already been irrel ersibly damaged during 
the agonal phase of donor life. Errors in judgment about donor suitability were 
often made, particularly early in our experience \vith lil er transplantation, and 
were probably at least partly responsible for many of the failures. 
DONOR SELECTION 
Several hours are usually required to study the donor, to make a discriminat- 
ing choice of a recipient. and to ready the equipment to be used for organ pre- 
servation. The criteria for accepting a donor are accordingly somewhat restric- 
tive. Someo~le n-ho is lifeless on arrival at the hospital or who dies unexpectedly 
within the institution and cannot be temporarily resuscitated is usually excluded. 
A good donor would be a young person who has had a grave brain injury due 
either to trauma or neurological disease. but ill whom an adequate cardiopul- 
monar)- state can be at least temporarily maintained n-ith I-entilator support 
and, if necessary, n-it11 cardiotonic and \ asopressor drugs. In many such patients, 
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it is evident from the outset that the damage to the central nervous system is 
incompatible with recovery. 
Cooperative action by the medical community at large is necessary if organs 
are to be procured under these circumstances. Often. the condition of the pros- 
pective donor is so patently hopeless at the time of initial examination or after 
varying periods of observation that attempts at reanimation or continued me- 
chanical support would be a cruelty to the patient and relati\ es if there were not 
another objective than the extension of life in a legetatile state. I11 Denver 
many physicians have assumed the responsibilit! of short term resuscitation in 
this kind of situation rather than stopping treatment. have talked frankly to the 
family about the reasons, and have then contacted the transplantation team. In 
such instances. permission for postmortem remoL a1 of the organs mas obtained 
at some time before death. There have been no adlerse legal consequences or 
known psychologic complications. 
The investigations which follow ha le  an ordered sequence. Blood is im- 
mediately dramn for a battery of standard lil er function tests. In addition, exam- 
inations are started which nil1 be crucial for the selection of a recipient. The red 
cell type is determined at once so that prospectix e recipients can be narrowed to 
those who are acceptable bj- the rules of blood group compatibility, which have 
been well worked out in renal transplantation') " (Table 1). 
A comment is in order about donor-recipient combinations in which there is 
compatibility but not conformity of ABO groups; examples avould be a trans- 
plantation from an 0 donor to an A, B, or AB recipient, or from an A or B donor 
to an AB recipient. Several years ago there was some uneasiness that the reti- 
culoendothelial system of the graft might react under these circumstances with 
the isoantigens of recipient red cells and cause red cell destruction."' This 
'inxiety has proved to be groundless. There have non been four cases in our 
experience with 0 to A (OT 4). 0 to B (OT 19), or A to AB (OT 15 and 23) trans- 
fers. A significant hemolysis did 11ot occur. One of the recipients (OT 4) died 
Table ,l: Direction of Acceptable Tissue Transfer When the Donor and 
Recipient Have Different ABO Red Cell Types 
0 t o  n o n - 0  Safe  
Rh- to  Rh+ Safe  
Rh+ to  Rh- Relatively safe 
A to non-A Dangerous 
B to  non-B Dangerous 
AB to non-AB Dangerous 
"0 is universal donor; AB is universal recipient. 
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after six and a half days. but the other three survived for many months (Chapter 
Seventeen). 
In addition to red cell typing. stud? of lymphocyte antigens is begun im- 
mediately in order to establish the histocompatibility profile as described in 
Chapter Three. For donors the necessary tests are first performed in Denver 
using antisera provided by Dr. Paul Terasaki of Los Angeles. and if time permits, 
confirmatory examinations are later carried out in the California laboratory. The 
analysis in Denver requires two to four hours. As soon as the results are avail- 
able. it is possible to compare the antigen characteristics of the potential donor 
with those of a pool of red-cell compatible recipients for whom the same in- 
formation has been previously obtained by Terasaki. A final recipient choice can 
then be made on the basis of this biologic criterion. 
Some thought must also be g i ~  en to the technical soundness of the proposed 
procedure. a consideration which in cases of nonmalignant lil er disease may 
determine whether an orthotopic or auxiliary operation should be done. For 
example, the availability of a well matched child's liver for an adult cirrhotic 
would dictate its use as an auxiliary organ, \\ hereas an adult sized homograft 
for the same patient would most likely be placed in the orthotopic position. The 
ages and weights of all donors and recipients in our series of both kinds of 
operations are given in Chapter Twenty-four. The ultimate decision about the 
mechanical feasibility of the undertaking was a highly individual one, based on 
careful physical examination of both the donor and the recipient. One of our 
female patients (OT 14). who was 16 years old. weighed 49 kg and received the 
. liver of a 27 vear old man who weighed 82 kg. There was no problem of size 
disparity because of the hepatomegaly which a hepatoma had caused in her 
excised organ. There were several other examples of age and weight dispropor- 
tions in our cases (Chapter Twenty-four). The most dangerous combinations 
seemed to be those in which the donors were larger than the recipients (see 
Chapters Nine and Ten). 
'The role of donor age in determining the quality of the organ is probably 
extremely unpredictable. It may be that the liver is less consistently affected 
than the kidney, lungs. or heart by the degenerative changes of senescence. 
This possibility was suggested by the autopsy investigation of Morgan and 
Feldman4 in which 62 of 74 livers from patients over 75 years of age were said 
to be normal: no lesions of the arterial blood supply were found. In a clinical 
study, Cohen and his associates2 reported that more than three fourths of pa- 
tients who were more than 65 years old had essentially normal liver function 
tests. 
At the Denver Veterans Administration Hospital a postmortem study was 
made by Dr. George Peters' of the livers of 30 consecutive older patients. The 
criteria for inclusion in his study group were: age exceeding 50 years (50 to 89; 
average. 65.5). freedom from tuberculosis or neoplasia. and absence of known 
extrahepatic biliary tract abnormalities or primary hepatic disease. A mani- 
festation of generalized atherosclerosis was the cause of death in half the pa- 
tients. The next most common primary diagnosis was pulmonary emphysema. 
Fifteen of the 30 patients in Peters' series had no atherosclerosis whatever 
in the celiac axis or any of its branches (Table 2), and in 80 per cent the hepatic 
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Table 2. Incidence of Atherosclerosis of the Celiac Axis or its Branches in 30 
Consecutive Autopsies of Patients \t7ho Were 50 to 89 Years Old 
(Average. 65.5)::: 
AREA OF ATHEROSCLEROSIS 
N o  involvement 
Celiac axis only 
Splenic artery only 
Celiac axis and  splenic artery 
Gastroduodenal and  splenic arteries 
Hepatic artery and/or lobar  branches 
TOTAL 
NO. O F  A U T O P S I E S  
15 
3 
5 
1 
1 
5 
"The study u-as carried out  by Dr. George N .  Peters.  Resident in Surgery,  VA Hospital, Denver ,  
Colorado. 
artery was completely spared. The other 20 per cent had grossly visible athero- 
sclerotic plaques in the common, proper. or lobar hepatic arteries, but these 
were neither circumferential nor occlusive in any case. Almost all the livers 
appeared to be in good condition by gross examination. However, the paren- 
chyma had minor histologic abnormalities in the majority of the specimens. 
Early in our experience several donors were accepted who were beyond 45 
vears (55 to 79; average. 69). None of the recipients (OT 2 to 6 and AT I )  lived 
more than three and a half weeks. In all there were histologic changes in the 
homografts recovered at autopsy which were thought to have predated trans- 
plantation. More recently. the less hazardous policy of using only donors less 
than 45 years old has been followed, and in fact no liver has been taken from any- 
one older than 27 years since Case OT 7. 
An accurate picture of the quality of the donor liver may be difficult to obtain 
during the terminal phases of life. The family can usually provide a history of 
the presence or absence of previous liver disease, drinking habits. and pre- 
existing nonhepatic disorders. The results of hepatic function tests are vital to 
the assessment. The most reliance is placed on determinations of serum bili- 
rubin, alkaline phosphatase. SGOT. SGPT, and total proteins. and upon measure- 
ment of the prothrombin time. 
However, the liver chemistries often have abnormalities which do not pre- 
clude proceeding if these are acute and due to a failing circulation. A good 
example was the 82 kg donor alluded to previously who provided a liver for the 
16 year old recipient. The man had been in good health until 10 hours before 
death when he sustained a fatal gunshot avound of the head while plaving 
Russian roulette with a small caliber pistol. Six hours after the accident, while 
life was being maintained with a mechanical ventilator and infusion of vaso- 
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pressor drugs. the prothrombin time was depressed to 30 per cent, the SGOT was 
200 SF units (normal 32) .  and the serum bilirubin was 1.8 mg per cent. Three 
hours later, and one hour before death. the prothrombin time was further de- 
pressed to 7 per cent. Nevertheless, the first prothrombin determination in the 
recipient after a seven hour preservation and orthotopic transplantation was 30 
per cent. In this case, the young age of the donor and the shortness of the interval 
between injury and death lvere highly favorable factors. 
THE EVENTS OF DEATH 
It is evident from the previous comments that serious damage to the vital 
organs can occur during the terminal stages of life. The magnitude of injury is 
probably proportional to the degree and duration of terminal circulatory failure. 
The extent of hepatic injury can be tracked with serial l i ~ e r  function tests. It 
can also be indirectly estimated with some accuracy by close attention to urinary 
output; if this remains adequate it is highly likely that the other viscera, includ- 
ing the lil er, are also being \\ell perfused. All organs are apt to be seriously or 
irreparably damaged in a patient who has been in agonal condition and anuric 
for several days or possibly even for several hours. 
The extraordinary efforts which must be made to prevent circulatory depres- 
sion in the face of a hopeless prognosis usually require explanation to the rela- 
tives who by this time appreciate the fact that there is no hope for recovery. 
This is especially true if cardiac massage becomes necessary in a patient who has 
an isoelectric electroencephalogram. fixed dilated pupils and no reflex initiation 
of spontaneous respiration: one of the donors in our series (OT 9) had 18 separate 
episodes of cardiac arrest and most had more than one. 
Until \ ery recently the ul t~mate definition of death in our institutions was 
cessation of heart beat in a patient who also had been shown to have a central 
nervous svstem injury which was incompatible with life. Consequently. a final 
cardiac massage usually triggered the subsequent activity which \sill be de- 
scribed in Chapters Five and Six. Hou ex er, adherence to the condition of cardiac 
asystole was not always easy. The reason was that cessation of the heart beat of 
several donors occurred outside the operating room area and at a time 1% hen the 
preparations for the recipient operation had not l e t  beell completed. Under these 
circumstances 1 igorous resuscitatory measures I\ ere taken. with temporary 
restoration of a spoiitaneous cardiac rhythm. In some of these cases. the donors 
were subsequentl? removed to the operating room. where respiratory support 
was discontinued by the service responsible for their terminal care. In others, 
the initial stages of the hepatectomy were carried out with the family's knowl- 
edge and permission in the presence of an intact circulat~on. \T'ith either set of 
conditions, reliance n a s  ultimately placed on rapidly instituted procedures to 
halt or slon normothermic ischemic injury after effective circulation had 
ceased. 
hlore recently there has been acceptance at the Unir ersity of Colorado of the 
concept of brain death as it avas first outlined. defended. and applied at the Univer- 
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sitv of Louvain by Alexandre.' Initially the fear that the quality of terminal care 
pro\ided for the donor might be thereby lessened caused us to speak out against 
the pronouncement of death in the presence of a heart beat.; ' Our later experi- 
ence, using the criteria outlined by Alexandrel and those similar ones of the 
Harvard University Committee.] has convinced us that such anxieties were 
unfounded. 
REFERENCES 
* 1. Alexandre. G.P.J.: Discussion of Murray. J.E.: Organ transplantation. the practical possibilities. 
1 7 2  IYolstenholme. G. E. IY.. and O'Connor. M. (eds.): Ethics in Medical Progress: With Spe- 
cial Reference to Transplantation. Boston. Little. Brown and Company, 1966: pp. 54-77. 
2.  Cohen. T. .  Gitman. L.. and L.ipschutz. E . :  Liver function studies in the aged. Geriatrics 15:824, 
1960. 
r 3. Definition of irreversible coma: Report of the ad hoc committee of the Harl-ard Medical School 
to examine the definition of brain death. J.A.11.A. 203:337. 1968. 
4, hlorgan. Z.R.. and Feldman. M.:  The liver, biliary tract and pancreas in  the aged: An anatomic 
and laboratory el-aluation. J .  Xmer. Geriat. Soc, 3:59.  1957. 
5. Peters, G.N.: Unpublished observations. 
6. Starzl. T.E.: Experience in Renal Transplantation. Philadelphia. n7. B. Saunders Company, 
1964, pp. 37-47. 249-251. 
7. Starzl. T.E.: Discussion of Alurray. J .E . :  Organ transplantation. the practical possibilities. In 
Rolstenholme. G. E. \Y.. and O'Connor, hl. (eds.):  Ethics in hledical Progress: If'ith Special 
Reference to Transplantation. Boston. Little. Brown and Company. 1966. pp. 54-77. 
8. Starzl. T.E.: A clinician's point of view. Ann. Intern. >led. 67 (Suppl 7):32. 1967. 
9. Starzl. T.E.. llarchioro. T.L.. Holnles. J.H.. Herlnann. G.. Brittain. R.S.. Stonington. O.H.. Tal- 
mage. D.W.. and IVaddell. W.R.: Renal homosrafts in patients with major donor-recipient 
blood group incompatibilities. Surgery 55:195. 1964. (See Addendum.) 
10. Starzl. T.E.. Narchioro. T.L.. Huntley. R.T.. Rifkind. D.. Ro\vlands. D.T.. Jr. .  Dickinson, T.C., 
and Waddell. IY.R.: Experimental and clinical ho~notransplantation of the liver. Ann. N.Y. 
Acad. Sci. 120:739. 1964. 
Chapter Three 
HISTOCOMPATIBILITY TYPING 
b y  Paul I .  Terasaki, Ph.D. 
That histocompatibility will influence the outcome of liver transplantation 
in man cannot be disputed, for genetically determined transplantation antigens 
have been shown to be of importance with every other organ and in every species 
thus far studied. The principal question to oz answered is to what degree  his- 
tocompatibility antigens will be of importance when their influence is modified 
by currently available means of immunosuppression. 
A precise answer to this question cannot now be formulated because of 
deficiencies of the tissue typing methodology currently being used to identify 
donor-recipient incompatibilities. Although a large amount of information has 
recently been gathered and collated. it must be recognized that typing of human 
cells is essentially an effort of the last five years and one that is still highly 
developmental. It is not known. for example, how many significant histocompati- 
bility antigens have yet to be discovered or even what are the relative strengths 
of those antigens which are already well recognized. 
In this chapter the material for discussion will be divided into three parts. 
The first will concern factors which could lead to typing errors or misinterpre- 
tation. Second, correlations will be described between tissue matching and the 
outcome after human renal transplantation. Finally. the use of histocompati- 
bility analysis will be discussed as it has been applied for clinical liver trans- 
plantation. 
SOURCES OF TYPING ERRORS 
There are several ways of assessing histocompatibility differences between 
donors and recipients. The ones with the most promise of clinical applicability 
are thought to be those which attempt to detect antigens in peripheral lympho- 
cytes. The reagents used for this purpose are human isoimmune antisera ob- 
tained from persons who have accidentally or deliberately been sensitized to 
white cell antigens. The cytolysis of test lymphocytes by such antisera implies 
2 2 
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the presence of the same or a similar antigen as that which originally sensitized 
the serum donor. and failure of such a reaction implies the absence of the anti- 
gen. The assumption inherent in the method is that the analysis of the peri- 
pheral lymphocytes will faithfully reflect the histocompatibility composition of 
all tissues within that individual. For the most part, this appears to be true, 
although certain histocompatibility antigens may be lacking on lymphocytes but 
present on different organs. 
The results of the antigen studies in the prospective donor and recipient are 
used for the matching. When the lymphocytes of both members of a pair react 
the same to a group of antisera which are thougqto measure a given histocom- 
patibility determinant, conforl?zzty of that antigen is said to be present. The 
absence of an antigen in a donor which is present in a recipient is defined as 
( o n z p a t i b i l i t y .  When an antigen is found on the donor lymphocytes but not on 
those of the recipient, a ~nisnzc~tc7z exists. For any given case. conformity of 
antigens would be preferable; compatibility would be the next most satisfactory 
condition; and the least desirable would be an overt mismatch. In practice, there 
are limitations to the accuracy and completeness with which the state of match- 
ing can be assessed at the present time. 
Reproducibility 
Even within the same laboratory, the results of antigen analysis for a given 
patient may be variable from day to day. The incidence of nonreproducibility 
ivith leukoagglutination techniques is reported to be in the range of 10 to 20 
per cent; it is less than 5 per cent using the lymphocyte cytotoxicity test.* 
False Values 
The incidence of false negative and false positive reactions is not known, 
although it will not be surprising if it is shown several years from now to have 
been fiigh in the currently studied cases. Detection of this kind of error is possi- 
ble by combined serologic and genetic studies. It is well known that red cell 
ABO typing had many technical errors even 20 years after its discovery."' Type 
0 and type AB children should not result from matings of 0 X AB parents, 
though their occurrence was said in different series to be as high as 26.3 per 
cent, until the publication of the triallelic hypothesis of Bernstein in 1926. 
Similar genetic analysis has already aided in the identification of false 
reactions, particularly when testing mas carried out within family groups. At 
the Third Histocompatibility \170rkshop in Torino, Italy. it was found that the 
antigenic specificities of the HL-A histocompatibility system could be fitted 
Into a hypothesis of a single chromosome locus n-ith almost no  exception^;^ 
furthermore, the alleles tended to be divisible into two distinct subloci. Some of 
the individual antisera gave conflicting answers. but the overall results indicated 
essentially no recombinants in all the 11 families studied.' With this kind of 
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information. it was possible to focus immediate attention upon tests which did 
not conform to a rational pattern. 
False negative reactions in which a cell possesses an antigen but fails to 
react ha1 e been described as "ANAP" (agglutination negative, absorption posi- 
tive) by Tan Rood" and >,CYNAP" (cytotoxicity negative. absorption positive) 
by Ceppe1lini.l Along these lines. reactions which are negative but become posi- 
tive with longer incubation could be called bbCYNIT" (cytotoxicity negative, 
insufficient time), as we have described." 
False positi~ e findings could result from the use of partially damaged cells or 
impure cell suspensions. or from other defects in the methodology. 
Incomplete Knowledge of Antigens 
Only a portion of the significant histocompatibility determinants have so far 
been identified. The consequent degree of incompleteness of antigen analysis 
with the currently available techniques is not known. However, within each of 
the two maln subloci of the HL-A system which have been proposed by several 
authors,$ 1) 1 7  25  the number of missing alleles may be estimated by adding to- 
gether the known gene frequencies. Singal's data (Table 3). which include a new 
allele (Te 12) plus four others at  the first LA sublocus and a total of five  allele^'^, IR 
at the second sublocus. suggest that 24 and 48 per cent of each of the two chromo- 
somal regions are not accounted for bv the methods used today." Thus, two or 
more additional antigens probably exist at the first site and three or more at the 
second sub loc~~s .  In non-Caucasian races even larger discrepancies in gene . 
frequency remain unresolved (Table 3 ) .  
A third "4a-4b" sublocus has been p r o p ~ s e d , ~  ?'' although the validity of these 
antigens has been questioned by Kissmeyer-Nielsen." Van Rood's original analy- 
ses of gene frequencies"' left no room for additional alleles in this area of the 
chromosome. However. the sum of the 4a and 4b gene frequencies (Te 3 and 
Te 7) in our laboratories was so low that several more alleles could be postulated. 
In addition to undisclosed antigens of the HL-A system, presumably weaker 
alleles at other sites within the same or different chromosomes will undoubtably 
be revealed as the serologic and genetic analyses are refined. In the meanwhile, 
the larger the proportion of unknown to known specificities. the poorer the 
correlation will be between typing and the controllability of rejection after 
human organ transplantation. Any dissociation between the tissue matching and 
the clinical results would be predicted to be greater in nonrelated than in intra- 
family pairs. If a good conformity of the known histocompatibility determi- 
nants exists between consanguineous donors and recipients, the matching of 
many unmeasured antigens may be assumed. since the unknown HL-A factors 
are probably linked closely to the known ones. Xloreover. non-HL-A histocom- 
patibility antigens determined by other loci would tend to be compatible by 
chance, more among related than nonrelated donors. 
An important point to be noted is that unknown antigens can account only 
for the poor outcome of b'matched'' transplants and do not explain "mismatched" 
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Table 3. Phenotype Frequency of HL-A Antigens in a Random Population',' 
ANTIGEhT C A U C A S I A N  x E G R O  O R I E S T A L  
- 
First sublocus 
H L-A 1 29.0 15.6 0 
Second sublocus 
Gene frequencies may be derived from these figures by the formula G = 1 - \ f; f =frequency 
of individuals negative for the determinant. Figures are percentages. 
grafts which appear to succeed. The number of cases in the latter category is 
apt to increase in the future. As new antigens are uncovered, the currently 
matched grafts may fall into the incompatible category. whereas mismatched 
grafts can only be changed to the category of those with a greater degree of 
incompatibility. 
Antigenic Strength 
Until more data become available about the relative strengths of the differ- 
ent antigens, it will not be possible to prognosticate the outcome accurately in 
the presence of incompatibilities of one or more of these determinants. It has 
been established that no single mismatch can cause uniform f a i l ~ r e . ' ~ , ' ~  The
largest reported series with an isolated specificity of mismatch has been of the 
HL-A2 (>lac) antigen. There were 26: recipients of renal homo graft^;?^ seven of 
the 26 had uncontrollable rejection leading to loss of the transplant or death. 
Eleven of the remaining 19 had excellent courses and 10 of these had been 
surviving for more than two years. The other eight patients had either shorter 
or less satisfactory courses but were still alive.'" 
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These observations suggest that the HL-A2 antigen did not always play an  
equivalent role in the severity of the immunologic repudiation. The variability 
could presumably be explained by the effect of other frequently unanalyzable 
factors. including differences in host responsiveness. the presence or absence of 
undetected antigens, and the efficiency with which i~nmunosuppression could 
be delivered. The influence of six other HL-A antigens was also recently studied 
after 147 parent to offspring and 107 sibling renal transplantations. None of the 
determinants was found to be of unique potency."' In fact. if all the specificities 
were pooled so that each one was considered to be roughly equivalent to the 
others and the cases were simply codified as mismatched or matched. then the 
results Tvere almost exactly as found with an even cruder classification in the 
first study of kidney patients in 1964 done on the Denver series of transplanta- 
tions."". " 
The failure in our laboratories"'~ 1 " " 6 ~ ' i  and in those of Payne." van 
Dausset.-i and Amos" to find a single antigen of overriding significance sug- 
gests that the major histocompatibility determinants are all of intermediate 
strength. Eventually. a relative risk factor for each one must be determined." It 
will not be surprising if the most unacceptable situations will involve mis- 
matches with certain special combinations of two or more antigen incompati- 
bili ties. 
CORRELATION OF HISTOCOMPATIBILITY WITH 
OUTCOME AFTER RENAL TRANSPLANTATION 
It is now generally conceded that the extreme view can no longer be sup- 
ported that the HL-A antigens are not histocompatibility determinants. However, 
in view of the many limitations just cited, the question must be raised about the 
advisability of using typing as an important criterion for donor selection. 
The justification for this continued practice comes from the fact that recipi- 
ents of HL-A compatible kidneys have generally fared better clinically than those 
who have not had this a d ~ a n t a g e . ~  I "  I f >  ' ' I  '" ?" " "' Not only has their survival 
been at a higher rate. but they have also had less histopathologic damage to the 
homografts" l 4  as well as better renal function." The most striking benefits of 
compatibility ha1 e seemed to accrue at a considerable time after transplanta- 
tion. Thus. the risk from early homograft repudiation was often not closely 
correlated with the degree of incompatibility. However. with the passage of time, 
a divergence of results became more clear between the matched and mismatched 
cases. 
In the foregoing studies the association of a good or bad match with a favor- 
able or poor clinical result. respectively. was most clear after sibling transplanta- 
tions. The correlation was less complete with parent to offspring combinations. 
In the latter group there was a incongruously large number of good results in the 
face of ad1 erse matching or. conversely. some poor results despite apparently 
satisfactory an t~gen  pairing."' The most likely explanation n-as the genetic basis 
discussed in the preceding section. It xvill be recalled that. according to current 
concepts. a parental donor would always automatically have at least half of the 
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HL-A antigens in common with any offspring. In contrast. the siblings from such 
a union could theoretically share all the antigens with 25 per cent of their mates, 
half the antigens with another 50 per cent. and none at all n-ith the remaining 
25 per cent. Thus, the spectrum with intersibling transplantation could range 
from an essentially perfect match to one equivalent to that obtainable by random 
pairing of nonrelated individuals. 
As might also be predicted, the poorest correlation of all between typing 
analysis and clinical outcome has been in nonrelated transplantations. Never- 
theless. there has been some evidence. albeit as yet equivocal. that donor selec- 
tion on the basis of typing may be of value even under these c i r c u m s t a n ~ e s . ~ ~ , ~ ~  
HISTOCOMPATIBILITY TESTING IN LIVER 
TRANSPLANTATION 
The logistics of obtaining antigen profiles for patients in widely separated 
parts of the country are discussed in Chapters Two and Four. Recipient typing 
has generally been carried out with blood that was shipped to Los Angeles. The 
donors were studied in Denver and. when time permitted, in Los Angeles as well. 
The matching of the donor with the most compatible recipient was facilitated by 
intercity telephone conferences. The efforts at prospective matching were begun 
in 1966 and have continued for all cases to the present time. 
The difficulty of obtaining conformity or compatibility of all measured anti- 
gens can be appreciated by a glance at Table 4. In this analysis 12 histocompati- 
bility groups were taken into consideration. There were 38 prospective liver 
recipients of blood type 0 who were studied in relation to 13 potential hepatic 
donors of the same erythrocyte group; there was a total of 494 possible donor- 
recipient combinations. 
It can be seen (Table 4) that conformity of match (grade A) was present in 
only 0.2 per cent of these donor-recipient pairs and that phenotypic compatibility 
(grade B) pertained in only 5.1 per cent. In most instances, one (20.9 per cent 
grade C) or more (73.9 per cent grade D) HL-A groups were incompatible. Not 
all the recipients were entered simultaneously into the pool of Table 4. In ad- 
dition, no more than one of the donors was ever available at any given time. Con- 
sequently, the actual number of theoretically possible matches was a tiny frac- 
tion of the proposed 494. Furthermore, the actual selectivity ivas even further 
limited by other considerations. These included the clinical condition of the 
donors and the recipients as well as their sizes and ages. The need for a massive 
pool, as has been ad~~ocated  for renal transplantation,'? is evident. 
Detection of Preformed Antibodies 
The ad\-erse effect of pre-existing antibodies upon a transplanted organ for 
which they have an avidity will be discussed in Chapters Fourteen and Nineteen. 
In our laboratory preformed antibodies have been considered to be present if the 
patient's serum caused cytolysis of the lymphocytes of more than four members 
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Table 4. AIatches Obtained Between 13 Prospective Donors and a Pool of 
38 Prospective Recipients 
RECIP.  k. mc ah Lr? t'-- am oc! 00- o? t- m c r ) c " - m ~ - - m C / ) - a - * m c r ) m L n ~ c D  an 
NAME ANTIGEXS d - t\l C'1 t\l 0.1 CJ + CJ 0.1 9 DONORS 
Bel 12,13 D D D D D D D D D D C D D  
Ben 1,2,5 D C D D D C D D B D B C D  
Ble 2,4,9 D D D D D B D D C D B C D  
Bro 2,3,5 D C D D C C D D B D B C D  
Bul 2,6,7,12 D  D  D  D  C  C  D  D  C  D  B  D  C  
Cal  1,7,8 D D D D D D D C D D C D D  
Col 8  D D D D D D D D D D C D D  
Cun 1,4,5,1 1  D C D D D C D D C D C D D  
Dor 2,5,10,11 D  D  D  D  D  C  D  D  B  D  B  C  D  
Dos 1,8,10,12 D  D  D  D  D  D  D  C  D  C  C  D  D  
Fol 1,8,1 1 D D D D D D D C D D C D D  
Ga l  5,12 D D D D D D D D C D C D D  
Gar 3,6,7,8,1 1 C  D  C  D  C  D  D  C  D  D  C  D  C  
Gar 3,5,7,11,12 C  C  D  D  C  D  D  D  C  D  C  D  D  
Gon 1,5,9 D C D D D D D D C D C C D  
Gr i  3,8,12 D D D D D D D C D D C D D  
Har 1,9 D D D D D D D D D D C D D  
Hic 2,3,5,1 1 D C D D C C D D B D B C D  
Joh 2,3,5 D C D D C C D D B D B C D  
Ken 1,7 D D D D D D D D D D C D D  
Kil 3,6,12 D D C D D D D D D D C D D  
Lab 4,10 D D D D D C D D D D C D D  
Lov 2,6,7,8 D D D D D C D D C D B D C  
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Table 4. Matches Obtained Between 13 Prospective Donors and a Pool 
of 38 Prospective Recipients C o n  t 1 1 2  lied I 
- < Ln^  a- LT): " 00- 00: 0:- c- 
RECIP. rn- m- mcr, a n v- v- m L? a* Ln cr, 
~ A M E  ANTIGENS + * a W- a * a * DONORS 
-- 
Mad 4,12 D D D D D C D D D D C D D  
May 1,3,5,6 D B B D D D B C C D C D D  
Mar 2,4 D D D D D A D D C D B D D  
Min 3,7,9,12 D  D  D  D  C  D  D  D  D  D  C  D  D  
Pic 3 D D D D D D D D D D C D D  
Roy 8,9 D D D D D D D D D D C D D  
She 1,2,8,9 D D D D D C D C C D B C D  
Sol 2,6,1O,ll D  D  D  D  D  C  C  D  C  D  B  D  D  
Sta 2,6,7,9,11 D  D  D  D  C  C  D  D  C  D  B  C  C  
Sto 1,7,8 D D D D D D D C D D C D D  
Thu 2,6 D D D D D C D D C D B D D  
Tru 2,5,1 1  D D D D D C D D B D B C D  
Wah 1,2,5 D C D D D C D D B D B C D  
You 3,5,6,8 D C C D D D D C C D C D D  
Zaw 1,6,8,9,12 D  D  C  D  D  D  D  C  D  D  C  D  D  
All donors and recipients Ivere red cell t ~ - p e  0. LIatchillg grades lvere assigned by the following 
criteria: A = identical: B = compatible (donor having no antigens foreign to the recipient): C = in- 
compatible for 1 group: D = incompatible for 2 or more groups. The potential matches totaled 494%, 
of ~ ' ~ h l c h  the f o l l o ~ \ l ~ l g  percentaqes fell into each grade A = 0 2 ' r ,  B = 5 l C c ,  C = 20 g C c .  and D 
= 73 9 ' r  
of a panel of approximately 40 normal blood donors. Of 113 prospective liver 
recipients there Tvere only 12 (10.6 per cent) who had such evidence of presen- 
sitization. The incidence was less than half of that seen in uremic patients under 
consideration for renal transplantation." 
There are two reasonable explanations for the smaller number in the hepatic 
cases. First, the frequency n i th  nhich these patients had been transfused was 
lower. In addition. there mere fener  parous females among the candidates for 
liver transplantation. It could be expected that the rlsk from immediate rejection 
tvould be correspondingly reduced. 
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In kidney transplantation, a very heavy risk of "hyperacute rejection" must 
be accepted if preformed cytotoxins in a recipient can be demonstrated to react 
against the l~~nphocy te s  of the renal donor." So far there have been no hepatic 
transplantations in the Den\ er series in which the recipient had a known posi- 
tive crossmatch with the donor (Table 5). None of the organs which did not func- 
tion well at the outset were thought to have failed because of an accelerated 
rejection. 
Quality of Antigen Matching 
The mismatches found between the recent liver recipients and their donors 
are shown in Table 5. Only three patients were judged to be completely compat- 
ible for all the major groups being tested at the times the operations were per- 
formed. Unfortunately, one of the recipients (OT 18) died after four days of a 
hepatic artery thrombosis. The fate of another one (OT 8), an 18 month old child, 
will be presented in detail in Chapters Fifteen and Seventeen. Here it will only be 
said that the magnitude of rejection did not seem to be particularly great, either 
early or late after transplantation. 
The third patient (OT 16) was thought to have an even better donor. In this 
case there was complete conformity of all nine antigen groups tested, includ- 
ing the six internationally accepted ones of the HL-A system that are listed in 
Table 3.  Nevertheless, an irreversible rejection developed within tmo weeks, 
necessitating retransplantation 68 days after the first operation. The patient was 
mismatched with the second liver donor in two determinants (HL-A5 and HL- 
A6). This homograft also underwent vigorous rejection but it has continued to 
support life for more than nine months. 
In all the other cases mismatches were present of one to three antigen 
groups. The number of observations in patients who survived the immediate 
effects of operation has been too small to permit meaningful correlative studies 
between the degree of compatibility and the ultimate clinical outcome. The 
difficulties of correlation were further compounded by the fact that the intensity 
of immunosuppression was very much less in some of the earlier cases as com- 
pared to the subsequent ones (see differences in Chapters Fourteen and Fifteen). 
Consequently, no statement can be made on the basis of these data at the 
present time, supporting a clear association between the results of any of the 
antigen studies and the clinical events. In Chaper Twenty it will also be noted 
that a decisive relation between donor-recipient compatibility and the histo- 
pathologic findings in the homografts studied to date has yet to be established. 
This does not mean that histocompatibility studies will not be used as 
grounds for recipient selection in future attempts at liver transplantation; the 
converse is true. It has become apparent that the validation of tissue typing 
principles and the improl-ement of the methodologic details for antigen analysis 
cannot be easily achieved by studying the extraordinarily complex cases of hepa- 
tic and cardiac transplantation. For the perfection of typing techniques, con- 
tinued dependence will be necessary on the simpler experimental model of 
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Table 5. Histocompatibility Data for All Liver Transplantations since 
May 21, 1967 
S L  RL-IVIL ( D a y s )  
C R O S S  H L - A  G R O U P  S C l I l I A R Y  
R E C I P I E I \ - T  LI.4TCH 3 I I S 3 I I T C H E S  G R A D E  L I V I N G  D E A D  R E M A R K S  
- 
OT 7 -- HL-A2,HL-A5 D 10 Died o i  unrel ieved hepa tc  nruff iciency 
OT 8 -- None B 400 Died of carcinomatoris 
OT 9 Negative HL-A2 C 133 H a d  septic hepatic infarct iont; d i ed  of 
liver f o ~ l u r e .  
OT 10 - HL.A7,1HL-A6 C 186 H a d  septic hepcltic infarction'; d i ed  of 
liver fa i lu re  
OT 11 Negat ive HL-A2 C 6 1 Died of septic hepatic in iarc t i0n. t  
OT 12 -- HL-A6, HL.A7, Te 1 I D 105 Dled of septc  hepatic in farc t ion. t  
OT 13 -- HL.A8, Te 11 D 41 6 Indolent la te  rejection starting a f ter  6 
months. 
OT 14 -- HL-A2 C 380 Indolent la te  rejection start ing in th i rd  
month. 
OT 15 Negat ive Te 9 C 339 Died of recurrent malignancy. See Chapter 
17 for  details. 
OT 16" Negat ive None A - - Homograft replaced af ter  68 days. 
OT 16" Negative HL-A6,kHL-A5 C 310: Indolent la te  r e e c t ~ o n  
OT 17 - HL-A1 ,HL-A8 D 35 Died of pneumonia 
OT 18 - None B 4 Died of hepatic ar ter ia l  thrombosis. 
OT 19 -- HL.A2,HL-A3,HL.A7 D 254 Normal liver function. 
OT 20 Negative HL-A1 , HL.AZ, HL-A8 D 
OT 21 -- HL-A1, Te 4, Te 9 D 
" 2  Hepatic artery occlusion 
'12 Portal vein thrombosis. 
OT 22 Negative Te 12 C 10 Extrahepatic b i l ia ry  obstruction; infection. 
C 
OT 23 Negative HL-A6 143 Died of recurrent malignancy 
OT 24 Negative HL-A1 C 11 Died of unrel ieved hepatic insufficiency 
OT 25 Negative HL-A7 C 39 Died b i le  fistula 
AT 4 Negative Te 4 C 24 Died of unrel ieved hepatic insufficiency. 
''As of April 1. 1969. 
'Septic hepatic infarction and its relation to rejection are discussed in Chapter F-ifteen. 
T h e  total survival of 310 days includes 68 days after the first transplantation and 243 after 
the second. 
clinical renal transplantation. The lessons learned from these efforts can then 
be generally applied. as has already been done, to the transplantation of other 
organs. 
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Chapter Four 
RECIPIENT SELECTION AND 
P R E P A R A T I O N  
As mentioned in Chapter Two, the availability of a suitable cadaveric organ 
is the central issue in determining whether a liver transplantation of one kind 
or other can be performed for any given patient. The degree to which the liver 
is thought to have been injured by the events of the donor death is one critical 
factor in the decision to proceed. In all recent cases another consideration has 
been to attempt before operation to demonstrate a reasonable histocompatibility 
match between the donor and the recipient (Chapter Three). The logistical 
problems posed by these requirements have been partly ameliorated by the 
creation of an intercity pool of collaborating physicians who care for the prospec- 
tive recipients until shortly before the transplantation. 
LONG DISTANCE EVALUATION 
All the initial steps are carried out by mail or telephone. Much of the neces- 
sary information can be obtained by asking the referring physician to provide 
copies of all operative notes, hospital discharge summaries, and pathologic 
reports and to fill out a short form which contains the following specific 
inquiries : 
Hepat ic  Recip ient  Protocol 
Patient's name 
Date of birth 
Sex 
Height 
Weight 
Pathologic diagnosis 
Previous operations 
Blood type 
3 4 
Clinical condition 
(a) Mental 
(b) Respiratory 
(c) Cardiovascular 
(d) Ascites 
(e) Renal 
(f) Developmental 
status 
Total protein and albumin1 
globulin ratio 
Prothrombin time 
Other associated disorders 
Terasaki antigens 
Parents' name 
Parents' address 
Parents' telephone number 
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The only special effort which is i nvo l~  ed is the drawing of a venous blood 
sample to be analyzed by Dr. Paul Terasaki of Los Angeles for the presence or 
absence of lymphocyte antigen groups (see Chapter Three). The results of the 
latter examination are returned from Terasaki's laboratory within a few days 
,lnd entered on the summary sheet in the patient's file. There is little more to do 
except to wait for a potential donor to appear who has the proper ABO blood 
type, the approximately correct size, and a reasonably compatible profile of 
lymphocyte antigens. These conditions may never be met. in which case the 
transplant candidate usually does not come to Denver. However, if a possible 
donor is found. the prospective recipient is flown from his home city to Colo- 
iado as quickly as possible. The times from notification to arrival in Denver 
have ranged from 20 minutes to 12 hours. 
The system has worked remarkably well as the result of the skill and judg- 
ment of the family physicians who have accepted the responsibility of coordin- 
ating these efforts in different cities. These men have often carried out extra 
diagnostic studies to establish the operability in cases of liver malignancy, or in 
benign disease to rule out abnormalities of extrahepatic organ systems. More- 
over. they have provided careful medical management, including paracenteses 
.~nd  thoracenteses during the waiting period, a task made less futile by the 
possibility of eventually obtaining a new liver. Thus far, we have yet to be 
surprised to meet patients for the first time who had either less or more ad- 
~ a n c e d  illnesses than would have been expected from their physicians' ap- 
praisals. 
Unfortunately, victims of liver disease who are valid candidates for hepatic 
transplantation cannot wait long for the foregoing appropriate donor circum- 
stances. On several occasions, such patients have died a fen7 hours before a 
phone call was placed to ask that they come to Colorado. More than 95 per cent 
of those on the waiting list have succumbed before anything could be done. 
The number of these tragedies will surely be reduced as more centers under- 
take liver transplantation. It should then be possible to exchange patient 
information so that a candidate could be on call from several clinics without 
any preconceived bias about where he would eventually go. An alternative solu- 
tion to that of sending patients to the organ source would be to ship cadaveric 
livers as needed from one city to another. This is not yet practical because of 
the limitations of hepatic preservation techniques. 
EMERGENCY EVALUATION 
The advantage of the foregoing approach is balanced by the very limited 
evaluation which is feasible at the time of admission for transplantation. In  
some of our cases. the recipient arrived after the donor had already died and the 
liver had been removed and placed in a preservation unit (Chapter Five). In 
others, only a few minutes were available for examination of the patient and 
the collection of samples before it was necessary to move to the operating room. 
After a preliminary physical examination, the situation required the mobiliza- 
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tion of a team of specialists n-ho. with the aid of a continuously present mem- 
ber of the transplantation teain, focused their attention upon a number of 
specific questions about the state of the heart, lungs. kidneys, and central 
nervous system, as well as that of the diseased liver. 
Special attention was paid to the cardiorespiratory system, particularly in 
children with biliary atresia. In these cases, the presence of enlarged livers and 
spleens with or without ascites usually caused elevation of the diaphragms and 
compression of the lungs. In addition, all the patients with this diagnosis had 
significant pulmonary arteriovenous shunting. an abnormality which was de- 
tected with arterial blood gas (PO,, pCO,, and pH) s tudies4 .and  which rapidly 
disappeared after successful orthotopic hepatic transplantation." The chest x- 
rays of these children had abnormally prominent hilar shadows (Fig. 6); flu- 
oroscopy usually revealed sluggish but otherwise normal movement of the 
diaphragms. 
In most cases a small catheter was placed into the trachea and used to 
collect samples for bacteriologic and virus cultures. Cultures were also taken 
from the blood, stool, skin, and sputum. The results were never available until 
after the transplantation but they then became indispensable (Chapter Sixteen) 
for the planning of postoperative antibiotic therapy. 
It was also often necessary to proceed without knowing the results of other 
hematologic or biochemical examinations. However, priority was given in the 
laboratory to the hematocrit, white cell count. prothrombin time, blood urea 
nitrogen, serum electrolytes. plasma glucose, and blood pH since each of these 
determinations was used to guide some aspect of the intraoperative care. Extra 
blood, plasma. and urine from both the donor and recipient were stored for less 
urgently needed routine or research studies to be carried out later. A collection 
was always made for confirmatory restudy by Terasaki of the lymphocyte 
antigens. 
Finally, the blood bank was informed of the impending procedure so that 
fresh blood could be drawn for transfusion and for the preparation of platelet 
concentrates. It has been shown that abrupt thrombocytopenia inay follow the 
revascularization of liver homografts in dogs or humans'; in some cases this 
has required prompt therapy. 
THERAPY 
Virtually all liver recipients are poor risks for a major operation, and many 
of those with hepatic failure from benign disease may appear at first evaluation 
to be hopeless. Symptomatic relief may be obtained by the performance of 
paracentesis or thoracentesis. Unfortunately, there is probably little of real 
value that can be done to reduce the consequent operative hazards short of 
providing liver tissue. It has been suggested1 ' that one n-ay of doing this before 
the definiti~ e procedure ax ould be with hepatic support. using an extracorporeal 
heterologous liver. 
Such an approach has not yet been tried. One reason is that even patients 
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! j t  6 The  ches t  x-ra?- of patient OT 10 jus t  before orthotopic traniplantation.  1-ore the  1-ery 
,~ ro in inen t  pulinonar>- x-asculal. markinqs  resultini? f rom arteriox-enous shunt ing.  T h e  osteoporotic 
changes  in  the  bones and  the  elevated d iaphragm seen he re  a r e  also typical f indings i n  t he  child 
11-ith extrahepatic biliar>- atresia. 
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near death from complications of hepatic disease can apparently be brought 
through the transplantation procedure with almost immediate improvement, 
providing the graft functions properly. A good example was patient OT 12 in 
our series (Fig. 4A. Chapter One). 1.r ho was admitted in terminal condition with 
a hepatorenal syndrome ( B U I i  70), a continuously draining peritoneal fistula 
from the site of previous paracentesis. and major hemorrhage from esophageal 
varices which ceased immediately after insertion of the neTv l i ~  er. She returned 
from the operating room in much better condition than she entered it, had 
normal renal function one day later. and was eating within 48 hours. The 
ascitic leak ceased spontaneously a few days later. 
It is possible that one reason for the paradoxical ability of these moribund 
recipients to survive such major surgery is the troublesome operative bleeding 
which is almost invariably encountered and the consequent necessity for major 
blood replacement. The intraoperative exchange transfusions usually given are 
of the magnitude of those which have been reported by Trey, Burns. and Saun- 
ders of Capetowni to be of benefit in acute liver insufficiency. 
Although little can be done for the liver failure. secondary effects on the 
kidneys can be effectively treated. One of our patients who was provided with 
an  auxiliary hepatic homograft (AT 4) had developed the anuria of an advanced 
hepatorenal syndrome with a serum sodium of 104 mEq liter, a potassium of 
6.2 mEq liter, a chloride of 70 mEq~liter and a CO? of 9 mEq~liter.  His blood 
urea nitrogen and creatinine were 140 and 15 mg per cent, respectively. The 
electrolyte disequilibrium was corrected by a four hour hemodialysis, after 
which he tolerated a prolonged transplantation procedure without difficulty 
(Chapter Twenty-two). 
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PART I1 
THE CADAVERIC LIVER 

Chapter Five 
DONOR HEPATECTOMY AND LIVER 
PRESERVATION 
The whole liver can be subjected to severe ischemia under normothermic 
conditions with the expectation of prompt recovery. but only if the insult is of 
very short duration. It has already been emphasized (Chapter Two) that part or 
all of this slender margin of safety may be used up during the terminal hours or 
days of donor life if there is a protracted premortem period of ineffective circu- 
lation. After death, further tissue injury is inevitable. but this can be 
minimized in various ways. 
THE "LIVING CADAVER" 
With the increasing acceptance of irreversible brain injury as sufficient 
justification for the pronouncement of death (Chapter Two). one of the most 
serious problems in liver transplantation will be alleviated. If donor hepatec- 
tomy can be carried out in the presence of an intact and effective circulation, 
the interval of normothermic ischemic injury should be virtually eliminated. 
Under these circumstances, either the donor or the organ. or preferably both, 
can be cooled at some time prior to the completion of the hepatectomy by use of 
the simple techniques that were first employed in canine experiments (see 
later). 
If there is time, it may be desirable to administer to the donor one of the 
drugs which have been said to reduce ischemic injury by stabilizing cell mem- 
l~ranes and thereby preventing the disruption of lysosome envelopes. The agents 
to which this effect has been ascribed include magnesium sulfate, sodium 
fluoride. adrenochrome. adrenocortical steroids. and chlorpromazine.'? l 4  1R,35,36 
EMERGENCY POSTMORTEM MEASURES 
Our experience with lil er procurement under the optimal conditions of a 
continuing donor circulation has been relatively limited. In the orthotopic 
4 1 
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series. for example, brain death (see Chapter Two) was accepted as a basis for 
organ removal only in Cases OT 19 onxvard. Virtually all the donors before this 
time also had cessation of heart beat. 
If cardiac arrest occurs, some perfusion of the l i \er can be restored by the 
immediate institution of cardiac massage. This \ \as carried out in most of our 
early cases. but usually only until effect i~e cooling could be accomplished by 
one of the methods described later. The use of external massage has the specific 
danger that the liver may be lacerated by the forceful compression of the 
xiphisternum."' Minor parenchymal lacerations were found in several of the 
organs used as homografts in our series. In one (OT 16), there were large 
bruises in both lobes at the time of donor hepatectomy. the one on the left side 
being extensive enough to be visible on the first post-transplantation liver 
scans (Fig. 7). 
A much more decisive step than these crude attempts to re-establish a 
circulation is to cool the liver. The extreme sensitivity of hepatic tissue to 
normothermic ischemia was learned by Goodrich and \Velchl' with the earliest 
attempts at  transplantation of the canine liver. In their laboratory experiments, 
in which the timing of donor and recipient operations could be precisely coordin- 
ated and the hepatic blood supply maintained virtually until the moment of 
DAY 1 
Figz1i.e 7 .  .A l i ~ - e r  scan obtained in  patient OT 16, one day after orthotopic homotransplantation. The 
donor had had man>- cardiac arrests.  ~ \ - l ~ i c h  had been treated \\it11 closed chest inassage. At the time 
of donor hepatectom!-. large and small bruises \rere noted in  the  right and  left liver lobes. respec- 
tively. It ~ 7 - a ~  decided to use the damaged orgall. Sore  that the right lobe appears ilorinal but that 
there is a n  area of decreased isotope uprake on the left ' a r ro~vsi .  This abnormality persisted for 
many 11-eeks. 
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homograft excision. livers removed at room temperatures became unsuitable 
for auxiliary transplantation within 20 or 30 minutes. 
It was later found that the permissible time of ischemia was extended 
when the dog livers were cooled, first by the induction of total body hypother- 
mia in the live animal and then by intraportal infusion of the excised liver with 
a chilled (4" C) electrolyte solution at the moment of sacrifice."":" The cooled 
organs could support life if revascularized as orthotopic homografts in recipient 
dogs within two hours. After longer intervals there was a high incidence of 
acute hepatic insufficiency, including a hemorrhagic diathesis and a rapidly 
lethal syndrome termed "outflow block" to which the dog liver is far more 
susceptible than the analogous pig or human organ. When the latter complica- 
tion of ischemia developed, the homograft became engorged.'" The inability of 
the blood to escape from the homograft probably was due to constriction of the 
small intraparenchymal hepatic veins studied by Deysachl" and Thomas and 
Essex.:':' 
The early studies2", :" and the subsequent ones of van Wyk,"-', Ono,"" Fonkals- 
rud,'" and Schalm" and their associates provided ample practical proof that 
the injury which follows the cessation of hepatic circulation is a graded one 
which can be considerably slowed by the immediate institution of hypothermia. 
A quantitative delineation of the protective effect of cooling was added by . 
the biochemical analyses of Sicular and 1Moore.'They showed that the ability 
of dog liver slices to oxidize glucose was lost very rapidly under normothermic 
conditions but, with immediate refrigeration, the same biochemical reaction 
remained relatively intact for a number of hours. 
Infusion Technique 
The objective of rapidly cooling human cadaveric livers can be accom- 
plished with a modification of the simple technique of intraportal infusion used 
in dogs. It is convenient to enter the splanchnic venous circulation through the 
superior mesenteric vein since this vessel can be easily and rapidly cannulated 
at the base of the transverse mesocolon (Fig. 8). There is another advantage. 
The required dissection, which must often be carried out in haste, is kept away 
from the structures of the portal triad, which can subsequently be skeletonized 
more deliberately and with less risk of injury. 
During intraportal infusion of one liter of a lactated Ringer's solution at 
4" C,  the core temperatures of dog livers fall to about 15" C within two or three 
minutes. Rewarming at room temperature occurs slowly." making it unneces- 
sary to resort to other chilling devices during the actual transplantation (Fig. 9). 
The constituents of the buffered infusate presently used clinically are 
shown in Figure 8. The low molecular weight dextran is included in the hope 
that its oncotic properties will reduce edema. As the cold solution passes into 
the liver, incisions are made in either the suprahepatic or infrahepatic inferior 
vena cava to permit egress of the fluid after it has passed through the sinu- 
soidal bed. The gallbladder is opened at the same time and bile vigorously 
flushed out (Fig. 8). In the dog, failure to observe the latter precaution may lead 
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Caanula in sm.Y 
Figure  8.  Core cooling of a cadaveric liver by intraportal infusion of a cold solution. The technique 
can be used as a n  emergency measure if the donor circulation has ceased. Alternatively, it can be 
used as  the last step before hepatectorny if death has been certified on the basis of irreversible brain 
injury in a patient who still has a heart beat. The cannula is placed into the readily accessible superior 
mesenteric 1-ein. This vessel is far enough away from the portal triad so that the portal vein. which 
will ultimately be used for anastomosis. is not in danger of injury. Egress of the perfusion fluid is 
pro!-ided b?- the \.enorom> in the sup~~thepa t ic  inferior 1-ena c a l  a.  Bile is 11-ashed fl.om the qallbladder 
through the cholecystotomy. (By permission of Ann. Surg. 168 :392, 1968.) 
to autolysis and later sloughing of the mucosa. As soon as these steps have been 
completed, removal of the cooled liver is begun. 
Several cadaveric homografts which were protected solely by this kind of 
hypothermic perfusion provided good early function (OT 9 and 18: AT 2) 
although one iOT 6) did not: Calne.' Birtch.? and n'ajarian2-i have also obtained 
satisfactory short term preservation in the same nay.  The greatest disadvan- 
tage of the method when used alone is the time limitation, estimated at two to 
three hours, within n hich re\ ascularization should be conlpleted in the human 
recipient. Consequent1~-. hypothermic infusion has most commonl~ been used 
as the first stage in more extended preservation by the ex vi\-o perfusion tech- 
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MINUTES AFTER REMOVAL OF PERFUSED LIVER 
Figure 9. Rewarming curve of the interior of a dog liver xvhich had been cooled to 16" C by intra- 
portal infusion of 1 liter of chilled (4" C) lactated Ringer's solution. Note the very slow rise in  the core 
temperature. (By permission of Surg. Gynec. Obstet. 1 1  1 :733. 1960.) 
nique to be described later, or as the last step before removal of the organ in 
cases in which donor life was said to have terminated on the basis of brain 
death. 
Cadaveric Perfusion 
An alternative and, in many respects, a more complete measure in cases in 
which there is no circulation is that of cadaveric perfusion with a heart lung 
machine.'" ?" " As quickly as possible after cardiac arrest. cannulas are in- 
serted into the aorta and abdominal vena cava via the femoral vessels. Circula- 
tion is instituted through a bubble oxygenator and pump system which has 
been primed with a cold heparin-containing electrolyte or glucose solution and 
which has a heat exchanger incorporated into the circuit. The whole cadaver 
can be thereby simultaneously perfused and cooled, or the perfusion can be 
confined to the loaver half of the body if the thoracic aorta is cross clamped 
(Fig. 10). The method has been used for donors from two to 73 years of age. 
The flow rates used during cadaveric perfusion in adults are usually started 
at about 35 ml kg min. The resultant arterial blood pressure is very low, ordi- 
narily less than 20 m m  Hg: efforts to drive this up with greater perfusion are 
usually unaTailing and may be harmful. hlarchiorol" ?" found that to increase 
the blood pressure to 50 to 70 mm Hg in dog cadaa ers. flow rates per kg of as 
much as 600 ml per minute were required, often resulting in acute sn  elling or 
even rupture of the visceral organs. 
In spite of the loas floavs, cooling of the human cadaver is quite rapid (Fig. 
1 I), the core temperature usually falling to 13  or 20- C within 15 to 30 minutes. 
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Figzc1.e 10. Technique of extracorporeal perfusion with a heart-lung machine. Catheters are in- 
serted via the femoral vessels into the aorta and vena cava as soon as  possible after death. The extra- 
corporeal circuit is primed with a glucose or electrolyte solution to which procaine and heparin are 
added. The cadax-er is thus anticoagulated xvith the first surge of the pump. Temperature control is 
provided b?- the heat exchanger. Cross clamping the thoracic aorta limits perfusion to the lower 
part of the bod?-. 
- .  
With deepening hypothermia. the perfusion rate i s  reduced even further,  
sometimes to as little as 5 to 10 ml  kg. At this stage the best clue that there is 
overperfusion is the gross finding of venous hypertension, particularly of the 
portal vein. If appropriate flow adjustments are not made. dissection of the 
portal triad becomes extremely bloody and difficult. 
The technique of cadaveric perfusion as a sole method of liver preservation 
was studied in dogs by nlarchioro.l" ?'I who instituted the artificial circulation 
from a few moments to 22 minutes after death from a massive overdose of 
pentobarbitol. A protectis-e effect was demonstrable. Livers removed more than 
eight hours after donor sacrifice and transplanted as orthotopic homografts 
supported recipient life for short intervals. However. all the animals had severe 
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i1.e 1 1 .  Temperature and flow changes during extracorporeal perfusion of an 83 kg adult male 
)r lvho died of an acute brain injury. IVhen the esopha~ea l  temperature begins to fall rapidly. the 
usion rates are a l~rays  reduced. In this case (OT 17). 86 minutes were required to remove the 
,. to n.ash it free of blood and to place it in the preserl-ation chamber. The homograft was ulti- 
:1y relascularized in the recipient six hours and 40 minutes after donor death. It functioned 
, 
90 
hepatic injury and died within five days. Mikaeloff and Kestens and their asso- 
ciates2' used a similar principle, in which hypothermic perfusion in situ was 
limited to the isolated dog liver and was instituted at the moment of death 
rather than at some time afterward as in Marchioro's experiments. Their 
method permitted good preservation for as long as six and a half hours. Some of 
the canine recipients of these organs, which were placed as orthotopic 
homografts, survived for weeks or months. 
In several of our early clinical trials (OT 1 to 5 and A T  1). whole cadaver 
perfusion was employed as the definiti~ e technique of preservation. The livers 
suffered variable ischemic injury as judged by their function in the recipient 
after postmortem intervals of 152 to 420 minutes. In these cases. which will be 
considered in detail in the next chapter. the poor quality of the homografts was 
almost certainly due to unwise donor selection rather than to any inherent 
deficiency of the hypothermic cadaveric perfusion. More recentl?, the same 
method has been used as a temporary protective device in both adult (OT 14, 
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15, 17. 22. and 23) and child (OT 16. 19. 20. 21. and 24) donors and it is now 
thought to be the preferred technique of preservation to be used until the liver 
can be remo\ ed from the cadaver. At this time the organ can be transplanted at 
once if the recipient is ready or. alternatively. it can be placed in the kind of 
conservation unit described later in this chapter. 
In most of the recent cases in nhich irreversible brain injury was used as 
the final criterion of death. the donors had some circulation when dissection of 
the liver was begun. Almost invariably there was deterioration of the cardiody- 
namic situation while manipulation continued. As soon as this was observed, 
the cardiocirculatory bypass was started and maintained until completion of the 
hepatectomy. 
DONOR HEPATECTOMY 
Extirpation of the liver can be completed within 15 or 20 minutes if neces- 
sary. However. about an  hour is required if the major hilar contents are to be 
carefully dissected. if all potential bleeding sites are to be ligated, and if long 
vascular cuffs are to be developed for later anastomosis. In donors who have no 
heart beat. the use of cadaver perfusion, as described previously, allows time 
for the more deliberate approach. 
Figure 12. Tctal abdominal incision (A) used to 
expose and remove the liver from a cadaveric 
donor. The lateral extensions (B) are usually 
made. In addition. one or both hemithoraces can 
be opened. 
DONOR HEPATECTOMY AND LIVER PRESERVATION / 49 
Preliminary Steps 
Good exposure is provided with a long midline abdominal incision with or 
without extensions laterally (Fig. 12) or into one or both hemithoraces. The 
Ligaments attaching the liver to the diaphragm are incised, leaving as much 
length as possible with the specimen to facilitate later resuture to the same 
structures in the recipient. The falciform and left triangular ligaments are cut 
first, beginning peripherally where their two component leaves are fused (Fig. 
13), and continuing centrally to where the leaves separate. enclosing a portion 
of the raw area of the liver. The left main hepatic and left phrenic veins can 
then be seen entering the suprahepatic vena cava (Fig. 14). These tributaries 
must not be injured. 
The Vena Cava 
Next, the anterior leaf of the right triangular and coronary ligaments is 
incised (Fig. 15) and the major raw area on the right is entered, as the liver is 
retracted up and toward the left (Fig. 16). This plane should be developed with 
1 n 
l e f t  
I i g. 
Figzcre 13 ,  initial steps in hepatic homograft removal. Note that the ligaments are incised as  far 
away from the Liver as possible so that they can be later resutured to the companion structures in the 
recipient. 
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Figure  14. Exposure and initial dissection of the suprahepatic vena cava and its tributaries. This 
J is done by entering the raw area formed by divergence of the leaves of the falciform and triangular 
ligaments. A short segment of the left hepatic 1-ein (L.H.Lr.) is usually seen first. 
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Figure  15.  Incision of the right triangular ligament and the anterior leaf of 
ligament. 
the right coronary 
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R.H.V. 
/ Figure 16. Retraction of the liver to the left. The bare area of the right hepatic lobe has been opened, 
exposing the adrenal gland. The right adrenal vein is ligated and divided. This is usually the only 
posterior tributary to the retrohepatic vena cava. At this stage of the dissection the right hepatic 
vein (R.H.V.) can be identified. 
sharp dissection: otherwise, injury to the hepatic capsule is apt to occur. With 
each scissors cut the right lobe can be more completely elevated until the right 
adrenal gland is fully displayed, as well as the short right adrenal vein, which is 
Ligated and divided (Fig. 16). Since the right adrenal vein is ordinarily the only 
posterior tributary to the retrohepatic vena cava. it is usually possible after 
dividing it to freely pass a finger behind the liver and vena cava all the way 
from the diaphragm to the level of the renal veins (Fig. 17). If anomalous small 
venous branches to the vena cava are encountered with this maneuver, they 
are also sacrificed. 
Attention is then returned to the inferior vena tala n-hich is between the 
dome of the liver and the diaphragm. This short segment of vessel is actually a 
confluence of the right and left (and often middle) hepatic leins n i th  the vena 
cava (Fig. 18. inset). The resulting cloaca is used for anastomosis in the re- 
cipient. The eventual task is made much easier xvith each millimeter of added 
length that is retained with the specimen. Extra tissue can be obtained ante- 
riorly and posteriorly by dissecting off the diaphragmatic reflection and laterally 
by ligating and dividing one or two phrenic veins on each side (Fig. 18). 
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Index f inger R. H.V. 
F i g u r e  17. Sweeping behind the retrohepatic rena  cava with a dissecting finger. This should be 
possible from the diaphragm to the renal reins. If resistance is encountered, it usually indicates 
the presence of extra branches which must be ligated and divided. R.a.v. -ligated right adrenal vein. 
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Diaphragm 
F i g u r e  18.  Dissection above the liver. A .  Development of suprahepatic vena caval cuff. At this stage 
-J it is desirable to ligate and divide one or more phrenic veins on each side. The latter step is not manda- 
tory but it allows the mobilization of a longer segment for subsequent anasroinosis. Extra length 
can also be obtained b>- dissecting off the diaphragmatic reflection, as is being shoxvn. B .  Cross sec- 
tional appearance of the venous confluence abox-e the liver as it is seen from above. The cloaca is 
formed by the junction of the right and left hepatic veins with the inferior vena cava. 
The P o r t a l  T r i a d  
Continuous downward traction is maintained on the duodenum. Dissection 
is kept as inferior as possible. The common bile duct is first transected low in 
its course. The incised upper end should be inspected to make sure that a single 
lumen is present; it can then be permanently ligated if biliary reconstruction is 
to be with cholecystoduodenostomy. If this is the plan. an additional safeguard 
is to introduce fluid into the gallbladder to make sure it distends the common 
duct. Failure to observe one or both of these precautions in the presence of 
undiagnosed anomalies of the homograft extrahepatic ducts has led to total 
biliary obstruction (Chapter Kine). 
The right gastric and gastroduodenal branches of the common hepatic ar- 
tery are next identified. doubly ligated, and divided (Fig. 19A). It is then pos- 
Figure  19. Dissection of the portal triad. A .  The  common duc t  and  the  gastroduodenal and  right 
gastric arteries are  tied off and divided. Before ligation of the  common duct .  it should be determined 
that it communicates  freel>- ~ i t h  the gallbladder via the  cystic duct (see text). If  anomalies are  pres- 
ent.  failure to observe these precautions may lead to accidental bile duct  obstruction (see Chapters 
Eight and Nine).  B. The hepatic artery has  been mobilized f a r  enough so that the anterior surface of 
the portal vein is uncox-ered. The  coronar>- x-ein entering the left side of the portal t runk is  almost 
aln-a)-s found:  this tributary is ligated and dix-ided. C.  The portal vein has  been freed and the  celiac 
axis mobilized. The splellic arter?- has  not yet been ligated and dix-ided. \Then the  lix-er is  r e m o ~ - e d .  
all the celiac axis is  usually retained \\-it11 the specimen and.  i n  children. it ma>- be advisable to in- 
clude a segment  of aorta a s  well ;see Figure 20;. 55 
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sible with blunt dissection to approach the portal vein anteriorly just where it 
emerges from beneath the neck of the pancreas (Fig. 19B). In the exposed 
segment of the portal vein, the left gastric (coronary) vein invariably enters on 
the left lateral aspect (Fig. 19B). This tributary is freed, doubly ligated. and cut 
in order to prevent its subsequent injury. One or txvo other variable branches 
often have to be similarly dealt with, after which the main portal trunk is 
encircled. At this stage. the tissues posterior to the portal triad are carefully 
examined. If an anomalous right hepatic artery emanating from the superior 
mesenteric artery is present it will usually be in this location and can be traced 
back to its origin. 
Thus far in the dissection no deliberate effort will have been made to iso- 
late the main hepatic artery. Honever. it ~vill  usually have been seen in the 
process of ligating its right gastric and gastroduodenal branches. If not. it now 
can be easily found to run almost directly left and at a right angle to the axis of 
the portal triad (Fig. 19). 
Having identified the major structures, the rest of the dissection is simple 
since all that is necessary is to ligate and divide the intervening tissues. always 
taking care to stay inferior to the common hepatic artery. As the latter vessel is 
liberated toward its origin. the left gastric and splenic arteries are ligated and 
divided. In adults (Fig. 19C), enough celiac axis can be freed from within the 
lesser omental sac to receive the perfusion cannula used for the interim preser- 
vation to be described later and have plenty left for anastomosis in the 
recipient. 
Aortic Dissection 
When it is planned to perfuse the liver of an  infant or child, it is frequently 
desirable to remove a piece of aorta in continuity with the celiac axis. This can 
best be done by lifting the spleen and left transverse colon into the wound (Fig. 
20) ,  opening the plane between the pancreas and left kidney, dividing the left 
renal vein, and incising the crura of the diaphragm. In the usual case the 
exposed aortic branches are ligated and cut except for the celiac axis, permit- 
ting the doubly transected aorta to be drawn into the lesser omental sac. When 
part of the hepatic arterial supply originates from the superior mesenteric ar- 
tery, the latter vessel can also be retained with the specimen so that rearterializa- 
tion can later be accomplished with a single aorto-aortic anastomosis (Chap- 
ter Eight. Fig. 52C). After removal of the specimen the cannula used for arterial 
perfusion is tied into one end of the aortic segment and the other end is ligated. 
Final Steps 
If a perfusion catheter has not already been placed in the superior mesen- 
teric vein this is now inserted below the transverse mesocolon (Fig. 8). The 
neck of the pancreas is cut across, the splenic vein and other venous tributaries 
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Figzi7.e 20. Mobilization of the aorta during donor hepatectomy. Rapid identification and ligation of 
the branches is facilitated if variable traction is applied to the distal aorta. During the initial dis- 
section. all the aortic branches except the celiac axis and superior mesenteric artery are ligated and 
divided: the latter vessel is cut only after it has been sho1r.11 not to give rise to an anomalous hepatic 
arterial branch. A segment of aorta is ordinarily removed only ~ v h e n  the donor is an infant. (By 
permission of Ann. Surg. 168:392. 1968.) 
to the portal system at this level are ligated and divided. and the mesenteric 
vein and its indwelling cannula are completely freed and delivered through the 
transverse mesocolon. The liver is now ready for removal except for incision of 
the avascular upper part of the gastrohepatic ligament and the vena cava above 
and below the liver. 
In the transection of the suprahepatic vena cal-a, all possible length is 
retained. Efforts at complete transection with one movement of a scissors are 
very apt to cause serious distortion, as well as sacrifice of posterior wall length. 
It is safest to first make a small incision in the presenting anterior surface of 
the vessel (Fig. 21A). into which one blade of the scissors is inserted. The cut is 
extended to include the anterior half of the circumference. The posterior wall is 
then incised from within the vessel (Fig. 21B). Next the infrahepatic 1-ena cava 
is cut across just abo1-e the renal veins. The organ can be immediately trans- 
planted if the recipient is ready or, alternatively, transferred to a preservation 
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F i g u ~ e  21. Formation of the supra- 
hepatic cuff. A. An incision is made 
in the anterior wall as high as pos- 
sible. B .  This is carried around to the 
back wall. taking pains to retain 
B. maximum length. The internal ap- 
pearance of the transected specimen 
is shown in Figure 18B. 
apparatus if there is to be a significant delay before the anastomoses can be 
started. 
If extended preservation is required, the cooled liver is again washed free 
of blood after its removal by a final infusion of both the portal and arterial 
systems with the cold solution shown in Figure 8. The fluid used is a balanced 
electrolyte solution to which low molecular weight dextran is added and of 
which the pH is adjusted to 7.45. The bloodless organ is then transferred to a 
preservation chamber. 
Until now there has been only one experimental technique for preserving 
the excised canine liver which has permitted the successful use of the organs 
as orthotopic homografts after much longer than two hours. The method was 
reported by Brettschneider et a1 in 1967' and was promptly applied clinically as 
will be described later. 
In some ways the bottleneck posed for a long time by the inability to 
develop effective means of hepatic preservation was surprising since ex vivo 
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techniques had been used to study hepatic physiology for almost four decades, 
at first by use of very crude mealis of perfusion. If'ith attention to the control 
of pH, temperature, and other physiologic ~ar iab les  and with perfusion of both 
arterial and portal venous systems, later investigators were able to demonstrate 
I iability and several kinds of function of canine.'. porcine." and bovineqivers 
for many hours or days after their removal; the literature on this subject has 
been summarized by O'Donnell and Schiff.?' The abilit) of these organs to 
extract metabolites from the perfusate or even to carry on complicated func- 
tions of synthesis was deceptively encouraging in view of the later difficulties 
encountered with the more stringent system of testing by transplantation. It 
eventually became clear that the retention of measurable function by an iso- 
I lated perfused liver was no indication of its capacity to support life. 
The Preservation Unit  
The technique of ex vivo perfusion developed by Brettschneider et a13a4 
employs a combination of hypothermia, hyperbaric oxygenation, and perfusion 
with diluted blood. The design of the unit permits gas sterilization of all the 
~nterior parts with ethylene oxide (Fig. 22) and continuous refrigeration at 4" C. 
One of these chambers is kept ready for use in each of the three major hospitals 
of the University of Colorado complex. 
When it is known that a liver may soon become available, a unit of blood is 
drawn from a volunteer who has the same ABO type and who is compatible by 
direct crossmatching with the prospective cadaveric donor. The homologous 
blood is added to an equal volume of balanced electrolyte solution which con- 
tains 10 mg per cent heparin. 5 gm per cent low molecular weight dextran, 150 
mg per cent glucose, 0.2 mEq per 100 ml magnesium sulfate and 5 mg per cent 
procaine. The mixture, which is buffered to pH 7.4. is slowly recirculated 
during the waiting period to ensure oxygenation and cooling to about 4" C. The 
diluted blood passes through pumps that are externally located. Inside the 
chamber, transit is through glass wool filters, a simple baffle oxygenator, and a 
reservoir. When the homograft arrives. it is interposed in the system by placing 
it in a receptacle and connecting the portal and arterial cannulas to the perfu- 
sion nozzles (Fig. 22). Outflow from the organ is by gravity drainage. 
Flow 
The blood flow delivered to the human homografts was 6 to 12 mllgm liver 
tissue per hour. divided in a 4: 1 portal venouslhepatic arterial ratio. The pumps 
were preset at  approximately the correct rate by estimating the liver to be 2.7 
per cent of the body weight of the donor. Thus, a 70 kg man would be predicted 
to have a 1890 gm liver. which would require perfusion at 11.34-22.68 
liters hour or 189-378 ml minute. The final decision to use a greater or smaller 
Bethlehem Corporation. Bethlehem. Pennsyl~ania. 
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Figzire 22. Preservation unit. The perfusion pumps are located outside the hyperbaric chamber; 
the organ receptacle. the oxygenator. and the 1-enous reservoir are inside. The various chamber in- 
lets permit sampling of the perfusate. gas sterilization. and oxygen delivery and removal. The 
temperature is electronicall>- controlled. (By per~nission of Surg. Gynec. Obstet. 126:263,  1968.) 
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flow was based upon the gross appearance of the organ. The slightest sugges- 
tlon of swelling was an indication to perfuse more slonly. 
The conditions of optimum flow I\ ere worked out by Brettschneider' -' with 
canine lil ers and applied directl! to human organs. In the dog experiments it 
na s  possible to quickly ruin homografts ni th  o\ erperfusion. On the other hand, 
a reduction of perfusion to 3 ml gm tissue hour also had an adverse effect upon 
the quality of the organs as judged by their later performance after orthotopic 
transplantation. 
Compression and Decompression 
Oxygen compression of 40 pounds per square inch pressure (PSIG) was 
reached within 20 minutes after insertion of the human organs into the cold 
chamber and institution of perfusion. At the end of residence in the chamber 
and in preparation for delivery of the livers to the recipient room, graded de- 
compression was begun and completed in 26 to 46 minutes. In dogs it has been 
noted that gas emboli may develop within hepatic grafts preserved for 10 to 15 
hours if decompression is carried out in less than 30 minu te sL4  The human 
livers. which were kept in the hyperbaric chamber for shorter periods (one to 
four hours). did not develop this complication. 
Final Washing 
Before transfer of the homografts to the recipient room, both arterial and 
venous systems are again flushed with the balanced electrolyte solution as 
shown in Figure 8. This step may be unnecessary, but it has practical advan- 
tages. First, the bloodless homograft is easier to work with as the various anas- 
tomoses are performed. Second, it would be possible to easily detect air emboli 
in the event of too rapid decompression. Finally, it may be desirable to rid the 
graft of blood which has been recirculated in an extracorporeal system for some 
hours. especially because of the finding of Joseph'" that the effluent of pre- 
served canine livers often contains a vasodepressor substance that can cause 
shock or even sudden death. 
limitations of the Method 
The effectiveness of the foregoing technique of ex vivo preservation was 
studied precisely in dogs with use of livers which had sustained little or no 
injury at the time of their insertion into the preservation unit." This was 
possible because the organs had a good blood supply until the moment of their 
removal and because they lvere immediately cooled thereafter. 
Under such circumstances, the livers al~vays provided life sustaining func- 
tion when transplanted to mongrel recipients as orthotopic homografts fol- 
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F i g u r e  23.  The course of a dog which r e c e i ~ e d  an orthotopic liver homograft that had been pre- 
served for more than 24 hour\. The sudden early rises in serum tra~lsaminases \\-ere due to ischemic 
injury. The animal did not become jaundiced for 10 da>-s and then developed chronic lolv grade 
hyperbilirubinemia. I~nlnunosuppression xsas discontinued after four months. Death from hepatic 
failure followed t ~ v o  weeks later. (By permission of Appleton-Century-Crofts. Inc.. 1968.) 
IMMUNOSUPPRESSION 
DISCONTINUED 
- 
2 s 
I3 
2 i5 
- 
lowing eight to 12 hours residence in the chamber. After 24 hours two of five 
preserved organs had been so badly injured that the recipients did not survive 
operation; in the three other one-day experiments, survival was eight to 128 
days (Fig. 23) before eventual death from rejection. All efforts to extend the 
conservation time to two days in either dogs or pigs with this or modified 
techniques have thus far failed.& " " 
Since cadal eric human livers do not begin their postmortem interval in a 
comparably uninjured state. it is not possible to say if the results of the canine 
investigations are completely applicable in a clinical setting. It is clear, 
however. that conservation of human livers in a highly satisfactory condition is 
possible for at least seven or eight hours since this has now been accomplished 
on several  occasion^.^ 
Efforts a t  Simplification of Liver Preservation 
In canine experiments. systematic variations from the method used clini- 
cally were evaluated in order to determine which details of technique were 
important and xvhich were nonessential. The quality of the homografts was 
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found to deteriorate with reduction or elimination of perfusion. the omission of 
hyperbaric oxygenation or hppotherinia. or elimination of blood from the 
perfusate.' 
The need for holnologous blood in  the perfusiiig fluid was exainiiied with 
special care in canine studies because of the associated inconvenience and 
potential dangers of a blood system. Unfortunately. it m-as found that the use of 
several substitute acellular solutions did not provide as  good results. These 
included low molecular weight dextran perf us ate^.^ diluted or full strength 
:I" undiluted plasma from which the lipoprotein flocculate had been 
rernoved"~ described by Belzer.' and heinoglobin  solution^.^ 
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Chapter Six 
CONSEQUENCES OF HEPATIC 
ISCHEMIA 
I11 almost all the first unsuccessful attempts at liver transplantation, poor 
initial function of seriously damaged homografts played an  important or 
decisive role in the early fatal outcome. Even in the later cases in which ex- 
tended survival was finally achieved, some element of hepatic malfunction in  
the early postoperative period jeopardized convalescence to a variable degree at 
a time before rejection had begun. This was a reflection of the combined injury 
incurred in the terminal phases of donor life. during the normothern~ic post- 
~nortem "dead time," and in the subsequent interval when active efforts were 
I~eing made to cool and preserve the liver. 
An analysis of the effect of these nonimmunologic factors upon the be- 
havior of liver homografts and their new hosts can most accurately be done with 
cases of orthotopic transplantatioii since, after this operation, the life of the 
recipient is both immediately and completely dependent on the transplanted 
liver. Consequently. the followiiig remarks will be based on observations made 
in dogs and patients after li\-er replacement. Undoubtedly the conclusions ap- 
ply to auxiliary homografts ivhich, ho.ivever. \rill not be mentioned further here 
I see Chapter Twenty-two) since their function cannot be so precisely followed. 
THE INJURED LIVER IN DOGS 
With paired organs such as the kidney, the degree to which ischemic tissue 
damage adversely influences either short or long term function can be investi- 
gated in the absence of an immunologic barrier since autografts can be used in  
testing. For livers. this approach is not feasible inasmuch as the test organ 
cannot be remol-ed, leaving the host in an anhepatic state for some hours, and 
[lien returned with much hope of survival even with a perfectly preserved 
organ: the problem is not dissimilar to that posed by the e\-aluation of heart 
preser\-ation by cardiac autotransplantation. Fortunately. \,er)- clear informa- 
tion has come from canine eqperinients with orthotopic hepatic homotrans- 
ldantation. 
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Minor Damage 
In Chapters Eleven and Twelve the postoperative course will be described 
which can be expected with orthotopic transplantations performed in dogs and 
pigs under ideal conditions. In such experiments livers are removed from 
cooled living donors, chilled further by immediate intraportal infusion of a cold 
solution, and revascularized in the recipient as quickly as possible. The interval 
of hypothermic ischemia is seldom much more than an hour. 
Abnormalities in the hepatic function of the recipient animal are trivial 
during the first few postoperative days. or may even be undetectable. There is 
no intraoperative bleeding diathesis or hypoglycemia. The animals awaken 
promptly from anesthesia, and can often eat by the following morning. Protein 
synthesis is normal or supernormal for at least several days. Commonly, the 
only detectable abnormalities in the liver function tests are minor and quickly 
reversible increases in the serum transaminases (Fig. 24). The animals usually 
remain in good health until the onset of rejection, which almost never is 
evident until the third or fourth day in untreated dogs; if immunosuppression 
is provided, many such animals live for a long time (Chapter Twelve). Com- 
parably perfect organs can probably never be expected in clinical liver 
transplantation. 
Massive Injury 
At the other end of the spectrum is liver damage of such magnitude that 
survival through the operation is not possible. As mentioned in the preceding 
chapter, the recipient dogs die within a few hours of acute hepatic insuffi- 
ciency (including hypoglycemia), uncontrollable bleeding, and "outflow 
block." 
Moderate or Serious Injury 
Between the extremes there is a syndrome of hepatic damage which is of 
the utmost importance since many or most of its elements have been seen in 
virtually every case of clinical liver transplantation. Its features were most 
clearly delineated during efforts to develop useful methods of organ conserva- 
tion?--' when all gradations of liver injury were caused. depending on the effec- 
tiveness of the method being tested and the duration of its use. The most 
precise information came from the studies of Brettschneider.' ' with ex vivo 
preservation for eight to 24 hours. 
Many of the recipients of these preserved organs were able to survive 
operation. However. hemorrhage was a difficult problem. even after conserva- 
tion for as short a period as eight hours under conditions nhich yielded good 
enough results to ultimately warrant clinical application. Typically. bleeding 
could be controlled on11 n-ith extraordinary mechanical efforts at hemostasis. 
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F I ~  2 P a t t e n ~ s  of hepatic in~jur>- in  two does follon-i~lg orthotopic l~on~otransplantation. Note 
that there TI ere allnost no changes of SGOT and bilirubin in the recipient of an immediately cooled 
and transplanted orqan: the hypothermic ischemia was 55 minutes. 111 contrast. acute rises of 
SGOT and serum bilirubin occurred after transplantation of a lix-er obtained from .I cadax-eric canine 
donor.. 111 the latter e x p e r i m e ~ ~ t .  the donor dog IT-as killed with :in overdose of anesthesia and total 
body hypot11er.mic perf'usion was started five minutes later.4 The time from death to homograft 
re \~ascular izat io~~ in the recipient Ivas 140 minutes. Postoperatively. both doss \yere treated with 
arathiopr.ine. (B? permission of Surgery 54900. 1963.) 
multiple blood transfusions, and often the admillistration of clot-promoting 
agents such as epsilon aminocaproic acid (EACA) and protarnine sulfate. The 
responsible clotting defecti has been shown to be a complex disorder (Chapter 
Ten) and one which is rapidly reversible providing the extent of liver damage is 
not too great. 
In such experiments the control of bleeding was only the first step in care. 
Intensive therapy was usually required with electrolyte solutions or plasma, 
apparently because of the development of a third fluid space not olilp within the 
abdomen where ascites formed and fluid was sequestered in the intestine in 
I 
proportion to the degree of liver injury, but also in tlie peripheral tissues where 
edema was commonly noted. At this time and during the ensuing two or three 
days there were sharp falls in the concentrations of plasma proteins (Fig. 25). 
A11 interesting study was performed by Kashiwagi on a number of these 
animals.' \\'hen damaged homografts were transplanted. he often found strik- 
ing changes in the serum protein constituents in that discrete fractions were 
found to have completely disappeared. The result was the development of a 
"stripped tree" appearance of the recipient serum as 1 iewed with immunoelec- 
trophoresis (Fig. 26). The abnormalities were totally reversible if the hepatic 
nljury avas moderate: when it was severe. the missing immuno-electrophoretic 
l~ands tended to return. but neLer completely to normal. hloreover. the latter 
animals were never able to eat and died in spite of treatment 1s ith immunosup- 
pression within a week or 10 dais as the consequence of wasting. infection. or 
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TIME IN DAYS 
F i g z ~ ~ e  25. The circulating plasma proteins in canine recipients of orthotopically placed preserved 
livers. In all series of experiments there bvas a prompt decrease in  plasma protein concentration. 
The hypoproteinemia was more profound and sustained in the experimental groups in which low 
flow liver perfusion (3 ml 100 gm hepatic tissue per hour) was used during conservation than when 
the flow rate was doubled. (Bl- permission of Surg. Gynec. Obstet. 126:263 .  1968.) 
other complications. In such experiments the aftereffects of ischemia in com- 
bination with an  unanalyzable further immunologic injury to the homografts 
apparently precluded more than temporary survival. At autopsy. the pre- 
dominant histologic features were those of healing parenchymal necrosis 
rather than rejection. 
It is of interest that the acute disturbances of protein metabolism were not 
necessarily accompanied by comparably severe abnormalities in all other 
measures of liver function. In this kind of unsatisfactory preservation experi- 
ment, early hyperbilirubinemia was common (Fig. 24). but a surprising number 
of the animals dled without ever becoming jaundiced. Transient increases in 
transaminases were invariably seen after operation. In most. there was some 
evidence of multlple gastrointestinal ulcerations by the time of autopsy, and 
often these acute lesions were the immediate cause of death by ~ i r t u e  of their 
perforation or hemorrhage. 
These larious obserlations had an important influence on the standards 
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Fiqur.e 26. Changes  seen by immunoelectrophoresis i n  t he  s e rum protein of a 
dog which received :r dan~agecl 1i1 e r  liomo.:raft. S o r e  t he  early postoperative 
disappearance of several  precipit:<tion b,indi including ceruloplaslnin (C,,), 
alpha:,,,. alpha., , beta,  ,. qanlni,i\,. cinti q,rmiiia,. These  ~ l ~ n o r ~ n ~ z l i t i e s  n-ere 
totally re\-ersible if the  l~epat ic  l ~ l j ~ ~ r y  r r ' i i  ~ n o d e ~ . ~ ~ t e .  i t  [lie dami1qe rr,is severe,  
as i n  this case.  the  electrol~horetic b,inds tendecl to r r t u rn .  but ilex-er com- 
pletely to normal.  ( B y  permission of Surgery 63:247. 1968.) 
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imposed upon the method of ex vivo preservation finally accepted for clinical 
use in many of our later cases. The ability of a conserved organ to support life 
during and for a few days after operation was not enough. It was necessary to 
demonstrate long term survival in canine recipients treated with immuno- 
suppression. This was achieved in our laboratories by Brettschneider using 
livers that had been kept in good condition for eight or 10 hours by the tech- 
nique described in Chapter Five. with about the same consistency as was pos- 
sible with immediately cooled and transplanted homografts.? Furthermore. 
chronic survival was obtained in some experiments in which the homografts 
were stored for more than 24 hours before transplantation (Fig. 23. Chapter 5). 
HOMOGRAFT INJURY IN MAN 
In the clinical orthotopic liver transplantations (Table 6), there were exam- 
ples of hopelessly, severely. moderately, and minimally damaged homografts. 
As a group, the worst organs were those which were used early in our ex- 
perience. The donors in the later transplantations were far more carefully 
selected. They were younger. had shorter terminal illnesses, and maintained 
more effective circulation until almost the moment of death. Moreover, the 
warm ischemia times of the organs were very short. Finally, the development 
of an  effective technique for more extended preservation (Chapter Five) made 
it possible to keep some of the excised livers in good condition for several hours 
until the recipient operation had been brought to the appropriate stage. 
Hopeless In jury 
One recipient (OT I), a 36 month old child with biliary atresia, failed to 
survive operation. The donor in this case was a three year old boy who had died 
during the attempted extirpation of a tumor of the diencephalon. External and 
internal cardiac massage were carried out for 45 minutes before death was 
pronounced. Fifteen minutes later extracorporeal cadaveric perfusion and 
cooling were instituted and continued for almost four hours; the liver was 
finally revascularized in the recipient patient 420 minutes after the cardiac 
arrest. 
A hemorrhagic diathesis ensued. leading to death in four hours. Massive 
fibrinolysis was demonstrated." which was not controlled by treatment with 
EACA, fresh blood. and fibrinogen (Chapter Ten). At autopsy, the liver was 
almost entirely necrotic (Chapter Twenty). 
Massive Injury 
In two other cases (OT 6 and 7), there was probably never any hope for 
recovery in view of the widespread hepatic necrosis found histologically in the 
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autopsy specimens seven and 10 days later. respectively. The older of these 
pLitiei~ts (OT 6). whose diagnosis was hepatoma. n-as 29 years old. He received 
the liver of a 73 year old man who had died 10 hours after suffering a massive 
The donor was in agonal condition with no detectable blood pressure for 
lljlle hours before death. The liver was cooled by intraportal infusion after a 
lr.;lrin ischemic period of four ininutes and Lvas re\-ascularized 148 minutes 
later (Table 6). Within less than an hour, a hemorrhagic diathesis was manifest, 
necessitating transfusion with 12.500 in1 fresh blood during the 14 hour opera- 
tion. Hemostasis was improved but not completely obtained after 0.9 gmlkg 
EXCA and 16 gnl human fibrinogen were given intravenously. At re-explora- 
tion 48 hours later three liters of blood were evacuated and residual diffuse 
bleeding lvas controlled mechanically. Four days after transplantation. reopera- 
tion again became necessary to suture ligate an arterial bleeder in the anas- 
tomotic line of the cholecystoduodenostomy; it was not clear if this was due to 
a technical error or acute peptic ulceration. Transfusions in the seven post- 
operative days totalled 22.000 ml. 
After transplantation. the patient was alert for one and a half days, but then 
became mentally obtunded and, finally. comatose. Serial determinations of 
liver chemistries showed grave derangements from the beginning. The serum 
bilirubin rose from 0.7 to 8.7 mg per cent within 48 hours and continued to 
increase until the time of death after seven days (Fig. 27); the conjugated 
component was always less than half the total. The typical acute rise and fall of 
the serum transaminases were observed (Fig. 27). The Quick prothrombin time 
fell to 20 per cent and remained fixed at about that level. Plasma fibrinogen 
ranged from 140 to 190 mg per cent. Plasma albumin levels Lvere maintained 
itit11 frequent infusions of concentrated human albumin. totalling 325 gm in 
the seven postoperative da-ys. That hypoglycemia was not observed may have 
been due to coilstant glucose infusion. Interpretation of any of the liver 
chemistry determinations was made inexact by the multiple transfusions of 
fresh blood given daily. 
I11 this case the development of a large third fluid space was evident from 
the beginning. Ascites accumulated rapidly at the same time as anasarca was 
diagnosed. Hyperaldosteronisn was apparently not responsible since urine so- 
dium concentrations Tvere ne\-er lower than 40 and Lvere usually 80 to 105 
nlEq liter; urinary output ranged from 1265 to 2020 ml day until the last day of 
life. During the first two days. intravenous therapy with noncolloid solutions 
T~as limited to 1200 ml over the total output. Later, as inilch as 6000 ml in 
excess of the measurable loss was required to prevent hypotension. Ultimately, 
the BUN (Fig. 27) and creatinine began to increase. the serum sodium rose to 
160 mEq liter, fluid retention became so extreme that the facial features of the 
Patient were scarcely recognizable, and he died with massil-e pulmonary 
edema. At autopsy. other findings included bilateral pleural effusions. massive 
ascites. and acute renal tubular necrosis. The septic coinplications in this case 
and the pathologic changes in the hoinograft are considered separately in Chap- 
ters Sixteen and Tn-enty. 
The other patient (OT 7) was an 11 month old boy n-ith biliary atresia. The 
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F i g u ~ e  27.  The clinical course of a patient (OT 6) who received a massively damaged homograft. 
The two re-explorations Xvere for the control of hemorrhage. Note the ma~lifold evidence of poor 
liver function. The output figures are the total of urine volume plus gastric aspirate and stool. The 
intake is the total of electrolyte solutions and colloids, including blood. 
liver was from a 12 month old girl with a diagnosis of microcephaly who died 
48 hours after aspirating a feeding and having a cardiac arrest at  a domiciliary 
home. The donor was in agonal condition for the last 14 hours of life with no 
detectable blood pressure. Liver cooling by infusion through the superior 
mesenteric vein was started 14 minutes after death. The hepatectomy was 
completed in 60 minutes, and the liver then perfused for 240 minutes in the 
hyperbaric preservation chamber. The time from death to revascularization in 
the recipient was 371 minutes. Complete hemostasis n-as obtained within one 
and a quarter hours. Blood transfusion to the 5 k g  recipient was 300 ml. 
Bleeding did not subsequently occur although all the liver-based clotting fac- 
tors fell to less than 10 per cent of normal n-ithin one day (Fig. 69. Chapter Ten). 
Immediately after operation the serum bilirubin, which had been 10.9 mg 
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per cent, was 4.7 mg per cent. The change was apparently due to exchange 
tralisfusion during operation since the bilirubin then began an  inexorable rise 
(Fig. 28). The postoperative increases in SGOT (to 6700 units) and SGPT (maxi- 
mum 1280 units) were the greatest in  our experience xvith the exception of a 
czje (OT 18) in which there was hepatic artery thrombosis (Chapter Nine). 
hl~iintenance of total serum proteins required the infusion of 85 gm of albumin 
d l i~ ing  the 10 days of postoperatil-e life. 
Uiine output was from 115 to 300 ml day. with a sod iu~n  concentration of 5 
to JO rnEq liter. Azotemia did not develop. Intravenous fluids were designed to 
kc>ep the child relatively dry with minimal weight gain (Fig. 28). Nevertheless, 
ascites. which eventually prompted repeated paracenteses, became evident at  
the end of the first week. The patient became comatose and hypotensive and 
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died 10 days after transplantation. During life, there were three bouts of 
hypoglycemia. all occurring after the temporary accidental cessation of intra- 
venous glucose infusion. The plasma blood sugars at these times were 5,27,  and 
58 mg per cent. 
At autopsy the vessels entering and leaving the liver were patent. However, 
there were large grossly necrotic portions of the liver, especially near the sur- 
face. The jejunum had sloughing mucosa, although gastrointestinal hemor- 
rhage had not occurred. The cause of death was acute liver failure. Histologically 
there was evidence in the homograft of both ischemic damage and severe acute 
rejection (Chapter Twenty). 
Serious Injury 
The homografts of four patients (OT 2 to 5) had early changes in liver 
chemistries as  severe as those described in the previous section. However, at 
least some of the abnormalities had already reached a maximum and were 
receding at the time of death 22, 7l12, 6l12, and 23 days post-transplantation, 
respectively. 
The normothermic "dead times" (Table 6) in the four cases were 5, 6, 4, 
and 4 minutes, respectively, after which extracorporeal cadaveric perfusion 
was instituted for 75, 104, 89, and 77 minutes, as described in Chapter Five. 
The total times from donor deaths to revascularization of the homografts in the 
recipients were 152, 192, 176, and 164 minutes. 
Paradoxically, the longest surviving patient (OT 5) was the one with the 
least satisfactory early function. She had a hepatoma and was not jaundiced 
before operation. Within four days afterward, her serum bilirubin had risen to 
45 mg per cent. By this time her prothrombin time had declined to 20 per cent. 
Total plasma proteins and the constituent fractions. including albumin and 
fibrinogen. had fallen drastically (Fig. 29). 
A week later the jaundice slowly began to subside. She began to eat. 
Although ascites developed, there still appeared to be hope for recovery. On the 
17th postoperative day she exhibited sudden signs of peritonitis and died a 
week later. At autopsy the choledochocholedochostomy was found to be dis- 
rupted as a result of necrosis of the homograft common duct. Terminally, she 
had pronounced fluid retention as 1% ell as a major gastrointestinal hemorrhage. 
The other three patients survived for 6 l 2  (OT 4). 7l2  (OT 3). and 22 days 
(OT 2), and died of multiple causes. Striking increases in serum transaminases 
had occurred shortly after operation follo~ved by a transient and reversible 
jaundice (Fig. 30). The direct or contributory cause of death in each instance 
was multiple pulmonary embolization. The three patients also had terminal 
gastrointestinal hemorrhage: two had sepsis. In one (OT 2) the abdomen was 
., completely free of ascites at  the time of autopsy. 
3 ,  \, --* , The pathologic features of all four homografts are described in Chapter 
Twenty. There was little e ~ i d e n c e  of homograft rejection in the specimens. The 
predominant histologic findings were those of fresh or healing ischemic 
damage. 
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F i c j u r r  29. T h e  course  of a patient (OT 3 )  ~ v h o  received a homograf't tha t  had been seriously in-  
, j u ~ e d  by iscllemia. 111 spite of the  1.er.y poor initial hepatic f'ullction, the  recipient rrm,lilled i n  good 
( otidition unti l  t he  de \  e lo l~men t  of 11ili:~rv perito~li t is  011 the  se\ enteenth  yostoperati\ e day. Surx-ival 
,i\ for 23 days. 
Moderate or Minimal Injury 
Whereas all the patients treated with orthotopic homotransplantation up  to 
LIav of 1967 received badly damaged livers. each of the subsequent recipients 
( O T  8 to 24) was given a11 initially satisfactory organ. Fil-e of the patients died 
11 ithin the first two postoperative weeks, but the failures were due to technical 
col~lplications (OT 18. 20, 21. 22. 24). 
The livers in all the later cases were obtained from donors who had had 
1.t:latively brief terminal diseases and in whom an eff'ective circulation was 
1:laintained until shortly before death (Table 6). Liver cooling was instituted 
rthin less than fil-e minutes after the cessation of an adequate circulation by 
one of the two methods described in the preceding chapter. After cooling and 
extirpation. the organs were immediately transplanted or they were maintained 
i l l  the hyperbaric preservation unit. The times from donor death to revasculari- 
i ~ t i o n  in  the recipient raliged from 170 to 431 minutes (Table 6). I11 the cases 
111 which the technique for extended preservation 17-as used the recipient opera- 
tion was not begun until the homograft had already been remol-ed and evalu- 
ated while it Tvas being perfused in the cold hyperbaric chamber. 
As in tlie earlier cases. colltrol of hemorrhage was often difficult, as can be 
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Figzi7.e 30. The course of the first patient (OT 2) who survived the operation of orthotopic liver 
transplantation. The indication for the procedure was hepatoma. The donor had a lingering terminal 
course caused by a glioblastolna multiforme. After death cardiopulmonary bl-pass was instituted 
(see text). The homograft apparently suffered a serious ischemic i~ljur!-. but one that was reversible. 
The immediate cause of death of the recipient was massive pulmonary embolization. At autopsy the 
homograft appeared grossly to be in  good condition; ascites was not present. 
appreciated by reviewing the magnitudes of intraoperative transfusions 
required (Table 6). However, hemostasis was obtained in all but two of the 
recipients (OT 8 and OT 17) without the administration of thrombogenic 
agents. 
On the day following operation there were always sharp rises in the trans- 
aminases which quickly returned tonard normal (Figs. 31 and 32): these were 
generally of the same magnitude as in the more seriously injured grafts 
described in the preceding section. In contrast. however, there was effective 
bilirubin clearance. Recipients who were jaundiced before operation had imme- 
diate improvement which was sustained until the subsequent onset of rejection 
(Fig. 32). Those patients without pre-existing hyperbilirubinemia maintained 
low values (Fig. 31) for at least several days. 
The recipients who did not suffer technical complications convalesced 
surprisingly rapidly and after two or three days usually did not appear to be ill. 
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Fiyu1.e 31. The course of a 16 year old girl (OT 14) who receiled the lix-er of a 27 year old adult 
niale. The indication for oper;~tion xi-as hepatoma. After the donor had ,I cardiac arrest. cardiopul- 
monary bypass tvas instituted xshile hel~atectomy was carried out. The lit-er tvas the11 preserved by 
perfusion in a cold 11~-perbaric oxygen cllarnber. The time from donor death to re\-ascularizatiol of 
tile li\.er in the recipient n-:is Inore than sex-en '~nd  a half' hours. Adequate initial function \ \ a s  ob- 
tallled and continued until the onset of' rejection on the sixth postoperati\ e day. Despite the acute 
hy~~ol~roteinemia.  there was little tendenc> to fluid accurnul:<tion. The ~xrtient is still e nlore than 
a year after the transplantation. 
Nevertheless. other measures of liver function were always demonstrably ab- 
normal in one or more ways. I11 every case a decline in serum protein concen- 
tration was ncted similar to that described in the patients n7ho received less 
adequately preserved organs. The falls were sometimes extreme (Fig. 32). Con- 
comitant fluid retention including ascites was variable at this time. There were 
also depressions of the liver-based clotting factors (Chapter Ten). These 
changes lvere relatil-ely transient. Within a few days a brisk diuresis ensued, 
and the temporarily depressed protein fractions returned toward normal and 
Il.ere usually very m-ell maintained el-en after the onset of subsequent rejection. 
The presence of less than perfect hepatic function during the initial stages of 
convalescence governed a number of specific details of postoperative manage- 
ment. These will be mentioned in Chapter Nine. 
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Figure  32. The early course of patient OT 10 after orthotopic hepatic transplantation. The liver was 
cooled by intraportal infusions six minutes after death was pronounced on the basis of cardiac arrest. 
The organ was then excised and placed in a hyperbaric conservation unit. The time from death to 
homograft revascularization was 271 minutes. Although the liver sustained a highly significant 
ischemic injury, it provided adequate initial function and cleared the pre-existing h>-perbiliru- 
binemia. Kevertheless. there was x-ery pronounced hypoproteinemia. Ascites dex-eloped \I-hich re- 
solved as  the serum protein values subsequently improved. The child developed partial gangrene of 
the right liver lobe one month after operation (see Chapter Fifteen) and eventually died more than 
six months after the transplantation. 
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Chapter Seven 
ANESTHESIA AND INTRAOPERATIVE 
CARE d ? q ~ h  S 3 - - / / (  
b y  J .  Antonio Aldrete, M.S . ,  M.D. 
The use of anesthesia for liver transplantation is complicated for reasons 
other than the fact that the operations tend to be long and difficult and at- 
tended with major blood loss. First, all commonly used anesthetics are at least 
partially metabolized by the liver; moreover, even those given by inhalation 
have intermittently been suspected of modifying hepatic blood flow or pro- 
ducing liver injury. Second, hemodynamic changes are caused during the or- 
thotopic operations since the inferior vena cava and the portal vein must tem- 
porarily be cross clamped during the anhepatic phase. Finally, the procedure 
causes major derangements in a number of metabolic processes, including 
those of blood sugar control and acid-base balance. In this chapter, the 
foregoing problems will first be considered individually; then the actual 
anesthetic methods and the techniques of early postoperative care will be 
described. 
P 
THE EFFECT OF THE LIVER O N  ANESTHESIA 
The role of the liver in the detoxification of anesthetic and related drugs 
has been summarized in the recent review by Greene.j8 At least some of the 
1-ery detailed information about the metabolic pathways of the various agents is 
derived from laboratory experiments that may not be applicable to humans. 
This is because enzyme representation and activity may be radically different 
from one species to another. The problem is not different from that discussed 
in Chapter Thirteen in relation to the toxicity of azathioprine in dogs as com- 
Pared to humans. 
Even within a species, there may be great \-ariability in the efficiency with 
'vhich anesthetic agents are eliminated. One of the factors with immediate 
significance in liver transplantation is that of age, since many potential recipi- 
8 3 
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ents are infants or very small children. Moreover, one of the most available 
sources of homografts could be the population of infants born with fatal con- 
genital defects. A l i ~ e r  from just such a donor was used in one of our adult 
patients as an auxiliary organ. 
In Chapter Twenty-two the limitations of homograft function which might 
be anticipated with physiologically immature organs will be discussed as they 
would be predicted to be expressed in defective bilirubin excretion. This is one 
detail of fetal and newborn hepatic function that has been well studied. Uridine 
diphosphogalactose (UDPG) dehydrogenase and glucuronyl transferase en- 
zymes, upon which bilirubin metabolism is partially dependent, are deficient at 
birth.-" 
The extent to which newborn or young livers cannot be expected for simi- 
lar reasons to normally detoxify a wide variety of drugs used in the practice 
of anesthesia can only be speculated upon at the moment in the face of insuffi- 
cient information on this important subject. It is of interest that at least one 
anesthetic agent. phenobarbital. can actually help to eliminate bilirubin at this 
age, apparently by stimulation of the quantitatively subnormal hepatic micro- 
soma1 enzymes."' 
A host of other factors. independent of age. can introduce intraspecies vari- 
ations in the rate of anesthetic metabolism. These include the degree of pre- 
existing hepatic or renal disease. the route of administration. total cardiac out- 
put or regional blood flow. body temperature, and acid-base balance. 
Intravenous Anesthetics 
There are few parenterally administered anesthetics in common use today 
that are not transformed in the liver in the course of their elimination. Conse- 
quently, these agents must be used with exceptional caution in cases of liver 
transplantation. 
Barbiturates. In older pharmacology texts correlations were often made be- 
tween the duration of action of the various barbiturates and the organ systems 
responsible for their degradation or excretion. Thus, detoxification of the short 
acting barbiturates was declared hepatic dependent. whereas drugs with a long 
effect were said to be predominant15 eliminated by the kidney. In actuality the 
duration of action depends primarily on the distribution and binding of the drug. 
rather than upon its degradation."' ' I  ' In the long run most barbiturates are either 
destroyed in the liler or conjugated there en route to their ultimate metabolic 
pathways. Presumably. hepatic microsomal enzymes play the crucial role; this 
has been particularly well documented with thiopental. hexobarbital and 
pentobarbital." 
The practical importance of this seemingly academic distinction is that 
poor liver function n-ill predictably enhance the pharmacologic effect of any of 
the barbiturate drugs. This is a well accepted clinical generalization. It has also 
been proved in animals subjected to lix er injury by means of chloroform inhala- 
tion,lO'' hepatic dearterialization."' and other techniques.'" 
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Narcotics. The same precautions pertain with the use of many narcotics. For 
example, one of the detoxification pathways of the mild and relatively safe 
analgesic codeine, is by demethylation in the liver and conversion into mor- 
phine." The X-demethylating enzyme is microsomal and requires nicotinamide 
adenine dinucleotide phosphate (NADPH) and oxygen; the 0-demethylating 
enzyme has a different cellular origin. The end product conjugates with glucu- 
ronic acid and is excreted in the bile." Some reabsorption occurs, but the 
majority of the glucuronide is eliminated in the urine.' 
Liver metabolism also plays an important role in the detoxification of 
papaverine. heroin, meperidine hydrochloride (Demerol), methadone, methyldi- 
hydromorphinone (Metopon). fentanyl (Sublimaze), and the narcotic antagonist 
n<~lorphine (Nalline). 
Other drugs. Ti'vo very short acting and apparently nontoxic agents will be 
mentioned here because of their potentially great value in permitting short 
procedures to be carried out in transplant recipients. One, CI-581::, has already 
been employed by us on a number of occasions. An intramuscular or intrave- 
nous injection renders the patient almost immediately lightly unconscious. The 
sivallowing, respiratory, gag, and cough reflexes are completely retained. The 
effect lasts for about 10 minutes, long enough to carry out short procedures or 
complicated dressings. The metabolic pathways of this agent are not known, 
although its oxidation and demethylation probably occur in the liverG30 
Nevertheless, we have not observed any unusual prolongation of effect in our 
transplant recipients. 
We have not had experience with the other drug. propanidid (Epontol), 
which has been receiving widespread trials in Europe.:':' The unique advantage 
of'its intravenous use is that the conversion from an anesthetized to a fullyawake 
state can be made within a few minutes after discontinuation of administra- 
tion. The means by which propanidid is detoxified have not yet been fully 
clarified, although one mechanism is apparently the splitting of its side chains 
by hepatic e ~ t e r a s e . ~ ~  
inhalation Anesthetics 
With the exception of trichloroethylene (Trilene), all gaseous and volatile 
agents used as anesthetics were considered until recently to be biologically 
inert. In 1964. Van Dyke. Chenoweth and Van PoznakI4' indicated that other 
~olat i le  anesthetics also undergo biotransformation. The other inhalation 
ayents which have either been proved or suspected to undergo chemical reac- 
t~ons  include the hydrocarbons. cyclopropane and ethylene. the ethers, and the 
h,llogenated hydrocarbons." Both the liver and the kidney appear to participate 
ill the process. 
For example, the inhalation of radioactive diethyl ether has been noted to 
lead to urinary excretion of the specific carbon label. With similar techniques 
blomine and chlorine isotopes can be found in the urine after the administra- 
2-Orthochlorophenvl. 2 meth~lamino  cvclohexanone HC1 or Ketalar. 
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tion of chloroform, trichloroethylene, halothane, and t r ichl~roethanol .~~'  It has 
been assumed that all these anesthetics undergo an enzymatic cleavage in 
hepatocytes before the degradation products are cleared by the kidney, em- 
phasizing again the primordial role that the liver plays with almost all anesthetic 
agents. 
Muscle Relaxants 
It is highly desirable to have adequate muscle relaxation during liver 
transplantation. especially to facilitate the demanding dissections and the vas- 
cular anastomoses that must be carried out at certain phases of the procedure. 
The problem is how to achieve this without paying the penalty of a later pro- 
longed apnea. In planning the administration of paralyzing drugs, it is neces- 
sary to have some idea of the mechanism of their removal. With all the agents 
under discussion, there are two main routes of elimination, renal and hepatic. 
These organ systems contribute in variable proportions to the disposition of the 
different compounds. 
Depolarizing agents. Succinyldicholine, which acts by depolarizing striated 
muscle fibers, is hydrolyzed in the serum by pseudocholinesterase (serum 
cholinesterase), an enzyme which is synt; ;zed and released by the liver. The 
hydrolysis takes place in two phases. First, succinyldicholine is rapidly broken 
into succinylmonocholine and choline. Then, in a slower reaction. succinyl- 
monocholine is further degraded into choline and succinic acid." 
Defective inactivation of succinylcholine would be anticipated if serum 
cholinesterase levels were lowered for any reason. The anticipated association 
of an  increased duration of action with depression of the enzyme has been 
noted with severe chronic liver disease,"' after the administration of AB-132 for 
cancer chemotherapy,I4" during organic phosphate i n t o ~ i c a t i o n . ' ~ ~ n   neonate^,^' 
in women at term pregnan~y."~  arid after the indiscriminate use of a variety of 
common "" 
Decamethonium, a muscle relaxant which is generally used in Great 
Britain and some of the Commonwealth Nations, is thought to be metabolically 
inert. It is mostly excreted by the kidney unchanged.lU4 
Nondepolarizing Agents. Whereas succinylcholine is exclusively dependent 
upon a liver-produced enzyme for detoxification, the nondepolarizing agents 
have alternative pathways of elimination. Kalo1v7' has described three phases in 
the metabolism of tubocurarine. First, there is passage into the interstitial 
space. Then. part of the drug is excreted unchanged in the urine, while the 
other major fraction passes into muscle cells. Finally, the intracellular portion 
is destroyed by enzyme action. 
Cohen and his  associate^^^ showed in normal dogs that almost 90 per cent 
of a dose of tubocurarine was recoverable in the urine: the rest appeared in the 
bile. H o ~ v e ~  r. the biliary component was increased from less than 10 to almost 
40 per cent by the simple expedient of ligating the renal vessels. IIoreover. 
Churchill-Davidson et al" pro1 ided evidence that the same kind of physiologic 
adjustment probably applies in humans. by demonstrating a prompt recol ery 
from paralyzing doses of tubocuraline in anephric patients. A reasonable con- 
clusion is that curare is ordinarily not significantly processed through the lil er, 
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but that this organ can promptly assume an increased burden of excretion in 
the face of renal failure. 
Gallamine (Flaxedil) is one of the most useful muscle relaxants in a case of 
l i ~  er transplantation which is not complicated by pre-existing kidney damage. 
There is much evidence that its elimination is almost entirely dependent on 
adequate renal function.yi 
local Anesthetics 
A discussion on the metabolic fate of these substances must begin by stating 
that the route of administration and the rate of absorption are more important 
111 determining toxicity than the mechanism of degradation. In a text on hepatic 
tl,lnsplantation it is equally important to note at the outset that the detoxification 
of all the locally used anesthetics is liver dependent in one way or another. In 
one class of agents, which includes procaine, tetracaine, chloroprocaine and 
p~perocaine, the breakdown is by the same hydrolytic process described earlier 
for suc~inylcholine.~'  It follows that patients with deficient pseudocholines- 
te~ase  as a result of liver failure should be given these substances with caution. 
The same applies to a second category of drugs that includes lidocaine, 
mepivacaine, prilocaine, and dibucaine. These drugs are all thought to be 
drqraded primarily in the liver by hepatic microsomes. The agent among those 
llited which has been most extensively studied is lidocaine.'ji It is of interest 
tllat a case of central nervous system irritation has been reported in a cirrhotic 
patient receiving conventional doses of intravenous lidocaine for treatment of 
cardiac arrhythmias.lJh 
Miscellaneous Agents 
Chloral hydrate,"-' tribromoethanol (Avertin),'%nd glutethimide ( D ~ r i d e n ) ' ~ ~  
depend almost entirely upon the liver for detoxification; the commonly used 
tranquilizers do so less ~ompletely. '~ 
It would serve no purpose to make a longer list to demonstrate that very 
few drugs used in anesthesia do not have at least a partial hepatic pathway of 
metabolism. The way in which this fact influenced the anesthetic techniques 
for recipients of liver homografts will be discussed later. 
THE EFFECT OF ANESTHESIA ON THE LIVER 
The planning of anesthesia for hepatic transplantation must take into ac- 
count the fact that two livers are involved in the course of a single operation. 
The first is the recipient organ which is almost always the site of chronic 
disease. The second is a homograft which is invariably injured to some extent 
as the result of acute ischemia. 
Many of the things that can be done to avoid the aggravation of the 
resulting potentially dangerous situation have little to do with the wise choice 
or proper administration of specific anesthetic agents. An example would be 
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the scrupulous maintenance of an adequate blood volume. When hemorrhage 
occurs, many investigators have reported very sharp declines in hepatic arterial 
and especially in portal venous blood f l o ~ . ~ ~ .  I"" The changes, which are usually 
ascribed to splanchnic vasoconstriction, are rapidly reversed by giving blood 
transfusions. 
Even a low blood pressure in the presence of normal blood volume may 
have a deleterious effect. Histopathologic evidence of liver injury has been 
reported after attempts to produce "controlled hypotension" with total spinal 
anesthesia"' or the administration of ganglionic blocking agents.'", 12: The value 
of hypothermia in preventing the adverse effects either of hypovolemia or hypo- 
tension or both" will not be discussed here since it was taken up in connec- 
tion with organ preservation in Chapter Five. 
~~~h hypoxip .  11;. ' 29  and hypercarbia":' "'3 ""have been demonstrated in 
well-controlled animal experiments to be capable of causing severe liver injury. 
Fisher et aP7 showed in dogs that significant decreases occurred in hepatic 
arterial flow when arterial saturations of less than 50 per cent were induced by 
the breathing of hypoxic gas mixtures. Under similar conditions Leevy et alx3 
were able to document the development of a hepatic oxygen debt. 
The safety with which anesthetic drugs can be administered, if other condi- 
tions are optimal, has been particularly well documented by the investigations 
by Burdette. Stevens and Groschel." They studied histologic sections, hippuric 
acid clearance. ammonia-transfer enzyme activity, and oxygen consumption in 
liver slices taken from normal patients and from patients with pre-existing 
liver disease. There were no changes with the use of various premedications or 
anesthetic agents. 
Nevertheless, numerous drugs are capable of producing hepatic injury. 
Among these it is important to distinguish between the agents that cause a 
direct injury to the liver and those which are apparently responsible for delayed 
sensitization reactions.'":' 
The anesthetics which are "directly" hepatotoxic inflict an injury upon the 
cellular membranes of the hepatocytes, some of which undergo necrosis. The 
damage is most heavily concentrated in the centrilobular or periportal zones 
and is not accompanied by prominent leukocyte infiltration. Fat accumulation 
is common in the cells which do not die, probably as a consequence of the block 
of triglyceride transport. The clinical features are quite diagnostic. The in,jury 
occurs in essentially all the individuals of the species tested, develops within 24 
to 48 hours, is dose related. and is frequently associated with renal failure.'" 
Classic examples of hepatotoxic agents are carbon tetrachloride and 
phosphorus. 
In contrast, the drugs which cause liver injury by a process of sensitization 
have a highly unpredictable effect from individual to individual and do not 
necessarily cause injury in proportion to the quantities given. The areas of liver 
necrosis. which are usually less extensive, have the hallmarks of an inflamma- 
tory response. An even more characteristic lesion is intrahepatic cholestasis. A 
toxic reaction essentially riel-er occurs n-ith the first dose. Finally, many of the 
clinical manifestations such as arthralgias, skin rashes. and eosinophilia are 
highly suggestive of an immunologic reaction.;; 
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Intravenous Anesthetics 
In man there is little reason to fear that conventional doses of barbiturates 
have a deleterious effect. Hyperglycemia has been reported during thiopental 
narcosis, presumably because of accelerated hepatic glycogenolysis.'" 
In animals overdoses of various barbiturates can produce transient depres- 
sion of liver function, including the ability to excrete bromsulphalein'; 14' or to 
clear endogenous bilirubin. With thiopental the sensitility to a given dose is 
increased after s t a r v a t i ~ n . ~ ~  Another kind of alteration was shown by Bloxam,14 
it110 found that pentobarbital and thiopental inhibited the synthesis of amino 
acids by perfused rat livers. 
Inhalation Anesthetics 
The first detailed case report of a fatal outcome after the administration of 
an anesthetic was written by Guthrie in 1894."" four year old boy died 30 
hours after a chloroform anesthetic that had lasted one hour. At autopsy there 
were findings of acute liver necrosis accompanied by intense fatty degener- 
ation. Since then innumerable reports have appeared indicting first one agent 
a ~ l d  then another as the cause for this kind of complication. ?'he supporting 
e\.idence has often been scanty. In the following remarks attention will be 
directed only to the most widely used inhalation anesthetics or to those which 
h i i ~ e  been most suspected of causing hepatic injury. 
Allegedly Dangerous Agents. It is not surprising that chloroform is hepa- 
totoxic in view of its structural similarity to carbon tetrachloride. There is no 
point in reviewing the large and generally unfavorable literature concerning 
liver complications after the administration of this agent, other than to note in 
passing that a few groups10X still believe it to be safe when given properly. In  
spite of the latter claims, chloroform has been noted to impair oxygen utiliza- 
tion by isolated perfused l i ~ e r s . ' ; ' ~  In tissue culture it can readily damage hepa- 
tocytes, especially if the nutrient medium is deprived of amino acids.::; 
The other halogenated hydrocarbons, halothane (Fluothanej and methoxy- 
flurane (Penthrane). produce similar but far less severe changes in laboratory 
animals.:'Vn general. the liver injury is aggravated by other adverse circum- 
stances such as dietary deficiencies, infection. pregnancy, arterial hypotension, 
hypoxia, and hypercarbia. The damage can be minimized or avoided by the 
coincident use of hypothermia. high oxygen tensions. amino acid infusion. res- 
erpine. and sympathetic blockade.hb 
Extrapolation to clinical anesthesia of the aforementioned animal experi- 
ments with halothane and methoxyflurane has resulted in large scale contro- 
1-ersy. With both agents there have been reports of necrosis of the human 
liver,". 23. 4 2  I;;. 7 . .  I44  more frequently with halothane probably because it has 
been used far more extensis-ely. As a result of these publications neither 
anesthetic was administered to the liver transplant recipients. 
Avoidance of these inhalation anesthetics will probably be continued for 
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future cases. Nevertheless, this precaution may be largely without scientific 
basis. Cases of massive liver necrosis attributable to halothane anesthesia are 
probably rare: an incidence of only one in 300,000 halothane anesthetics has 
been reported.lJh The same general conclusion was reached recently by a study 
group of the National Academy of Sciences.':'The evidence has been that most 
well documented instances of liver injury following the use of halothane may 
be through a mechanism of repeated exposure to this agent and immunologic 
sensitization.ii. 140. I48 
Reputedly Safe Agents. Trifluorethylvinyl ether (fluoroxene. Fluoromar) has 
been in clinical use since 1956.:"' Liver function tests have apparently been 
unchanged during and after the use of this anesthetic.'"', '" 'No cases of sensiti- 
zation have been reported. The agent has other advantages which will be dis- 
cussed later. 
Of the other commonly used ethers, only ethyl vinyl ether (Vinamar) has 
been thought to be almost completely free of liver t o ~ i c i t y . ~ ~ ' . ~ '  Diethyl ether 
and divinyl ether (Vinethene) have both been reported to cause hepatic mal- 
function or structural injury in experimental animals'" .;'Ii. h' ,  10'). as well as in 
patients;:"' 46 .  x i ,  102.  112 divinyl ether has been particularly notorious in this 
respect. 
Because the hydrocarbon cyclopropane has long been thought to be almost 
completely free of hepatotoxicity, it is one of the agents of choice for patients 
with liver disease. In the few reported cases of liver necrosis with the use of 
this agent,':'" other etiologic factors ha\-e almost always been identifiable. These 
have included massive hemorrhage, metabolic disequilibrium. and other medi- 
cations. Cyclopropane has not been given to our liver recipients, since its ad- 
ministration would preclude the use of electrocautery. 
Nitrous oxide is also considered innocuous to the liver, providing adequate 
oxygenation is maintained during its use.YX 
METABOLIC ALTERATIONS 
During orthotopic liver transplantation all patients must pass through a 
totally anhepatic state which is well tolerated for short intervals. Then, the 
liverless state is ended more or less rapidly according to the quality of function 
provided by the newly arrived homograft. 
The profound metabolic changes that may occur during this intraoperative 
period could instinctively be anticipated with no other information than that 
concerned with the hemodynamics of the normal human liver. The adult organ 
is perfused with almost one-third of the total cardiac output. the flows per 
minute through the hepatic artery and portal vein being 300 ml and 1200 ml of 
blood. respectively. The oxygen extracted from these sources is approximately 
60 mllminute. or about 20 per cent of that used by the entire body. Both the 
flow and the oxygen consumption are altered by a number of influences. They 
are increased by hyperthyroidi~m."~ hyperthermia, and shivering." They are 
decreased by hypothermia.'. 
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Acid-Base and Electrolytes 
The effects of total hepatectomy on serum electrolytes was studied in dogs 
b! Fisher et aL4' Sodium, potassium, and chloride concentrations were altered 
~ e r y  little by this procedure. However. there were progressive drops in the 
carbon dioxide content of the blood. The authors suggested that the latter 
change was secondary to hyperventilation. which in turn was a physiologic 
compensation for the accumulation of pyruvic. acetic, hydroxybutyric. acetoace- 
tic, uric, and other organic acids. 
This sequence of events can be produced short of hepatectomy by interrup- 
tion of the vascular supply of the canine liver. Resulting pH falls have been 
noted within the hepatic parenchyma7 or in the peripheral blood"' after oc- 
clusion of either the hepatic arterial or portal venous supply; the most extreme 
changes were produced with complete devascularization. 
There is the possibility that partial hepatic devascularization could result in 
a \ icious cycle in which the remaining circulation is impaired even more. Eise- 
man and his associatesJ4 and Kestens. Farrelly and hlcDermotti4 have demon- 
strated in experiments with isolated perfused livers that acidosis increases 
hepatic vascular resistance. 
In view of the foregoing information, the finding of acidosis in the liver 
homograft recipients was not a surprise. As will be described later, the situation 
was corrected intraoperatively at frequent intervals: here it will only be men- 
tioned that such therapy could entail a theoretical risk. The rapid administra- 
tion of alkaline solutions to fetal rhesus monkeys' and infants" has resulted in 
fatal liver injury. 
Modifications in hepatic blood flow may affect other serum electrolyte con- 
centrations. Prompt hyperkalemia has been the most consistent change 
reported in dogs following portal vein occlusion."' The alteration was apparently 
not exclusively due to the resultant intestinal injury since the same thing has 
been noted following Eck fistula."t will be seen later that similar potassium 
shifts have been characteristic in human recipients of orthotopic livers. 
Carbohydrate Metabolism 
It has been known for almost 50 years that glucose infusions prolong life in 
animals subjected to total hepatectomy.'", ' J ' 3  ", The obvious benefit of such 
therapy is to prevent the rapid and fatal hypoglycemia which otherwise 
develops. There are probably more subtle implications. For example, glucose 
infusions have been shown to decrease the severity of the acidosis in anhepatic 
dogs"'and to reduce the rate of accumulation of plasma amino  acid^.^" 
The provision of glucose treatment and the maintenance of normal or hy- 
perglycemic blood levels does not long prevent the development of cerebral 
manifestations in liverless dogs. Vang. Weiss and Drapanasl-"' have published 
data indicating that one possible explanation may be the progressive inability of 
the brain cells to metabolize glucose. It is not known how many other tissues 
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eventually lose this or other of their intrinsic metabolic capabilities. In hepatec- 
tomized pigs Norman et alliN1 reported decreases in oxygen and ATP concentra- 
tions of 32 and 63 per cent. respectively. suggesting a marked general depres- 
sion of oxidative phosphorylation. 
When discussing the management of hypoglycemia, the mistake should not 
be made of equating this problem solely with the anhepatic state. With hypoxe- 
mia Hannon et al"' have produced low blood sugar values in normal animals. 
Their explanation was that the ability of the liver mitochondria to produce 
high-energy phosphate bonds was depressed. In human recipients of hepatic 
homografts, life-threatening hypoglycemia has been observed in the early post- 
transplantation period, in spite of the fact that other measures of hepatic func- 
tion seemed adequate. 
Other Considerations 
Absent or poor liver function could profoundly affect the physiology of a 
wide spectrum of hormones since many of these are known to be degraded 
through hepatic pathways. Two specific examples will be given because of 
their practical implications. It must be assumed that a variety of sympathomi- 
metic amines undergo metabolic changes in the liver since large amounts of 
monoamine oxidase (MAO) and catechol 0-methyltransferase (COMT) are 
present in this organ.-' Failure of the process of efficient amine inactivation 
could promote depletion of the homograft's glycogen stores by glycogenolysis. 
Moreover, the inability under these circumstances to detoxify administered 
vasoactive substances could predispose to hypertension in the postoperative 
period. It will be docurnented in Chapter Nine that persistently elevated blood 
pressures have been observed in recipients of orthotopic liver homografts and 
that these patients have had an elevated urinary concentration of vasopressor 
substances. 
VENOUS STAGNATION 
During orthotopic transplantation it is necessary to cross clamp the portal 
vein and inferior vena cava (see Chapter Eight). In normal dogs it is mandatory 
that the distal venous pools, particularly that of the portal system, be effectively 
decompressed during the anhepatic phase. Failure to do this leads to death on 
the operating table or shortly afterward from a syndrome of irreversible 
45 "Y 1 3 3  The essential explanation for the lethal events is the sequestra- 
tion of blood volume in the splanchnic bed."' ""3 "' coupled with an injury to the 
capillary bed inflicted by the acute venous hypertension."" 
In other animals, including the pigeon" and turkey."' portal vein occlusion 
is far better tolerated. apparently because naturally occurring collaterals are 
more a~ai lab le  to return the blood to the right heart. The innocuousness of 
portal vein ligation in birds is explained by the existence of large portal-sys- 
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temic communications through the venous system of J a ~ o b s o n . ~ W o g s  can 
tolerate slow portal occlusion if the vessel compression is gradual enough to 
permit collateral pathways to open up." "' 
As will be mentioned later. it was eventually found that patients subjected 
to orthotopic transplantation did not usually become seriously hypotensive 
during crossclamping of both the portal vein and inferior vena cava. It was 
thought that the extensive venous collaterals caused by the hepatic disease had 
*lade this detail of the operation safer than would have normally been the case. 
This hypothesis has been confirmed in the laboratory by Picache et al."'" They 
submitted dogs to common duct ligation. About two months later, after venous 
collaterals had formed, orthotopic liver transplantation was performed without 
provision for decompressing bypasses. The venous occlusion was well tolerated 
tvithout the dramatic adverse effects invariably seen in normal animals. 
In our own animal experience the danger from hypotension has been essen- 
tially terminated with revascularization of an adequately preserved homograft. 
However, Joseph et a l" .70bserved reduced blood pressures after this time, 
especially just following the restoration of hepatic blood flow. They suggested 
that the transplanted organ might contain a vasodepressor material (VDM) simi- 
lar to that described by Schorr et al.I2:' Joseph's recommendation was that the 
initial circulation of the homograft be flushed through a venotomy and dis- 
carded. We have not observed this precaution. 
CLINICAL ANESTHESIA 
Although it has already been amply emphasized (Chapters One and Four) 
that all candidates for liver transplantation are poor risks for anesthesia, some 
of the reasons will be briefly recapitulated. First, there are usually pre-existing 
abnormalities of respiratory function. The changes which have been most 
thoroughly documented are arterial desaturation and hyperventilation. with the 
secondary development of a compensated respiratory alkalosis and a reduced 
buffer base. The most plausible explanations for one or more of these findings 
have been based upon the presence of a variety of shunts which apparently 
divert considerable volumes of blood from the pulmonary arteryh" ' I "  or from 
portal-systemic collaterals" directly into the pulmonary veins. Additional arterio- 
~ e n o u s  anastomoses have been described within' or outside the liver.h" ljO 
M7ith the multiplicity of widely distributed shunts, it is not surprising that the 
cardiac output of cirrhotic patients is usually increased.hx 
Other authorsh2 ;j have suggested that biochemical factors may play a role 
in the respiratory and cardiodynamic changes. Keys and Snel17' observed a de- 
creased affinity of hemoglobin for oxygen in cirrhotic patients, although this 
finding could not be confirmed by Rodman et al.Ilh Elevated ammonia levels 
have been said to stimulate the medullary respiratory centers."' Kontos et also 
have postulated that vasoactive substances may be present as a result of 
chronic liver failure and that these may contribute to any of the foregoing 
alterations. 
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The list of other physiologic derangements consequent to liver insuffi- 
ciency is a long one and will not be presented here. However, it can be as- 
sumed that most patients with chronic hepatic disease will come to the 
operating room with an increased plasma v01ume.~" '"j hyperaldostero- 
n i sm,~o~ 1 j x  and a reduction in the red cell mass."4 The anemia is probably partly 
due to an  increased rate of erythrocyte destruction."" although abnormal matu- 
ration of red cells may be a contributory factor.'' 
The presence of ascites can pose a serious problem, since the amount of 
intra-abdominal fluid is often \ ery large. Of necessity, this is abruptly removed at 
the time of transplantation. The effect of massive but gradual paracentesis in 
cirrhotic patients has been studied by Knauer and Lowe. 'Vhen quantities less 
than one liter were aspirated, the cardiac output and stroke volume increased. 
When this amount was exceeded, both values were markedly decreased, presum- 
ably because of fluid shifts and a resultant fall in the circulating blood 
volume. 
The Importance of Monitor ing 
During the actual operation additional physiologic and metabolic derange- 
ments are predictably superimposed upon those already present. Control and 
adequate study of the resulting situation is heavily dependent upon accurate 
moment-to-moment monitoring of a number of measurements. Provision for 
this must be assured before the final draping of the patient is begun. The 
devices used to follow the intraoperative course in all our recent patients have 
included the following: (1) bipolar electrocardiogram. (2) esophageal 
stethoscope, (3) rectal thermistor, (4) bladder catheter. (5) venous catheter in 
the superior vena cava, (6) standard blood pressure cuff, and (7) radial arterial 
catheter. 
The general value of all these methods for increasing the safety of intraop- 
erative management during a variety of complicated procedures has been well 
established."# This will not be detailed here, except to draw attention to the 
special importance of having access to frequent arterial samples. In the course 
of a hepatic transplantation, it is essential to be able to obtain serial measure- 
ments of the blood gases and pH. blood sugar. and electrolytes. Moreover, sev- 
eral determinations of clotting factors are highly desirable (see Chapter Ten). 
Finally, samples can easily be removed for more esoteric research studies. 
At the same time as the monitoring equipment is being attached. a large 
caliber intravenous catheter should be inserted in the arm or neck. No infu- 
sions are used in  the lower extremities since inferior vena caval cross clamping 
will eventually be necessary. A final precaution as equipment is being made 
ready is to place the patient on a temperature control blanket. At first it was 
suspected that hyperthermia avould be a significant problem after revasculari- 
zation of the large foreign organ. I11 actuality the converse proved to be true; 
hypothermia was very regularly seen. The blanket permitted control of this 
complication. In addition. heating coils were used in all the later cases through 
which to run the blood and other intravenous fluids. 
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Anesthetic Techniques 
The haste with which anesthesia must be started for hepatic transplanta- 
tion was considered in Chapter Four; the degree of urgency was dictated by the 
e1 ents of donor death. At times it was necessary to rush the recipient to the 
operating room before medical evaluation could be completed or even shortly 
after the ingestion of a meal. A number of precautionary measures were taken 
to reduce the consequent hazards in the course of induction. 
Standard doses of atropine sulfate were given intravenously after the pa- 
tient's arrival in the operating room: this was the only preoperative medication. 
A nasogastric catheter was then immediately passed and irrigated. If food was 
detected within the stomach. it n7as removed as completely as possible. 
However, it was not assumed that this objective had been fully met. Instead, an 
induction technique was used which promptly ensured an adequate airway and 
which would prevent aspiration. The safest approach was to carry out tracheal 
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use of the electrocautery. A final advantage was the ease and rapidity with 
\ \ l~ ich  anesthesia could be lightened or deepened according to the circum- 
stances of the moment (Figs. 33 to 35). It was especially important to have this 
capability during the anhepatic phase or at times of sudden hemorrhage. 
Throughout the operation ventilation was assisted or controlled. When indi- 
cated to provide adequate exposure and an  immobile operating field. nondepo- 
lallzing muscle relaxants were administered (Figs. 33 to 35). This was most 
com~nonly necessary at the time of the anhepatic phase. during which interval 
the inhalation anesthetics were either sharply reduced or stopped altogether. 
The adjustment was made at this time not only for the objective of obtaining 
better relaxation as the vascular anastomosis was performed, but also to 
mlnimize the hypotension which was sometimes induced by the venous oc- 
clusions during that period. 
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Intravenous Therapy 
It is obvious that the actual anesthetic techniques used during liver trans- 
plantation were not unusually complex (Figs. 33 to 35). The other aspects of 
intraoperative care were by no means so simple. The main problems were to 
maintain an  adequate blood volume, to repeatedly correct acid-base abnormali- 
ties. to prevent hypoglycemia. and to administer other drugs as needed. 
At the outset of operation, children were given 5 per cent dextrose in 0.25 
per cent sodium chloride solution. Adults were started on 5 per cent dextrose in 
lactated Ringer's solution (pH approximately 6.8). The exact volumes infused 
were varied according to the state of hydration of the patient. the amount of 
ascites removed upon abdominal entry, and the physiologic indices of urine 
flow and central venous and arterial pressures. 
Well before the beginning of the anhepatic phase, the quantities of glucose 
were increased by adding 25 per cent dextrose in water to the infusion (Figs. 33 
to 35); the amounts were calculated to supply 0.5 gmlkgihour. Blood glucose 
measurements were thereafter obtained every 15 minutes. The glucose input 
was modified according to the results of these measures, in an attempt to 
maintain a blood concentration of 150 to 350 ing per cent. On one occasion, the 
level rose to 1500 mg per cent within a few minutes; when the infusion rate 
was lowered, it fell just as quickly. 
After revascularization of the homograft, the amounts of dextrose given 
were slowly reduced to 0.2 gmlkglhour. At no time was the glucose therapy 
deliberately stopped either during operation or for many hours or even days 
afterward. In two patients the intravenous noncolloid solutions were acciden- 
tally discontinued briefly in the process of transfer to the intensive therapy 
unit. Very severe hypoglycemia resulted. with convulsions, unconsciousness, 
and transient respiratory arrest. Emergency therapy with 50 per cent glucose in 
water was required. 
The magnitude of blood replacement that was necessary has been docu- 
mented in Chapter Six. The estimation of the adequacy of blood volume was 
made difficult for special reasons. For one thing, an unknown quantity of blood 
was removed with the extirpated host liver and an equally immeasurable quan- 
tity was required to fill the new organ at the time of its revascularization. 
Moreover, the extent of fluid shifts consequent to the removal of ascitic accum- 
ulations could not be identified. Finally, the venous crossclamping during the 
anhepatic phase undoubtedly led to sequestration. which could not be 
quantitated. 
Some of the hazards of massive transfusion were minimized or circum- 
vented by the use of fresh blood. In this way the elevated concentrations of 
potassium. phosphates. ammonia. and lactic acid found in stored blood were 
avoided. However. special precautions were necessary because of the large vol- 
umes of citrate preservative nhich had to be gi\-en. Each unit of ACD blood 
contains 0.6 gm of citric acid. equivalent to 8.6 mi\l of hydrogen ion.?] The 
consequent acidosis is ordinarily quickly buffered by plasma bicarbonate, hemo- 
globin. and proteins. Meannhile. the organic acids are promptly metabolized 
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bv the liver. The latter counterregulatory mechanism is either impaired or 
totally lost for long periods during hepatic transplantation. Consequently. treat- 
l ~ l t s l l t  with bicarbonate was necessary not only to compensate for the ACD but 
in order to neutralize endogenous acid products as well. 
The exact quantities of alkalinizing agents that were required varied from 
cabc to case (Figs. 33 to 35) and were adjusted according to the results of 
rel!eated blood gas, pH. and bicarbonate determinations. With each set of data 
the base excessEi was calculated and the necessary changes made. The general 
foi,mula that was followed until this information became available was to ad- 
m~ilister 2.5 mEq;kg,hour sodium bicarbonate. beginning as soon as significant 
mLinipu1ation of the host liver was started and continuing for at least an hour 
after revascularization of the homograft. To this basic regimen 10 mEq of 
sodium bicarbonate were added for each unit of ACD blood. 
Prevention of acidosis reduces the hazard of citrate intoxication.2L26 
Ho\vever. ACD blood can produce direct myocardial depression even with per- 
fect acid-base control. This effect is more or less completely counteracted by 
the provision of exogenous calcium.':". I-" Consequently the adult liver recipients 
1vt:l.e intermittently given 300 to 400 mg of calcium in the chloride or gluconate 
form. Smaller doses were administered to children. 
The calcium administration was especially helpful in the anhepatic phase 
(Figs. 33 to 35). On several occasions during the liverless intervals of venous 
crossclamping there was a progressive decline in the blood pressure. This was 
h'llted or reversed by the administration of calcium. The same kind of observa- 
tion has been made in pigs by Terblanche et al.'"" 
The other intravenous therapy needed during the operation will not be 
coasidered here. In all cases azathioprine and prednisolone are begun during or 
shortly after homograft revascularization in the dose schedules described else- 
\\.here in the text. Antibiotics are invariably given by intermittent pulses (see 
Chapter Sixteen). In the event of dire need platelet concentrates, EACA, and 
fibrinogen may be required (Chapter Ten). 
Postoperative Care  
The care in the first few hours in the intensive therapy unit was not particu- 
larly different from that during the actual operation. All the monitoring proce- 
dures mentioned previously were continued. At intervals which were progres- 
slr-ely closer together, ventilation support was temporarily discontinued. On  
these occasions blood gas studies were obtained, the volume of respiratory 
exchange assessed, and the advisability of 17-ithholding further respiratory sup- 
port considered. In most instances the ventilatory assistance was continued for 
ser era1 hours. Even after adequate air exchange was evident, the endotracheal 
tube iyas usually not removed until the patient was obliously objecting to its 
presence. Both before and after extubation, tracheobroncliial suctioning was 
, 
assiduously carried out. An approximately equal mixture of oxygen and air was 
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passed through a humidifier and delivered to the area of the face. The infusion 
of noncolloidal and colloidal fluids was continued at a generally reduced rate: 
in a few cases, human albumin was given for intravascular volume expansion. 
Particular attention was paid to ensuring a continuous glucose source. Electro- 
lyte determinations every few hours were used to guide other aspects of fluid 
therapy. 
Most of the pediatric patients left the operating room slightly hypothermic. 
usually around 35" C (Figs. 33 to 35). During the time they were still on the 
mechanical ventilator. rewarming to 37" C was accomplished. In almost ever) 
case, a rebound increase in the temperature occurred, which ordinarily stopped 
rising at 38 or 39" C. 
Complications 
The principal difficulties during the transplantation were for the most part 
those of the procedure rather than the anesthesia. There were instances when 
adequate circulating blood volume could not be maintained in the face of hem- 
orrhage or cross clamping of the great veins. Moreover, the blood sugar level 
and the acid-base balance could not always be kept at the optimum physiologic 
state. Data on these problems will be presented in the next section. 
The operations were often extremely long. The protracted presence of endo- 
tracheal tubes probably accounted for the laryngeal and subglottic lesions in 
two patients (OT 11 and 14) as described in Chapter Nine. The tracheal granu- 
loma in patient OT 14 might have been avoided if the endotracheal cuff had 
been more frequently deflated. 
In some of the earlier patients the mistake was made of attempting to 
extubate too soon in the postoperative period (AT 1 and 2; OT 2 and 10). Emer- 
gency replacement of the airway was necessary. An explanation for the neces- 
sity of prolonged ventilatory support in some of the recipients was never com- 
pletely determined. However, the duration of surgery, the very large incisions, 
the pre-existing debilitation and the common presence of mild hypothermia, as 
well as the variable malfunction of the newly placed homograft, could all have 
played a role. In addition. it is conceivable for reasons mentioned earlier in this 
chapter that some of the intravenous medications. including the muscle relax- 
ants. could have had a more enduring action than normal. 
CLINICAL OBSERVATIONS 
This chapter has dealt so far with the principles upon which the anesthetic 
management during liver transplantation was based and with the actual tech- 
niques applied for the human recipients. Now some additional observations will 
be presented which relate to several more or less unique problems encountered 
in  this kind of procedure. 
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The Effect of Venous Occlusions on Blood Pressure 
The difficulties of evaluating the need for blood replacement as well as the 
pr,lctical problem in some cases of keeping up with the hemorrhage were 
de.cribed earlier. One of the useful guidelines for transfusion therapy was 
protlded by serial hematocrit changes (Figs. 36 and 37) when these measure- 
mc nts were considered in relation to the arterial and central venous pressures 
anii to the urine output. In spite of all efforts the completeness of blood replace- 
mc ilt was undoubtedly highly variable when the interval of venous cross clamp- 
i i ~ ~  nas  reached. In some cases. the bleeding could not be controlled until the 
dlbt,ased liver was finally removed; in others, the recipients were in a very 
st<xule condition at the beginning of the anhepatic phase. 
If7ith occlusion of the suprarenal inferior vena cava and the portal vein, a 
fulther decline in blood pressure invariably developed, although this was 
usl~ally not severe. The magnitude of the change in each instance is shown in 
T,l!~le 7. The most serious depression was during the second transplantation of 
P,iuent OT 16 (Fig. 35). On the first occasion extensive venous collaterals had 
bc (In found; there were no major cardiodynamic alterations during the anhe- 
p, tic phase. The second time, 68 days later, the collaterals had partially involuted. 
\I 'len the vascular structures entering and leaving the rejecting homograft 
11 re occluded, the blood pressure fell almost 100 mm Hg. In this case, as well 
OT 17 
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Figu1.e 36. hletabolic changes in the recipient of an orthotopic lil-er homograft (OT 17). An over- 
correction lvas made in the planning of the glucose infusion. Note the very striking hypokalemia 
after ~~evascularization of the homograft. 
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F i g u ~ e  37. Physiologic measurements in patient OT 20. Before and after the anhepatic phase there 
was a S ~ O M ,  rise in the serum sodium concentration, probably secondary to bicarbonate therapy. 
Eventually a slight overcorrection of the acidosis was achieved. 
as in all the others. an improvement was immediately seen with reopening of 
the vessels (Figs. 33 to 3 5 ;  Table 7). A consistent correlation could not be 
established between the extent of gross collateral formation and the tolerance 
to venous occlusion as judged by the degree of hypotension. 
However. it was our impression that the four patients who had hepatomas 
without concomitant cirrhosis (OT 8. 14. 17  and 23)  were placed at the greatest 
risk. Their intestines became definitely congested. a change which was not 
obvious in most of the other cases. \f7hen this was seen a request was made that 
the blood flow be restored through the reconstructed vena cava immediately, 
rather than wait for the remaining vascular anastomoses to be completed. In 
this wav the duration of stagnation of one of the obstructed venous systems 
was reduced by 20 to 60 minutes. 
Acid-Base and Electrolyte Changes 
The final extent of the metabolic acidosis which would have developed in 
these patients could not be measured since prophylactic therapy was always 
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Table 7.  Changes in the Systolic Blood Pressure (mm Hg) Caused by 
Simultaneous Cross Clamping of the Portal Vein and Inferior Vena Cava" 
PRESSURES 1VITH C R O S S  CLAMPIXG 
PATIENT Before Dzil.i?zg A f t e l  
OT 7 115 110 110 
The control measurements \sere all five minutes before the venous occlusions. The blood 
Pressure declines during clamping Ivere the maximums observed. The final values were obtained 
15 minutes after homograft rel-ascularization. 
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provided, particularly before. during, and just after the anhepatic stage (Figs. 
33 to 35). In spite of treatment, and although the patient was continuously 
hyperventilated throughout, it was usually found that there had been an  under- 
correction (Fig. 36). Additional quantities of bicarbonate were then given accord- 
ing to the calculated base deficit. There was only one instance in which too 
much alkalinization led to a transient but moderately severe alkalosis. The pH 
in this recipient (OT 18) rose to 7.68, along with a temporary hypernatremia of 
166 mEqlliter. 
The administration of large quantities of sodium bicarbonate was apparent- 
ly made safer by the invariably pre-existing hyponatremia; this may have been 
the consequence of secondary hyperaldosteronism as discussed earlier. With 
the progress of the operation and the repetitive correction of alkalosis with the 
sodium buffer, serum sodium concentrations tended to become progressively 
increased toward normal (Figs. 36 and 37). 
The only other consistent change was in the serum potassium concentra- 
tion. The values were within normal limits in all the recipients at the beginning 
of the procedure. The concentrations remained about the same or were slightly 
elevated until the homograft was revascularized. From this time onward there 
invariably was a steady decline (Figs. 36 and 37) which usually lasted for sev- 
eral hours. The lowest potassium recorded in any patient was 1.8 mEqlliter. 
The reason for the potassium "leak" can only be speculated upon. It may 
have been related to the large amounts of sodium bicarbonate, which were 
always given in the preceding hour or two.X1 A much more plausible explana- 
tion would be that the potassium was suddenly taken up by the homograft. It 
has been shown that the liver liberates potassium after conditions of ische- 
mia.hs "'s 'ji Presumably, an  increased uptake by the liver cells to replace the 
deficit could account for the apparent loss of potassium from the serum. 
Blood Cholinesterase 
Plasma and red cell cholinesterase levels were measured in five recipients 
of orthotopic homografts. The results are summarized in Figure 38. The plasma 
cholinesterase (pseudocholinesterase). which is synthesized mostly by the liver, 
was discussed earlier in connection with its role in detoxification of various 
drugs, including succinylcholine. In all five recipients the preoperative values 
were abnormal. In four of the patients the diagnosis was biliary atresia, but in 
the fifth (OT 17) it was primary hepatoma. The last patient had no pre-existing 
serious abnormalities of liver function. 
During operation the abnormally low plasma cholinesterase levels rose be- 
fore the onset of the anhepatic period (Fig. 38), probably as the result of blood 
transfusions being given. Afterward the values did not decline as transfusions 
were diminished and discontinued. It was suspected that the late maintenance 
of the higher concentrations was due to synthesis and release of cholinesterase 
by the new organs. LVhether this conclusion was correct remains to be deter- 
mined from a greater number of observations. 
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CHANGE OF CHOLINESTERASE 
DURING LIVER TRANSPLANTATION 
PLASMA ( M U )  : o j F r . c l . 8  .. .... -o 
....' 
.4 0 
- 1  ! 
Control PreTxl 30 60 1 120 180 240 I 
I ANHEPATIC; POST- I 
REVAS. 
M I N U T E S  
F i g u ~ e  38.  Intraoperative changes in red cell and plasma cholinesterase. See text for discussion. 
The results of red cell cholinesterase determinations neither supported nor 
contravened this idea. The red cell values were initially normal, a finding 
which was not surprising since erythrocyte cholinesterase is not dependent on 
l i ~  er function. However. small and sustained rises occurred during the proce- 
dures. which had not yet returned to the control status at  the end of the obser- 
vation periods (Fig. 38). 
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Chapter Eight 
THE RECIPIENT OPERATION IN MAN 
The first known efforts at experimental orthotopic transplantation of the 
liver were made by Dr. Jack Cannon of Los Angeles:? With the expectation that 
the liver played an  important role in rejection, he apparently hoped that a 
hepatic homograft might suffer a different fate from that of other transplanted 
tissues since it presumably would not contribute to its own repudiation. Details 
of the procedure or of the animal species in which the experiments were done 
were not given. Cannon referred to "several successful operations" but without 
survival of the recipients. 
In June, 1958, a well organized program of orthotopic transplantation of 
the canine liver was undertaken at the Peter Bent Brigham Hospital under the 
direction of Dr. Francis D. Moore.]', Later that summer our own first experi- 
ments were begun in the same species at  Northwestern University in Chicago. 
There, a new method for one stage total hepatectomy in dogs had been 
developed"' and, in the course of this work, the concept of replacing the excised 
o r g a n s ~ .  2,s was first envisioned. The methods independently developed by 
workers in the two laboratories were not compared until the meeting of the 
American College of Surgeons at  Atlantic City in the autumn of 1959. The 
absence of communication during the initial year was reflected in a number of 
differences in the techniques used by the Boston  group"'^:" and our own.'.'" 
However, the objectives of the methods were identical in every important 
respect. 
It is unlikely that anyone would wish to attempt a clinical liver transplanta- 
tion without personally recapitulating in the laboratory at least some of the 
earlier experience in dogs or, alternatively. in pigs (see Chapter Eleven). The 
surgical techniques in both species ha\-e become well standardized.'. " ] I 0 .  '" 2 6 ,  
However, the descriptions in this chapter will be confined to the details of 
orthotopic hepatic transplantation as it has been carried out in humans. Various 
aspects of the surgical technique in man have been reported.'" .", ? "  .":. ';. "3 30 
but never in one publication. 
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RECIPIENT HEPATECTOMY 
, i 
The Incision 
I 
The first orthotopic transplantations in humansly were performed through 
thoracoabdominal wounds (Fig. 39C). The view was excellent both for the 
hepatectomy and insertion of the homograft. However, it is now thought that 
the advantage of the extra exposure was more than offset by the effort of 
making and closing the thoracic extension and by the possible introduction of 
an increased morbidity. In the last 2 0  patients long transverse abdominal in- 
cisions of one kind or other have been used (Fig. 39A and B);  if additional room 
had been needed, entry into the chest could easily have been accomplished 
(Fig. 39B). 
In every case in our series, with a single exception, one or more earlier 
explorations had been carried out at other institutions. Whenever possible the 
old scar was reopened and made part of the incision for the transplantation; 
this was always feasible in the cases of biliary atresia. Two of the adult patients 
with hepatoma (OT 15 and 1 7 )  had short and infected vertical incisions from 
operations that had been carried out 1 0  days and three months earlier, respec- 
tively. The old wounds were excised and exposure obtained by making fresh 
transverse incisions (Fig. 39A) across the first operative site. Primary healing 
was obtained. 
Determination of Operability 
The order in which dissection is carried out is influenced by the disease for 
which transplantation is being done. In biliary atresia, it is attempted first to 
skeletonize the structures of the portal triad. If a dilated duct were found which 
communicated with the intrahepatic biliary tree. a reconstructive procedure 
nrould be strongly considered in preference to transplantation but. to date, this 
circumstance has not been encountered. 
Preliminary dissection of the portal triad may also be indicated in hepatic 
malignancy if the tumor is located centrally or in the hilar region. On several 
occasions an evaluation of inoperability was quickly reached when extrahepatic 
nodal metastases were found in this area. Often, however, it is the convex 
surface of the liver which requires the closest inspection to rule out invasion of 
the diaphragm or to be sure that tumor has not extended into the thorax via the 
hepatic veins and suprahepatic inferior lens cava. In some cases it may be 
necessary to skeletonize all the major structures entering and leaving the liver 
before reaching a decision to proceed. 
Portal Hypertension 
Eighteen of our 25 patients treated with orthotopic homotransplantations 
had portal hypertension and extensive high pressure venous collaterals. Exsan- 
Figure  39. Incisions used for orthotopic liver transplantation. The preferred approaches are shown 
in A and B: with either of these wounds. an extension into the right thorax can easily be made. 
Vertical incisions I C  and D r have not been used in recent cases. 
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guinating hemorrhage from these vessels must be prevented. If transplantation 
has been decided upon, a time-saving maneuver is to ligate the thin walled 
I eins on one side and to cauterize them on the expendable liver side which will 
be removed. For the latter purpose, a high setting (60 megacycles) is required, 
great enough to create a spark across a gap of several millimeters from the 
cdutery tip. With this technique the tissue is burned as with an actual cautery. 
In some instances where dissection is close to the hepatic capsule, this may be 
the only way to stop the bleeding from the liver. 
In spite of these efforts, it was not possible in any of our patients with 
portal hypertension to obtain a completely dry wound prior to completion of 
hepatectomy. Fortunately, decompression of the splanchnic system through the 
homograft resulted in  most cases in prompt cessation of the diffuse venous 
bleeding. 
Dissection of the  Portal Tr iad 
Access to the portal structures may be hampered not only by the presence 
of venous collaterals, but also by adhesions from previous operations. A combi- 
nation of these factors makes a particularly difficult and dangerous situation in 
children with biliary atresia. All such patients have had earlier explorations in 
order to rule out the feasibility of duct reconstruction and multiple loops of 
l~owel are always found to be adherent to the liver or gastrohepatic ligament. 
Sometimes these are stuck so firmly that they can be removed onlj with the 
cautery knife and at great risk of their instrumental perforation. Moreover, the 
cicatricial distortion or foreshortening of the portal triad can make difficult 
even its identification. It may then be necessary to find the anterior surface of 
the infrahepatic inferior vena cab a and redevelop the obliterated foramen of 
[Vinslow. Alternatibelp, it may be possible to achieve this objective from the 
left side through the lesser omental sac. 
Once the portal triad has been encircled (Fig. 40A).  its three constituent 
structures can be freed with relative safety providing their triangular spatial 
]-elationship is appreciated as shown schematically in Figure 40B. Long enough 
segments of the vessels to permit subsequent anastomosis are developed. This 
may require ligation and division of the right gastric and gastroduodenal 
branches of the hepatic arterl (Fig. 41). Sacrifice of these vessels has another 
advantage. As soon as they are cut. it is much easier to see and clean off the 
portal l e in  just where it emerges from behind the neck of the pancreas (Fig. 
41). Branches of the portal ~ e i n  also have to be ligated and severed: of these, 
the coronary (left gastric) vein lvhich enters on the left side and posterolaterally 
a few millimeters abos-e the pancreas is the most constant (Fig. 42). Control of 
hemorrhage after accidental a\-ulsion of this vessel n-ith blunt dissection may 
be exceptionally difficult. 
If it is planned to eLentually perform choledochocholedochostom~ for bil- 
iary drainage (an option not available in biliary atresia). the distal common 
duct and its surrounding adventitia and I essels are left long. Otherwise, it is 
doubly ligated close to the duodenum (Fig. 42). 
T e l t  colztllzltecl 0 1 1  page  1 1  9.1 
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Figure  40. A. Encirclement of the portal structures preparatory to their individual dissection. 
This can be done either from the right side as indicated or from the left through the lesser omental 
sac. B. Spatial relationships of the components of the portal triad. 
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Commo 
bi le du 
Hepat i c  
Fzgure 41. The appearance of the hilum after ligation and division of the right gastric and gastrc 
duodenal arteries. Note the access that is provided to the anterior surface of the portal vein. 
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Recip ient  
Common duc 
Figure  42. The common duct and several tributaries of the portal vein have been doubly ligated 
and divided. 
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ducts  I ' \  
Figure  43. Ligation and division of tissue between the major hilar structures. 
As the major structures of the triad are skeletonized, lymphatics, nerves of 
the hepatic plexus, and areolar tissue are severed (Fig. 43). In order to prevent 
later lymph leaks, all such intervening bits of tissue must be tied. 
Completion of Mobilization a n d  Removal 
The steps in the remainder of the hepatic liberation are almost identical to 
those already described for donor hepatectomv (Chapter Five). The falciform 
ligament is incised up to the suprahepatic \ens cava. taking care to leave 
enough ligamentous tissue to permit its later suture to the same structure of 
the homograft. After the left triangular ligament is cut, about half of the cir- 
cumference of the vena ca\ a and the left main hepatic vein can be seen between 
the liver and the diaphragm (Fig. 14. Chapter Fi\ el. 
hlobilization of the right and posterior parts of the li\-er is more difficult. 
The first steps are to incise the anterior leaf of the right triangular and coronary 
ligaments. to retract the 1ir.e~ tonard the left. and to enter an extensil e raw 
area to which the :.ight adrenal gland contributes a portion of the floor. The 
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plane is opened n-ith sharp and blunt dissection until the retrohepatic vena 
cava is seen. 
Behind the liver the vena cava usually has only a single tributary, the right 
adrenal vein, which must be ligated and divided (Fig. 16, Chapter Five); 
although this is ordinarily well tolerated, two of our patients (OT 7 and 17) 
developed venous infarction of the gland (Chapter Nine). At this stage the 
remaining tissue attaching the retrohepatic vena cava to the posterior body wall 
is detached, making sure that any unexpected venous branches are ligated and 
divided. It should now be possible to pass a finger behind the vena cava from 
the diaphragm to the renal veins without meeting an obstruction. just as was 
described in the donor operation (Fig. 17, Chapter Five). 
Additional work is usually necessary, however, to make the short expanse 
of suprahepatic vena cava ready for subsequent anastomosis. Even at best, the 
length which can be made available is limited, but additional mobility is at- 
tainable if the diaphragmatic veins that enter the segment are ligated and 
divided as already described in Chapter Five. There may be only two large 
phrenic tributaries, one on each side, but more commonly two or three addi- 
tional smaller vessels must also be similarly disposed of. By so doing, room is 
made for later application of a vascular clamp which can then be placed 
without grasping a portion of adjacent diaphragm. If the latter maneuver be- 
Figure  44. Transection of the supra- 
hepatic inferior vena cava. Note that 
the line of incision is kept as close to 
the liver as possible in order to retain 
the maximum vessel length for sub- 
sequent anastomosis. R.h.v. = right 
hepatic vein; L.h.v. = left hepatic 
vein: I .17.C.  = inferior vena cava. 
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I' ;q~ci 'e  45. Diseased recipient lix-ers removed at  the time of orthotopic hepatic transplantation. 
'4 Patient OT 4. The diagnosis in this 32 year old Inan was hepatoma superimposed upon cirrhosis. 
The specimen weighed 2400 gm. B .  Patient OT 3. The hepatoma and lix-er excised from a 29 year old 
\\-oman weighed 10 kg. C .  Patient OT 8. The specimen in this 19 month old girl weighed 1163 gm. 
The diagnosis was hepatoma. D. Patient OT 10. A 633 gm liver removed from a 13 month old girl 
mith extrahepatic biliary atresia. 
comes necessary it introduces the risk of crushing the right phrenic nerve and 
causing paralysis of the right diaphragm (Chapter Nine). It is worth noting that 
the foregoing extensive manipulations. including dislocation and even twisting 
of the liver, have had unexpectedly minor cardiocirculatory effects, probably 
for the reasons to be discussed in the next section (see also Chapter Seven). 
After the vessels entering and leaving the l i ~ e r  are skeletonized, they are 
individually occluded with noncrushing clamps and divided. As much length of 
these structures as possible is left with the patient. Particular care must be 
taken in transecting the vena caval cuff at the diaphragm. The vascular clamp 
is placed as superiorly as is feasible without draning a piece of the contiguous 
diaphragm into the bite. A venotomy is then made in either the main right or 
left hepatic vein. i17ith one blade of the scissors in the lumen and the other 
outside, the cloaca formed by the confluence of the \ ena cava and hepatic veins 
is incised close to the liver around the entire 360 degrees (Fig. 44). The flap 
developed for eLentua1 circumferential suture is only a fen- millimeters long. 
After cutting the infrahepatic vena cava. the portal vein, and the hepatic artery, 
the specimen is removed (Fig. 43). 
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The Bypass Problem 
In at least one important way an  erroneous conclusion was reached from 
animal experimentation about the technical requisites for successful human 
liver transplantation. With removal of the host liver it is necessary to tempo- 
rarily cross clamp the great veins which drain the intestine and lower half of 
the body (Fig. 46). It was soon learned in the experimental laboratory that dogs 
subjected to orthotopic hepatic transplantation regularly died of shock if the 
portal vein and inferior vena cava were not decompressed during this anhepatic 
interval. Even animals which did not die during operation developed 
irreparable damage to the small bowel and a resulting hemorrhagic enteritis 
that caused death from delayed irreversible shock. Moore'' dealt with the prob- 
lem by inserting external bypasses into the two venous systems so that the 
blood could be rerouted to the jugular veins; premature clotting in the tempo- 
rary prostheses was prevented with systemic heparinization. 
An alternative solution was used in our laboratories." The two venous sys- 
tems of the dog were first placed into communication by performing a side-to- 
side anastomosis between the partially occluded inferior vena cava and the 
superior mesenteric vein. Then a single vena caval-jugular bypass permitted 
decompression of both venous pools (Fig. 47). Heparin was not given. After the 
Figure  46. The operative field after removal of the diseased recipient liver. In  the illustration a n  
incision in the diaphragm is shown as  part of a thoracoabdominal exposure. In all more recent 
cases. the chest has not been entered. C.d. =common duct: H.a.  =hepatic artel'!-: I.V.C. =inferior 
Vena cava; P.v. = portal 1-ein. (By  permission of Surg. Gynec. Obstet. 11 7:639. 1963.) 
THE RECIPIENT OPERATION IN MAN / 123 
Figure 47.  Method used in dogs for decompression of inferior vena caval and splanchnic systems 
during removal of recipient liver and replacement with a homograft. Note that a preliminary 
portacaval shunt has been placed. B5- means of' this remporar!- anastomosis the t~r-o venous s?-stems 
are connected. allolving their decompression n-it11 a s i n ~ l e  xternal bypass. (By  permission of Surg. 
Gynec. Obstet. 11 1 : 733.  1960.) 
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homograft was in place, the caval-mesenteric shunt was taken down and the 
resulting defects closed by vascular suture. 
The absolute necessity for effective venous decompression in animals was 
unfortunately extrapolated to be a mandatory technical condition in the first 
trials of orthotopic liver transplantation in man. In our first five patients as well 
as those of o moo re" and Demirleau,; plastic tubes were used to bypass the ob- 
struction of either the vena cava or the portal vein, or both (Fig. 48). 
The details of the bypass techniques will not be described since it has since 
been learned that such measures are not needed. In the last 22 orthotopic 
transplantations they have not been used. Simultaneous cross clamping of the 
inferior vena cava and portal vein in these patients was for 30 to 95 minutes. 
The consequent hemodynamic changes were tabulated in Chapter Seven. A 
slight duskiness of the intestine developed in some patients, but this immediate- 
ly disappeared when blood flowr was restored through the reconstructed ve- 
nous channels. 
The demonstration that bypasses are unnecessary in human recipients of 
orthotopic homografts was a significant advance since there were serious 
complications from the techniques used for venous decompression, as will be 
mentioned in Chapters Nine and Ten. The fact that acute physiologic alterations 
Figure 48. One svstem of venous bypassing ~ h i c h  was used in the earlv cases of clinical liver 
transplantation. It has since been learned that these pro\-isions for venous decompression are not 
necessar). in humans. The technique used in our early experience is shown because it helps to 
explain the pulmonary emboli xrhich xvere the iillmediate or contributory causes of death in the first 
three patients who survil~ed orthotopic transplantatioil (see Chapter Ten). The clots in tn-o of the 
patients originated at or near the site of insertion of the femoral catheter. (B?- permission of Surg. 
Gynec. Obstet. I 1  7:659. 1963.; 
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caused by obstructing the two great veins Lvere so minimal in patients 
prolmbly is partly explained by an  inherently richer network of potential col- 
latrlLxls in man by which blood can be rerouted back to the right heart.6 An 
addltlonal decisive factor is presumably the increase in the size and ramifica- 
t i o l l ~ f  such collaterals as the consequence of liver disease. The latter factor 
has I~een proved by Picache et all" to be important in canine experiments. as 
was discussed in Chapter Seven. 
Deviations in Hepatectomy Technique 
The portal hilum was so scarred in two of the children with biliary atresia 
t h a ~  it was impossible to liberate the separate structures; in one child, efforts to 
do s o  resulted in laceration of the hepatic arterv. In both instances the liver 
-
c o ~ ~ l d  be removed only after a vascular clamp was placed just above the h ,ecof  
___ _  -
the vancreas across the entire triad and the g a s t r o h e p a t i c & a w ~ ~ u t  
_ _.....____-____-__  _ _  - - - - -  - -- - 
aciGes7'Tlie portal vein and hepatic artery could then be identified in the cross 
sec~~oiial  view (Fig. 49) and freed for a long enough distance to permit perfor- 
mdllce of the anastomoses. Hemorrhage from the intervening tissue was con- 
trolled with suture ligatures placed both before and after the eventual release 
of the clamp. 
4 life-threatening technical error was made in another patient (OT 6) when 
a lalqe right phrenic vein was avulsed from the side of the suprahepatic vena 
ca\ LI. The rent quickly extended through the diaphragm, and air was observed 
to he passing into the lumen. A large noncrushing Potts clamp designed for use 
in the gastrointestinal tract was applied to a generous rim of adjacent 
diaphragm, and the retracted vena cava was eventually retrieved for 
anastomosis. 
HOMOGRAFT INSERTION 
In principle, the organ placement could hardly be more straightforward 
since it involves simply the reconstruction of the major vascular channels en- 
tering and leaving the liver and the creation of a passage for bile drainage. 
Suprahepatic V e n a  C a v a  
This is the most difficult and dangerous of the vascular anastomoses, not 
only because the lengths of host and homograft vessel which are available for 
sewing are very short. In addition. the presence of the new liver makes it diffi- 
cult to improve exposure by retraction or other manipuiations. Finally, the 
fact that the suture ljne. particularly its posterior portion, cannot easily be re- 
exposed for control of hemorrhage at any subsequent time makes it mandatory 
that a perfect result be obtained. This must be achieved by fashioning the back 
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F l g u r e  49.  Incision en masse of the portal triad. This maneuver has been necessary on two 
occasions when the individual structures could not be dissected free. After the transection, the 
portal vein and hepatic artery could be liberated enough to permit the vascular anastomoses to be 
performed. See text for discussion. 
portion of the anastomosis from within the lumen. For this purpose we have 
used continuous over and over suturing."." The technique will now be 
described in detail since it can often be used to advantage in other situations in 
organ transplantation where there are similar limitations of vessel length and 
exposure. 
The principle of the method." as demonstrated in Figure 50A for a side-to- 
side anastomosis. is the immediate formation of intralurninal shoulders in both 
vessels to be joined. First. sutures are placed in the extremities [Fig. SOA-1) of 
the anastomosis. The snaged needle is passed into the posterior part of the 
lumen of one of the 1 essels 1 or 2 m m  from the line of incision (Fig. 50A4-2). A 
firm bite of the other vessel is then taken, making sure that the entry and exit 
sites of the needle pass through the intima at some distance from the cut edge 
(Fig. 50A-3). The full thickness of the wall is included. If the thread is pulled 
tight, a mound of protruding tissue presents which makes easy the similar 
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Cross- s e c t a n  to 
F i g u r e  50. The principle of the intraluminal suturing technique used in liver transplantation. 
A .  The application of the method for a side-to-side anastomosis. B.  An end-to-end anastomosis such 
as that employed for the suprahepatic vena caral,  infrahepatic vena cal-al, and portal venous recon- 
structions. C .  End-to-side anastomosis. (By permission of Surg. Gynec. Obstet. 127:125, 1968.) 
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placement of subsequent sutures (Fig. 50A-4). When the opposite end of the 
posterior anastomotic line is reached. the needle is passed outside (Fig. 50A-4) 
and the anterior row is completed with an everting oler  and over suture (Fig. 
50A-5). The steps are almost exactly the same for an end-to-end (Fig. 50B) 01. 
end-to-side anastomosis (Fig. 50C). 
The degree of eversion obtained in the back wall is the same as if the 
sewing were done from the outside (Fig. 5OA-6). Consequently, the amount of 
intraluminal suture material is not increased. There are other advantages. A 
perfect intimal coaptation can be assured. If the orifices of tributaries to the 
anastomosed vessels are identified near the suture line, they can be incorpo- 
rated into the shoulder, thereby circumventing potentially lethal para-anasto- 
motic leaks. Immediate tightening of each stitch facilitates placement of the next 
bite, making it unnecessary to grasp or manipulate the vessel wall with forceps. 
For adults and children, respectively, 4-0 and 5-0 silk are used for the 
suprahepatic anastomosis. In most cases the two orifices are of different size. 
necessitating constant correction as individual bites of tissue are taken. There 
is ordinarily no need to have more than the single layer closure around the 
entire circumference (Fig. 50B). In some cases, however, it may be desirable to 
reinforce the back wall. This can be accomplished by a second intraluminal 
layer which everts the first (Fig. 51). 
lnfrahepatic Vena  Cava \ 
In spite of the facts that an extra length of subhepatic vena cava is retained 
with the homograft and that the host vena cava is also left long, tailoring is 
usually not required (Fig. 52). The technique of anastomosis is identical to that 
described above, including intraluminal suture of the back wall. 
Portal Vein  
Excess lengths of both host and homograft portal vein are usually available. 
Both vessels must ordinarily be re-cut so that there is approximation without 
F i g u r e  5 1 .  An alternative technique for performance of the suprahepatic vena caval anastomosis. 
LVith this method the pcsterior row is fashioned in two layers from the inside of the lumen. In recent 
cases this added precaution has seldom been taken. So te  that the cuff of the hoinograft \-essel is 
actualll- the confluence of the hepatic veins and the vena cal-a. (By  permission of Surg. Gynec. 
Obstet. 11 T:659, 1963.) 
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Anomalous Bo 
Figure  52. Recipient operations. In  most recent cases cholecystoduodenostomy has been performed 
for biliary drainage as  shown. C.a. = celiac axis: C.d. = common duct: G.B.  = gallbladder: H.a. = 
hepatic artery: I.v.C. = inferior vena cax-a: P.V. = porta vein: S.m.a. = superior mesenteric artery. 
A .  The kind of arterial anastomosis most commonly used. The homograft celiac axis or common 
hepatic artery is attached to the proper or common hepatic artery of the recipient. B .  Arterial re- 
collstruction of t17-o homograft arteries. The vessels are indi~iduall>- anastomosed to the branches 
of the recipient proper liepatic artery. This technique was used in patients OT 4 and 9. C. 
.\nastomosis of the homograft aorta to the recipient aorta (patient 0 T  12). The variation !$-as used 
in this 16 month old recipient because of the double arterial supp1~- to the transplanted liver. 
'BY permission of Ann. Surg. 168 :392 .  1968.) 
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tension (Fig. 52). In one patient sufficient tissue was not excised; the recon- 
structed vessel was kinked. necessitating reanastomosis. 
Because of the foregoing requirement of perfect length, there is not usually 
enough room to turn the vessels for external suturing of the back wall. The 
continuous intraluminal technique mentioned earlier is applied. employing 6-0 
vascular silk. 
Hepatic Artery 
The usual technique of rearterialization is by anastomosis of the homograft 
common hepatic artery or celiac axis to the recipient common or proper hepatic 
artery (Fig. 52A).  In humans the decision for or against ligation and division of 
the host gastroduodenal and right gastric arteries is one of convenience since 
there is no attendant risk of devascularizing the pancreatic head or duodenum 
as is the case in dogs. A standard continuous arterial suture technique is used 
for the anastomosis. 
The reconstruction is easy in adults inasmuch as the vessels are large. 
being about the same size and consistency as renal arteries; 6-0 silk is used. In 
contrast. the hepatic arteries in young children are both small and fragile, the 
internal diameter at one to two years often being 1 or 2 mm. In such cases the 
use of the graft celiac axis is usually adbisable. This can be connected without 
difficulty to the recipient common hepatic artery. which is always larger than 
normal in patients with biliary atresia. The anastomosis is usually made proxi- 
mal to the right gastric and gastroduodenal branches (Fig. 52A). The suturing 
is greatly facilitated in infant vessels by the use of continuous 7-0 or 8-0 arterial 
silk. 
Homograft Vascular Anomalies 
Some of the most serious technical problems with orthotopic liver trans- 
plantation were caused by abnormalities or anomalies of the blood vessels, 
either of the recipient or of the transplanted liver. Of the first 26 orthotopic 
hepatic homografts used at the University of Colorado, five had two arteries 
each (Table 8). In three patients the vessel to all or part of the right lobe came 
from the superior mesenteric artery. In a fourth the right hepatic artery origi- 
nated from the aorta. The other liver had an aberrant left lobar branch from the 
left gastric artery. 
Se\-era1 different techniques of reconstruction were used. In one adult (OT 
4) and one child (OT 9). the indi~idual  1 essels were anastomosed to the right 
and left branches of the proper hepatic artery (Fig. 32B). In the infant the tiny 
right branch thrombosed nithin 48 hours, causing regional hepatic gangrene 
(Chapter Fifteen). In another child. aged 16 months (OT 12). both homograft 
vessels Jvere removed from the donor in con ti nu it^- n-ith the parent trunks and 
the aorta. The distal end of the homograft aorta n a s  then a~lastomosed to the 
side of the upper abdominal aorta of the recipient, proximal to the celiac axis 
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Table 8 .  Abnormal Blood Vessels Either of the Recipient or the Homograft 
Encountered in 25 Consecutive Human Cases of Orthotopic Liver 
Transplantation at the University of Colorado 
- 
RECIPIENT H O R I O G R A F T  T O T A L  
- 
-- 
Double hepatic artery 3 5 8 
Single hepatic artery from SMA';' 1 0 1 
Hypoplastic portal  vein 1 0 1 
Anteduodenal portal  vein 1 0 1 
Hypoplastic inferior vena cava 1 0 1 
Absent infer ior vena cava 
TOTAL 
SMA = superior mesenteric artery. 
1 The eight variations n-ere observed in five recipients: there were three in one patient, two i n  a 
second. and one each in the three others. Death from technical complications resulted in  three of the 
f i ~  e patlents (see text) 
I11 foul of the fixe patlents a satisfactor\ result n a s  obtalned In the fifth (OT 9). the smaller 
r l ~ h t  hepatlc a r ten  thiombosed vl thln 48 postoperat11 e hours 
(Fig. 52C). Sufficient exposure could be obtained only after incision of the 
covering diaphragmatic crura. The proximal end of the graft aorta was ligated. 
A satisfactory result was obtained. 
The other homografts with two arteries were used for adults. In one patient 
(OT 22) the larger left hepatic branch was removed in continuity with the 
celiac axis which, in turn, was anastomosed to the common hepatic artery of 
the host (Fig. 53). After blood flow was restored through this channel to most of 
the liver, the smaller right hepatic artery. which had originated from the su- 
perior mesenteric artery (Fig. 53A), was attached to the long splenic stump of 
the homograft celiac axis (Fig. 53B) .  Complete hepatic rearterialization was 
accomplished. 
In the final patient (OT 4 )  a single arterial allastornosis of the graft celiac 
axis would have been feasible since a small left hepatic artery originated from 
the left gastric artery (Fig. 54A). Unfortunately the anomalous vessel was in- 
jured during donor hepatectomy. The accident was recognized and a repair 
carried out by an end-to-end anastomosis (Fig. 54B). 
Variants of the  Recipient Vasculature 
These anomalies pro\-ed to be exceptionally dangerous. There were eight 
abnormal situations (Table 8) of which five were found in two patients. One 
child (OT 24) had an absent retrohepatic inferior vena cava, a single hepatic 
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3 C N 3 R  L I V E R  
R h a  M h  a  
F i g z i r e  53.  Method of vascular reconstruction used in patient OT 22 because of the presence of 
two homograft arteries. A.  The anomalous arterial supply. B. The homograft celiac axis was 
anastomosed to the common hepatic artery of the recipient. After blood flow was restored through 
the larger left branch. the homograft splenic artery was attached to the small right hepatic branch. 
C.d. = common duct: L.g.a. = left gastric artery: L.h.a. = left hepatic artery: 3I.h.a. = middle hepatic 
artery: R.h.a.= right hepatic artery: S.a. = splenic artery: S.m.a. =superior mesenteric artery. 
D O N O R  L I V E R  
/"-', 
Aorta 
r Cellac a x ~ S  
, 
R. gastric a .  -' 
F i g u r e  54. Arterial anomaly in patient OT 4. A .  A small left hepatic artery arose from the left 
gastric artery. The variation was not recognized and the left gastric arter)- was ligated. B.  An arterial 
supply to the lateral segment of the left lobe was restored as shown. 
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artery that arose from the superior mesenteric arter? and passed anterior to the 
duodenum, and a portal vein that was also in front of the duodenum (Fig, 55A). 
The reconstructive procedure that was carried out in~ol ' i ed  mobilizing and 
relouting the portal vein and hepatic artery. I11 so doing, the first portion of the 
duodenum was devascularized and had to be resected (Fig. 55B). Postopera- 
tl\ el) the liver functioned poorly and the patient died after 11 days. At autopsy 
thc homograft vessels were patent. Hom ever, the tortuous reconstructed hepat- 
lc irtery was of tiny caliber (Fig. 36). It was suspected that poor hepatic blood 
fln11 had been obtained. The impression was supported by the finding of mas- 
s l ~  necrosis of the homograft (Chapter Twenty). In addition. the head of the 
pailcreas was the site of fat necrosis and other findings of pancreatitis. 
Another pediatric patient (OT 21), aged two years, had two diminutive 
hepatic arteries and a hypoplastic portal vein supplying her diseased liver (Fig. 
571:). Because of the small size of the recipient arteries, an attempt was ini- 
tiall) made to anastomose the hoinograft celiac axis to the host aorta. It was 
nott>d that the hepatic artery was compressed by the overhanging liver; conse- 
quc>ntly. the transplant hepatic artery was eventually connected to the larger of 
the two recipient vessels (Fig. 57B). Systemic heparinization was carried out. 
The arterial supply remained open, but the patient died 12 hours later of a 
pol tal vein thrombosis. 
A similar arterial problem led to the death of anothei patient (OT 20). In 
t h ~ s  patient the celiac axis was also anastomosed to the recipient aorta because 
nelther of the host arteries was of large caliber. Compression of the homograft 
blood supply by the caudate lobe of the transplanted liver apparently occurred 
(Fig. 57A). The patient died of acute hepatic insufficiency 15 hours later. The 
l i ~  er had undergone massive necrosis. 
In two other patients the presence of s double hepatic artery (OT 3) or a 
h~poplastic inferior ~ e n a  cava (OT 10) was riot associated with unusual tech- 
nical complications. In the first patient the larger host hepatic artery was of 
adequate caliber for anastomosis. In the second. the tiny host suprarenal vena 
caLa (about 2 m m  diameter) was anastomosed to the infrahepatic vena cava of 
the homograft. The vena caval orifice of the recipient at the diaphragm was of 
normal size. permitting the suprahepatic anastomosis to be performed in the 
standard way. 
the Question of Size Discrepancy 
Ideally, liver homografts would be obtained from donors of approximately 
the same size and age as the recipients. However. it has become clear that 
highly significant disparities do not preclude success. In Table 9 the body 
eight ratios are summarized for 26 consecutive orthotopic homotransplanta- 
tions. There \rere 17 instances in which the donors and recipients nere  about 
Phs sically equil alent. seven in arhich the donors were distinctly larger, and two 
111 n hich the donors lvere 1 ery small. The most oversized organ was used for 
Patient OT 16B. a tn-o >ear old infant n-ho weighed 11 kg :  the homograft was 
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. b e  
R h v  L h v  
Blind end Iv,c 1 
Figure  55. Multiple anomalies of recipient OT 24. The consequent technical problems of orthotopic 
transplantation are described in the text. 1.v.c. = inferior vena cava: L.11.v. = left hepatic vein; 
P.v. = portal vein: R.h.v. = right hepatic vein; R.v.= renal vein: S.m.a. =superior lnesenteric artery. 
A,  The recipient anatomy. B.  The technique of reconstruction (see text). 
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Fig 11 re 56. Autopsy aortogram in the 
patient (OT 24) whose multiple con- 
genital anomalies are depicted in  
F i g ~ ~ r e  55. There \?-as no celiac axis i n  
the host and the common hepatic 
artery originated from the superior 
mesenteric artery. A .  Anteroposterior 
 vie^^. The origin of the recipient he- 
patic artery is indicated by the lolver 
arl.on-. Its anastomosis to the cornlnon 
hepatic artery of the homograft is at 
the upper arrolr-. Note the extremel?. 
small size of the reconstructed arterial 
chailnel. as well as  the sharp angula- 
tion at the take off of the host hepatic 
arlery. B .  Lateral view. The upper and 
lo\\ ~r arrows indicate the same points 
as 111 2 1 .  A =  aorta. B = catheter ballooi~. 
C l i  = common hepatic artery of graft. 
LII = left hepatic artery of graft. LPH 
= lrf't phrenic artery. LR = left reiial 
artery. RH = right hepatic artery of' 
graft. RPH = right phrenic arterj.  
RK = right renal arter!-. ShlX = su- 
perior mesenteric artery. 
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obtained from a seven year old child whose weight was 25 kg. The most ex- 
treme opposite example was in Case OT 23. in n-hich a 15 year old boy with a 
hepatoma had a 5500 gm liver replaced with the organ of a six year old 27 kg 
donor. The weight of the homograft was estimated to be 750 gm. Calne has 
recently reported a similar e ~ p e r i e n c e . ~  
At first glance the data compiled in Table 9 would suggest that the accep- 
tance of excessively large donors was attended bv an exorbitant risk. In ac- 
tuality, this may not be true. Although prompt vascular calamities occurred in 
three of the seven cases in this category. two of the three accidents were prob- 
ably attributable (Fig. 57) to the recipient anomalies described in the pre- 
ceding section. 
Table 9. Donor-recipient Weight Disparities in 26 Consecutive Orthotopic 
Liver Transplantations in 25 Recipients::: 
SATISFACTORY V A S C U L A R  
NUMBER R E V A S C U L A R I Z A T I O N  C A L A M I T Y  
-- -- 
- 
Weights about equal 17 16 1 t 
Donor larger 
(1.5 -2.3:l ratio) 
Donor smaller 
(< 2:3 ratio) 
Patlent OT 16 lecelr ed t u o  homografts The actual ages and neights for each patlent a le  gl\ en 
In Chapter Tnent\-foul  
+The  recipient n a s  the one n l t h  multlple congenital anomalies (Fig 35) At autopsk the \ essels 
were patent but 1: \ras suspected that an effectlr e blood floxr had not been restored to the homograft 
(see text) 
:In trio of these three patlents there Lrele allornal~es of the recipient essels (Flg 37) \rhlch 
probably played the key role In precipitating the vascular calamities (see text). 
Biliary Drainage 
In four of our first five patients. a two-layer choledochocholedochostomy 
was performed, the inner row being with interrupted 6-0 chromic catgut su- 
tures. A T-tube was placed through a stab wound in the recipient common duct 
and the upper limb passed proximally through the anastomosis (Fig. 58). The 
homograft gallbladder was remol ed. It was hoped to obtain a physiologically 
normal reconstruction. This method cannot, of course. be used in biliary 
atresia. 
hIore recently. Calne' has also emplo>ed choledochocholedochostoiny or, 
alternatively. cl~olecystocholedocliostomy to effect bile drainage. The benefit of 
preserving function of the sphincter of Oddi for the prelention of subsequent 
cholangitis is probably a significant one. as will later be suggested in discussing 
infectious comphcations (Chapters Fifteen and Sixteen). 
from sup. rnesenterlc a. 
Cdlac axis , ,, __,, L.H a. 
Flglcre 57 Anomalous hepatic arterlal supplr encountered In two pediatric recipients of ortho- 
topic homografts In each the larger right hepa t~c  alter1 ol~glnated from the superlor mesenteric 
a l t e l ~ ,  the small left branch came from the cellac axls d Attempted arterial leconstruction The 
homograft cellac axis was anastornosed d l rec t l~  to the leclpient aorta Vote the compression of the 
110 lloqraft altellal s u p p l ~  b~ the oxelslzed hoinoglaft This n a s  not detected ln patient OT 20 and 
leculted In death 13 houls later B In the second patlent OT 21) ~t \ \ a s  lecogil~zed that the abole 
letonsr~ucrlon nould not be sat lsfacto~\  the homoelaft cellac avls \!as then anastoinosed to the 
.i11o11ialous essel orlplnatli~g flom the supello1 mesentellc altel\  H o ~ i  el el the chlld dled 12 hours 
ldrri of poltal i eln thlolnbos~s to ~ \ h l c h  the slze dlspalltr of the poltal 1 essels plobabl\ contllbuted. 
t1lr iecipleilt poltal xeln IIas h~poplast lc  ,B) pelmisslon of Gluile S Stlatroll, Inc , 1969 
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Figure 58. Method of biliary tract reconstruction used for patients OT 2 to 5 .  A choledochochole- 
dochostomy was performed with an inner layer of 6-0 chromic catgut. reinforced with an outer 
row of 6-0 silk. A T-tube was placed through the recipient portion of the reconstructed duct. The 
gallbladder was removed. 
However. there are important disadvantages of choledochocholedochos- 
tomy. One i s  the necessity of leaving a tube prosthesis and a drain in  a patient 
who must  be treated with immunosuppressive agents. and in  whom the duct 
reconstruction must  be placed in close proximity to the vascular anastomoses 
of the hepatic artery and portal 1 ein. Also, there may not always be a n  adequate 
blood suppl! to the distal portion of the homograft cotnmon duct mhich nor- 
mally receil es its principal arterialization from retroduodenal sources.'-l and 
which no\\ depends on retrograde flon from arteries in  the central hilum. One 
of our early patients died from slough of the distal common duct and conse- 
quent bile peritoilitis iOT 3 ) .  
In  all cases subsequent to OT 3 ,  biliary drainage has electively been with 
c h o l e c y s t o d u o d e ~ ~ o s t o ~  after ligation of the distal colnnlon duct of the 
homograft. X t \ \ o - l a ~ e r  anastomosis n-as used with a n  inner mucosal row of 
continuous 4-0 chromic catgut and a n  external layer of interrupted 5-0 silk 
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through the serosa and submucosa (Fig. 32). In a fe\v patients, a Kocher ma- 
neuver was needed to obtain adequate duodenal mobility. 
The technique of biliary tract drainage had to be modified in two patients. 
The variation in one (OT 24) was described before (Fig. 55). In the other patient 
(OT 17) the change was necessitated by a concomitant gastric resection. A 
hepatoma which had been diagnosed three months previously had invaded the 
p!lorus and antrum. Two thirds of the stomach was removed; the gallbladder 
\\,IS anastornosed to the second portion of the duodenum and gastric drainage 
provided by a posterior gastrojejunostomy (Fig. 59). Bilateral truncal vagotomy 
was added. 
Figure 59. Method of reconstruction used in patient OT 17. The modification which included 
gastrectomy was necessary because of invasion of the stomach by the hepatoma. Before closing the 
abdominal incision, the gastrojejunostomy IT-as drawn down and sutured circumferentially to the 
transverse mesocolon, eliminating the potential defect. 
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In one of our more recent recipients (OT 25). a primary cholecystoduode- 
nostomy failed because of the accidental production of complete biliary ob- 
struction. Re-exploration was carried out three days later and a conversion 
made to a choledochocholedochostomy. The case will be presented in detail in 
Chapter Nine. 
Operative Staging 
In four of our first patients (OT 2 to 5) the recipient procedure was done in 
two stages. At a preliminary operation the major structures above and below 
the liver were skeletonized. The incision was then closed and patient taken to 
the recovery room with provisions for return to the operating room at a mo- 
ment's notice. In each instance, a desperately ill potential donor was in the 
hospital. FonkalsrudX has used the same kind of double operation. 
At the time this approach was used there were no effective means of organ 
preservation. The staging was, of course, designed to shorten the interval be- 
tween donor death and graft revascularization in the recipient. Within a few 
minutes after donor death the recipient incision could be reopened and the 
diseased liver removed. 
The need for such urgency no longer exists, not only because of improve- 
ments in conservation techniques (Chapter Five), but also because of the emerg- 
ing new criteria to define donor death (Chapter Two). This is fortunate since 
the two closely spaced recipient operations were poorly tolerated. Moreover, it 
was impossible to predict the time of complete circulatory arrest in the donor 
with any degree of certainty. In one of our cases, the interval between the first 
and second operation was 22 hours. In the others. it was from two to 14 days. 
l iver Fixation 
In animals the supporting ligaments of the liver are not reattached. A seal 
quickly forms between the homograft and the diaphragm. Torsion of the liver 
has never been observed in our experience after orthotopic transplantation in 
either pigs or dogs. The omission of this step in patients may have serious 
consequences, as mill be discussed in Chapter Fifteen, probably because of the 
assumption of an  upright position by humans. Consequently. in all of our later 
cases, the li\-er homograft was firmly reattached to the diaphragm. 
The falciform ligament is the easiest structure to n-ork with in both the 
homograft and the patient: the cut edges are firmly sewed together with con- 
tinuous 3-0 chromic catgut. Less complete reunion of the left triangular liga- 
ment can also usually be accomplished in the same n-ay (Fig. 60). A continuous 
suture cannot be used for the coronary or right triangular ligaments. but tags of 
these structures can usually be tacked with figure of eight sutures to portioils 
of the retroperitoneal raw area. 
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Figzire 60. Resuture of the suspensory ligaments of the transplanted liver. 
Splenectomy 
Eighteen of the 25 patients treated with orthotopic liver transplantation 
have also had splenectomy. This procedure has been used in our institutions for 
recipients of renal homografts for a number of years. although it has not been 
proved that it is a worthwhile adjuvant immunosuppressive measure. The ra- 
tionale for splenectomy. which has been discussed at length e l ~ e w h e r e . ' ~ ~ ~ ~  is 
based primarily upon the demonstration in experimental animals that the re- 
sponse to intravenous antigens is attenuated after splenectomy. A second pos- 
sible benefit could be that a restraining influence upon the peripheral white 
blood count might be removed by this procedure. thereby permitting better 
dose control of azathioprine. 
In many recipients of liver homografts. particularl? children with biliary 
atresia, there are less esoteric justifications for splenectomy. The organs are 
often extraordinarily large. In the children with biliary atresia in our series the 
spleens weighed from 93 to 415 gm. It was thought desirable to remove them 
for purely mechanical advantages. hIoreo\er, secondary hypersplenism was 
thought to exist before transplantation in these children as well as in some of 
the adults with hepatolna superimposed upon cirrhosis. Preoperatil e leukope- 
nia and thrombocytopenia mere colnnlon in such cases. 
In all instances in n-hich it was performed. the splenectomy was carried out 
as the last step in the operation. By so doing. the portal hypertensi~n had al- 
ready been partially relieled by decompression through the nen-ly placed 
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homograft. Difficulties with venous bleeders in the splenic bed were thereby 
minimized. 
Splenectomy was omitted in seven patients (OT 1. 3. 4. 5. 14, 22, and 24) 
because the operation had already been too traumatic or because the presence 
of a bleeding diathesis made the undertaking too hazardous. 
Closure 
Drains were not used except in the early cases in which biliary reconstruc- 
tion was with choledochocholedochostomy. The wounds were closed with in- 
terrupted fine silk technique. Stay sutures were not used. 
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Chapter Nine 
INTRA- AND POSTOPERATIVE 
COMPLICATIONS AND CARE 
Much of the remainder of this book will be preoccupied with the therapy that 
is necessary to prevent rejection of homografts without at the same time causing 
death by overcomplete crippling of the host immunologic defenses. The risks 
thereby introduced are probably greater (Chapters Fourteen to Sixteen) than 
those which must be borne by recipients of other organs such as the kidney. 
heart, or lung. 
There are, in addition, a number of other hazards with hepatic transplanta- 
tion, many of which derive from the complicated surgical requirements for 
successful replacement of the whole liver as well as from the metabolic 
derangements that can follow even after a technically perfect operation. In this 
chapter, the incidence, treatment, and prevention of these essentially nonim- 
munologic complications will be described. 
THE INTRAOPERATIVE PERIOD 
Earlier the complexities of anesthetic management during and after the 
anhepatic phase were described. The rapid and potentially life-threatening meta- 
bolic changes during this interval could be accurately corrected only with the 
aid of frequent measurements of several biochemical indices. This aspect of 
the intraoperative care (Chapter Seven) will not be mentioned further except to 
draw attention to its importance in preventing sudden death or permanent 
brain injury on the operating table; instead, the following section will be con- 
cerned with a variety of technical problems. 
Special Problems 
Hemorrhage. It is not surprising that bleeding has often been difficult to 
control during and after orthotopic transplantation. Some of the causative fac- 
tors such as  portal hypertension may be mechanical, secondary to the pathology 
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afflicting the liver which is removed (Chapter Eight). Others are due to the 
decreases in the effectiveness of clot formatioil (Chapter Ten). which are 
roughly proportional to the magnitude of ischemic injury to the liver (Chapters 
Six and Ten). The result may be diffuse oozing from all raw surfaces. When a 
bleeding diathesis develops, the diagnosis usually becomes clinically evident 
lvithin 30 to 60 minutes after revascularization, in some cases after an  initial 
period of completely adequate hemostasis. 
Unless the new liver has been irreparably damaged. the hemorrhage will 
often cease spontaneously without any specific therapy. It is important to 
quickly survey the entire operative field for major bleeding sites, particularly at 
the anastomoses. If localized hemorrhage cannot be found and controlled by 
ligature or suture, the best policy is usually to place the homograft in the liver 
f'ossa and avoid all manipulation for a half hour or longer. As the portal hyper- 
tension is relieved through the new liver and the organ resumes elaboration of 
clotting factors, the wound may become dry. 
If this does not happen, the fact that a coagulation disorder may be present 
should not obscure the possibility that there might be a defect in the vascular 
system of the homograft in some inaccessible location. In several cases we 
have found an untied tributary in the posterior wall of the retrohepatic vena 
cava, and in another there was a leak in the posterior part of the suprahepatic 
vena caval anas tomosis. 
Continuation of hemorrhage from multiple locations after these maneuvers 
have been completed is an ominous sign. Exhaustive efforts must then be 
made at mechanical hemostasis of capillary bleeders with suture ligatures and 
cautery. As a last resort, thrombogenic agents can be given (Chapter Ten) de- 
spite the risk that these may contribute to later thrombotic  complication^.^^^^^ 
This kind of case may gradually take on a nightmare quality when it is realized 
that bleeding cannot be controlled sufficiently to permit closure of the incision 
with any hope of survival. Two such patients (OT 5 and OT 6) required 12 and 
18 hours of continuous effort, respectively, before their operations could be 
successfully concluded. One of our recipients (OT 1) bled to death on the 
operating table. The same complication has been reported from other 
centers.& lo .  l 1  
Total Arterial Thrombosis. There have been two examples of main hepatic 
artery thrombosis within a few minutes after homograft revascularization. One 
was in our series (OT 18) and the other was reported to us by Dr. Allan Birtch of 
the Peter Bent Brigham Hospital in Boston.The events in the two cases had 
certain similarities. 
The circumstances of donor death were unusually advantageous for the 
procurement of minimally damaged organs since total body hypothermia was 
being used in an attempt to treat the ultimately lethal brain injury. In both 
cases the recipient was brought to the operating room and had mobilization of 
the diseased liver while the donor still had an effective circulation and was 
being maintained on a respirator. When ventilator support was stopped, the 
donors died within a few minutes. Their lix-ers were further cooled by infusion 
(Chapter Five), quickly remox-ed. and immediately transplanted. Both 
homografts were thought to have sustained almost no ischemic damage. They 
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promptly excreted large volumes of bile. The wounds were noted by the sur- 
geons in both institutions to be remarkably dry. However. within an hour the 
hepatic arteries had clotted at the sites of anastomoses. The livers, which were 
now perfused only with portal flow, became cyanotic. 
Reanastomosis was performed. In the Brigham case. excision and recon- 
struction resulted in a second thrombosis. The right kidney of the 16 year old 
recipient was then removed and a renal to hepatic artery anastomosis per- 
formed. In our patient, who was 12 months old, the anastomosis was locally 
excised and reconstructed. Unfortunately, heparin therapy was not instituted in 
either case, although the Boston patient was given dextran. The vessels of both 
homografts reclotted during the early postoperative period with eventual disas- 
trous consequences. 
Complete thrombosis of the homograft arterial supply leads to the death of 
canine and porcine recipients within a few hours. The effects in the two pa- 
tients just described were much more indolent and they were slow enough in 
evolution so that corrective surgery might have been possible had the diagnosis 
been made promptly. In the Boston case the rethrombosis was proved by aor- 
tography on postoperative day 21. several days after partial necrosis of the left 
liver lobe had already occurred and had become the focus for a gram negative 
septicemia. It was suspected that the dearterialization had occurred at a much 
earlier time, probably within 36 hours after transplantation. Except for early 
high increases in the transaminases, the hepatic function tests were disturbed 
very little at any time during postoperative life. Furthermore, the dearterialized 
liver visualized well with radioisotope scanography, as might have been pre- 
dicted from the experimental studies of Groth." Eventually the left upper abdo- 
men was re-explored and the partially necrotic liver was drained. The patient 
died six and a half weeks after transplantation with widespread sepsis. At au- 
topsy there were scattered small mature infarcts in the periphery of the right 
lobe in addition to the drained septic infarct on the left. The great bulk of 
hepatic parenchyma was viable and structurally intact. 
The downhill course of our patient (OT 18) was more rapid but illustrated 
some of the same points. After the transplantation she was returned to the 
intensive care unit in excellent condition at one o'clock in the afternoon. 
During the day she had hypertension, with systolic blood pressures of 150 to 
200 m m  Hg, and was wide awake. At 6:15 P.M. she was weighed on a bedside 
scale, and immediately afterward was noted to be somnolent and to have a 
systolic pressure of 80 m m  Hg (Fig. 61). 
Reclotting of the hepatic artery mas suspected, but the serum trans- 
aminases then and at six-to 12-hour intervals for the next 24 hours were only 
slightly elevated. Hornever, at 10:OO p.nr.  the following evening both the SGOT 
and SGPT suddenly rose to more than 10.000 units (Fig. 61). A liver scan 
showed almost no isotope concentration in the area of the liver. It was con- 
cluded that the opportunity to restore the arterial supply had been lost by 
procrastination. that massive necrosis had already occurred, and that the only 
hope of survival would be the transplantation of a second graft. A donor could 
not be found and the child died t n o  and a half days later. Blood cultures just 
before death contained Eschericlzin coli. 
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Figure  61. The course of a one year old child (OT 18) with extrahepatic biliary atresia who was 
treated with orthotopic liver transplantation. The hepatic artery of the homograft apparently under- 
went thrombosis within a few hours after operation. but this fact mas not reflected in transaminase 
rises until almost a day later. The eventual drop of the hematocrit to allnost zero was due to massive 
hemolysis. (By permission of Grune & Stratton. Inc.. 1968.) 
The infant's original disease was biliary atresia. Before operation her serum 
bilirubin was 16.2 mg per cent. This fell to 3.2 mg per cent and then rose 
progressively until death (Fig. 61). The significance of the deepening jaundice 
was obscured by hemolysis which began on the second postoperative day and 
which eventually was so overwhelming that the hematocrits fell to zero during 
the last 24 hours of life (Fig. 61); on peripheral smear it was impossible to find 
a single intact red cell except just after an i s o ~  olumetric exchange transfusion. 
At autopsy there was massive but incomplete necrosis of the liver (Chapter 
Twenty). which had a thrombosed artery and an intact portal L ein. There was 
also widespread blood pigment deposition throughout all tissues. 
Study of these two cases does not provide clear guidelines for the early 
detection of hepatic artery occlusion, although in our patient the sudden changes 
in peripheral vascular dynamics and in sensorium should have made the diag- 
nosis possible had not a judgment error been committed. It is clear from this 
experience that tests such as the serum transaminases or liver scans can re- 
main normal or at least nondiagnostic until the situation has become irrever- 
sible. It is likely that aortography will prove to be the only really decisive 
148 / INTRA- AND POSTOPERATIVE COMPLICATIONS AND CARE 
way of consistently establishing the diagnosis nhile there is still time to at- 
tempt repair. providing this procedure is done at the first suspicion of a vascu- 
lar accident. I11 turn. surgical restoration of arterial flow is mandatory if there is 
to be hope for long sur\ival. Although hepatic arterial ligation is surprisingly 
well tolerated in both cirrhotic4% 1 o  and noncirrhotic' I ?  patients, this cannot 
be expected to be equally true early after orthotopic hepatic transplantation. 
It is ironic and probably more than coincidental that these two vascular 
accidents occurred in patients who received superb liver grafts and who prob- 
ably lost the "auto-anticoagulation" effect which follows hepatic injury. The 
same thing had been previously noted in laboratory experiments." With in- 
creased experience and with improved immunosuppression it was observed 
that there was a rise in the incidence of arterial thrombosis after orthotopic 
transplantation of the canine liver. Under optimal clinical circumstances of 
organ procurement and preservation it may, therefore, be appropriate to con- 
sider prophylactic anticoagulation after human liver transplantation. Certainly, 
if intravascular clotting is demonstrated during operation, as was the case in 
the patients just described, heparin therapy should be started at once. 
lobar Arterial Thrombosis. A homograft with two hepatic arteries underwent 
partial gangrene within 48 hours postoperatively, when the anastomosis of the 
smaller right branch thrombosed. The case (OT 9) is more fully described in 
Chapters Eight, Fifteen and Sel enteen. Survikal was for four and a half months. 
Nonthrombotic Arterial Occlusion. In Chapter Eight, two cases were cited in 
which 1 ascular anomalies in the recipients necessitated the use of nonstandard 
implantation techniques. In one of the patients (OT 20), the hepatic arterial 
supply was apparently pinched off. although it did not clot (Fig. 57A, Chapter 
Eight); death followed 15 hours later as the result of acute hepatic insuffi- 
ciency, including an uncontrollable bleeding diathesis. The other pediatric 
recipient (OT 24) who had complex congenital malformations of the upper 
abdominal viscera (Fig. 55. Chapter Eight) probably had poor blood flow 
through a kinked hepatic artery (Fig. 56. Chapter Eight). She died of hepatic 
insufficiency after 11 days; at autopsy the homograft was necrotic. 
Portal Vein Thrombosis. In the child (OT 21) who died 12 hours after opera- 
tion from this complication, anatomic anomalies of both the recipient portal 
vein and hepatic arteries probably played an important role (Fig. 57. Chapter 8). 
Complete Biliary Obstruction. The only patient in our series who received an  
orthotopic l i ~ e r  transplantation for Laennec's cirrhosis (OT 22) died as the 
result of a technical error. The c) stic and common ducts of the homograft were 
fused. being separated by a septum. The common duct ligature occluded both 
lumens and prel ented the passage of bile into the gallbladder (Fig. 62). 
Postoperatively. jaundice inexorabl) dex eloped: other indices of hepatic 
function were initially adequate (Fig. 63). Although the correct diagnosis was 
entertained, re-exploration was not carried out until 10 days later when a sec- 
ond cadaveric donor became available. The patient was desperately sick by 
this time and died on the operating table. 
An opportunity was lost in this case to determine if the hepatorenal syn- 
drome could be relersed by tlie provision of a new liver. During the days pre- 
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Figure  62.  The anatomic basis for a technical error which cost the life of patient OT 22. Distal 
ligation of the double-barreled extrahepatic duct system resulted in  total biliary obstruction. 
ceding operation the patient had become oliguric and azotemic. After the 
transplantation renal function did not improve (Fig. 63). 
A second patient (OT 25) was also lost because of a similar unrecognized 
anomaly. In this case. the homograft cystic duct passed behind the common 
duct and descended for almost tmo inches in the relationship shown in Figure 
64. The obstructing ligature was placed just at its entry into the common duct. 
The resulting pattern of the early postoperative course was almost identical 
to that of the earlier recipient in that the biochemical changes were highly 
huspicious of obstruction. Re-exploration was carried out after three and a half 
days. The gallbladder was removed. the duodenotomy was closed. and biliary 
drainage was re-established \vith a choledochocholedochostomy (Fig. 64B). The 
anastomosis was performed n-ith interrupted 6-0 and 7-0 silk in bites that just 
stayed outside the mucosa. The cystic duct portion of the double lulnened 
homograft structure was incorporated into the posterior nall  of the suture line 
Fig. 64). Neither a T-tube nor any other kind of internal splint mas employed. 
During the next fen  days there n a s  marked clearing of the hyperbilirubine- 
~nia .  Jaundice then deepened again. apparently as the consequence of rejection. 
The in~munologic process n a s  controlled. but t n o  neeks after the secondary 
procedure a bile fistula and peritonitis developed. The patient died 39 days after 
transplantation. 
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Figure  63. The course of a patient (OT 22) n7hoJe hiliar?- duct system was completely obstructed 
by the accident shown in Figure 62. The alkaline phosphatase values are in Bessev-Lowry units 
(normal 1 to 3 ) .  
jr 
common duct 
duct  
/ <  
Panc reas  
Figure  64. A. An anomaly encountered in patient OT 25. The cystic duct passed posterior to the 
common duct and descended for almost 2 inches as  one compartment of a double-barreled lumen. 
The distal ligature caused total biliary obstruction. B .  Three and a half days later the gallbladder 
was removed and biliary continuit>- restored with a choledochocholedochostom~ 
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Air Embolism. In several recipients tears Tvere made in the inferior vena 
ca\ a or its tributaries during mobilization of the diseased liver. During repair of 
the defects the anesthesiologist was asked to maintain continuous positive 
pressure ventilation. In spite of this precaution. air bubbles were observed to 
ellter the venous system and pass into the thorax. 
Only one patient (OT 2 3 )  had aftereffects which might have been attribut- 
able to this complication. Immediately after the operation he had diffuse 
neakness of both legs, with the predominant involvement being of the muscles 
supplied by the peroneal nerves. Ankle braces were required for several months 
to permit ambulation. It was speculated that the air might have passed to the 
systemic arterial circulation via a small patent foramen ovale. However, at 
autopsy 143 days later. the atrial septum was intact. 
Adrenal Infarction. In removing the recipient liver and the enclosed seg- 
ment of vena cava, the right adrenal vein must be sacrificed (Chapter Eight). 
The adrenal gland underwent venous infarction in two of our patients. The 
necrotic organ was discovered at autopsy 10 days after operation in patient OT 
7. In the other case (OT 17), the congested gland ruptured 24 hours after 
transplantation, causing a massive intra-abdominal hemorrhage. An emergency 
right adrenalectomy was performed. 
Right Diaphragmatic Paralysis. Four of our patients, all children (OT 8. 9, 10, 
and 16), were found after transplantation to have paradoxical movement of the 
right hemidiaphragm. The finding, which had not been present at preoperative 
fluoroscopy, was thought to have resulted from crushing of the right phrenic 
nerve by the vascular clamp which was applied to the suprahepatic inferior 
s ena cava (Fig. 65). The diaphragmatic paralysis (Fig. 66) persisted for ten, 
seven, two, and six weeks, respectively. In one patient (OT 8), failure of the 
right upper pulmonary lobe to expand prompted its removal during the fourth 
postoperative week. In most cases the complication can be avoided by 
developing a longer host vena caval cuff and by taking care not to include any 
diaphragm in the bite of the clamp. 
Intestinal Injury. During removal of the liver of several patients with biliary 
dtresia. bowel trapped at the site of previous hilar dissection was perforated. 
Rents in both small intestine and colon were immediately closed in two layers. 
They healed without complication. 
THE POSTOPERATIVE PERIOD 
Acute Problems 
The first several hours after return from the operating room must be con- 
sidered as an extension of the anesthesia time and. accordingly. this interval is 
considered in detail in Chapter Seven. The patient is ordinarily kept on a 
mechanical ventilator until he resists this kind of support. The endotracheal 
tube is not removed until the adequacy of spontaneous respiration has been 
established by serial blood gas studies which can be obtained from the 
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Diaphragm 
L i v e r  
Figure 65. Probable mechanism of operative injury of the right phrenic nerve in  four pediatric 
patients. Note the inclusion of the nerve in the bite of the vascular clamp. which has been placed 
across the suprahepatic vena cava and which has also included a piece of diaphragm. 
Figzcre  66. Paralysis of the right diaphragm four da>-s after orthotopic lil-er transplantation in  a 
19 month child !OT 8 ) .  The arrolr. indicates the trans\-erse fissure. ~1-11ich i i  displaced superiorly. 
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indwelling radial artery catheter. In the meann-hile the fluid replacement 
described later is stabilized. 
Continued Respiratory Care. There are many reasons why tracheobronchial 
care has overriding significance in recipients of orthotopic liver homografts. 
First, the operation is a long and difficult one which usually involves con- 
siderable trauma to both diaphragms. Second, it has been speculated'!' that the 
placement of a foreign organ in the subphrenic spaces might predispose to 
fluid accumulation or other sympathetic reactions in the overlying thorax; 
pleural effusions or lower lobe atelectasis have been seen in several of our 
patients. Finally, the patient with serious liver disease can be expected to go to ' 
the operating room with a variety of easily measurable cardiorespiratory handi- 
caps, which have been summarized by Bashour. McConnell. and Miller.:' These 
can include a loss of vital capacity, an increased physiologic dead space, an 
inefficient kind of hyperventilation, and large volume venoarterial shunting 
rvith consequent peripheral oxygen desaturation. Fortunately at least some of 
these abnormalities are rapidly corrected by successful liver replacement. For 
example, the V-A shunts have been shown to close, at least functionally. within 
hours or days after transplantation in children with biliary atresia.'" 
The recipient should be fully awake by the time of extubation and capable 
of voluntary coughing. The slightest unwillingness to do so is an indication for 
vigorous nasotracheal suctioning. This can be done in the semi-Fowler position. 
Except for this concession: the patients are kept in a supine position for the 
first 24 to 48 hours. Humidified oxygen is given by face mask or through a 
nasal tube. 
There may be special problems in very young children who cannot follow 
commands, and in whom effective nasotracheal suction may- be difficult. In 
such cases catheters have been inserted into the trachea by direct laryngoscopy 
every three or four hours. To minimize upper airway trauma and irritation, 
continuous gastric intubation has been avoided. Instead: a tube is passed into 
the stomach every two hours and then immediately removed after the comple- 
tion of aspiration. After one or two days postural drainage exercises are begun. 
Several acute respiratory problems were encountered in our series. The 
four right phrenic nerve injuries were mentioned earlier in this chapter. One 
other patient (OT 11) developed a left pneumothorax which was treated with 
catheter drainage: the source of the air leak n-as never determined. Several 
patients required the needle aspiration of serous pleural fluid. Bronchoscopy 
was performed in two patients (OT 14 and 17). because of persistent segmental 
atelectasis in the lower lobes. 
Two patients had very troublesome laryngotracheal complications. One was 
an infant (OT 11) who \vas not kno~vn to have had previous feeding problems. 
After transplantation. aspiration occurred with every meal until it was found 
that this could be pre~rented by keeping her in a chalasia chair. The difficulty 
spontaneously resol\-ed in two weeks. The other patient (OT 14), a 16 year old 
girl. developed a circumferential granuloma in the subglottis which was 
thought to have resulted from prolonged endotracheal intubation during and 
after operation. \{'hen she developed a high degree of airway obstruction, the 
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area was given 1800 R local irradiation OF er a one-week period which resulted 
in amelioration of the symptoms. 
Pulmonary sepsis eventually developed in almost all our first liver recipi- 
ents (OT 1 to 7) and either caused or contributed to the fatal outcome. There 
were apparently a number of factors which played a cumulative role in the 
genesis of these complications (Chapters Thirteen and Sixteen). of which 
overimmunosuppression and use of badly damaged homografts were probably 
the most important. Patients treated subsequently (OT 8 onward) were less 
susceptible to pulmonary infection. 
Intravenous Therapy and Alimentation. The first seven recipients of orthotopic 
livers (OT 1 to 7) either never could take a full diet or were able to do so for only 
brief periods. The consequent difficulties with fluid therapy. particularly when 
secondary renal failure developed, were recounted in Chapter Six. In contrast, 
most of the later patients who survived operation without serious technical 
complications did not require parenteral fluids for more than a few days. 
In the later cases the guidelines for intravenous therapy were relatively 
simple. They called for the constant delivery of appropriate doses of glucose, 
the maintenance of a normal acid-base balance, and the avoidance of fluid 
overload. The first tnro objectives were easily and accurately met with the aid 
of frequent measurements of serum electrolytes and plasma glucose. Usually 
standard solutions of 5 per cent glucose in 0.1 or 0.2 normal saline were ad- 
ministered; sodium bicarbonate and potassium were added according to the 
calculated need. The patients were also kept relatively dry, despite which tran- 
sient edema, ascites, and hypoproteinemia were frequently seen (Chapter Six). 
The fluid intake for the infants was 40 to 60 mllkg per day: for adults it was 
usually less than 3 liters per day. In a few cases in which hypoproteinemia 
became severe or in which there was evidence of low blood volume. intravenous 
human albumin nras given. 
Gastrointestinal Ulceration or Bleeding. Three (OT 3, 5, and 6) of the first 
patients (OT 2 to 7) who survived operation developed significant gastro- 
intestinal hemorrhage during the few remaining days of life and were found 
at autopsy to have erosive esophagitis with invasion by Carzdidn albica7zs 
(Chapter Sixteen). These complications were largely prevented during the early 
convalescence of the subsequent recipients; the only GI hemorrhage during the 
first postoperative month was after heparin therapy had been started in Patient 
OT 17. The difference in these results was probably due to the better quality 
homografts used in the later series. Hoxaearer, as will be mentioned in Chapter 
Seventeen, the patients with protracted survival were not exempt from gastro- 
intestinal hemorrhage many months after operation. 
Pulmonary Embolization. At autopsy 22. seven and a half. and six and a half 
days after transplantation. multiple emboli were found in the pulmonary ar- 
teries of the first three patients (OT 2 to 4) xvho lived through the operation.'O, 
It is probable that the use of external bypasses and the administration of clot- 
promoting agents in these cases nere  at least partially responsible (Chapter 
Ten). After these practices were discontinued, there were no additional exam- 
ples in the next 21 recipients. 
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pancreatitis. There were tm-o examples of clinically significant pancreatitis. 
~ 0 t h  were apparently caused by operative trauma to the gland. In one patient 
(OT 17) the pancreatic tail may have been injured during splenectomy. There 
were no symptoms for the first postoperative month. Then she developed episod- 
ic cyanosis which was erroneously thought to be due to pulmonary emboliza- 
tion; in actuality, the etiology was a Pseudomonas pneumonitis. On the basis of 
the incorrect diagnosis, systemic heparinization was instituted. Gastrointestinal 
and intra-abdominal bleeding followed. At re-exploration, fat necrosis 
surrounded the entire pancreas. The source of the intraperitoneal hemorrhage 
was near the tail. The tail was resected and contained histopathologic evidence 
of' pancreatitis. Cultures from the specimen and from the left subphrenic space 
revealed Cundidn nll?icu?zs. 
Acute inflammation of the head of the pancreas and extensive fat necrosis 
of the surrounding tissues was found at autopsy in Patient OT 24, 11 days after 
transplantation. This was the child with multiple congenital anomalies whose 
duodenum had undergone necrosis at  the time of the original operation (Fig. 
55, Chapter Eight). 
Pancreatic tissue was studied in all the other recipients who died from a 
few days to more than 13 months after orthotopic liver transplantation. There 
were histologic findings of mild acute, subacute, or chronic pancreatitis in 
some of the patients, but the disease had not apparently contributed to the fatal 
outcome in any of these patients. 
Arterial Hypertension. An extremely perplexing observation was made in 
three children (OT 13, 16, and 18). After their return to the intensive care unit, 
they had hypertension of such severity that therapy with reserpine was started. 
One of these patients died after four days. The other two continued to require 
treatment for several months. The urines from these three recipients and from 
another child who did not develop high blood pressure (OT 19) were examined 
by Dr. Charles Chidsey%f our institution and by Dr. Lawrence Krakoff of 
Columbia University. 
The excretion of aldosterone was not increased, nor were there elevations 
of the plasma renin concentration. However, abnormally high levels of norepi- 
nephrine and'or tyramine were found in two of the three patients with hyper- 
tension (Table 10). The serial changes were of particular interest in the child 
(OT 16) who received two livers. After the first operation the initially normal 
1-alues began to rise with the onset of a rejection that ultimately necessitated 
retransplantation. In the first weeks after placement of the second homograft, 
the measurements of tyramine returned to normal. 
The findings provided a plausible explanation for the hypertension. It is 
probable that tyramine degradation by the liver avas depressed in at least some 
of the recipients. Tyramine is an aromatic amine which is normally formed in 
the gastrointestinal tract by the decarboxylation of tyrosine and which is then 
detoxified by hepatic monoamine oxidase. The sympathomimetic properties of 
tpramine are thought to be by its induction of norepinephrine release from 
adrenergic nerve endings. 
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Table 10. Twenty-four Hour C'rinary Catecl~olamine and Tyramine 
Determinations (pg) in Four Pediatric Recipients of Orthotopic Liver 
Homografts and in Sel-en Normal Children 
POST- BLOOD A ~ T I H Y P E R -  
OPERATIT  E E P I \ E P H -  hOREP1-  P R E S S L R E  T E h  S I l  E  B I L I R U B I h  
P A T I E ~ T  DAY R I Z E  VI.PHRIVE T Y R A \ I I ~ E  (min Hg) D R U L S  (mg ' r )  
OT 16A 2 0 18.7 8.7 120/70 - 3.4 
3 0.5 5 .7  10.9 16011 12 - 2.9 
10 0 27.5 46.2 1901120 + Reserpine 1.4 
148190 
16 0 .7  10.4 143.5 130176 Reserpine 4 . 0  
24 0 33.0 968.0 142188 Reserpine 7.3 
25 0 33.6 892.0 l50/90 Reserpine 8.0 
OT 168 
(2nd Jiver) 
OT 18 1 25 3.5 10.6 19511 10 + Reserpine 3.5 
70lP 
Control 1 
2 
3 
4 
5 
6 
7 
Continuing Care 
None of the patients who were given badly damaged organs or who had 
uncorrected technical complications were ever returned to a reasonable state of 
health. During their remaining days they passed from crisis to deepening crisis 
until the time of death. which was usually caused by a multiplicity of factors. 
In contrast, the recipients of homografts which functioned reasonably well at 
the beginning were usually able to begin eating and to resume a number of 
other normal activities within a few days. 
With the latter kind of patient it was not possible to predict the magnitude 
of the rejection which was anticipated to follo~v. Consequently, all were treated 
with the expectation that the process of homograft repudiation would be severe 
and that a period of secondary hepatic dysfunction svould have to be endured at 
some time during recovery. Prophylactic measures were always taken against 
the complications of hepatic failure. 
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For one thing, fluid balance was carefully monitored. It was noted in Chap- 
ter Six that water retention was common in the first days after operation, but 
that this tended to be transient unless severe injury to the homograft had 
occurred. Later, daily weights, intake-output records. and physical examina- 
tions were used as a guide to determine if fluid restriction should be re-insti- 
tuted. This was not usually necessary except in the patients who underwent 
explosive acute rejection (see Chapter Fourteen). 
Close attention was also paid to renal excretion. partly because of the kid- 
ne\- inalfunction that can be caused by liver failure.'. ';' In addition, many of the 
antibiotics. which must be administered to these patients to prevent invasion of 
their new livers by gram negative bacteria. have pronounced nephrotoxicity. It 
\!-as necessary to change the doses and frequency of administration of these 
aqents from time to time on the basis of relatively minor alterations in renal 
f'unction or urinary sediment. 
Vitamin K was usually administered daily for at least the first postoperative 
month. Other vitamins were also given. All narcotic or sedative medications 
\yere avoided for reasons discussed in Chapter Seven. 
All liver transplant recipients must be treated with large doses of ulcero- 
genic steroid agents. Consequently, it is mandatory that they be placed on a 
strict peptic ulcer regimen. The importance of such a precaution is well known 
from experience in renal homotran~plantation. '~ The need is probably even 
greater following hepatic replacement, especially if there is a protracted or 
severe rejection. Observations will be cited in Chapters Eleven and Twelve 
showing that both porcine and canine recipients of orthotopic liver homografts 
have a very high incidence of peptic ulceration with fatal hemorrhage or perfo- 
ration. The patients are started on a bland diet with multiple feedings. Between 
meals they are given antacids or milk and cream every hour. 
There is another advantage from around-the-clock feedings. The adult pa- 
tients in our series who have had prolonged survival after orthotopic liver 
transplantation have had initial marked weight loss. The most severe example 
was Patient OT 15 whose indication for treatment was hepatoma. In the six 
months preceding the liver replacement his weight had fallen from 165 to 140 
pounds. After operation, he continued to lose weight. reaching a nadir of 128 
13ounds despite an intake of 4000 to 8000 calories per day. It required five 
months to restore his original pre-illness weight. 
In general. the patients were permitted to regulate their own physical ac- 
tivity. During periods of deteriorated liver function. which was due to the vio- 
lent variety of rejection crisis (Chapter Fourteen). they usually preferred to 
remain in bed and sleep much of the time. \\'hen rejection developed more 
indolently, they Lvere less affected. 
One justification for sanctioning as much exertion as could be tolerated 
was the hope that pulmonary colnplications such as atelectasis and postoper- 
ative pneumonitis could be thereby reduced. In both the short- and long-term 
follow-up of these patients it is important to perform frequent chest examina- 
tions and to ha\-e chest x-rays at regular inter\-als. Only in this m-ay can poten- 
tially lethal pneumonitis be detected in time to institute effectil-e treatment. 
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Chapter Ten 
CHANGES IN COAGULATION 
by Carl G .  Groth, M.D. 
Most of the hemostatic factors are hepatic in origin. In addition, the liver 
is involved in the clearing of several substances active in coagulation and 
fibrinolysis. Consequently, it is not surprising that derangements of coagula- 
tion have been responsible for bleeding diatheses and possibly also for intravas- 
cular clotting during and after clinical hepatic transplantation.', "-3 l o .  ", '"24. 263 27 
The potential seriousness of these problems was not fully appreciated from 
the early canine studies, probably because the appropriate measurements were 
not obtained. In one of his first articles on orthotopic transplantation Moore" 
reported the absence of significant coagulation abnormalities. Our own early 
publications" referred only to the development of fibrinolysis. which was sug- 
gested by the secondary dissolution of clots in the operative field or in a test 
tube. The complication was particularly lethal in experiments in which there 
apparently had been severe ischemic injury to the liver. Inadequate homograft 
preservation as the cause for a bleeding diathesis was later more specifically 
indicted both in the first human recipients of hepatic homografts" and in dogs 
studied under similar experimental conditions at about the same time."' The 
characteristic abnormalities in both species were increased fibrinolysis, de- 
creased plasma fibrinogen, and prolongation of thrombin times. Several of the 
patients who survived developed peripheral venous thrombosis and pulmonary 
embolization at a later time. It was suggested that the initial clotting deficiency 
might have been succeeded in these cases by a state of hyper~oagulability.~~,'~ 
Subsequently several investigations of the effect of liver transplantation on 
blood coagulation were carried out in dogs and pigs.'. ". I : ' .  "" ." This experi- 
mental work will first be reviewed: then the changes in hemostasis in patients 
undergoing hepatic transplantation will be described. The methods used at our 
institutions for the assays of coagulation and fibrinolysis has-e been described 
before1:l 14, 20  and the details of methodology will not be repeated here. 
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ANIMAL STUDIES 
Dogs 
Well Preserved Orthotopic Homografts. Most of these experiments1j3 '" "' in- 
volved the immediate transplantation of a homograft that was protected from 
ischemic injury by rapid cooling at the time of its removal. However, good 
livers were also obtained after preservation for as long as 24 hours-' by the 
techniques described in Chapter Five. Under both circumstances all measures 
of recipient hepatic function were adequate from the beginning, although 
rarely completely normal. Obvious bleeding diatheses did not develop. 
Nevertheless, changes in clotting could always be detected by the appropriate 
examinations (Table 11). 
One of the most consistent alterations was increased f ibr in~lysis . '~  'O The 
euglobulin lysis time (ELT) started to decrease during the anhepatic phase and 
became markedly shortened immediately after graft revascularization. Subse- 
quently the ELT started to recover and some 24 hours after transplantation it 
had rebounded to values well above the control levels. The concomitant depres- 
sion in fibrinogen levels and the prolongation of thrombin time were of 
moderate degree and often transient. Besides shortening of the ELT and hypo- 
fibrinogenemia. direct evidence of fibrinolysis was obtained with the fibrin 
plate method as well as by the demonstration in the plasma of falls in plasmino- 
gen levels and increases in fibrinogen split products (Table 11). Analogous 
findings have also been reported in simulated autotransplantation experiments 
in which the liver was temporarily isolated from the circulation and perfused 
with cold electrolyte solution." 
A second characteristic change in the canine recipients was thrombocy- 
topenia. This aspect of the problem was most completely studied by Hutchison 
et all3 and later by Pechet'" and Boehmigi and their associates. A drop in the 
circulating platelets regularly occurred immediately after the revascularization 
of auto- or homotransplants. Normal counts were not restored until several 
days later. Other factors including immunosuppression. which can accentuate 
thrombocyte depression, will be discussed in Chapter Thirteen. 
More recent studies have stressed the complexity of the alterations in coagu- 
lation caused by hepatic transplantation' I '  e\ en when using satisfactorily 
preserved homografts. In our own laboratories. decreases could invariably be 
detected of the clotting factors synthesi~ed by the liver (I. 11. V. VII, IX, and X) 
as well as of Factor VIII. which is also produced'' in othel than hepatic tissue 
(Fig. 67). The changes commenced during the anhepatic phase, became most 
pronounced one to four hours after revascularization. and lasted for lariable 
intervals. Factors V. LTIII. and IX usually recol ered in 24 to 72 hours. 1% hereas 
I1 and X usually required three or more days. 
It is of interest that the factor depressions considerably outlasted the burst 
of fibrinolytic a c t i ~ i t ?  measured by the ELT ~vhich was usually of only a few 
hours' duration. The evolution of the changes in the factors more closely con- 
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HOURS DAYS 
F i g u r e  67. Measures of coagulation Factors I (fibrinogen), I1 (prothrombin), and VIII (antihemo- 
philic globulin) in  a canine recipient of a promptly transplanted orthotopic hepatic homograft. 
EACA and protamine were administered intraoperatively. No significant bleeding diathesis occurred. 
The coagulation factors recovered within a few days after transplantation and remained essentially 
normal until immunosuppression was discontinued and homograft rejection occurred. (By permis- 
sion of J .  Lab. Clin. Med. 73:91, 1969.) 
formed to those of plasminogen. In one of five recipient dogs studied for the 
presence of circulating heparin, very small amounts were detectable (22 
pglml); in vitro the antithrombin activity could be diminished by heating the 
plasma or by the addition of protamine. The abnormalities in coagulation and 
fibrinolysis were not prevented by the administration of epsilon-amino caproic 
acid (EACA), protamine, or heparin. Two dogs given intravenous Trasylol, a 
proteinase inhibitor, had somewhat less marked changes. 
In the foregoing 17   experiment^,?^' as in the previous canine studies of von 
Kaulla et al.I4 there was little or no objective evidence from the different assays 
of delayed hypercoagulability. The only suggestive finding in Pechet's 
analysis"' was a marked prolongation of the ELT. Nevertheless, txvo of the dogs 
died with a thrombus in the superior vena cava a few days after transplanta- 
tion; both had received EACA and protamine during operation. Three more 
succumbed within one week with hepatic artery thrombosis. 
Poorly Preserved Orthotopic Homografts. Four animals which received 
homografts damaged by inadequate 24 hour preservation all bled profusely 
during operation and died within 24 hours. The concomitant changes in coagu- 
lation and fibrinolysis assays were profound (Fig. 68) and there was little or no 
recovery (Table 12). The platelet counts were the least affected. 
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F i g z i r e  68 .  Changes in coagulation Factors I. 11, and \'I11 in a dog receiving a liver homograft which 
was badly damaged during 24 hours of preservation. The recipient animal developed a marked bleed- 
ing diathesis and died of uncontrollable hemorrhage. Note absence of recovery of the coagulation 
factors. (By permission of J .  Lab. Clin. &led. 73:91. 1969.) 
Auxiliary Homografts. Somewhat different coagulation changes were seen 
by Stremple, Hussey, and Ellison after transplantation of a heterotopically 
placed extra liver.Lx When their recipients developed an intraoperative bleeding 
diathesis, the levels of fibrinogen, Factor V,  and platelets became depressed; 
there was an  increase in the prothrombin time. No pathological fibrinolysis 
could then be demonstrated. However. increased quantities of circulating endog- 
enous plasma heparin 1% ere found concurrent with a prolonged thrombin time. 
In other animals in which there was no problem with bleeding, only depression 
in the fibrinogen and platelets mas recorded. Subsequent removal of the host 
liver had no influence on any of the parameters studied. 
Late Changes. In a number of the first dogs surviving for a prolonged period 
after liver transplantation. clotting studies after recovery from the acute effects 
of operation were observed to range from normal to a degree of depression that 
was in general accordance lvith the quality of hepatic function as judged by 
other measures.' The same thing has been more completely documented by 
Pechet et al.?" In his dogs both the coagulation factors and fibrinolytic activity 
tended to remain near normal until after the onset of delayed rejection. If the 
graft was then repudiated abruptly. the clotting factors fell M-ithin a few days 
after the onset of enzyme changes and jaundice (Fig. 67). The thrombln times 
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became prolonged, and there was increased fibrinolysis. Hutchison has 
reported that thrombocytopenia is usually not associated with either acute or 
chronic rejection.'" 
Analogous studies have been carried out after orthotopic liver transplanta- 
tion in p igs .The  animals received heparin during operation. The results were 
almost identical to those in dogs except that thrombocytopenia was much less 
common. An example of the latter finding is illustrated in Figure 83 (Chapter 
Eleven). 
Interpretation of Findings 
In the first quantitative studies of the bleeding diathesis during and after 
tran~plantation'~ considerable emphasis was placed on the role of an explosive 
intraoperative fibrinolysis. It was suggested that the problem might have been 
contributed to by the release of plasminogen activators during the extensive 
surgical procedures, by a reduced clearance of these substances from the circu- 
lation during and even after the anhepatic phase, or by failure of the liver to 
produce fibrinolytic inhibitors. It is known from other kinds of investigations 
that each of these conditions can be a factor in the promotion of clot lysis.!', 
In addition, however, von Kaulla et all4 speculated that intravascular coagu- 
lation coupled with temporary cessation of the synthesis of proteins essential 
for coagulation must be an  important component of a much more complicated 
total process. This point of view has been strongly supported by Hutchison13 
PechetqZo Blecher,' and Boehmig' and their associates. The findings that all 
measured clotting factors declined far more rapidly than would have been ex- 
pected from their biologic half-lives and that these alterations were accom- 
panied by thrombocytopenia and fibrinolysis were characteristic of a consump- 
tion coag~lopathy. '~ ,  " The failure of heparin to prevent these changesL ?' '  may 
have been due to the acidosis regularly seen during transplantation (Chapter 
Seven): such pH shifts suppress the anticoagulant effect of heparin.]" 
In spite of the strong evidence of intravascular coagulation. a systematic 
search of canine homografts as well as the recipient tissues has failed to reveal 
microthrombi.':' The only morphologic evidence of consumption was the se- 
questration of platelets in the perisinusoidal spaces. Presumably the absence of 
thrombi was ascribable to the effectiveness with which the fibrinolysins were 
capable of sweeping away the products of coagulation. It is probable, as Blecher2 
and Pechet"' have suggested. that the anticoagulant effect of the fibrinogen 
split p r o d u c t s ' ~ v a s  one element in the prolongation of the thrombin times 
mentioned earlier. This explanation was at variance ~v i th  that proposed by 
Stremple." who concluded that the antithrombin activity he observed in canine 
recipients of auxiliary homografts was caused by endogenous heparin. 
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CLINICAL OBSERVATIONS 
Coagulation During and Shortly After Orthotopic 
Transplantation 
It was noted in the introduction to this chapter that the essential features 
of the bleeding diathesis rvere actually first defined in patients and only subse- 
quently subjected to complete analysis in laboratory animals. The studies that 
were carried out in the earliest human cases (OT 1 to 5) revealed very sudden 
but generally transient increases in plasma fibrinolytic activity. longer lasting 
acute hypofibrinogenemia, prolongation of the thrombin and prothrombin 
times, and thrombocytopenia.' 3 ,  '" 
During the procedure the first four recipients were given large quantities 
of intravenous human fibrinogen and EACA. One (OT 1) exsanguinated on the 
operating table despite the fact that the EACA seemed to partially control the 
fibrinolysis as judged by serial thromboelastograms; fatal bleeding has also 
been reported from other institutions." Hemorrhage was controlled in the 
other three patients (OT 2 to 4) who lived for another 22, seven and a half and 
six and a half days, respectively. In the later postoperative period the euglob- 
ulin lysis times (ELT) tended to become abnormally prolonged, now sug- 
gesting low fibrinolytic activity. At autopsy all three recipients were found to 
have multiple pulmonary emboli. The source of the clots could not be found in 
one case; in the other two the origin was in the iliofemoral system at or near 
the femoral venotomy sites where plastic catheters had been inserted for the 
purpose of decompressing the vena caval system. It was concluded that the 
intraoperative efforts to manipulate the clotting mechanism may have led to 
hyper~oagulability. '~ 
In the next patient (OT 5) an attempt was made to avoid pulmonary emboli- 
zation by administering 2 mglkg heparin and by inserting the bypass into the 
femoral system via the saphenous vein, which was later tied off at its proximal 
termination. EACA and fibrinogen were not given. Hemorrhage was controlled 
with great difficulty. At the time of death 23 days later there was no evidence 
of any clotting complications. 
The role of the bypass catheters in promoting either bleeding or throm- 
boembolic complications can only be speculated upon. In dogs submitted only 
to external blood bypass without transplantations Boehmig has noted consump- 
tion of various coagulation factors as well as the induction of morphologic 
changes in platelets.' In patients OT 2 to 4 the generation of clots at or near the 
location where the inferior limb of the plastic prostheses were introduced into 
the venous system was probably more than coincidental. The most important 
precipitating event may have been mechanical trauma to the vessels. 
In all the later recipients the decompressing bypasses were omitted when it 
was learned that they m-ere not necessary (Chapters Seven and Eight). Subse- 
quent to this important change in technique no patient has suffered from 
peripheral thrombophlebitis or has developed pulmonary emboli. >loreover, it 
became possible to perform studies free of the potential artefacts that might be 
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introduced by the temporary extracorporeal venous circulation. The results will 
be classified on the basis of observations in a small number of cases in which a 
relatively complete panel of examinations could be carried out. The findings 
have been confirmed in many later recipients whose data will not be included. 
Poorly Functioning Homografts. In two of the first patients for whom bypasses 
were not employed. organs were used that had sustained a grave ischemic 
injury as judged by high postoperative rises in the recipients' serum trans- 
aminases. poor liver function from the outset including rapidly progressive 
jaundice, and death in seven and 10 days, respectively, from combined hepatic 
and renal failure. 
The first studies were obtained in the postoperative period. at which time 
profound coagulation abnormalities were already present. In a 13 month old 
child (OT 7) the liver-produced Factors 11. V, IX. and X were all less than 15 per 
cent of normal; fibrinogen (Factor 1) was never higher than 125 mg per cent 
(Fig. 69). The Quick prothrombin time and the thrombin time were both ex- 
tremely prolonged. In contrast Factor VIII was supernormal for the entire 10 
postoperative days. There was a progressive thrombocytopenia despite daily 
platelet infusions. Euglobulin lysis times were always prolonged. Hemorrhage 
was not troublesome until gastrointestinal bleeding became continuous during 
the last two days of life. 
The other patient. a 29 year old man (OT 6), had similar but widely fluc- 
tuating changes. However, bleeding was a far more significant problem. 
During operation and the seven postoperative days he received 33 liters of 
blood and several hundred grams of fibrinogen. 
Adequately Functioning Homografts. The next seven recipients (OT 8 to 14) 
benefited from more discriminating donor selection and from the application of 
an effective technique for interim preservation of the homografts (Chapter 
Five). Early liver function was satisfactory. A hemorrhagic diathesis was either 
not obvious or else very transient. 
During operation only one of the patients (OT 9) received EACA; 0.1 
mglkg, was given just after revascularization of the liver. This recipient as well 
as all the others developed coagulation abnormalities that varied only quantita- 
tively from case to case. The data for the two patients with the most and the 
least profound changes, respectively. are summarized in Figures 70 and 71. 
The factors synthesized by the liver. which began to fall during the hepatec- 
tomy, decreased further during the anhepatic phase and reached a nadir shortly 
after the homograft was revascularized. Factors V and IX were usually the 
most severely affected: Factors 11. VII, and X next; and fibrinogen the least. 
The alterations in Factor VIII. which is not exclusively produced in hepatic 
tissue, varied from profound depression in some cases (Fig. 70) to a moderate 
decrease in others (Fig. 71). The platelets were moderately depressed in five of 
the se\ en patients. 
In every case there was marked intraoperative activation of the fibrinolytic 
system as shown by the occurrence of lysis on heated plates. decreases in 
plasminogen lei-els, and shortening of the ELT. Concomitantly, fibrinogen split 
products appeared in the serum. 
T e x t  contz)2zied on p a g e  171.) 
168 / CHANGES IN COAGULATION 
DAYS 
F i g u r e  69. Measures of coagulation and fibrinolysis in  a 13 month old child (OT 7) who never had 
satisfactory function of his orthotopic liver homograft. Note that Factor VIII  remained supernormal 
while all the l i ~ e r  based coagulation factors xvere severely depressed. The euglobulin lysis time 
(ELT) was infinity. (By permission of Arch. Surg. 98:31, 1969.) 
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-HOURS- +DAYS--+ 
Figzcre 70. Intraoperative and early postoperative coagulation changes in a 16 month old child 
with life sustaining but impaired immediate homograft function !OT 12). A11 the coagulation factors 
studied mere depressed belon- 30 per cent of normal. Holr-evel.. these gradually returned toward 
normal. ESP = fibrinogen split products. (B!- permission of Arch. Surg. 98:31. 1969.) 
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Figz11.e 71. Changes in a 14 month old child with satisfactor>- immediate lix-er function (OT 11). 
All the coagulation factors studied Tvere transiently but only minimally depressed. FSP =fibrinogen 
split products. (By  permission of Arch. Surg. 98:31, 1969.) 
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Invariably there was prolongation of the thrombin time after revasculariza- 
tion of the homograft. In the patient with the most serious changes in hemos- 
tasis. measurable amounts of plasma heparin became detectable at this time 
(47 ,uglmi). The small quantities may have come from the homograft. which 
17ns perfused and flushed with anticoagulant solutions during preservation. 
Three other patients studied had no detectable heparin in their plasma in spite 
of prolonged thrombin times. 
Two hours after revascularization of the homograft a restitution of the 
clotting factors had generally begun, and during the ensuing week they usually 
returned to essentially normal levels. Similarly, the evidence of fibrinolysis 
promptly diminished or disappeared. After 24 hours the ELT had recovered, 
er en though the plasminogen levels ordinarily remained below normal for sev- 
eral weeks (Figs. 70 and 71). The platelet counts were also usually quickly 
restored. Secondary declines a week or so later were thought to be due mainly 
to ALG therapy (Chapter Thirteen). 
Early Homograft Devascularization. Data were collected in two patients who 
died within 24 hours after operation as the result of external compression of 
the main hepatic artery (OT 20) and thrombosis of the portal vein (OT 21); the 
details of these cases are given in Chapter Eight. Six to 10 hours after revascu- 
larization of the livers both recipients had marked hypofibrinogenemia (41 and 
67 mg per cent). In the first patient there was a marked depression of Factors 
1'111 (0 per cent) and IX ( 3  per cent). The other variables of coagulation and 
fibrinolysis were similar to those in patients who survived. 
Later Changes 
In eight patients (OT 8 to 15) coagulation studies were carried out for many 
weeks or months postoperatively. The clotting values were closely correlated to 
the quality of homograft function as measured by standard liver function tests. 
The patient with the longest survival (OT 8) had good liver function and essen- 
tially normal coagulation and fibrinolysis until shortly before death. Two pa- 
tients who died of progressive liver failure four and a half (OT 9) and six 
months (OT 10) after transplantation had slo~vly declining levels of the clotting 
factors synthesized by the liver as well as decreases in plasminogen (Fig. 72) .  
During this course. Factor VIII remained unaffected. Splenectomy had been 
performed in both patients at the time of transplantation. 
In three of the patients who developed delayed septic hepatic infarction of 
the right lobe of the liver and who were subsequently proved to have throm- 
bosed their right hepatic artery (Chapter Fifteen), clotting studies were ob- 
tained at about the time of this complication. Tlto of the recipients (OT 10 and 
11) had essentially normal coagulation measurements. The third (OT 8) had 
had supernorinal values of some of the clotting factors in the preceding days 
(Fig. 73) .  
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Figure 72 .  Postoperative changes in  a 201 a month old patient (OT 9). Early homograft function 
was satisfactory. but progressix-e liver failure due to chronic rejection subsequently developed. 
During the late course Factor VIII  remained supernorn~al.  Plasminogen and the liver based Factors 
I1 and V ultimately declined. (By permission of Arch. Surg. 98:31. 1969.) 
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T IME IN D A Y S  
Figu~.e  73. Serum proteins after liver homotransplantation in patient OT 8. The septic infarction 
of the right hepatic lobe developed about three and a half weeks postoperatively. apparently at  about 
the same time as thrombosis of the right hepatic artery. h-ote the supernormal values of Factors I1 
and V In the three neeks preceding thls compllcatlon. and the maintenance of hlgh lelels even 
af temard.  (Bq permission of Sulgelq 63.349, 1968.) 
Retrospective Evaluation 
It is obvious that the changes in blood coagulation in the human cases of 
orthotopic liver transplantation were very similar to those recorded in 
analogous animal experiments. The initial findings were suggestive of intra- 
vascular coagulation associated with pathologic fibrinolysis. The alterations 
were quickly reversible providing an adequately preserved and functional 
homograft was used. 
A number of practical lessons have been learned about the proper manage- 
ment during the critical operati\ e and early postoperative period. The most 
important is that the situation may be made hopeless from the beginning by the 
use of a poor quality organ. Under these circumstances the prevention of fatal 
hemorrhage may require the use of throlnbogenic agents such as EACA,  fibrin- 
ogen, or protarnine sulfate. Even though Pechet et a1 were unable to report 
significant benefit from these substances in animal experiments.?" there was 
evidence from clinical observations that they helped to control severe bleeding 
diatheses in some of our patients.I4 ?'I 
\17ith better quality homografts, there should be no need for efforts to pro- 
mote clotting and, indeed. such inter\ ention is probably strongly contraindi- 
cated since it may add to the already significant risk of major intravascular 
thrombosis. The iatrogenic induction of hypercoagulability may ha1 e been part- 
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Table 13. Homograft Vascular Thromboses in 17 Consecutive 
Recipients of Orthotopic Livers (OT 8 to 24) 
NUMBER LOBAR T O T A L  P O R T A L  
C A S E S  ARTERY ARTERY VEIN TOTAL 
-- 
-- 
Adults 5 0 0 0 0 
Children 12 5 1 1 7 
ly responsible for the three examples of thrombophlebitis and pulmonary em- 
bolization among our first four recipients. An added factor in those cases was 
probably the unnecessary use of external venous bypasses. 
The avoidance of plastic bypasses and iatrogenic manipulation of the hemo- 
static mechanism has not prevented a high incidence of clotting of the 
homograft blood supply in our more recent experience2-l4 ?' and in that of 
others.'. 6.  l o  In our own cases vascular calamities have often occurred in the 
absence of striking hypercoagulability as judged from the results of a number 
of individual tests. However. such a panel of intermittently performed exami- 
nations may not be able to accurately track the balance of coagulation and lysis 
upon which normal hemostasis is dependent. This would be particularly true 
during the early postoperative period of very rapidly evolving change; it is 
during this interval that the euglobulin lysis times tend to become unusually 
prolonged. 
In view of the past frequency of homograft vessel thrombosis. it may be 
warranted to consider prophylactic total body heparinization beginning at the 
time of homograft revascularization and continuing thereafter. Special con- 
sideration should probably be given to this possibility in pediatric patients. In 
such patients the very small size of the vascular structures has seemed to pose 
a special risk. Of 17 consecutive recent recipients of orthotopic hepatic 
homografts (OT 8 to 24), 12 were infants; there were seven examples of throm- 
botic sequelae affecting the homograft from two to 104 days postoperatively 
(Table 13). In contrast none of the five adults suffered this kind of 
complication. 
There are. of course, other mechanical and flow factors which can contri- 
bute to late thrombosis. These are considered elsewhere in the book (Chapters 
Eight and Fifteen). 
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Chapter Eleven 
REJECTION IN UNMODIFIED 
ANIMALS 
With renal homotransplantation the first clinical trials were in patients who 
were not altered by therapy inasmuch as techniques of immunosuppression 
were not then available. Important observations were made, particularly by 
Hume,Ix about the behavior and fate of kidney homografts in uremic recipients 
whose immune capabilities were not further modified by iatrogenic means. 
That some of these transplants functioned for a surprisingly long time was at 
least partially explained by the fact that there is often a loss of immunologic 
reactivity accompanying renal failure."'. ':' Apparently. renal homografts in- 
serted by Lawler;"' Murray.'"' and Hume1"xcreted urine for several months 
before slowly being rejected. 
It is conceivable that a privilege comparable in magnitude to that accom- 
panying uremia exists as a consequence of chronic liver failure and slows the 
pace of homograft repudiation. Gardnerl-' has provided evidence that this may 
be so in skin transplantation experiments carried out in normal volunteers and 
in patients with severe Laennec's cirrhosis. The average rejection time of skin 
from nonrelated donors was 11.6 days in the control group compared to 16.3 
days in the victims of hepatic disease. 
There will never be an occasion with liver grafts to obtain information 
analogous to that acquired in untreated humans during the early trials of renal 
homotransplantation. Instead. reliance must be placed on extrapolation to man 
of the events of hepatic rejection in unmodified animal recipients. In this chap- 
ter these will be described as they has-e been seen in dogs and pigs. Companion 
studies of the pathologic changes in such experiments are documented in 
Chapter Twenty. 
DOGS 
Time of Survival 
At the beginning the mortality was exorbitant after orthotopic transplantation 
of the canine liver."-'. 3 5 3  - ' T h e  deaths were due to deficiencies in surgical 
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technique, inadequate organ preservation, and anesthetic mismanagement. 
Later it became possible to obtain consistently good results. For example. 22 of 
23 dogs (96 per cent) who received livers from nonrelated mongrel donors in 
one of our control series4" survived for at least two days after operation, and 19 
(83 per cent) lived for at least six days. All the animals were dead by the tenth 
day. The mean survival was 7.1 i 2.2 (SD) days. 
However, there have been occasional instances of relatively long survival 
in unmodified canine recipients, probably because of the fortuitous pairing of 
donor-recipient combinations with good histocompatibility matches. Examples 
are shown in Figures 74 and 75. The first of these dogs had evidence of sponta- 
neous reversal of hepatic rejection. His death was caused after 201/2 days by 
disruption of the hepatic arterial anastomosis at a time when the serum 
bilirubin was declining (Fig. 74). In the other experiment the liver function 
tests did not become grossly abnormal except for an elevated alkaline phospha- 
tase during the three weeks of postoperative life. nor was there the reduction in 
hepatic blood flow which is characteristic (see later) during rejection (Fig. 75). 
A postoperative survival of 31 days is the longest known to have been achieved 
ni th  these conditions of liver transplantation between nonrelated mongrel do- 
nors and  recipient^.'^ 
Control 3 6 9 12 15 18 2 1 
Days after liver transplant 
Figure  74. The course of a n  untreated dog obserl-ed after orthotopic liver transplantation. The 
experiment was carried out in 1939. The donor and recipient viere nonrelated mongrels. 1-ote the 
apparent spontaneous re\-ersal of rejection. The anillla1 died after 201r days of rupture of the 
hepatic arterial anastomosis. ( B y  permission of Surg. G>-net. Obster. 112 :135. 1961.) 
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4 u J U  
~d Ts2 DAYS POST - TRANSPLANT 
Fig1~1.e  75. Absence of classic rejection after orthotopic liver transplantation in a dog; the only 
abnormality in  liver function was an elevated alkaline phosphatase. Note that the decline i n  
hepatic blood flow usually observed at  the time of rejection (see Fig. 79) did not occur. The animal 
died after 21 days of wasting. Immunosuppressive therapy was never given. Under these conditions, 
survival of more than tm-o weeks can be expected in  only about 5 per cent of experiments. 
Pathologic processes other than rejection often contribute to the death of 
the animals. The most frequent is pneumonitis, but ulceration of the gastro- 
intestinal tract, intussusception. peritonitis, and atelectasis are also 
common. 
Usual Postoperative Course 
The examples just cited of long survival or spontaneous reversal of rejec- 
tion are distinctly uncommon after orthotopic transplantation in untreated 
dogs. In the usual experiment a straightforward and almost invariable se- 
quence of events follows a well executed operation. Immediate excellent hepat- 
ic function can be expected (Fig. 76). The animals recover promptly from 
either inhalation or barbiturate anesthesia: parenteral glucose therapy is 
usually not required. They often can resume an oral diet by the following 
morning, and they ordinarily appear to be quite normal. There may or may not 
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M O C - I  
Figure 76. The biochemical changes 
usually seen after orthotopic liver trans- 
plantation to the untreated recipient. A 
brief period of good function follows 
operation, but deterioration of the bio- 
CONTROL 
chemical pattern is unrelenting once it 
has begun. (By permission of Year Book 
Medical Publishers. 1966.) 
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be immediate transient rises in the SGOT and SGPT caused by the ischemic 
injury incurred during operation. 
Within four or five days. however. there is manifold evidence of rejection 
(Fig. 76). The dogs stop eating. The SGOT and SGPT increase, usually to high 
levels, in rough temporal relation to parallel changes in alkaline phosphatase. 
Jaundice develops rapidly at the same time. The ultimate degree of hyper- 
bilirubinemia often exceeds that which can be produced by ligation of the 
common duct in normal animals. With the latter procedure the serum bilirubin 
does not usually increase above 6 or 8 mg per cent, evidently because of 
moderately efficient clearance of bilirubin glucuronide by the canine kidney.' 
In contrast, the dog n-ith a rejecting liver may have serum bilirubins of 20 or 30 
mg per cent. 
The character of the jaundice in animals undergoing rejection is of in- 
terest. A variable but substantial fraction of the bilirubin is in the glucuronide 
form (Fig. 77). With the development of icterus. conjugated bilirubin appears in 
the urine. usually before the disappearance of urine urobilinogen. Finally, the 
stools became clay-colored. Thus. the syndrome of rejection has features of 
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Days after liver transplantation 
Figzire 77. Changes in  serum bilirubin in  a series of untreated canine recipients of orthotopic 
liver homografts. Note that jaundice does not usually appear until the fourth to sixth days and that 
the conjugated or direct fraction (dashed line) contributes a major portion to the total bilirubin 
values. (By permission of Surg. Gynec. Obstet. 1 1 2 : 1 3 5 ,  1961.) 
parenchymal cell injury and necrosis plus an element suggestive of biliary 
obstruction. The histologic finding of intracanalicular bile stasis (Chapter 
Twenty) helps to explain the component of obstruction. 
The ability of the transplanted liver to promptly carry out complex func- 
tions of synthesis has been well established. In our first experiments4j it was 
noted that the total plasma proteins were often well maintained, in some cases 
long after overt rejection had commenced (Fig. 78). A similar durability of 
carbohydrate metabolism in the face of unmodified rejection was also evident. 
Fasting plasma glucose levels were usually maintained for several days after 
clinical rejection was diagnosed: hypoglycemia was a terminal event. 
Subsequently K~kral"-~" showed that there was actually heightened protein 
metabolism. He studied the synthesis rates of protein in untreated canine recipi- 
ents by determining the incorporation of "S-methionine into plasma proteins. 
The specific activity of discrete protein fractions was separated by paper block 
electrophoresis and other standard radioisotope techniques. The synthesis (35S 
uptake) was increased 40 to 200 per cent. with considerable variability in the 
different protein moieties. At the same time the biologic half-lives of the iso- 
topes were shortened (increased turn01 er). The changes were similar in auto- 
and homografts. except that the latter had a disproportionate intensification of 
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3 6 9 12 15 Control 18 D a y s  a f t e r  liver transplantation 
Ftgure  78. The serum protems in the same dog ~ z h o s e  course 1s shonn  in Flgure 74. Serious 
l~jpoproteinemia did not develop even after the onset of moderately selere  jaundice. (By permission 
of Surg. Gynec. Obstet. 11.2:135. 1961.) 
gamma globulin activity. Kashiwagi's studies of haptoglobin and group specific 
component in human recipients of orthotopic hepatic homografts (see Chapter 
Eighteen) have suggested that accelerated protein turnover is also characteris- 
tic after clinical liver transplantation." The failure of commensurate increases 
in protein synthesis because of ischemic injury to the transplant probably con- 
tributed importantly to the "third space" syndrome described in Chapter Six. 
Hepatic Blood Flow 
It has long been thought on the basis of observations with vital microscopy 
that a sudden decrease occurs in the blood flow of skin homografts at the time 
of their r e j e ~ t i o n . ~ " . ~ ;  This has also been shown to be a feature of rejecting 
renal homografts ill  dogs.^^. 2 5  21;. :3h. 1 1 .  311. i 2  Similar observations have been made 
by GrothlVn unmodified canine recipients of orthotopic liver homografts by 
use of a xenon isotope ("':'Xe) washout technique." 
Eight animals Lvere studied. In seven n-hich died of rejection after six to 10 
days. there was a decrease in both hepatic arterial and portal blood flows con- 
comitant with a deterioration in hepatic function at the same time as the car- 
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diac output was relatively stable (Fig. 79). The other animal, in which there 
was never e\ idence of rejection until death 22 days later, did not have a diminu- 
tion in hepatic blood flow (Fig. 75). It will be shown later (Chapter Twelve) 
that these hemodynamic changes of rejection can be prevented and or reversed 
by adequate immunosuppression. 
Groth's findings confirmed the suspicion that there was an important com- 
ponent of ischemia in the rejection of liver homografts. Earlier it had been 
speculated that blood flow might be choked off at a sinusoidal or, 
alternatively, in larger vessels within the intrahepatic portal tracts.{' The best 
evidence now'" is that the immunologically mediated ischemia is due mainly to 
damage of the veins and sinusoidal bed of the homograft (Chapter Twenty) and 
that it cannot be favorably influenced by the intra-arterial administration of 
vasodilating agents." 
Variations in Portal Revascularization 
Early in our experience4\ three methods of revascularization were com- 
pared. After normal reconstruction of the portal system (Fig. 80C), eight of 11 
dogs lived for at least four days. When a small portacaval shunt was left in 
place (Fig. 80B), only six of 15 animals survived this long. An important con- 
tributory cause of the mortality in many of the latter dogs was a distinctive syn- 
drome consisting of intractible vomiting and retching which began immediate- 
ly after operation and continued until death. This was thought to be due to 
acute Liver failure. Recently Fonkalsrud" has also reported poor results with a 
modification of this method; less than a third of his azathioprine treated recipi- 
ents lived for as long as one week. 
Efforts to augment portal venous flow by means of a reverse Eck fistula in 
26 animals (Fig. 80A) were even less successful.-l-l Only four survived for as 
long as four days. Often, the newly transplanted liver could not transmit the 
increased flow. Immediate hepatic congestion and outflow block or delayed 
ascites were the consequences. 
The desirability of restoring a normal blood supply to orthotopic liver 
homografts is evident from this kind of experiment. Such considerations are 
even more important in auxiliary liver transplantation, as will be discussed in  
Chapter Twenty-one. 
The Ortkotopic Liver in a Composite Graf t  
The li\ er has been transplanted as part of a relatively enormous multiorgan 
graft4? 4 '  which also included the spleen, pancreas, omentum, stomach, small 
bowel. and colon (Fig. 81). The cooled liscera were used to replace the same 
structures T.\ hich \$-ere removed en bloc from the recipient. 
Only fia e of 38 animals survived the first 24 postoperative hours: most of 
the rest de\-eloped irreversible shock secondary to congestion of the intestinal 
portion of the homograft complex. The exceptional dogs lived for five and a 
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DAYS BEFORE DEATH 
F i g u r e  79. Liver blood flo~r. x-alues obtained on portal (FPI) and hepatic arterial (FAI) injection, 
cardiac output (CO) and liver function in sel-en unmodified recipients that died of rejection. The 
mean values = SE are sho~r-11. as n-ell as the number of obserl-ations :in parentheses) for each day. 
Note that both the hepatic arterial and portal blood flo~z-s. as determined b?- the xenon isotope 
('"'Xe) washout technique, decreased collcon~itant ~ i t h  deterioration of hepatic function. (By per- 
mission of Surgery 63 :658, 1968.) 
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Figzire 80.  Methods of venous reconstruction evaluated in  canine recipients of orthotopic homo- 
grafts. u ,  Reverse Eck fistula O. Anatomic reconstruction with a small portacaval shunt left in place. 
c. Complete anatomic reconstruction with closure of the preliminary portacaval shunt. Both a and 
b carried a prohibitively high early mortality and were, therefore, abandoned in subsequent canine 
experiments. (By permission of Surg. Gynec. Obstet. 111 :733, 1960.) 
I -_ _ - 
half to nine days, were able to eat, and maintained essentially normal glucose 
homeostasis. Two of them never became jaundiced. The abnormalities found in 
the liver after death were less advanced than those usually seen at comparable 
times when this organ is transplanted alone. 
Potentially there could be an occasional clinical use for a composite trans- 
plant of this kind. We have seen two relatively young men with thrombosis of 
the celiac axis and mesenteric arteries who developed gangrene of all the same 
organs contained in the homograft, including the liver. In dogs the technical 
requirements of the procedure were no more difficult than with a standard 
orthotopic hepatic transplantatiorl since only three vascular anastomoses with 
large caliber vessels were involved. The limiting factor was the intestinal con- 
gestion and hemorrhage which promptly killed more than 80 per cent of the 
recipients during and just after operation. and for which there has not yet been 
a satisfactory explanation. 
The foregoing background in dogs was later supplemented by analogous 
studies in untreated pigs. It is quite likely that the choice of the pig as a second 
species was influenced by the extensive investigations by Eiseman of the extir- 
pated and perfused porcine liver." j1 Other factors were the similarity of the 
pig liver and its vessels and biliary tract to that of man2 and the resistance of 
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Figure  81. Schematic view of the canine multiorgan graft. The l i ~ e r ,  spleen. pancreas, omenturn, 
stomach, small bowel, and colon of the donor itissues not shaded in the diagram) were transplanted 
en bloc following removal of the corresponding structures from the recipient. No immunosup- 
pressive therapy n-as given. The longest survival was nine days. (B>- permission of Xmer. J .  Surg. 
103:219. 1962.) 
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the porcine organ to development of "outflow block,"" which is a major prob- 
lem in dogs (Chapter Five). 
The surgical techniques were adapted from those developed in the 
d0g.j. h 3  X,  li i i  J'J The only noteworthy point is that a single bypass from the 
splenic to the jugular vein is all that is necessary for venous decompression 
during the anhepatic phase, at least in our hands (Fig. 82). Systemic heparin is 
F i g u ~ e  82.  The bypass system used for orthotopic transplantation in  pigs. Only portal decompres- 
sion is necessary. The vessels entering and leaving the hepatic homograft are reconstructed in  
a n  essentially normal manner. \I7e have provided biliary drainage with cholecystoduodenostomy. 
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given before removal of the recipient liver and is not subsequently neutralized. 
Survival for at least several days has been obtained in more than three-fourths 
of the porcine experiments in our laboratory (Table 14). 
Professor Henri Garnier and Dr. J .  P. Clot of Paris" ' w e r e  the first to 
investigate orthotopic porcine liver transplantation. Using unrelated large 
white pigs, they confirmed that the general events after operation were usually 
comparable to those in dogs. The biochemical changes during rejection were 
similar. although the rises in the transaminases were less pronounced than 
after canine hepatic transplantation. They also described acute peptic ulceration 
which led to the death of their longest survivor. 
The unique contribution of Garnier's work was his observation of the mild 
and indolent nature of the rejection. Because of technical and anesthetic dif- 
ficulties, he lost most of his animals during operation or within the first 48 
postoperative hours. There were, however. seven pigs which lived as long as 
two days, and four of these seven survived for 25 days or longer (maximum 35). 
This interesting finding was soon confirmed by Peacock, Terblanche, and 
pLiddell in ~ ~ i ~ ~ ~ l , : f i .  :"I. ah. 49 who began their studies without knowledge of Gar- 
nier's prior work. Of 15 of their pigs which passed the two-day postoperative 
mark, three survived for more than 25 days. The last animal in the series was 
sacrificed at two years because of failing health. Hunt'" reported serial bio- 
chemical as well as histopathologic studies in these animals which indicated 
that the rejection was feebler than in untreated dogs. A few of the pigs never 
had postoperative deterioration of liver function, and some of the others ap- 
parently passed through a rejection within four to 10 days that underwent 
spontaneous reversal. As in Garnier's earlier experiment. several valuable 
recipients ultimately died because of hemorrhage from peptic ulceration. The 
most common site of ulceration was at the esophagogastric junction, where 
this species has a long tongue of squamous epithelium extending into the body 
of the stomach." 
Jaffe, Symes, and Terblanche" sought an explanation for the surprising 
survival of porcine liver recipients with a series of immunologic studies, includ- 
ing lymphocyte transfer tests, mixed lymphocyte cultures, and skin grafting. 
The results in the first two examinations were difficult to interpret, but the 
skin grafts were invariably rejected within 11 days. The authors suggested that 
liver tissue might be relatively nonimmunogenic. a hypothesis supported by an  
earlier report of Kaliss." 
Further proof of the blandness of hepatic homograft rejection in pigs was 
contributed by Calne and his associates at Cambridge. England."" and from our 
own laboratories (Table 14 and Figs. 83 and 84). One of Calne's animals survived 
for seven months, eventually dying of intestinal obstruction; there was no 
evidence of active rejection and only minimal liver damage. In the second of 
Calne's two reports. 20 of 36 liver recipients lived for at least three postoperative 
days and 12 of these 20 had survival exceeding 25 days. The problem of 
delayed gastrointestinal hemorrhage was avoided by the performance of 
prophylactic gastroenterostomy and bilateral \-agotomy. 
The Cambridge workers also added to the evidence that a lack of recipient 
immunologic reactivity was not the essential reason for these results, since 
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Table 14. The Results in  Our Denver Laboratories with Orthotopic Liver 
Transplantation in Untreated Pigs and in  Pigs Given ALG" 
POST-  LAST 
EXPERI-  O P E R A T I V E  BILIRUBIN 
MENT SURVIVAL HERI-ATOCRIT (mg per 
NUMBER (Days) CHAXGE 100 ml) GROSS C A U S E O F D E A T H  
Untl.ented rec ip ien ts  
1 37 46-19 7.0 Rejection; esophagogastric ulcer; 
GI  hemorrhage 
2 1 - - Atelectasis 
3 Alive 40 + 0.0 Alive 15 months 
4 Alive 36' 0.2 Alive 15 months 
5 2 - - Congestive atelectasis 
6 8 38 -+ 34 1.8 Rejection; esophagogastric ulcer; 
G I  hemorrhage 
7 2 0 40- 33 6.6 Rejection; L. bronchopneumonia 
8 8 42 + 46 6.1 Rejection; agonal  intussusception 
9 6 42 + 38 1.5 Not  specified 
Rec ip i en t s  t rea ted  w i t h  horse an t ip ig - l ymphocy te  globulin (ALG)  
1 7 35-21 < 1 .O ? Rejection; ? G I  hemorrhage 
2 15 40+ 1 1  6.1 Rejection; duodenal ulcer 
3 2 3 36-11 6.6 Rejection; esophagogastric ulcer; 
G I  hemorrhage 
4 1 - - Congestive atelectasis 
5 7 46+ 34 10.2 Rejection; pneumonitis; cholangitis 
6 28 50'32 6.4 Rejection 
7 Alive 40' 0.5 Alive 15 months 
8 1 - - Congestive atelectasis 
9 13 35 ' 33 1.1 Rejection 
Outbred aninlals n-ere used and donors and recipients Irere selected of different color and  
appearance. The  exper i lne~l ts  were performed by Dr. George V. Smith. who is presently located in 
Hartford. Connecticut.  
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Figure 83. The first six months in  the postoperative course of a n  untreated pig after orthotopic 
transplantation of the liver. Rejection was not diagnosed at any time. Note the abrupt thrombo- 
cytopenia which persisted for the first few days after transplantation. The same phenomenon has 
been noted by Hutchison after auto- and homotransplantation of the li\-er in  dogs. The animal is 
still alive 15 months after operation. The experiment was performed by Dr. George V. Smith. 
F i g u r e  84. Three gro~ving piqs \I-hich \rere subjected to orthotopic liver transplantation five 
months earlier. The txro on the left r~ceix-ed no treatnlent xx-it11 immunosuppressi~-e agents. The 
one on the right had PO injectio~ls of horse antipig-l>-inphoc~te globulin (XLG).  All three animals 
are still alive, noxr- 15 to 151 r months after operation. The experinlents n-ere performed by Dr. George 
V. Smith. 
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both skin' and kidney graftsi were rejected in the expected way. In a control 
investigation with renal homotransplantation and bilateral recipient nephrec- 
tomy. there were 13 technically satisfactory experiments. One animal lived for 
33 days but all others died of uremia within three weeks.' 
Interestingly enough, this aggressive rejection of porcine renal homografts 
was substantially mitigated andlor delayed if a kidney and a liver from a com- 
mon donor were simultaneously transferred to the same r e ~ i p i e n t ; ~  now the 
same privilege of mild rejection seen with transplantation of the liver alone 
extended as well to the renal tissue. The specificity of this finding is open to 
some question since it has also been shown, as mentioned earlier in this chap- 
ter, that other combinations of organs can lead to a less vigorous host reaction 
than that evoked by the individually transplanted constituent parts. The units 
tested have included multiple gastrointestinal viscera4.' and the kidney plus the 
spleen.24. "
The observations from hepatic transplantation in pigs have given sub- 
stance to earlier suspicions from dog experiments4" that, in terms of the host 
response it evokes, the liver may be one of the ',easiest" organs to transplant. 
Although conceivably valid. this view could easily be overstated and, as will be 
emphasized in the succeeding chapters. could lead to erroneous and self-defeat- 
ing conclusions about the requirements for therapy after hepatic transplanta- 
tion in man. 
At a research level another danger stems from the notion that the pig 
model is somehow qualitatively unique as compared to that in the dog or 
human. The differences are almost certainly only quantitative. as will be dis- 
cussed in the next chapter. In the series of pig liver transplantations in our 
laboratories in which the recipients were either unmodified or treated with a 
few injections of ALG (Table 14). the majority of animals developed the overt 
clinical signs and the characteristic pathologic findings of fatal acute rejection 
(Chapter Twenty). Even when this did not occur. homograft biopsies taken 
later often showed evidence of healed earlier rejection (Chapter Twenty). The 
abnormalities were entirely analogous to. although less marked than, those 
in many dogs which had been given azathioprine or ALG for several postoper- 
ative weeks or months and then had had this therapy stopped with long subse- 
quent survival. 
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Chapter Twelve 
EFFORTS TO MITIGATE OR PREVENT 
REJECTION 
The immunosuppressive treatment given to human recipients of liver 
homografts is considered in Chapters Thirteen to Seventeen. Combination drug 
therapy was used for these patients in a regimen similar to that widely em- 
ployed for renal homotransplantation in man. However, the most precise infor- 
mation about the immunosuppressive agents has come from controlled animal 
experimentation in which the individual drugs were used aloneic'~ssential1~ all
the meaningful research of this kind in the field of liver transplantation has h 
been carried out in dogs2 
TOTAL BODY IRRADIATION 
The only reported attempts to prolong hepatic homograft survival by host 
total body irradiation were completely u n s u ~ c e s s f u l . ' ~ ~  In these experiments 
1400 R were given to dogs. Eighteen to 40 hours later, before the development 
of leukopenia. total hepatectomy and orthotopic homotransplantation were car- 
ried out. The recipients all died within 36 hours from diffuse hemorrhagic 
gastroenteritis and1or intrapulmonary hemorrhage. The combination of the 
operative trauma and irradiation appeared to preclude even temporary success. 
The intestinal injury was a particularly discouraging finding. It was probable 
that irradiation injury to the bowel was aggravated by transient elevations of 
portal pressure during the transplantation. 
The first efforts to prevent rejection of liver homografts with azathioprine 
were in 1963, at least two years after the value of this agent in protecting renal 
homografts had been proved." The initial results were extremely p ~ o r . " ~ , ' ~ ~  
Only one of the first 25 liver recipients in our laboratory lis-ed for as long as one 
193 
194 / EFFORTS TO MITIGATE OR PREVENT REJECTION 
month, and in the Boston report on 10 dogs the observations were similarly 
discouraging. Nevertheless. there was unequivocal evidence that rejection had 
been at least partially controlled. The deterioration of postoperative hepatic 
function occurred later or, in some cases, was avoided altogether.Ihh "i The 
majority of the deaths were due to pneumonitis. Other causes of failure were 
perforated gastric ulcer, peritonitis. liver abscess formation, and intussuscep- 
tion. 
In retrospect, the lack of success seemed ascribable to several factors 
which probably played a cumulative role. First, the perfect technical perfor- 
mance necessary for consistently good results was achieved only with a great 
deal of subsequent practice. In addition. too much azathioprine was probably 
being given, accounting for the almost invariable development of sepsis; the 
susceptibility to pneumonitis under these circumstances may have been accen- 
tuated by subdiaphragmatic irritation caused by the large mass of subjacent 
foreign tissue. Finally. it was learned that azathioprine was hepatotoxic in 
dOgS.61 171 I X O  
Hepatotoxicity 
The last finding had special significance since the target tissue of rejection 
was also being injured by the drug used to prevent this process. This was easily 
demonstrated in experiments on normal animals which were given a 40-day 
course of azathioprine. using doses which would have been considered reason- 
able for antirejection therapy."' Transient increases in the serum trans- 
aminases and the alkaline phosphatase were invariably manifest within a few 
days after the institution of treatment (Fig. 85). The features of the hepatic 
injury were suggestive of a direct toxic rather than a hypersensitivity 
mechanism inasmuch as the deleterious effect was dose-related, was seen 
promptly, and tended to diminish with continued treatment. Although none of 
the animals became jaundiced. the enzyme alterations were reflected in anatom- 
ic changes, as \vill be described in Chapter Twenty. The animals often be- 
came anemic and lost weight during therapy (Fig. 85). 
Relevance of Canine Hepatotoxicity to M a n .  This question has never been 
adequately settled. A high incidence of human liver injury has been docu- 
mented with the use of 6-mercaptopurine for cancer chemotherapy;"" I"* 6-mer- 
captopurine is a chemical from which azathioprine is derived. Similarly. many 
patients administered azathioprine for long periods after renal homotransplan- 
tation have developed either acute or chronic liver disease.'!', ";. 1: i73 I 6 O ,  169 
However. the etiologic role of the drug has been difficult to prove since the best 
diagnosis in many such cases was infectious hepatitis."'; a complication also 
commonly seen in uremic patients under treatment with chronic hemodialysis 
without subsequent transplantation.:';. 4i. h 4 .  lJii Furthermore, it is possible that 
other agents used in the complicated clinical regimen of therapy could have 
been contributory. particularly the prednisone which was almost invariably ad- 
ministered in high doses. Steroids can cause hepatic parenchymal injury in 
rats,9, 71 .  1:" rabbits,"ogs: and man.';;. 
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Figure  85. The toxicity of azathioprine when used alone or in  combination with '% methionine 
or methionine. Six dogs were in  each of the three test groups. There were easily detectable abnor- 
malities of liver function but jaundice did not develop. The azathioprine doses were 1 to 4 mglkg 
per day. Note that the animals tended to lose weight and become anemic. (By permission of Surgery 
58:131, 1965.) 
An effort was made by Hill, Porter, and Massionh3 to establish whether 
azathioprine had a consistent hepatotoxicity in man. They systematically re- 
viewed the autopsies of 34 recipients of renal homografts who had been treated 
with this agent for a few days to many months before their deaths. A pattern of 
hepatic injury could not be found which could be attributed to the prior ad- 
ministration of azathioprine. 
Nevertheless, there have been a number of clinical cases, as was discussed 
in a recent m~nograph."~' in which it mas difficult to dismiss lightly the possi- 
bility of azathioprine liver toxicity. An example is shown in Figure 86. The 
patient r e c e i ~  ed two renal homografts. Five months after the first operation he 
developed jaundice which slo~vly receded after his azathioprine dose had been 
reduced from 150 to 30 mg day. Ultimately, the kidney was rejected. A second 
homograft was then transplanted after two doses of 200 and 175 mg azathio- 
prine had been given, one the evening before and the other on the day of 
operation. Folloning surger) the SGOT and SGPT rose to more than 4000 Inter- 
national Units (normal less than 40) and he became jaundiced. He died 23 days 
later and was found at autopsy to have massive liver necrosis. 
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Figure  86.  The course of a kidney transplant recipient  rho appeared to have suffered lil-er damage 
from azathioprine toxicit).. About five months after his first renal homotransplantatioil. he de- 
veloped low grade jaundice and increases in his transaminases. The azathioprine dose was cut im- 
mediately and further reductions made at subsequent intervals. The homograft eve~ltually failed 
and was removed after about two years. \?'hen retransplantation was performed, four large doses 
of azathioprine were given just before and after operation. Iminediately the transalninases rose to 
more than 4000 units. The patient became intensely jaundiced and died of hepatic and renal failure. 
Vague though the conclusions may be about the presumed multiple etiol- 
ogies of liver disease in patients receiving renal homografts while under im- 
munosuppressive therapy. it is crucial for obvious practical reasons to have an 
idea of the frequency of this kind of complication before embarking on trials of 
liver transplantation in which the differential diagnosis and proper manage- 
ment could become hopelessly confused by the coexistence of rejection and 
liver injury from other causes. Penn's studies1" have demonstrated the number 
of instances in which such a perplexing distinction might have to be made. 
Penn examined the pre- and postoperative courses of 146 kidney recipients. 
At some time 88 (60 per cent) of the patients de\ eloped abnormalities in the 
serum bilirubin. alkaline phosphatase. SGOT. SGPT. prothrombin time. serum 
protein concentration, or bromsulphalein (BSP) clearance. The hepatic dys- 
function appeared in the majority of cases within the first six postoperative 
months (Fig. 87). In most instances the changes were transient and mild but in 
20 they were marked and persistent: four of the patients died of hepatic failure 
five to 18 months follon-ing operation. The derangements in the liver function 
were variable from case to case and were accompanied by clinical complaints 
in only a small minority. For example. it was extremely comlnon to ha1 e eleva- 
tions in the serum transaminases (Fig. 88) at a time of apparent good health 
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Figure  87. Time of onset in  human renal transplant recipients of abnormalities of one or more 
liver function tests. One hundred forty-six patients were studied. Of these. 88 (60 per cent) had 
some evidence of hepatic damage. usually during the first six postoperative months. This was usually 
mild. but in  20 patients (14 per cent) it was severe. (By permission of Current Topics in Surgical 
Research I :November: 1969.) 
I .  U./Liter 
Figzi1.e 88. Serurn transaminase determinations in all but one of the patients included in Figure 87. 
The SGOT was elel-ated in 39 per cent of these patients and the SGPT in 31 per cent. The normal 
values are less than 40 International Units tIL-). The lei-els sho~r-n here and in Figure 89 are the 
most abnormal obserl-ed in any gix-en patient. (By permission of Current Topics in Surgical Research 
I :November. 1969.) 
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and in the absence of jaundice or other alarming findings. Even the appearance 
of hyperbilirubinemia was not necessarily a bad prognostic sign since 52 pa- 
tients (36 per cent) had icterus (Fig. 89) of 1.0 mg per cent or greater; however, 
in most cases this was short-lived. The increased bilirubin concentration was 
usually an approximately equal combination of the conjugated and unconju- 
gated forms and was almost invariably accompanied by increases in alkaline 
phosphatase. The prothrombin times, serum protein concentrations. and BSP 
excretion Tvere most markedly affected in the patients who developed symp- 
toms of serious liver disease. 
Eighty of the recipients studied by Penn were treated before June of 1966 
with azathioprine and prednisone. Fifty-two (65 per cent) of the 80 had 
evidence of liver damage; all four of the fatalities caused by hepatic failure 
were in this group. The next 66 patients were also administered heterologous 
ALG and were given reduced quantities of the other two agents (see Chapter 
Thirteen). Thirty-six (54 per cent) of the 66 recipients treated in the latter 
period also had some findings of hepatic damage, but generally to a less severe 
degree and never with a fatal outcome. Consequently it has been our con- 
clusion that the magnitude of the problem has been distinctly less since the 
addition of ALG to the immunosuppressive regimen. 
Prolonged Survival af ter  Canine  l iver  
Transplantation 
Despite the handicap imposed by its undoubted hepatotoxic effect in dogs, 
azathioprine has permitted extended survival after orthotopic transplantation 
TOTAL BILIRUBIN 
( 143 patients) 
Milligrams per 100 ml  
F i g z l r e  89. The maxinlunl total serum bilirubin concentrations in all but three of the patients 
shown in Figure 87. At solne time the bilirubin was ele1-ated abox-e 1.0 mg per cent in 52 cases (36 
per cent). (By  permission of Current Topics in Surgical Research 1 : No\-ember, 1969.) 
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of canine livers between nonrelated donors and recipients. The first of many 
successful experiments was performed on March 23. 1964,168.16!3.1i2 about a year 
after the initially discouraging results mentioned earlier. That animal and 43 
and 23 others from the same era lived for at least 25 and 50 days, respectively, 
after operation. Nineteen of the dogs survived for three months or longer, five 
li\-ed for more than a year, and two are still in perfect health four and a half and 
five and a quarter years later (see Frontispiece). 
Dr. Philippe Mikaeloff of Lyon, who assisted in the compilation of this 
experimental series, was able to reproduce many of the findings promptly after 
his return to France that autumn;"'-""n addition, he demonstrated the feasi- 
bility of extended survival (three months) after transplantation of livers pre- 
served for several hours after donor death (see Chapter Five). F o n k a l ~ r u d ~ ~ , ~ ~  
and StuartlxO have also extended survival of canine recipients of orthotopic liver 
homografts with the aid of azathioprine therapy. 
The ability of azathioprine to prevent homograft repudiation was unpredict- 
able from dog to dog, a variability which was presumably due to differences in 
the quality of histocompatibility (Chapter Three) fortuitously achieved by ran- 
dom donor-recipient pairing in the outbred canine population. The onset of 
rejection was delayed little if at all in slightly less than one third of our experi- 
ments."' Destruction of the hepatic grafts in these recipients proceeded relent- 
lessly until the time of death (Fig. 90). 
At the other end of the spectrum were about 23 per cent of the recipients in 
which overt early rejection was not diagnosed on the basis of serial liver func- 
tion tests (Fig. 91) or else occurred to a very mild degree. From this minority 
group came all five of the animals that eventually survived for a year or longer 
out of the total series of 84 technically satisfactory experiments. 
Finally, almost half the animals followed a course between these two ex- 
tremes. Rejection developed by the diagnostic criteria outlined in the preceding 
chapter on untreated recipients but, in contrast. did not cause early death (Fig. 
92). In some instances there was marked hyperbilirubinemia. In others, the 
jaundice was not so extreme, but there were comparable elevations in the 
serum transaminases and alkaline phosphatases. These abnormalities even- 
tually tended to spontaneously revert toward normal with the passage of time 
even though no attempt was made to intensify immunosuppressive therapy 
(Fig. 92). The time before reversal became obvious was as long as six weeks, 
during which time many of the dogs appeared to be in terminal condition with 
clay-colored stools. dark urine. profound anorexia and rapid weight loss. As 
liver chemistries subsequently impros-ed. there was often a return of appetite. 
Later, hepatic failure tended to recur with an ultimately fatal outcome, 
both in the animals which continued to receive azathioprine and in those in 
which it was stopped (Fig. 92). Kevertheless, there was survival of 30 days or 
more in 16 of these 41 experiments, the maximum being 204 days. Eventually 
death was usually due to pneumonitis or to complications of chronic liver in- 
sufficiency such as gastrointestinal ulceration and hemorrhage. 
The waxing and waning of li\-er function abnormalities in the foregoing 
studies during intervals of unchanging therapy lvere of considerable intrinsic 
interest. The findings suggested that the intensity of the rejection process was 
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Figzire 90. An example of inexorable rejection despite therapy n-ith azathioprine. The sequence 
of events was almost identical to that expected in the unmodified dog (Chapter Eleven). but de- 
veloped at a somewhat slower pace. The reason for the methionine administration is explained in 
the text. (By permission of Surgery 38:131. 1965.) 
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Figure  91. Course of a dog after orthotopic homotransplantation of the liver. Overt clinical re- 
jection has never been observed. Liver biopsies after three, six and a half and 10 months were 
normal. The operation was performed on illarch 23.  1964. The animal is in  good health more than 
five years later (see frontispiece). Note that immunosuppression \\-as discontinued after four post- 
operative months without subsequent deterioration of liver function. Resumption of treatment has 
never been required. (By permission of Surgery 58: 131. 1365.) 
remitting independently of alterations in treatment in many cases. It was 
highly likely that the same explanation accounted for the surprising secondary 
recovery of the occasional dogs (Chapter Eleven) which received no im- 
munosuppressive treatment at all. The demonstration of spontaneous reversal 
of rejection in these two kinds of experiments introduced a note of caution 
about attributing this effect to any preceding variation of therapy not only after 
liver transplantation but also in experiments involving other organs. 
As also described in Chapter Eleven. the same thing has been seen com- 
monly after orthotopic liver transplantation in unmodified porcine recipients. 
In retrospect. it can now be suggested that the use of azathioprine as the single 
therapeutic agent in dogs pro~ided an experimental situation not dissimilar to 
that which exists naturally in the untreated pig model. The variability of host 
response to the foreign tissue, the spontaneous reversibility of rejection, and 
the eventual frequent development of a more or less complete state of graft 
acceptance (to be discussed later) were common observations in both varieties 
of laboratory studies. 
Effect of Methionine or Its Radioisotope 
Certain lipotropic factors including methionine have been demonstrated to 
protect against or facilitate recovery from various liver  poison^,'^^ 3 4 3  Because 
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F i g z i r e  92. Course of a dog showing nearlj- complete reversal of a rejection episode follon-ing ortho- 
topic liver transplantation. Note the sevece jaundice which ultimately completely disappeared. The 
animal received :"S methionine. L-methionine and choline in  addition to azathioprine; no alterations 
in immunosuppressi~~e therapy IT-ere made at  the time of rejection. The dog died 203 days post- 
transplantation. Azathioprine therapy n-as stopped 127 days after operation. Slow deterioration of 
hepatic function developed. The immediate cause of death was perforation and bleeding of a peptic 
ulcer at the esophagogastric junction. (By  permission of Surgery 58: 131. 1965.) 
of the therapeutic dilemma posed by the necessity of using a hepatotoxic im- 
munosuppressive agent it seemed reasonable to see if there was a protective 
effect from the concomitant administration of methionine, an amino acid 
which has been reported to prevent the toxicity of b r o m ~ b e n z e n e , ~ ~  
pyridine,12 ?'I chloroform." ~Mapharsen ,~  and butter-yellowi" and to accelerate 
recovery from chronic carbon tetrachloride poisoning."' 
In the nontransplanted control dogs described earlier in this chapter the 
pattern of hepatic injury caused by azathioprine therapy was compared to that 
observed when methionine or its radioisotope \$-as also administered intra- 
venously. The degree and duration of the abnormal changes of liver chemical 
values were not influenced (Fig. 85). Moreover. administration of methionine 
or its radioisotope did not potentiate homograft survival after homotransplanta- 
tion to the otherwise untreated host. In spite of these negatis e findings, slightly 
better results were obtained after transplantation to the immunosuppressed 
recipient when methionine or its "S isotope was gis en in addition to azathio- 
prine.17? Hon-ever. the improvement in survival was of negligible statistical 
significance (P=0.17). 
The difficulty of evaluating such adjuvant agents was greatly increased by 
the extreme variability of host response to the foreign tissue, which. as men- 
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tioned earlier, ranged from complete absence of rejection to uncontrollable 
repudiation of the liver homograft. The inability to demonstrate a statistically 
significant advantage with the use of methionine or its isotope may have been 
due to the system of testing in which the variables of uncontrolled donor-recipi- 
ent selection were of far greater importance in the individual experiment than 
the therapeutic parameter being examined. In any event. methionine has not 
been used clinically. 
Graft Versus Host Reaction 
A hepatic homograft retains its metabolic specificity after transplantation. 
The interesting question of the effect upon its new host of the "foreign pro- 
tein" synthesized by the organ is considered in Chapter Eighteen. It can be 
stated here that there i,s no clear evidence that a hostile liver homograft can 
mount a clinically significant immunologic attack upon its recipient. 
However, increased red blood cell destruction has been recorded after this 
kind of operation"' as well as after homotransplantation of the spleen." l o l  With 
either organ it is possible that erythroclastic activity by the transplanted reticulo- 
endothelial system is responsible; such grafts often contain prominent he- 
mosiderin deposits (see Chapter Twenty). A typical example of the phenom- 
enon is shown in Figure 93. The red cell half-life was reduced to less than 50 
per cent of its normal value during the first postoperative month but subse- 
quently returned to normal. Conceivably the increased red cell destruction was 
at least partially due to mechanical factors secondary to ischemic injury of the 
transplanted organ rather than to any immunologically specific antierythrocyte 
activity of the reticuloendothelial portion of the graft. Excessive hemolysis has 
not been seen in any of our human recipients of liver homografts except one 
who developed this complication after complete hepatic artery thrombosis 
(Chapter Nine). 
Although red cell destruction has not been prominent after clinical liver 
transplantation, thrombocytopenia has been extremely common. apparently as 
the result of platelet trapping in the homograft. This important subject will be 
discussed in Chapter Thirteen. 
The Discontinuance of Therapy 
The ability of 6-mercaptopurine to modify the rejection of canine renal 
homografts was first studied almost a decade ago. Shortly afterward an obser- 
vation of great fundamental importance was made by workers in two laborato- 
ries. ZukoskiN6 and Pierce and Varcol-" noted that it was eventually possible 
to stop treatment with this drug in some of their recipients with prolonged 
subsequent function of the renal homografts. 
Comparable findings were soon reported with the use of azathioprine for 
irnmuno~uppression.~"~ "  ">" In some experiments1"" it was demonstrated that 
discontinuance of therapy was sometimes feasible after as short an  interval as 
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Figure  93.  Red cell s u r v i ~ a l  and hematocrit 1-alues in  a canine recipient of a.n orthotopic liver 
homograft. Note the sharp reduction in red cell half-life in the first postoperative month. with a 
gradual return to~vard normal. Red cell survival was not altered by the withdrawal of azathioprine 
at the end of four months. but the depressed hematocrit rose sharply after the discontinuance of 
immunosuppressio~~.  The animal is still alive Inore than fi\-e years post-transplantation. (By per- 
mission of Surgery 58 : 131. 1965.) 
four months; about a quarter of the animals had prompt acute homograft rejec- 
tion. another half had slow repudiation of their transplanted kidneys, and the 
rest had continuing stable homograft function for months or )ears. One of our 
canine kidney recipients from that study is still alive with normal urine excre- 
tion six years later. 
The same phenomenon has been demonstrated in dogs after orthotopic 
liver transplantation. probably with an even greater frequency than in the kid- 
ney experiments. Later, more will be said about the mechanism by which it 
becomes possible to attenuate or stop therapy. hon this is apparently dependent 
on a progressive reduction in the immunologic interreaction of a homograft and 
its host, and hon the extent to which this change occurs determines the need 
for immunosuppression and. in turn, the long-term prognosis of the recipient. 
For the moment. hos~el-er.  attention will be directed to some laboratory investi- 
gations which bear on the question of survi\-a1 in dogs subsequent to cessation 
of all treatment. 
In  the series of 84 hepatic recipients cited earlier in this chapter, there 
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were 14 still alive at the end of four months. Treatment of 10 of these dogs was 
discontinued at that time or slightly before. The subsequent e\ents in all 10 
experiments are summarized in Table 15. 
There were no examples of abrupt late rejection and, in fact, the measured 
llver chemistries slowly deteriorated in only two of the animals (Fig. 92). In the 
other eight the hepatic function stayed at about the same level of quality as 
before. If this had been subnormal (Fig. 94). it remained so and the dogs were 
prone in succeeding weeks or months to fatal complications such as gastro- 
intestinal ulceration and pneumonitis (Table 15). which are common in 
chronic liver disease. In contrast. four animals with good four-month function 
survived for more than a year after the cessation of treatment (Table 15) and 
two are still alive almost half a canine lifetime later (see Frontispiece). 
When these findings were reported. the reason for the apparently favored 
situation of late hepatic as opposed to renal homografts was speculated upon."" 
It was suggested that the disproportionately large antigenic mass could have 
been a factor or, alternatively, that the liver with its enormous regenerative 
capacity was simply capable of sustained function in the face of continuing but 
minimal chronic rejection. The latter hypothesis received minimal support 
from histopathologic studies of the late homografts. Other possibilities might 
be that liver tissue 1s inherently less antigenic than the kidney or that the new 
environment created by the metabolites synthesized by the hepatic homografts 
is in some way made less hostile to the source gf these products. Similar 
Table 15. The Fate of 10 Dogs Which Lived for I-our Postoperative 
 months and Had Azathioprine Therapy Stopped 
DAY CHEZIISTRIES XVHEN S C B S E -  
EXPERI-  TREAT-  T H E R A P Y  S T O P P L D  Q U E X T  LAST CHEZIISTRIES C A C S E S  OF DEATH 
>TEST AIENT S U R V I V A L  
SUMBER STOPPED Alkcil ine (days) . ~ / / ~ o l i i ~ e  
B i l i -  P1zok- B i l i -  P ~ I O S -  
1.111ii1z pi ici tcise SCOT' ~ . r t h t ~ z  pizcitcrse" S G O T t  
yjj4 120 0.3  25 47 1820 0.1 1 20 Alive, Apr i l ,  1969 
S'"27 109 0.1 43 24 1640 0.1 2 35 Alive, Apr i l ,  1969 
5 " " ~ ~  99 0.5 5 2 62 31 0.4 55 49 Pneumonitis 
5'33 1 8 120 0.1 156 100 217 0.1 34 28 Perforoted duodenal  ulcer 
SS 4 117 1.3 106 350 120 4.0 114 755 Rejection; G I  hemorrhage; 
pneumonitis 
HHM 2 120 0.1 41 115 443 1.0 454 310 Portal vein thrombosis; 
7 rejection 
HHM 12 I 1 9  0.1 4 7  22 1041 0.5  96 590 Pneurnonitir; oscites; atrophic l i<er 
1 1 0  116 3.3 433 380 48 4.6 166 62 Bleeding duodenal uce t  
ICBM 13 130 5.1 293 240 27 4.8 485 280 Chronic v e r  fa i lu re  
Schime 9 127 0.1 71 100 77 2.9 134 160 Rejection; erophagogoi t r ic  ulcer 
w ~ t h  hemorrhage and  per fora-  
t ion 
Bodansk\ u n l t s  ( n o r m a l  xaiues 3 to 6) 
' S l g m a - F r a n k e l  u n l t s  ( n o r m a l  \slues 10 to 30) 
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500- 
400- 
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PHOSPHATASE 200- 
(Bodansky Units) lo* 
I 
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PRE&sT-oP TIME I N  DAYS 
F i g u ~ e  94. The course of a n  animal treated with azathioprine for the first 116 post-transplantation 
days. Under therapy a severe rejection developed which spontaneously reversed. After the aza- 
thioprine was discontinued the liver function tests actually improved. However. the dog died 48 days 
later of a massive hemorrhage from a large duodenal ulcer* (By permission of Surgery 38 : 131.1965.) 
thoughts have been expressed by Jaffe et ali4 and Calne3?n attempts to inter- 
pret their observations in pigs (Chapter Eleven). 
Gastrointestinal Ulceration 
In the first publications on the subject of orthotopic liver transplantation to 
unmodified dogs, a high incidence of acute gastroduodenal ulcerations was 
164 The immediate cause of death in many of the animals was hemor- 
rhage from these lesions or, frequently, perforation. Such complications 
seemed related to the development of rejection and were considered to repre- 
sent an ulcer diathesis generated by poor hepatic function. Hon ever. Garnier?6 
Peacock and Terblanche.I1" and Calne'" lost a number of their untreated porcine 
liver recipients from gastrointestinal erosion and perforation or bleeding at a 
time when rejection mas thought to be minimal or altogether absent. 
Similar problems were encountered in dogs r ece i~ ing  azathioprine in suf- 
ficient quantities to mitigate rejection and to obtain chronic survilal. In our 
early series1;' there were 12 examples of hemorrhage or perforation in 69 
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which died from one week to five months after transplantation. Biliary 
tract reconstruction had been with cholecystoduodenostom~. 
Even after this interval, there was continued risk, as noted by Faris3" in a 
subsequent report of the residual animals from the same study. Gastric or 
duodenal hemorrhages or perforations were the commonest causes of late 
death. The most likely victims were dogs with chronically abnormal hepatic 
homograft function. 
Subsequently S t ~ a r t ' ~ "  reported an even higher incidence of gastric or 
duodenal ulceration in dogs which had generally poor hepatic function despite 
treatment with azathioprine alone or with azathioprine in combination with 
actinomycin C and/or local homograft irradiation. Of nine dogs which lived 
for 25 to 88 days postoperatively, six had gastrointestinal ulceration as the direct 
or an important contributory cause of death. The type of biliary tract reconstruc- 
tion was not a critical factor in promotirlg the ulcer diathesis. The finding that 
1,~gotomy and pyloroplasty was an inadequate prophylactic measure, whereas 
g'istric resection was highly effectile, prompted Stuart to speculate that the 
etiology was the inability of the poorly functioning liver to inactivate humoral 
gastric stimulants such as histamine. In contrast, Calne found vagotomy and 
pvloroplasty to be an almost uniformly protective procedure in pigs."' 
Taken together the foregoing information has raised the question of 
whether human recipients should automatically receive a gastric acid-control 
procedure at the time of orthotopic liver transplantation. The more recent clini- 
cal experience suggests that this will not be necessary if good early and sus- 
tained hepatic function can be obtained from the transplanted liver (Chapters 
Fourteen, Fifteen, and Seventeen). 
HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN 
Other than azathioprine, the only agents which have been proved to pro- 
long life when used alone after orthotopic liver transplantation in dogs have 
been heterologous antilymphocyte serum (ALS) and its globulin derivitive 
(XLG). Historically, the first experiments with ALS were performed by Metch- 
nikoff. who clearly appreciated the potential therapeutic value of such serum 
products. In 1899 he wrote somewhat philosophically of the struggle between 
the various cells of an organism and added:"' "The time is not remote when 
medical art will actively intervene to maintain the integrity of the whole or- 
ganism. the harmony of \\ hich is broken by the preponderance of certain cells, 
mononuclear cells in the atrophies, several other elements in the malignant 
diseases. Therefore. I undertook the study of the effect produced by the resorp- 
tion of macrophages. To attain this end I initially injected guinea pigs subcu- 
taneously with an emulsion of rat spleen or lymph nodes ground up in saline 
solution. Forty-seven days after this injection, guinea pig serum agglutinated 
and dissolved rat leukocytes.  lon no nuclear cells were the most sensitive and 
were converted into transparent vesicles. Later the granulocytes underwent the 
same changes and finally the mast cells." hIetchnikoff pointed out that nonim- 
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munized serum did not have these properties. In addition, he observed that the 
guinea pig antirat serum which he used did not agglutinate lymphocytes from 
other species. 
In the next 60 years there were a number of reports on the properties of 
ALS. These contributions as well as the subsequent literature on ALS were 
recently summarized by Meda~var"" of London who, with his colleagues at  the 
Mill Hill laboratory. has played a leading role in the development of this field. 
In the follo~ving remarks no attempt will be made to present such a general 
survey; instead. attention will be directed to the may in which information from 
research laboratories concerning ALS and its by-products was reviewed and 
expanded with the ultimate objective of administering these substances to 
patients. 
Preliminary Steps 
The first to demonstrate the ability of ALS therapy to mitigate homograft 
rejection n7ere Waksman, Arbouys, and Arnason in 1961.18' They obtained pro- 
longation of skin homograft survival. The effect was a weak but significant 
one. The subsequent investigations of Woodruff and Anderson'!", '!':j catalyzed 
widespread interest in the possibility of using such antisera for clinical therapy 
by demonstrating a striking protection of homografts in rats treated with ALS 
alone or in combination with thoracic duct drainage. Within two years antisera 
of comparable or greater potency were developed by many other investiga- 
tors.'"'. 6". 2'. " 8 .  "!I. I":'. I: '" In all these early studies the experimental model con- 
sisted of skin grafting in mice, rats, or guinea pigs which were treated, usually 
by intraperitoneal injection. with antisera raised in rabbits. The use of geneti- 
cally controlled donor and recipient strains for transplantation permitted 
precise delineation of many of the features of the tested sera which have direct 
clinical applicability. 
Nevertheless, a number of intermediate steps were required before 
heterologous antilymphocyte products could be considered for clinical trial. It 
was necessary to demonstrate a beneficial effect of ALS after xvhole organ 
transplantation in outbred large animals, to determine the therapeutic 
schedules which Tvere the most effective with the least toxicity. and to evolve 
practical techniques of administration which would be acceptable for use in 
man. This kind of information was sought in dogs by use of heterologous ALS 
in horses,l, 7, 69, i 2 ,  138, 110,  165, 171 Sheep,120. I 4 0  or rabbits.2 95,  121 
Raising the Antiserum 
One of the first practical problems to be solved was to raise an antiserum of 
sufficient potency so that it could be given in small volumes. The experiments 
with rodents cited previously usually involved the intraperitoneal administra- 
tion of 0.23 to 1.0 ml of raw ALS. ~ o l u m e s  which rvould be 1 to 2 liters if 
extrapolated on a weight basis to adult humans. In most of these earlier reports 
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the activity of the antisera was not quantitated except for its ability to prevent 
skin homograft rejection. When stated. the antiwhite cell titers as measured by 
leukoagglutination tests never exceeded 1:64. Consequently an attempt was 
nlade to improve this situation. using the horse as the heterologous serum 
source. This animal was chosen primarily because its large blood volume would 
permit enough ALS and ALG to be prepared for adequate trials in large animals 
and. ultimately. in man. 
The dose of lymphoid antigen used for immunization proved to be a critical 
factor in raising a high potency serum."!'. ", I"'' Early in our experience lympho- 
cytes from lymph nodes or thymuses were given subcutaneously in doses of 
0.18 to 1.4 billion cells (Fig. 95). Within a few- weeks the leukoagglutinin titers 
rose from control values of 0 to 1:4 to a maximurn of 1:236. These did not in- 
crease further despite similar repeated booster doses over periods of as long as 
six months. 
Subsequently the dose was greatly increased by using splenic lymphocytes. 
This source of antigen ~ 9 s  selected because of its bulk availability from human 
cadaveric sources. When 4 to 200 billion spleen cells were used the antiwhite 
cell titers rose within a few weeks (Fig. 95) to as high as 1:16,000 in parallel 
L-LYMPH NODES 
T-THYMUS 
S-SPLEEN 
T IME IN D A Y S  
F i g u r e  95, Effect of immunizillg dose upon the  leukoagglutinin titer of a horse inoculated with 
cadal-eric human  lynlphoid tissue. Note that the rise in  titer was ler!- modest in the  first three 
months.  during which time small doses of cells were used. \l'hen the quantity of antigen was in- 
creased by the use of spleen cells. abrupt elelations in titer r.iere observed ~v i th in  a f ew days. If 
large antigen doses are  gil-en f rom the beginning, a high titer antiserum can be obtained i n  about 
60 days. (BJ- permission of Surg. Gyilec. Obstet. 124 : l ,  1967.) 
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with comparable increases in lymphocytotoxicity titers. There was some vari- 
ability of the ALS or the globulin (ALG) extracted from it inasmuch as the white 
cells from individuals of the species against which immunization was con- 
ducted were not all agglutinated or lysed to the same d i l~ t ion .~ '  '. -' PutnamI4? 
explained this by differences in the antigens of the original immunizing cells 
as these related to the antigenic profile of the cells ultimately used for testing. 
He suggested that a serum to be used in the outbred canine or human popula- 
tions would ideally be raised with the lymphoid tissue of the individual to be 
eventually treated, or else that many donors should be used to assure adequate 
representation of the variable immunizing antigens. 
As yet there has been no convincing evidence that immunization with a 
particular kind of lymphocyte results in the production of an antiserum with 
inherently superior immunosuppressive qualities. The only investigators to sys- 
tematically examine this question were Ono et al.13' In parallel experiments in 
our laboratories they raised ALS in rabbits with rat splenic, thymic, and lymph 
node lymphocytes. The three resulting sera, which had equal antiwhite cell 
titers. had exactly the same ability to mitigate the rejection of heterotopically 
placed hearts which were transplanted across an AgB (Wistar-Furth to Fischer) 
barrier. The only special drawback with the use of splenic antigens was that the 
ALS had a significantly higher antiplatelet titer. As will be discussed in Chap- 
ter Thirteen, this disadvantage has special implications in liver transplantation. 
The work of Jooste et a18' has emphasized that much still needs to be 
learned about the optimum techniques for immunizing the heterologous serum 
donor. The exact technique used may have a very important effect on the 
immunosuppressive qualities of the ultimate product and. equally important, 
may determine its toxicity. In Jooste's report it was noted that the use of an 
adjuvant caused a marked increase in undesirable side effects. 
Standardization of  ALS 
It was soon shown in dogs that the high titer ALS mitigated rejection in 
volume doses which were only a fraction of those required for the same effect 
with the previous low titer products."!'. l i l  Nevertheless, there was initial 
widespread beliePC" that the antiwhite cell titers would not be an expression of 
the immunosuppressive efficacy of ALS, a point of controversy that has not yet 
been completely r e~o lved .~ .  ' 8 .  :" However, there now seems to be agreement 
that essentially all good quality antisera possess high titers. particularly when 
these are measured by lymphocytotoxicity tests. The converse is not necessarily 
true. In several laboratories occasional batches of high titer ALS have been 
assayed which were ineffective for the prevention of skin homograft r e j e c t i ~ n . ~ ~  
Since ALS is in no sense a standardized product like azathioprine and pred- 
nisone, this introduces special complications in the interpretation of its effects. 
Methods are still badly needed for the accurate prediction of the immunosuppres- 
sive properties of XLS and ALG which are prepared for use in humans. X poten- 
tially fruitful approach may be one based on the interspecies cross-reactivity of 
ALS which was demonstrated by Iwasak i7and  Putnam.I4-' Putnam showed 
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that antihuman ALG lysed or agglutinated the white cells of African green 
monkeys almost as efficiently as those of man. Balner, Eysvoogel, and Cletonll 
have tested the ability of antihuman sera to prevent or to delay the rejection of 
chimpanzee homografts. Such an approach may ultimately shed more light on 
the issue of the titer-to-immunosuppression relationship, and on the other im- 
portant questions of whether the source of the human lymphoid tissue or the 
timing and other details of immunization have an important influence on the 
eventual product. Until such standardization methods are evolved. it is unlikely 
that ALG for use in humans will be released by commercial drug companies. 
Absorption o f  ALS 
The raw serum from the clotted blood of immunized horses is usually ex- 
tremely toxic because of the presence of extraneous antibodies directed against 
the red cells, thrombocytes, and plasma proteins of the species to be treated. 
For example. injections of unabsorbed or inadequately absorbed ALS or ALG 
can cause immediate and precipitate falls in the hematocrit of dogs (Fig. 96) or 
thrombocytopenia in monkeys"' or man.';' The complications can be avoided or 
at least minimized by the absorption methods described by Iwasakii' as later 
modified and improved by K a s h i ~ a g i . ~ ;  
Briefly, these techniques consist of absorbing the horse serum first with 
- .  i r - .  - - - - .  .  - - ; . $ I  - . z . -  
- . .  . . -  z . . .  - - . - - .  - - - .  
- -  . .  
- - -  
F i g z ~ 7 . e  96. The effect of horse plasma or serum and crude horse globulin upon the hematocrit, 
1vrnphoc)-te count. total white count,  and  11-hire cell differential during 13 days of daily administra- 
tion. In  all but the  control experiments on the right. the agents lvere prepared from horses immu-  
nized against dog I?-mphoid tissue. Yote that acute  anemia was largely prevented onl>- when com- 
plete absorption had been carried out 11-ith canine red cell pack. (By permission of Surg. Gynec. 
Obstet. 1 2 4 : 1 ,  1967.) 
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fresh human plasma, then platelets and, finally. red cells. Before the last step, 
the ALS is decomplemented by heating at 56" C for 30 minutes in order to avoid 
the hemolysis which otherwise occurs. Singly or together, these procedures 
have little or no effect on the antiwhite cell titers. 
In contrast, absorption of the ALS by nucleated cells of the donor species 
causes a profound loss of titer. All workers from Pappenheimer':'4 to the present 
time who have performed the necessary experiments agree that the antiserum 
is largely inactivated if it is exposed to the lymphoid tissue of the original donor 
species. In addition, there is a ma,jor loss of titer if the ALS is absorbed with 
kidney, liver, lung. or skeletal muscle,'""'!' an observation explained by the dem- 
onstration in other ways of ALS antibody binding to these various tissues."" 14" 
These findings indicated that there was a considerable antigen sharing 
between all nucleated cells of the species being treated. They also suggested 
that if antigens. which would react only with tissue-specific ALS antibodies, 
were uniquely represented in the lymphocytes, these unshared determinants 
were few in number. Levey and Medawar!'!' strengthened the latter conclusion 
in  a crucial experiment in which sera were raised in rabbits by immunization 
with mouse epidermal cells or even L-cells or fibroblasts from tissue culture. 
Mice treated with the resulting antisera developed lymphopenia and had 
definite prolongation of skin homograft survival. 
The lack of strict immunologic specificity of the antisera has not proved to 
be a fatal flaw, probably because the lymphoid system is a highly vulnerable 
target to which ALS antibodies selectively "home" despite the fact that the liver, 
kidney, and other organs possess potentially competitive binding sites. Using 
unabsorbed rabbit ailtisera. Levey and M e d a ~ a r " ~  were able to show that fluor- 
escein-tagged antibody m7as heavily concentrated in the lymphoid elements of 
treated mice. Furthermore. the toxicity studies to be reviewed later did not re- 
veal a direct injury to other organ systems7+xcept under exceptional circum- 
s t a n c e ~ : ~ ~  Even the renal abnormalities which will be described subsequently 
were thought to be due to the immunologically nonspecific lesions of '.serum 
sickness nephritis" rather than to a direct nephrotoxic action of the ALS. Con- 
sequently. we have not used absorption with any nucleated cell suspensions 
in the preparation of our antihuman sera. 
Purification 
Although the application of absorption techniques was important, it was 
also necessary to obtain purified derivatives for human use. Simultaneously, 
several investigatorswY 7 2 .  7 5 ,  14k, 194 found the desired antibody to be chiefly in the 
gamma G globulin by means of chromatographic (Fig. 97) or other techniques. 
However, there is good evidence, as will be re-emphasized later and in Chapter 
Thirteen. that the antileukocyte antibodies of horse XLS are distributed rather 
widely in the equine iinmunoglobulins and that excessive refinement of the 
serum may therefore lead to a serious loss of potency. 
The first steps to extract the active elements of ALS were taken by Waks- 
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U N A B S O R B E D  t 3 2 S E  
---, Al\Tl - I V J M A N  L Y M P H O I E  I SERUM 
T U B E S  7 - 1 4  
lA11_ TUBES 79-  86 
TUBES 118 - 121 
TUBES 1 2 5 - 4 0  
Figure  97. Studies of the leukoagglutinin-containing fraction in  horse antihuman-lymphocyte 
serum {ALS) 1~1 th  the  use of column chromatography, electrophoresis, and immunoelectrophoresis. 
The various eluates f rom the  dieth)-laminoethanol (DEXE) cellulose column Tvere analyzed spectro- 
photometrically for proteili content (expressed as  optical densityj. and  the presence or absence of 
leukoagglutinins was determined for each collection tube. The shaded areas indicate leukoagglutinin 
actil-iry. The electrophoresis and  imniunoelectropliores~s permitted relati\-ell- complete classifica- 
tion of the active immunoglobulins. (By permission of Surg. Gynec. Obstet. 124 :1 ,  1967.) 
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man and his associates, who reported in 1961 that crude globulin obtained by 
ammonium sulfate precipitation retained the same properties as the original 
a n t i ~ e r u m . ' ~ ~  This finding was confirmed by later workers."" ;' "' With the prop- 
er selection of ammonium sulfate concentration7' most of the antibody con- 
tent could be recovered in the precipitate. The product prepared in bulk quanti- 
ties by this method and used for a large number of patients at our institutions 
from June, 1966. onward (Chapter Thirteen) is shown in Figure 98. It con- 
tained principally gamma G globulin, as well as significant quantities of T- 
equine globulin and traces of alpha globulin. 
More recently a highly refined ALS consisting entirely of gamma G 
globulin (Fig. 99) has been used in a clinical trial at  our institutions. The 
refined globulin (called ALGG) was obtained from immune horse serum by 
preliminary ammonium sulfate precipitation followed by batch extraction with 
a DEAE-cellulose technique. ALGG, prepared in this way for use in dogs, had a 
definite, though limited. ability to slow the repudiation of canine renal 
homo graft^.^'^ X X  a result which was not surprising since the gamma G fraction 
of rabbit ALS had already been proved by actual testing to retain significant 
antirejection properties."' "' 
Unfortunately there was evidence in the patients8" Ih1 that ALGG 
E LECTROPl iORESI  S IMMUNOELECTROPHORESI S 
ABSORPTION AND 
PRECIPITATION WITH 
0 4 SAT (NH4)2 So4 
Figz11.e 98. Electrophoresis and immunoelectrophoresis of absorbed horse antihuman-lymphocyte 
serum (ALS) and the globulin obtained from it (ALG) by two precipitations with 0.4 saturated am- 
monium sulfate. two dialyses. and lyophilization. The final product, which was used clinically, con- 
sists chiefly of gamma G and T-equine globulin. (By permission of Surg. Gynec. Obstet. 124:  1. 1967.) 
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ELECTROPHORESIS IMMUNOELECTROPHORESIS 
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I 
AFTER SINGLE 
PRECIPITATION 
I 1  I 
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0.4 SAT (NH4),S04 
I I I  I I 
I I AFTER SUBSEQUENT DEAE - CELLULOSE 
4 4 !  4 
ALBUMIN a P y EXTRACTION 
F i g u r e  99. Electrophoretic and immunoelectrophoretic patterns of unabsorbed antihuman ALS, 
the raw globulin obtained with a single ammonium sulfate precipitation of absorbed XLS. and the 
final product (pure gamma G globulin) after subsequent DEAE-cellulose batch extraction. (By per- 
mission of Surgery 65:477, 1969.) 
provided immunosuppression which was inferior to that previously observed 
when using the less pure ammonium sulfate-precipitated ALG (see Chapter 
Thirteen). The possibility that this kind of refinement may diminish the po- 
lency of horse ALG was also raised by Clunie et al" on the basis of observations 
in dogs that were subjected to renal transplantation. 
The explanation of these findings is probably that the active fraction of 
horse ALG is not confined to a narrowr band of the gamma G globulin, as it 
apparently is in rabbit serum. I~vasaki~'  thought he could also identify antiwhite 
cell antibodies in the T-equine globulin component of horse serum (Fig. 97), a 
contention which was supported by the investigations of P i~h lmayr"~  and 
which was not weakened by the studies of James and 51edawar.i' hIore recently 
in our laboratories Kashi~vagi"" '"I has demonstrated conclusively that very im- 
portant antileukocyte factors in horse ALS reside in the ..fast" gamma (IgA) 
and possibly in other globulin constituents of the T-equine fraction. He also 
confirmed that the desired element of rabbit ALS is almost exclusively in the 
gamma G globulin. 
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The Problem of Dosage 
The lack of an  accepted standard assay for ALS and ALG has made it 
difficult to interrelate much of the research carried out in different centers. In 
our own laboratories the quantities of ALS or ALG administered were varied 
according to the weight of the treated subject and the antiwhite cell titer of the 
material administered. The system was an arbitrary one and based on the con- 
ceivably false (as discussed earlier) assumption that the effectiveness was di- 
rectly related to the leukoagglutinating titer. Thus. 1 ml of reconstituted 
globulin with a titer of 1:8000 was said to contain 8000 "units." With a titer of 
1:  16,000 the same volume contained 16,000 units according to this nomencla- 
ture. Individual doses in our laboratory experinlents were usually 500 to 1000 
unitslkg. a range which was eventually also used in patients. 
Influence on the Rejection of Canine Kidney 
Homografts 
Within a six month period in late 1966 and early 1967 there were several 
reports that the functional survival of canine renal homografts was prolonged 
by the intravenous. intraperitoneal, or subcutaneous administration of 
horse,]. 7 ,  I;!'. I:]". 163.  171 rabbit,', "4. !I% 1 2 1  or sheep"" antidog-lymphocyte serum (ALS) 
or globulin (ALG). These findings have since been confirmed in a tidal wave of 
similar publications too numerous to warrant annotation here. 
The imn~unosuppressive effect was not necessarily dependent upon the 
use of doses large enough to produce lymphopenic responses such as those 
shown in Figure 96. Survival was maximal if ALS or ALG was started several 
days before operation,"!'. "I a conclusion previously reached by Monaco with 
skin homotransplantation in mice'" and subsequently confirmed in canine kid- 
ney experiments by Clunie." Even at best. ho.czrever, the results after kidney 
transplantation. with or without lymphopenia. were inconsistent in our studies 
and those of all other investigators working with dogs. There were some extraor- 
dinarily long-term sun-ivors, but most animals eventually rejected their 
homografts. The spectrum of response to therapy was not dissimilar to that 
observed in the e\-aluation of azathioprine as described earlier in this chapter. 
With both agents the variability of results was presumably due to differences in 
the quality of chance histocompatibility matching in randomly paired mongrel 
dogs. 
Orthotopic l iver Transplantation 
The same variabilit? of effect was evident in experiments with orthotopic 
liver transplantation. In the first trials nine dogs were treated with unrefined 
ALS which was given in t raper i t~nea l ly .~~ "'I I c 7 ' I h 7  17" Nine more animals 
received subcutaneous anlmonium sulfate-precipitated ALG. Treatment was 
started one to 86 days before operation. One of the dogs received no further 
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treatment and the other 17 were given additional injections for as long as 60 
days postoperatively. In no case was therapy continued after t n  o months and in 
most instances it was discontinued before this time. 
The results in this series of experiments are shown in Table 16. Of the 18 
recipients 10, 9. 7. and 6 s u r v i ~  ed for 15. 20. 30. and 50 days. respecti1 ely: four 
of the animals were still living at four months. Once rejection had begun, its 
features (including spontaneous reversal in se\ era1 instances) were undistin- 
guishable from those described earlier for the period during or after treatment 
with azathioprine. The magnitude of histologically evident rejection in these 
livers was less extreme than in renal homografts provided with comparable 
therapeutic protection.lil 
Table 16. The Fate of 18 Dogs Which Received Orthotopic Liver Homografts 
in 1965 and Early 1966 
D A Y  POST 
E X P E R l  OPEKATIX L 
M E U l  T R F  \ I R I E N T  C H E \ I I S T R I E S  \\ HEh L A 5 1  CHE\IlSTRIES S L R \ I \  A L  
PILWBER STOPPLD TXEArllEh r S T O P P E D  E E F O R E  DEATH I U  DAYS C A U S E S  O F  DEATH 
VKC None given 0.2 14.9 I8 177 Volvulus 
HL 3 Did not stop 6.0 535 3 75 33 Rejection; pneumonit ir  
HL 4 Did  not stop 11.4 172 200 11 Rejection; pneumonitis 
HL 6 Did  not stop 0.6 31.6 38 7 Hemorrhagic enteritis 
HL 7 Did  not stop 11.7 118 410 7 P.V. Occl; reject ion 
HL 8 Did not stop 9.7 173 560 21 Rejection 
HL 20 Did not stop 3.2 4.6 110 6 Rejection 
HL 22 21 0.3 59 60 0.2 60 42 390 Cholangitis; liver abscesses; 
? rejection 
HL 23 Did  not stop 9.1 128 700 16 Rejection; liver sepsis 
SUN 1 Did not stop 0 3.1 28 7 Rejection; 
hemorrhagic enteritis 
SUN 2 57 3.5 210 114 8.2 236 236 122 Hepatic artery 
thrombosis 
SUN 3 D i d  not stop 0 52.5 81 60 Died after liver biopsy 
S U N 4  55 0.2 77.6 33 4.2 221 65 128 Rejection 
SOLARIS 5 Did  not stop 5.3 352 2 75 72 Hepatic artery thrombosis 
SOLARIS 6 Did  not stop 5.7 ' 108 5700 7 Rejection; pneumonit ir  
SOLARIS 7 Did not stop 6.8 151 3 70 21 Rejection; pneumonitis 
SOLARIS 8 Did not stop 6.1 168 1960 11 Rejectton 
SOLARS 9 Did  not stop 3.5 112 5 70 8 Rejection; pneumonia 
The a ~ i l m ~ ~ l i  1yei.e treated with ALS or A L G  beginning one to 26 days before operation. 
+ Bodansk! units nol.nla1 alues 3 to 6). 
:Sigma-Flankel units : ~ i o r ~ n a l  values 10 to 30). 
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Some interesting observations were made in the dogs which lived for the 
longest time. One animal received only six injections of antilymphocyte serum 
over a 26-day preoperative period. A definite lymphopenic effect was not pro- 
duced (Fig. 100). After liver transplantation no further therapy was given. The 
dog always had satisfactory hepatic function and ultimately died of intestinal 
obstruction six months postoperatively. The second animal, which had pretreat- 
ment for one month, received ALS postoperatively for only 21 days. After 
therapy was stopped there was a striking lymphocytosis (Fig. 101), despite 
which acute rejection did not occur. The dog eventually died of liver sepsis 13 
months after transplantation. 
In many of the foregoing experiments with livers, as well as in others 
involving transplantation of the dog kidney.', "''s IL'. Ii' it was proved that the 
subcutaneous injection of small volumes of potent ALS or ALG produced a 
readily detectable immunosuppressive effect. From a practical point of view 
this was an important advance since it pointed the way to one acceptable method 
for the administration of ALG to humans. Ultimately. however, it was decided 
to use the intramuscular route clinically since, unlike the situation in dogs, 
injections of irritating substances are poorly tolerated in the fatty subcutaneous 
tissues of man. 
Other proof of the therapeutic value of ALS in canine liver transplantation 
was quickly forthcoming from two groups. The first was by an intra-European 
team headed by Rudolph Pichlmayr of Munich and by Philippe Mikaeloff of 
Lyon. The ALS was raised in Germany in horses and shipped to the French 
laboratory where the orthotopic transplantations were performed. There were 
10 dogs in the I:"' all treated with intravenous ALS; twice daily injec- 
tions were started four days before operation and continued indefinitely after- 
Figzc  re 100. X dog which received a n  orthotopic liver homograft af ter  six intraperitoneal injections 
of antilymphocyte serum (ALS). Yo postoperatil-e therapy was ever gil en. Note that the lymphocyte 
count was little changed. The dog li\-ed for six months.  finally d?-ing of a n  unrecognized intestinal 
~ o l v u l u s .  (B>- permission of Surg. Gynec. Obstet. 124:301. 1967.) 
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Figure  101. The first postoperative year of a dog which was treated with intraperitoneal ALS 
before and for 20 days after orthotopic liver transplantation. Note the prorlounced lymphocytosis 
late in the postoperative period. The animal finally developed ascites and died of chronic liver failure 
390 days after operation. (By permission of Butterworth & Co.. Ltd.. London, 1967.) 
ward. Five of the animals lived for at least 20 days, the longest survival being 
four and a half months. 
More recently Birtch,Ii of the Peter Bent Brigham laboratories in Boston, 
has reported even better results from giving equine ALS or ALG by the subcuta- 
neous route. Birtch's studies focused particular attention upon the effect of 
dosage on his results. Below a given threshold there was no demonstrable pro- 
longation of recipient life. 
There have been no reports of immunosuppressive therapy of any kind after 
orthotopic homotransplantation of the pig liver. The only attempts known to 
have been made were summarized in Table 14. Chapter Eleven. Horse antipig- 
lymphocyte serum was used as the sole means of therapy. The results in a 
small series were not so good as in untreated animals. 
The Reversal of Rejection 
In some of the early investigations with skin homotransplantation in inbred 
rodents it was shown that ALS given even several days after application of the 
homograft resulted in definite prolongation of transplant ~urv iva l .~ '  9' This was 
not surprising since it was already known that ALS could prevent or blunt the 
220 / EFFORTS TO MITIGATE OR PREVENT REJECTION 
expression of pre-existing immunization states.;". '"3 18' including that of a sec- 
ond set <l!l. 1 2 2 .  12-1 
A logical extension of this kind of information should be that ALS n70uld be 
useful in treating an established rejection. The hypothesis was tested by 
Smith1" in mongrel dogs that were subjected to kidney transplantation and not 
treated with ALG until there was evidence of deterioration of renal function. 
Death from homograft failure was significantly delayed by the treatment and in 
several experiments the rejection was at least partially reversed (Fig. 102). His 
report also contained an account of one orthotopic liver transplantation. The 
recipient dog developed hepatic rejection after a week. was treated with three 
subcutaneous injections of ALG, and lived for an additional 100 days. 
ALG Synergism 
Before ALG was used in patients it was highly desirable to know about the 
immunologic interaction between the antilymphocyte substances and the more 
conventional immunosuppressive agents. At the time that a clinical trial was 
first being considered this was a particularly important question since an early 
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hypothesis of Levey and M e d a \ ~ a r " ~  held that the immunosuppressi\ e proper- 
ties of ALS were due to binding of the heterologous antibodies to recipient 
1s mphocytes, thereby "blindfolding" and functionally emasculating them. Such 
a possibility implied that the action of the antisera \vas dependent upon a stable 
lymphocyte population and that the superimposition of agents which caused a 
rapid turnover of stem cells might cancel the effect. 
Experiments were therefore undertaken in which ALG plus azathioprine 
were used for immunosuppression."" I?' It was found in the canine kidney 
transplant model that the limited but definite prolongation of surkival which 
could be achieved with suboptimal doses of either agent was slightly increased 
when the two were employed together. Although this improvement was not 
statistically significant, the really important obserlation was that survival was 
not made worse. Moreover, the extent of histologic damage was less in 
homografts retrieved from dogs that had been given the combination therapy.lX 
Later, Weil and S i m m ~ n s ' ~ "  and Alexander et al' reported a much more striking 
synergism of ALS with azathioprine under conditions of testing that were simi- 
lar except that large drug,doses were used. 
The two agents. ALG and azathioprine, were also used together by Grothi2 
in his canine experiments on blood flow in orthotopic liver homografts. In  
Chapter Eleven the results of such studies in unmodified recipients were 
described; characteristically, there were sharp declines in hepatic blood flow 
with the adbent of rejection. Such changes were completely al~oided in four of 
five treated recipients (Fig. 103). Three of the five dogs lived for more than 
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500 50 5.0- _ _ _ _ _ - - - - - -  SGPT 
250 25 2.5- 
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DAYS POST - TRANSPLANT 
F i g u r e  103.  Lirer blood flow. cardiac output. and liver function in four canine liver recipients 
11-hich received im~nunosuppression 11-ith ALG and azathioprine and had little or no evidence of 
rejection. 1Iean 1-alues = SE. as \re11 as the number of obserl-ations (in parentheses). are given. (By 
Permissio~l of Surgery 63 :638 ,  1968.) 
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four months after operation. One of the residual animals is still alive after two 
and a half years: of the other two one died after 125 days of intestinal obstruc- 
tion and the other after 185 days of duodenal ulceration with hemorrhage. 
A complementary effect of the antilymphocyte substances with other im- 
munosuppressive measures has also been dem~nstrated.~ ' .  "".". '" ""' The 
studies which were most relevant to the therapeutic regimen finally used clini- 
cally (Chapter Thirteen) were performed by Levey and Medawar.!"' They 
showed a profoundly synergistic effect of adrenal corticosteroids with ALS, an  
observation not dissimilar to that of Woodruff and Anderson,""~'!'" who com- 
bined serum therapy with thoracic duct drainage in rats. Levey and Medawa?" 
have also demonstrated that total body irradiation and immune serum treat- 
ment can be used together with benefit, providing the roentgenotherapy is 
given before exposure to the antigen. When irradiation was used late, well 
established skin homografts in serum-treated mice were rejected within a few 
days, long before the expected times established in control experiments with 
the administration of ALS alone. 
ALS and Thymectomy 
It has been shown in otherwise unaltered adult mice, rats, and hamsters 
that thymectomy causes a slowly developing loss in immunologic reac- 
t i v i t y . ~ ~ ~ ) ,  119, GI, 1h3 Miller" I i 8  demonstrated with skin transplantation experi- 
ments in mice that this process could be accelerated if sublethal total body 
irradiation was also given. Later. Monaco,"-' J e e j e e b h ~ y , ? ~  and DavisJq reported 
that thymus excision in mice potentiated and prolonged the action of ALS. 
Efforts to reproduce the latter findings in dogs treated with ALS or ALG 
have not been successful either in our laboratories"" I:' or in those of Atai and 
Kelly.' Furthermore. no worthwhile consequence of thymectomy could be de- 
monstrated in a series of patients subjected to this procedure before renal ho- 
motransplantation and subsequently followed for two and a quarter to four 
years.lhl This clinical investigation included several cases in both the thymec- 
tomy and control groups in which ALS was part of the therapeutic regimen 
described in Chapter Thirteen. 
The failure to demonstrate an effect of thymectomy in the foregoing 
studies does not prove that the thymus has no immunologic function in adult 
dogs or humans. At the least, however, it does indicate that other factors are so 
much more important in determining survival and homograft function that the 
loss of the thymus resulted in no detectable therapeutic benefit under the 
stipulated experimental conditions. Conceivably, future improvements in 
management might permit unmasking of a presently unrecognizable subtle 
influence of thymectomy in these species, but at present there seems to be no 
justification for continued use of the procedure in clinical organ 
transplantation. 
Mechanism of ALS lmmunosuppression 
In spite of numerous publications on the subject, the action of ALS and 
ALG are very incompletely understood. A discussion of this question is beyond 
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the scope of this chapter and the competence of the author. The interested 
reader is referred to Medawar's recent s~mmary'~%which analyzes the case for 
or against several hypotheses. including those of simple lymphocyte depletion, 
coating of the lymphocyte recognition sites with the heterologous globulin 
(blindfolding theory), and stimulatory redirection of lymphocytes into immu- 
nologically nonspecific pathways (sterile activation). Medawar's survey of the 
known facts makes it clear that more than one and possibly all of these theories 
could have validity and that the ALS effect does not necessarily have a mono- 
lithic explanation. 
From a practical point of view it is important to realize this, since the 
induction of overt peripheral lymphocyte or central lymphoid depletion by ALS 
or ALG is definitely not a requisite for the modification or prevention of 
homograft f i ~  cf i .  99, 163. l i I  The magnitude of the immunosuppression, 
even in the absence of detectable lymphopenia, is often of a much higher order 
than that resulting from profound lymphocyte depletion produced with 
mechanical techniques such as extracorporeal blood irradiation8" and thoracic 
duct drainage."", ' "Mar t in  and Miller,HJ2 Lance,":' Taub and Lance,18'~ '" Denman 
et al,"(t:~ Leuchars et al," Tyler et al,lx5 and Medawarl"%ave all suggested a 
common explanation for the immunosuppression caused by ALS in the absence 
of detectable lymphopenia. They have proposed a selective killing of the 
thymus-derived lymphocytes that subserve delayed hypersensitivity and 
homograft rejection. either by recognizing antigen and reacting against it, or 
else by activating a different kind of lymphoid cell derived from bone 
marrOw.2:3. 24 Under these circumstances the loss of the thymus-derived lympho- 
cytes might not be reflected in the blood because of the overproduction of other 
lymphoid cells which then spill out into the circulation. 
The hypotheses listed above are based on essentially incontrovertible 
evidence that the lymphocyte is altered in one way or other or else destroyed by 
ALS. An alternative suggestion has been made by Guttman and his asso- 
ciates ,,j:j-",j who proposed that the antisera acted by coating the cells of the graft 
rather than by altering the host. They reported that donor pretreatment resulted 
in prolongation of skin homograft survival in unmodified mouse recipients. 
These observations could not be confirmed by Cerilli" in dogs. 
Toxicity of ALS and ALG in Animals 
There is no question that administration of antilymphocyte substances 
causes a general weakening of immunologic reactivity. Nevertheless, the many 
investigations in rodents and dogs cited earlier have made it clear that 
homograft s u r v i ~  a1 is often attainable without the penalty of total immunologic 
crippling and consequent overwhelming sepsis. Most of the canine experi- 
ments were carried out in a standard kennel environment. The incidence of 
infectious complications was noted to actually be less than with other effective 
immunosuppressive agents. 
This aspect of toxicity is almost certainly dose related. Monaco et allZL 
showed that an invariably fatal nasting disease could be induced in mice heav- 
ily treated with rabbit ALS. At autopsy the animals had virtually complete 
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lymphoid depletion. In contrast. such lymphoid involution has not been ob- 
served in several other studj.es in which ALS or ALG provided significant pro- 
tection of the homografts.;" .', ';' The striking feature in our dogsi2 and Lance's 
mice9Qvas not atrophy of the lymphoid tissue. but the loss of small lpmpho- 
cytes and their replacement by large and medium-sized pyroninophilic blast 
cells. 
Apart from the risks of overimmunosuppression, there are other specific 
dangers with ALS and ALG administration. These were not appreciated until 
recently since many of the early investigators working with ALS in mice and 
rats reported freedom of their animals from obvious side effects. In such 
studies the periods of administration were limited to a few days or weeks. 
Furthermore, a systematic search was not made in various organs for evidence 
of the kind of damage that is classically associated with foreign protein therapy. 
The hope was expressed by several authors that the immunosuppressive quali- 
ties of ALS would blunt or prevent a reaction to its own alien protein. This may 
be partially true. 
Gray et al:;lU Levey and Medawar,!18 and Lance"" found that the appearance of 
antirabbit-protein antibodies was inhibited in mice during a course of therapy 
with rabbit ALS as compared to that which occurred in response to normal 
rabbit serum. The same thing was documented by Huntley"" and Iwasakii2 in 
dogs receiving horse ALS. However: in all these experiments there was even- 
tually some evidence of a host antibody reaction against the heterologous 
serum (Fig. 104). 
Lance's study"3rom the Mill Hill laboratories was a particularly important 
one in terms of clinical applicability. He showed that intermittent "pulse" 
therapy with intervening rest periods resulted in a much more rapid sensitiza- 
tion to the injected immune serum than chronic steady administration and that 
the former regimen of treatment, in turn, led to a loss of the immunosuppres- 
sive effect; Ono's experiments demonstrated essentially the same thing.l3'l This 
was not unexpected in view of Lance and Dresser'sY4 observation that animals 
preserlsitized with rabbit gamma G globulin obtained from ALS eliminated 
ALG much more rapidly than the corresponding globulin prepared from normal 
rabbit serum. 
Because of the immunogenicity of ALS and ALG (even of pure gamma G 
globulin), it was also not surprising that a number of dogs studied during 
chronic administration of ALS or ALG developed classic complications of 
foreign protein therapy. The most dramatic were anaphylactic reactions. which 
were usually mild and nonfatal1. "" 7 2 ,  '-"', lti" and which often did not necessitate 
the discontinuance of therapy. 
Even more alarming was the development in many of these test animals of 
histopathologic evidence of serum sickness nephritis after treatment with rela- 
tively large doses of ALS or ALG for longer than two weeks.ti!', ". I i "  In some of 
these animals in which the canine precipitating antibodies against horse pro- 
tein were studied, the titers had risen little or not at all. The incidence of the 
complication was increased if intravenous therapy was given. and uremia was 
induced only with the latter route of administration. Similar lesions have been 
described since then by almost all investigators ~ v h o  administered ALS or ALG 
chronically to animals as the sole form of treatment. The reports of Lancew and 
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Ficjui'e 104. The response of canine precipitin titers to horse protein during daily injection of 
qlobulin prepared from the serum of noliimmunized and immunized horses. Note the striking dif- 
ference in the two  groups of dogs. (By permission of Surg. Gynec. Obstet. 1 2 4 : l .  1967.) 
Clunie'j were particularly significant because their mice and dogs. respectively, 
had been given pure gamma G globulin. Lance showed that the incidence of 
the complication was reduced with continuous as opposed to "pulse" therapy. 
In one of Clunie's renal homografts there was an apparent disappearance of the 
renal lesions 250 days after ALG treatment had been stopped. 
Serum sickness nephritis is not based upon a specific reaction of the 
heterologous antibody with host renal tissue. Instead, the injected foreign pro- 
tein causes a host antibody response, with the result that soluble antigen-anti- 
body complexes are formed peripherally, coincident with a depression of 
complement. The complexes are mechanically trapped in the microcirculation 
of the glomeruli where they provoke a secondary inflammatory reaction.33 The 
consequences are not readily reversible since heterologous globulin, host 
gamma globulin. and complement can be identified in these kidneys long after- 
lvard,40 IO 3 The only exidence of late clearing of the foreign protein in a trans- 
plantation experiment was cited earlier." In Chapter Thirteen it will be shown 
that if ALG is used in combination with azathioprine and prednisone, the in- 
cidence of serum sickness nephritis in patients is essentially zero. 
The potential reactivity of ALS or ALG with a ~ a r i e t y  of nucleated cells was 
mentioned under the section on absorption. This mas apparently not a source of 
morbidity in our studies since direct binding of ALG ni th  other than lymphoid 
tissues has almost ne.i er been demonstrated: specific lesions in the heart, liver, 
and other organs could not be found. IIoreover. there n-as no e\idencei2 of 
direct binding of XLG to renal tissue (3Iasugi-type nephritis). The latter kind of 
nephrotoxicit) could be produced by Gut tn~an . '~  but he infused the XLG direct- 
ly into the renal artery. 
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PREDNISONE 
During the several years after the reports of Billingham, Krohn, and Meda- 
war,14 and of Morgan12x in 1951, there were several descriptionsw~ l" of the 
ability of adrenocortical steroids to significantly delay the rejection in rodents 
of first set skin grafts; the same effect has been seen in chickens." Further- 
more, it was demonstrated by Peter Krohn as early as 1954"' that cortisone 
acetate could abolish a pre-existing state of sensitivity induced by full thick- 
ness skin homografts that were rejected in about nine days in rabbits. Thirty- 
seven to 60 days after the primary exposure regrafting was carried out with 
slun from the same donor. An accelerated rejection was avoided if subcutane- 
ous steroid therapy (10 mglday) had been instituted several days in advance of 
the reoperation and, in fact, the second transplants often survived longer than 
had been the case with the untreated first ones. 
The crucial role of prednisone for the control and reversal of the rejection 
process has been unequivocallv established in clinical renal homotransplanta- 
tion?& " 8 %  68% 174 and there is no reason to doubt its utility in protecting hepatic 
homografts as well. It is ironic that the effect of steroid therapy has never been 
adequately tested in animals after liver transplantation. One reason is the re- 
markable propensity of dogs receiving prednisone to develop widespread gastro- 
-intestinal ulcerations and fatal hem~rrhage. '~"' .  l'" 
Examples have been reported of the reversal of rejection after prednisone 
treatment was started in canine recipients of orthotopic liver homo graft^.^^^ 
The interpretation of these observations was later made less clear by the de- 
monstration that reversal of hepatic rejection often occurs without any change 
in therapy.liWevertheless, the liberal use of steroid therapy is an  extremely 
important facet of the treatment of human recipients of liver homografts 
(Chapters Thirteen to Fifteen). 
OTHER IMMUNOSUPPRESSIVE DRUGS 
Stuart l U 0  and MooreE%nd their associates were unable to demonstrate any 
beneficial effect of actinomycin C, local homograft irradiation, or azaserine 
when administered alone or in combination with azathioprine. 
GRAFT ALTERATION 
Many of the problems of organ transplantation could be minimized if it 
were possible to mitigate graft rejection by modifying the transplanted tissue 
rather than the host immunologic response. Efforts to achieve this objective 
have been unsuccessful with occasional possible  exception^.'^ *' of which 
the most intriguing was described by Jolley. Hinshaw. and Peterson.&? They 
reported that rabbit skin grafts which were first immersed in homologous ribo- 
nucleic acid (RNA) and then transplanted to recipient animals which were 
given intravenous RNA had a survival four times longer than controls. The role 
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of the preliminary soaking was not analyzable in these experiments, but the 
authors also reported that human skin homografts subjected only to RNA 
soaking had unusually protracted viability when placed upon patients with 
burnss1 Similar findings have been reported by Lernperle in mice."" 
In our laboratories attempts to "pretreat" whole organ homografts have 
been made in dogs by perfusing kidneys for about 30 minutes with RNA 
prepared by phenol extraction from the spleens of the prospective recipients 
i"autologous" RNA) or other dogs ("homologous" RNA). After transplantation 
to unmodified recipients, about one fourth of these life-sustaining organs had 
prolonged homograft viability." Maximum survival of recipients which were 
subjected to simultaneous removal of their own kidneys was 123 days. The 
mean survival in a group of 40 recipients was more than 20 days as opposed to 
approximately 10 days in 30 control animals. Furthermore, there were seven 
homografts of the 40 which had no histologic evidence of rejection, whereas all 
the control homografts had the typical findings of unmodified rejection. The 
protection afforded by recipient specific RNA was not significantly different 
from that obtained with homologous RNA. 
The foregoing effect was not increased by the addition of a supposed 
RNase inhibitor, DEAE-dextran, but it was abolished by the addition of com- 
mercial RNase. The treatment of renal autografts with homologous RNA did 
not result in their rejection. The latter finding and the fact that the results after 
homotransplantation were equivalent with either homologous or autologous 
RNA suggest that the homograft protection was not due to RNA-induced 
changes in the genetic characteristics of the homograft cells. 
Seven orthotopic liver transplantations were also performed after 
preliminary RNA perfusion of the homografts. The transplanted organs sup- 
ported life for 46, 14, 13, 11. seven, seven, and seven days." Specific control 
experiments were not performed. However, it was stressed in Chapter Eleven 
that survival in the unmodified canine recipient rarely exceeds 10 days and 
that the longest survival ever obtained after liver transplantation under these 
conditions was 31 days. 
It is not yet certain that the foregoing findings represented more than an  
experimental artefact, since a logical explanation for the surprising results was 
not available and because the degree of homograft protection was so relatively 
limited that its statistical significance in terms of survival mas marginal. I t  will 
be of interest in laboratory experiments to first confirm these observations and 
then to determine whether such graft conditioning can be advantageously com- 
bined with effective host immunosuppression. 
CHANGING HOST-GRAFT RELATIONSHIPS 
Since each of the systemic immunosuppressive agents mentioned earlier in 
this chapter can cause general immunologic crippling. it has been customary to 
categorize as nonspecific all the treatment protocols (Chapter Thirteen) in  
which they ha l e  been employed. The implied criticism of using a bludgeon 
where a therapeutic scalpel would be preferable is not without justification. 
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Nevertheless. there has been for some time an impressive body of information 
indicating that whole organ homotransplantation with such therapy can even- 
tually lead to selective abrogation of the host rejection response, that the suc- 
cess with which this can be done is related to histocompatibility factors, and 
that the degree to which it is achieved is the most important determinant of 
prognosis in any given case. Appreciation that the immunologic relation of the 
graft to the host is a fluid rather than a fixed one adds an important dimension 
to the consideration of any kind of immunosuppression. 
Rejection and Its Remission 
There are two clinically identifiable phases in the chain of events under 
discussion. The first consists of an attack by the host's immune defenses upon 
the new organ, usually within a few days or weeks after its transplantation. The 
vigor of the process is highly variable, as judged by the magnitude of the 
changes caused in the morphology and function of the homograft. 
Whether severe or mild, the intensity of the acute rejection ultimately 
tends to abate in the second phase in many cases, parficularly if short-term 
increases in immunosuppression are instituted. However, the forcefulness of 
the rejection may diminish without making such changes in therapy, or oc- 
casionally in animals that have not received any treatment at all (Chapter 
Eleven). 
Human Renal Recipients. The remission of rejection was not convincingly 
demonstrated In animals until it had been obserled following clinical renal 
homotransplantation. In retrospect, it is probable that the two earliest success- 
fully treated human recipients of renal transplants passed through mild and 
spontaneously reversible rejection crises; both received kidneys from fraternal 
twins, one in Boston"'" and the other in Paris."" after being submitted to total 
body irradiation. Hamburger ascribed the changes to a spontaneously reversible 
immunologic crisis. \Vithout changing this view, he later speculated" that the 
long survival both in his case and in that of Merrill may have been partially due 
to a high grade although incomplete pre-existing tolerance such as that seen in 
cattle siblings that have had a shared placental circulation during gestati0n.j. l i 8  
Strong indications that rejection mas a highly controllable and regularly 
reversible phenomenon, and that it was often followed by a state of relative 
"host-graft nonreactivity." came in a later report from our i n s t i t ~ t i o n . ' ~ ~  In that 
series of renal homotransplantations. there were 10 patients treated in late 
1962 and early 1963. S e ~ e n .  not including an) recipients of fraternal twin 
homografts, had clear-cut rejection commencing four to 34 days after opera- 
tion. I11 each instance the process was relersed by the addition of massive 
doses of prednisone to the pre-existing therapy n i th  azathioprine. \Tithin a 
surprisingly short time ~t became possible to drastically reduce the steroids that 
initiall) had been necessar!, to rescue the grafts. In se1-era1 instances the pa- 
tients were soon returned to treatment on11 ni th  azathioprine. the agent which 
at the beginning had not been capable of prei enting an acute rejection crisis. 
Three of these seven patients are still alil e more than six years later and are 
now among the longest surviving recipients of non-twin renal homografts in the 
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world. After the remarkable effectiveness of steroid therapy in this situation 
]lad been established from our own experience, but before our findings were 
published. it was learned that the same kind of observation had been made by 
Goodwin and his associates4* in a young n oman who ultimately died of sepsis 
144 days after receipt of a maternal homograft. 
There is no point in commenting further about the fully accepted fact that 
kidney rejection can undergo remission beyond noting that such an occurrence 
1s uncommon in dogs and probably also in humans if immunosuppression is not 
increased. It is also worth mentioning that the central role of steroids in promot- 
ing this event in clinical practice was probably predictable on the basis of 
Krohn's report'" of 1954 (see description earlier in text), although the implica- 
tions of his findings were not fully appreciated until many years later. 
Animal  Liver Recipients. Although recovery of a rejecting kidney graft cannot 
usually be expected unless treatment is intensified, numerous examples were 
cited in this chapter as well as in Chapter Eleven of spontaneous reversal of 
hepatic rejection both in unmodified dogs and pigs (especially the latter) and in 
dogs provided with unvarying azathioprine or ALS therap). f ith resolution of 
the process. abnormalities both of the liver function tests and hepatic blood 
flow tended to return toward, although often not completely to, normal. 
The histopathologic changes at various strges after orthotopic lil er trans- 
plantation are considered in Chapter Twenty. Here it need only be noted that all 
the canine hepatic homografts examined after four to six days for the next two 
postoperative weeks were invaded wit11 mononuclear cells. 1% hether or 11ot the 
biochemical and clinical findings of rejection had deleloped. After this time 
the infiltrate decreased in density or even disappeared nhile the evidence of 
repair became predominant. Thus. the morphologic changes also supported the 
idea that there was an initial forceful host attack which subsequently tended to 
exhaust ~ tse l f ,  or at least to become less effectil e. 
The foregoing comments should not be construed as suggesting that the 
desired change in the host-graft relationship is dependent upon an overt rejec- 
tion crisis. Earlier in this chapter it was remarked that most of the canine liver 
recipients in which a more or less completely "tolerant" state developed, as 
defined by the ability to discontinue all therapj, were those in which diagnos- 
able acute rejection either had been very minor or had not occurred at all. In 
these experiments the first wave of iinmunologic reaction had apparently been 
insufficient to cause significant deterioration of hoinograft function. There 
have been well-documented examples of this kind of "subclinical rejection" in 
patients (Chapter Fourteen). 
The Mechanism of Gra f t  Acceptance 
Although it has been well established that a homograft may come to be 
more or less tolerated in its nen- host, the explanation for the privileged status 
is not accepted n-ith any more unanimity today than it was five years ago. One 
of the reasons probably is that more than one immunologic pathrva)- may be 
involved. 
Specific ~mmunoIogic ~ o l e r a n c e .  It is almost certain that the continuous pres- 
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ence of a tran'splanted organ in a host being treated with immunosuppressive 
therapy often leads to a se lec t i~e  loss of responsiveness to the antigens of the 
homograft (tolerance). The evidence that chemotherapy can be used for the 
induction of narrow range tolerance is unequivocal. The literature on this sub- 
ject will not be reviewed here since it has been well summarized by 
S c h w a r t ~ . ~ ~ ' ' " ~  who was the first to call attention to this possibility.IT4 Suffice it 
to say that azathioprine. 6-mercaptopurine, amethopterin. cyclophosphamide, 
and even total body irradiation can be used to promote specific tolerance, 
providing the antigen in question is administered in an appropriate dose and in 
close temporal approximation to the immunosuppressive treatment. 
One of the theories advanced by Schwartzlj" I i '  to explain the specific ef- 
fect of chemotherapy under these circumstances is depicted in Figure 105. The 
illustration suggests that a clone of lymphocytes which presumably have an  
active metabolism as the result of stimulation by antigen should be differen- 
tially susceptible to antimetabolites. The same reasoning in connection with 
the convalescence after human renal homotransplantation had also been ex- 
Ant igen , 
/ 
Macrophage i 
Lymphocy tes  
F i g u r e  105.  Hypothetical mechanisms by which nonspecific immunosuppression may lead to 
selective abrogation of the host immune response. Special susceptibilit!- to these agents of a fraction 
of the lymphoid population c - _ t p f  a ~ n n n c e ,  tolerance. Since main- 
tenance of such cell lines e w n  in adult life is a p p a r e n t l > - w c  dependent in experimintal animals, 
thymectom!- xould be expected to aid the process: this appears to be true in rodents. but such a n  
effect of thymus removal has not been detected in dogs or humans.(see discussion under ALS sec- 
tion). A possible protecti~-e role is also shox\-n of i m m ~ ~ n o ~ l o b u l i n s  elaborated b~ the replicating cells. 
Conceivably the antibodies could act either at the site of the antigen :enhanceinent) or by affecting 
the macrophage processing of the antigen. See text for discussion. 
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pressed in the following clinical terms:lm) .QTemporally. the first evidence of 
adaptation is often coincident with reversal of the rejection crisis. It has been 
&nted out that both events can occur in most cases without the necessity for 
---_ 
es en temporary suppression of the total white blood count below normal levels. 
Here, the peripheral white cells as well as the-humoral antibodies with which 
the graft is in constant contact appear to have ultimately lost at least part of 
their capacity to injure the foreign tissue.. . . In these cases, the ultimate leu- 
kocyte population seemed to be inactive, at  least -- in a relative sense, against the 
l e a  antigen. It is tempting. to believe that immunosu~pressive therapv caused -
'1 progressive attrition of those cells which were immunologically sensitized 
,- 
.~qainst the homograft antigen and that the replacement cells had an  absent or 
reduced memorv of the alien tissue." A similar hvpothesis could be proposed as 
. - > 
a p m e w n a t i o n  for some of ;he specificity of action of ALG. 
T-t of "clone stripping" in this schemp is-consistent -- wiLh the 
cyclic phenomena which occur characteristically after whole organ transplan- 
- <.--- --/ --A - - 
tation bothTn treat& animals and man. With the existence of very close bio- 
logic compatibility between donor and recipient, it could also explain the ap- 
parent acceptance of weakly antigenic homografts as has apparently occurred 
in unmodified pigs (Chapter Eleven). Under either set of circumstances the 
sequence might be analogous to that demonstrated by Brent and Gowland17 in 
~vhich tolerance in mice was preceded by a transient period of sensitization 
(Fig. 106). 
Nevertheless, there has been a widespread reluctance to believe that specif- 
ic immunologic tolerance has been produced with the immunosuppressive 
regimens described in this and the next chapter after either experimental or 
clinical whole organ transplantation. The article most often quoted as contraven- 
ing this possibility is that of lMurray et all2" despite the fact, as the authors 
took pains to make clear, that the evidence in that report was inconclusive and 
involved only two canine experiments of a potentially crucial nature. These two 
dogs had been given renal homografts nine and 18 months previously and had 
received long-term therapy with one of the purine analogs. Throughout the 
postoperative course, renal function appeared from the published charts to 
have been unstable. Moreover, it was deteriorating at the time the other kid- 
neys from the original donors were transplanted; in both instances, the blood 
urea nitrogen (BUN) had become significantly elevated by the time of the 
retransplantations. The second organs were rejected after 23 and three days, 
respectively. It could be persuasis-ely argued that there was not good justifica- 
tion to believe that the first kidneys in these animals were well tolerated, in 
which case there would be little reason to anticipate that the second organs 
would be kindly accepted. 
To date, few investigations have been carried out in human recipients of 
renal homografts surviving for proloqged periods to establish the presence or 
absence of tolerance to their donor tissue. One of the reasons has been the 
potential risk which could attend some of the testing m-hich might be done, 
such as skin transplantation. However. it is worth mentjoning that Dr. Fritz 
Bach of BIadison. TT7isconsin, perfollned mixed lymphocyte culture examina- 
tions from the peripheral blood of a number of our recipients and their donors, 
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\ I SENSITIZATION 
NUMBER OF INJECTIONS 
Figure  106. The experiment of Brent and Gowlandl; showing the induction first of sensitization 
and then of tolerance in  mice treated r i t h  donor-specific spleen cells. The survival times of sub- 
sequently transplanted skin homografts are plotted against the number of preconditioninginjections. 
Note that a small number of injections sensitized the animals, but that tolerance developed if the 
treatment was more protracted. The analogy between these findings and those of a reversible acute 
rejection clisls is e ~ l d e n t  (Xlodlfied from an ~llpstratlon in Uatuie [London] 196 1298. 1962 ) 
i I 
two to four years after transplantation. In scme cases in which clear donor- 
recipient %ist#kompatibilities were detectable by serologic typing he found that 
the recipient lymphocytes no longer underwent blast transformation when 
exposed to killed donor white cells, although they reacted vigorously to third 
party  lymphocyte^.^ The findings were interpreted as indicating specific ac- 
quired immunologic tolerance. 
Enhancement. It n-as shown by Kaliss in tumor systems that homografts 
may be protected by the presence of certain kinds of antigraft an t ib~dies ."~  It is 
conceivable by a feedback mechanism that the same thing occurs ilnder the 
conditions of whole organ transplantation. The process could be envisioned as 
shown in Figure 105. whereby imnlunoglobulins synthesized by the activated 
clone return to the target tissue and coat or protect it in some other way. 
Certainly it has been possible to demonstrate antigraft antibodies in the 
serum of patients carrying chronically functioning and apparently well tol- 
erated kidneys. Using an antiglobulin consumption test. Iwasaki-' and also 
RapaportI4' showed that the serum of' most of the tested human recipients 
contained 7 s  immunoglobulins which could be selecti~ely absorbed b) the 
nucleated cells of the original donor, hIoreover, there have been numerous 
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reports of more or less extensive imnlunoglobulin deposition. as detected by 
im~nunofluorescence techniques, in long fufictioning human kidney trans- 
p l a l ~ t ~ . U '  l i i  '"' By and large. however. the latter finding does not connote a 
fa\ orable prognostic sign but rather the converse. 
The mechanism of enhancement may explain the kind of observation orig- 
inally made b) \f700druff and \Yoodruff1'" and termed b! them "adaptation." In 
then experiments n i th  guinea pigs, bits of homograft tissue were implanted in 
the anterior chamber of the eye and later transferred to a subcutaneous loca- 
tiori. There, rejection occurred very slowly or not at all. In contrast, subcutane- 
ously placed thyroid from the same donor n a s  repudiated promptly. Some of 
RIurray's experiments'?" with canine reiial transplantation were designed along 
similar lines ar,d yielded comparable results. He shoned that a secondarily 
placed kidne) could undergo rejection while the contralateral organ which had 
been transplanted earlier from the same donor could continue to function. The 
differential ability of the first kidney to resist destruction was not due to a 
change in its genetic character since it could also function when replaced back 
ill the original donor. The same general observations had been made in 1954 by 
IVcber, Cannon, and Longmire'" using skin grafts in chickens. 
It is not necessary to believe that enhancement must exert its influence in 
an isolated way. as the recent studies of Stuart et all;%ave made clear. They 
showed that the survival of renal homografts in rats could be more consistently 
obtained with the combination of tolerance induction plus the administration of 
enhancing antibodies than when either approach was used alone. 
Failure of Antigen Processing. There is the added possibility that a defect in 
antigen process' the reticuloendothelial s j  stem could be responsible for 
graft acce p t a n c !  concept for which there is not yet any firm e~idence .  
Honever, it is knoa n that antisera can under certain circumstances markedly 
and specifically inhi it for long periods the responsiveness to the antigen rec- 
ornition."' The way in which an analogous ',equence of e\-ents could be hypo- 
thetically injected i b to the picture after organ transplaiitat~on is shown in 
Figure 105. I L ! !  $, fl+ f i  & ,  , - : d ' & ~ f i i  
. r  , i7 
'r 
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Chapter Thirteen 
IMMUNOSUPPRESSION IN MAN 
In the two preceding chapters attention was focused upon the kind of labo- 
ratory research which could be applied in one way or other to the problem of 
liver replacement in man. The investigations proved that a protracted and 
healthful life was possible in dogs after this kind of operation with the use of 
either azathioprine or ALG as the sole immunosuppressive therapy, or in pigs 
with no treatment at all. Bevertheless, the consistency with which really long- 
term survival was obtained was poor. There were at  least two obvious reasons. 
First, complete control of rejection was usually not achieved. Second, it was 
difficult to prevent or to treat infectious disease complications or to provide 
other niceties of special care in a standard kennel or piggery environment. 
Whatever the explanation, it is probable that the animal data would have 
indefinitely discouraged a clinical trial had it not been for the example of renal 
homotransplantation.pith the latter procedure, the surprising frequency with 
which long survival-was eventually achieved in man could hardly have been 
predicted from the prior laboratory results which, if anything, were less favor- 
able than those after experimental liver transplantation. In addition, the 
human experience with the kidney did more than serve as an incentive. It also 
provided the conditions in which complex and effective immunosuppressive 
regimens could be evolved in man and applied, in turn, to the transplantation of 
other organs. 
In this chapter the two treatment protocols will be described which were 
used for human recipients of both orthotopic and auxiliary liver homografts 
after extensive personal experience had already been acquired in clinical renal 
transplantation. The first program consisted of double drug therapy with aza- 
thioprine and prednisone to which less important or even questionable ancil- 
lary measures were sometimes added: there were no surs-ivals of more than 34 
days. The later li\ er recipielits were given triple agent therapy with azathio- 
prine, prednisone, and heterologous antilymphocyte globulin (ALG). 
DOUBLE DRUG THERAPY 
Background in Renal Transplantation 
In the field of kidney transplantation the most important development 
which made immunosuppression practical was the discovery of the way in 
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which azathioprine and prednisone could be advantageously used together. As 
summarized by Mannick and Egdah1,'"here were essentially no preceding labo- 
ratory data to indicate that the benefit with this now universally accepted 
combination of agents would be as great as proved to be the case. Indeed, the 
first publication on experiments in animals2'l was a belated confirmation of the 
far more convincing observations already made in  human^."^ 
Furthermore. it is difficult even in retrospect to ascribe priority for standard- 
ization of azathioprine-steroid therapy to any single authority or transplanta- 
tion group. What is clear is that by late 1962 the two drugs were being used 
together in one way or other and with varying degrees of conviction about their 
synergism for the prevention or reversal of renal homograft rejection in at  least 
one Britishi5 and three American1;. ';. "' centers. Since then, comparable regi- 
mens have been adopted throughout the world. 
The Timing of  Therapy. Treatment was provided in two ways. In both azathio- 
prine was started shortly before operation and continued indefinitely thereafter, 
generally in the maximum doses which were thought to be possible without 
causing leukopenia. Prednisone was either used prophylactically beginning on 
the day before or the day of operation or, alternatively, withheld until the onset 
of a clinically evident rejection. The techniques, virtues, and drawbacks of both 
approaches were analyzed several years ago4' from our own experience. In re- 
trospect, the most important advantage of withholding steroids until graft repu- 
diation had clearly started was that the features of rejection and host-graft 
adaptation as well as the influence of drug therapy on these processes could be 
delineated with some precision. These concepts were discussed in Chapter 
Twelve. The greatest disadvantage was that the rejections which developed 
under treatment with azathioprine alone were sometimes very severe and dif- 
ficult to reverse with delayed steroid therapy. It was found that their incidence 
and seriousness were reduced if prednisone was given from the beginning.45 
Consequently, it has been our policy since December. 1963, to immediately 
treat virtually all recipients of organ homografts with both drugs, as will be 
described in detail further on in the discussion of the cases of human liver 
transplantation. 
Kountz and Cohnii recently reported that azathioprine and prednisone de- 
livered directly into the arterial supply of renal homografts had an  increased 
protective effect on the organs compared to that obtained with oral or intra- 
venous administration. At the time of their publication 17 of 18 patients treated 
with this modification had survived from one to 13 months after transplanta- 
tion of kidneys. The method has not been tested for liver transplantation. 
Ancillary Measures. Other weakly immunosuppressive drugs have been 
added to the basic treatment with azathioprine and prednisone either in a con- 
tinuing program or. more commonly. for the treatment of an acute rejection. 
The most widely used have been azaserine and actinomycin C (see previous 
chapter). The value of these agents has not been nell  established. \Ye have 
never used azaserine. Early in our experience act inom~cin C was given freely, 
but in recent years 1% e ha1 e been less and less inclined to use it because of its 
tendency to cause sudden bone marron- depression. 
The second line immunosuppressis-e measure that has been most generally 
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accepted because of its safety has been local homograft irradiation. The first 
description of this method was by Dempster," but Hume et all" and Martin 
and his associates" have been its leading proponents. Hume's recommendation 
was that 150 R (at depth) be given to renal homografts on post-transplantation 
days one, three. five, and seven. All the foregoing authors agreed that, if 
homograft irradiation had an ameliorating effect on rejection. it was a feeble 
and transient one. \Ve h a ~ e  often used local irradiation after renal homotrans- 
plantation. Although Stuart et alh7 could demonstrate no benefit after orthotopic 
liver transplantation in dogs, we have irradiated the hepatic homografts of 
several of our patients. primarily in an effort to reduce the swelling (Chapter 
Fourteen). 
Thoracic duct drainage before and after renal transplantation was intro- 
duced clinically by Franksson" as an adjuvant immunosuppressive technique. 
He, and later Murray et had the impression that the control of rejection was 
made easier. We have not constructed lymph fistulas in our patients. 
Results with Double Drug Therapy for Renal Transplantation. With the combined 
use of azathioprine and prednisone the previous air of hopelessness about the 
prospects of successful clinical renal homotransplantation was dispelled almost 
overnight, and with good reason. It became apparent that many patients dying 
of terminal renal disease could be restored to relatively good health and that the 
benefit was apt to be long lasting, especially if a kidney was transplanted from 
a blood relative. The latter conclusion can still be well supported by a notation 
about the ultimate fate of the 64 patients treated by us who provided the 
material for an earlier book on renal tran~plantation.~' Their operations were 
performed between November, 1962, and March, 1964, using kidneys obtained 
from volunteer living donors. At the time the book was finalized in June, 1964, 
37 of the recipients were surviving. Now, five and a sixth to more than six and 
a half years post-transplantation, 30 of these 37 patients (47 per cent of the 
original 64) are still alive (Fig. 107). Furthermore, all but three of the residual 
group still has e adequate function of their original homografts; the exceptional 
patients received second kidneys two and a half, five and a quarter and five and 
a half years after the first transplantation. 
Because of its pertinence to liver transplantation, one striking observation 
in this early series of cases deserves special emphasis, namely the disparity in 
results with intrafamilial transplantation as opposed to transplantation between 
unrelated individuals. In the consanguineous group, which comprised 46 of the 
64 cases alluded to abose. the early death rate was lower. Moreover, the pa- 
tients who survived through the dangerous first few months had a very good 
chance of living for at least half a decade (Fig. 107). Twenty-eight (61 per cent) 
of the 46 recipients of familial kidneys in this series survive to date: only two 
patients in this surviving group have had a late retransplantation. 
In contrast. the acute mortality was higher in the other 18 cases in which 
transplantation was from nonrelative donors. One half the recipients were dead 
at the end of three months. and six remained at the end of one year. In addition, 
a steady loss rate continued into all subsequent postoperative years (Fig. 107) 
until, at the present time. there are only two left of the original 18 patients, one 
by virtue of a second kidney. In 1966 at the New York Meeting of the Trans- 
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Figz1i.e 107. The life survival curve of 64 consecutil-e patients provided with renal homografts 
obtained from living volunteer donors between November. 1962, and Rlarch. 1964. Follow-ups of 
five and a sixth to more than six and a half years are now available: the minimum periods of obser- 
vation are indicated by vertical arrows for the two subgroups. All but three of the patients were 
treated with one of the double regimens of azathioprine and prednisone described in the text: one 
of the exceptions also had 400 R total body irradiation and the other two received azathioprine only. 
Note the striking difference in  prognosis with consanguineous as opposed to nonrelated donors. 
plantation Societyi4 attention was redirected to the implications of the findings 
in this series. The statement was made that ". . . it seems clear that the long 
term prognosis of recipients of randomly selected unrelated homografts is ex- 
tremely guarded. . . . The observations emphasize that development of better 
immunosuppressive regimens and or perfection of tissue typing techniques 
will be necessary before even moderately satisfactory long term results can be 
expected within the unrelated donor-recipient human population." 
The poor prognosis of recipients of kidneys from nonrelated donors in that 
era can be illustrated in another wa). In March, 1968, inquiries were made to 
all the American and European transplantation centers which had been active 
from 1962 to the spring of 1964. Only nine patients were found at that time in 
whom there had been continuous function of nonrelated renal homografts for 
as long as four years. One of these patients was given an  "expendible" kidney 
by Dr. \/T7illard Goodwin of UCLA in June. 1963: another six recipients of cadav- 
eric homografts had been cared for by Dr. David Hume of Richmond, Dr. Guy 
Alexandre of Louvain, Dr. Richard Lillehei of 3Iinneapolis. Dr. Satoru Naka- 
mot0 of Cleveland (two cases). and Dr. Charles Zukoski of Nashville. The two 
others were in our original series4' It is worth noting that four of these nine 
recipients (Goodwin's. Hume's. Lillehei's and one of ours) have died since the 
time of the survey. 
In the years following the early trials just alluded to, further experience 
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with double drug therapy at several centers, including our own," led to a reduc- 
tion in the early mortality after homotransplantation outside of family groups. 
This information will not be reviewed here except to say that it did nothing to 
allay the fear that the average nonrelated renal homograft, be it from a cadav- 
eric or living donor, would have a functional lifetime inferior to that to be 
expected from a familial kidney. The point was particularly well made by 
Hume's group"' who, using their own version of the double drug regimen, noted 
that the renal homograft loss rate during the second post-transplantation year 
was 10 times greater with cadaveric kidneys than with consanguineous organs. 
Few words need to be wasted explaining the relevance of these observa- 
tions to hepatic transplantation, an undertaking in which all homografts must 
come from nonrelated cadaveric sources. Suffice it to say that strenuous efforts 
were made in all cases after 1965 to upgrade the projected outlook of liver 
recipents by using improved methods of immunosuppression (see second sec- 
tion of this chapter) and by trving to select donors on the basis of prospective 
histocompatibility typing (Chapter Three). 
Histocompatibility Matching and the Double Drug Regimen. At the time the series 
of renal transplantation just described was compiled, there were no practical 
means of assessing in advance the biologic suitability of donor-recipient combi- 
nations. The only immunologic screening that was systematically applied pre- 
operatively was designed to avoid red blood cell incompatibilities (Chapters Two 
and Fourteen). Consequently, the transplantation itself served as a test system 
in which the recipients of histoincompatible kidneys were presumably weeded 
out either by death or by loss of their homografts at varying times after the 
transplantations. Realizing this to be the situation, a six-month moratorium on 
new cases was declared at the University of Colorado from March to October, 
1964. During this time a program was planned, in collaboration with Dr. Paul 
Terasaki of Los Angeles, which for the first time would attempt donor selection 
by prospective histocompatibility matching with serologic methods. 
The impressive evidence that the techniques of tissue typing used by 
Terasaki and a number of other workers in this field actually measured his- 
tocompatibility antigens is considered separately in Chapter Three. Here it will 
only be mentioned that efforts to improve the quality of matching in 25 new 
intrafamilial transplantations from October. 1964, to April. 1966. were not suc- 
cessful to a statisticall) significant degree. The reason was that a commitment 
was made only to find the best among whatever otherwise suitable donors were 
available; transplantation was not refused if a good match could not be found. 
Since most family groups were small, the degree of compatibility actually ob- 
tained was not essential11 different from that which could ha1 e been achieved 
by random selection."" "' Consequently, it was not surprising to find that the 
results after consanguineous transplantation were not materially improved 
(Fig. 108). The life survival curve had a somewhat different shape from that in 
the original series (Fig. 108). but the number of patients who were alive after 
one to three years was not changed at all. 
In contrast. the choice was much more discriminating for 17 patients who 
were treated with nonrelated homografts in the 13 months beginning in Octo- 
ber, 1964.". '+'During that time the since abandoned policy was beicg followed 
IMMUNOSUPPRESSION IN MAN / 247 
of accepting organ donation from a pool of penal donors which contained as  
many as 80 volunteers for any given recipient. The matches obtained were 
almost always imperfect, but as a group they were significantly better than 
\vould have been expected with random selection in the nonrelated population. 
There is now a follow-up in the latter 17 cases of three and a half to more 
than four and a half years (Fig. 108). The kidney and patient survival at  one 
year were nine of 17 (53 per cent). Today, five of the recipients (30 per cent) are 
still alive, having had continuous function of their homografts for 42 to 50 
months. Thus, there had been an  improvement in the results in comparison to 
that in the original nonrelated series, but not to a satisfactory level. Moreover, 
the characteristic late failures after nonrelated homotransplantation had not 
been eliminated. The deaths which occurred in the second (one case), third 
(one case) and fourth (two cases) postoperative years were due, respectively, to 
hepatitis (one example). generalized sepsis (two examples), and quadriplegia 
secondary to a compression fracture of an  osteoporotic cervical vertebra (one 
example). A contributory factor in all the late deaths was thought to be the need 
for chronic therapy with moderately large doses of prednisone (see later). 
In reporting these cases in January. 1967."' Marchioro remarked that the 
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Figure  108. The life surl-ix-a1 curve obtained xi-hen donor selection xras attempted on the  basis of 
h i~ tocompa t ib i l i t~  matching. Since the  series xi-as coinpiled betxreen October. 1964. and  April, 
1966, follow-ups of three to four and  trio thirds !-ears are  now ax-ailable. The inilliinum periods of 
observation in  the  tn-o subgroups are  indicated b! x-ertical arroxi-s. Note that the  acute inortality 
was reduced after intrafanlilial transplantation. but that the ultimate prognosis xi-as no different 
than in  the first series (Fig. 107). Hoxi-ex-er. the earl! and late outlook of recipients of nonrelated 
homografts was somewhat improx-ed. 
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results did ". . .not imply either that the tissue typing methods then being de- 
veloped were not a direct or indirect measure of histocompatibility factors, or 
that the use of these techniques would play an insignificant role in transplanta- 
tion practices of the future.. . . Instead the observations suggested that antigen 
matching techniques could not receive a fair trial with the treatment programs 
then widely being used unless transplantation was performed only between 
almost perfectly matched pairs. Alternatively. they required for exploitation a 
setting of far more adequate immunosuppression. The former approach would 
limit consideration to only a very small number of patients who needed this 
kind of therap). The latter development would allow extension rather than 
restriction of the indications for acceptance into a transplantation program." 
Deficiencies of the Double Drug Regimen. When azathioprine and prednisone 
were first used together for patients treated by renal transplantation, there 
were a number of deaths froin drug toxicity during the early postoperative 
period. Many of these fatalities were due to bone marrow depression that had 
been caused by overdoses of azathioprine. A common story was that good initial 
kidney function was obtained from the homograft, that a severe rejection crisis 
then supervened causing a secondary return of uremia, and that leukopenia 
and lethal sepsis followed shortly afterward. Apparently at least part of the 
explanation was that the renal pathway of detoxification of this drug had been 
lost to a variable degree as the consequence of rejection. It was learned that the 
doses had to be considerably reduced under these circumstances or after the 
placement of cadaveric homografts which functioned poorly from the begin- 
ning.?' As experience increased the complication of acute azathioprine over- 
dosage was virtually eliminated. 
Avoidance of the hazards of steroid therapy was less simple. In many cases 
continued function of the transplanted kidneys proved to be dependent upon 
the chronic administration of unacceptably large quantities of prednisone. The 
complications that often followed ranged from exceedingly troublesome to 
lethal. They included cosmetic deformity, bone demineralization often with 
spontaneous fractures, muscle wasting, arrest of growth in infants, fatty infil- 
tration of the liver. pancreatitis, and gastrointestinal ulceration and hemor- 
rhage. Most serious. however, was the resulting susceptibility to microorgan- 
isms of all types. 
If the consequent infections nere due to common pathogenic bacteria, they 
could be treated with properly chosen antibiotics. Very often, however. they 
were caused by fungi, protozoa, or viruses for which specific therapy was not 
available. The way in which this sequence of events manifested itself in a 
series of autopsies of renal transplant recipients at our institutions has been 
summarized by Hill." 
The therapeutic dilemma often posed by the foregoing situation, with 
either intrafamilial or cadaveric transplantation. but far more commonl~ after 
the latter, is evident. On the one hand. life nas  threatened b~ reduced or failing 
function of the homograft and. on the other. by the measures taken to prevent 
its further deterioration or complete loss. Largely as the result of Hume's ef- 
forts,'" one of the great lessons learned in the field of renal transplantation has 
been that it is often desirable to stop immunosuppression, to remove the renal 
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homograft, to return the patient to maintenance on an  artificial kidney, and to 
consider retransplantation at a later date. Unfortunately, this well ordered and 
leisurely approach to treatment is not possible with a rejecting orthotopic liver 
homograft. Nevertheless, hepatic retransplantation has been shown to be 
feasible, as will be mentioned in Chapters Fourteen and Seventeen. 
Double Drug Therapy After Liver Transplantation 
An azathioprine-steroid regimen was used in all the early recipients of both 
orthotopic (OT 1 to 5) and auxiliary (AT 1 to 3 )  homografts. Whether adequate 
control of rejection might have been achieved in some of these cases will never 
be known for certain since all the recipients died in 34 days or less. '%. ' i - -5 i ,  ~3 
Invariably there were a host of complications of which only a portion were 
related to drug therapy or to the rejection process. However, as will be docu- 
mented in Chapter Sixteen, overwhelming bacterial, fungal, and viral infec- 
tions were characteristic in this early experience, indicating that gross over- 
dosage had occurred. 
The Therapeutic Schedule. In all these liver recipients, azathioprine was 
started on the day of operation and prednisone was also begun then or within a 
short time afterward. Azathioprine was given in quantities that were somewhat 
smaller than those used for recipients of renal homografts in that era of our 
program (Table 17). The average dose per day during the post-transplantation 
Table 17. Immunosuppression Used in the Liver Recipients Who Survived 
Operation and Received Double Drug Therapy. Compared to That 
Administered to 18 Consecutive Recipients of Nonrelated Renal 
Homografts Who Were Treated in the Same Era 
\VHITf.  
A \  E R L E  HO\lOC.R \ k T  IILOOI) PL \ T I  1.1.1 E A R L Y  
L T H I O -  A\ -ERAGE ACTISO- i R R A D l 1  C O L  h 1 C O L  YT LIVER 
SURVIIAL P R I Z E  PREDSISOZE \ I Y C I ~ -  c TIOS ,cu i n n )  ~ c u  mni; t u h c -  SPLEN- 
iso. (Days) (mg k q  day) ( m e  k g  dn) . (Total @gin)  'Total R; Lo\\-e5t Da\ Lo\\ est Da) TIOS ECTOMY 
-- 
-- 
~~~~~ 
OT 2 22 3.51 1.45 2,200 None 1,800 16 29,000 15 Fair Yes 
OT 3 7.5 4.10 1.53 600 None 4,050 7 15,000 7 Poor No  
OT 4 6.5 3.65 0.21 None None 12,500 2 28,000 4 Poor No 
OT 5 23 4.49 3.50 800 None 1,400 22 40,000 13 Poor No 
AT 1 22 1.34 1.78 1,200 600 2,000 19 Studies Good No 
lnodequate 
AT 2 34 1.23 1.75 1,600 450 2,000 27 20,000 33 Excellent No  
Renal t 4.72 1.98 Frequently Frequently I 
recipr. Used Used 
The liver patients had a much higher lncidente of leuhopenia and th~ornboc)-topenia despite the fact that 
they n ere g i ~  en smaller quantities of azathioprine. 
+The renal I~omografts n-ere obtalned from liling ~ o l u n t e e r s  111 1963 and 1964. The average dail) prednisone 
and azathioprine doses are i \ - e n  for the first three post-trai~splal~tation ~ r r e k s  or for h o ~ r  111an~ da!-s of that time 
the patients 111 ed: 15 of the 18 recipients su1\1\ ed tl~roui?ll the pe~ iod  of a n a l ? s ~ s  and the other tlilee died after 8, 
1.2. and 13 days ~.especri \e l) .  Splenecron~\  \as performed 111 1 7  of the 18 c~ i ies .  
IFIT e of the 18 lenal lecipients del eloped leuhol~eni~i  -(3000 d~urinq the fil.st three poitoperatl\ e weeks but 
only one had severe thrombocytopenla (<30,00Oi. 
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period and the ranges employed are summarized in Table 17 for each of the 
four orthotopic and the two auxiliary liver recipients who survived operation 
and the early postoperative period between May, 1963, and July, 1965. 
Similar information is given for the use of prednisone (Table 17). The 
steroids were started at 0.4 to 1.5 mg'kg per day either on the day of operation 
or shortly thereafter. In all cases the doses were subsequently increased when 
liver function became worse and the cause for this was assumed to be rejec- 
tion. In actuality, the ultimate explanation for the deterioration in the orthoto- 
pic cases was in large part serious ischemic injury to the transplanted organs 
(Chapter Six). During the post-transplantation period the lymphocyte counts of 
the recipients were generally lower than prior to operation (Fig. log), probably 
because of the prednisone administration. Steroids are well known to cause 
lympholysis, lymphoid depletion, and lymphopeniai~ in experimental animals. 
Similarly, it has been shown in human recipients of renal homografts that the 
numbers of peripheral lymphocytes during the post-transplantation period are 
inversely related to the quantities of prednisone being given."' 
AT 2 
69 -+63 kg. 
PREDNISONE 2 
(mg )  
TIME IN  DAYS EXP~RED 
F i g u ~ e  109. The  double drug regimen used for one of the  recipients (.AT 2: of a well functioning 
auxiliary homograft (Fig. 252. Chapter T\T-ent!--t~vo~. Splenectomy was not performed. Bone marrow 
depression and  leukopenia \\-ere produced. and the patient et-entually died of TT-idespread infection 
from mixed microorganislils (Chapter Sixteen''. The I!-mphoc:-te count postoperatil-el>- \\-as lower 
than before transplantatio~i.  a change TT-hich xvas probabl!- brought about b!- the  prednisone being 
administered."' S o t e  the remittent throlnboc!-topenia. The first platelet falls occurred promptly 
after operation dulirig a period of relati! 1eukoc:-tosis. The later throinboc!-te declines Ivere coin- 
cident n-ith leuhopenia. Each !-ertical arroxt- equals 200 pg of intrax-enous actinom!-cin C .  The doses 
of local homograft irradiation R: re  ere calculated a t  the center of the organ. 
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Two of the ancillary measures described in the preceding section were 
taken, but without demonstrable effect. These were the intravenous adminis- 
tration of actinomycin C and local homograft irradiation (Table 17). Thrombo- 
cytopenia (Fig. 109 and 110) developed in almost all the patients (Table 17). At 
the time it was suspected that the actinomycin C might have been responsible. 
Since then it has been established that several other factors predispose to 
platelet depression after liver transplantation, including the procedure itself. 
This important subject will be returned to later in the chapter in the discussion 
of triple drug therapy. 
Results w i th  Double Drug Therapy. There was a uniform inability of the pa- 
tients to tolerate this kind of immunosuppressive treatment. Four of the six 
recipients had at least one episode of leukopenia during the brief postoperative 
interval of follow-up. The infectious complications which occurred at these 
times, or commonly even before the onset of peripheral white blood cell 
declines, were unmanageable (Chapter Sixteen). 
In most cases the downhill course of the recipients was so rapid that the 
OT 5 63+56 kg. 
WBC 10,000 
5,000 
PREDNISONE :gg 
( m g )  300i 0 pre-op , 0 1 2 3  4 6 8 10 12 14 16 18 20 22 24 
PLATELETS 200,000- 
( m m 3 )  
SGOT - 
SGPT -- - - -  
( I. u. 1 
BILIRUBIN 
( mg /I00 ml) 
TOTAL - 
CONJUGATED - - - - - -  O. 
TIME IN DAYS 
600- AZATHIOPRINE 400. 
(mg) 200- 
0- 
F i g t i i e  110. The effect of orthotopic lil-er transplantation and immu~~osuppression upon the 
peripheral white blood cell and platelet counts ;OT 5\. Splenectomy ~x-as not performed. Thrombo- 
cytopenia appeared almost immediately after operation at a rilne when there xras no clear evidence 
of bone marrow depression. The other factors TT-hich call contribute to platelet depression in such 
cases are discussed in the text. Each T-ertical arroli- equals 200 p g  of intrax-enous actinomycin C.  
' ACTI-C 
$ 1  7 i.( 
B~ 
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full extent of the bone marrow depression could not be completely evaluated 
during life. However, in both the recipients of auxiliary transplants in whom 
there was surLival of 23 and 34 days (AT 1 and 2) the peripheral white cell 
counts fell to ver) lo\\ levels during the last f i ~ e  and 12 days of life, 
respectively. 
The latter patients will be discussed separately in Chapter Twenty-two, but 
two observations are pertinent here. First, both received well functioning aux- 
iliary liver homografts which then underwent severe rejection despite treat- 
ment which proved to be so toxic as to be incompatible with life. Moreover, 
there was never any evidence of reversal of the rejection process. Second, the 
doses of azathioprine which caused the lethal bone marrow depression were 
conservatively designed (Fig. 109) and were much smaller than those which 
could usually be gi\ en to kidney recipients without such uniformly fatal conse- 
quences (Table 17). 
From these observations rose the strong suspicionx that the margin be- 
tween effective and lethal immunosuppression. which at best was often slender 
in renal recipients being treated with double drug therapy, did not usually exist 
at  all after clinical liver transplantation. Experience in subsequent cases to be 
described later has only fortified the view that azathioprine must be given to 
human liver recipients in incongruously small doses. 
The inabilitj of the liver recipients to support azathioprine treatment has 
never been satisfactorily explained. Furthermore, it was unexpected since such 
a striking intolerance to this drug has not been seen after canine hepatic 
transplantation. It is conceivable that the pre-existing liver disease in the pa- 
tients was responsible by having depleted in advance the hemo- and lymphopoi- 
etic reserves. Cirrhosis, hepatitis, and a number of other liver ailments are 
often attended by leukopenia and thrombocytopenia. Hypersplenism may be a 
contributory factor in such cases, but bone marrow depression has also been 
well documented." 4' 
Another factor M hich is probably variably present in ever) human case is 
injury to the transplanted liver of such an  extent that the potential for azathio- 
prine elimination is compromised to at least some degree. It was mentioned 
earlier that azathioprine has an  important. although not exclusive, renal path- 
nay of removal; azathioprine is excreted in the urine in unchanged form or 
after having been broken down to 6-mercaptopurine, thiouric acid, or other 
derivatives.The liver is probably an even more crucial instrument of detoxifi- 
cation. The studies of Elion and Hitchings and their associates' "" indicated that 
the breakdown of azathioprine to 6-mercaptopurine should not be hepatic de- 
pendent, since a number of nidel) distributed organic or inorganic sulfhydryl 
compounds can initiate this reaction. Howel er. it is highl) likel) that further 
steps in degradation are at least partially liver based. For example. the change 
from 6-mercaptopurine to 6-thiouric acid is thought to be subserved by 
xanthine oxidase. an enzyme nhich in man (but not in the dog) is principally 
concentrated in the microsomal systems of hepatic parenchymal cells.] Con- 
ceivably. species Lariations in the distribution of this or other enzymes could 
explain the differences in dose responsiveness in dogs and humans. 
The practical implication of the foregoiilg remarks might be that a n j  major 
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liver injury in humans would be analogous to that described earlier with the 
loss of renal function, namely unreliable dose control. This chain of events has 
been observed most clearly in recipients of renal homografts who have 
developed "hepatitis" in the post-transplantation period (see Chapter Twelve). 
In our experience. reductions in the quantities of azathioprine are invariably 
necessary in this circumstance in order to prevent the complication of bone 
marrow depression. 
The role of steroid therapy in the deaths of the six patients was more 
difficult to analyze, although the unfavorable influence on the infections is 
undoubted. In addition, three of the patients developed gastrointestinal 
bleeding in the postoperative period. This complication may have partly derived 
from the poor liver function which was present in several of the patients, but 
prednisone can be responsible for the same result. The esophagogastric or 
intestinal ulcerations in the recipients were found at autopsy to be invaded 
with fungi (Chapter Sixteen). 
TRIPLE DRUG T H E R A P Y  
Justification for further efforts at  clinical liver transplantation came large- 
ly from the laboratory research with the globulin derivative (ALG) of 
heterologous antilymphocyte serum (ALS) that was described in the preceding 
chapter, and from the encouraging results obtained with ALG treatment after 
human renal transplantation. The therapeutic regimens tested clinically with 
the kidney model were then adapted to the problems of liver transplantation. 
Background in Renal Transplantation 
The Therapeutic Schedule in the First Kidney Trials. f The regimen of ALG which 
was used in man was guided by several general conclusions that emerged from 
the experimentations with large animals in our laboratories and elsewhere 
(Chapter Twelve). These can be summarized as follo~vs: (1) ALG had potent but 
imperfect immunosuppressive qualities when used alone; (2) with continued 
administration of the heterologous serum derivatives, there was a highly signi- 
ficant risk from a variety of foreign protein reactions: and (3) ALG could be 
used effectively and probably with increased safety in combination with other 
drugs. Each of these factors contributed to the initial decision to employ 
heterologous ALG as an  adjuvant agent added to therapy with azathioprine and 
prednisone and to limit its use to the first four postoperati~e months. It was 
hoped that the predictability and safety with which homograft rejection could 
be prea ented would thereby be i m p r o ~  ed and that the hazards of immunologic 
reactions to the serum products n-ould be accordingl) reduced with the effi- 
cient level of immunosuppression to n hich all three agents n-ould cont r ibu te3  
The way in which this pol ic~ decision was translated into the treatment 
program is shown in Figure 11 1. Dail? intramuscular injections of ammonium 
sulfate-precipitated ALG (Fig. 98, Chapter Twelve) were started several days in 

IMMUNOSUPPRESSION IN MAN / 255 
6 PATIENTS 
- L Y M P H O C Y T E  COMPONENT 
- STABS 
0 
LL 
I 2 3 4 5 
C 
Z 
1 PRE-TRANSPLANT THERAPY WITH ALS (DAYS) 
0 
0 
F i g u ~ e  112. The effect of horse ALG in six patients treated daily for five days before renal homo- 
transplantation. No other therapy was being given. A leukocytosis was induced. The lymphocyte 
fractions declined. but with the increased total ~vhi te  count the number of peripheral lymphocytes 
per cu mm was not significantly changed. Compare these results n-ith those obtained when twice 
as much ALG was gi1-en in later cases (Fig. 117). "Stabs" refer to nonsegmented neutrophils. (By 
permission of Surg. Gynec. Obstet. 124:1, 1967.) 
the institution of globulin therapy, indicating that the ALG prevented expres- 
sion of a previously established delayed hypersensiti~ity.~, fi5 
Similar clinical observations have been reported by others.", :'" 4" '.;' It should 
be added that in i\/lonaco's studies," he also demonstrated prolonged survival of 
skin homografts in human volunteers who were treated only with ALG. During 
the brief periods of therapy with ALG alone changes were not detected in 
hematocrits or platelet counts. 
The Effect on Results After lntrafamil ia l  Renal Transplantation. The foregoing 
therapeutic program was used in 58 consecutive patients who received intrafa- 
milial homografts from donors of variable histocompatibility matches from one 
and a half to three years ago. The outcome in part or all of these cases has been 
on several o c c a s i o n s ~ ~  3'.2. 38.  16: but will be summarized here. The one- 
year survival after consanguineous renal hoinotransplantation avas in excess of 
90 per cent, the ultimate kidney function was superior to that in comparable 
past cases, the quantities of azathioprine and prednisone necessary to achieve 
these results were decreased, and lethal septic complications were virtually 
eliminated. Other encouraging clinical trials with ALG have been reported, 
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with the use of similar therapeutic protocols.". ", 663 70, i1 When the ALG was 
discontinued after these intrafamilial renal transplantations, delayed rejection 
was uncommonly seen and, if it did occur, it was easily controlled by minor 
upward adjustments of prednisone dosage (Fig. 11 1). Most of the deaths which 
did occur were the consequence of technical surgical mishaps. Late retrans- 
plantation or return to chronic dialysis has become necessary in only one of the 
surviaing patients in this series. As will be discussed later. the results after 
transplantation between nonrelated individuals have been far less satisfactory. 
Toxicity of ALG in the First Trials of Triple Drug Therapy. A number of side effects 
were seen in the above experience"' '" as well as in patients given comparable 
treatment at other institutions. There was usually pain, tenderness, erythema, 
and swelling at the injection sites. Fever commonly developed. Annoying sys- 
temic side effects included hives, generalized rashes, arthralgia, and periorbital 
edema. 
The most serious toxic manifestation of ALG therapy was the development 
of anaphylactic reactions in 17 per cent of the patients. These were seen at the 
earliest three weeks after the beginning of triple drug treatment and were 
absolutely characteristic. Within a few minutes following an ALG injection 
profound anxiety developed, followed by nausea and sometimes by an urge to 
defecate. Many of the patients complained of low back pain and dyspnea. The 
usual physical findings were hypotension and cyanosis of variable severity. The 
blood pressure falls were usually minor, but in some the recorded values were 
40 to 60 mm Hg. At this time cyanosis with distention of the neck veins was 
observed. A temperature spike usually followed, occasionally accompanied by 
chills. 
In most patients no specific treatment was instituted. To some. 50 mg intra- 
venous prednisolone and nasal oxygen were given. A few patients also 
received 100 mg diphenhydramine hydrochloride (Benadryl) intravenously. A 
liter of lactated Ringer's solution was given. Epinephrine was not required. All 
patients recovered in five to 90 minutes. In no instance were there any demon- 
strable aftereffects. Usually ALG therapy was stopped with the first evidence 
of an anaphylactic reaction. but several patients were given a number of addi- 
tional injections.?" Ultimately this practice was abandoned because the in- 
cidence of similar further difficulties was too high. 
These patients and all those subsequently treated with ALG were followed 
with a batter!: of immunologic examinations. including serial skin tests to horse 
protein and the measurement of precipitins and heterohemagglutinins in the 
serum. Precipitating antibodies regularly developed against the horse globulins. 
Hemagglutinating antibodies against sheep red blood cells presumably repre- 
sented a response to the Forssman antigen ashich is present in horse plasma 
protein. 
All three immunologic monitors were of value in predicting the probability 
of an anaphylactic reaction. but the discrimination was imperfect (Fig. 113). 
Most of the anaph)lactic reactions were in patients who had high grade sensiti- 
zation as judged on the basis of skin testing or serologic examination, but there 
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2 0 0 1  
PATIENTS WITH ANAPHYLACTOID REACTIONS 
. . 
I 
I 
. . 
. . .  
. . . .  
**' * *  
t ANAPHYLACTOID REACTION 
- MEAN PREClPlTlN VALUE 
PATIENTS WITHOUT ANAPHYLACTOID REACTIONS 
100- 
. . 
. .  . 
5 0 -  . : 
. . 4 0 -  . * i e : : B  . . :  
. . .  
END OF STANDARD 
COURSE OF ALG 
4 
4 1 2 3 4 5 6 7 8 9 10 11 12 13 I4 I5 16 I7 18 1920212223242626272829X)3l 32333435 
CONTROL 
TIME IN WEEKS 
F i g u r e  113.  The de~-elopment of precipitins in 40 patients receiving horse ALG. The titers of 
precipitating antibodies Ivere determined b!- the electroimmunodiffusion technique of Merrill, 
Hartley. and Claman.': The same general inforlnation pro\-ided by this special method can be less 
yuantitatil-el!- obtained 17-it11 a silnple tn~ofold dilution measurement. 3Iost of the anaphylactic 
reactions Kere in the patients ~ \ h o  de~-eloped high titers. but the correlation was imperfect. The 
results were similar using rising helnagglutinin titers against sheep red blood cells as an indicator 
of sensitization to the horse protein. (By permission of Ann. Intern. AIed. 68:273 ,  1968.) 
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were some in patients who had low antibody titers or reassuring intradermal 
tests. 
In Kashiwagi's toxicity study'" an  effort was made with special techniques 
to determine the relative immunogenicity of the constituents of the crude 
globulin then being used clinically. He found that most of the precipitating 
antibodies which developed in these patients were directed against the horse 
beta and alpha globulins which the ALG contained. In only one instance could 
precipitins be found against the gamma G globulin. Tsirimbas et ali2 of Munich 
reported similar findings after giving intravenous ALG to six patients with 
leukemia. These observations supported the hope that a safer ALG could be 
made by more complete refinement of the gamma G globulin in which the 
desired antibodies were thought to chiefly reside (see Chapter Twelve). As will 
be mentioned later, such an effort was eventually made with extremely unsat- 
isfactory consequences. 
A number of other side effects of ALG were looked for. A few of the pa- 
tients had thrombocytopenia (<50,000) at some time in the postoperative 
course when leukopenia was not present. Bleeding did not occur. There were 
no examples of neurologic complications, myositis, abdominal pain, or pericard- 
ial and pleural effusions. 
In Chapter Twelve the potential dangers of Masugi (direct nephrotoxicity) 
and serum sickness nephritis were discussed. Fortunately this kind of compli- 
cation has not been a serious problem in the clinical cases. The first eight 
patients treated with ALG had biopsies of their renal homografts after comple- 
tion of the course of globulin therapy. Equine protein could not be found in the 
renal tissues of any patient.'" About 40 other kidneys have since been similarly 
studied in our series: in only one was horse globulin detectable within the renal 
tissue with standard immunofluorescence techniques. Recently Traegerio and 
Konomi?" and their associates also reported the absence of horse protein in 
biopsy specimens of human kidney homografts after prolonged ALG therapy. 
An ALGG Ttial. Because of Kashiwagi's findings that the serologic response 
to the injected ALG was largely directed against its alpha and beta constituents, 
a technique was developed for the extraction of pure gamma G globulin, 
hereafter called ALGG, in bulk quantities.?' ?' The resulting product (Fig. 99, 
Chapter Twelve) was given to the next 13 recipients of intrafamilial renal 
homografts. The horse ALGG batches used had leukoagglutinin titers of 1:  2000 
to 1: 8000 and protein concentrations of 1.9 to 3.5 gm per cent. The lympho- 
cytotoxicitv titers, which had usually been about 1 :4000 in the original ammo- 
nium sulfate-precipitated ALG. were now also lowered. The intramuscular 
doses were 4 to 8 ml in adults. depending on the leukoagglutinin titers. 
Measurable precipitating antibodies against the ALGG developed in only 
one of the 13   patient^.^" The hemagglutinin response against sheep red blood 
cells was about the same as in the original series. Although minor toxic 
manifestations at  ere seen n ith about the same frequenc) as with the previous- 
ly used ALG, there mere no anaphylactic reactions. Unfortunately l t  soon 
became apparent that the immunosuppressi~ e effect of the product had largely 
been lost.?? 4' 
All 13 of the patients had a satisfactory post-transplantation d~uresis.  How- 
ever. selen developed severe rejection crises from one half to 14 days later, 
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requiring prednisone dose increases to as much as 400 mg per day. The rejection 
was so severe that five of the recipients had secondary elevations of the B U N  
to more than 150 mg per cent, and in four. return to the artificial kidney became 
necessary for one to five weeks before adequate urine excretion resumed. The 
incidence of these complications was about 10 times as great as in the patients 
treated with ammonium sulfate-precipitated ALG. Three of the 13 recipients 
died before the end of the first postoperative year. The clinical difficulties in  
these casesAx were entirely similar to those during the time when the azathio- 
prine-prednisone double drug combination was being used without adjuvant 
globulin. 
The Penalty of Overrefinement. As the consequence of this experience it 
was necessary for us to return for the time being to the clinical use of the 
crude globulin obtained with ammonium sulfate precipitation. A possible expla- 
nation of the apparent loss of potency of the ALGG was discussed in Chapter 
Twelve. First, it was pointed out that the antilymphocyte antibodies in horse 
ALS are more widely distributed than in the immune sera of certain other 
animals. Significant activity is not limited to the IgG; it can also be found in the 
T-equine fraction, just as with the preparation of tetanus or other antitoxins.ls 
The implication of discarding the latter portion of the raw globulin. as was 
done in the preparation of the ALGG. can be appreciated by the analysis per- 
formed by Kashin~agi et all3 4%f the serum of horses that had been immunized 
with splenic lymphocytes for six to nine weeks (Fig. 114). The three horses were 
considered to be early serum donors since essentially no leukoagglutinins or 
lymphocytotoxins were in the IgM. as has been described by Fateh-Moghadam 
at a later time."' It was estimated by Kashinragi that more than three-fourths of 
HORSE ANTIHUMAN 
h A LS 
Figure 114. The location of leukoagglu- 
tinins, hemagglutinins. and throinboagglu- 
tinins in a horse that had been immunized 
with human splenic lymphocytes for a little 
more than tn-o months. Note that the T- 
equine globulin contained the prepon- 
derance of all three kinds of antibodies. The 
cytotoxins (not shown) were mainly in the 
IgG.'" 
ACTIVITY 
HEMAGGLUTININ 
ACTIVITY 
I I I I I  
I  I 1  1 I I I I - 100Q 
I l l  I I -80 
THROMBOAGGLUTININ I :24  1 1 1 1 I I -60 
ACTIVITY I l l 1  I 1  -40 
I l l  - 20 8 -0 
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the leukoagglutinins in the sera of his horses were in the T-equine fraction; the 
lymphocytotoxins were predominantly in the IgG. Similar findings have been 
reported by Carraz et a1 of Lyon.' Moreover. Kashiwagi showed in companion 
canine experiments involving differential separation that the discarded T-equine 
globulin had a lylnphopenic and immunosuppressive effect at least as great as 
that caused by the highly refined and cytotoxin-rich gamma G globulin from 
which it had been separated.?' 
The more recent studies of Kashiwagi et al'" alluded to previously have 
not seriously weakened the previously held proposition that most of the active 
portion of equine ALS is gamma G (7s) globulin. Rather. such investigations 
have only emphasized how difficult it may be in the immunized horse to retrieve 
all the desired globulin in unadulterated form. Because of its sluggish electro- 
phoretic mobility, the part referred to as "s1o.r~" garnma G globulin remains 
sufficiently isolated to permit its easy removal. In contrast, the antibody-rich 
"fast" gamma G globulin, with its slightly greater electrophoretic mobility, re- 
mains buried in the heterogenous T-equine globulin which, in turn, also contains 
variable quantities of irrelevant beta and alpha globulins. Separation of the 
"fast" gamma from the other components of the T-equine globulin is the prac- 
tical problem that has not yet been satisfactorily solved for mass production. 
Better techniques are needed for this purpose. 
Alternatively, it may eventually prove more expedient to use other animals 
than the horse as an ALS source. For example, both the rabbit (Fig. 115) and the 
goat have less overlap of the different immunoglobulins, thereby greatly simpli- 
fying the methodology for removal of pure gamma G globulin. In addition, the 
RABBIT ANTIHUMAN 
A L S  
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RAW S E R L I M , ~ ~ ,  lu21 , PI 7 ,  
HEMAGGLUTININ I : 
ACTIVITY 
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Figure 11 3. The location of leukoagglu- 
tinins. hemagglutinins, and thromboagglu- 
tinins in  the serum of a rabbit that had 
been immunized n-ith human splenic lym- 
phocytes for two months. The antibody con- 
centration is almost entirely in the gamma 
globulin. Illoreover, a heterogenous area 
comparable to the T-equine fraction of the 
horse (Fig. 114) is not present. The l>-mpho- 
cytotoxic antibodies (not shown) were also 
in the IgG. 
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problem of refinement should be made easier by the fact that there is probably 
less tendency for the location of the active antibodies to change during a course 
of immunization. 
Cadaveric Renal Transplantation. In discussing double drug therapy in the 
first part of this chapter, a distinction was made between the long-term progno- 
sis in recipients of consanguineous as opposed to nonrelated homografts. Be- 
fore the advent of ALG use, there was an unacceptably high mortalit) in both 
kinds of cases during the first few postoperative months after renal transplan- 
tation. However, the recipients of homografts donated by family members who 
survived this critical period in good condition had a good chance of living for 
years with stable homograft function. The same was not true when kidneys 
from nonrelatives were used. Not only was the early death rate greater but, 
even in those who survived, delayed homograft failure proved to be the rule, 
not the exception. 
The addition of a four-month course of ALG to the immunosuppressive 
regimen reduced the early mortality in our hands after both consanguineous 
and unrelated renal transplantation. It did not, however, prevent the delayed 
homograft deterioration so often previously seen in the latter kind of case 
during the era of double drug therapy. Our own experience with cadaveric 
renal transplantation, while not extensive, has proLided incisive information on 
this point.4x It was found that rejection of the cadaveric kidney could be easily 
controlled during the period of triple drug therapy. However, after the discon- 
tinuance of ALG, progressive deterioration of renal function was soon detect- 
able in virtually all recipients of histoincompatible cadaverjc kidneys, and 
even in some cases in which good compatibility was thought by Terasaki to 
have existed. A typical example is shown in Figure 116. In this case, there was 
a donor-recipient mismatch in the HLA group 5 as well as in another group 
termed Te 3 which has not yet been universally accepted as an  HLA antigen. 
After an  initial acute tubular necrosis the transplanted kidney functioned 
stably for several months. Then, within a few weeks after cessation of globulin 
therapy. the creatinine clearance slo~vly began to decline and the blood urea 
nitrogen to rise. The organ has supported life for almost two years but it is 
highly unlikely that it will do so for much longer. 
The foregoing has not been an  isolated observation. \T7e have followed 13 
cadaveric kidne) recipients treated with the triple drug regimen after their 
operations from one to almost three years ago. In one patient there was no 
opportunity to evaluate the immunosuppression since the homograft was lost 
on the operating table by hyperacute rejection (see Chapter Fourteen). Of the 
remaining 12. 10 (83.3 per cent) lived for at least one year. with continuous 
function of the homograft: the other two recipients had good renal function 
before they died of pulmonary embolization three months postoperatively. 
Although the one-year patient and kidney s u n  i~ a1 was not discouraging, 
the term "successful" could be applied to the series onl? with qualifications. In 
eight of the 10 cases in which one-year survival n-as obtained. ALG n-as stopped 
after four months or less. Deterioration of function follon ed after .i ariable inter- 
vals in five patients. and in two of these the homografts es entually failed 
altogether and had to be removed during the second postoperative year. It is 
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worth mentioning that the same adverse chain of events was not seen in either 
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of the two patients in whom ALG was not stopped after four months but con- 
tinued for another four to six months. 
It will become apparent in the succeeding chapters that the kind of "es- 
cape" from immunosuppressive control just described. after stopping ALG, was 
- 
commonly seen in recipients of orthotopic liver homografts. Thus. the may in 
which ALG was initially used was eventuall) judged to be unsatisfactor) and 
was systematically altered in later cases. 
Alternative ALG Regimens. The previous obser~at ions~".  '? as at  ell as similar 
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Figzire 116. The course of a patient who received a kidney from a histoincompatible (HLA 5 :  Te 
3) cadaveric donor. He was gil-en triple drug therapy. After an initial period of poor urine excretion 
due to acute tubular necrosis, there xvas excellent renal function. Holvel-er. ~2-ithin a fexv weeks 
after completion of the four-month XLG course, the homograft began to deteriorate sloxvly. The 
patient is now 22 months post-transplantation. His creatinine clearance is 20 ml min and his B U N  
is 70 mg per cent. 
ones reported by Traeger et ali" of Lyon, France, have underscored the potential 
inadvisability. especially in cadaveric cases. of arbitrarily stopping ALG therapy 
after any preordained interval. The decision to continue is not difficult in the 
kind of patient ~ v h o  continues to tolerate the globulin injections without com- 
plaint and who does not de\-elop the signs of dangerous foreign protein sensiti- 
zation mentioned earlier. In the majority of patients. however, horse XLG can- 
not be given indefinitely and one of several alternate possibilities must be 
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selected after variable periods. The first is to stop globulin therapy and place 
reliance on the efficacy of azathioprine and prednisone: the frequently un- 
desirable consequences of this approach were described in the preceding sec- 
tion. Second, an  attempt at desensitization to the horse protein can be made, as  
will be described later. Finally, it may be possible to switch to ALG prepared 
from the sera of a different heterologous species. Rabbits, goats, and cows have 
been immunized in our laboratory against human lymphoid tissue in order to 
permit a broader choice of second line immune globulins. In our experience it 
has been safe to change from one kind of ALG to another.-" h4 
The foregoing modifications of ALG administration have in common the 
objective of extending the permissible duration of globulin treatment. A dif- 
ferent approach that is currently under investigation is to use larger doses of 
ALG with the other two agents of the triple drug regimen in an  attempt to 
induce an  early and long lasting tolerance of the kind often achieved with ALG 
alone in rodents". j4 or, less frequently, in dogs.jh The mechanism by which 
such an effect might be achieved with any good immunosuppressive agent is 
considered separately in Chapter Twelve. The following remarks will be con- 
cerned only with a description of a clinical trial begun in June 1968 and con- 
tinued until the present. 
In these patients an  effort was made with a "blitzkrieg" approach to 
therapy to achieve lymphoid depletion before and immediately after arrival of 
the antigen. High-titer ammonium sulfate-precipitated ALG was started in elec- 
tive cases three to five days before operation, using twice the previous doses. 
The individual injections in adults were usually 8 ml of horse globulin which 
had a protein concentration of 4 to 6 gm per cent and a leukoagglutinin titer of 
1 :4000 to 1 : 16,000. In children the quantities given were individualized accord- 
ing to size. After two to four days, about 3 mg kg of prednisone per day was 
started. The first dose of azathioprine was given on the day before transplanta- 
tion. For cadaveric cases, the regimen had to be modified by starting all three 
drugs on the day of operation. Except for the increased quantities, the subse- 
quent ALG schedule was about the same as in the earlier trials. 
The double doses of ALG were generallj well tolerated. inasmuch as the 
complaints of pain at the injection sites were not increased, nor was the in- 
cidence of other clinical side reactions greater than in the earlier cases. 
However, the resulting hematologic response was substantially different from 
that previously observed. 
Whereas the 4 ml doses had not caused significant acute lymphopenia, the 
8 ml injections did so without fail. Both the lymphocyte fractions and the total 
lymphocyte counts were abruptlj decreased within one day after the first intra- 
muscular injection (Fig. 117): leukocytosis \ \as almost a1s.r-ays observed. In the 
usual patient the lymphopenia n a s  further accentuated when steroids were 
added. Concomitant falls in the hematocrit did not occur. 
In these patients 11 mphopenia 1.r as usual11 maintained for several as eeks as 
an isolated finding. Then a secondar? depression of the platelet count com- 
monly de~eloped.  From this point onnard it n a s  necessary either to give the 
ALG in smaller quantities. to reduce the frequency of administration (Fig. 117), 
or to make both adjustments. Several of the patients developed nosebleeds or 
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F i g u r e  11 7.  Hematologic changes observed in a recipient of a renal homograft who was treated 
with triple drug therapy including double doses of horse ALG. Splenectomy and bilateral nephrec- 
tomy were performed on the same day as the transplantation. Lymphopenia was immediately 
produced by the first injection of ALG and Tvas moderately \re11 maintained until the globulin 
injections \rere reduced in frequency. Note the development within three weeks of thrombocytope- 
nia. The latter colnplication has been common in patients given increased quantities of the 
heterologous ALG (see text for discussion). 
hematuria. The complication of thrombocytopenia proved to be only a nuisance, 
since it could be quickly corrected by fresh platelet transfusions. It is sus- 
pected, however, that if such a blood bank service had not been available, the 
consequences could have been serious. 
When the frequenc) of ALG injections was reduced, sustained lymphope- 
nia could often no longer be maintained, especially in those patients in whom 
the d e ~  elopment of thrombocytopenia made it necessary to give the globulin on 
an  irregular basis (Fig. 11 7). The lymphocytes returned to the peripheral smear 
in nunibers that sometimes exceeded those present before operation. Thereaf- 
ter, sporadic lymphopenia seemed to be produced shortly after individual injec- 
tions, but frequently there were concomitant and parallel falls in the platelet 
counts. 
The ALG used for these patients had been raised n i th  splenic lymphocytes 
and absorbed with human platelets. After absorption it contained either unde- 
tectable or L er> lon- titers of antiplatelet antibodies. as measured by a standard 
thromboagglutinin method. It is probable that part of the delayed thrombocy- 
topenic effect was due to equine antibodies raised against antigenic deter- 
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rninants which are shared by both platelets and lymphocytes. This explanation 
as suggested by Pichlmayr,-1° who noted a reduction in the leukoagglutinin 
titers of his horse ALG after absorption with platelets from the species against 
t ~ h i c h  immunization was conducted. KashiwagiiVvas unable to confirm these 
findings but he provided support for the concept of cross reactivity by showing 
that leukoagglutinins and thromboagglutinins in raw horse antidog ALS were 
reduced in parallel by absorption with washed canine lymphocytes (Fig. 118). 
15'hatever the explanation for the thrombocytopenia, its appearance has imposed 
a very practical limitation on the doses of ALG that can be given to humans. 
Ono's studies from our laboratory have suggested that the magnitude of the 
problem should be reduced by special pains to remove contaminating platelets 
from the immunizing cell suspensions and by more complete subsequent ab- 
sorption with thrombocytes.'" 
The usual relationship of the other immunosuppressive measures to ALG 
therapy in this series of kidney transplantations is shown in Figure 117. The 
steroid doses in adults were ordinarily reduced steadily at the rate of 10 mglday, 
so that within two weeks the daily quantities were 40 to 60 mglday. In the 
elent  of rejection during this interval, attenuation of the steroid doses was 
stopped or slowed. Later reductions were determined on an  individualized 
basis. Thus, someone with a smooth postoperative course would be apt to have 
reached a maintenance prednisone level of 15 to 30 mg per day within three 
weeks. On the other hand, difficulties with rejection prolonged the time before 
ABSORPTION OF HORSE ANTIDOG ALS WITH: 
CELLS PER ABSORPTION ( x  10' ) OF 3 ml SERUM 
Figzcre 1 1 8 .  Absorptioil studies of raTv antidog ALS. L e f t .  .Absorption ~ r i t h  platelets sharply re- 
duced the  throinboagglutiniil titer n-ithout affecting the  leukoagglutinins. Rig11 t .  I11 contrast. absorp- 
tion with lymphocytes caused declines i n  both kinds of antibodies. 
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this level was reached. Azathioprine was administered in small enough quanti- 
ties to avoid bone marrow depression. 
There have been more than 40 renal transplantations in the high dose ALG 
series, including six cadaveric cases. All but two of the recipients are still alive, 
with function of their originally transplanted kidneys from three months to 
more than one year after operation. The two deaths were caused by pulmonary 
emboli 52 and 51 days after transplantation. It is, of course, too early to specu- 
late about the induction of homograft tolerance in these patients and, con- 
ceivably, such a determination may never be possible with certainty under the 
conditions of such a trial. All that can be said at  present is that the therapeutic 
regimen employed was exceptionally effective and relatively safe. 
Triple Drug Therapy in Liver Transplantation 
As was made clear earlier in this chapter, there was little evidence from the 
early experience with human liver transplantation that long survival could ever 
consistently be achieved with the double drug therapy then being used. Despite 
the administration of the azathioprine in quantities that almost always resulted 
in complex and fatal infections or other lethal side effects, rejection was ap- 
parently not well controlled. The most discouraging notations were in those 
patients in whom the presence of satisfactory initial hepatic function allowed 
the clinical diagnosis of homograft repudiation to be made with certainty and in 
whom the failure to control this process was equally well demonstrated (Chap- 
ter Twenty-two). The addition of heterologous ALG to therapy with azathioprine 
and prednisone changed this picture to the extent that a number of patients 
became available for the kinds of studies and more chronic observations that 
form the basis for several of the next chapters. 
The way in which azathioprine, prednisone, and heterologous ALG were 
used together was not precisely the same in any two cases since the doses and 
timing of the agents were constantly adjusted. The variability of treatment can 
best be appreciated by comparing the graphic records of the many individual 
patients whose courses are illustrated in the balance of the book. Nevertheless, 
the general guidelines of therapy were well defined. 
The First Triple Drug Schedule. Twelve consecutive orthotopic liver recipients 
(OT 6 to 17) were treated with the basic triple drug regimen used in the first 
ALG kidney ~ e r i e s . ~ '  "I3 h4  Azathioprine, prednisone. and horse ALG were all 
started on the day of operation. The doses of the same ammonium sulfate- 
precipitated horse globulin described earlier in this chapter were 4 ml in the 
adults. The children, whose ages averaged about 18 months, received 1 or 2 ml 
per injection. Lymphopenia was not consistently produced (Fig. 119). In the 
patients IT ho had extended survil al. XLG was e\-entually stopped in all but one 
(OT 13) either because the end of a four-month course had been reached or 
because local or s) stemic toxic reactions had occurred before this time. 
The administered quantities of prednisone differed from patient to patient 
"For exact ages and weights of all patients see Chapter Twenty-four. 
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F i g z ~ ~ e  119. Peripheral ~vhi te  cell and platelet changes in an orthotopic liver recipient (OT 13) 
who received heterologous ALG prepared from sera from three different species. The indication for 
transplantation was extrahepatic biliary atresia; sp1enectom)- was also performed. Horse globulin 
Iras begun in 1 ml doses on the day of operation and continued for four months. with a gradual 
reduction in the frequent) of the injections. When jaundice recurred about two months after the 
horse ALG had been stopped. the prednisone dosage Tvas increased and a course of immune rabbit 
qlobulin (4 ml daily) xras instituted. Eight weeks later a reaction to the second globulin prompted 
the transition to goat ALG. also in 4 ml doses. The relatix-e lyrnphopenia present during therapy 
with horse ALG was succeeded by lymphoc!-tosis ~ v h e n  this agent lras discontinued. The lympho- 
cyte increases n-ere not affected b>- the rabbit XLG but appeared to decline lvhen goat ALG was 
>tarted. Note the acute thromboc!-topenia immediatel!. after operation and compare to the same 
finding (Fig. 83. Chapter 11) in a pig that received no treatment at  all. 
and are summarized for the first three postoperative weeks in Table 18. These 
were somewhat higher than had been used in the earlier experience with hepat- 
ic transplantation using double drug therapy. The most important change from 
the policy followed with the previous l i ~ e r  patients was a drastic reduction in 
azathioprine. (Compare Table 18 with Table 17). With this adjustment, the 
dread complication of leukopenia \ \as avoided. The peripheral nhi te  blood 
counts of none of the 12 recipients dropped to belon 3000 cu m m  in the first 
three postoperative n-eeks. 
In Table 18 the therapeutic schedules for the first 21 postoperati\ e days in 
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Table 18. Triple Drug Immunosuppression Used During the First Three 
Postoperative Weeks for All Lil er Recipients Treated Since the Autumn 
of 1966, Excluding Only Three Patients (OT 18, 20, 21) Who Died 
Just  After Operation of Technical Complications 
(Chapters Eight and Nine) 
\ V H I T E  
A V E R A G E  HOAIO(.XAFT B L O O D  PLXTELET EARLY 
AZATHIO- AVER.4C.E CTINO- IRR.XLIIA- C O L  K T  COLTST LIVER 
SURVIVAL PRISE PREDSISOYE I \ I Y C I ~ -  c TIOS ( C U  nnn)  (cu m m )  FUNC-  SPLEN- 
N O  (Days) (mg kg day) (mg kg day) (Total pgm)  (Total Rj Lo~vest  Day Lowest Day TIOX ECTOMY 
pppppppp 
Standa rd  ALG doses 
OT 6 7 1.06 1.7 None None 4,900 1 15,000 2 Poor Yes 
OT 7 10 2.1 4.2 None None 13,000 2 37,000 6 Poor Yes 
OT 8 400 1.2 1.6 None N o n e t  7,500 20 78,000 6 Excellerit Yes 
OT 9 133 2.0 2.4 None4  None t  10,000 1 7,700 13 Good Yes 
OT 10 186 1.7 1 2  None None' 22,000 5 12,000 15 Excellent Yes 
OT l l  6 1 1.1 2.6 120t 45 0 15,700 6 32,000 15 Fair Yes 
O T 1 2  105 1.3 5.7 120 300 15,800 6 19,000 19 Fai r  Yes 
OT 13 Alive 1.2 4.3 None None 12,900 2 25,000 4 Good Yes 
OT 14 Alive 0.7 3.0 None N o n e t  4,900 5 42,000 5 Good N o  
OT 15 339 1 .O 2.4 None None 7,600 21 158,000 2 Fair Yes 
OT 16A Regraft 0.7 4.9 None N o n e t  7.300 3 14,000 4 Good Yes 
B Al ive 0.2 3.5 None None 3,200 22 49,000 5 Excellent 
OT 17 35 1.3 2.8 None None  9,600 5 28,000 12 Fair Yes 
Mean 1.2 3.1 
High dose ALG 
OT 19 Alive 1 .O 4.0 None None  7,700 7 14,500 14 Excellent Yes 
OT 22 10 0.6 3.0 None None 7,800 5 24,000 3 Poor N o  
OT 23 143 2.3 1.9 None None 11,900 8 224,000 5 Good Yes 
OT 24 1 1  0.5 3.9 None None 5,000 1 1  25,000 7 Poor N o  
Cadaver 1.6 2.5 Rarely Commonly 5 5 
kidney Used Used 
recips. 
The immunosuppression is contrasted with that employed In a parallel series of 12 consecutive cadaveric 
renal transplantations co~npiled from 1966 to 1968. The sur l i r a l  notes are to April 1. 1969. 
+Recei\-ed this kind of therapy at some time after three n-eeks 
;Two of the patients died after three months of pulmonary embolization. The other 10 li\-ed for at  least one 
year n i t h  origi~ial homograft function. Concomitant splenectomy \\.as performed in onl? three of the cases. Results 
are means. 
5None of the kidne? recipients de\eloped leukopenia <3000 durlnri the first three postopelative weeks. 
During the same time f i ~ e  of the 12 exhibited thrombocytopeaia {<50,00Oj. 
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the liver recipients are also compared to those used in 12 consecutive patients 
who had cadaveric kidney transplantation while under the same kind of triple 
drug therapy and during the same general period. The renal recipients were 
able to take considerably larger average quantities of azathioprine without a 
single incident of leukopenia. 
During the period of analysis, and afterward for as long as any of our liver 
recipients have lived, efforts to increase the azathioprine doses have proved to 
be dangerous. Even among the longest survivors, the largest quantities consis- 
tently tolerated have ranged from as little as 0.15 mg (OT 14) to a maximum 
(OT 15) of about 1 mglkg per day. In most of the latter patients, ALG was 
eventually stopped. In the ensuing months, efforts to increase the quantities of 
azathioprine usually resulted in leukopenia, necessitating its temporary discon- 
tinuance. The fact that the permissible azathioprine doses were about the same 
whether or not ALG was also being given suggested that the globulin had not 
contributed to the azathioprine intolerance. 
The complication of postoperative thrombocytopenia was alluded to earlier 
in describing our initial unsuccessful experience with human liver transplanta- 
tion. Severe platelet depression was even more troublesome and persistent 
when heterologous globulin was added for the later hepatic recipients. In 11 of 
the 12 liver cases listed in Table 18 thrombocytopenia of less than 50,000 cu 
mm appeared within the first three weeks, invariably in the absence of other 
evidence of bone marrow depression. The ALG clearly contributed to the sever- 
ity of the problem by the meclianism described in the preceding section on 
kidney transplantation with triple drug therapy. However, additional factors 
were also undoubtedly significant in the hepatic cases since thrornbocytopenia 
can develop after liver transplantation to untreated animals (Fig. 83, Chapter 
11) or in human liver recipients not treated with ALG (Table 17). 
Hutchison et all" have formally evaluated the problem in dogs after orthoto- 
pic hepatic transplantation. Both in untreated animals and in those adminis- 
tered ALG (Fig. 120), he found significant platelet depressions which often 
began immediately after revascularization of the hepatic homografts and con- 
tinued for several days thereafter. There appeared to be pronounced platelet 
clearing b j  the new livers, a conclusion supported by the histologic demonstra- 
tion of thrombocyte sequestration in the spaces of Disse. Collateral data 
showing a shortened platelet half-life and abrupt reductions of fibrinogen 
prompted the authors to speculate on the possibility of intravascular coagula- 
tion within the transplanted organ. The studies of Boehmig and his associates2 
have strengthened this suspicion and, in addition, have confirmed the fact that 
the declines in platelets and other clotting factors ma> actually begin during 
host hepatectomy. (See more complete discussion in Chapter Ten.) 
It is of interest that similar but somewhat less se\ ere platelet changes were 
also detected by Hutchison in animals subjected to simulated autotransplanta- 
tion.''' Thus, the risk of acute thromboc) topenia after li\-er transplantation is 
probably due at least in part to a nonimmunologic etiology such as ischemic 
injury to the transplant rather than to any specific interaction between the liver 
and the platelets of the host. The practical problem is apparent. Because throm- 
bocytopenia can be regularly caused by the procedure of liver transplanta- 
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Figu1.e 120. The effect of orthotopic liver transplantation on the platelet coullts of five dogs. The 
animals were treated with doses of horse ALG that did not cause thrombocytopenia. With the 
transplantation there Tvere sharp declines in  the peripheral thromboc?-tes and these persisted for 
several days afterward. The same kind of platelet depression lvas noted in the absence of all 
therapy or even after simulated autotransplantation. (BJ- permission of Arch. Surg. 97:27. 1968.) 
tion as well as by the ALG or, presumably, even by the azathioprine given in the 
immunosuppressive regimen, platelet counts must be considered a standard 
and frequently obtained laboratory determination in this kind of case, and the 
results used for the planning of the drug therapy. 
Variations in ALG Use. Earlier, an attempt at "blitzkrieg" therapy was 
described in a series of renal transplant recipients. ALG was given in double 
the doses used in the first triple drug the rap~  trials. The justification for the 
change was the high incidence in nonrelated cases of delajed rejection after 
ALG was stopped. As will be made clear in succeeding chapters. the same thing 
had also been verl common after hepatic transplantation. It was hoped to avoid 
this complication after transplantation of both organs by intensifying the initial 
immunosuppression and thereby inducing a longer lasting state of tolerance. 
The trials in kidney transplantation have already been discussed. 
Efforts to apply this principle after liver transplantation were not very suc- 
cessful when 8 ml of XLG per dose were administered to adults and 2 to 4 ml 
were g i ~  en to children (Table 18). At these lex els, relati1 e lymphope~lia was 
promptly produced (Fig. 121). Hon el  er, do~vnrvard re\-isions of the quantities 
and frequency of the injections were soon necessitated by the appearance of 
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F i g z i r e  121.  Hematologic changes in an orthotopic liver rec ip i~n t  (OT 19) who was given triple 
drug therapy. The donor-recipient histocompatibility was poor. since there were mismatches in  the 
HLA antigens 2 .  3 and 7.  High dose XLG treatment was attempted (see text). Initially. striking 
lylnphopenia xras obtained: ho1.r-ex-er. thromboc!-topenia xras concomitantly induced n-ith almost 
every injection after the first \reek and the frequent!. and quantity of the ALG administration had 
to be reduced. Thereafter. lymphoc>-tosis gradually became ex-ident. At the end of four months the 
.ALG xvas not stopped. as in many earlier cases. The child ~ r h o s e  original diagnosis n-as biliary 
atresia is nolr- almost one !-ear post-transplantatiol~ and has completely norimal lix er function. 
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thrombocytopenia which was sometimes severe enough to require platelet trans- 
fusions (Fig. 121). but which was never accompanied by evidence of bone mar- 
row depression. The lymphocytes then returned to the peripheral blood in large 
numbers. In the long run the irregularity of globulin treatment often resulted 
in smaller total volumes being given than when more conservative doses were 
used from the outset. 
Thus, it became apparent that the best hope of improving the ALG regimen 
was to extend its use beyond the four months to which its administration was 
originally restricted. This was not possible indefinitely because of the eventual 
development of toxic reactions. The longest courses of continuous horse ALG 
treatment have been eight months (OT 15 and 19). One of these patients ulti- 
mately died of metastases from the hepatoma for which liver replacement was 
undertaken. The other still has perfect hepatic function (see Chapter 
Seventeen and Figure 128, Chapter Fourteen). 
Desensitization to the horse protein was attempted in two patients (OT 14 
and 16) who had equine ALG discontinued because of severe local reactions 
ten and a half weeks and 18 days after operation, respectively. In both patients 
progressive jaundice appeared soon afterward. The desensitization procedure 
involved the repeated injection of initially minute but progressively larger 
quantities of the ALG, first by the subcutaneous and then the intramuscular 
routes. The schedules and techniques were those of classic tetanus antitoxin 
de~ensitization.~'  Both patients developed high fevers and became so ill that the 
effort was abandoned. 
In a number of other recipients who had toxic reactions to the horse 
globulin, the better alternative nras taken of switching to ALG prepared from 
the serum of immunized rabbits or goats. In the first two of these patients (OT 
13 and 16) rejection had already developed after stopping treatment with the 
horse globulin. The consequent deterioration of hepatic function was not 
reversed with the institution of the new ALG although its progression was 
halted (Fig. 119). The other patients were immediately transferred from horse 
to goat or rabbit ALG (see Chapter Seventeen). 
The doses and titers of the immune globulin prepared from rabbit and goat 
serum are given in Table 19. It was of interest that neither lymphopenia nor 
Table 1 9. The Leukoagglutinin and Lymphocytotoxin Titers of the Rabbit and 
Goat Antilymphocyte Globulins Administered to S e ~ e r a l  Orthotopic Liver 
Recipients After Sensitization to Horse ALG Had Occurred 
LEUKO- LYAIPHO- PROTEIN 
A G G L U T I K I S  C Y T O T O X I S  COXTENT 
SPECIES TITER TITER DOSE (ml) (gm per 100 ml) 
Rabbit 1 :2000 - 1 :4000 1 : 1000 - 1 :2000 1 - 4  2.3 -5.2 
Goat 1 :2000 - 1 :8000 1 :1000- 1 :2000 1.5-4 4.2 - 8.3 
'The doses TI-ere adjusted according to the leukoagglutinin titer and the patient's weight. 
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thrombocytopenia was caused by the secondarily employed ALG. There was, in 
fact. an apparent lymphocytosis with the rabbit globulin (Fig. 119), suggesting 
that there had been suboptimal dosage. 
Ancillary Measures. Intravenous actinomycin C and local homograft irradia- 
tion were occasionally used during the first three postoperative weeks, or in 
some instances after this time. The x-ray therapy was ordinarily prompted by 
swelling of the liver. In the usual patient two or three doses of 150 R each (at 
1 depth) were given. There was no demonstrable effect. 
Splenectomy was performed in about two thirds of the liver patients. This 
adjuvant measure has been used in our institution since 1962-" h" as part of the 
treatment protocol for kidney transplant recipients. It has been omitted in our 
renal patients only when nephrectomies were not performed simultaneously 
with transplantation or when splenic extirpation was judged to be technically 
dangerous. The latter criterion was the only contraindication to splenectomy 
in the liver recipients. The rationale for the procedure4' 'I" was based on the 
known primary participation of this organ in the immune response to intra- 
venous antigens. That the value of splenectomy in mitigating rejection is 
unproved can be appreciated by noting the published articles on the subject of 
splenic extirpation alternately appearing to opposeli ' j  or to s ~ p p o r t ' ~ . ~ '  its 
use. In liver transplantation. however, there are other special reasons why 
splenectomy is advisable if it can be conveniently and safely done. These were 
discussed in Chapter Eight. 
REFERENCES 
1, al-Khalidi. V. A. S., and Chaglassian, D.: The species distribution of xanthine oxidase. Biochem. 
J. 97:318. 1965. 
2. Boehmig. H. J.. Fritsch. A,. Kux. AT.. Lechner, G.. Lechner. K.. Reich, N.. Stockinger, L.: and 
Zeitelberger, P. :  Gerrinnungsveranderungen bei Orthotoper Lebertransplantation a m  
Hund. Thromb. Diath. Haemorrh. 21 :170, 1969. 
3. Bresnick, E. :  The metabolism in z i t~ .o  f antitumor in~idazolyl derivatives of mercaptopurines. 
Fed. Proc. 18:549. 1959. 
4. Brunstetter, F.  H.. and Claman, H. S.: Impairment of delayed hypersensiti'r~ity in uremic pa- 
tients by antilymphocyte serum. Transplantation 6:485. 1968. 
5. Carraz, AI.. Traeger, J. .  Fries. D.. Perrin. J.. Saubier. E.. Brochier. J. .  Ire)-sse)-re, C.. Prevot, J., 
Bryon. P.,  Jouvenceaux. A,. Archimbaud. J .  P.. Bonnet. P..  Manuel. Y . .  Bernhardt. J .  P.. and 
Fouillet. Y. T.:  Preparation, proprietes et activite d'immunoglobulines de cheval antilym- 
phocytes humains. Revue de 1'Institut Pasteur de Lyon 1 :17. 1967-1968. 
6. Dempster. LY. J . :  Kidney transplantation. 1 1 2  Rob. C . .  and Smith. R. !eds.): Operati\-e Surgery 
Serl-ice. London. Butterworth & Co.. Ltd.. 1962. 
7. Dougherty. T. F.. Berliner. 11. L.. and Berliner. D. L.: Hormonal influence in  lymphocyte dif- 
ferentiation from RES cells. Ann. s'i.Y. ;\cad. Sci. 88:78. 1961. 
8. Elion. G. B.. Callahan. S..  Bieber. S . .  Hitchinys. G.  H.. and Rundles. R. IT.: .A summary of inves- 
tigation with 6 (1-methyl-4-nitro-5 imidazole) thiopurine (B.lT. 57-3221. Cancer Chem- 
other. Rep. October. 1961 !So. 14). 
9. Elion, G. B.. Callahan. S. IT.. Hitchings. G. H.. and Rundles. R. if-.: Relationship between drug 
and antitumor effects of thiopurines in lnouse and man. 1 1 1  Proceedings of the VIII Inter- 
national Congress of Hematolo%!-. Tokyo. Pall Pacific Press. 1960. pp. 642-645. 
10. Fateh-AIoghadam. A, .  Pichlma!-r. R.. Jarosch 1-011 Schx\-eder. H. IY.. and Knedel. 11.: Isolierung 
immunologisch ~rirksamer :/-Globulille eines Pferdeantih~~ndely~~~~~liocytenserums Klin. 
IVschr. 43:578. 1967. 
11. Franksson. C.: Letter to the editor. Lancet 1 :1331. 1964. 
274 / IMMUNOSUPPRESSION IN MAN 
12. Gleason, R. E.. and hlurray. J .  E. :  Kidney Transplant Registry: Analysis of variables in  the 
function of human kidney transplants. I. Blood group compatibility and splenectomy. 
Transplantation 3:343. 1967. 
13. Halgrimson. C. G.. XIarchioro. T. L.. Faris. T. D.. Porter. K .  A.. Peters. G. N..  and Starzl, T. E. :  
Clinical and experimental auxiliary hepatic homotransplantation with emphasis on host 
portacaval shunt. Arch. Surg. 93:  107. 1966. 
14. Hill. R. B.. Jr.. Dahrling. B. E.. Starzl. T. E..  and Rifkind. D.: Death after transplantation: An 
analysis of 60 cases. Xmer. J .  RIed. 4 2 3 2 7 .  1967. 
15. Hume. D. RI.: Progress in  clinical renal homotransplantation. 11, LYelch. C. E. (ed.): Advances in 
Surgery. Chicago. Year Book lIedical Publishers. Inc.. 1966. pp. 419-498. 
16. Hume, D. ;\I.. Lee. H. AI.. L~'i1liams. G. hI., Li'hite. J .  0.. Ferre. J . .  LYolf. J .  S.. Prout. G. R.,  Jr.. 
Slapak. 11.. O'Brien. J . .  Kilpatrick. S. J . .  Kauffman. H. AZ.. Jr.. and Cleveland. R. J . :  Com- 
parative results of cadaver and related donor renal holnografts in  man. and immunologic 
implications of the outcome of second and paired transplants. Ann. Surg. 164:352. 1966. 
17. Hume. D. 11.. 1Iagee. J .  H.. Kauffman. H. RI.. Jr. .  Rittenbury, R I .  S . .  and Prout. G. R..  J r . :  Renal 
transplantation in  man in modified recipients. Ann. Surg. 158:608. 1963. 
18. Humphrey. J .  H.. and LYhite. R. G.: Irnlnunology for Students of hledicine. Philadelphia, F. A. 
Davis Co.. 1963. 
19. Hutchison. D. E.. Genton. E. .  Porter. K. A,. Daloze. P. 11.. Huguet. C.. Brettschneider. L.. Groth. 
C. G.,  and Starzl. T. E. :  Platelet changes following clinical and experimental hepatic homo- 
transplantation. Arch. Surg. 97:27. 1968. 
20. Kashi~vagi. N.. Brantigan. C. 0.. Brettschneider. L.. Groth. C.  G.. and Starzl. T. E . :  Clinical 
reactions and serologic changes following the administration of heterologous antilvmpho- 
cpte globulin to human recipients of renal homografts. Ann. Intern. 1Ied. 6'8:275. 1968. 
21. Kashiwagi. N.. Groth. C. G..  Amend. J .  R.. Gecelter. L.. Blanchard. H.. and Starzl. T. E.: Im- 
provements in the preparation of heterologous antilymphocyte globulin ~v i th  special 
reference to absorption and DEAE-cellulose batch production. Surgery 65 :477, 1969. 
22. Kashiwagi. h'.. Groth. C. G.. Gecelter. L.. Amend. J .  R.. Blanchard. H.. and Starzl. T. E.: A 
DEAE-cellulose hatch technique for antilymphoc?-te globulin preparation. Surg. Forum 
19:196. 1968. 
23. Kashiwagi. N..  Sherer. D., Townsend. C.. Jacobs. R.. Ono. K.. Kapur. B.. and Starzl, T. E.: Anti- 
body localization in horse. rabbit and goat ALS. Surgery. in press. 
24. Kauffman. H. LI.. Cleleland. R. J . .  DTVJ-er. J .  J . .  Lee. H. AI. .  and Hume. D. R I . :  Prolongation of 
renal homograft function by local graft radiation. Surg. G!-nec. Obstet. 120:49, 1963. 
25. Kimber. C.. Deller. B.. lbbotson. R. N.. and Lander. H . :  The mechanism of anaemia in  chronic 
liver disease. Quart. J .  LIed. 34:33. 1965. 
26. Konomi. K.. Deodhar. S. D.. Tung. K. S. K.. and Nakamoto. S.: In~n~unosuppression ~ v i t h  an- 
tilymphocyte globulin in clinical renal tra~lsplantation. Surg. Forum 19:  194, 1968. 
27. Kountz. S. L.. and Cohn. R. B. :  Successful intrarenal treatment of the allograft reaction. Surg. 
Forum 18:231.  1967. 
28. Mannick. J .  A.. and Egdahl. R. H . :  Endocrinologic aqents. 111 Rapaport. F. .  and Dausset. J .  (eds.): 
Human Transplantation. New York. Grune & Stratton. Inc..  1968. pp. 472-481. 
29. Xlarchioro. T. L.. Axtell. H. K.. Lavia. 11. F..  IYaddell. IY. R..  and Starzl. T. E.:  The role of 
adrenocortical steroids in reversing established homograft rejection. Surgery 3 5 4 1 2 .  1964. 
30. Marchioro. T. L.. Terasaki. P. I . .  Hutchison. D. E.. Brettschneider. L.. Cerilli. G. J . .  Groth. C.  G.. 
and Starzl. T. E . :  Renal transplantation at the Unix-ersity of Colorado. Transplantation 
5:831. 1967. 
31. Martin. D. C.. Van De LYater. J . .  Randel. D.. and Lee. D. '4.: Prolonged functional survival of dog 
renal grafts n-it21 local radiation. Surq. Forurn l3 :156 .  1963. 
32. Medawar. P. B. :  Biological effects of heterologous antil>-mphocyte sera. 111 Rapaport. F.. and 
Dausset. J .  (eds.): Human Transplantation. New York. Grune 8i Stratton. Inc.. 1968. pp. 
501-509. 
33. Merrill. D.. Hartley. T. F.. and Claman. H. 1.: Electroi~nmunodiffusion (EID;: X simple, rapid 
method for quantitation of iml~lulloglobulili n dilute biological fluids. J .  Lab. Clin. Xled. 
69:131. 1967. 
34. Xlonaco. A. P..  IYood. 31. L.. and Russell. P. S . :  Studies on heteroloqous antil!-mphocyre serum 
in mice. 111. Imn~unoloeic tolerance and chimerism produced across the H-2 locus with 
adult th!-mectom?- and .intil!-mphocyte serum. .Ann. S . Y .  rlcad. Sci. 129 : 190. 1966. 
33. RIIonaco. .A. P.. \Yood. 31. L.. \-all der \I-erf. B. -4.. and Russell. P. S. :  Effects of anti1~-mphocytic 
serum in mice, do:s and mall. 111 \Yolstenholme. G. E. \Y.. and O'Connor. 31. {eds. : Antilym- 
phocytic Serum. London. J .  8; .A. Churchill. Ltd.. 196;. pp. 111-134, 
36. 1Ioore. T. C . :  Discussion of 3Iurra?-'s paper. reference 38. 
37. illurray. J .  E . .  IIerrill. J .  P.. Harrison. J .  H.. \T-ilson. R. E.. and Dammin. G. J . :  Prolonged 
IMMUNOSUPPRESSION IN MAN / 275 
survival of human kidney homografts with immunosuppressive drug therapy. New Eng. J. 
Med. 268:1315. 1963. 
38. Murray. J .  E.. Wilson. R. E.. Tilney. N.  L.. Illerrill. J .  P. .  Cooper. IT. C.. Birtch. A. G.. Carpenter, 
C. B.. Hager. E. B.. Dammin. G. J . .  and Harrison. J .  H.: Five years' experience in  renal 
transplantation rr-ith immunosuppressive drugs: Sur\-ival. function. complications. and the 
role of lymphocyte depletion by thoracic duct fistula. Ann. Surg. 168:416. 1968. 
39. Ono. K.. Bell. P. R. F.. Kashirr-agi. N..  and Starzl. T. E.: The comparatil-e 1 1 1  z i t r o  and iiz vizo 
activity of ALS raised by immunization ~v i th  thymic, splenic, and lymph node 1)-mphocytes. 
Surgery 66:  1969. in press. 
40. Pichlmayr. R.. Brendel. \V.. Tsirimbas. '4.. Bock. E.. Thierfelder. S.. Fateh-lloghadam. A, ,  Hor- 
nung. B.. and Pfisterer. H . :  Use of heterologous antilymphocyte sera in man. J .  Cardiov. 
Surg. \'I11 Congress of the International Cardiovascular Society. 1968, p. 37. 
41. Pierce. J .  C.. and Hume. D. 21.: The effect of splenectomy on the survival of first and second 
renal hornotra~lsplants in man. Surg. Gynec. Obstet. 127:1300. 1968. 
42. Rubin. E.. Gottlieb. C.. and \logel. P.:  S?-ndrome of hepatitis and aplastic anemia. An~er .  J .  Med. 
45:88. 1968. 
43. Sheldon. J .  AI., Lox-ell, R. G.. and hlathexrs. K. P.:  A 3Ianual of Clinical Allergy. Philadelphia, W. 
B. Saunders Company. 1967. pp. 461-462. 
44. Shorter. R. G., Hallenbeck. G. A,. Nax-a. C.. O'Kane. H. 0.. De\Teerd. J .  H.. and Johnson, W. J.: 
Antilymphoid sera in renal allotransplantatiol1. Arch. Surg. 5)7:323. 1968. 
45. Starzl. T. E . :  Experience in Renal Transplantat io~~.  Philadelphia. IT. B. Saunders Company, 
1964. 
46. Starzl. T. E.. Brettschneider. L.. 3Iarti11. A. J . .  Groth. C.  G.. Blanchard. H. ,  Smith. G. V.. and 
Penn. I.:  Organ transplantation: past and present. Surg. Clin. N. Amer. 48:817. 1968. 
47. Starzl. T. E.. Brettschneider. L.. Penn. I . .  Bell. P.. Groth. C. G . .  Blanchard. H.. Kashixvagi, N., 
and Putnam. C. IT.: Orthotopic liver transplantation in man. Transplantation Proceedings 
1 (No. 1):216. 1969. 
48. Starzl. T. E.. Brettschneider. L.. Penn. I.. Schmidt. R. \T.. Bell. P.. Kashixvagi, N.. Townsend, C. 
M.. and Putnam. C. \V.: A trial with heterologous antilymphoc>-te globulin in man. Trans- 
plantation Proceedings I (No. 1):448. 1969. 
49. Starzl. T. E.. Groth. C. G.. Brettschneider. L.. 31oon. J .  B.. Fulginiti, 1.. X.. Cotton. E. K., and 
Porter. K. A , :  Extended survi\.al in 3 cases of orthotopic homotransplantation of the human 
liver. Surgery 63 :549. 1968. 
30. Starzl. T. E.. Groth. C. G.. Brettschneider. L.. Penn. I.. Fulginiti. TT. A,. 3Ioon. J .  B,. Blanchard, 
H., and Porter. K. A,: Orthotopic holnotransplantatio~~ of the human liver. Azn. Surg. 
168:392. 1968. 
51. Starzl. T. E..  Groth. C .  G.. Brettschneider. L.. Smith. G .  V . .  Penn. I.. and Kashixr-agi. N . :  Perspec- 
tives in organ transplantation. Proceedings of the S~viss  Societ>- cf Immunology. Antibiot. 
Chemother. (Basel) 1 5  :349. 1968. 
52. Starzl. T. E.. Groth. C. G.. Terasaki. P. I.. Putnam. C. IT.. Brettschneider. L . .  and llarchioro. T. 
L.: Heteroloqous antilymphocyte globulin. histocompatibility matching, and human renal 
homotransplantation. Surg. G>-nec. Obstet. 126:1023. 1968. 
53. Starzl. T. E.. 3Iarchioro. T. L.. and Faris. T. D.: Lix-er transplantation. (Editorial.) Ann. Intern. 
%led. G4:473. 1966. 
34. Starzl. T. E.. Ilarchioro. T. L.. Faris. T. D.. Hutt. 31. P.. Carey. T. A.. Ogden. D. A.. Porter, K. A., 
and \Taddell. IT. R.: The problems and prognosis of the chronicall>- surviving patient after 
renal homotransplantation. Ann. N.Y. Xcad. Sci. 129:398. 1966. 
33. Starzl. T. E.. 3Iarchioro. T. L. .  Hunt1e~-. R. T.. Rifkind. D. .  Roxrlands. D. T.. Jr. .  Dickinson, T. C. ,  
and \I-addell. IT. R. :  Experimental and clinical hon~otransplantation of the lix-er. Ann. N.Y. 
Acad. Sci. 120:739. 1963. 
56. Starzl. T. E . .  llarchioro. T. L.. and Porter. K. .4.: Proqress in homotranspla~ltation of the liver. 111 
IVelch. C .  {ed.!: Advances in Surger>-. Chicago. Year Book AIedical Publishers. Inc.. 1966. 
pp. 295-370. 
57. Starzl. T. E . .  1Iarchioro. T. L.. Porter. E;. -4.. Faris. T. D. .  and Carey. T. .A,: The role of organ 
transplantation in pediatrics. Pediat. Clin. I. Amer. 13:381. 1966. 
38. Starzl. T. E.. llarchioro. T. L.. Porter. K. A . .  Irvasaki. Y.. and Cerilli. G. J . :  The use of 
heterologous antilymphoid agents in canine renal and lix-er homotransplantation. and in 
human renal homorransplal~ratio~~. S L I ~ ~ .  G!-nec. Obster. 124:301. 1967. 
59. Starzl. T. E . .  IIarchioro. T. L.. Rorrlands. D. T..  J L .  Kirkparrick. C. H.. I\-ilsoli. IT. E.  C.. Rifkind, 
D.. and iyaddell. IT. R.: Immunosuppressiol~ after experimental and clinical homotrans- 
plantation of the liver. Ann. Surg. 160:411. 1964. 
276 / IMMUkOSUPPRESSlON IN MAN 
60. Starzl. T. E..  IIarchioro. T. L.. Talmage. D. It'., and IITaddell. IV. R.: Splenectomp and thymec- 
tomy ill human renal hoinotransplantation. Proc. Soc. Exp. Biol. Med. 113:929. 1963. 
61. Starzl. T. E..  3larchioro. T. L.. Terasaki. P.  I.. Porter. K. A,. Faris. T. D.. Herrmann, T. J. ,  
\'redex-oe. D. L.. Hutt. hI. P.. Ogden. D. A , .  and If-addell. It'. R.: Chronic survival after 
human renal hornotrailsplantation. Ann. Surg. 162: 749. 1963. 
62. Starzl. T. E.. JIarchioro. T. L.. yon Kaulla. K.. Hermann. G.. Brittain. R. S. .  and \Taddell. LV. R.: 
Homotransplar~tation of the liver in humans. Surg. Gynec. Obstet. 11 71659. 1963. 
63. Starzl. T. E..  Rlarchioro. T. L.. and IT'addell. LT'. R.: The reversal of rejection in human renal 
homoqrafts ~ v i t h  subsequent development of hoinoqraft tolerance. Surg. Gynec. Obstet. 
11 7:383. 1963. 
64. Starzl. T. E.. Porter. K .  A,. Brettschneider. L.. Penn. I.. Bell. P.. Putnam. C. if-.. and RlcGuire. R. 
L.: Clinical and pathologic observations after orthotopic transplantation of' the human liver. 
Surg. Gynec. Obstet. 128:327. 1969. 
65, Starzl. T. E.. Porter. K. A , .  I~vasaki.  Y.. ?Iarchioro. T. L.. and Kashin-agi. N. :  The use of antilym- 
phoc>-te qlobulin in human renal homotransplantation. I11 \t 'olstenhol~ne. G.  E .  \IT.. and 
O'Connor. 31. (eds.): Antilymphocytic Serum. Londoli. J .  & A. Churchill. Ltd.. 1967. pp. 4-34. 
66. Stevens. L. E.. Freeman. J .  S.. Kentel. H..  and Reerntsma. K.: Preparation and clinical use of 
antilymphocyte globulin. Amer. J .  Surg. 116:793. 1968. 
67. Stuart. F. P.. Torres. E.. Hester. Lt'.  J . .  Damn~in .  G. J. .  and AIoore. F. D.: Orthotopic autotrans- 
plantation and allotransplai~tation of the liver: Functional and structural patterns in  the 
dog. Ann. Surg. 165325 .  1967. 
68. Terasaki. P. I.. Porter. K. A , .  RIarchioro, T. L.. lIickey, RI.  R.. Vredevoe. D. L.. Faris. T. D., and 
Starzl, T. E . :  Serotyping for hoinotransplantation. 1'11. Selection of kidney donors for 32 
recipients. A1111. N.Y. Acnd. Sci. 129:300. 1966. 
69. Terasaki. P. I.. Vredevoe. D. L.. Porter. K. A,. LIickey. hI. R.. Xlarchioro. T. L.. Faris. T. D.. 
Herrmann. T. J . .  and Starzl. T. E. :  Serotyping for homotransplantation. V. Evaluation of a 
matching scheme. Transplantation 4:688. 1966. 
70. Traeger, J . .  Carraz. LI.. Fries. D..  Perrin. J. .  Saubier. E.. Bernhardt. J. .  Bonnet. P.. and Archim- 
baud. J . :  Preparation, biological ac t i~ i t i es  and long term clinical studies xvith ALS made 
from thoracic duct lymphocytes. Trai~splantation Proceedinqs 1 (No. 1):433. 1969. 
71. Traeger. J . .  Perrin. J . .  Fries. D.. Saubier. E.. Carraz. AI.. Bonnet. P. .  Archimbaud. J .  P.. Bern- 
hardt. J .  P.. Brochier. J . .  Betuel. H.. \'eysseyre. C.. Br>-on. P. A . .  Prelot.  J. .  Jou\.enceau. A , ,  
Banssillon. V. .  Zech. P. .  and Rollet. X.: Utilisation chez l'homme d'une qlobuline antilpm- 
phocytaire: Resultats cliniques en transpl~intation rGn,lle. Lyon hIed, 5:307. 1968. 
72. Tsirimbas. A.. Pichlmayr. R.. Homung. B.. Pfisterer. H.. Thierfelder. S..  Brendel. LV.. and Stich. 
If-.: Therapeutische LVirkungen von heteroloqein Antihuman-1)-mphoc!-tenserein (XHLS) 
bei chronischer lymphatischer Leukamie. Klin. \t'schr. 46 :383. 1968. 
73. Veith. F. J. ,  Luck. R. J . .  and hIurray. J .  E . :  The effects of splenectomy on immunosuppressive 
regimens in dog and man. Surq. Gynec. Obstet. 121 :299. 1963. 
74. White. A.:  Influence of endocrille secretions 011 the structure and function of 1~-mphoid tissue. 
Harvey Lect. 43:43.  1948. 
75. Woodruff. RI. F. A.. Robson. J .  S.. Nolan. B.. Lambie. A. T..  I\-ilson. T. I . .  and Clark. J .  G.:  
Homotransplantation of kidne!- in patients treated by preoperative local radiation and post- 
operati\-e administration of an antimetabolite (Imuran). Lancet 2:673. 1963. 
Chapter Fourteen 
EARLY LIVER REJECTION IN PATIENTS 
WITHOUT HEPATIC GANGRENE 
In many of our patients it was impossible to define the features of rejection 
with any degree of certainty. This was particularly common at the beginning of 
the experience, but even later there were several instances in which it could 
not be determined to what extent immunologic repudiation of the homograft 
contributed to an early unfavorable outcome. The reason was that the abnor- 
malities in postoperative hepatic metabolism were predominantly reflections 
either of tissue injury inflicted during donor death and organ transfer or else of 
grave technical complications. If there was an added element of dysfunction 
due to homograft rejection, this could not be readily distinguished during the 
short survival periods. There were no recipients who had really poor initial 
graft function for nonimmunologic reasons who recovered and became 
available for long-term observation. Such patients have been considered in 
other portions of the book (Chapters Six. Eight and Nine). 
In this chapter only cases will be reviewed in which the presence of reason- 
ably satisfactory initial homograft function made it possible to ascribe subse- 
quent deterioration to an  immunologic etiology. The patterns of rejection were 
not dissimilar to those after orthotopic l i ler transplantation to modified dogs 
(Chapter Twelve) or untreated pigs (Chapter Eleven). The only special problem 
which had not been anticipated on the basis of previous animal experimenta- 
tion was regional hepatic necrosis. This complication will be considered 
separately in Chapter Fifteen. However. it will be suggested both now and in 
Chapter Fifteen that the incomplete control of rejection mas an important etio- 
logic factor in the development of the partial homograft gangrene. 
HYPERACUTE REJECTION 
Red Cell Group incompatibility 
There have not yet been any fully documented examples of the "rejections 
on the operating table" which have not infrequently led to the immediate loss 
277 
278 / EARLY LIVER REJECTION IN PATIENTS WITHOUT HEPATIC GANGRENE 
of renal homografts. With kidneys, this kind of disaster was first (although not 
invariably) seen1"." when donors and recipients had different ABO red cell 
groups in violation of the rules sho~vn in Table 1. Chapter Two. An effective 
blood flo\v was not restored when the vascular anastomoses were opened. Later 
the small vessels of the excised kidneys were found to be plugged with erythro- 
cytes, platelets. white cells, and fibrin. A rational explanation was available 
since the blood group substances which allow red cells to be typed are also found 
in other tissues including the kidneys."". Thus, if the kidney of an A or B donor 
were placed in a patient of 0 blood type. the naturally occurring anti-A and anti- 
B isoagglutinins. respectively. in the serum of the recipient might be expected 
to bind with the renal red cell antigens. Serologic studies by Wilson and Kirkpat- 
rick:':' provided evidence that this actually occurred. Subsequent authors have 
reached similar coi~clusions about the role of red cell isoagglutinins in precipi- 
tating accelerated rejections.'<. :j4 
Hepatocytes also contain erythrocyte antigens,"," for which reason it may 
well be equally dangerous to perform transplantation of this organ in the face 
of a red cell group incompatibility. It is unlikely that future liver transplanta- 
tions will be carried out under these circumstances in view of the information 
now available. However. it is of interest that before the adverse consequences 
of erythrocyte mismatches were fully appreciated, two such attempts were 
made, one by   moo re" and the other by Absolon.' The ABO incompatibilities 
were B to A and A to 0. respectively. The organs functioned for 13 and 11 days 
and at autopsy did not have any obvious distinguishing pathologic features 
suggestive of a hyperacute rejection. 
Red Cell Group Compatibility 
Hyperacute rejection of renal homografts has also been seen in the absence 
of red cell group incompatibility. The first case was described briefly by 
Terasaki2"nd many others were added later;". ''. '!'. : ' I .  :I2 they occurred usually 
in patients who had preformed lymphocytoxic antibodies. The sequence was 
typical. After the opening of the renal vessels, the kidney surface was not well 
perfused and became cyanotic. The consequence was complete or nearly com- 
plete cortical necrosis. Circumstantial evidence that the destruction was 
caused by preformed antibodies directly binding to the grafts has been pre- 
sented by several authors.", ''I. " V n  cther cases. the possibility has been 
raised that an inherently less violent antigen-antibody reaction in combination 
with depressed reticuloendothelial function of the recipient precipitated a gen- 
eralized Sh~vartzman-like reactionu that secondarily resulted in the plugging of 
the renal x-essels n-ith fibrin filtered by the kidney micro1-asculature from the 
perfusing blood. The analogy betn-een the consequences of such states of host 
presensitization and those of heterograft reactions will be discussed in Chapter 
Nineteen. 
Sooner or later it is almosc inevitable that hepatic hoinografts will be 
placed, by accident or lvith foreknon-ledge. into recipients xvith preformed an- 
tibodies induced by prior blood transfusion, pregnancy, previous homotrans- 
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plantation, or in other ways. Presumably an accelerated rejection of the liver 
IT-ould follo~v if these immunoglobulins had an avidity for the tissues of the 
transplanted organ. There is also the possibility. if an antigen-antibody reaction 
in the liver were capable of triggering a Sh~vartzman reaction. that the normal 
host kidneys could be damaged as innocent bystanders by virtue of their pro- 
pensity for clearing the products of generalized fibrinogen degradation. 
There is no proof that hyperacute rejection of a hepatic homograft has 
occurred in any case to date. However. Hume and Williams"' ha\ e told us of an 
experience that may represent an example. An infant with extrahepatic biliary 
.itresia was given an orthotopic homograft at the Medical College of Virginia 
under almost ideal circumstances of organ procurement. The new liver prompt- 
ly excreted bile. About 10 hours after completion of the operation, the abdo- 
men was re-explored because of evidence of hemorrhage. By this time the 
transplant had become mottled; the left lobe was now selectively indurated. A 
biopsy revealed widespread necrosis. In some of the portal veins there was 
margination of polymorphonuclear leukocytes similar to that found by the same 
authors in immediately rejecting kidneys." When the child died seven days 
later. the liver was almost completely necrotic even though its major vessels 
Fvere patent. Immunofluorescence studies disclosed no significant immunoglo- 
bulin deposition in the graft. However, eluates of the autopsy specimen 
caused lysis of the cultured renal cells of the original donor: the same effect 
was also produced by the serum collected preoperatively from the recipient. At 
no time during life could lymphocytotoxic antibodies be detected in  the serum 
by the Terasaki method. , , 
ACUTE REJECTION (FIRST TWO MONTHS) 
The variety of rejection which has been compared to the cell-mediated 
delayed type hypersensitivity response has been more or less clearly identifi- 
able in all the patients who received orthotopic hepatic homografts at our insti- 
tutions and who survived for more than a month:';-?' 'h the same has been true 
in other centers.' " In our own patients the criteria upon which the diagno- 
sis was made lvere highly variable and subject to the reviem of a large number 
of facts on a day-to-day basis. These included the results of multiple liver func- 
tion and hematologic tests. measures of abdominal girth and body weight, and 
serial liver scans. to mention only a f e n .  Judgments about the presence or ab- 
sence of rejection or the need to adjust therap! mere never made on the basis 
of limited obserl ations. Instead. an attempt was made to develop a panoramic 
~ i e w  of the whole course. This n-as best done with the use of large nall  charts 
which were brought completely up to date each e\  ening before rounds. 
As experience \vas accumulated, it became ev~dent  hat there \\ere several 
distinctive clinical syndromes of early rejection which could be expected. 
These have been used as the basis for the following classification of eight 
orthotopic homotransplantations performed prior to October 26. 1968. in seven 
patients. In each instance the postoperatlr e course began satisfactoril> enough 
280 / EARLY LIVER REJECTION IN PATIENTS WITHOUT HEPATIC GANGRENE 
to permit the meaningful analysis of subsequent events. All the recipients were 
treated with the triple drug regimen of azathioprine, prednisone, and ALG. 
Subclinical Rejection 
Only tn70 of the patients (OT 13 and 23) failed to manifest an unequivocal 
rejection during the first two postoperative months. The recipients, who were 
two and 16 years old at the time of their transplantations, had no overt symp- 
toms and no depression of appetite. Nevertheless, there were sound reasons to 
suspect that they passed through very mild rejection episodes, beginning in the 
fourth (OT 13) and second (OT 23) postoperative weeks. 
Physical Signs. The most objective evidence was swelling of the 
homografts. The enlarged livers were firm, had well defined inferior edges, and 
were nontender. The degree of hepatomegaly could conveniently be quantitated 
with serial scans (Figs. 122 and 123) using """-technetium.' This isotope. which 
is picked up by the reticuloendothelial portion of the graft, had a special advan- 
tage after liver transplantation. Since its physical half-life is only six hours, the 
background activity of the isotope was gone by the time of each succeeding 
examination even if this was performed on the same day. Moreover, the calcu- 
lated irradiation dose to the liver mas only about one rad. no more than that 
delivered during performance of an intravenous pyelogram. The homografts of 
patients with early subclinical rejection had an essentially normal intensity of 
isotope concentration (Figs. 122 and 123). 
Although jaundice did not develop. the stools of the recipients intermittent- 
ly became light colored and the urine dark. These changes were fleeting, 
coming and going within a few hours or in the course of a day. Temperatures 
remained relatively normal. The patients were discharged from the hospital 
after 14 and five iveeks, respectively. 
Laboratory Studies. Major secondary rises in the serum bilirubin were not 
observed. However. there were ~~ariat ions in the serum transaminases and the 
alkaline phosphatase (Figs. 124 and 125). Other measures of liver function 
were generally not altered. These included the total serum proteins and the 
albumin fraction (Figs. 124 and 125) as well as the liver-based clotting factors I 
(fibrinogen), I1 (prothrombin). 1' (accelerator globulin). VII (procon~ ertin), IX 
(Christmas), and X (Stuart). The gamma globulin tended to remain at normal 
levels. 
Treatment. hlajor adjustments were not made in the doses of azathioprine 
and ALG. The quantities of prednisone. which were already being reduced, 
were slo~vly dropped e\  en more despite the fact that an anicteric rejection was 
thought to be el  olx ing. The rationale of this approach will be returned to later 
in discussing the treatment of more seT ere problems of graft repudiation. Other 
aspects of general care have been described in Chapter Nine. 
Reversibility. The various changes described above gradually returned to- 
ward. although not necessarily completely to. the pre-rejection state. Even- 
tually the liver size decreased (Figs. 122 and 123). The abnormalities in hepatic 
function. which were mainly detectable in the enzyme determinations, slowly 
improved (Figs. 124 and 125). 
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3 days 
F1qui.e 122.  X~~te ropos t e r io r  li\-er scans  perforlned 11 it11 " ' : - t echne t iu~n  in orrhorol~ic recipient OT 
13. The  t imes after operation are  sllo~r-11. sore the  marked liepaton~eqal!- dur ing the  third to fifth 
postoperatil-e TI-eeks at  the  t ime of an a~l ic ter ic  rejection: isotope concentra t ine  ahilit> rvas not 
perceptibly altered.  Compare n-ith Figure 121  and note that  511-elling of t he  organ occurred coin- 
cident \!-ith rises i n  the  s e rum e n z ~ - m e s .  \ Iuch later in the  course jaundice de\-eloped. .It that  t ime 
the lil-er scan did nor shon- l i epa to lneqa l~ .  as  exenlplified b!- the  11 m o n t l ~  examination.  
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3 days 
F i g u r e  123. See facing page for legend. 
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Figure  123. Anteroposterior and lateral lix-er scans in patient OT 23. usinq """-technetium. The 
patient. whose diagnosis was hepatoma. was 15 >-ears old. He receix-ed the lixer of a six year old 
cadaveric donor. The el-idence for rejection is shoxvn graphicall>- in Figure 123, beginning about 
one week after operation. Kote the remarkable liver sn-elling ~vhich  occurred at this time and 
which lasted for more than t11-o subsequellt weeks. By 68 days the a~lteroposterior vie\\- appeared to 
ha\-e returned to about the sallle dimensions as  had been present shortlJ- after operation. However, 
the lateral vie\\. showed that the 1i1-er mass Ivas increased: lix-el. function was then colnpletely 
normal. Note that the pickup of the isotope remained llomoge~leous t h r o u ~ h o u t  the period of 
observation. except possiblJ- at 31 days. 3Iore scans of' this patient taken at the time of' in\-asion of 
the homograft by recurrent tumor are shown in Chapter Sebenteen. 
Long-term Prognosis. Avoidance of a florid rejection crisis during the early 
course did not assure stable long-term hepatic function. This aspect of the 
problem is going to be considered in Chapter Seventeen. Here it will be noted 
only that both the patients who passed through an anicteric early rejection 
became jaundiced several months later, although the delayed deterioration in 
one case was due to invasion of the homograft by recurrent carcinoma. 
Rejection Crisis 
There were three recipients (OT 15, 17, and 19) who passed through rejec- 
tions which evolved so suddenly that they have been termed "crises." The 
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Figure 124. Example of subclinical rejection (OT 13). The indication for operation Jras extra- 
hepatic biliary atresia. The bilirubin fell almost imnlediately from more than 30 mg per cent to less 
than 5 mg per cent.  There \\-as no recurrence of the jaundice in the interl-a1 sho~vn .  Holvex-er. there 
were rises in the alkaline phosphatase. SGOT, and SGPT fro111 the third to the se\-enth postoperative 
- - -  
weeks. Antibiotic therapy xras stopped after four 11-eeks. The teinperatures sho\rn are the 
maxilnulns for each da>-. Sex era1 months later a dela!ed rejection dex-eloped: the late course of the 
child is graphicall). depicted in  Figure 176, Cl~aprer  Set-enteen. ,B J permissioi~ of Ann. Surg. 1 6 8 :  
392, 1968.) 
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F i g u r e  125. The first tu-o post-transplantation months of a 15 year old boy (OT 23) with hepatoma 
who received a n  orthotopic liver from a six year old donor. An overt rejection was not diagnosed 
during this time. Nevertheless. there was evidence of a subclinical rejection beginning on day 
seven. See text for discussion. The febrile episodes at  the end of the fourth week were probably 
related to the administration of influenza 1-accine. 
onset came six, six. and 29 days after operation. The process developed with 
extreme abruptness. reached a peak within a day or two, and then receded with 
surprising rapidity. Two of the three patients (OT 15 and 17) became acutely ill. 
The recipients were aged 42, 23. and four years. All three, especially the 
two older ones, complained of pain in the center of the back which occurred 
intermittently. sometimes extended to the right flank or right upper quadrant, 
and was relieved by mild analgesics. Extreme fatiguability and anorexia were 
prominent complaints but there was no loss of mental acuity. 
This was the most explosil e kind of rejection observed in our experience 
and in two of the patients it could be described as violent. However. even in 
this very acute form, rejection did not precipitate anything resembling an 
anhepatic state: there lvere, for example. no recognized bouts of hypoglycemia. 
This was fortuliate since there are no effective techniques available for liver 
support during a protracted functionless interval a~lalogous to those which can 
tide over temporarily anuric recipients of renal homografts. 
Physical Signs. At first glance. tivo of these three patients looked like vic- 
tims of fulminating viral hepatitis. There was an increase in the size and con- 
sistency of the transplanted organs. Paradoxically, however. this was not nearly 
so prominent a finding as with the milder rejection described earlier. Aloreover. 
the liver scans did not permit as precise delineation of the dimensional anato- 
my since there was a loss of the ability to concentrate isotope in two of the 
three patients. Other important observations were made from the scans which 
will be returned to later. 
With the onset of the crisis. the stools immediately became white and the 
urine dark colored. The rapidity with which visible jaundice developed and 
deepened was surprising. but the visual impression was in conformity with 
concomitant chemical determinations. Liver percussion caused a very poorly 
localized abdominal pain. 
Two of the patients had high fevers. It is well known that hyperpyrexia is a 
characteristic sign of renal transplant rejection in patients being treated with 
azathioprine alone, but that the fever can be prevented if heavy doses of pred- 
nisone are given conco~nitantly."~ Steroids also blunt the febrile response often 
seen after the administration of heterologous ALG (Chapter Thirteen). Pred- 
nisone had been given from the beginning in large quantities to all three of the 
recipients who underwent acutely evolving rejection crises: consequently. tem- 
perature elevations which developed during these episodes of apparent immu- 
nologic repudiation were construed as infectious in etiology. The point of view 
will be developed later that at least some of the fevers may have been caused by 
bacterial invasion of the besieged and vulnerable homografts. 
The two patients with the most severe crises had moderate fluid retention. 
Coincident with a weight gain of 3 to 6 kg. they could be seen to have slight 
periorbital and dependent edema: at the same time. x-rays of the abdomen were 
interpreted as showing fluid between the intestinal loops. Associated with 
these findings was a fall in urinary sodium concentration to below 20 
mEqlliter. 
Laboratory Studies. The most striking feature in this group of patients was 
the suddenness with which hepatic malfunction developed. The details ~ ~ a r i e d ,  
but in all the serum bilirubin concentration rose from essentially normal to 
relatively high levels (6. 14, and 18 mg per cent) within a 24- to 48-hour period 
(Figs. 126. 127 and 128). About half the bilirubin was in the conjugated form. 
Associated with, or slightly preceding, the icterus were increases in the alkaline 
phosphatase. 
The changes in the serum transaminases were of special interest in view of 
the findings in the liver scans to be described later. Both the SGOT and SGPT 
rose. although not to alarming levels in patients OT 13 and OT 19 (Figs. 127 
and 128). However. there was good reason to suspect massive hepatic necrosis 
in the third recipient (OT 17): her SGOT and SGPT (Fig. 126) Ivere recorded at 
peaks of 2600 and 3200 Interllational Units (normal 9 to 43 and 3 to 33. respec- 
tively). A lil-er scan was obtained at this time. 
There was a reduced uptake of """-technetium in her swollen transplant 
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Figure  126. The course of a patient (OT 17) \rho underwent a violent rejection crisis after ortho- 
topic liver transplantation. The first abdominal re-exploration (arrolv) \vas for the control of 
bleeding. Even before the onset of jaundice. her course was markedly febrile. Note the drastic 
depression of prothrombin time on postoperatix-e days 10 through 13. Recox-ery from the rejection 
crisis was prompt. but the patient died of Pseudomollas pneu~nonia fter 33 days. The radiographic 
changes in the lung \rere first thought to be the consequence of pulmonary emboli: consequently 
intravellous heparin therap!- Ivas started. This resulted in intra-abdominal hemorrhage. necessi- 
tating the second Idparotom!- ~arroxr-). The alkaline phosphatase \ d u e s  are in Besse!--Lo~\-rj- units 
(normal 1 to 3 ) .  h-ormais for the SGOT and SGPT are less than 30 units. 
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Figure 127. The postoperative events in patient OT 15. A n  explosive rejection began on the sixth 
da?-, reached a peak within two days and receded promptly. Gram n e g a t i ~ ~ e  bacteren~ia was diag- 
nosed from a blood specimen obtained on post-transplantation day 14. The liver scans indicated 
by the letters A to F a r e  shown in Figure 130. Note that the immunosuppressive therapy was actually 
lightened with the development and evolution of the rejection episode. 
A LG 
which it was feared had undergone irreparable injury (Fig. 129. left); the distri- 
bution of the isotope was relatively homogeneous. The magnitude of the im- 
pairment of the hepatic reticuloendothelial function was demonstrated by the 
large fraction of the technetium which was located in extrahepatic sites (Fig. 
129. top, left). Within a few days the situation improved and the homograft was 
able to carry out this function far more completely (Fig. 129, top, right). By  three 
weeks the organ swelling had markedly subsided (Fig. 129, bottom, right). 
Even more alarming changes were seen in the liver scans in one of the 
patients (OT 15) whose serum transaminases had not risen to such extreme 
levels (Fig. 127). Coincident with the onset of the severe rejection crisis there 
was palpable hepatomegaly. Ho\ve\-er. the homograft actually appeared smaller 
on the scan, presumably because of its generally reduced uptake (Fig. 130B). 
Moreover. there seemed to be a regional loss of isotope concentration affecting 
mainly the left hepatic lobe (Fig. 130B): on lateral l i e n  a n-edge of the dome of 
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Figure 128. A four year old child (OT 19) with intrahepatic biliary atresia who lvas treated with 
orthotopic liver transplantation. X ver? transient rejection occurred after one month. This under- 
nen t  almost immediate and complete remission. A late rejection xvhich began on postoperative day 
72 lvas also easily controlled. Note the change in time scale after four m o n t h s . j ~ h e  patient still has 
perfect lix-er function after 10 months. He is still receiving XLG. The norma1 enzyme values in  
international units a t  this age are: alkaline phosphatase, 57 to 151; SGOT 3 to 27: and SGPT, 2 to 
3 0 . 2  
the liver was not visualized (Fig. 131, left). One day later a more normal scan 
was obtained (Fig. 130C). 
During the next several days most of the liver functions improved. On the 
morning of the fifteenth postoperative day the patient's temperature rose 
sharply coincident with the appearance of E.  coli in a peripheral blood culture. 
At the same time, a liver scan (Fig. 1300)  showed only a fraction of the trans- 
plant. Again. nearl? the full dimensions of the organ had been restored by the 
time of the succeeding examination (Figs. 130E and 131. right) a short time 
later. 
Probably serial l i ~ e r  scanning in such cases provided a crude means of 
obtaining the sort of information that has been sought in dogs with more direct 
techniques. Groth' showed striking reductions in hepatic blood flo\v at the time 
of canine liver rejection (Chapters Eleven and Tnelve). It is not difficult to 
conclude that the same kinds of flon- changes. with remissions and exacerba- 
tions, were present in the clinical cases to account for the bizarre and volatile 
abnormalities of the liver shadoxvs as viewed by scanography. 
The concept that drastic reductions in hepatic blood flon were responsible 
for the "disappearing liver" are consonant with the other findings at about the 
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F i q z ~ r e  129. !""'-Technetium scans of the 
liver in a patient (OT 17) at the peak of and 
just after a n  explosive rejection crisis. The ra- 
diographic findings should be correlated with 
the clinical course shown in Figure 126. Six 
days post0peratiL.e: The poor function of the 
slvollen homograft is evident from the heavy 
concentration of the isotope outside the liver. 
14 days postoperati\-e: Hepatomegaly persists. 
but now the lix-er has captured most of the 
technetium. 21 days postoperative: The 
swelling is beginning to recede. 
same time, including the biochemical measures in the serum suggesting hepa- 
tocyte necrosis. The invasion of the ischemic homograft by microorganisms 
from the adjacent intestinal tract under these circumstances would not be 
surprising. This was apparently the pathogenesis of the gram negative septice- 
mia (Fig. 127). 
Other determinations of hepatic function were also often affected by im- 
munologic repudiation of the homograft. but not with such consistency as 
those already described. In the most mild example of abrupt rejection (OT 19) 
there were no changes at all in the collcentration of the total or fractional 
serum proteins (Fig. 128) or in the prothrombin times. The plcture n a s  not 
really distinguisliable from that of a 1-ery transient intra- or extrahepatic biliary 
obstruction. It was in this patient that serial liver scans did not reveal any 
striking change in the homograft size. 
In contrast. the young xvoman iOT 17) with the most sel-ere rejection crisis 
manifested deterioration of ex er? lix er fuliction that \vas measured. Her total 
serum protein and albumin concentrations began to fall ~vithin a fen days (Fig. 
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Figz1i.e 130. ,\nteroposterior lix-er scans attained ~ v i t h  ""-technetium in patient OT 13. S o t e  the  
temporary disappearance of' portions of the  homograft 011 the eiqlith and  fifteenth postoperative 
days: the  first of these occasions !\-as at the  beginning of all explosive rejection crisis. .At the  t ime 
of the 13-da>- scan. the  patient had de\-eloped gram neqati! e septicemia. presumably fro111 a hepatic 
focus. The remittent changes in  the 1i1-er scans !!-ere thouu l~ t  to be due to ~ a r i a t i o n s  in  hepatic 
blood f l o ~ r  durinq the  rejection crisis. The patient recol-ered completel! from these episodes and 
!!-as discharged fro111 the hospital 63 days postoperati!-el!. Correlate the scans with the clinical 
el ents sho!~-n in Figure 1.27. 
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8 days 1 23 days I 
A B 
Fzguie  131 Lateral scans obtained at  the same tlmes as the studles shomn In Flgures 130B and E 
at elght and 23 daxs postoperatlr el\ in patlent OT 15 A Note the wedge of absent Isotope plck-up 
at the dome of the l i ~ e i  B This area 1s nom nel l  seen 13 d a ~ s  late1 although a small defect 
perslsts 
126). There were life-threatening changes in the clotting factors. For example, 
the prothrombin times were prolonged to 45 to 75 seconds (control 13 seconds); 
expressed in percentages, these values were essentially zero for almost a week 
(Fig. 126). At the same time the plasma fibrinogen (Factor I) fell to a low of 146 
mg per cent. 
The other patient (OT 15) was between these extremes. Although there 
were temporary declines in the serum protein concentrations, the predominant 
findings were those of obstructive jaundice. The prothrombin times were not 
affected. 
All three patients had a leukocytosis at  the time of the rejection episodes 
with maximum total white blood cell counts of 18.000 (OT 15). 39.000 (OT 17), 
and 19,000 cu mm (OT 19). The preponderance of the increased numbers of 
cells was of the unsegmented polymorphonuclear variety. Thrombocytopenia 
was common before, during, and after rejection but did not seem to be made 
worse by this process: the multiple factors contributing to platelet depression 
were discussed in Chapter Thirteen. Acute anemia of the kind that might have 
been caused by accelerated hemolpsis (see Chapter Twelve) was not observed. 
During the immuilologic crises. none of the patients developed hemorrhage or 
other evidence of the gastrointestinal ulcerations that have often been seen at 
comparable times in animal experiments. 
Treatment. The general care of the patients was along the guidelines 
described in Chapter Nine. with emphasis on the provision of a strict antacid 
diet, sitamin supplementation (especially K), and bronchopulmonarp care. 
Fluid intake was restricted if edema became detectable or in the event of exces- 
sive weight gain; \>ith amelioration of the crises, there was a brisk diuresis. 
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Because of the evidence that the transplanted organs were in danger of being 
invaded by intestinal bacteria, or that this had already happened in one case 
(OT 15). intensive antibiotic treatment was maintained either continuously or 
intermittently (Fig. 127) throughout the rejection episodes and for some time 
afterward. This important subject is covered in Chapters Fifteen and Sixteen. 
In the two patients in whom the rejections mere the most severe. signi- 
ficant changes were not made in the schedules of azathioprine. ALG, and pred- 
nisone that were in effect at the time the process began and, in fact. the steroid 
doses which were already being attenuated were further cut (Figs. 126 and 
127). The third patient (OT 19) was kept on the pre-existing daily quantities of 
prednisone (Fig. 128). 
This approach during episodes of hepatic rejection was different from that 
which is standard practice in our institution after renal transplantation. When 
renal homografts undergo deterioration, steroid doses are invariably increased 
and maintained at whatever levels are necessary to restore good kidney func- 
tion. With the liver. the assumption was made that return of hepatic function 
would occur without such heroic measures. Whether this was an  appropriate 
policy is a matter that has still not been completely settled. However. there 
were specific reasons for the decision to follow7 a conservative approach with 
immunosuppression. 
The expectation that the reversal of hepatic rejection would be less depen- 
dent on the intensification of treatment than is the case with the kidneys was 
based on the results of the animal investigations described in Chapters Eleven 
and Twelve. It will be recalled that hepatic rejection in dogs and pigs often 
underwent spontaneous resolution without any change in therapy or in some 
animals in the absence of any therapy at all. The explanation for these events 
has been of great interest to investigators of transplantation immunology and 
was speculated upon earlier (Chapter Tm elve). 
The prospect of achieving the same result in humans wras especially ap- 
pealing because of the overwhelming infectious complications which 
developed in all the unsuccessfully treated liver recipients in our initial ex- 
perience (see Chapters Thirteen and Sixteen). The high dose immunosuppres- 
sive therapy in these first cases had seemed to be incompatible with survival. 
The experimental observations alluded to previously had raised the possibility 
that such stringent treatment might not actually have been necessary to 
achieve continued graft viability. 
Reversibility. The point of view just mentioned received support from the 
prompt improvement of these three patients. Liver function began to return 
rapidly toward normal (Figs. 126-128). The recipient (OT 17) whose trans- 
planted organ had suffered the most violent assault made an amazingly quick 
recovery and she began to leave the hospital for most of each day by the end of 
the third aveek. Unfortunately she d e ~  eloped se\ era1 infectious complications 
including a monilial granuloma in the left subphrenic space which hemor- 
rhaged and necessitated laparotomy for control. She dled 35 days postopera- 
tls ely of pneumonitis caused by Pseudomonas. The other tlso recipients (OT 15 
and OT 19) had a 1 ery benign subsequent course and n ere discharged in excel- 
lent condition fil-e and four weeks after their transplantation. By  this time, 
294 1 EARLY LIVER REJECTION IN PATIENTS WITHOUT HEPATIC GANGRENE 
measurements of their hepatic function were at least as normal as in the pa- 
tients whose homografts had passed through the much milder anicteric rejec- 
tions. With the impro~ement  in liser function, the abdominal and back pain 
ceased. Li\ er size became stable both by palpation and by scanography. 
It was established from these observations that complete reversal of hepat- 
ic homograft rejection could occur without increasing the level of the pre- 
existing immunosuppression. Holve~ er, it might have been safer to have been 
more aggressive. particularly with the use of prednisone. In the group of pa- 
tients to be described in the next chapter it is almost certain that efforts to keep 
the steroid doses as small as possible contributed to eventual devitalization of 
large areas of the homografts. Even in the recipients of the group now under 
discussion. one of the patients (OT 17) nearly underwent total destruction of 
the transplant and another iOT 15) apparently came perilously close to 
developing large areas of focal necrosis. 
Long-term Prognosis. An early rejection crisis, e \en  a very severe one, did 
not have adverse implications for long-term survival. The two patients who 
returned to their homes enjoyed long periods of good health. Their later courses 
will be described in Chapter Seventeen. One of these recipients had a very 
minor late rejection in the third postoperative month. The other survived for 
almost a year until he died of metastases from his original hepatoma. 
Indolent Reiection 
A third variety of rejection, having certain features of both the kinds already 
described, proved to be the most difficult of all to treat. The process now to be 
discussed affected three homografts in two patients. In one of the recipients 
the first transplant eventually had to be removed and replaced with another 
graft. The immunologic attack on the second organ was similar to, but less 
severe than. that which had destroyed the first. 
The two recipients were 16 (OT 14) and two (OT 16) years old. The rejec- 
tions began on the sixth. 13th, and 32nd post-transplantation days, and 
developed in a disarminqly slo~z way that required from four to seven weeks to 
reach a peak. On no occasion did the patients seem ill, at least at the outset. 
They became icteric but had good appetites and were physically active. Even- 
tually the older child complained of a dull but very annoying paill in the back 
which persisted in spite of treatment with analgesics. 
Physical Signs. With the onset of jaundice, the stools became progressively 
whiter and the urine darker in color. At the same time there mas gradually 
developing palpable hepatomegaly (Figs. 132 and 133). Eventually the liver 
Figzl1.e 132. Lix-er scans  ~ v i t h  "" '  -technetiuin of a patient !OT 14) I{-ho dex-eloped a n  indolent re- 
jection that could riel-er be completely re\-ersed. 4 da>-s: The isotope is not very xrell concentrated. 
Hoxvex-er. there was  no el-idence of rejection. 9 da>-s: IVith the onset of a n  indolent rejection there 
was  no striking chanee  ill lil-er size. 16 da>-s: The rejection persisted. Definite s\velling of the homo- 
graft  is noxi- obi-ious. especially on the  lateral 1-ielx-. 10 \!-eeks: The dil~lellsions of the transplant had 
nearly returned to those first obserx-ed. Subsequentl!- the  patient d e ~  eloped a I erJ- chronic late re- 
jection and .  ex-entunll!-. str ikin? shrinkage of the transplanted organ became e\-ident :Fig. 182. 
Chapter S~I -en teen ; .  
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Flgzli e 132 See opposlte page for  legend. 
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Figure  133. Liver scans performed with "'"-technetium after the first orthotopic lix-er transplan- 
tation in  patient OT 16. 8 da?-s: In  this patient the first scan was obtained on the day after operation 
(Fig. 7. Chapter Five). By eight da:-s organ swelling had already started. but the isotope concentration 
was essentially normal. 44 days: The marked hepatomegal? and the reduced concentration of isotope 
are evident. 68 days: The liver appears smaller than at 4 3  days. In  actuality it \\-as probably even 
larger since, n-hen it was remol.ed later the same da?-. it weighed 880 gm. Note the large patches of 
radio1ucenc:- in the left lobe. .it the time of homograft excision these areas as well as the right por- 
tion of the liver contained lnultiple small infarcts (Fig. 138). For s e ~ ~ e r a l  n-eeks before the retrans- 
plantation the child had almost continuous high fever. 
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became at least as pronounced as in the patients with subclinical 
or explosive rejections. The swelling could be only incompletely documented 
on the liver scans in one case (OT 16A) since eventually there was a loss of 
isotope concentration. Shown in Figure 133 is the changing appearance of the 
first homograft in this patient. The last examination at 68 days was obtained 
shortly before the organ was excised and replaced. The size of the radiographic 
shadow looked very much smaller than the surgical specimen proved to be at 
the time of its removal. There were other abnormalities on the scans which will 
be discussed later. 
This child, who received two homografts. had extensive venous collaterals 
on the surface of the abdomen and lower chest prior to both transplantations. 
After each procedure the abnormal vascular pattern disappeared transiently 
only to return with the onset and persistence of rejection. The infant also had 
intermittent mild generalized edema. Neither he nor the other patient (OT 14) 
e\.er developed detectable ascites. 
Hyperpyrexia was not a prominent early feature of the indolent rejections. 
The temperature of the older patient (OT 14) remained normal as the icterus 
deepened. The infant (OT 16) had intermittent low grade fevers for several 
weeks after the first homotransplantation. However, he then became toxic and 
almost continuously febrile just before the removal of the organ. There was 
prompt defervescence with receipt of the second homograft, followed later by a 
return of a low grade fever. 
laboratory Studies. When the syndrome of indolent rejection was first ob- 
served, it was assumed that the process would be relatively self-limited. There 
mere two reasons for this: first? the patients did not immediately become ill; 
second. the degree of deterioration in liver function occurred gradually. Ini- 
tially the abnormalities were mainly those which are commonly found with 
incomplete biliary tract obstruction. The serum bilirubin. which rose slowly 
and irregularly over a period of many days, had an exceptionally high glucuron- 
ide fraction which was almost invariably 75 per cent of the total (Figs. 134 
and 135). Paral le l i~g the insidiously deepening icterus were rises in the 
alkaline phosphatase (Figs. 134 and 135). 
There was no reason to suspect massive. or even moderate, hepatic necrosis 
from the transaminase determinations. The SGOT and SGPT were transiently 
elevated immediately after operation. presumably due to ischemic injury. They 
did not rise again to extreme levels as the jaundice progressed. The greatest 
abnormalities were in case OT 14 (Fig. 134) in which there was a dissociation 
between the SGOT's which underwent very minimal changes and the SGPT's 
~vhich rose to a maximum of 700 International Units (normal 5 to 35). The 
child who received two homografts did not have early increases in either kind 
of transaminase to much more than 200 International Units. 
An additional paradox was noted in that the complex functions of synthesis 
!$-ere exceptionally well preserved for long periods. For example, the patient 
tvho required eventual retransplantation had improving total serum protein 
concentrations for many weeks as his condition deteriorated (Fig. 135). He 
maintained a prothrombin time of greater than 80 per cent until the day the 
extensively damaged transplant +%-as removed. The only- severe hypoproteine- 
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Figure  134. The early course of a 16 >-ear old girl (OT 14) !rho received orthotopic transplantation 
for the treatment of a hepatoma. She developed an indolent rejection which lasted for almost two 
months before remission n-as obtained. S o t e  the hypoprotei~lemia that appeared several weeks 
after rejection had started. 
mia within the first six weeks was in  the 16 year old girl. Her serum protein 
concentration fell below 5 gm per cent one month after transplantation, three 
weeks after the onset of the rejection. There were no striking early changes in 
gamma globulin although this fraction increased to 2 gm per cent in one pa- 
tient after about tsvo months (Fig. 134). 
The hematologic changes were generally similar to those in the patients 
described earlier who had explosive rejections. The child who received two 
livers had a leukocytosis on both occasions. However. the teen-age girl had 
virtually no white cell response. Thrombocytopenia avas seen in both cases but 
not in particular relationship to the rejections. Anemia did not des elop. 
Treatment. Antibiotic therapy svas maintained for a longer time than usual 
because of the fear that focal hepatic necrosis might occur n i th  the protracted 
rejections. As ~vill  be described later, focal infarcts did in fact develop in the 
homograft that was eventually removed. 
The other aspects of general care were no different than those described 
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Figul-e 135.  A slo.ivly de~~elop ing  rejection in patient OT 16 \rhich led to the destruction of the 
homograft. The patient xi-as a txvo year old child n-ith extrahepatic biliary arresia. I t  n-as necessary 
to stop horse ALG after 18 da?-s because of' local reactions at the injection sites. The progressive 
jaundice then developed. Other measures of lil-er function Irere ~vel l  maintained for man)- rveeks. 
Howel-er, the child then becarne febrile and extremely ill. Dese~lsitization n-as attempted with the 
hope of resuming horse ALG treatment. but it lvas e\ entually abandoned. the hypergammaglo- 
bulinemia ton-ard the end of' the second postoperative month. 
earlier. However, the details n7ere extremely complicated in case OT 16 after 
the second transplantation. Most of the problems resulted from the transfer of a 
liver from a seven year old donor to the two year old recipient. After operation 
the consequent abdominal overcrowding made it difficult for the recipient to 
breathe and almost impossible for him to eat for seleral postoperative weeks. 
The situation was also later aggravated by the swelling of the homograft that 
occurred with onset of a rejection which fortunately was delayed for a month. 
Eventually the child was able to resume a full diet. Thereafter anorexia was 
never a significant problem. On the contrary it was later necessary to prescribe 
a diet in order to prevent serious obesity. The same restrictions of caloric intake 
were imposed on the older recipient as n ell. 
The older of the t n o  patients receiled triple drug immunosuppressive 
therapy for more than two months. ALG was finally stopped after 73 days 
because of a suspected anaphylactic reaction. The daily doses of all three 
agents are shon-n graphically in Figure 134. It should be noted that the quanti- 
ties of azathioprine that could be glren to her nithout causing leukopenia were 
very small. averaging less than 0.3 ing kg day. On the other hand. steroid doses 
were kept at  levels which habe been shorn-n from past experience in renal 
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transplant patients to be dangerous (see Chapter Thirteen). Even after two 
months she was still receiving daily doses of 50 mg day. 
A highly significant deviation from the aforementioned regimen was 
required in the infant who received two livers. It was necessary to discontinue 
the horse ALG after 18 days because of severe reactions at the injection sites. It 
was almost immediately after this that the indolent rejection began its inexo- 
rable course. An attempt at desensitization (Chapter Thirteen) was made but 
ultimately abandoned. 
When retransplantation was undertaken, ALG raised in another species was 
not yet available. Almost three weeks after the second operation a course of 
rabbit ALG was started and continued for the next six and a half weeks. A final 
switch was then made to goat ALG for three and a half months. Eventually 
therapy with immune globulin had to be discontinued because of the suffering 
that attended every injection. 
It was necessary to maintain very high doses of steroids after the first 
transplantation. probably because of the inability to continue ALG. Following 
the second operation, the quantities of prednisone were cut more quickly. As 
soon as a maintenance schedule of 5 to 10 mg'day had been established. inter- 
mittent single boosters of 100 mg were given intravenously every fibe to 20 
days. In this patient as in OT 14, it was never possible to consistently exceed an 
azathioprine dose of more than 0.5 mglkglday without causing leukopenia. 
Reversibility. In the final analysis, the fate of these patients became depen- 
dent upon reversal of an immunologic disease in which the inability to affect 
bile drainage seemed eventually to contribute to a slow later deterioration of all 
other facets of hepatic function. It was well known from histopathologic 
studies of homografts in animal experiments that the cause of the obstructive 
jaundice was apt to be found within the lobules of the liver (Chapter Twenty). 
Nevertheless. efforts were made in the clinical cases to prove the patency of 
the extrahepatic ducts. Operative cholangiography was finally resorted to 
(Chapter Seventeen) in one of the patients (OT 14). In both recipients. nonop- 
erative diagnostic tests were obtained. 
It was possible to visualize the cholecystoduodenostomies with gastro- 
duodenal x-rays after a barium meal. The dye passed through the anastomosis 
and more or less completely outlined the gallbladder (Figs. 136A and B).  It did 
not regurgitate into the common duct, but from time to time air could be de- 
tected in the major or minor radicles (Figs. 136B and C). The only conclusion 
that was possible was that the distal segment of the reconstructed biliary tract 
was open. Intravenous cholangiography was also attempted. Good visualization 
was not obtained because of poor dye concentration in these jaundiced patients. 
The use of "'I-rose bengal l i ~ e r  scanningi yielded equally indecisive 
results. This isotope is processed by hepatocytes and. except for a normally 
minor extrahepatic "leak." is excreted through the minor and major biliary duct 
radicles into the small bon el. It has been reported4 "' that high grade intra- 
hepatic retention of the isotope is a diagnostic sign of biliary obstruction. The 
scans obtained with this method revealed prolonged trapping of the isotope in 
the homografts (Fig. 137). but it could not be determined whether the site of 
the block was intra- or extrahepatic. 
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F i q n  re 136.  Radiographic evidence of extra- 
hepatic biliary patent).. A. An upper gastro- 
intestinal examination performed 69 days 
after operation. Bariuni has  refluxed through 
the cholec5-stoduodenostomy and  has  partially 
filled the  gallbladder. the  remainder of which 
is faintly visible a s  a radiolucent gas shadow. 
B.  Later in the  same series the  biliary tract 
1vas visualized in  a double contrast study. The  
wall of the  gallbladder has  been coated with 
contrast medium.  The cystic duct and the left 
and  right hepatic ducts appear a s  gas-filled ra- 
diolucencies. GR = gallbladder: CD = c!-stic 
duct:  RHD = right hepatic duct :  LHD = left 
hepatic duct.  C. In  a routine intral-enous 
p!-elogram obtailied 88 days post-transplanta- 
tion air is seen 11-ithin the  gallbladder (GB) 
which 01 erlies the  right t11-elfth rib. The  radio- 
lucencies ol-er the elel-enth rib and in  the  
tenth interspace 11-ere interpreted a s  air within 
the biliarl- radicles :arrows). 
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A B 
Figz i re  137. A ]."I-rose bengal scan in a patient whose liver homograft underwent a n  indolent 
but inexorable rejection. eventually necessitating retransplantation (OT 16). A .  Five minutes fol- 
1017-ing intravenous injection of the isotope. The examination was performed 38 days after orthoto- 
pic transplantation. The liver concentrates the rose bengal xrell. B. Fix-e hours after the rose bengal 
injection. l l u c h  of the isotope is still entrapped in the homograft and ver!- little is detectable in  the 
intestine. The delayed scan xvas performed in a n  effort to prove the patency of the extrahepatic 
biliary tract. 
It nras eventually concluded that a very persistent and relatively nonrever- 
sible form of rejection was responsible for the jaundice. Remission was 
achieved in only one instance (OT 14) and then only incompletely. In this case, 
the icterus persisted somewhat variably for almost two months before it signi- 
ficantly lightened (Fig. 134). During all this time the SGPT and alkaline phos- 
phatase remained slightly elevated even though the SGOT was usually essen- 
tially normal. The SGPT and alkaline phosphatase levels began to fall slowly 
several weeks before the alleviation of the hyperbilirubineinia. 
As the weeks went by. the patient gradually developed muscle weakness 
which was attributed to the continuing high dose steroid therapy. Otherwise, 
she did not seem to be particularly ill. \\'hen the indolent rejection very slowly 
reversed. the hepatomegaly partially receded. She was discharged from the 
hospital on the 68th postoperati~ e day. 
Neither of the transplants in the other patient had a delayed i m p r o ~  ement 
in function. Once jaundice had started it progressil ely increased until a plateau 
was reached. Increases in the transaminases also became fixed at a slightly 
elevated day-to-day level (Fig. 133). The alkaline phosphatases began to fall 
after the first postoperati~ e month. 
The most important difference between the two recipients n-as that the 
child T I ~ O  ultimately required retransplantation became violently ill n i th  hy- 
perpyrexia. tach! cardia. and profound d? spnea. At frequent inter\ als during 
the two weeks preceding reoperation he had many episodes of transient cyano- 
sis and appeared to be moribund. During the same period hepatic function 
began to deteriorate further. After two months there were striking increases in 
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the serum transaminases for the first time. Moreover, hypoproteinemia then 
began to develop (Fig. 135). 
The extreme swelling of the homograft in this case was mentioned earlier. 
Now. another finding appeared which suggested that the prognosis had become 
hopeless; on the liver scan a large portion of the left hepatic lobe failed to 
1-isualize (Fig. 133). This was interpreted as a beginning devitalization of this 
area of the liver which was progressing despite the most intense immuno- 
suppression that seemed compatible with recipient survival. The radiographic 
findings were very similar to those described earlier during the explosive kind 
of rejection. However, it was concluded that reversal of the process and restora- 
tion of an adequate blood flow to the endangered region could not be expected. 
Septicemia secondary to the impending hepatic gangrene was anticipated to be 
the next complication. Before this occurred. another organ became available 
and retransplantation was carried out. 
The rejection of the second transplant followed very much the same pat- 
tern as that of the first. although it was less severe. The jaundice which was 
temporarily relieved became stable between 15 and 20 mg per cent and per- 
sisted for many months without the slightest indication of receding (Chapter 
Seventeen). Other measures of liver function were adequate although not 
normal. 
Retransplantation. By the time it was decided to replace the holnograft in 
case OT 16, the child was gravely ill, although not primarily from liver failure. 
The reason for the toxic syndrome became immediately evident when the old 
incision was reopened and the abdominal cavity entered. The liver was enor- 
rnously enlarged. Its rounded inferior surface protruded through the wound. 
'The entire presenting surface of the organ was mottled (Fig. 138A). There were 
many cyanotic areas interspersed with islands of pink tissue. The discoloration 
affected both lobes but was most severe on the left side in about the same 
location as the poorly visualized region identified with a scan the day previously. 
It was suspected that there were many foci of fresh infarction. At that time 
the transplant had been in residence in the nelv host for a full 68 days. 
After its removal, the homograft weighed 880 gm compared to its esti- 
mated weight of 250 gm at the time of the original procedure. The impression 
of multiple infarctions \vas confirmed when the organ was transected (Fig. 
138). Some of the necrotic areas appeared to ha\-e been devitalized \-ery recent- 
ly. whereas others seemed to be older. Both \-arieties of infarcts tended to be 
near the surface. The main hepatic artery. the portal vein, and the major di- 
visions of both vessels were patent and contained no clots whatsoever. Far 
distally within the liver there were very tiny but easily visible clots in some of 
the terminal portal ramifications. The extrahepatic duct system was patent 
from the cholecystoduodenostomy as far into the hilum as the ducts could be 
traced. The histopathologic findings are re\-iewed in Chapter Twenty. 
Technically, extirpation of the rejecting organ \\-as not \-ery difficult. 
Adhesions had formed between its capsule and the diaphragm but these could 
be stripped away n-ith blunt dissection. Similarly the vessels in the hilum were 
easily reisolated. The nen- organ was placed n-ith the same techniques as those 
described in Chapter Eight with one possibly significant deviation. \Vhen the 
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F i g u r e  138, A rejecting homograft  in patient OT 16. The badly damaged and  swollen organ was 
remo1-ed 68 da!-s af ter  i ts  transplantation. -4. The protruding homograft  a s  it ~ i - a s  een ~ v h e n  the 
transverse abdoinillal incision was reopened. S o t e  the enormous s11-elling. as 11-ell a s  the  heterogen- 
ous appearance of its surface.  B.  After extirpation and slicing. gross subcortical infarcts 'lighter 
colors) \\-ere easil!- seen. 
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Homograft 1,V.C. 
Donor l i v e r  
Fzgure 139 Technique of anastornosls of the suprahepatic inferlor vena cava a t  the time of 
retransplantatlon in patlent OT 16 A Aftel cross clarnplng of the reciplent Inferlor t e n a  caba, the 
tessel mas transected beloxr the orlglnal sutuie llne t h e r e b ~  leating a cuff of the original 
homograft B The suprahepatlc ena c a l a  of the nexr homograft xzas anastornosed to the recipient 
\ essel Incorporating the cuff of the letained T ena c a l a  In the suture line The technique used was 
designed to prel ent the sacrifice of \ ena ca1 a1 length 
upper vena cava was cross clamped just below the diaphragm, it was obvious 
that the cuff was excessively short. Consequently the original suture line was 
left with the patient. \Tihen the nem anastomosis was performed, the old suture 
line was incorporated in the freshly formed one (Fig. 139). In this way, the 
length of the host vena cava was not unnecessarily sacrificed. 
Prognosis w i t h  ~ n d o l e n t  Rejection. It will already ha1 e become elident that the 
ultimate course of these two patients n-as difficult. The rejection was tempo- 
rarily controlled and reversed in the teen-age girl. Honever. within a few weeks 
after discontinuation of ALG therapy. the process recurred in an e\ en more 
severe form (Chapter Sel-enteen). Nevertheless. the homograft supported life 
for more than a year. 
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The same kind of chronic course was seen in the infant after the second 
transplantation. He lived in a jaundiced state for many months. His late fate 
will be returned to in Chapter Seventeen. 
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Chapter Fifteen 
ACUTE REJECTION AND HEPATIC 
GANGRENE 
In the preceding chapter two examples of rejection were cited that ap- 
parently nearly resulted in devitalization of discrete fractions of orthotopic 
hepatic homografts. It was suggested that the etiology of the threatened necro- 
sis was an immunologically mediated reduction in the blood flow to the trans- 
planted livers and that the most affected portions of the organs became dif- 
ferentially susceptible to invasion by bacteria from the gastrointestinal tract. 
The dire sequelae that nrould have been expected if frank gangrene had fol- 
lowed were circumvented either because the process initiating the ischemia 
spontaneously reversed (OT 15) or because the stricken homograft nTas removed 
and replaced (OT 16). 
An extension of these events will now be described as they were observed in 
five consecutive earlier cases (OT 8 to 12) in which orthotopic hepatic 
homografts actually did undergo regional necrosis. The five recipients were the 
first humans to s u n  i~ e for long periods after this kind of operation,'"" 2 3  and 
the reasons for the complication were anything but clear at  that time. Later it 
was concluded, partly because of the greater insight provided by the further 
experience documented in Chapter Fourteen, that a primary element in the 
pathogenesis had been incompletely controlled rejection. In addition. evidence 
was uncovered that contributory mechanical factors determined, at least in 
part, the localization of the gangrene." 20 
It was not anticipated from the animal experimentation described in Chap- 
ters Eleven and Twelve that liver infarction and secondary infection would be 
such a major deterrent to success in the clinical trials. Nevertheless. it was 
appreciated in a d ~ a n c e  that homograft sepsis might be a special problem for 
several reasons. First. the graft duct system must be exposed to the endogenous 
flora of that portion of the gastrointestinal tract to ~ ~ h i c h  it is anastomosed. 
Second, a l i ~  er which r e c e i ~  es its portal inflon from the nonhepatic splanchnic 
bed may be directly inoculated with bacteria to the extent. whether great" or 
small,'' that microorganisms are present in the intestinal venous effluent. 
Finall!, the reticuloendothelial element of the liver homograft. which is also 
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under immunologic attack, is thought to be normally an  important and effec- 
tive bacterial fi1ter.l 4 .  "' The degree to which this function might be lost, either 
because of hepatic rejection or because of the immunosuppression given to 
prevent this process, could be expected to influence the efficiency of host de- 
fense against both local and systemic infection. 
THE SYNDROME OF SEPTIC INFARCTION 
The consequences of septic hepatic infarction were characteristic7, 1 9 a 2 0  
and resulted in three clinical or laboratory findings that together were abso- 
lutely diagnostic. The components of the triad were gram negative septicemia, 
evidence from transarninase determinations of massive liver necrosis, and the 
development on serial liver scans of large areas of persistently absent isotope 
concentration in the honiograft. 
Symptoms and Signs 
The complication of regional hepatic gangrene occurred in children who 
were 13  to 201/2 months old at the time of transplantation. The young age 
distribution may have had no more profound significance than the fact that 
only children were treated with orthotopic liver transplantation during this era 
of our experience. The diagnosis was made 24 (OT 8). two (OT 9), 25 (OT lo),  
52 (OT l l ) ,  and 104 (OT 12) days after operation. 
All but one of the patients had previously been in good condition, although 
variable fevers had been observed in each recipient for several days or even 
weeks before the onset of obvious liver necrosis and septicemia. Thereafter, 
their temperatures rose to very high l e ~ e l s  (Figs. 140-143) and they were pros- 
trated. Hypotension was always observed, either in a transient or more persist- 
ent and serious form. 
There mere few other diagnostic clues from obserlation or examination. 
The children all became extremely irritable and had labored respirations. One 
(OT 12) stopped breathing altogether and would have died if temporary ventila- 
tor support had not been instituted: a sample of her peripheral blood drawn at 
the time of the apnea was later found to have a glucose content of 0 mg per 
cent. This child and another developed repeated retching and vomiting. All five 
recipients appeared to be moribund within a few hours. 
Bacteriologic Findings 
Invariably bacteria could be found in the peripheral blood. Persistently 
positive blood cultures were first documented in four of the five patients coin- 
cident with or just after the moderately sudden onset of severe hyperpyrexia 
(Figs. 140-142). In the other patient (OT 12), who also had a pre-existing mixed 
(Text contizued 012 page 314.) 
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F i g z ~ ~ e  140. The first 60 post-transplantation days in patient OT 8. During the third postoperative 
week there was evidence of an "anicteric" rejection, but the significance of the function changes 
was not appreciated at the time. The lung resection \ \ as  carried out because the right upper lobe 
was collapsed (see Chapter Yine) and it Iras suspected that this Iras the source of the unexplained 
fever. In retrospect. the pulmonar!- lobectom!- was probably not indicated. One day later the defini- 
tive ex-idence of the septic hepatic illfarction had appeared. All the positix-e blood cultures were of 
Aerobacter-Klebsiella. This patient n-as the first to surx-i~-e for a prolonged period after human liver 
transplantation. The indication for operation n-as hepatoma. The late course rvill be described in 
Chapter Seventeen. 
ACUTE REJECTION AND HEPATIC GANGRENE / 31 1 
BLOOD CULTURE 
4 1 
40 
TEMPERATURE $ 
( "C)  37 
36 
3000 
SGOT (I.U.) 2000 
- 
SGPT (I.U.) 1000 
- - - - - -  
0 
(rng per 100 rnl) 
TOTAL - 
AZATHIOPRINE :: 
(mg 10- 0.- m-- 
PREDNISONE 
(mg)  30- 4 I- 
50. 
A LG DAILY EVERY THIRD  DAY^ 
0 10 20 30 40 50 60 70 80 90 100 10 120 30 140 50 160 170 180 190 
TIME IN DAYS 
Figure  141. The course of patient OT 10 after orthotopic 1i1-er transplantation for extrahepatic 
biliary atresia. Homograft function prior to the onset of a septic hepatic infarction on the twenty- 
fifth day mas excellent: the only consistent abnormality was an elel-ated alkaline phosphatase. 
Even after the infarctions destro!-ed large portions of the central and right lobar liver tissues, 
function remained good until the end of the third postoperati~ e month. Thereafter. liver failure was 
progressive, Kote the late parallel increases in  alkaline phosphatase and bilirubin. The immediate 
cause of death was intraperitoneal rupture of an undrained residual abscess of the left lobe. Sur- 
vival was 186 days. Liver irradiation was n-ith 130 R depth dose at each arron-. The temperatures 
are the daily maximum. At autopsy the right hepatic arter>- was the site of a completely occlusive 
old thrombosis. (By pernlission of Ann. Surg. 163:392. 1968.) 
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Figure  142. A child (OT 11) ~ v h o  dex-eloped a rapidly fatal septic hepatic infarction which was 
superimposed upon a n  indolent rejection of almost txto months' duratlon that \?as undergoing very 
slow remission. In the second and third postoperative weeks numerous blood cultures of an uniden- 
tified yeast Tvere obtained (6's in squares'. The source of the microorganisn~s Tvas never deter- 
mined, but the fungernia cleared ~v i th  ainphotericin B therapy. ITith the onset of the regional 
hepatic gangrene. gram negative organisnls were found in the peripheral blood (-'s in circles). At 
autopsy the right lix-er lobe Tvas necrotic and the right hepatic arter>- xvas thrombosed. 
ACUTE REJECTION AND HEPATIC GANGRENE / 313 
BLOOD CULTURE ( ( 
PT. C.B. 10.0 kg. 
TEMPERATURE 
( " C )  
8 
..---.-- --- ---.--- -. - .., - . ' -.... ---. .-A 
0- ; *- 
BILIRUBIN 30- 
(mg per 100 ml) 20. 
TOTAL - 
CONJUGATED - - - -  10- 
ALG DAILY EVERY OTHER DAY EVERY THIRD DAY 
0 10 20 30 40 50 60 70 80 90 100 10 
TIME IN DAYS 
F i g u ~ e  143. Course in patient OT 12 after orthotopic liver transplantation for extrahepatic biliary 
atresia. A vigorous and protracted rejection began postoperatively n-ithin a few days and was not 
reversed for 10 weeks. Function Tvas improving u-hen persistent gram negative septicemia 
presaged liver sepsis. Complete right lobar infarction finally occurred. causing death ~ i t h i n  a few 
hours. At autopsy the right hepatic artery was thrombosed. Xcti C=intra\-enous actinomycin C in  
micrograms, 150 R=homograft irradiation. (By pernlission of Ann. Surg. 168:392, 1968.) 
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bacterial, protozoal, and viral pneumonitis (Chapter Sixteen), gram negative 
bacteremia presaged the impending regional hepatic gangrene for more than 
two weeks (Fig. 143). 
The microorganisms collected from the blood stream in these five patients 
at the time of septic hepatic infarction are shown in Table 20. They were all the 
type normally found in the intestinal tract. In one case (OT 12), two species 
were identified. Antibiotic agents were given according to the sensitivities 
determined from the cultures.' I " .  "' In the three patients who survived at least 
temporarily, such therapy was necessary on a continuing basis and undoubtedly 
contributed to the high incidence of extrahepatic infections from opportunistic 
organisms, as discussed in Chapter Sixteen. 
RELATION TO REJECTION 
The occurrence of regional liver gangrene in these five consecutive pa- 
tients made it appear for a time that the operation of orthotopic liver transplan- 
tation was fundamentally unsound and that further attempts at  its application 
for the treatment of human disease should not be made. The most compelling 
I justification for not accepting this point of view was that the feasibility of the 
undertaking had already been established in animals. It would have required an 
extraordinary pessimism to believe that the same objective could not be 
achieved in man. 
Nevertheless, the dismay with which the septic hepatic infarctions were 
v i g ~ e d  was heightened by three exceptionally disquieting features. First, par- 
' ' tial homograft gangrene was seen without fail in each of the five first patients 
who lived for more than a few weeks after transplantation. Second. it was also 
observed in at  least one other institution by an independent team that employed 
a significantly different orthotopic procedure.'' Finally, any explanation for the 
deadly complication had to be considered highly speculative at that time. 
Although it was suggested from the beginning1" that incomplete control of 
Table 20.  The Bacteria Cultured from the Blood Stream at the Time of Septic 
Hepatic Infarctions 
NO. TIME OF DIAGNOSIS (HR) ORG.4NISLI 
-- 
OT 8 24 Aerobacter-Klebsiella 
OT 9 2 Bacteroides fragi l is 
OT 10 25 Aerobacter-Klebsiella 
OT 1 1  52 Escherichia coli 
OT 12 104 Aerobacter-Klebsiella 
Escherichia coli 
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rejection must be one responsible factor, evidence in support of this contention 
from several indices of liver function was initially thought to be weak. 
In retrospect, such an equivocating position need no longer be taken. As the 
later experience recounted in Chapter Fourteen accumulated and the distinc- 
tive patterns of rejection were delineated under less confusing circumstances, 
it became increasingly clear that all the homografts that underwent regional 
necrosis had cotemporaneously been under immunologic attack. Furthermore, 
failure to recognize this fact at the time the patients were being cared for led to 
the error of minimizing immunosuppression in several of these cases at 
precisely the moment when this therapy should have been intensified (Figs. 
140 and 141). The underlying rejections were highly variable in their ante- 
cedent manifestations. 
Subclinical Rejection 
Three of the recipients (OT 8,9, and 10) probably belonged in the category of 
bland rejection described in Chapter Fourteen. However, only two will be ana- 
lyzed in this section. In the third (OT 9), two arteries of the homograft were 
individually anastomosed to the host right and left hepatic arteries (Fig. 52, 
Chapter Eight). The smaller of the vessels which supplied part of the right lobe 
apparently clotted about two days later. It will have to be assumed that the 
accident was due to a technical error in the performance of the tiny anas- 
tomosis, although this evaluation may be incorrect since right hepatic arterial 
clotting regularly occurred in subsequent cases despite more favorable anatom- . 
ic situations. 
The two patients to be considered had extraordinarily smooth early post- 
operative courses. One of the children (OT 8), who was not preliously jaun- 
diced, did not become icteric after transplantation (Fig. 140). The elevated 
serum bilirubin concentration in the other (OT 10) promptly fell to near normal 
(Fig. 141). Serum proteins and all clotting factors were M-ell maintained. 
Nevertheless, both recipients had a number of physical and biochemical 
findings which would now be regarded as significant but which then did not 
cause alarm. Their newr livers became sufficiently enlarged and firm so that the 
alterations were quite evident by palpation; from time to time the children 
seemed to be suffering abdominal pain. Persistent or remittent fever 
developed. There were small but recurrent e le~at ions in the serum trans- 
aminases and a slow but steady rise in the alkaljne phosphatases (Figs. 140 
and 141). 
The changes made so little impression that adjustments in the immunosup- 
pressive regimen were not even seriously considered. The failure to react was 
doubly tragic since the doses of steroids gil en in the days preceding the actual 
infarctions avould now be considered to be dangerously lon.  This can be illus- 
trated by comparing the a \  erage dail) quantities of prednisone given these two 
patients for the first 24 postoperative days (1.27 mg kg) n i th  those adminis- 
tered during the same time (2.9 mg kg) to the two more adequately treated 
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recipients with the same kind of subclinical rejection whose early convales- 
cence periods were described in Chapter Fourteen. 
Another reason why septic hepatic necrosis was not immediately identified 
as a consequence of rejection in patients OT 8 and 10 was our failure even after 
its onset to observe acute deterioration in most kinds of liver function. As al- 
ready mentioned, there always followed very dramatic and sudden increases in 
the SGOT and SGPT (Figs. 140 and 141). However. this was a relatively disso- 
ciated finding. Jaundice did not promptly develop, although there were slight 
rises in the serum bilirubin concentrations in both patients (Figs. 140 and 141). 
Moreover, the patients maintained their serum proteins and prothrombin times 
at about the same levels as had been present before (Fig. 140). 
The retention of generally good function in spite of the evidence of major 
hepatic necrosis was explained by the localized nature of the process as seen on 
the liver scans (Figs. 144 and 145). Isotope uptake was retained in most parts of 
the homografts although the concentration was somewhat reduced. In contrast, 
the afflicted areas, which were predominantly in the right lobe, had essentially 
no specific activity at  all. The devitalized region remained relatively constant in 
one case (OT 8) (Fig. 144). but it extended very rapidly in the other (OT 10) to 
several times its original size (Fig. 145). 
Since immunosuppression was not increased even at this late time, con- 
tinued survival of the patients is probably attributable to the inherently self- 
limited nature of the rejection. Significant changes in treatment were made 
only after the regional necrosis had already gone to completion. With the subse- 
quent advent of low grade jaundice in the ensuing days or weeks. prednisone 
was restarted or given in larger daily quantities (Fig. 141). A slow subsequent 
deepening of the icterus was not thereby prevented, a problem which will be 
discussed more extensively in Chapter Seventeen. 
Persistent Rejection 
The evidence that an  underlying rejection was present in the other two 
cases (OT 11 and 12) was not vague. The pre-existing disease in both instances 
was extrahepatic biliary atresia. After operation there was a prompt but tran- 
sient alleviation of the jaundice. Within a few days, the serum bilirubin concen- 
tration began to rise again (Figs. 142 and 143). Heavy steroid therapy was 
instituted and continued for weeks or months. 
Eventually improvement was obtained. but the reversal was very slow and 
incomplete in both recipients. The secondary increases in bilirubin began to 
recede in four to six weeks (Figs. 142 and 143) but they never returned to 
normal. During the remainder of life the alkaline phosphatases were always 
F i g 1 ~ 1 . e  144. Radioisotope lix-er scans in  0 T  8 obtained x7-ith """-technetium. A .  Sex-enteen days 
after transplantation. The isotope uptake is diminished but  there are no defects.  B.  Large nonopac- 
ifying areas  are  denionstrable (arrows; 29 da>-s after transplantation in  the  posterior part of 
the  right lobe. The patient had septicemia. C .  Three da>-s later. The ~lecrot ic  t issue had been 
debrided. D. The  defects are  no longer seen 252 da>-s af ter  operation. Note that the liver has  
progressix-ely increased in  size. ;B J permission of Aillll. Surg. 1GS:392, 1968.: 
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F i g u r e  144. See opposite page for legend. 
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F i g u r e  145. Postoperatir-e technetium scans of the liver in patient OT 10. 2 days: The small 
homograft is normal. 10 dal-s: An increase in size is evident although the general configuration of 
the organ is still normal. 20 days: S o  further change is noted. 23 days: The examination was 
conducted as a n  emergency TT-hen the child dex-eloped gram negatir-e septicemia and r-ery high 
increases in  the transa~ninases (Fig. 141). Areas of decreased isotope uptake are obvious in  the 
right lobe and the centl-a1 part of the liver. 27 da!-s: .A striking extension of the process can be seen 
less than 18 hours later. -4 debridement procedure !{-as carried out the same eveninn. 31 da!-s: Four 
days after debridement the radiographic appearance was improved. 
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elevated and there were minor fluctuations of the transaminases. Intermittent 
fevers were recorded. The homografts became and remained large (Figs. 146 
and 147) and firm. 
When regional liver gangrene finally developed. 52 (OT 11) and 104 (OT 
12) days after transplantation, its features including the explosive rises in the 
transaminases (Figs. 142 and 143) were not qualitatively different from when 
it presented against the background of the milder kind of rejection. However, 
its evolution was considerably more fulminant inasmuch as the defects on the 
liver scans expanded with great rapidity. Death followed within a few hours or 
days. The magnitude of the problem can be appreciated by reviewing the scans 
in Figure 146. Initially, necrosis involved only the inferior portion of the right 
lobe; this was debrided under local anesthesia. By the next day the process had 
begun posteriorly. At the time of death eight days later, virtually the entire 
light lobe was dead. The unsuccessful attempts at  surgical therapy will be 
described later. 
EFFORTS AT SURGICAL TREATMENT 
Initial Procedures 
Removal or drainage of the infarcted area was attempted shortly after the 
diagnosis was made. A formal hepatic resection was carried out in one patient 
(OT 9) eight days after transplantation. Through the original abdominal in- 
cision, about half of the anatomic right lobe was removed. Two weeks later a 
large subphrenic abscess required drainage. This was the patient in whom two 
arteries supplying the homograft had been individually anastomosed to the 
recipient right and left hepatic arteries. The excised portion of liver was that 
which had been supplied by the smaller right artery. 
The right lobe of the liver was explored in the other four recipients through 
incisions designed to avoid entry into the chest or abdomen. These were placed 
in the tenth intercostal space with subcostal extensions of 1 ariable length (Fig. 
148). A thin fluid was found in the right subphrenic space and patchy necrotic 
areas were evident on the surface of the homograft. The dead liver tissue was 
traced into the interior of the right lobe where ramifying tracks were invariably 
found. Frank pus \+-as never present. The dead tissue had a yello~t cheesy 
appearance. There was no e+ ident fibrous reaction around the necrotic tracks. 
The cavities created by the debridement were packed. 
Additional Procedures 
Two of the five patients (OT 11 and 12) died eight days and 12 hours, 
lespectively, after the initial debridements. The outlook was made hopeless in 
both cases by rapid extension of the infarctions. which were initially relatively 
small. As already mentioned, efforts to keep up n-ith the process by repeated 
debridements in the child lvho survived for several days (OT 11) resulted in the 
e+ entual piecemeal removal of almost all the right lobe. 
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F i g  lc re 146. S e e  facing page for legend. 
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F i g u r e  146. Serial PA and lateral liver scans (technetium) in a child (OT 11) who received a n  
orthotopic liver transplant. 2 days: Norinal organ. 33 days: The homograft is greatly increased in 
size. 52 days: A defect is visible in the lateral projection. It Lvas localized to the inferior portion of 
the right lobe. Gram negative septicemia had developed (Fig. 142). 54 da!-s: The defect persists. 
Later the same day the necrotic portion of the right lobe mas debrided through a n  extraperitoneal 
incision. 57 days: The right lobe is becoming more extensively involved. 58 days: Further spread 
can be seen. Yote that the ability of the homograft to concentrate the isotope well has been lost. A 
disproportionate fraction of the technetium is now found in extrahepatic areas, particularly in the 
thorax. The child died three days later. 
Two other recipients (OT 9 and lo) ,  including the one treated with partial 
hepatectomy. were temporarily rescued but died of chronic liver failure four 
and a half and six months after transplantation. In both, sepsis in the right 
subphrenic space and the contiguous liver tissue persisted until the time of 
death. The infected and draining serpiginous intrahepatic tracts were irrigated 
twice a day. Fragments of dead tissue nere  repeatedl~ removed from the 
exposed hepatic parenchyma. These were usually plugs. adjacent to portal ves- 
sels, which could be pulled out of the remaining ~ i a b l e  surface. Failure to 
keep the wound meticulously clean often seemed to dispose to septicemia (Fig. 
141), although not always n-ith the same bacteria then present in the depths of 
the wound. At first there \ \as evidence of liver regeneration, but eventually the 
organs began to shrink (see Chapter Seventeen). Both homografts had residual 
sepsis at the time of autopsy. The patient who survil ed for more than six months 
isas found to have ruptured an unrecognized satellite abscess of the left lobe into 
the free peritoneal cal ity. 
O n l ~  one patient (OT 8) recol ered relati1 el) completely from the complica- 
tion of septic liker infarction. After extensive debridement, the defect was 
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F i g z c ~ e  147. 'l"l-Technetiun~ li\-er scans in  patient OT 12. 35 days: The homograft is already consider- 
ably enlarged b!- comparison ~ i - i th  previous scans. 91 days: The hepatomegal? has become extreme. 
The absence of a filling defect ~v i th  this examination was unexpected since gram n e g a t i ~ e  
septicemia had developed (Fig. 143). 105 da>-s: The infarcted region of the right lobe of the liver 
is evident. especially on the lateral view .An emergency debridement procedure was attempted 
but the patient died a f e ~ i -  hours later. 
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/ 
for  d r a i n a g e  of 
F i g u r e  148. Operative approach to septic liver infarctions through the tenth intercostal space. 
Neither the pleural nor peritoneal cavities mere entered. (By permission of Ann. Surg. 168:392, 
1968.) 
slowly filled in, apparently by hepatic regeneration. The process required eight 
months to become almost complete (Fig. 144). Until the time of her death from 
carcinomatosis more than a year later. a sinus tract to the right subphrenic 
space required daily irrigation. 
MECHANICAL CONSIDERATIONS OF ETIOLOGY 
The Homograft Arterial System 
Emphasis has so far been placed on the role of rejection in the genesis of 
regional hepatic infarction. The studies of Grothqn dogs left little doubt about 
the importance of this factor (see Chapters Eleven and Twelve). His results 
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indicated that the vascular supply to the homograft was endangered by an 
immunologic assault. However, it was not necessary to believe that the blood 
flow to all parts of the liver was equally reduced during rejection. Presumably 
the most deprived portions would be the ones to undergo ischemic necrosis. 
The first to suggest the latter hypothesis was Moore" more than five years ago. 
on the basis of canine experiments. 
It follows that a number of nonimmunologic conditions could also contri- 
bute to regional devascularization. This possibility was eventually examined 
with special care in the human recipients of orthotopic livers because of two 
findings that were present in each case. First, it was always predominantly the 
right lobe which was affected by the gangrene. Second, selective thrombosis of 
the right hepatic artery was proved at autopsy in the four children who either 
died promptly after the development of septic infarction or w-ho lingered on in 
poor condition and then succumbed several months later (Chapter Twenty). 
Later, evidence was found from studies in fresh cadavers"' that an anatom- 
ic distortion of the course of the right hepatic artery could accidentally be 
produced during transplantation in man (or at  least small children), partly be- 
cause of the erect position assumed by higher primates. In humans the right 
hepatic artery is longer than the left branch (Fig. 149) and usually traverses 
behind the other central hilar structures, where it is held by surrounding 
tissues. 
When the restraining ligaments of the liver were cut and when the vascu- 
lar structures entering and leaving the liver were skeletonized in fresh 
cadavers, the released right lobe rotated to a somewhat more posterior and 
inferior location than normal. If the head of the x-ray table was now elevated to 
60 degrees, an  incompletely occlusive kink of the proximal right hepatic artery 
could often, although by no means invariably, be demonstrated (Fig. 149). Pre- 
sumably such a dangerous situation could be further aggravated in the post- 
transplantation period either by the diminutions in blood flow alluded to earlier 
or by the swelling of the organ at the time of rejection. The constellation of 
circumstances nould be especially hazardous in infant livers with their fine 
caliber thin-walled arterial branches. 
OTHER FACTORS 
Insufficient attention was paid to the problem of sepsis in the transferred 
organs in all the early studies of homologous liver transplantation to modified 
or unmodified animals (Chapters Eleven and Twelve). Usually heavy antibiotic 
treatment was given postoperatively. In spite of the latter precaution, there 
were a number of examples of purulent cholangitis or li\-er abscess formation 
$.in every large canine series." Later. Alican and Hardy1 showed that such 
complications could not all be ascribed either to rejection injury of the 
homografts or to the agents \vhich were used to prevent this process, and 
which coincidentally rendered the recipients more susceptible to infection. In 
the studies of Alican and Hardy dog livers were autotransplanted. thereby auto- 
matically eliminating both the iinnlunologic barrier and the need for im- 
munosuppression. Abscesses developed in several of the autografts. 
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/ , , i i r tJ  149 ,  ringiographic studies performed in  a five year old child immediate1~- after her  death 
f i k ) ~ n  head injuries. Dye l ras  injected into the common hepatic artery (CHA) proximal to the  gastro- 
duodenal artery (GDA). .A. Initial injection. Note the smooth course of the  right hepatic artery 
I I ~ H A ) .  B. The  restrailling ligaments of the  liver h a l e  been incised. a cholecystoduodenostomy 
pe~f'ormed. and  the head of the x - r a ~ -  table elevated to 60 degrees. The right lobe of the  liver has  
rotated dolrn and  medially. The  course of the  left hepatic arterJ- i s  undisturbed. Howel-er, the  right 
hepatic artery (RHA) is nolr severel?- kinked where it passed beneath the  common duct.  See text for 
discussion. (By perlnission of Ann. Surg. 168:392,  1968.) 
After the septic hepatic infarctions were observed in the clinical cases, a 
number of experiments were performed in our own laboratory' in order to 
define more accurately how the liver came to be invaded by microorganisms 
after a variety of insults. Dogs and pigs n ere used and treatment with antibiot- 
ics was omitted. It was shown that the normally low incidence of positive 
cultures from the liver tissue of both species was increased even after sham 
operations in which the abdomen was simply opened for several hours and the 
hr er not disturbed. itThen a hepatic ischemic injur) mas added by performance 
of simulated autotransplantation. all lil ers became contaminated, primarily 
~ ~ i t h  the same microorganisms shown to be concomitantly present in the upper 
intestine. Bacterial counts were somenhat lower if the common bile duct was 
left intact than n h e n  the duct mas ligated and bile drainage restored mith a 
cholec~stoduodenostomy. The bacteriologic changes lvere even more pro- 
nounced in lix er homografts transplanted either to unmodified or immunosup- 
pressed canine or porcine recipients. 
The conclusion was that the numbers of bacteria that could be harvested 
from the liver reflected more or less accuratel) the magnitude of hepatic injury 
from mechanical causes as well as from rejection. Presumably any necrotic 
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Figure 150. An explanation of the predisposition of the.liver to bacterial sepsis. Presumably the 
invading microorganisms enter via the portal vein or through the reconstructed biliary tract. (By 
permission of Ann. Surg. 168:392. 1968.) 
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area, whatever its cause, could become a septic focus (Fig. 150), particularly if 
the host were being given immunosuppressive therapy and could not respond 
normally to the invading microorganisms. 
PREVENTION OF SEPTIC HEPATIC INFARCTIONS 
It is almost ironical to state that one of the most important ways to prevent 
this peculiar form of liver infection is to provide very heavy immunosuppres- 
sion, especially during the early postoperative period. Adherence to the con- 
\erse policy of minimum immunosuppression at the time when the five pa- 
tients discussed in this chapter were treated was a key factor in at least some, 
and probably all, of the consecutive tragedies of that era. Subsequent recipients 
were given much higher doses of prednisone. beginning during operation. This 
was the only real adjustment that could be made since there was little maneu- 
\ erability in the use of azathioprine and ALG. 
The second step that should be taken is to prevent distortion of the right 
hepatic artery. This can be done by the simple expedient of fixing the falciform 
and other ligaments of the homograft to the companion structures in the recipi- 
ent, as described in Chapter Eight. 
Finally, a systematically designed program of antibiotic therapy should be 
used. In the early postoperative period a narrow spectrum antistaphylococcal 
drug such as methicillin may be advisable for several days. In addition. ampi- 
cillin, cephalothin, kanamycin, chloramphenicol. or polymvxin should be given 
prophylactically by the intravenous route for one to four weeks. The latter 
drugs require change el  ery few days from one to the other in order to avo~d the 
toxicity peculiar to each agent and to prevent the overgrowth of resistant 
strains; although they are potentially dangerous antibiotics, their effectiveness 
against gram nega t i~  e bacteria makes them indispensible in liver transplanta- 
tion. The importance of beginning therapy in the operating room can be appre- 
ciated by the fact that a highly significant and easily detectable ischemic injury 
must be imposed on all l i ~  er grafts, rendering them immediately \ ulnerable to 
bacterial invasion. How fast this can occur was illustrated in one of our patients 
(OT 10) in whom E. coli m-as cultured from the homograft gallbladder during 
transplantation. b7ithin four hours the same microorganism mas found tran- 
siently in the blood stream (Fig. 141). 
The foregoing guidelines ha1 e been followed in all patients treated since 
February. 1968, with liver transplantation. There ha l e  been no further exam- 
ples of regional hepatic gangrene. Furthermore. it has been possible to discon- 
tinue safely the proph~lactic antibiotic treatment within two to six weeks. The 
a1 oidance of chronic antimicrobial therapy in the later cases has been accom- 
panied by a reduction in the incidence of serious extrahepatic infections (Chap- 
ter Sixteen). 
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Chapter Sixteen 
INFECTIOUS COMPLICATIONS, 
EXCLUDING PARTIAL HEPATIC 
GANGRENE 
Increased susceptibility to infection is a problem common to the transplan- 
tation of all organs as the result of the measures taken to prevent repudiation of 
the grafts. The role of the immunosuppressive drugs in lowering host reactivity 
to inimical environmental antigens is undoubted even when they are given at 
medium or low dose ranges which do not cause bone marrow depression. 
The mechanism by which immunologic responsiveness is variably lost is 
not known. However: the consequences are well recognized. Infections often 
develop which are comparable in many respects to those seen in children who 
have a congenital lack of cellular immunity with or without impaired im- 
munoglobulin synthesis.' " .  ';' Functional impairment of the small and medium 
lymphocyte is probably one common link between the naturally occurring and 
iatrogenic disorders, as Gowans' recent expanded views of lymphocyte function 
would indicate." 
The infection of necrotic regions of hepatic homografts was discussed 
.T@ys ,,p 
separately in Chapter Fifteen. A \-ariety of other septic complications were a l ~ o ~ , , ~ , , t #  d 
seen in the liver recipients. Many of these were similar to those previously d ~ & p r ; j s  
reported after transplantation of the kidne)-,:3. 6 .  "HI. I:'. 1 ~ 2 ~ .  2 1 .  2:'. 24 Common fea- 
tures after both kinds of operations included the predisposition to pneumonitis; 
the tendency for localized sepsis to quickly become multifocal: and the fre- 
quent etiologic role of grain negative bacteria. fungi. and other less common 
microorganisms of normally low pathogenicity. 
In the description of the infectious complications after liver transplanta- 
t ion~.  2% 26 the patients will be divided into those treated early in our experience, 
at an intermediate stage. and in a final series. 5Iajor changes in surgical tech- 
nique and or immunosuppressive therapy (Fig. 131) n-ere made during these 
times which slon-ly transformed treatment from a hopeless to a feasible under- 
taking. One of the most important lessolls that was learned was that the quality 
of the transplanted liver played a prime role in determining the frequency and 
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E = EARLY CASES (OT 2 - 7) 
I = INTERMEDIATE CASES (OT 8 - 12) 
L = LATER CASES (OT 13 - 17) 
PREDNISONE 
mg/kg/day 
WBC 
F i g u r e  1 3 1 .  Pooled data from the first six postoperative days showing the changing policy of 
immunosuppression ~ r h i c h  evolved in cases of orthotopic lix-er transplantation. .A11 the early pa- 
tients died in  23 da)-s or less. Each of the recipients in the intermediate period de\ eloped a septic 
hepatic infarction. The later patients surl-ix-ed the operation and immediate postoperative period 
and were spared the coinplicatioil of partial liver gangrene. S o t e  that the therapeutic adjustments 
consisted of progressil-e reductions in the daily quantities of azathioprine and increases in  the 
amounts of' prednisone. More complete information about the treatment of the indilidual recipients 
is gix-en in Chapter Thirteen. 
severity of sepsis elsewhere in the body. Patients who received promptly and 
adequately functioning organs tended to recover very quickly from the acute 
insult of operation. Those ss hose transplants were badly damaged remained 
bedridden and almost invariably fell prey to explosi~ e and lethal infections. 
During the entire period of the study, the approach to diagnosis and anti- 
biotic therapy was similar. On admission of the recipient, cultures n-ere taken 
from the skin, trachea, urine. and feces. During operation. additional specimens 
were cultured from the donor and recipient duodenum and the donor gallblad- 
der bile. After transplantation. bacterial cultures ssere taken dail! or at least 
twice a n-eek from the n-ounds, nose. throat, trachea, urine, feces. and 
peripheral venous blood. In  addition. I irus isolation was attempted. as reported 
by Rifkind'; I' and Fulginitia4 in specimens obtained from the nose and throat, 
feces. and urine. 
AIethicillin or one of the other narrow spectrum antistaph>lococcal drugs 
was started intras-enousl! before or during operation and coiltinued afterward. 
Other antibiotics were selected on the basis of the endogenous flora demon- 
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strated in the preoperative bacterial cultures. These were changed according to 
the cultures and sensitivities in subsequent specimens from the multiple sam- 
pling sites. For reasons discussed in Chapters Fourteen and Fifteen agents 
were often used which are usually effective against gram negative organisms. 
These included ampicillin. cephalothin, kanamycin, chloramphenicol and poly- 
myxin. In the later cases, one or more of these potent drugs were always started 
at the time of operation. rather than later when infection was already evident. 
EARLY CASES 
There were 10 patients treated between March 1, 1963, and May, 1967, 
seven with orthotopic and three with auxiliary transplantation. One patient in 
each group (OT 1 and AT 3) died during operation and will not be considered 
f'urther in this analysis. The first four recipients had staged procedures, hepatic 
mobilization being carried out one to 14 days before the actual transplantation. 
Biliary reconstruction in all these cases was with choledochocholedochostomy 
and T-tube drainage. The other two recipients of orthotopic homografts had a 
one stage operation, and provision for biliary drainage was with cholecysto- 
duodenostomy. The two auxiliary homografts (AT 1 and 2) Lvere placed in the 
right paravertebral gutter three and one days. respectively. after the perfor- 
mance of portacaval shunts (Chapter Twenty-two): biliary drainage was with a 
Roux-Y cholecystojejunostomy. In most of the orthotopic cases, the livers were 
gravely or seriously injured and functioned poorly (see Chapter Six). 
General Postoperative Condition. Five of the eight patients were more than 47 
years old and seven were badly debilitated before operation. After transplanta- 
tion most were further enfeebled by the absence of satisfactcry hepatic func- 
tion. The consequences were that prolonged ventilatory support was always 
needed. that tracheostomies became necessary in three instances. that blad- 
der catheters usually had to be left in place for many days. and that the resump- 
tion of an oral diet was delayed or poor, if this was ever achiel-ed at all. 
Immunosuppression. Azathioprine and prednisone were given to six of the 
patients and supplemented irregularly with intravenous actinom>-cin C andlor 
local homograft irradiation. The other two recipients (OT 6 and 7) n-ere also 
treated with horse ALG. The errors made in drug therapy in this group of 
patients. particularly with respect to azathioprine. \\-ere described in Chapter 
Thirteen. Briefly, the latter agent n-as given in average daily quantities that 
proved to be 01-erdoses. Five of the eight patients became leukopenic at some 
phase of their course. \vith total white blood cell counts of 4000 cu mm or less; 
in four, the white cell counts fell to 2000 cu mm or lo~ver. During the post- 
operative period the average prednisone doses were about 2 ing kg per day (see 
Chapter Thirteen for details). 
Nonhepatic Infections. Septic complications were prompt and overwhelming 
in these physically in\-alided and iminunologicalls- crippled patients. The local- 
ization, etiology. timing. therapy. and outcome of the extrahepatic septic 
episodes are summarized in Table 21. Seven of the eight patients had a total of 
29 separate infections. Of these only one, an E. coli urinary tract infection (OT 
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5). definitely existed before operation, although in another case (OT 3) sterile 
biliary peritonitis before transplantation probably contributed to the subsequent 
bacterial in\asion of the peritoneum. The diagnoses were made from the first 
to the last day (maximum 34) of postoperative survival or at  autopsy. There 
were eight. f i ~ e ,  four, three. and three examples. respectively, of pneumonitis, 
urinary tract sepsis, peritonitis. esophagitis and bacteremia. 
, pJ Multiple foci of infection with the identical organism Tvere common. Thus. p3L , yh ree  patients had pneumonitis and septicemla with the same bacteria Two of pf' + ? 
6 +% the four examples of peritonitis xvere in patients who had the same culture jn 
the trachea or blood stream. Two of the five urinary tract infections were asso- 
ciated with septicemia (Table 21). 
It is noteworthy that pyogenic cocci were not responsible for any of the 
foregoing infections. Gram negative enteric bacilli mere the causative agents in 
14 instances. including six of the eight pneumonias. The organisms were E. 
col i ,  Aerobacter-Klebsiella species. Psezldo)~zorzus  nerzlgznoscl and Proteus 
species. 
,v" There were also infections with Ctr~zd ldu  ulb~ccc,zs resulting in erosive 
P ",d' esophagitis (OT 3. 5, and 6), pneumonitis (OT 2 and 3), pyelonephritis (AT 2). P. ,&:- 
t 
fungemja (OT 6) and panenteritis (AT 2) (Table 21). The invasive moniliasis of 
the small bowel in AT 2 was responsible for an eventually fatal hemorrhage. 
Examples of fungus infections in different locations are shown in Figures 152 
and 153. 
In one patient (AT 2) cytomegalo~irus (CMV) infestation was found at au- 
topsy in the lungs, in the intestinal tract, and in the homograft. 
Hepatic Sepsis, Excl~ding Gangrene. A single microabscess was detected with 
- histologic study of the postmortem homograft of one patient (OT 7). The right 
$ ~."l. lobe of another (OT 5) was found at autopsy to contain a discrete 2 cm abscess. 
" .. 8 ,&' E*.S* i" In the patient (AT 2) with widespread cytomegaloairus, inclusion bodies (. rl , 
were found in the small intrahepatic bile ducts (Fig. 154). 
INTERMEDIATE CASES 
These five orthotopic liver recipients were treated between July 23, 1967, 
and November 27. 1967. Biliary tract reconstruction was with cholecystoduode- 
nostomy (Chapter Eight). None of the patients was older than two years of age. 
Their homografts. which lvere moderately or even minimally damaged by 
ischemia. performed reasonably well from the beginning. although there were 
always some initial abnormalities in hepatic function. Eventually, recovery was 
jeopardized or prevented in each case by the del-elopment of the septic hepatic 
infarctions described in Chapter Fifteen. 
General Postoperative Condition. All the children were strong after transplan- 
tation. even one iOT 12) who had been in terminal condition before operation. 
They were remol-ed from mechanical respiratory support after t~t-o to 12 hours. 
were not exposed to the risks of prolonged bladder catheterization. and were all 
able to resume eating within 48 to 72 hours. 
Immunosuppression. Therapy was with azathioprine. prednisone, and 
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iqli1.e 152 .  Opportunistic organisms identified in  the lungs of patient A T  3.  24 days after aux- 
iliary hepatic transplantation. Aerohacter-Klebsiella and C(i i~c l i t l~ i  c ll~ic.ci 1 1  s n ere recol ered f rom 
rracheal aspirates during the  postoperatile period. .A. C .  i i l l ~ i c r i i ~ ~  infiltration of' the pleura (PAS 
itain,  x 400). B.  Large intranuclear inclusions of cytomegalovirus i n  alveolar lining cells (hema- 
toxylin and eosin stain. X 400). 
Fiqz11.e 153.  Cnizrliiiii iiibicii12 i ~nfec t ions  of the G I  tracts of two recipients of hepatic holnografts. 
The specimens \\-ere obtained a t  au tops~- .  sex-ell and a half and 34 daxs. respectir-el!-. after trans- 
?lantation. .A. Ulcerative esophagitis in  patient OT 3 \PAS stain, x 200).  B.  Enteritis in  patient AT 2 
PAS stain. x 200). 
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F i g u r e  154. Cl-tomegalovir~~s in a small bile duct of' the auxiliary homograft of patient AT 2. 34 
days after operation. (hematoxylin and eosin stain. x 200). (By permission of' Ye\\- Eng.  J. bled. 
279:619. 1968.) 
heterologous ALG. The azathioprine doses per kg per day for the first six days 
were 1.5 mg, about one half on a body weight basis of those used in the earlier 
series (Fig. 151). Leukopenia was avoided. The quantities of steroids were larg- 
er (Fig. 151). 
Nonhepatic Infections. Although leukopenia was avoided, there were 26 
episodes of extrahepatic infection (Table 22) which were at least partly 
explained by the prolonged antibiotic treatment made necessary by the partial 
liver gangrene. Apparently the consequences of chronic antimicrobial therapy 
were the emergence of bacterial populations which were resistant to the agents 
used, as well as the overgrowth of fungi. 1-iruses, and protozoa. This "unbal- 
ancing" effect of antibiotics on the natural flora has often beer1 observed in non- 
transplant patients 1% 1 4 .  11;. 5. 2" and has also been reflected in the etiology of 
infectious deaths after renal homotransplantation." 
There were 16 bouts of gram negative bacteremia which did not occur at 
the same time as the septic liver infarctions. A fen- of these positil-e blood 
cultures occurred before the appearance of hepatic gangrene, but most ap- 
peared sporadically aftern-ard. \Then the sinus tracts into the liver were cul- 
tured in the three patients n-ho survived debridement, they sometimes con- 
tained the same bacteria as those simultaneously found in the blood stream, but 
often they did not. Because of this frequent lack of association, the intermittent 
late gram negative bacteremias were classed as nonhepatic in origin [Table 22). 
Nevertheless, it is highly likely that the homograft was the responsible focus 
since recurrent gram negative septicemia has not been nearly so common in 
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the course of subsequent patients in whom liver sepsis was largely avoided. An  
E. coll meningitis (OT 11) found at autopsy in one of the patients was probably 
hematogenously "seeded" during the septicemic episodes. 
There were twTo bacterial pneumonias, these being caused by gram nega- @,vA4* 
f .  
tive microorganisms (Table 22). In addition. cytomegalovirus (CMV) was iso- ! : """ 
lated by Dr. Vincent Fulginiti from the lungs of three children (OT 9, 10, and !'"* '* 
12) at the time of autopsy (Fig. 155, A). During life the same virus had been 
repeatedly isolated from the tracheal aspirates in two of these patients. In both 
the CMV was only part of a complex infestation which also included Pneu- 
~~zocystzs cnrznii (Fig. 155. B )  and Aerobacter-Klebsiella (Fig. 155. C) in one 
patient (OT 12), and P~zez~~nocyst ls  ca1.zn11 in the other (OT 9). Premortem, the 
former patient had clinically evident pneumonia (Fig. 156). whereas the latter 
recipient did not. 
Three of the five recipients in this series developed fungemia (Table 22), 
two with Calzdzdn alblca~zs (OT 8 and 9) and one (OT 11) with an  unidentified 
least. The blood cultures of all three patients cleared with antifungal therapy 
iamphotericin B or 5-flurocytosine ). However, silent residual abscesses of the 
cerebellum were found in one (OT 9) at  autopsy (Fig. 157). 
These five patients lived from two to more than 13 months after operation 
(Chapters Fifteen and Seventeen). Their postoperative courses were dominated 
by the septic hepatic infarctions. The numerous extrahepatic infections contri- 
buted to the morbidity but were not directly responsible for any of the deaths. 
Hepatic Sepsis, Excluding Gangrene.  The direct cause of death in patient OT 
10 was intraperitoneal rupture of an abscess in the left hepatic lobe 186 days 
after transplantation. This portion of the liver had not been involved by the 
septic infarction that developed at the end of the first postoperative month 
[Chapter Fifteen). However, the later infection may have spread by local in- 
\ asion from the chronically suppurating wound. 
All five of the homografts from these patients have now been examined at 
autopsy frorn 60 to 400 days after transplantation. There was one example of bac- 
terial cholangitis (Chapter Twenty). In this transplanted liver (OT 8), the intra- 
hepatic ducts after 400 days were dilated and filled with a chalk-like debris 
which consisted of polymorphonuclear leukocytes. gram negative bacteria, and 
an amorphous material. In some areas the bile epithelium had sloughed (Chapter 
Twenty). In this case. there was obstruction of the duct system by a large recur- 
rence of tumor (Chapters Seventeen and Twenty). 
LATER CASES 
In the last cases of liver transplantation collected from July 23, 1967, to 
xovember 10, 1968. attempts were made to avoid the circumstances that had 
previous1~- made infectious disease control either exceptionally difficult or im- 
Roche Companj,  Piofesslonal Serllce Department, 212 Oxford, h e n  York, Kew York 
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F i g z ~ r e  1 5 5 .  ~ u l ' t i ~ l e  infectious agents in  the 
lungs of OT 12 a t  autopsy three and a half 
months after transplantation. A, Cytomegalo- 
virus (hematoxylin and eosin stain, x 200). B, 
P I I ~ I L  ~izocys t i  ccirz?~ i i (methenamine silver 
stain. x 200). C. Gram negative bacteria (hema- 
toxylin and eosin stain, x 200). 
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Flcjzc~.e 156 .  Chest x-rays in patient 07 12. -1. 82 days after transplantation: There are  prominent 
I~roncho\-ascular markings but no evidence of' pneumonitis. B. 93 d'iys: B1~onchopneumonia on the  
~ ~ q h t  is evident. C .  104 days: Diffuse pneumonitis has de \  elopcd. D .  103 da \ s .  12 hours after the  x- 
1 , ~ )  sholr-n i n  C :  The infiltrate has  increased. The child died 105 da!s after transplantation, shortly 
'ifter an a t tempt  to debride a septic hepatic infarction. At autopsy c>-tornegalo\ irus (CAI\'). Pnezc- 
~ ~ z o c y s t i  cnviilli and .lerobacter-Klebsiella \ \ere  found in the 1:111gs. 
possible. There were 1 3  patients in  this final series. of whom 12 received ortho- 
topic homografts. Three of the 1 3  recipients died shortly after operation of 
technical complications (Chapter Nine) and will not be included in  this discus- 
sion. None of the remaining 10 developed partial gangrene of their transplants, 
although in two patients (OT 15 and 23) the homografts tvere inr-aded by recur- 
rent hepatoma many months later (Chapter Seventeen). 
Genera l  Postoperative Condit ion. Se\-en of the patients I\-ho obtained well 
functioning livers recovered quickly from the immediate effects of the opera- 
tion and n-ere able to eat and ambulate \vithin a few days. The other three (OT 
22 and 24 and AT 4) suffered from severe hepatic insufficiency and were 
bedridden: the>- died after 10. 11. and 24 days. respectively. 
Immunosuppression. The agents xvere used during the first n-eek in the same 
~ v a ) ~  as  in the intermediate series except that the doses of azathioprine were 
even smaller and the a1-erage quantities of prednisone \\-ere further increased 
I Fig. 131). There 11-ere no bouts of leukopenia. 
Nonhepat ic  Infections. The three recipients wit11 inadequate homograft func- 
tion all developed 01-ern-helming infections. I11 t11-o of these patients (OT 24 and 
.IT 4), Ca,zdiclu a l b ~ c a ~ z s  had been identified in  preoperative cultures of the 
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Figure 157.  Cerebellar monilial abscess found at autopsy (OT 9). 1Iore than two months previously 
she had had Ci1izdidil iill~ictiil,~ cultured from the peripheral blood on several occasions. The blood 
stream had cleared with amphotericin B therapy. (PAS stain, x 400.) 
&, -,"97 
.J P. ' 
 tracheal aspirate or stool. In both instances the fungus apparently became inva- 
21. ' sive in the postoperative period (Table 23). The problems were compounded by 
the appearance of gram negative bacteria in the lungs. urinary tract. and blood 
- # ,  ,* * #  
f :  stream. A third patient who received a liver with an obstructed duct system (OT 
22) died of multifocal gram negative sepsis. 
:.. r4n contrast: the seven patients with good early liver function had fewer and 
6 ,  # 8  ? 8 ,  . 
E mpre controllable infections. These are listed in Table 23. Early death resulted 
'I." 
, d . "". 
only in patient OT 17. who died after 35 days of pneumonitis caused by 
Pseudomonas. 
The nonlethal infections in the remaining six recipients were of great in- 
terest (Table 23) .  Bacteremia was documented at some time in all but patient 
OT 14. In four of the five patients the microorganisms grown from the blood 
stream either early or long after transplantation were of varieties that most 
likely originated from the intestinal tract. These included E. col i .  Aerobacter- 
Klebsiella. Enterococcus. Pseudomonas, diptheroids. C l o s t i ~ i c l i r ~ ~ n  pei fr i i zgerzs ,  
and Coi.yl-zebncte~.iri~?z boz is .  
At the time of most of the septicemias there was no er-idence from trans- 
aminase determinations or liver scans that major focal necrosis was occurring 
within the transplanted lir-ers. Furthermore, the patients n-ere sometimes not 
clinically ill on these occasions. This was especially surprising in the two pa- 
tients (OT 16 and 19) w11ose peripheral blood contained clostridia. In each 
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instance the infections were quickly controlled by the institution of antibiotic 
therapy (Table 23). 
In addition to the microorganisms that probably came from the intestinal 
tract, bacteremias were also seen (OT 13 and 16A) with Dlplococcris plzeumo- 
Izlae, Hemophilus and S t a p h .  a lbz ts;  the same organism could not be isolated 
from the upper airway. the trachea, or any of the other sampling sites. 
In fact, the source of the blood stream bacteria in the six patients could be 
found only in two (OT 15 and 23) who, coincident n i th  one of several bouts of 
septicemia late in their lives, had the same microorganisms in the urine. 
Hepatic Sepsis. Infection within the hornografts was probably caused in two 
of the long surv i~ inq  patients b> metastases (Chapter Selenteen). It Isas in 
these two cases ( 0 1  15 and 23) that the same bacteria were simultaneousl$ 
cultured from the urine and blood stream. The biliary ducts of one graft (OT 15) 
were obstructed by tumor with secondary cholangitis (Chapter Twenty); the 
other transplant was nearly replaced with metastases. 
There was one example of histologically diagnosed cholangitis in the ab- 
sence of duct obstruction (Chapters Seventeen and Twenty). The homograft 
was removed and replaced after 380 days (OT 14). 
" ' I  f '  /..W# 
THE INFECTIOUS PROBLEM IN 
Early in this chapter, emphasis46as placed on the general role of im- 
munosuppression in causing infektion in recipients of different whole organ 
homografts. It has become iwreasingly obvious that the consequent risks may 
be disproportionately gI:@t after liver transplantation. This fact was appre- 
ciated from the k g p h i n g  of our experience. but the reasons were not well 
defined Initially i t  was thought that drug o.i erdosage (Chapter Thirteen), LQ'ischemic inju~ir-io the homografts (Chapter SIX), and the need ior chrpgic 
antxiotic - therapy in patients mith'partial l i . ~  er gangrene (Chapter Fifteen) were 
the primar); factors that mere reiponsible for the extraordinarily hlgh incidence 
of extrahepatic septic complications. Obse~vations of inore recent cases of liver 
t r ~ p l a n t a t i o n ,  in which these adverse conditions were ax oided, have added a 
more sinister dimension. 
In the later patients there Tvas strong justification for belief that the trans- 
plazed_liv_er \$-as itself the portal of entrj  by which microorganisms of all u d s  
gained direct access to the blood stream. The lariety of bacteria that were 
--- 
cultured from peripheral I eins. e a r l ~  or many months after operation. n a s  strik- p.d I ingly similar to that found b! Brettschneider et all in dogs and pigs subjected ,L- 
to liver injury or hepatic transplantation. In the patients the failure to find any 
other focus of infection necessitated indictment of the holnograft by the pro- 
cess of exclusion, e ~ - e n  -hen the microorganisms were gram positi1.e cocci. 
The exposed relation of the orthotopic 1i1-er to gastrointestinal flora carried 
to it through the portal 1.enous and duct systems \\as discussed in Chapter 
Fifteen in describing ho11 gangrene developed in large focal areas of hepatic 
necrosis. The same routes of contanlinaticn n ere probabl! responsible for the 
sporadic bacteremias from the intact homografts. If the bacterial "leak" oc- 
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curred through the ducts, this was apparently possible without the presence of 
significant cholangitis since histopathologic evidence for the latter diagnosis 
has not commonly been found (Chapter Twenty). It should be added that portal 
phlebitis had not been diagnosed on morphologic grounds in any of the grafts; 
nevertheless. visible injury to the intrahepatic portal veins with consequent 
increased "porosity" is a hallmark of immunologic injury of transplanted livers 
(Chapter Twenty). 
The ease with which bacteria seemed to enter the circulation through the 
hepatic homografts may be partly due to the kind of alteration that cannot be 
seen through a microscope, namely, a subtle decline of a particular kind of 
graft reticuloendothelial activity. Conceivably this could lead to the loss of the 
normal function of bacterial filtration. Not only would this result in greater 
permeability of the transplant to microorganisms, but it could in a more general 
way undermine the total host defenses against infection of other organ 
systems. 
In spite of the special problems of infectious disease control which are 
introduced by liver transplantation, long-term survival after such procedures 
has not thereby been precluded in dogs (Chapter Twell-e). pigs (Chapter 
Eleven), or humans (Chapter Seventeen). Many factors which are essential for 
success have already been discussed in this and the preceding chapters. Of 
these, only the need for accurately controlled antibiotic administration will be 
mentioned again. Treatment must be guided by repeated cultures and sensitivi- 
ties. Otherwise, the overgrowth of resistant populations will be promoted. For 
the same reason, chronic antibiotic therapy should be avoided if at all possible. 
As was demonstrated in the later patients in the series, most of the bac- 
terial infectious complications could be promptly cleared with the institution of 
carefully selected antimicrobial drugs. An aggressive attempt at  accurate diag- 
nosis may be lifesaving even with infestations by opportunistic organisms such 
as fungus, cytomegalovirus. or Przeu??zocystis car in i i .  It has been reported that 
ccntrol of infections caused by these agents can sometimes be obtained by 
intensive courses of uncommon experimental drugs or by the administration of 
immune globulin." 4 . 1 8 . "  
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Chapter Seventeen 
LATE RESULTS AND COMPLICATIONS 
In this chapter attention will be focused primarily upon observations that 
were made two months or longer after orthotopic liver tran~plantation.'~, i"8X' 
Before doing this a capsule summary will be presented of the survival statistics 
in our total experience from March 1, 1963, to February 11, 1969. 
OVERALL RESULTS 
Throughout the book details have been given about all the 25 recipients of 
replacement homografts. Included have been analyses of the causes of early 
failure as well as suggestions for the avoidance of a number of acute or delayed 
complications of a serious or lethal nature. In the course of this exposition the 
length of survival of each recipient has been mentioned on one or more oc- 
casions. Since the same information will be documented in tabular form in 
Chapter Twenty-four, additional discussion now about this aspect of the prob- 
lem might seem superfluous. Nevertheless. there may be merit in examining 
the highly variable quality of the results in the different phases of our 
experience. 
The outcome in the total series is shonn in Figure 138. Twelve of the 25 
patients. including the first seven. did not live through the first postoperative 
month. As a consequence the life su r~ iva l  curve had a shape that was very 
similar to that with our first trials five to six years ago of renal homotransplan- 
tation betmeen nonrelated individuals (Fig. 107. Chapter Thirteen). The 
reasons for the steep acute loss rate have been thoroughly described in other 
chapters. In all sel-en of the earliest cases, the use of damaged homografts 
played an important role (Chapter Six). The death of subsequent recipients 
within the first four n-eeks was invariably related directly to a technical sur- 
gical accident of one kind or other (Chapters Elght and Sine) .  E ~ e n  in the 
second month two more patients (OT 17 and 23) died of coinplications which 
had their genesis from difficulties at the original operations (Chapter Kine). 
The absolute necessit! of having a technically perfect transplantatlon was 
particularly n-ell illustrated b! the experience which began on July 23. 1967. 
348 
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TOTAL SERIES - 25 PATIENTS 
- 
.9 \ @THROUGH JUNE 1967 - 7 PATIENTS @ JULY 1967 + MAY 1968 - 9 PATIENTS .8 a JUNE 1968 + FEB. 1969 - 9 PATIENTS 
TIME IN MONTHS 
Fi ,q lc~e  158 ,  Life survival curl-e of 2.5 patients treated at our institutions with orthotopic liver 
transplantation. The shortest follon--ups for recipients who are still alive on \lay 15. 1969, are 
10 (OT 19) and 12 (OT 16) months. Since Patient OT 19 still has perfect hepatic function, the curves 
inay be considered essentially complete to one year. The results have also been divided according 
to the first, second, and third intervals of our total experience. The ordinate indicates the fraction 
surviving. 
All patients treated after that date had the benefits of efforts at  histocompati- 
bility matching (Chapter Three), better immunosuppression (Chapter 
Thirteen), and an improved quality of the homografts (Chapter Six). The next 
nine consecutive recipients lived for at least tsvo postoperative months. At 3, 6, 
9, and 12 months there were 8. 5, 4, and 3 patients, respectis-ely. still surviving 
(Fig. 158). 
In contrast, the early results were much poorer in a final series of nine 
cases compiled from June. 1968 to Februar?. 1969. in n hich an array of anoma- 
lies was encountered (Chapters Eight and Nine) of either the host or 
homograft vascular system or of the graft extrahepatic biliary tree. There were 
only tno  of the nine later patients li\ing 60 days after transplantation, and by 
the end of the fifth postoperati\-e month only one was still s u r ~ i l i n g  (Fig. 158). 
An abnormal anatomic disposition of the hilar structures was an important 
factor in all but two of the seven lethal technical calamities which were respon- 
sible for the earl! failures. In Chapters Eight and Nine recommendations 
were made which might help In future cases to avoid similar accidents. Con- 
ceivably an additional useful practice lvould be to perform aortography prior to 
transplantation, at least in the recipients and possibly also in the donors. The 
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detection of unusual vascular patterns could lead to a decision against opera- 
tion or. at least, the information obtained could aid in the advance planning of a 
variant procedure. 
RECURRENCE OF MALIGNANT DISEASE 
There were 11 recipients of 12 homografts who survived for at least 60 
days after operation. With a single possible exception (OT 9), the subsequent 
events could not be said to have been influenced by earlier technical surgical 
complications. Nevertheless. not all these cases could be used to study in a 
clear way the life expectancy of patients with chronically functioning orthoto- 
pic livers. The reason was that several deaths were caused by the neoplastic 
process for which treatment was initially undertaken. 
As mentioned in Chapter One, the most absolute indication for liver replace- 
ment was thought at first to be primary hepatic malignancy that had ad- 
vanced to the stage at which a standard resection was no longer possible. This 
was the diagnosis in 11 of the 25 recipients of orthotopic liver homografts in 
our series. In each case extrahepatic metastases were not identifiable before or 
at the time of operation. Consequently it was thought that ali the total hepatec- 
tomies were potentially curative procedures. This proved to be an overly op- 
timistic projection. 
Clinical Observations in Liver Recipients 
E a r l y  Death. Seven of the 11 patients with primary cancer of the liver died 
from six and a half to 39 days after orthotopic hepatic homotransplantation (OT 
2 to 6 .  17. and 25). At autopsy an exhaustive search was made to determine if 
any metastases had been missed with the preoperative survey and the operative 
examination. No residual tumor was found in six of the seven cases. In the 
other patient (OT 4), there had been spread to one of the lumbar vertebrae. 
Prolonged Survival .  The other four recipients (OT 8. 14. 15. and 23) lived 
through the immediate effects of the operation and became available for longer 
term studies. In all four hepatic cell carcinoma (hepatoma) was the histologic 
diagnosis (Fig. 159A). One of the patients is still alive after 14 months, but with 
slo~vly growing metastases (OT 14). Recurrent neoplasm lvas responsible for 
the death of the other three after 143. 339. and 400 days. respectively. 
The general features of the four cases are summarized in Table 24. In the 
three patients who died of carcinomatosis. the diagnosis of recurrent inalignant 
disease was first made from 29 days to 13 weeks postoperatively 011 the basis of 
new abnormalities in the chest x-rays. After the first lesions became x-isible. 
these and other deposits enlarged 11-ith great rapidity (Figs. 160 to 162). 
The first chronic surx-il-or after orthotopic hepatic homotransplantation 
was a 19 month old child. 3Iore than three months after operation and a few 
days after pulmonar!- metastases had been diagnosed, she was found to have a 
mass in the light upper quadrant between the trans\-erse colon and the liver. 
'Te.1-t c o i z t i ~ z ~ i e d  011 p a g e  355.  ) 
LATE RESULTS AND COMPLICATIONS / 351 
Figure 159. Histologic similarity of pri- 
mary and secondary neoplastic growths in  a 
19 month old infant (OT 8) with a hepatic cell 
carcinonla. She was treated n-ith orthotopic 
lil-er transplantation. .4. Hepatoma xr-ithin the 
diseased lir er at the time of' transplantation. 
H and E stain. * 100.) E .  Portion of' a n  intra- 
'~bdominal nletastasis remol-ed at laparotomy 
Inore tllan se\ en months later. H and E stain, 
400. ' C. -1 secondar>- tumor found at autopsy 
11-ithin the lix-el holnoqrafr. 400 days post- 
tranil~lantatioll. The qross appearance of the 
ipecinlen can be seen in Fiqu1.e 163. H and E 
~ t j i l l .  x loo . ,  
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Table 24. Four Patients with Hepatoma" 
3IEThSTASES 
FIRST h I E T A S T A S E S  O R L A S S  
PATIENT DETECTED LOCATIOK FIRST TREATXIEST O F  TO YLTIMATELY CAUSE OF 
NUMBER (Days Postop) METASTASES ~ I E T A S T A S E S  HOLIOGRAFT I ~ O L E D  DEATH & TIME 
- 
-- 
OT 8 9 0  Lungs Vincri i t ine sulfate, Yes Bra in ,  lungs, liver, Carcinomatosir 
5 FU; surgical other abdomina l  400 days 
excision of intra- organs 
abdomina l  
masses; local 
x.ray therapy 
to pelvis 
OT 14 380 Diaphragm, liver, - 
retroperi toneal 
space 
OT 15 60 Lungs 
OT 23 2 9  Lungs 
Yes Diaphragm, retro- Al ive 14 months 
peri toneal space, 
ribs, liver, ? 
pancreas 
Yes Lungs, liver, Carcinomatosir 
d iaphragm 339 days 
Yes Brain, lungs, liver, Carcinomotosis 
retroperi toneal 143 dayr  
space 
"The fate of four patients who receix-ed liver replacement for the indication of hepatoma and who lived long 
enough after operation to permit observations about the course of the malignancy. 
F/c j z i i . t ,  I G O .  Chest x-rays of a 19 month 
old child tOT 8) ~ v h o  was treated with 
orthotopic lil-er tra:isplantation for the 
indication of hepatoma. .A. Preoperative 
study. The elevation of the  right hemi- 
diaphragni was caused b>- [lie marked 
hepato:neqal>-. B .  1Iultiple pulmonary 
nletastases sel-en months after trans- 
plantarion. El-idence of spread to the  
lungs had first been detectable in  the  
third post opera ti^-e month. C. Ilassive 
pullllonary metastases at one !ear. The 
child died of carcinomarosis 300 days 
af ter r ranspla l l tar io~~.  t B> permission of 
Surq. G!-nec. Obsret. 128 :327.  1969.) 
days 
4 days 
43 days 
F1cjzii.e 1 6 1 ,  . ippearance a n d  ex.olution of pulmonary lnetastases i n  patient OT 15. xvho received 
lix-er replacement for lippatoma, r l r  the  r i ~ n e  of operation there  17-as no ex-idence of' extrahepatic 
tumor  :roy\tli, 4 .  Chest  fihn obtaiiled 60 d,lx-s aftel  t ranip lanta t io i~ .  -I sinole neoplastic iiodule was  
detected .arro\i-".  In retrospect.  t he  lesion Ilas probabl> pre ient  011 earlier exami~ia t ions .  B.  S ine ty -  
fou r  da!-s postoperati\-ely. The ine ta i ta i l s  seen earlier has  enlareed heax->- a r ro~ \ - '  and  a t  least six 
:nore are  x-isible. C. Durino the  sex-ell ~ v e e k s  i i ~ i c e  the  pre7-ious x-ra!-. the  nodule indicated by the  
arrow has  more than doubled in  size. D. Six mon ths  postoperatix e. E .  Se7-en mon ths  postoperative. 
F .  S i n e  months  postoperati \e.  The  patient died 339 d a y  post-transplantation of pulmonary in-  
sufficiency. 
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F i g u  1.e I G2. Tlle extremely rapid der elopment of pulmonar?- metastases i n  patient OT 23. A, The  
ches t  i s  clear six d a y  af ter  lix er replacement for the  indication of hepatoma.  B .  TI\-ent>--nine days 
post opera ti^-e. TIT-o metastases a r e  1-isible in the  left loxi-er lung field tarroTrsi. C .  F i l e  days later 
the  t umor  deposits prel-iouil>- seen ha\-e nrolr-n in size l ~ o r i z o n t a l  arrox7 s I a nd  a third focus is now 
present i n  the  r icht  upper lobe twertical arro~r-3. D .  Fort>--four days. Only 10 da!-s ha! e elapsed since 
the  last examination.  3Ietasratic qroxr-t11s are  scattered throuqhout the  l u ~ s  arrolr-SI. E .  Seventy- 
four  d a y  postoperati\-e. F .  F O L I ~  ~ l l o n t l ~ s  af ter  operarioll. Transient d>-spnea was  first noticed a f e w  
days later. The  patient died of pu l~nona r>-  insuificieni> 113 d a > s  af ter  trallsl:lantation. 
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Because of its proximity to the cholecystoduodenostomy. the recurrence was 
excised; it weighed 28 gm. Other intra-abdominal masses soon appeared. The 
l'lrgest of these was in the left lower abdomen and pelvis. It eventually caused 
obstruction of the sigmoid colon and both ureters (Fig. 163A and B). More than 
scrven months after transplantation, 164 gm of the bulky pelvic tumor were 
rc~moved piecemeal along with the uterus and one ovary (Fig. 159B). Small 
~netastatic nodules were present throughout the rest of the abdomen. Tempo- 
r x y  palliation was obtained (Fig. 163C and D). 
Eventually a huge metastasis became evident in the same approximate 
subhepatic location as the first one that had been resected. It appeared to com- 
press the cholecystoduodenostomy and it was probably at least partly respon- 
sible for the jaundice that developed during the last few weeks of life (Fig. 
164), since, at  autopsy, the intrahepatic ducts were dilated and there was 
e~.idence of cholangitis (Chapter Twenty). 
Terminally, the child developed Jacksonian seizures. lapsed into coma and 
died 400 days after the homotransplantation. At autopsy large deposits of tumor 
t\.ere found within the calvarium, thorax, and abdominal cavity. It was of spe- 
cial interest that the liver homograft was the site of two moderately large neo- 
plastic nodules (Figs. 159C and 165) (the probable route of the metastatic 
spread will be discussed later); the transplanted organ weighed 520 gm. 
The distribution of the recurrences in the other three patients is given in 
Table 24. The most explosive metastases were in patient OT 23, beginning in 
the lungs (Fig. 162). However? the unique feature in this patient was the sud- 
denness and completeness with which tumor destroyed the homograft. This 
was eventually ref  ected in the development of hepatic failure. 
The benign early course of the recipient was considered in Chapter Four- 
teen. The only rejection that was encountered in the first two months was the 
mild "anicteric" variety. Then, about 13 weeks after transplantation, jaundice 
appeared and progressed until the time of death 143 days after operation. Ulti- 
mately, deterioration occurred of all other hepatic function tests (Fig. 166), 
although the immediate cause of death was pulmonary insufficiency. Late in 
the course there were two bouts of gram negative septicemia (Fig. 166). 
The reason for the homograft functional abnormalities was at first SUS- 
pected to be delayed rejection. However, liver scans revealed very rapidly enlarg- 
ing areas of poor or absent isotope concentration in both hepatic lobes of the 
enlarged transplant (Fig. 167). Since these changes were not initially accom- 
panied by fever. septicemia, or the high transaminase rises seen with septic 
hepatic infarction (Chapter Fifteen), the diagnosis was made of recurrent hepa- 
toma. An aortogram showed the arterial blood supply to be intact. 
At autopsy the liver weighed 3000 gm compared to an estimated \veight of 
- - 130 gm at the time of transplantation. Its blood supply was intact and the 
biliary duct system lvas unobstructed (Fig. 168). An estimated 93 per cent of 
the organ consisted of tumor. The only tissue that resembled hepatic 
parenchyma grossly was in the central portion. The outer shell of carcinoma 
had the same necrotic appearance (Fig. 169, u p p e r )  and crumbly consistency of 
the widespread pulmonary metastases (Fig. 169. loz~mer). The cell type of the 
recurrences was similar to that of the original hepatoma. 
(Te.1-t con t i7z~ ied  on pnge  364.) 
356 1 LATE RESULTS AND COMPLICATIONS 
Figzcre  163. Palliation achie1-ed in patient OT 8 follo11-illy illtra-abdolliiliC~l t umor  recurrences.  
A 28-gram metastasis i n  the  riqht upper quadrant  had been excised 99 da!-> post-transplantation. 
Four  n ~ o n t l ~ s  later esp!oration 11-as again necessar! i n  order to relie1 e o b s t r ~ ~ c t i o n  of the  signloid 
colon a n d  both ureters.  .i. Intrar-enous pyeloyram obtained 219 da?-s af ter  transplantation.  B .  Bar ium 
e n e m a  performed the  s a m e  da!. Tlle r ec tum is deflecred ro tlie r ight:  tlie sigmoid cololl is displaced 
upward a n d  posteriori!-. C .  Shortl?- a f ter  the  abo1-e esaminar ions .  163 q ~ i  of rhe tumor  Illass xrere 
removed f rom the  pel1 is. A11 11-P pelformed 111 o TI eehs later denlollstrates relief of t he  bilateral 
ureteral  obstruction.  D .  Bariuni el lema esa i~i ina t ion  241 days post-transplallrarion. The  colon a n d  
r ec tum appear  normal  and  1~-itliout displacement.  
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1 Pulmonary lobectomy 4 E x c ~ s ~ o n  recurrence 6 Adhes~olys~s for 
upper abdomen n tes t~na  obstruct~on 
8 Evacuation-necrot~c rlght 1 2 Debr~dement s e ~ t ~ c  upper quadrant tumor 
hepatc ~nfarc ion 5 Portal excs~on pelv~c 7 Compress~on of liver h~lum 9 Convuls~ons 
or hepatc scan 
on cnest x ray I0 Re castructor of ureters ard slamold colon 
SGOT ( I .U.)  6 0 0  
10.8+ 12.4 kg. 
I 
SERUM PROTEIN 8 
PHOSPHATASE zoo 
TOTAL- 5 
HORSE A LG 
T I M E  IN DAYS 
Fvjl ire 164.  Tlie total course of the first cliro~iic survivor after orthotopic li\-er transplantation. 
Tlie 19 month old child :OT 8 )  liad a hepatoma ri-hich eventually caused multiple recurrences i n  
the lungs, homosraft .  other abdornilial viscera. and brain. The early conr-alescence was complicated 
b> a septic hepatic infarction, the details of rrhich are docun~en ted  in Figure 110. Chapter 15; both 
the earl!- and the  later positive blood cultures rrith gram negative organisms probably came from 
the liver. The  administration of \-incristine and  3-fluorouracil i5-Fu)  had no effect 011 the rate of 
l ~ ~ e t a s t a t i c  progression. nor did the  local irradiation of the  pe1r.i~ tunlor. The increasing h>~perbili- 
lubinemia during the last three months of life n-as thouqht to be due to con~press ion of the  biliary 
drainage system by a hug? riqht upper quadrant mass,  Kote that a11 expanded time scale has  been 
used in  the last 130 da>-s of life. during n.liicli tinle there \\-as marked 11>-pergalnmaglobulinemia. 
The normal ranges a t  this age for the enz>-me measurements rr-ere: alkaline phosphatase (73  to 225 
1. U. )  and SGOT (less than T O  I. U.). 
358 1 LATE RESULTS AND COMPLICATIONS 
F i g u r e  165. The hepatic homograft remox-ed more than 13 months after orthotopic lix-er trans- 
plantation in patient OT 8, r o t e  the txy-o lar2e metastatic nodules. :B>- permission of' Surq.  Gynec. 
Obstet. 128 :317, 1969.) 
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CORRELATION WITH 
SCANS OF FIG I68 
BLOOD CULTURES I 1 
SERUM PROTEIN 7 5  
( g n / l 0 0  ml) 
TOTAL - 5 0 -  _ _ _ _ _ - - - - -  _ _ _ - - - - _  
A L B U M I N - - - -  25. ..,.......\.. --,,----- - - - - - -  -. -- _ _ - - - _ _ _ - - -  - - - - - -  -..- _____.  _ _  
y GLOBULIN . . . . .  . . . . . . . . . .  . . . .  . . . . .  
. . . .  0 
S G O T  ( I U )  
ALKALINE 
PHOSPHATASE 
( 5 - L  U )  
3 
BILIRUBIN 
TOTAL - 
CONJUGATED-- - -  
0 -  
..,~ 
3 \--.,-- ....... 
203 1 
- -- - ~ ~p 
- - 
A L G ~  E A L Y  b39SE b 0 E  iC3SE l  33:-SCAT I TK:E 2 N!EK - 716317 1 
1reG3 5 c ' 5  23 25 <2 35 4i ' 5  53 55 EC 65 -3 83  e5 93  95 CC. C 5  C I 5  23 25 I33 3 5  4 0  
CRTH3TCalC 
TOL~SP'.A~-&T 31, T I M E  I N  DAYS 
F i g u r e  IG6. The  nlanifestations of the  inr-asion and nearly complete destruction of an  orthotopic 
liver homograft  by recurrent hepatoma (patient OT 23). The sporadic large doses of intravenous 
ljrednisolone were given because of the possibility that the deteriorating li\ e r  function n a s  due  to 
delal-ed rejection. .At autopsy almost all the t rans l~lanted hep,~t ic  t i s iue  \la5 replaced by tumor  
Fig. 169). Note that the  patient had hyperqammaglohulillenlia before transplantation and  that this 
finding persisted during most of the postoperative period. The  normal ranqe for Bessey-Lowry (B-L) 
cilkaline phosphatase units is  1 to 3. The normals for the SGOT and  SGPT units at  this age  are  60 
to 100 and 5 to 35. r e spec t i~e ly .  
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Figz11.e 167.  Destructio~l of the homograft in patient OT 23 by tumor recurrence. The postero- 
anterior and lateral lil-er scans \\-ere obtained xrith """technetium, A. 68 days: The scan is the same 
as the last one sholr-n in Figure 123. Chapter 14. E .  94 da!-s: The patient had become jaundiced. 
Hepatomegal? is ex-ident. 
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F I 6 C o r ~ t i i r  z~('il .  C. 101 da!-s: IIult iple areas of poor isotope collcentratioll a re  noxv visible. 
D. 111 days:  The  process has  continued its rapid progression. By the t ime of death  one  mon th  later, 
the homograft  xras allnost completely replaced with carcinoma. 
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F c  1 The posrmortem cho1an:iosram in patient OT 23. At transplantation. 113 days earlier. 
biliary reconstraction   as \\it11 a cholecystoduodenostomy. The autopsy stud>- Ivas made by tying 
a catheter into the gallbladder ( G B ) .  CED=common bile duct: CD=cystic duct:  CHD=common 
hepatic duct. The parench5-ma1 extra\-asation indicated by the arrolr. \ras due to removal of a speci- 
men from the left lobe. 
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F i g u r e  169. 3Ietastases in  patient OT 23.  143 d a ~ s  after orthotopic lil-er transplantation. A ,  The 
111-er homograft. It has been replaced b!- rumor except for a vex)- small residual area of hepatic 
parenchyma (anon.). B .  Loic er.. Extensix e pulmonar!- metastases. 
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A third patient (OT 15) lived for 339 days despite the presence of lung 
metastases (Fig. 161) during most of this time: death was caused by pulmonary 
insufficiency. During the first few weeks after operation he had passed 
through an explosive rejection crisis (Chapter Fourteen), but homograft func- 
tion was thereafter excellent for more than two thirds of a year (Fig. 170). In 
the tenth postoperative month jaundice suddenly appeared, which waxed and 
waned for the remaining two months of life. usually in parallel with variations 
of the alkaline phosphatase. Moderate transaminase rises were also recorded, 
but there was serious deterioration of protein metabolism only terminally. 
During the period of survival numerous liver scans were obtained. In re- 
trospect, it was oblious that the homograft had begun to increase in size sev- 
eral weeks before the abnormalities in hepatic function became detectable. At 
the same time an  area of decreased isotope uptake had become evident in the 
SERUM PROTEIN 
(grn/lOO rnl) 
OT 15 
62+74+63 kg. 
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Fiqu1.e 170. The  course of a patient (OT 13) ~ h o  died of recurrent  hepatoma despite total hepa- 
tectom!: and  orthotopic liver transplantation. He passed through a n  earl>- and vigorous rejection 
crisis but  then had norliial liver function for man?- months .  Note that a condensed scale has  been 
used for the  first 240 postoperatix-e days: the  details of the  earl!: portion of the  convalescence are  
sholvn in  Figure 127. Chapter 14. The recurrent rumor Tras first diagnosed n-ith the lix-er scan about 
eight tnontlis af ter  transplantation (Fig .  171)  and biopsy confirmation was  obtained more  than a 
month later. The episodic septiceniia and deterioration of lit-er function were probably the con- 
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sequence of in\-asion by tu~lnor of the extraliepatic ducts Fig. 172).  The interrnittellt large steroid 
doses were gi! e n  on the zhance that rejection \\-as also occurring. Fro111 left to right the different 
shadings in  the ALG bar indicate that the  illjectiolls \\-ere daiil-. ex erl- other day. every three days, 
and t11-ice a week. Tile normal alkaline phosphatase range in  Bessel--Lo;x-r> units is  1 to 3. For the  
SGOT and SGPT the  norlnal rallses are 60 to 100 and 5 ro 35 units.  respecti!-el!:. See tes t  for dis- 
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hilum (Fig. 171). Shortly after the development of icterus, positive blood cul- 
tures of E ,  coli or Pseudomonas began to appear remittently (Fig. 170). It was 
decided to explore the suspicious region because of the possible diagnoses of 
liver abscess, septic hepatic infarction. or tumor metastases. At operation the 
1i1-er in this area was somewhat firmer than normal but there was no evidence 
of necrosis. When a needle was placed into the zone of selective reticuloen- 
F1cjlcl.e 171 .  The  progression of recurrenr hepatoma in  a transplanted orthotopic l i l e l  O T  13). 
3 months :  The  examination 1s essentially ilormal. 6 1no1:rhs: There  has  'Dee11 no siq:lificLint change.  
S mon ths :  .A llorcll i n  the  h i lum is noll- 1-isihle. 8' i inonrlls: TI\-o TI-eeks later rhe defect  has  become 
m u c h  lnore e l - ide~l t .  IIoreox-er, the  lil-er has  irlcreased in  size. 9 moi l th i :  Fu r the r  proqression. 
cjl 2 rno~l t i l s :  . i t  the  t ime of rhis scan.  jaundice appeared.  Tlle patient evenruall\- died 339 days after 
:ransplantation. 
366 / LATE RESULTS AND COMPLICATIONS 
dothelial nonfunction, increased resistance was encountered for several centi- 
meters. The needle then passed into softer hepatic tissue. A biopsy extracted 
through the needle contained carcinoma. 
At the time of autopsy the diaphragmatic surface of the liver appeared 
grossly normal. By postmortem angiography, its blood supply was demonstrated 
to be unobstructed. Cholecystograms and cholangiograms were also made 
which showed that the gallbladder was collapsed and that the cystic duct was 
open. hTevertheless, there appeared to be a dye extrayasation in the hilum as 
well as a general dilation of the entire intrahepatic collecting system (Fig. 172). 
When the 1950 gm homograft was sliced in a coronal plane (Fig. 173, A), 
two large metastases were found. The one previously identified in the hilum by 
the liver scan was 10 cm in diameter. Its postero-inferior portion impinged 
upon the common hepatic duct. In this area there was a cavity which contained 
necrotic tissue and bile. Erosion of the duct system at this point was thought to 
Figzc1.e 172. Postmortem cholan~ioi. ,ram ill patient 07 13.  Biliary reconstruction had been with 
a cholecystoduodenosrolny The  d>-e !\-as injected through a ca theter  tied illto the  collapsed gall- 
bladder (GB\. \-ore the  extra\-asation of contrast  material  extra!:  and  the  senera1 dilatation of 
t he  duct  sys tem.  The  correlation of these findings with t he  del-elopmenr of metas tases  is  discussed 
in  the  text. The  1 - a s c u l a ~  s h a d o ~ i s  resulted fro111 a n  aortogram. The  art ifact  indicated by the  ar row 
was  caused by removing a parenchymal  specimen.  
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A B 
Firlure 173. Large metastases 339 days after transplantation in the  l i rer  homograft  of' patient 
0 r  15. A. hlass in  hilusn seen on the  liver scans  durinq life (Fig. 171): it apparently had eroded into 
tile distal duct system (Fig. 172). B.  Larqer metastasis in the \ i ~ p c r i o ~ ,  portion of ' the  riqht hepatic 
lobe. I t s  presence had not been detected n-ith premortem scans.  ..\ sholr-s the riqht lobe: B ,  the left. 
have occurred, accounting for the dye extravasation seen on the cholangiogram 
(Fig. 172). The dilated biliary radicals within the liver contained a few stones 
and extensive "sludge." The duct obstruction may have been the basis for the 
episodic septicemia in the last two months of life: cholangitis was present 
lvithin the homograft (Chapter Twenty). 
An even larger recurrence which had not been suspected on the basis of 
the liver scans during life was found in the center of the right lobe: it was 13 
cm in diameter (Fig. 173. B). The only other metastasis in the homograft origi- 
nated in the suprahepatic vena caval suture line. It had a tail that was floating 
up the superior vena cava almost to the right atrium. 
The lungs were nearly replaced with tumor. Metastases were also found in 
several plaques in or near the central tendon of the diaphragm. 
The fourth patient (OT 14) was thought to be free of metastases for more 
than a year after operation. during which time her homograft function slowly 
deteriorated. After 380 days retransplantation was carried out. as will be dis- 
cussed later in this chapter. \T7hile the li\-er was being removed, plaques of 
localized neoplasm were encountered in both halves of the diaphragm, in the 
light retroperitoneal space near the adrenal gland, and in the posterolateral 
parts of several of the lolver ribs. In addition, several tiny nodules of tumor 
Tvere found imbedded in the con\-ex surface of the right lobe of the homograft: 
all these were less than 1 cm in diameter. There were no detectable metastases 
within the interior of the transplanted organ. 
Hepatic Arterial Thrombosis. As mentioned pre1-iously. the patency of the 
homograft blood supply was pro\-ed by postmortem angiography in two of the 
four recipients with recurrent malignant disease (OT 13 and 23) .  In a third (OT 
b) .  the hepatic artery had throinbosed (Fig. 174). presumably a long time before 
her death at 400 days. The observations in this case were germane to the ques- 
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Fig1ci.e 174.  Pos tmortem aortoqram obtained 300 dal-s af ter  orrhotopic 1i1-er transplantation.  
Note that  the  hepatic arter! i s  not present and  that  t he  only demonstrable arterial supply to t he  liver 
is f rom some smal l  r~v igs  a r r o ~ l - ,  of the  riqht phrenic artery (RPX). C, axis=celiac axis:  LGA=left 
gastric arterl- :  L P - k l e f t  phrenic artery:  R R . I = r i ~ h t  renal  artery:  S.A=splenic artery:  SlIA=superior 
mesenteric arterl-. 
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tion" of "whether or not metastases metastasize." They had apparently done so 
(Fig. 165) and via the portal venous route. 
At the time of retransplantation of patient OT 14, the reconstructed com- 
mon hepatic artery was also found to be occluded by an old thrombosis. There 
nas  no tumor in the vicinity of the arterial anastomosis to suggest that metas- 
tases were responsible for the complication. 
It is of interest that one of Calne's patients who lived for more than two 
postoperative months also had clot formation in the hepatic artery. Emboli 
apparently passed from this source to cause infarcts in the distal tissue, includ- 
ing the gallbladder. The recipient died after 72 days.Ih 
The Possible Effect of lmmunosuppression on 
Tumor Growth 
It might be argued that the frequency and seriousness of the recurrences 
were approximately predictable from what is already known", ",4" 73 about 
the highly unfavorable natural history of primary hepatic malignancies. 
However, there is the additional possibility that the metastatic growth may 
actually have been accelerated as  a consequence of the immunosuppressive 
therapy in those patients who were unknowingly left with residual neo- 
plasm.~" 81. 82 There has been increasing acceptance of the concept that the 
immunologic system provides a "surveillance" function". 44 by which mutant 
neoplastic cells are identified and either eliminated or restricted in their 
qrowth potential. The individuality of such cells, which allows theirrecognitionas 
foreign? has been thought to be due to tumor specific antigens.".:". "'.4:'.44.4X.i9~"3". 
Should the surveillance hypothesis be valid it would follo\~- that neoplastic 
sequelae of one kind or other would constitute a threat in immunosuppressed 
patients after clinical transplantation procedures. Several observations that 
have been made in human recipients of renal homografts have tended to con- 
firm this expectation. 
lmmunosuppression and the Transplantability of Tumors. A few years ago three 
different teams employed renal homografts that had been obtained from pa- 
tients whose deaths were caused by carcinoma of the lung"" * K  or of the pyri- 
form sinus." In each instance the transplanted kidney was not thought to be 
involved by tumor at the time of the organ removal. Good homograft function 
rvas obtained with the aid of azathioprine and prednisone therapy. Four to 18 
months later neoplastic growth of the same histologic type as that which had 
been present in the donor was found in the transplanted organs. 
In all three cases the accidentally transplanted tumors had become autono- 
111ous by the time the diagnosis was made."L". *"yen though immunosuppres- 
sion was discontinued. metastases developed in tn-o of the recipients and led to 
death. The third patient recol-ered after drug therap>- was stopped and after 
radical but incomplete excision was carried out of the renal homograft and the 
local neoplastic grolvth in the transplant ~vound."' It was concluded that the 
remaining tumor had undergone rejection coincident with reco\-ery from par- 
tial immune paralysis. 
370 1 LATE RESULTS AND COMPLICATIONS 
The Spontaneous Development of N e w  Tumors. Since neoplastic and non-neo- 
plastic tissues are rejected by a common mechanism and are subject to similar 
rules of hist~compatibility, '~ 'h 30 4"'" '" ."'% protection of inadvertently 
transferred tumor by antirejection therapy in the renal patients was hardly 
surprising. A much more specific example of the oncogenic effect of im- 
munosuppression has been the development of new malignancies in a number 
of renal homograft recipients whose kidneys were obtained from healthy do- 
nors. This complication was first reported from our institutions"' i 4 3  X L  on the 
basis of four of our own cases and two more contributed from other centers 
(Table 25). In five of the six patients the neoplasia was of cells of mesenchymal 
origin. More than a dozen other published", hH or unpublished instances of de 
novo malignancies after renal transplantation have since been brought to our 
attention. About half of these were carcinomas and the rest were lymphomas. 
The diagnosis of an occasional neoplasm in any patient group of substantial 
size would not be particularly alarming. However, the incidence of malignant 
disease in our renal recipient pool far exceeded that which would have been 
expected by chance. Before May, 1967. approximately 170 patients were treated 
with renal homografts. In about 70 per cent of the patients survival of six 
months or longer was obtained. It was within this group of approximately 120 
chronic survivors that the four malignancies were detected, giving an in- 
cidence of between 3 and 4 per cent in those patients who lived long enough for 
meaningful observations to be made. 
The diagnosis of malignant neoplasia was made post mortem in one of the 
four patients followed by us. In that patient renal homotransplantation had 
been carried out more than two and a half years previously. Death occurred six 
days after emergency vagotomy and gastrectomy were performed to control 
massive upper gastrointestinal bleeding. The resected portion of the stomach 
contained several ulcers in the bases of which were small foci of reticulum cell 
sarcoma that were strikingly similar histologically to larger deposits found at 
autopsy in many other organs. 
In  the other three patients the presence of neoplasm was recognized during 
life. In one patient the diagnosis of reticulum cell sarcoma was made by cranio- 
tomy a few da)s before the very extensive tumor of the brain caused the pa- 
tient's death almost six and a half months after renal transplantation. A third 
patient developed a mass in the basal diencephalon a few months following 
renal transplantation. A biopsy was taken with a stereotaxic instrument and the 
lesion proved to be a plasmacytoma. The doses of the immunosuppressive 
agents were drasticall) reduced and the brain stem was treated with local irra- 
diation. Fortunatel) the kidney did not reject. but the tumor apparently under- 
went involution. since the patient has non been well for more than a year. The 
fourth patient developed a squamous cell carcinoma of the ear, two and a half 
years after renal transplantation (Table 23). Radical surgical excision resulted 
in an apparent cure. 
In recipients of renal homografts there could be many ways in n hich bio- 
logic surveillance might be eroded. beginning n i th  the loss of the immu- 
nologic react i~i ty  that may accompany the pre-existing uremia (See Chapter 
Eleven). In addition, each of the main immunosuppressi~e agents. azathio- 
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prine,19, 20 prednisone!~, L 8, 9, xs and ALG,"', 1 5 3  2 3 3  2 4 3  36 has been shown in animals 
either to: (1) increase the incidence of spontaneous, virus-induced, or 
chemically initiated tumors, (2) facilitate the ease with which malignant cells 
can be transplanted, or ( 3 )  accelerate metastatic growth. In addition, thymec- 
tomy& "'3. : j2. 4;. 34. . j i  or splenectomy" has a similar but less certain effect. 
Another factor was suggested in our reports". i43 to explain the dispropor- 
tionate number of mesenchymal tumors in the patients. The possibility was 
raised that chronic stimulation of the host reticuloendothelial system by anti- 
gens of the homograft was responsible for the nature of the malignancies. The 
role of antigenic stimulation in increasing the incidence of experimental lym- 
phomas has been well establi~hed. '~.  "" 6 i 3  xX" 
The Effect on Metastases. As already mentioned, each of the immunosuppres- 
sive measures used in our patients can increase the rapidity of metastases of 
experimental tumors under the appropriate circumstances. Acceleration of 
spread has been described with the administration of prednisone,', " $!'% X" ALG,36 
and azathioprinellQr after the performance of splene~tomy.:~ There is no real 
reason to think that the same factors would not be significant clinically. The 
very explosive behavior of the recurrent disease in all but one of the liver 
transplant recipients was compatible with this concept. 
In the field of kidney transplantation, an  observation by Williams et alRi 
may be relevant to the question of metastatic acceleration. They performed 
renal homotransplantation in a child six months after excision of a Wilms' 
tumor. Sixteen months after transplantation, at a time when cure of this kind 
of neoplasm would usually have been assured under normal conditions, metas- 
tases became apparent and led to death within a few weeks. The experience 
was reminiscent of an earlier one reported by K u ~ s . ~ "  One of his first renal 
recipients died of carcinomatosis 129 days after transplantation for the indica- 
tion of hypernephroma of a solitary kidney. 
General  Conclusions 
Even though all four patients developed recurrences of their hepatic carci- 
nomas, there is no question but that life was prolonged and at least temporarily 
made more pleasant by the removal of the primary neoplastic focus. If only for 
this reason, it would seem premature at the present time to abandon the hope 
of using liver replacement for the treatment of hepatomas or cholangiocarcino- 
mas. In addition. the feasibility of achieving a more lasting benefit has not 
necessarily been precluded. The original tumors in these cases were so large 
that it may have been unrealistic to hope that microscopic spread had not 
already occurred. 
Nevertheless, if it is elected to attempt this form of therapy in future cases, 
it will be of great importance to be even more careful than in the past in 
screening prospective candidates. The experience acquired so far suggests that, 
if the neoplasm is not completely removed, a progressive downhill course from 
carcinomatosis can be expected. Under these circumstances there is a good 
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possibility that the immune suppression can contribute to the rapidity of 
growth of the secondary deposits. 
Even if orthotopic liver transplantation proves to be curative for the oc- 
casional patient with hepatoma. it can be predicted that the greatest value of 
this procedure will be for the treatment of non-neoplastic hepatic diseases. In a 
historic perspective the experience with hepatomas will probably be viewed as 
significant principally because the efforts at therapy were responsible for de- 
monstrating that the operation of liver replacement could be successfully per- 
formed in man. 
LATE REJECTION (AFTER TWO MONTHS) 
In the patients with hepatoma a complete and decisive assessment of the 
potential value of liver transplantation was not possible. First, the mortality of 
the pre-existing malignant process within the first 400 postoperative days 
proved to be 75 per cent despite total hepatectomy and otherwise successful 
liver replacement. Second, studies of the effectiveness of the therapeutic proto- 
cols designed to prevent graft repudiation became obscured in three of the four 
patients with malignant recurrences since the transplanted organs were in- 
vaded by tumor and either thereby destroyed (OT 23) or seriously compromised 
by obstruction of the biliary duct systems (OT 8 and 15). Finally, it could be 
speculated that the vigor of the host response to the homografts may have been 
initiated at a low level in these recipients since patients or animals with carci- 
noma may have a reduced immunologic reactivity.Ih "' "'s " - " Hi Under the 
latter circumstance a deceptive idea could be obtained of the requirements for 
control of rejection if the conclusions were extrapolated against a background 
of non-neoplastic hepatic disease. 
Fortunately there were a number of opportunities to study chronically sur- 
viving patients without the complicating factor of serious injur) to their 
homografts by recurrent hepatoma. There were eight recipients of this kind 
who lived for two months or longer. The original diagnosis %\as hepatic malig- 
nant disease in only one patient (OT 14): in the others it \$-as biliary atresia. The 
complete courses of patients OT 11 and 12 have already been presented (Chap- 
ter Fifteen) and will therefore be omitted from the following account. In these 
two patients death occurred a short time after the development of gangrene of 
part or all of the right lobe of the liver. S u r ~ i ~ a l  was for 61 and 105 days, 
respecti~ ely. The other six patients contributed to a delineation of the problems 
to be discussed no\\-. 
Time of Onset and Relation to Previous Rejection 
In the field of renal transplantation the term late rejection has been loosely 
used to describe the failure of kidney grafts, either suddenly or gradually, 
months or even years after operation. An analogous delayed deterioration of 
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hepatic homograft function has commonly been seen after liver transplanta- 
tion. The histopathologic findings in a number of the livers will be described in 
Chapter Twenty. 
In the six cases under discussion, delayed homograft repudiation was diag- 
nosed from 63  to 175 days after transplantation. The exact timing in each 
instance is given in Table 26, as well as a notation about the kind of course that 
had been encountered earlier. Two (OT 10 and 13) of the six patients. including 
one with a prior septic hepatic infarction, had previously passed through what 
was called an  "anicteric rejection" (Chapters Fourteen and Fifteen) which be- 
gan during the first postoperative month. They then became significantly jaun- 
diced for the first time in the post-transplantation period after a variable subse- 
quent interval. 
The other four recipients had suffered either an  explosive but quickly 
reversible early rejection (OT 19) or else the indolent and persistent variety (OT 
9, 14, and 16). In all but one of the latter four patients the hyperbilirubinemia 
which resulted from the first assault upon the homografts had more or less 
completely abated. An intervening jaundice-free period of 27 days to five 
months followed before the arrival of the second bout of icterus. The excep- 
tional patient (OT 16) was one who received two consecutive livers. The fate of 
his primary homograft was described in Chapter Fourteen. The next transplant 
underwent a vigorous and refractory rejection beginning during the fourth 
Table 26. Late Rejection in Six Transplant Patients" 
PATIE>-T PRE\'IOLS E.4RLY REJEC T I O S  A L L  L A T E  H O R I O G R A F T  D E T E R I O R  \TIOX O V T C O M E  A 
NUhIp,ER 5 IOppE" 
O1z,5rt Re? e r j -  :days) 0 1 1 i e t  Rrzr ers -  
' d u y ,  y e  i i ~ l e  tlcig\ D c ~ ~ e l o l ~ i n e ~ ~ t  ible 
OT 9 5  17  Indolent Yes 49 63 Gradual  No  Died hepatic fai lure, 
133 days 
OT 105 14 Anicteric Yes 5 1 8 4  Gradual  No Died hepatic fa i lu re  & 
sepsis, 186 days 
OT 13 25 Anicteric Yes 112 175 Gradua l  N o  Alive & jaundiced 14 
months; received sec- 
ond course ALG 
OT 14 6 Indolent Yes 73 84 Gradua l  No  Alive 15 days after re- 
transplantat ion a t  
380 days 
OT 16A 13 Indolent N o  18 Contin. G radua l  No  Retransplantation, 68 
of early days 
rejection 
OT 168 32 Indolent N o  134 Cantin. G radua l  N o  Alive & jaundiced 8 
of early months after second 
reject ion transplantat ion 
OT 19 29 Crisis Yes Sti l l  7 1 Sudden Yes A l ~ v e  9 months, normal 
given, liver function 
9 moi  
Features of late rejection in six patients whose delayed deterioration of liver function w-as not 1,elated to 
invasion of their holnoyrafts by recurrent hepatoma. 
Classification defined in Chapter Fourteen. 
' A s  o f  .April 13. 1969.  
5 Early septic hepatic infarction (see Chapter Fifteen). 
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postoperative week. The consequent jaundice could never be reversed, 
although the organ has continued to support life for many subsequent months; 
the processes of early and late rejection were inseparable by clinical and bio- 
chemical criteria. 
Relation to Adjustments in immunosuppression 
In Chapter Thirteen it was pointed out that the extent to which im- 
munosuppressive treatment could eventually be lightened without precipi- 
tating rejection was one of the most important determinants of long-term prog- 
nosis after human renal transplantation. It was also made clear that the fre- 
quent feasibility of attenuating antirejection therapy has been established in 
both animal (Chapter Twelve) and human (Chapter Fourteen) recipients of 
orthotopic liver homografts. Now the evidence must be considered that the 
poorly understood alterations in the host-graft relationship that make such 
therapeutic adjustments possible have proved in the clinical cases of liver 
transplantation to be less complete than had been hoped for. 
A striking observation in several instances was that of an  apparent long- 
term dependence upon ALG therapy. In five of the six patients globulin treat- 
ment was started on the day of or the day before transplantation. Afterward, 
injections were continued for 18 days to nine months. sometimes with a 
change from one heterologous species to another. They were finally stopped in 
all but one of the patients either because of a variety of toxic reactions or 
because the preplanned interval of treatment had ended. Within a few days to 
two months, a progressive deterioration of hepatic function (Fig. 175) became 
detectable (Table 26). It was particularly disquieting to have this happen very 
promptly after discontinuing ALG in one patient (OT 13) whose course had 
been excellent and very stable for the previous five months (Fig. 176). The 
most satisfactory long-term result in the entire series (Fig. 128. Chapter Four- 
teen) was in a recipient who is still being given horse ALG more than nine 
months after liver replacement for intrahepatic biliary atresia. He has normal 
hepatic function despite the fact that he had a very poor histocompatibility 
match with his donor (Table 5, Chapter Three). 
The circumstances of treatment were different in the sixth patient, since 
ALG was not given following retransplantation until after the onset of a severe 
rejection (Fig. 177). Immune globulin prepared from rabbit or goat ALS was 
then administered for the next four and a half months. Homograft function 
worsened slightly during this time. After the injections were finally stopped 
there was no immediate dramatic change in the measured hepatic metabolism 
(Fig. 177). 
The Presentation of l a t e  Rejection 
The hepatic function in five of the six patients (OT 9, 10, 13, 14, and 16) 
became progressive11 abnormal over a period of several weeks. The bio- 
chemical manifestations were similar to those of complete or nearly complete 
biliary obstruction. Bile disappeared from the stools and appeared in the urine. 
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OT 14 
SGOT - 
TOTAL- ALBUMIN---4 ,. ..., ". .-,...--...... - - - - - -  - -  - - - -  -.- ____.__----- ... _ _ _ _  , ,---" ,I,---______----.._ .-..- -----. _,\ \.-- 
7 GLOBULIN- ,.-' 
BILIRUBIN 35. 
( r ng / l 00  ml) 30 
TOTAL - 25 
CONJUGATED-.. 2 0 ~  
CESEhlSTlZATON 
ALG 
ORTH3T:'C 
TRANSPLCYTCTCN T IME IN DAYS 
F l g r i ?  e I T 3  The course of a patient (OT 14) after t n o  olthotopic l i ~  er transplantations The second 
llrer replacement was  380 daxs after the first At the time of retransplantation local lecurrence 
of the neoplasm was demonstrated but there was very little tumor in  the liver to account for its 
functional deterioration. Holvever. the hepatic artery of the discarded homograft was completely 
occluded by a n  old thrombosis. Throughout the period of fol1ox~--up ver!- small doses of azathioprine 
were given, usually 12.3 mg per day. Shortly after the discontinuance of the first course of ALG, 
a chronic rejection developed. An effort at desensitization to the horse globulin was not successful. 
Despite the deepening jaundice. the synthetic functions of the liver were rvell maintained for a 
long time, Note the low gamma globulins late in the course. The earl>- convalescence of this patient 
after the first transplantation is depicted in inore detail in Fiqure 134. Chapter 14. The l i ~ - e r  function 
tests were performed wit21 ~nicrochernical techniques. tf'itli these methods. the norrnal ranges in  
International Units (1.U.)  of alkaline phosphatase. SGOT and SGPT. respectively. are 60 to 260. 
0 to 65, and 0 to 33. 
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OT 13 
BLOOD CULTURES 
SERUM PROTEIN 
ALBUMIN - - - - -  
ORTHOTOPIC 
TRANSPLANTATION T I M E  IN MONTHS 
Figure  176. The first 14 months after the orthotopic liver transplantatioll of patient OT 13. The 
original diagnosis was extrahepatic biliary atresia. A n  overt early rejection did not occur: however, 
delayed repudiation of the homograft became apparent a fexr weeks after discontinuation of horse 
ALG. The manifestations of late rejection \\-ere principally those of' obstructive jaundice. Biochem- 
ical evidence of severe hepatic necrosis Iras noted only at the time of the late septicemias. The 
source of the blood stream bacteria was never found, Kormal ranges of serum enzymes: alkaline 
phosphatase, 75 to 225; SGOT, 0 to 6; SGPT, 0 to 55. 
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IST 2ND 
HOMOGRAFT HOMOGRAFT OT 16 2 3  m . 0 . 8  
BLOOD CULTURES 
31?theroias t C bovls 
500. 11.0+13.2 kg. 
SGOT (I.U.) 
SERUM PROTEIN 
(g/100 ml) 
\ _  , ,-__--. ,-..,-.__ --  - -  - - - - \  ,- .-- C * - - - - - _ _ _ _ _ _  TOTAL- ALBUMIN - - - g . . . . . . .  .,:.L:., .... \- . .  - _ .... ._ ,... .. ......  _ .,......  .................. .._._.... .. ......................... 
,..._( ,....... .' 
7 GLOBULIN -...-.-.. 1500.- " I 
ALKALINE 
PHOSPHATASE 
( I. U.) 
BILIRUBIN 
( mg/100 ml ) 
TOTAL - 
CONJUGATED - - - - - lo' 
PREDNISONE ( mg) 
AZATHIOPRINE (mg) 50. 
A LG 
pre-op 0 30 60 90 120 150 180 210 240 270 
T IME IN DAYS 
Figure  177. The course of a 23 month old child 17-ith biliary atresia n.ho receix-ed two orthotopic 
liver transplantations. A s e ~ - e r e  indolent rejection was encountered on both occasions. but the func- 
tion of the second homograft eventually became relatively stable. The patient is non. one pear post- 
operative. The normal ranges for the enzymes in international units are the same as in Figure 176. 
The hyperbilirubinemia in all five patients consisted predominantly of the 
glucuronide (direct) fraction (Figs. 175 to 178: Fig. 128. Chapter Fourteen; Fig. 
141, Chapter Fifteen). Increases were seen in the alkaline phosphatase either 
coincident with or before the deepening icterus. 
None of the patients immediately became seriously ill as a consequence of 
the delayed rejection. They frequently had low grade fevers, but these could not 
always be proved to be related to the events within the transplanted organs. 
Bacteremia reappeared in two of the three recipients who previously had suf- 
fered septic infarctions (Fig. 178: Fig. 141. Chapter Fifteen). Positive blood 
cultures were obtained as the rejection developed in only one (OT 16R) of the 
three patients in whom the liver had not undergone partial necrosis earlier in 
the postoperative period: the microorganisms identified in this patient were 
C l o s t r i d i ~ ~ ? n  p e r f r i n g e n s  and C o i ~ y i 2 e b a c t e 1 ~ ~ ~ ~ ~ ~ 1  b o z l s .  
There was usually little evidence of major generalized hepatic necrosis 
with the advent of the indolent late rejections. The SGOT and SGPT 1-alues rose 
to very high levels (exceeding 1000 International Units) only in patient OT 9 
(Fig. 178). In the remainder (Figs. 175 to 177: Figure 141. Chapter ~ ik teen) ,  the 
increases ranged from moderate to almost undetectable. 
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BILIRUBIN 
img per 100 ml l  
TOTAL - 
CONJUGATED--- 
TOTAL PROTEIN - 
ALBUMIN - - - - -  
v GLOBULIN 
(mg per 100 ml) 
AZATHIOPRNE 
(mg) 
PREDNISONE 
(mg) 
ALG 
- 
......,. - ........ ... .- -, - ...................... ".....- .... ",-" '..., "" ..... _.-.-.,.-.---.- ...........-. 
....-. 
PERITONEAL 
EVERY THIRD DAY 1 
0 0 PO 30 4 0  5 0  60 7 0  80 9 0  100 0 120 3 0 1 3 5  
TIME IN DAYS 
Figure 178. The course of a child (OT 9) who developed late rejection which mas superimposed 
on a n  earlier septic hepatic infarction. The original diagnosis was extrahepatic biliary atresia. Jaun- 
dice did not recur until the third postoperative month. EL-entually hepatic and renal failure de- 
veloped, the latter leading to hyperkalemia and cardiac arrest. Bacteremia and later fungemia were 
intermittent1)- demonstrated until el-entual death from massive intestinal necrosis. Survival was 
four and a half months. Acti C=intra\-enous actinomycin C in micrograms: 150 R=depth dose of 
homograft irradiation. The temperatures are the maxiinuins for each da?-. (By permission of Ann. 
Surg. 168 :392, 1968.) 
Moreover, there was little reason to suspect from the liver scans that the 
patients with previously established partial hepatic gangrene (OT 9 and 10) 
were having a significant extension of this process or that the recipients who 
entered the later rejection with intact homografts (OT 13. 14, and 16B) were 
developing fresh focal infarctions. Generally the transplants had a transient 
secondary increase in size. although the swelling was less than that observed 
during the early postoperative rejections (Chapters Fourteen and Fifteen). 
The onset of delayed rejection in the sixth patient (OT 19) differed only 
quantitatively from that in the other patients. Its onset was slightly more 
abrupt, but the resulting abnormalities in hepatic function were minimal (Fig. 
128, Chapter Fourteen): there was no detectable hepatomegaly. 
The Course of Irreversible l a t e  Reiection 
The delayed homograft deterioration was decisively reversed only in patient 
OT 19 (Fig. 128. Chapter Fourteen). This was a recipient who developed the 
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abrupt but mild late rejection while still on treatment with horse ALG; the only 
change in therapy was a small upward adjustment in the prednisone. The sec- 
ondary icterus in all the other patients became permanent despite increases in  
the steroid doses which were sometimes drastic. The subsequent courses of the 
latter five recipients will nomT be described, with subdivision into two groups 
according to the presence or absence of earlier septic hepatic infarctions. 
Previous Septic Hepatic Infarction. The functional deficiencies of these two 
homografts (OT 9 and 10) tended to become gradually worse despite the inten- 
sification of steroid therapy. The bilirubins slowly climbed back to levels as 
high or higher than those caused by the original disease of extrahepatic biliary 
atresia. For a long time the serum protein concentrations were reasonably well 
maintained, but eventually these began to fall (Fig. 178); there were also 
declines in the liver-based clotting factors (Chapter Ten). Ultimately both the 
patients manifested multiple findings of chronic hepatic insufficiency with 
abdominal wall collaterals and spider angiomata, radiographic evidence of pul- 
monary veno-arterial shunting, peripheral edema, and ascites. Secondary renal 
failure in one of the children led to an electrolyte disequilibrium and a cardiac 
arrest. Resuscitation was successful, but she died a month later of massive 
intestinal gangrene (Fig. 178). The immediate cause of death in the other pa- 
tient (Fig. 141, Chapter Fifteen) was rupture of an  unrecognized abscess of the 
left hepatic lobe into the free peritoneal cavity. 
In both the foregoing cases the homografts weighed 320 gm and were 
grossly fibrotic (Chapter Twenty). The latter finding had been anticipated from 
the results of liver scanning during life, since the transplanted organs had 
begun to shrink (Fig. 179). The final result as judged by the radiographic ex- 
amination was indistinguishable from that described by Christie2' and Rozen- 
taPh and their associates in end stage cirrhosis. In addition to the reduction in 
size, the ability of the transplant reticuloendothelial system to concentrate the 
isotope was diminished. 
Previously Intact Homografts. As discussed in Chapter Fifteen, the reasons for 
the foregoing progression of events could not be determined with certainty at 
the time the patients with septic hepatic infarction were being cared for. An 
alternative explanation to that of rejection might have been that the daily 
debridements, dressings, and irrigations of the draining intrahepatic tracts 
were partly responsible for the shriveling and fibrosis of the homografts. It was 
not hard to imagine that the late functional deterioration of the lilers could 
have been due to the continuous presence of bacterial Infections in the residual 
hepatic tissue adjacent to the debrided areas. H o ~ v e ~  r. there is no longer justi- 
fication to suspect an explanation other than delayed rejection, since many of 
the same observations \sere subsequently made in three patients in 11-hom early 
regional gangrene of the transplanted organs mas avoided (OT 13. 14. and 16). 
In the latter recipients the delayed rejections had been of the indolently 
developing L ariety. In all three patients the essential features for long periods 
were those of obstructil e jaundice n i th  selectir e preservation of the functions 
of hepatic synthesis (Figs. 175 to 177). Once late icterus appeared in these 
cases. it never again diminished. X plateau in the serum bilirubin concentration 
was reached on n hich a very gradual further trend upn ard lvas based; alkaline 
phosphatases nere  also consistently elexated (Figs. 173 to 177). 
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F l y ~ ?  e 179 Lil er scan in a 21 month old female made t\.r o (left) and four ( T I C ~ ~ )  months after ortho 
topic hepatic homotransplantation Betneen the tline of the t n o  s t u d ~ e s  the blllrubln had risen 
from 2 to 16 3 mg per cent as a consequence of chlonlc homograft rejection In the second study, 
note the marked decrease 111 11r er slze and Isotope uptake and a commensuiate Increase of radio- 
ictlritT In the bone mairolr The llrei appeals inoth e&en The patlent 'OT 9) died 11 d ~ v s  later 
of massir e intestinal ganglene (BT perm~sslon of Sur r: G ~ n e c  Obstet 127 808 1968 ) 
As the months went by it was surprising to find so few serious effects upon 
other tests of hepatic function. The day-to-day measures of serum trans- 
aminases were not alarming. For a long time total serum protein and albumin 
concentrations were depressed very little, if at all (Figs. 175 to 177). As long as 
litamin K was administered parenterally or orally in a water soluble form, the 
prothrombin times remained at or near 100 per cent. Failure to give the vitamin 
led to marked prolongation of the prothrombin times within a fen days. 
At one time or other thought was gil en to the possibility of re-exploring the 
homografts in all three of the patients in order to rule out mechanical obstruc- 
tion of the extrahepatic duct system. This was e\ entually done in patient OT 
14. The duodenum was opened and the cholecystoduodenostomy was found to 
be widely patent. A dye study n a s  obtained (Fig. 180) which did not reveal any 
dilatation of the intrahepatic or extrahepatic duct system (Fig. 181). The fine 
peripheral intrahepatic ducts did not fill nell. giving the cholangiogram a 
"stripped tree" appearance. A liver biops! was taken which revealed intrahepa- 
tic cholestasis (Chapter Twenty). 
All three of the patients (OT 13. 14, and 16R) who deleloped a late indolent 
rejection in the absence of partial hepatic gangrene are still alile. one (OT 14) 
by virtue of a second homotransplantation more than a bear after the first 
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Duo 
C hol ecystoduodenostomy 
Figure  180. Operative technique used to study the duct system of the homograft in patient OT 14. . 
Biliary reconstruction had been with a cho lec~s toduodenos tom~ A.Counter-incision in duodenum. ' ' 
B ;  Insertion of a Foley catheter through the anastomosis and inflation of the balloon. 
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F i g u r e  181 .  Operatix~e cholangiogram of a 16 year old girl COT 11; obtained three and  a half mon ths  
c ~ f t e r  orthotopic lix-er transplantation for the indication of hepatoma. Re-exploration n-as carried out 
because of persistent jaundice. The d ~ e  \\-as injected after illsertillr a Fo1e)- catheter through the  
c h o l e c ~ s t o d u o d e n o s t o m ~  into the gallbladder (Fig .  1801. S o t e  that the biliary drainage f rom the  
homograft is not obstructed but that the fine ra:nifications of the intrahepatic ductal  system a re  
not seen. CBD=common bile duct :  CD=cystic duct :  CHD=cornmoll hepatic duct :  GB=gallbladder. 
,By pernlission of Surg. Gl-nec. Obstet .  128:327 ,  1969.: 
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procedure (see later). Although the effects of the chronic hepatic dysfunction 
were supported surprisingly well for protracted periods, there were eventual 
signs of decompensation. The transplanted organs in two of the three recipients 
(OT 14 and 16B) underwent a slow but steady shrinkage (Figs. 182 and 183). In 
all three patients the ability of the homograft reticuloendothelial system to 
concentrate the isotope remained permanently diminished. 
The slender margin by which life was still being maintained was illustrated 
in one of the patients (OT 13) when pneumococcal bacteremia developed in the 
twelfth postoperative month (see Chapter Sixteen). With the infection came 
hypoglycemia which required intravenous glucose therapy for the next several 
days. The same patient has had several significant gastrointestinal hemor- 
rhages from an  undetermined source and has recently developed intermittent 
ascites. 
The Question of l a t e  Arterial Thrombosis 
In the section on tumor recurrence, two examples were cited of apparently 
delayed complete hepatic arterial thrombosis It is unlikely that the vascular 
occlusions were related to the underlyic . -alignant disease; instead, they prob- 
ably represented a complication which ulll also be seen in patients treated 
with liver transplantation for non-neoplastic hepatic disease. The most impor- 
tant etiologic factors in the dearterialization were probably immunologic (Chap- 
ter Twenty). 
So far. this concept has not been proved in the clinical series. Since none of 
the recipients with pre-existing benign disease has died after seven months, the 
state of their homograft vascular systems has not been accurately studied. 
However, one of the chronically surviving patients (OT 13) has been submitted 
to aortography. Fourteen months postoperatively a stenosis was found at or 
near the arterial anastomosis (Fig. 184A). Striking abnormalities were found in 
the distal vascular bed. The small terminal arteries were serpiginous and there 
were areas of dye staining that may have been sites of arteriovenous shunting 
(Fig. 184B). The angiographic changes were reminiscent of those found in 
~ i r rhos is .~ '  
The Feasibility of Retransplantation 
As described in Chapter Fourteen the feasibility of retransplantation was 
first established under the urgent circumstances imposed by uncontrolled early 
postoperative rejection. The courses of the patients with delayed rejection 
provided a clear indication that most recipients with late failing hepatic 
homografts could be considered under more elective conditions for the same 
kind of treatment since the extreme slowness with ~vhich the organ deterio- 
rated allowed considerable time to try to find a new liver. Parenthetically it may 
be suggested that similar opportunities to replace deteriorating cardiac 
homografts will almost certainly become available. The experimental studies of 
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F i g u ~ e  182. Progressive shrinkage of the 
first orthotopic liver transplant in  patient OT 
14. The posteroanterior and lateral scans were 
obtained with '"""technetium. Note that the 
spleen. rvhich was not remo\-ed at the original 
operation. became enlarged and began to pick 
up an increasing fraction of the isotope. The 
hepatic homograft was replaced with another 
liver after 380 da?-s: its hepatic artery was 
found to be thron~bosed. R=right: L=left; P= 
posterior: X=anterior. 
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After 2nd Tx - 142 days 
A B 
F i g u r e  183. Homograft shrinkage seen late after a second orthotopic liver transplantation in pa- 
tient OT 16. The scans were obtained lvith "'",technetium. .A. 142 days after replacement of a failed 
first homograft with a second organ. R .  262 days after the retransplantation. Note the diminution 
in size in the intervening four months. 
Lower and Shumway and their associates5' have shown that the late rejection 
of transplanted hearts often occurs gradually enough so that repeat operations 
could be considered. However, there may be serious judgment problems with 
either organ about when reintervention is justified. For example. the two long- 
est survivors in our liver series remained continuously jaundiced for eight 
(OT 13) and 11 (OT 14) months. When the icterus first developed it was 
thought that a second homograft would be required within a very short time. 
Fortunately, suitable donors could not then be found. The anticipated rapid 
downhill course did not materialize. The realization that prolonged survival 
was often possible under these circumstances led to a conservative attitude 
about recommending a second organ replacement. However. one of the patients 
(OT 14) was eventually provided with another orthotopic liver after the initial 
organ had sustained life for 380 days. The histocompatibility match mas a bet- 
ter one (Table 5. Chapter Three) than had been present n i th  the first donor. 
The technique of operation was approximately the same as for the other 
retransplantation described in Chapter Fourteen. The homograft .iihich was 
removed did not have a cirrhotic appearance although its weight (1230 gm) and 
size were subnormal, as n-ould have been predicted from the shrinkage that 
had been seen on the liver scans in the preceding months (Fig. 182). 
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F i c / u ~ . ~  184. Aortograln obtained 425 days after operation in patient OT 13. The original arterial 
anastomosis had been bet~veen the host proper hepatic arter?- just beyond the gastroduodenal artery 
8 GDA) and the homograft celiac axis. .-I. There is a stenosis (arrolr-j at or near the anastomosis. Note 
the large caliber of the right phrenic artery (RPA). probably as the result of its participation in a 
collateral blood supply. CHA=cornmon hepatic arter>-: LGA=left gastric artery: LPA=left phrenic 
artery: SA=splenic artery. The x-ray is one second after injection. B.  The terminal vessels are race- 
mose. There are d?-e accumulations (arro~vs)  suggestive of intrahepatic arterio'r-enous shunts 1.5 
seconds after injection. 
The recipient hepatectomy was not particularly difficult since the 
adhesions attaching the liver to adjacent structures could easily be broken 
down. When the new homograft was inserted, it was necessary to attach its 
celiac axis to the celiac axis of the recipient inasmuch as the recipient common 
hepatic artery had thrombosed (see earlier section). A cholecystoduodenostomy 
was constructed for biliary drainage at the same site as had been previously 
used for the earlier anastomosis to the duodenum. 
There was prompt and adequate function of the homograft (Fig. 175). 
Although the patient had been sensitized to the horse ALG a year previously, it 
was possible to start a new course of the equine globulin without any systemic 
reactions. Because of the recurrent tumor found at the time of retransplanta- 
tion (see section, Recurrence of Malignant Disease). there is little or no hope for 
protracted continuing survisal el-en if good liver function can be maintained. 
OTHER CAUSES OF LIVER MALFUNCTION 
In all the liver recipients thus far followed more or less chronically, any late 
bouts of hepatic malfunction ha\-e seemed ascribable to the two main etiologies 
to which most of this chapter has been devoted. namely metastases to the 
homograft or immunologic rejection. As further experience accumulates it is 
probable that other causa t i~  e factors will be found to be important, although 
these may be dificult to identify. 
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Drug Toxicity 
The liver injury that can be induced by immunosuppressive agents was 
reviewed at length in Chapter Twelve, with particular attention being focused 
upon azathioprine and prednisone. It will be recalled that deranged hepatic 
function tests were detected at some time in more than 50 per cent of human 
recipients of kidneys who were treated postoperatively with the same agents as 
those given to the liver patients. A differential diagnosis between drug toxicity 
and viral hepatitis was not generally possible. 
For obvious reasons it was even less feasible to estimate the extent to 
which hepatotoxic effects of the drugs occurred after orthotopic liver trans- 
plantation. However, an interesting observation was made in two patients who 
received large quantities of steroids for long periods because of the persistence 
of jaundice. Eventually both recipients became chronically ill, for which reason 
the prednisone doses Tvere drastically reduced. Their general condition im- 
proved remarkably. The liver function remained relatively stable for long peri- 
ods despite the lightening of the immunosuppression (Figs. 175 and 177). 
Hepatitis 
The difficulty of diagnosing viral hepatitis is understandable since the 
agents responsible for this kind of disorder have not been isolated."~ Recently 
there has been increasing interest in techniques to detect specific antigens 
associated with the virus. 
The Australia and SH Antigens. Antigenic factors have been described in the 
blood of patients with viral hepatitis. To identify the antigens, blood from he- 
mophiliac patients has been used as a source of antiserum. Because these do- 
nors had received multiple transfusions (as many as 10,000), they were con- 
sidered by definition to have had multiple exposures to the hepatitis virus. 
Blumberg et all2, "" first described the Australia antigen in a high percent- 
age of native aborigines who were thought to represent a hepatitis reservoir. 
Later he also found an increased incidence in certain patient populations 
within institutions in which there was also apparently endemic hepatitis.l33 " 3  84 
Finally, it has been noted that the hospitalized patients in whom the Australia 
antigen has been found with high frequency have often had diseases charac- 
terized by a reduced immunologic reactivity."-'-' The argument has been ad- 
vanced that the partial immune paralysis in the latter cases was responsible for 
an  increased susceptibility to infection by the virus. 
Prince and his associates of New York4-'" I"" have studied a similar fac- 
tor, termed the SH (serum hepatitis) antigen which is rarely found (0.1 per 
cent) in the normal United States population. Their most decisive observations 
were in recipients of blood transfusions. In the patients 1~110 subsequently 
developed serum hepatitis. they demonstrated the appearance of the SH anti- 
gen during the incubation period and the early clinical course. 
Cross reaction studies by Prince",'. "i ha\-e stressed the high degree of simi- 
larity between the Australia and SH factors. However, he has also em- 
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phasized that there is insufficient evidence to conclude that they are iden- 
tical.":' " Electron micrographic studies of the serum from patients with either 
the Australia1" or SH" antigen have revealed virus-like particles similar in size 
and appearance to the picorna group. 
Studies in Liver Transplant Recipients. In January, 1969, the resident physician 
on the liver service developed severe hepatitis. Within a 10 day period two of 
the chronically surviving recipients for whom he had been caring also became 
jaundiced after having had many previous months of normal homograft func- 
tion. Because of the highly suspicious association of events, the sera of the 
physician and the two patients bvere submitted to Dr. Alfred M. Prince. 
It was found that one recipient (OT 15) was SH positive and had been since 
the sixty-sixth postoperative day (Fig. 170): during his transplantation he had 
received 7000 ml of blood. The sera of the other patient (OT 23) and the house 
officer were negative. In actuality, the primary explanation for the deteriora- 
tion of hepatic function in both the patients proved to be the invasion of their 
transplants by recurrent hepatoma (see earlier section). 
Thirty-six sera from nine other orthotopic liver recipients were also ex- 
amined by Dr. Prince. None contained the SH antigen (Table 27). These nega- 
tive findings did not exclude the diagnosis of hepatitis since the SH antigen 
can be found in only about half the patients in whom this diagnosis is made on 
Other 3 5 .  6" 65 
Table 27. Immunoassays for SH Antigen': 
PATIENT O T  P O S T O P E R A T I V E  SAMPLES 
NUMBER (days) RESULTS 
8 P t ,  1 ,  15, 82, 117 Negative 
10 48,97,147 Negative 
1 1  22,60 Negative 
12 1, 17,67 Negative 
Negative 
Negative 
Positive 
Negative 
Negative 
Negative 
Negative 
Negative 
"'The results of immunoassays for SH antigen in the sera of 11 recipients of orthotopic liver 
homografts. The analyses mere performed by Dr. Alfred M. Prince of New York. See text for 
discussion. 
+ P : Preoperative. 
:The results of the individual tests are shown in Figure 170. 
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Extrahepatic Obstruction 
At autopsy the extrahepatic duct system of three of the homografts was 
found to be partially obstructed; provision for biliary drainage had been with a 
cholecystoduodenostomy. As described earlier in the chapter, recurrent tumor 
was responsible for death in two of the patients (OT 8 and 15). In the other (OT 
l l ) ,  a 16 month old child who died after 105 days of septic hepatic infarction 
(Chapter Fifteen), there may have been a kink at the junction of the cystic and 
common ducts. The dilated intrahepatic ducts of these three livers were filled 
with inspissated bile and also contained several soft stones. 
So far there are insufficient data to reach a definitive conclusion about the 
incidence of cholangitis which will be seen in chronic survivors. However, 
Chapter Twenty will report some encouraging pathologic observations made in 
13  livers which had been transplanted from three weeks to more than a year 
before their examination. Histologic evidence of cholangitis was found in only 
three of the homografts; the duct system of two of the three affected organs 
had become obstructed with recurrent tumor (OT 8 and 15). Biliary tract recon- 
struction in 12 of the 13 recipients was with cholecystoduodenostomy. 
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Chapter Eighteen 
SPECIAL IMMUNOCHEMICAL STUDIES 
b y  Noboru Kashizcagi, M.D. 
About five years ago studies were published analyzing the immunologic 
capabilities of human recipients of kidney homografts.'", "I These investigations 
provided a quantitation of the changes in immunologic reactivity that could be 
produced with antirejection treatment and still be compatible with life in a 
relatively uncontrolled social environment. Such information is generally appli- 
cable for the transplantation of other organs. 
With hepatic transplantation, additional intriguing possibilities are intro- 
duced because of the liver's essential participation in all pathways of protein 
metabolism. It is with the questions raised by this fact that the present chapter 
will deal. 
THE SOURCE OF NONIMMUNOGLOBULIN 
PROTEINS 
There is strong evidence that liver homografts retain their metabolic speci- 
ficity after transfer to new hosts. This was first shown by studies of serum 
haptoglobin" ?' and the group-specific component of the alpha globulin frac- 
tion'? in our patients before and after orthotopic liver transplantation. 
The recognition of discrete protein fractions in orthotopic liver recipients 
was made possible by the earlier studies of S m i t h i e ~ ? ~  " on haptoglobin (Hp) 
and of Hirschfeld"" on group-specific component (Gc). These authors had de- 
monstrated that three kinds of Hp and Gc were identifiable in the human 
population, that the type present in any indi\-idual \ \as subject to genetic con- 
trol. and that the phenotypic expression could be detected n i th  electrophoretic 
techniques. 
In several of our cases of orthotopic transplantation, the donors h a ~ e  had 
different Hp and or Gc types than the recipients. \l'ltliin a fen hours to a few 
days after operation, only the donor protein fractions were present (Figs. 185 
and 186): the changes were complete and permanent. The poteniial therapeutic 
394 
DONOR (TYPE 2-2) 
RECIPIENT - PRE-OP ( 2 - 1 ) 
i f  POST-OP 24 HOURS 
# I  I i  2 DAYS 
I t  i l 3 
li  E l i  5 
II I f  10 l1 
I t  I I 15 
I I  i I 31 
Fiqzire 185. Effect of orthotopic liver transplantation on serum haptoglobin (Hp). The studies 
were in patient OT 12, who preoperatively had Smithies Hp type 2-1: her donor was Hp type 2-2. 
After transpla~ltation only the donor type was detectable in the recipient sera. The determinations 
were with starch gel electrophoresis. 
DONOR (TYPE 1-11 
RECIPIENT - PRE-OP ( 2 - 1 ) 
8 1  POST-OP 10 DAYS 
Ficjzc~.e 186 The effect of orthotopic li!-er transplantation 0x1 eroup specific component (Gc). 
Before operation the recipient (OT 8: had Gc t?-pe 2-1. ~1-hereas the donor had type 1-1, .After trans- 
~)lanration. onll- the donor r y e  !!-as detectable. The recipient. 1i-Ilose oriqinal disease 11-as hepatoma. 
died more than 13 mont l~s  after transplantation of n-idespread metastases. The immunoelectro- 
phoretic studies were performed ~>- i th  colnmercial anti-Gc antisera. 
395 
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implication of these findings in terms of treating hepatic-based inborn errors of 
metabolism was discussed in Chapter One. 
It is highly likely that similar information will be forthcoming about a 
number of other protein genotypes. Alper et a1 have traced a C'3 complement 
phenotype from a donor to a human liver recipient treated in Boston.' There 
was substitution of the new complement for the old type during the 45 days of 
postoperative survival. 
IMMUNOGLOBULINS 
In other parts of the book, particularly in  Chapters Fourteen, Fifteen, and 
Seventeen, data were given on the plasma protein concentrations, including the 
gamma globulins. These day-to-day determinations were performed with cel- 
lulose acetate membrane electrophoresis. Now, a more detailed breakdown of 
the immunoglobulin fractions will be described. The different studies were 
carried out in six to 10 of the patients who lived for two months or longer after 
operation. 
Serum Concentrations 
There were six recipients of seven homografts (OT 10, 12, 13, 14, 16, and 
19) in whom the gamma G ,  A, and M globulins were serially measured with a 
single radial immunodiffusion method. Except for one patient with hepatoma 
(OT 14), the pre-existing disease was biliary atresia. The results are sum- 
marized in Figure 187. 
Immediately after transplantation the serum concentrations of all three of 
the measured immunoglobulins fell sharply from preoperative levels. which on 
the average were slightly higher than normal. This occurred in parallel with 
similar declines of the total proteins as described more fully in Chapter Six. 
The changes Tvere transient in patients who received adequately functioning 
livers and who recovered from the acute effects of the operation. 
The Indiv idual  Fractions. After the immediate postoperative period had 
passed, the most consistent finding was a tendency for increased concentra- 
tions of gamma G globulin to develop. The elevations came at variable times 
but they ne\ er preceded the o~ ert manifestations of rejection: rather, they were 
first seen from three to 62 days after this diagnosis was made (Table 28). In 
some patients the delayed rises of gamma G globulin were persistent, but in 
others they were either transient or else they waxed and waned from week to 
week (Fig. 187). The a\-erage gamma G concentrations weeks or months after 
trarisplantation n-ere distinctl~ abox e normal and the! I\ ele generally higher 
than those present before operation. 
In contrast, the levels of both gamma hl and gamma A globulin usually had 
a decline relati\ e to the supernormal \-alues n hlch had been present preoper- 
Using a n  Immunoplate. Hyland Laboratories. Los Angles. California. 
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Normal 
Range 
pre-opO 10 2 0  3 0  40 5 0  60 70 8 0  9 0  
T IME IN DAYS 
Figure  187. The changes in serum gamma, G.  A,  and lLI after seven orthotopic hepatic homo- 
transplantations in six patients. (See text for discussion.) 
atively. Even so, the average concentrations throughout the courses were still 
slightly above the normal for healthy persons. 
Fractional Interrelationships. In a number of instances the serum concentra- 
tions of the three measured classes of i~nmunoglobulins changed in a rough 
parallel to one another; thus. a rise or fall in the gamma G globulin was apt to 
be accompanied by a similar fluctuation of the gamma M or gamma A compo- 
nents (Fig. 188). However. an association of the alterations \vas by no means 
invariable. 
The Source of the  immunoglobulins 
In some pathologic conditions in which the liver contains abnormal num- 
bers of plasmacytes, gamma globulin has been demonstrated by immunofluor- 
escence techniques in the latter cells.4 '' However. i: has been said that there 
is normally little or no hepatic synthesis of immun~g lobu l in s .~~  j, 14, " 
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Table 28. Elevations of Gamma G Globulin' : '  
TIME ELEVATIONS GAMMA G ONSET O F  
PATIENT GLOBULIS NOTED REJECTION 
NUMBER (days) (days) 
OT 10 25 14 
':'The times when definite elevations of gamma G globulin were observed in relation to the 
diagnosis of homograft rejection. 
ONSET I 
\ 
TIME IN DAYS 
F i g u r e  188. The changes in  serum immunoglobuli~~s in a patient (OT 19) who had two rejection 
episodes during the 90-day period of the study. 
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It has been possible to examine this question in 10 recipients of orthotopic 
homografts by the use of phenotype tracing analogous to that described earlier 
in this chapter for haptoglobin, group-specific component, and C ' 3  com- 
plement. It was found that the transplanted livers made a substantial contribu- 
tion to the total immunoglobulin pool of the recipients. Since the data have not 
been previously published, the details of the analyses will be fully documented. 
General  Principles. At least 21 gamma G globulin phenotypes have been 
identified in man with the hemagglutination-inhibition test.'4 Seventeen of 
these types constitute the ,'Gm system"' for which it is presently thought that 
the genetic determinants are all located in either three or four alleles of a single 
chromosome."~'The Gm marker has been used to determine the success or 
failure after clinical bone marrow transplantation."" 
Detection of Phenotypes. The Gm types 1. 2. and 12 were determined in our 
studies by a modification of   mart ens son's hemagglutination-inhibition 
method."l In principle the technique involved the addition of phenotvpe-specif- 
ic antisera" to the tested samples. The presence or absence of consumption of 
the commercial antisera by the patients' gamma G globulin was quantitated by 
adding the mixture to an  indicator suspension. The latter was made by adding 
anti-D antiserum:;: of the same Gm type being tested to 0 positive human red 
cells. If the coated red cells underwent agglutination, it was considered that the 
Gm type had not been present in the recipient serum; if agglutination did not 
occur, the presence of the phenotypes was considered to be established. The 
quantity of a Gm substance was designated with the number of the highest 
dilution of the patient's serum with which the hemagglutination was inhibited, 
the first tube being counted as 8. 
There was only one modification"' from RiIartensson's original technique. 
As a preliminary step each volume of test serum was diluted by adding three 
volumes of phosphate-buffered saline. The diluted sera were then heated for 10 
minutes at  63" C to inactivate the rheumatoid factors that were present in six of 
the 10 recipients before transplantation and in all 10 afterward. With a few 
exceptions,lx rheumatoid factors are gamma M globulins which are directed 
against gamma G globulin;" ': consequently they can interfere with the just 
described indicator system by reacting with the anti-D red cell coat and causing 
agglutination, which may result in a false negative test. More will be said later 
about other implications of the rheumatoid factors. 
Conversion of Phenotypes. In five of the patients the presence or absence of 
the Gm types was determined without efforts at quantitation. before transplan- 
tation and on a single occasion afterward. The postoperative sera were ex- 
amined from one to 25 days following the li\-er replacement. In every instance 
it was possible to find phenotypes 1. 2 ,  and 12 n-hether or not these had been 
previously represented in the serum of the donor or the recipient (Table 29). 
The indiscriminate conversion of the gamma G globulin types was thought to 
be ascribable to the administration of blood or blood products, which were 
required in large 1-olumes in these patients during the intraoperatil-e and early 
Antisera against G m  types 1. 2. a n d  12 as I$-ell as the anti-D antisera were obtained from the 
Certified Blood Donor Service, I n c . ,  iYoodbury: S e ~ r  l o r k .  
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Table 29. Gm Types in Five Liver Transplant Recipients':; 
PATIENT 
G M  TYPE 0 ~ 1 0  0 ~ 1 1  0 ~ 1 2  0 ~ 1 7  0 ~ 2 3  
G m  (1)  
Preop, donor a - - - + 
Preop, recipient + - + - + 
Postop, recipient + t T + + 
Days postop 25 15 6 13 1 
G m  (2) 
Preop, donor 
Preop, recipient 
Postop, recipient 
Days postop 
G m  (12) 
Preop, donor + + + + + 
Preop, recipient + + + + + 
Postop, recipient + + + + + 
Days postop 25 15 6 13 1 
'Qualitative studies of the Gm types in  five orthotopic liver recipients. The examinations were 
one to 25 days after transplantation. Note that all three of the phenotypes became detectable after 
transplantation whether or not these had been present in either the donor or recipient; the indis- 
criminate conversion was probably due to multiple blood transfusions. 
postoperative period. The artifact introduced by transfusions has been well 
documented under less complex clinical  circumstance^.^^ Moreover, the 
gamma G globulin apparently infused by this means was noted in some of our 
other more completely studied recipients to disappear completely within a few 
days or weeks (see patients OT 14 and 16A in Table 31). 
Serial quantitative studies were carried out after six homotransplantations 
in five patients. In three of the six sets of ohserlations. the donor did not have 
one or more of the gamma G globulin phenotypes that were in the recipient. 
After the transplantation the pre-existing Gm types of the recipients were not 
altered during follo~v-up eriods of from six months to almost a year (Table 30). 
In the other three transplantations the situation was the converse (Table 
31) in that the donors each had one Gm t)pe not naturally found in the recipi- 
ent. During follow-ups of 60 to 326 days the phenotypes could now be detected 
in the recipient serum in highly significant quantities. In some instances the 
amounts of the nem gamma G globulin maintained a consistent le\ el, whereas 
in others there was a 1 ery gradual diminution but never a complete loss of the 
titer (Table 31). The persistence of the nev phenotype for such long intervals 
was strongly indicati~ e of its synthesis and release by the homograft. 
Exactly the same examinations were performed in 11 recipients of renal 
homografts and their respective donors. There n-ere several examples of post- 
operative rises of Gm types that had not been present before transplantation. 
Ho~vever, these disappeared within two months. There n-ere no permanent 
changes such as those described following liver transplantation. 
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Table 30. Transplantations Between Differing Phenotypes::' 
PATIENT 
NUMBER DAYS GM (1) GM ( 2 )  GM (12) 
OT 13 Donor, Preop <8 <8 
Recip, Preop 256 64 
1 128 3 2 
14 256 3 2 
40 256 64 
68 256 3 2 
96 512 64 
124 512 64 
1 94 512 64 
250 5 12 64 
284 512 64 
325 256 64 
Donor, Preop 
Recip, Preop 
3 
10 
24 
3 8 
7 1 
101 
129 
157 
185 
213 
24 1 
2 76 
Donor, Preop 
Recip, Preop 
1 
2 
18 
3 9 
69 
151 
179 
"Three liver homotransplantations in which the recipients possessed gamma G globulin pheno- 
types not found in their donors. 
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Table 3 1 .  Transplantations Between Differing Phenotypes'' 
PATIENT 
NUlMBER DAYS GM (1) GM ( 2 )  GM (12) 
OT 14 Donor, Preop 
Recip, Preop 
3 
24 
52 
8 7 
129 
179 
213 
244 
2 72 
306 
326 
Donor, Preop 256 <8 128 
Recip, Preop < 8 <8 128 
2 256 64 128 
10 256 128 
32 256 8 128 
45 256 8 128 
60 256 '< 8 128 
Donor, Preop 
Recip, Preop 
8 
2 8 
49 
77 
1 1  1 
152 
"hree liver homotransplantations in which the donors possessed gamma G globulin phenotypes 
not naturally present in  the recipients. Note that the recipients Tvere thereby endowed with the 
new Gm types for very long intervals and perhaps permanently. 
The Rheumatoid Factors 
The foregoing studies indicated that the maintenance of a specific gamma 
G globulin phenotype was not hepatic dependent, a conclusion in accord with 
that reached by NIathe et all" on the basis of their observations after bone 
marrow transplantation. Hon ever, the investigations in the hepatic recipients 
also showed that the l i ~ e r  could introduce and support a new Gm type not 
previously present in a gii en patient. There n ere no easily detectable specific 
adverse consequences in these cases of having a genetically heterogenous ad- 
mixture of immunoglobulins. However. studies of the rheumatoid factors were 
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conducted to examine the possibility of an inter-reaction between the im- 
munoglobulins of host and graft origin. 
Methods of Detection. It was mentioned earlier that the rheumatoid factors 
are anti-gamma G globulin antibodies and that their presence may invalidate 
the results of Gm typing by their reacting with the coated red cells of the 
indicator system and causing agglutination. It follows that the same indicator 
system can be used as a direct test of anti-gamma globulin antibodies. 
This was done by serially diluting recipient sera after first decom- 
plementing them by heating for 30 minutes at 56" C. The diluted test sera were 
then added to the 0 positive red cells that had been sensitized by mixing with 
commercial anti-D serum that was known to contain the Gm (I+, 2+, 12+) 
types. The agglutination of the coated erythrocytes by the patient sera was 
indicative of anti-gamma globulin activity to a degree that could be quantitated 
by the highest dilution at which this effect was observed. 
The Incidence of the Rheumatoid Factor. The sera of 10 recipients were ex- 
amined before and serially after transplantation. Preoperatively, anti-gamma 
globulin antibodies were present in six of the 10 patients; after operation, posi- 
tive results were obtained in all 10. 
In Table 32 the results are shown from two patients whose serum con- 
tained anti-gamma globulin antibodies prior to transplantation. Afterward the 
titer was reduced temporarily only to return to very high levels during some 
stage of convalescence. A similar waxing and waning of titer was seen in all 
the other eight patients. 
The Specificity of the Anti-gamma Globulin Antibodies. This information was 
sought by assessing the effect of sera of known Gm phenotypes on the 
rheumatoid factor present in patient OT 14's serum before and 87 days after 
Table 32. Serial Studies of Antigamma Globulin Antibodies 
(Rheumatoid Factor)" 
OT 14 OT 16A OT 16B 
D a y s  Titer D a y s  Titer D a y s  Titer 
--- 
Preop 64 Preop 64 Preop 32 
3 4 2 16 8 < 2  
2 4 <2  10 <2  2 8 4 
5 2 32 3 2 <2  49 4 
8 7 1000 45 4 77 4 
129 64 6 0 32 1 1 1  16 
1 79 4 152 51 2 
213 4 
244 4 
2 72 4 
306 < 2  
326 < 2  
'Studies in two human recipients of orthotopic liver homografts. Patient OT 16 received two 
livers, the second 68 days after the first (see Chapter Fourteen). 
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transplantation. The absorbing sera were from the liver donor (Gm 1+, 2- and 
12+), professional blood donor A (Gm I-, 2-, 12+) and professional blood donor 
B (Gm l+, 2+, 12-). These were individually added in an  equal volume to the 
patient's twofold diluted test sera and the rheumatoid factor titers were redeter- 
mined by the same indicator hemagglutination system described previously. 
The results are summarized in Table 33.  The serum of the liver donor as 
well as  blood donor A caused a drastic reduction in the titer of the rheumatoid 
factor in the pre- and post-transplantation samples from the recipient. These 
absorbing sera had gamma G globulin of Gm (12) type. In contrast. absorbing 
serum B (Gm l+. 2+, 12-) had no such effect. It was concluded that the anti- 
gamma globulin (rheumatoid) antibody was directed against Gm (12) gamma G 
globulin both before and after transplantation. 
To strengthen this conclusion the patient's serum was now compared with 
commercial anti-Gm (12) serum in the determination of the Gm (12) phenotype 
in her own serum, using the hemagglutination-inhibition test of Martensson. 
The results were essentially the same with use of the commercial antiserum 
and the donor serum (Table 34), confirming that the rheumatoid antibody in 
the patient had an  anti-Gm (12) specificity. 
The Significance of the immunoglobulin Studies 
As mentioned earlier, it is improbable that the normal liver elaborates de- 
tectable quantities of gamma G globulin. This contention has been supported 
by several studies not involving any kind of transplantation." j* 1 4 3  22  Moreover 
the observations of Mathe in human recipients of bone marrow homografts 
have strengthened this position."' In Mathk's patients the Inv phenotypes be- 
came those of the donor, whereas the types originally represented only in the 
recipients completely disappeared in the event of a bone marrow take. In these 
cases the presumably normal livers made no detectable contribution to the 
circulating immunoglobulins. Consequently it is necessary to believe that the 
gamma globulin production by the transplanted l i ~ e r  is an abnormal occur- 
rence and one that may be similar to that in certain chronic hepatic disorders 
Table 33. Effect of Absorption with Sera of Known Gm Phenotypes 
upon the Antigamma Globulin (Rheumatoid) Antibody 
Titers in Patient OT 14 
TITERS A F T E R  A B S O R P T I O N  WITH 
Pretransplantation 64 Not  done 4 64 
87 days Postoperative 1000 32 64  500 
"Donor: Gm (I-. 2-. 12-). 
+ A :  Gm (I-. 2-. 12+). 
:B: Gm (I+. 2+. 12-). 
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Table 34. Detection of Gm (12) Phenotype::+ 
GM (12) GM (12) 
WITH COMRIERCIAL WITH PATIENT'S 
DAYS A S T I S E R U M  O W N  SERUM 
Donor, Preop 
Recip, Preop 
3 
24 
5 2 
8 7 
129 
179 
213 
244 
2 72 
306 
326 
"The detection of the Gm (12) phenotype in the serum of patient OT 14 by the use of anti-Gm 
(12) antibodies in  her own serum. The results are compared with those obtained with a commercial 
anti-Gm (12) serum. 
+ hlartensson's hemagglutination-inhibition test. 
such as lupoid hepatitis" and c i r rho~ i s .~ .  ""n these diseased livers',' and in the 
hepatic homografts as well, intrahepatic lymphoid depots are presumably re- 
sponsible for synthesis of the immunoglobulins. In the case of liver transplanta- 
tion, the immunoglobulins released from such donor-specific lymphoid accu- 
mulations could be construed as being directed against host antigens. At the 
same time the immunoglobulins of host origin could be viewed as a response of 
the recipient against the graft and possibly also against the protein synthesized 
by the graft. 
There has been no clinical indication that the immunoglobulins released 
simultaneously from the transplanted livers and the host tissues have had a 
mutually antagonistic effect or one that was inherently detrimental to the host. 
The universal presence of anti-gamma globulin (rheumatoid) antibodies in the 
liver recipients postoperatively could suggest that an interaction actually oc- 
curred, particularly since the rheumatoid factor in at least one case avas specifi- 
cally directed against a Gm phenotype found only in the donor. The force of 
the argument in this instance was weakened by the fact that the rheumatoid 
test v a s  positi~ e preoperati~ ely and that the anti-gamma globulin specificity 
predated the transplantation. 
Moreover it is clear that the presence of anti-gamma globulin activity is by 
no means a special feature of hepatic transplantation. In 60 of our kidney 
recipients studied by Bra\-o. Herman and Smyth.' 56 developed a positive 
rheumatoid factor: t15o of the four exceptions were identical tnins  and a third 
was a fraternal tnin.  Similar obserl ations ha1 e been reported by other au- 
t h o r s . ~ ~  II 3 0  In these cases. i t  could be suggested that lymphoid tissue 
transferred In the hilum of the renal homografts n as at least partly responsible 
for the temporar) elaboration of an alien gamma globulin and that this gamma 
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globulin evoked the rheumatoid response. The studies of Wilson and Kirkpat- 
rick1' have pro1 ided evidence that functioning lymphoid tissue is usually 
transplanted along with the renal homografts, since the pre-existing delayed 
hypersensitivity reactions of the donors were conferred upon the recipients and 
thereafter remained for some time before eventually dying away. 
With hepatic transplantation it may be that donor lymphoid depots which 
are accidentally carried with the livers (see Chapter Twenty) are even more 
durable, accounting both for the much more permanent support of new Gm 
phenotypes by the transplanted livers and for the presence long after operation 
of anti-gamma globulin activity. Porter's sex identification studies (Chapter 
Twenty) do not support the idea that reinforcement lymphocytes of donor geno- 
type are differentiated from the graft Kupffer cells. 
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Chapter Nineteen 
HETEROTRANSPLANTATION 
A serious limitation to the widespread use of liver transplantation is logistic 
in nature as  emphasized in  Chapters One, Two, and Four. Because artificial 
livers are not available with which to support a patient dying of hepatic disease, 
the chance for treatment with transplantation is very quickly lost if a suitable 
donor does not become available at precisely the right time. In practice the 
proper circumstances to proceed arise with distressing infrequency. 
An ideal solution to the problem might someday be the use of organs from 
lower animals. The donors could be carefully selected from within a given 
species on the basis of size as well as by criteria of biologic suitability such as 
tissue matching. Moreover, operation could be carried out in an elective and 
highly planned way. Such an attempt at treatment was made at the University 
of Colorado in a child who was dying from end stage liver disease. Before 
describing this unique case. a brief review would be appropriate of the pre- 
ceding clinical experience with heterotransplantation of other organs. 
HETEROTRANSPLANTATION OF EXTRAHEPATIC 
ORGANS 
The first attempts to transplant vital whole organs from animals to man 
were made in Europe at the beginning of the twentieth century. On about a 
half dozen occasions between 1906 and 1923 kidneys were removed from a pig, 
goat, lamb, or subhuman primate and transferred to patients who were ter- 
minally ill with uremia. These historically important cases have been reviewed 
and tabulated in more recent  publication^.'^. Interest quickly waned because 
of the lack of benefit from the procedures and was not aroused again until the 
results became known of several much more encouraging clinical trials with 
heterotransplantation in 1963 and 1964. 
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Clinical Observations 
In the latter two years more than a dozen renal heterotransplantations were 
performed. Eventually all the patients died. but not before it was established 
that function of kidney heterografts could be maintained for many weeks or 
even months. It had become evident that the ability to exploit animals as organ 
sources for humans was almost: but not quite, within the grasp of surgeons 
using the immunosuppressive techniques then available. All but one of the 
recipients were treated with azathioprine and prednisone, to which were added 
intravenous actinomycin C andlor local homograft irradiation. 
The therapeutic exception was in the first of the modern trials, made by Dr. 
Claude Hitchcock of the Hennepin County Hospital, Minneapolis. On February 
16, 1963, he revascula.rized a single baboon kidney in the right femoral triangle 
of a 65 year old woman and established urine drainage with a skin ureteros- 
tomy. After a brisk diuresis, the organ continued to function for four days. It 
then became anuric and was removed; the renal artery had thrombosed. Un- 
fortunately the experience was not reported by publication or even by word of 
mouth until more than a year later,14 after the much more significant and 
successful clinical investigations of Dr. Keith Reemtsma of New Orleans had 
become well known."'-"" In Reemtsma's first case,:'!' in which a Mucacn mulat ta  
(rhesus) monkey was the donor, the outcome was similar to that observed by 
Hitchcock. 
Chimpanzee to M a n  Heterotransplantation. For subsequent patients Reemtsma 
used chimpanzees, with strikingly different  result^.:'^. :jX Several heterografts in 
the latter series functioned at least temporarily in the same way as might have 
been expected with homografts and one patient led a full life, much of it out- 
side the hospital, for nine months before dying of infection and an electrolyte 
disorder. At autopsy"0, :". :'" some although not all of the transplanted chim- 
panzee kidneys had histologic abnormalities which were in no way different 
from those to be expected in homografts after similar periods of time. However, 
in the majority of cases there were special anatomic features ~vhich were most 
dramatically seen with gross examination. These included obvious swelling and 
scattered areas of hemorrhagic infarction.:ji 
In Reemtsma's first six chimpanzee to man heterotransplantations, there 
were two recipients m-ith survival and graft function for more than two months. 
In the rest, rejection was very severe and led to loss of the organ or death of the 
patient in less thzn three weeks. Six more attempts by the same investigator 
under similar circumstances were less ~ u c c e s s f u l . ~ ~  None of the latter group 
survived for as long as one month. 
Other clinical attempts have been made at heterotransplantation of chim- 
panzee kidneys, using the same general immunosuppressive regimens. A pa- 
tient of Hume died as the consequence of an uncontrollable postoperative diure- 
sis which totalled 34 liters on the first postoperative day.'" Traeger of Lyon, 
France. reported three more cases ."In one. the graft failed immediately be- 
cause of a technical accident. In another, the kidney was rejected abruptly after 
six days. The third patient died of sepsis after 50 days. but the transplant was 
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said to contain no histopathologic signs of rejection. Finally, Cortesini of Rome8 
lost a patient from peritonitis 31 days after renal heterotransplantation. There 
had been no evidence of rejection at any time. The histologic appearance of the 
transplanted chimpanzee kidney was described as normal; host immunoglo- 
bulins could not be detected with immunofluorescence techniques. 
During the same era an  orthotopic cardiac heterotransplantation was per- 
formed by Dr. James Hardy of Jackson, i\/lississippi. The chimpanzee heart 
contracted promptly after revascularization but could not support the circula- 
tion of the adult human recipient and stopped beating after an hour. It  was 
suggested in the report of this case that the organ had failed acutely more 
because of its small size than for any immunologic reasons.':' 
Baboon to Man Heterotransplantation. Within a few months after Reemtsma7s 
first experience, the East African baboon (Papio dogr iera )  was given a systemat- 
ic trial in our institutions as an organ donor for man. Six renal heterotransplan- 
tations were performed in December, 1963, and January, 1964, using both the 
baboon kidneys in each case.-". -'" Good heterograft function was obtained imme- 
diately in all instances. Urine excretion of a variable quality", -"3 -"' continued for 
nine to 60 days. Although immunologic repudiation could be at least partially 
controlled or even reversed, all the organs eventually were completely or nearly 
completely rejected, as judged by serial studies of their function and by subse- 
quent pathologic examination. 
The six recipients died 19 to 98 days after operation. including two in 
whom the heterografts were ultimately removed. The results were better when 
there was identity of the ABO blood groups or else compatibility as shown in 
Table 1, Chapter Two. The degree of histologic injury to all the heterografts 
was considerably greater:"'~:"34".4Vhan had been the case with many of the 
chimpanzee organs: damage to the vascular system was particularly striking. It 
was concluded that the conditions were not yet propitious for further efforts at 
animal to man transplantation, but that when the time came the chimpanzee 
would be the preferred subhuman primate donor. 
,, . 
immunologic Studies 
In both the chimpanzee and baboon series of renal heterotransplantations, 
special attention was paid to the humoral antibodies which were either present 
in the patient serum before arrival of the grafts or else developed subsequently. 
The studies in Reemtsma's cases were carried out by DeWitt"10,34 38 and in 
ours by Kirkpatrick and il'ilson. lk 
Chimpanzee to Man. Blood groups 0 and A have been found in chimpanzees 
with frequencies of about 10 and 90 per cent, respectively," using standard 
blood bank detection procedures. In animals of A erythrocyte type. it is almost 
certain that the isoantigen is also found in the renal and other tissues, just as 
has been well established in humans." -'- Consequently the guidelines of red 
cell compatibility between humans, discussed in Chapters Two and Fourteen, 
apply equally in chimpanzee to man combinations. Reemtsma and DeiYitt have 
reported that the consequences of violating these rules are indistinguishable 
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from those following human homotransplantation under such circumstances. 
In one well documented case involving the transfer of an A chimpanzee 
heterograft to a B group patient. the kidney was immediately destroyed. Con- 
comitantly, there were sharp falls in the heat-stable anti-A isoagglutinins of the 
recipient serum, suggesting that the antibody had promptly fixed to and ad- 
\-ersely affected the revascularized organ."' The same kind of accident also 
apparently occurred in one of their later patients.:j4 
The problems of blood group mismatching are avoidable. However, other 
antibodies (heat-labile heterohemagglutinins) which react with chimpanzee 
red cells irrespective of their blood type are almost invariably present in the 
serum of humans. Fortunately there was no evidence from Reemtsma's obser- 
vations that these heterohemagglutinins fixed to the chimpanzee grafts. After 
operation the titers usually remained stable for a few days and then transiently 
increased; there was no apparent correlation between such variations and the 
development of rejection crises. 
In contrast lymphocytotoxic antibodies similar to those described by 
Terasaki after homotransplantation (Chapter Three) usually appeared at the 
time of overt heterograft rejection. The cytotoxins. which Tvere never present 
preoperatively, became detectable subsequently in all but one of Reemtsma's 
recipients.:j4 The killing ability of the serum waxed and waned with the onset 
and remission of rejection episodes. The antibody was characterized as a heat- 
stable, complement-dependent immunoglobulin located in the gamma G and 
gamma M  fraction^."^ 
Baboon to M a n .  All baboons studied so far belong to red blood cell groups A, 
B' or AB."' Since the red cells of these animals do not react with human anti-A 
and anti-B typing sera, the "blood group substances" of the donor baboons were 
determined by Dr. J. Moor-Jankowski with indirect methods, including saliva 
analysis and reciprocal agglutination testing.Is. 
The penalty of using mismatched donors in respect to the red cell groups 
was by no means so severe as with the chimpanzees. Immediate urine excre- 
tion was obtained in three 0 type patients who were given the kidneys of B or 
AB baboons. Nevertheless, the average functional survival of the organs was 
only 28 days compared to 44 days in the other three patients in whom red cell 
compatibility had been present. Moreover. those isoagglutinins in the sera of 
the mismatched recipients, which svould have been predicted to be absorbed on 
the kidney if the "blood group" antigens were represented there. tended to 
decrease in titer after the transplantation. 
Before operation the sera of all six of the recipients also contained 
heterohemagglutinins for baboon erythrocytes. These antibodies were probably 
less innocuous than had apparently been the case after the chimpanzee to 
human transplantations. In each instance the titers were depressed within 
hours or days after revascularization of the heterografts. only to rise again, 
often with the advent of a rejection crisis. Electron micrographic studies of one 
of the baboon kidneys 49 days after its placement re]-ealed subendothelial 
deposits in the small vessels and glomerular capillaries." It was speculated that 
these might have been the site of fixation of heteroagglutinins and other pre- 
formed heterospecific antibodies, that the antibodies did not immediately de- 
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stroy the graft because of a comparatively low avidity with the binding sites, but 
that they could have contributed to the massive injury to the vascular system 
seen by light microscopy in all the specimens. 
. '  
b 
Experimental Clarification 
d It is no exaggeration to state that the hope of transplanting animal organs 
to humans was universally conceded to be completely unfounded until after the 
trials with subhuman primate organs just described. The pessimism was not 
based primarily on prior work with skin transplantation, since skin transferred 
between some species of rodents may evoke a rejection which is not obviously 
different but only more vigorous than that of homografts. Instead, it was ap- 
parently founded on the disastrous results of transplanting animal kidneys to 
recipients of widely disparate species. 
The first clear example of a hyperacute heterograft reaction was reported 
in 1926 in the classic and neglected paper of C. S. Williamson." In the course of 
investigating the fate of renal auto- and homografts, he also transplanted goat 
kidneys into two dogs. The organs failed to be revascularized. Histologic exami- 
nation of the kidneys revealed the vessels to be plugged with tightly clumped 
red cells, but without real clot formation. The recipients both died. Thirty years 
later Brul12 also noted that the blood flow through cat kidneys ceased rapidly 
after transplantation to dogs. For the same reason Calne:' and Mowbray" found 
the canine environment to be almost immediately lethal for goat and rabbit 
kidneys, respectively. Calne's description was particularly graphic. After revas- 
cularization the goat kidney appeared initially to have a good blood supply, but 
within a few minutes the cortex first became pale and then deeply cyanotic. 
Microscopic examination of the removed kidney showed interstitial edema, dis- 
ruption of cortical vessels, and numerous hemorrhages. Calne suggested that 
naturally occurring humoral antibodies might have been responsible. 
The short and unsatisfying nature of these experiments helps to explain 
the paucity of further reports until after the trials of clinical heterotransplanta- 
tion. Since then. many studies have been undertaken with the objectives of 
better understanding whole organ heterograft rejection or. alternatively, of 
preventing this process. The need to divide such investigations on the basis of 
genetic diversity has been recognized bl- Reemtsmi'" :'"n his suggestion that 
the term heterograft be used only if the donors and recipients are closely placed 
on the phylogenetic scale and that the word xenograft be reserved for distant 
relationships. This classification will be observed in the follo~ving discussion. 
Wide Genetic Disparity. The studies of Clark and Gewurz and their asso- 
ciates". 6 .  7 .  12 from the Unil-ersity of hlinnesota were the first serious efforts to 
dissect the el-ents of whole organ xenograft rejection. Rabbit kidneys were 
placed into the circulation of dogs. Blood flow through the transplant n-as vigor- 
ous at first but rapidly diminished n-ithin three to 10 minutes. During this 
time from 25 to 30 per cent of the dog complement presented to the organ was 
consumed as well as a significant fraction of the heterospecific hemolysins and 
hemagglutinins. There Ivas also a striking clearance of formed blood elements 
other than erythrocl-tes. Up to 70 per cent of the white blood cells and 90 per 
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cent of the platelets supplied to the grafts failed to emerge in the venous ef- 
fluent. The remarkable sequestering properties of a variety of other xenografts 
have been confirmed by Marceau and his associates , '~vho were unable to 
modify the changes with a panel of antiseritonin. antihistamine, and antipro- 
tease agents or with azathioprine. Only intra-arterial prednisolone significantly 
delayed the total devascularization. In some of their pig kidneys that had been 
perfused with dog blood, there was "pavementing" of polymorphonuclear leu- 
kocytes on the vascular endothelium. A similar finding has been reported by 
\5'illiams3' in renal homografts rejected immediately by patients whose blood 
contained lymphocytotoxic antibodies. 
Clark" concluded that the violent rejection was caused by naturally oc- 
curring humoral antibodies in the recipient. which reacted with the xenograft 
renovascular tissue. In an effort to reduce these hostile immunoglobulins, he 
exposed the canine blood repetitively to rabbit kidneys: the last organ had pro- 
longation of function by several hours."i Survival was also slightly increased 
by reducing dog complement with aggregated gamma globulini or by the injec- 
tion of Egyptian cobra venom." ' S n y d e r  has also reported that the venom 
increased by more than tenfold the viable period of pig kidneys transplanted to 
dogsS4' 
Perper and Najarian" have added to the circumstantial evidence that 
humoral antibodies may be responsible for immediate xenograft destruction. 
They transplanted pig kidneys into dogs and vice versa. With either combina- 
tion there was a sharp fall in complement within a few minutes. However, the 
pig xenografts underwent rejection 10 times more rapidly than the dog kidneys. 
The authors explained the difference by their demonstration that heterospeci- 
fic cytotoxins and hemagglutinins in the canine serum reacted with porcine 
renal cells: the converse was not true when canine renal cells were exposed to 
pig serum. The severity of rejection after transplantation in either direction 
could not be altered by treatment with azathioprine, prednisone, and actino- 
mycin C. 
Major genetic diversity does not always lead to the kind of hyperacute 
rejection just described. This m-as demonstrated several years ago by Eiseman 
and his associates, who were able to circulate human blood through isolated pig 
livers for as long as 30 hours." The organs could clear bile. ammonia. and other 
metabolites from the perfusate and could carry out synthesis of porcine pro- 
tein. 1. 2 1 ,  '6 Eiseman has since connected pig livers directly to the circulation of 
patients dying of hepatic failure. usually for six-hour treatment periods." He 
and others2"ave reported temporary benefit from the procedure with a mini- 
mum of side reactions. 
In an extension of these obserl-ations. Calne tested orthotopic pig 
xenografts in seven  baboon^.^ The first three recipients bled to death in six to 
nine hours: the other four were gi\-en human fibrinogen to prevent this compli- 
cation and lived for 19 hours to three and a half days. The animals an-oke from 
inhalation anesthesia and were temporarily alert. In the longest surs-ivor the 
hepatocytes of the xenograft n-ere preserved at the time of autopsy, although 
there xvas mononuclear cell infiltration of the portal tracts. This baboon had 
been treated with steroids. 
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Thus far all the comments in this section have applied to whole organ 
transplantation. The experiments of Lance and Meda\varN with skin xenografts 
must be mentioned because of their potential cljnical significance. Using ALS 
as the sole immunosuppressive therapy. they were able to transplant skin from 
rats. guinea pigs. rabbits. and humans to adult male CBA mice with prolonga- 
tion of survival in each instance. Some of the human xenografts were in good 
condition as long as two months after operation. By all odds these have been 
the most encouraging efforts at mitigation of xenograft rejection. The results 
also established that the repudiation of skin xenografts, at least in these species 
combinations, is due to an immunologic etiology and not to mechanical or 
other factors. 
Minor  Genetic Disparity. Perper and Najarian2" exchanged kidneys between 
unmodified sheep and goats; neither species possessed easily detectable natu- 
ral antibodies against the tissues of the other. The behavior of the 
heterografts was compared to that of goat homografts. Although the 
homografts functioned slightly longer, the results with all three donor-recipient 
combinations differed only quantitatively. Erythroagglutinins and cytotoxins 
appeared in the sera of each group of recipients. but rose to higher titers after 
the heterotransplantations. If a heterograft recipient was challenged with the 
other kidney from the same donor, the second set rejection appeared to be 
entirely mediated by humoral antibodies. 
Reemtsma has carried out renal heterotransplantation between monkeys of 
the same genus but a different species as well as across a genus barrier.:':' The 
recipient animals were treated with azathioprine, prednisone, actinolnycin C, 
and local homograft irradiation. Prolongation of survival was obtained, but only 
to a maximum of 38 days. The pathologic findings m7ere similar to those of 
homograft rejection. 
Relevance to Clinical Heterotransplantation. The general conclusions from the 
foregoing animal experiments were, by and large. confirmatory of those 
reached from the preceding clinical heterotransplantations. TT7ith close genetic 
similarity the events of rejection are apparently served by cellular immunity to 
which is later added a humoral antibody component that is far more easily and 
consistently detectable than after homotransplantation under the same condi- 
tions. With progressively greater donor-recipient disparities. an increasingly 
prominent immediate role in the destruction of the homograft is played by 
naturally occurring heterospecific antibodies, which probably primarily attack 
the vascular system of the transferred organ. The consequences under the 
latter circumstances ha1 e many analogies to situations in which renal 
homografts have undergone hyperacute rejection after placement in recipients 
who have had preformed isohemagglutinins that attached to the kidneys4' -" or 
lymphocytotoxins'" 44 48 4" '? ' I  that prosed to be hostile in one way or another 
to the transferred tissue. If the preformed antibodies have a lon avid~ty for the 
heterograft. as was apparently the case in the baboon to human transplanta- 
tions, such a dramatic immediate outcome may not occur. 
The successful restoration of a blood supply does not, of course. preclude 
subsequent immunologically mediated damage to the ~ a s c u l a r  supply of the 
kind that is a vital factor in both the short- and long-term prognosis of 
homografts (see Chapters Ele\-en. Tn-elve, and Twenty). The threat of delayed 
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devascularization of heterografts is probably significantly greater than with the 
average homograft, even in the relatively favorable chimpanzee to human com- 
bination. Although some of the better tolerated chimpanzee kidneys have been 
free of arterial lesions after residence in human hosts for several weeks or 
~ n o n t h s , ~  '" " '* j0 many others have developed multiple areas of parenchymal 
infarction similar to those after baboon to human heterotran~plantation.~" 33 As 
ivill be mentioned. the same thing was seen in the chimpanzee orthotopic liver 
heterograft. 
CLINICAL HEPATIC HETEROTRANSPLANTATION 
Liver heterotransplantation for a 28 month old child was the product of 
desperation. The procedure was finally decided upon because of the en- 
couraging results already obtained after renal homotransplantation with the 
triple drug immunosuppressive regimen that included heterologous ALG 
(Chapter Thirteen). Moreover, the efficacy of ALS in mitigating skin 
heterograft rejection had been learned by personal communication with Mon- 
acoL4 and M e d a ~ a r . ~ "  Finally. it was thought that a donor might be selected on 
the basis of histocompatibility antigens that Tvere shared by both species. The 
potential value of this approach was later supported by the studies of Metzgar 
and Z m i j e ~ s k i . ' ~  
The patient had intrahepatic biliary atresia which was diagnosed by open 
biopsy in the first month of life. Subsequent mental development was normal, 
although the child nras physically stunted. His condition had progressively 
deteriorated from the age of 18 months onward, with recurrent gastrointestinal 
hemorrhages and severe ascites that required multiple paracenteses. 
Preoperative Evaluation 
At admission the boy was 88 cm in length. He weighed 13.6 kg, of which a 
large fraction was ascites and edema. There were numerous spider angiomata 
in the skin of the anterior thorax and abdomen, and large venous collaterals 
were evident in both locations. He was very pale. 
Liver chemistr? determinations were markedly deranged. The ~ a l u e s  in- 
cluded: bilirubin. 16 to 21 mg per cent: alkaline phosphatase. 7.4 Bessey-Lowry 
units (normal. 0.8 to 2.3): total protein, 4.5 gm per cent: albumin. 1.6 gm per 
cent; SGOT. 86 International Units: SGPT. 43 International Units. Clotting 
studies included a plasma fibrinogen of 332 mg per cent. a partial throm- 
boplastin time of 38.6 sec (normal. 37 to 30 sec). a prothrombin time of 17.2 sec 
(50 per cent), a bleeding time of 8.5 minutes and a platelet count of 3 7 . 0 0 0 1 ~ ~  
mm. Fibrinolytic activity was subnormal, n-ith a euglobulin lysis time that was 
greater than fi\-e hours. The hematocrit was 18 per cent. His red blood cell 
group n as 0 positive. 
During the tn  o weeks of preoperati~ e hospitalization, no c a d a ~  eric donors 
became available. In this i n t e r ~ a l  the child's condition became grave. He had 
almost continuous slon- bleeding from the gastrointestinal tract. Repeated para- 
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centeses were required in order to permit adequate respiration. Finally it was 
decided that he could wait no longer for the possibility of a cadaveric liver. 
Arrangements were made with Colonel Clyde H. Kratochvil of the Holloman 
Air Force Base, New Mexico, for the shipment to Denver of a 12.2 kg 
chimpanzee. 
The animal was a young adult male of 0 blood type which had been under 
medical scrutiny at the Federal research facility for almost two years. He was 
thought to have been free of infectious disease and in good health for all of that 
time. The chimpanzee lymphocytes were found by Dr. Paul Terasaki to react to 
his antihuman-lymphocyte typing sera. Incompatibilities, as defined by anti- 
gens in the donor but not the recipient lymphocytes (Chapter Three), were 
detected by nine of the 51 antisera in the panel then being used in Los Angeles; 
there was one group mismatch of what is now known as the HLA 5 antigen. 
The sera of both the donor and recipient caused agglutination of the red cells of 
the other species. Cytotoxins were not detected in the recipient serum. 
The Operation 
Orthotopic transplantation was performed on July 15, 1966. The chim- 
panzee was ane~the t ized~wi th  a combination of gallamine triiodide (Flaxedil) 
and phencyclidine hydrochloride (Sernylan) and cooled to 31" C by immersion 
in an  ice bath. Removal of the liver was by the same technique described in 
Chapter Five except that the vascular supply was preserved until the last pos- 
sible moment in the same way as has been employed in canine  experiment^.^^ 
An aberrent small left hepatic artery originated from the left gastric artery, 
necessitating retention of a stump of the latter vessel in continuity with the 
celiac axis; the main artery supplying the right three hepatic segments had the 
same course as is ordinarily found in man. Just as it was excised, the liver was 
further cooled and washed free of blood by intraportal infusion of 2 liters of 
chilled (4" C) lactated Ringer's solution. 
In the recipient, massive vascular adhesions around the enlarged and cir- 
rhotic liver, coupled with selere portal hypertension, made the hepatectomy 
exceptionally difficult. It was nearly eight hours before this stage could be 
completed. Otherwise there were no unusual technical features of the recipient 
procedure. The heterograft was inserted with the standard technique. attach- 
ing the graft celiac axis to the recipient proper hepatic artery (Fig. 5211. Chapter 
Eight). Biliary reconstruction was with a cholecystoduodenostomy. 
When blood flon was restored to the transplanted organ after a total hy- 
pothermic ischemic inter1 a1 of 102 minutes. the characteristic flush normally 
seen immediately after revascularization n a s  not apparent. Instead, the liver 
appeared diffusely cyanotic. Later, a fen tiny pink islands of tissue could be 
seen on the surface but these never coalesced to g i ~  e a completely homogene- 
ous bright color to the presenting surface. For a time. it n a s  feared that an 
immediate rejection was occurring. 
The anxiety was reinforced b) the development asithin the next hour of a 
serious bleeding diathesis. Extensive coagulation studies showsd about the 
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same clotting abnormalities as had been present preoperatively, including a 
platelet count of 4 0 , 0 0 0 1 ~ ~  mm. The only significant change from the pre- 
existing studies was a moderate fibrinolysis as indicated by a euglobulin lysis 
time of less than 40 min. Clot promoting agents were not used. Instead, almost 
tive hours were spent in mechanical efforts at hemostasis with little apparent 
benefit. At the end of this time the generalized hemorrhage spontaneously 
ceased as suddenly as it had begun. It was then possible to perform splenec- 
iomy and to close the abdomen. The total operating time was more than 20 
hours. Blood transfusions totalled 3500 ml. The patient awakened within a few 
minutes after returning to the recovery room and seemed to be in excellent 
general condition. 
immunosuppressive Therapy 
Treatment was with the triple drug therapy employed for the later cases of 
hepatic homotransplantation (Chapter Thirteen), including azathioprine, pred- 
nisone, and horse ALG. The actual daily doses are shown in Figure 189. Depres- 
sion of the white blood count was avoided (Fig. 189). 
TIME IN DAYS 
Figtcre  189. The course of a child with intrahepatic biliar>- atresia n h o  recei\-ed an orthotopic 
chimpanzee heterograft on July 15. 1966. ALG \\-as started txl-o 11-eeks in ad\-ance of operation. The 
30 R indicates local homograft irradiation. 
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In contrast, there were early and serious difficulties with thrombocytopenia 
beginning on the second postoperative day (Fig. 189). Because of the lou- 
platelet counts the patient developed epistaxis and wound bleeding which 
ceased promptly after platelet transfusions. At the time it was assumed that 
thrombocytes xvere being sequestered in the heterograft, as was subsequently 
shown by Hutchison" to occur to a lesser extent in liver homografts or even 
autografts. In retrospect, an even more important role was probably played by 
the heterologous ALG which can also produce severe thrombocytopenia (Chap- 
ter Thirteen) when given in as large doses as were used for this patient. The 
heterograft was irradiated with 50 R the day before death. 
Postoperative Course 
In spite of the extraordinarily long and traumatic operation, the recipient 
had a very satisfactory early course, except for a remittent fever which first 
appeared after 48 hours. He began to eat on the third postoperative day. On the 
morning of the sixth postoperative day it was noted that marked ascites had 
developed during the preceding night. Because of respiratory distress, 1050 ml 
of the fluid was removed. It reaccumulated with such rapidity that three more 
needle paracenteses and finally the insertion of an indwelling catheter for con- 
tinuous intra-abdominal drainage became necessary during the next 48 hours. 
Several cultures of the peritoneal fluid contained Aerobacter-Klebsiella. The 
patient remained mentally alert until the last few hours of life. He died at 8:30 
A.M.. July 24. almost nine days after insertion of the heterograft. 
The fatal outcome was not well explained by any changes in the serial liver 
function tests (Fig. 189). On the day after operation the bilirubin had fallen 
from a preoperative level of 21 to less than 5 mg per cent. where it remained 
for the entire period of survival. The serum transaminases were transiently 
elevated but never to the extreme lea els associated with massive necrosis sec- 
ondary to dearterialization of homografts (Chapters Nine and Fifteen). 
Hypoglycemia svas not a problem until tn  o da) s before death. 
The measures of protein metabolism were less satisfactory. The total serum 
proteins never rose above 3 gm per cent despite repeated albumin infusions 
that totalled 75 gm during the postoperative period (Fig. 189). Nevertheless, 
there was evidence of protein synthesis: for example. as late as the seventh 
postoperative day, the plasma fibrinogen was 350 mg per cent. The liver-based 
clotting Factors I1 (prothrombin) and 1'11 (proconvertin) were measured at the 
same time at 88 and 39 per cent, respectia ely. The gamma globulin did not vary 
significantly during the postoperative period (Fig. 189). 
At autopsy the heterograft n-eighed 340 gm, approximately the same as at 
the time of its transplantation. All the a ascular anastomoses n ere patent and 
the major vessels contained no clots. The cholec~stoduodenostom~ avas intact 
and was open. The surface mas p~edominantly tan. but there asere numerous 
discolored areas which appeared to be ecchymoses. After sectioning, similar 
hemorrhagic foci n-ere found in the interior of the liver. as were scattered but 
extensive islands of obvious necrosis. The latter nere  most h e a ~ i l p  concen- 
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trated near the surface. Histopathologic studies of the specimen are described 
in Chapter Twenty. 
In addition, there were focal hemorrhages in the skin, brain, and GI tract, 
~vhich were presumably secondary to the persistent thrombocytopenia. The 
lungs were affected by moderate pulmonary edema and contained several very 
small emboli. The lymph nodes had many germinal centers but few small 
lymphocytes. 
Retrospective Analysis 
The immunosuppression given to the patient was badly managed. First, the 
lelation of the ALG to the profound thrombocytopenia was not appreciated at 
rhe time, and the appropriate adjustments in dosage were not made. 
An even more fundamental error was administration of azathioprine and 
prednisone, particularly the latter, in such small doses. The quantities of both 
,lgents were less (average 0.9 and 2.2 mglkg day, respectively) than have fre- 
quently been used in subsequent patients who survived after orthotopic homo- 
transplantation (Table 18, Chapter Thirteen). Rejection was uncontrolled, prob- 
ably accounting for the multiple areas of parenchymal infarction by the same 
mechanism as that described for homografts in Chapters Fourteen and Fifteen. 
In turn, the necrotic foci in the liver undoubtedly became infected and 
ivere responsible for the Aerobacter-Klebsiella peritonitis. Blood cultures were 
not systematically obtained, as has been our practice in subsequent cases of 
homotransplantation. If they had been, it is highly likely that a septicemia 
would have been demonstrated. 
Even if the immunosuppressive drugs had been administered more effi- 
ciently, it is doubtful that prolonged survival could have been obtained; there 
have been difficulties enough in achieving this objective in subsequent cases 
using homografts. Consequently. no plans have been made for additional 
heterotransplantations unless there is a fundamental improvement in the treat- 
ment protocol which can be offered. 
REFERENCES 
1. Bibler. D. D.. Condon, R. E., a n d  Nyhus ,  L. M.: Active sensitization f rom heterologous liver 
perfusjon. Bull. Soc. Int .  Chir.  23:671. 1966. 
2. Brull. L.. Louis-Bar, D.. a n d  iLIarson. F .  G. \f7.: Auto- a n d  homotransplanted kidneys on the  s a m e  
dog. A functional comparison. Arch. In t .  Physiol. 64:269. 1956. 
3. Calne.  R.  Y . :  Renal Transplantation.  Baltimore. T h e  \\-illiams & \f-ilkins Co.. 1963. 
4. Calne.  R. Y.. \Vhite. H. J .  0.. Herbertson. B.  11.. 1Iillard. P .  R . .  Dax-is. D. R.. Sa laman,  J .  R., a n d  
Samuel .  J .  R . :  Pig-to-baboon liver xenografts.  Lancet I :  1176. 1968. 
3. Clark. D. S.. Foker.  J .  E..  Pickerinq.  R.. Good. R. A.. and  Yarco. R. L.: EL-idence for tn.0 platelet 
populations i n  xenograft  rejection. Surg.  Fo rum 17:263. 1966. 
6. Clark. D. S . .  Gexrurz. H. G . .  Good. R.  A. .  a n d  1-arco. R.  L.: Complement fixation dur ing 
heterograft  rejection.  Surg .  Forurn 15:133. 1963. 
7. Clark. D. S. .  G e x ~ u r z .  H. G..  a n d  Yarco. R.  L.: Serologic studies on accelerated graft rejection. 
Fed. Proc. 24:621. 1965. 
420 / ORTHOTOPIC HETEROTRANSPLANTATION 
8. Cortesini. \'. R.: Discussion of paper by Reemtsma, K., on renal heterotransplantation. In Seif- 
fert. K. E.. and Geissendorfer. R. (eds.): Transplantation von Organen und Geweben. Stutt- 
gart. Georg Thieme Yerlag. 1967, pp. 133-133. 
9. De\T7itt. C. \V.:  Serologic response of humans to chimpanzee tissue. (Abstract.) Fed. Proc. 
24:573. 1965. 
10. DeWitt. C. \!-.. Huser. H.  J . .  3Ioor-Janko~7-ski. J . .  Shulinan. N. R., and \Yiener. A. S.: Some 
immunological aspects of homo- and heterotransplantation in  man and other primates. 
Bibl. Haemat. 23:213. 1963. 
11. Eiseman, B.. Liem. D. S..  and Raffucci. F. :  Heterologous liver perfusion in treatment of hepatic 
failure. Ann. Surg. 162:329. 1963. 
12. Gemurz. H.. Clark. D. S.. Finstad. J . .  Kelley. \Y. D.. Varco, R. L. .  Good. R. A,. and Gabrielson. A. 
E.: Role of the complement system in graft rejections in experimental animals and man. 
Ann. N.Y. Acad. Sci. 129:673. 1966. 
13. Hardy, J .  D.. Chavez, C. 11.. Kurrus. F. D.. Neely. \Y. A, .  Eraslan. S.. Turner, AI. D.. Fabian, L. W., 
and Labecki. T. E. :  Heart transplantation in  man:  D~T-elopmental studies and report of a 
case. J.A.1I.A. 188:1132. 1964. 
14. Hitchcock, C. R.. Kiser. J .  C.. Telander. R. L.. and Seljoskog. E. L.:  Baboon renal grafts. J.A.M.A. 
189:934. 1964. 
15. Hogman. C. F.: Blood group antigens X and B determined by means of mixed agglutination on 
cultured cells of human fetal kidney. liver. spleen. lung, heart, and skin. \'ox Sang. 4:12, 
1959. 
16. Hume. D. hi.: Discussion of paper by Reemtsma. K. :  Ann. Surg. 160:384. 1964. 
17. Hutchison. D. E.. Genton. E.. Porter, K. A, .  Daloze. P. $1.. Huguet. C.. Brettschneider. L.: Groth, 
C. G., and Starzl, T. E. :  Platelet changes follon-ing clinical and experimental hepatic homo- 
transplantation. Arch. Surg. 97:27. 1968. 
18. Kirkpatrick. C. H.. and \\'ilson. If'. E. C.: Immunologic studies of baboon-to-man renal hetero- 
transplantation. 111 Starzl. T. E. :  Experience in Renal Transplantation. Philadelphia, \I7. B. 
Saunders Company. 1964. pp. 284-298. 
19. Kissmeyer-Nielsen. F.. Olsen. S.. Petersen. 1'. P., and Fjeldborg. 0.: Hyperacute rejection of 
kidne>- allografts associated with pre-existing humoral antibodies against donor cells. 
Lancet 2:662. 1966. 
20. Lance, E. YI.. and nledalvar. '2. B.: Survival of skin heterografts under treatment with anti- 
lvmphocyte serum. Lancet 1 : 1174. 1968. 
21. Liem. D. S.. Waltuch. T. L.. and Eiseman, B.: Function of the ex-vivo pig liver perfused with 
human blood. Surg. Forum 15:90, 1964. 
22. Marceau. J .  P. .  Hallenbeck, G. X.. Zollman. P. E.. Butler. H. C.. and Shorter. R. G.: A comparison 
of autoplastic. allogeneic. and xenogeneic perfusion of isolated kidneys. J .  Surg. Res. 5:492. 
1963. 
23. Metzgar. R. S.. and Zmijewski. C. 31.: Species distribution of human tissue isoantigens. I. 
Detection of human tissue isoantigens in chimpanzees. Transplantation 4:84. 1966. 
24. Illonaco. A. P..  \f-ood, hI. L.. Gra!-. J.  G.. and Russell. P. S.: Studies on heterologous antilympho- 
cyte serum in mice. 11. Effect on the immune response. J .  Iminunol. 96:229. 1966. 
25. hIo~vbray. J. F.. and Kenyon. J .  R.: An experimental stud!- on the action of 3-hydroxytryptamine 
antagonists on the recentl!- transplanted renal autograit. homograft and heterograft. Bull. 
Soc. I11t. Chir. 20:604. 1961. 
26, Norman. J .  C.. Saravis. C. A , .  Bro1r.n. 11. E.. and 1IcDermott. \Y. \'.. J r . :  Immullochemical 
observations in clinical heterologous (xenogeneic) l i ~  er perfusions. Surger!- 60: 179. 1966. 
27. Ogden. D. A,. Sitprija. V.. and Holmes. J .  H . :  Function of the baboon renal heterograft in man 
and comparison TI-ith renal homograft function. J .  Lab. Clin. 1Ied. 63:370. 1963. 
28. Perper. R. J. .  and Najarian. J .  S.: Experimental renal heterotransplantation. I. In Tridely diver- 
gent species. Transplantation 4:377. 1966. 
29. Perper. R. J . .  and Najarian. J .  S. :  Experimental renal heterotransplantation. 11. Closely related 
species. Transplantation 4 :  700. 1966. 
30. Porter. K. A,: Pathological changes in transplanted kidne>-s. l i t  Starzl. T. E. :  Experience in 
Renal Transplantation. Philadelphia. \f'. B. Saunders Coinpan!-. 1964. 
31. Porter. K. h . .  .\Iarchioro. T. L.. and Starzl. T. E . :  Pathological changes in six treated baboon to 
man renal heterotransplants. Brit. J .  Urol. 37:273. 1963. 
32. Reemtsma. K.: Yerbalization (Letter to the Editor). Ken- Eng. J .  AIed. 272:380. 1963. 
33. Reemtsma. K.: Renal heterotransplantation. I i z  Seiffert. K. .I.. and Geissendorfer. R.. (eds.): 
Transplantation T-on Organen und Ge~r-eben. Sruttgart. Georg Thieme Yerlag. 1967. pp. 141- 
152. 
ORTHOTOPIC HETEROTRANSPLANTATION / 421 
34. Reemtsma, K.: Heterotransplantation. 1 1 2  Rapaport. F. T.. and Dausset. J .  (eds.): Human 
Transplantation. New York. Grune 8i Stratton. Inc..  1968, pp. 337-366. 
35. Reemtsma. K.: Heterotransplalltation. Transplantation Proceedings 1 (KO. 1) :25l .  1969. 
36.  Reemtsma. K . :  Personal con~munication. November 24. 1968. 
37. Reemtsma. K.. 3lcCracken. B. H. .  Schlegel. J .  U.. Pearl. 11. '4.. De It'itt. C. W.. and Creech. O., Jr.: 
Reversal of earl:- graft rejection after renal heterotransplantation in man. J.A.1I.A. 187:691, 
1964. 
38. Reemtsma. K.. 1IcCracken. B.  H. .  Schlegel. J .  U.. Pearl. 11. A, .  Pearce. C. IT.. Den'itt. C. W.. 
Smith. P. E.. Hen-itt. R. L.. Flinner. R. L.. and Creech. 0 . .  J r . :  Renal heterotransplantation 
in man. Ann. Surg. 160:384. 1964. 
39. Reemtsma, K.. 2lcCracken. B. H.. Schlegel. J .  U . .  and Pearl. 11. :  Heterotransplantation of the 
kidney: T M  o clinical experiences. Science 143 :700. 1964. 
40. Ron-lands. D. T.. Kirkpatrick. C. H.. lTatter. A. E.. and if-ilson. \V. E. C.: Imnlunologic studies in 
human organ transplantation. IT'. Serologic and pathologic studies follolving heterotrans- 
plantation of the kidne!-. Amer. J. Path. 50:605. 1967. 
41. Snyder. G. B.. Ballesteros. E.. Zarco. R. hl.. and Linn. B.  S.:  Prolongation of renal xenografts by 
complement suppression. Surg. Forum 17:478. 1966. 
42. Starzl. T. E. :  Experience in Renal Transplantation. Philadelphia. \V. B. Saunders Company, 
1964. 
33. Starzl. T. E.. Kaupp. H.  A,. Brock. D. R.. Lazarus. R. E.. and Johnson, R. lT.: Reconstructive 
problems in canine liver homotransplantation with special reference to the postoperative 
role of hepatic venous flow Surg. Gynec. Obstet. 11 1 :733. 1960. 
44. Starzl, T. E.. Lerner. R. X.. Dixon. F. J. .  Groth. C. G.. Brettschneider. I... and Terasaki. P. I . :  The 
Shwartzman reaction after human renal transplantation, New Eng. J .  Xled. 278:642. 1968. 
45. Starzl. T. E..  Xlarchioro. T. L.. Holmes. ,J .  H.. Hermann. G.. Brittain. R. S..  Stonington. 0. H., 
Talmage. D. W.. and Waddell. IV. R.: Renal homograf'ts in patients I\-ith major donor-recipi- 
ent blood group incompatibilities. Surgery 55:195. 1964. 
46. Starzl. T. E.,  RIarchioro. T. L.. Peters. G. N.. Kirkpatrick. C. H.. \Vilson. \V. E. C.. Porter, K. A, .  
Rifkind. D.. Ogden. D.  A, .  Hitchcock. C. R.. and R'addell. \V.  R.: Renal heterotransplantation 
from baboon to man:  Experience with 6 cases. Transplantation 2:732, 1964. 
47. Szulman. A. E . :  The histological distribution of the blood group substances A and B in man. J. 
Exp. Ned. 11 1 : 785. 1960. 
48. Terasaki, P. I.. SIarchioro. T. L.. and Starzl. T. E . :  Sero-typing of human lymphocyte antigens: 
Preliminary trials on long-term kidne>- homograft surx-ivors. 111 Russell. P. S.. and Amos, D. 
B. (eds.): Histocompatibility Testing. If-ashington. D.C.. Kational Research Council. 1965, 
pp. 83-95. 
49. Terasaki. P. I.. Thrasher. D. L.. and Hauber. T. H.: Serotypillg for homotransplantation. XIII. 
Immediate kidne!- transplant rejection and associated preformed antibodies. 112 Dausset, J.. 
Hamburger. J . .  and 2lathe. G .  (eds.): Advance in Transplantation. Copenhagen. Munks- 
gaard. 1968. pp. 225-229. 
50. Traeger. V. J . :  Discussion of paper by Reemtsma. K..  on renal heterotransplantation. 112 Seiffert. 
K. E..  and Geissendorfer. R. (eds.): Transplantation von Organen ulld Gel\-eben. Stuttgart, 
Georg Thierne Verlag. 1967. pp. 153-156. 
31.  Wiener. A. S.. and 3Ioor-Jankolr-ski. J . :  Blood groups in anthropoid apes and baboons. Science 
142:67. 1963. 
32. \f-illiams. G. 31.. Hume. D. XI.. Hudson. R. P.. Jr . .  1Iorris. P.  J . .  Kano. K.. and hIilgrom, F.: 
"Hyperacute" renal-homograft rejection in man. New Eng. J .  >led. 2T9:611. 1968. 
53. ITilliams. G. 11.. Lee. H. XI.. If-e!-moutll. R.  F. .  Harlan. \V. R.. Jr . .  Holden. K. R.. Stanley. C. M., 
1Iillington. G .  '4.. and Hume. D. 31.: Studies in hyperacute and chronic renal homograft 
rejection in man. Surger?- 62:204. 196'7. 
54. \Villiamson. C. S.:  Further studies on the transplantation of the kidne!-. J .  Urol. 16:231. 1926. 
Chapter Twenty 
PATHOLOGY OF THE ORTHOTOPIC 
HOMOGRAFT AND HETEROGRAFT 
by K . A .  Porter, M.D., D.Sc. 
Before discussing untreated and treated orthotopic hepatic homografts, 
consideration must be given to the structural changes that are encountered in 
the livers of animals that are subjected to sham operations, and in autotrans- 
planted livers. Use of these two control groups is essential if one is to distin- 
guish surgical artifacts from immunologically produced changes. 
THE LIVER AFTER SHAM OPERATION 
In this procedure all the vascular attachments to the liver are mobilized, 
plastic bypasses are inserted for venous decompression during the period of 
liver isolation, and many other details of the orthotopic operation are carried out 
including some of the vascular a n a s t ~ m o s e s . ~ ~  " The most detailed examina- 
tions of the histopathologic consequences of this kind of instrumentation were 
reported by McBride and his colleagues1-' on the basis of studies in 11 dogs. 
Their animals, after making a good recovery and returning to a normal dietary 
intake, were killed at periods ranging up to 63 days. Various lesions were found. 
A few of the livers contained areas of infarction caused by thrombosis at the 
anastomotic site in the hepatic artery. In others there avas evidence in the early 
postoperative period of outfloav obstruction (see Chapter Five). This phenom- 
enon of outflon block is particularly frequent in dogs and is usually ascribed 
to constriction of the hepatic veins with trapping of large amounts of blood in 
the liver." It is characterized by a sa? ollen. firm, cyanotic organ. The centrilobu- 
lar sinusoids become distended with blood, the adjacent hepatocytes undergo 
necrosis. and fat droplets accumulate in the liver cells of the middle zone of the 
lobules (Fig. 190). 
In the longer sur~ivors  of hlcBride's series the hepatic architecture was 
normal, but dilated lymphatics xs ere frequently seen in the walls of the central 
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i icjure 190. Outfloxv block in a canine hepatic homograft four days after transplantation. The 
centrilobular sinusoids (arro~vs) are distended with blood and the adjacent hepatocytes are necrotic. 
There is an accumulation of fat in the lil-er cells of the middle lobular zone. Only hepatocytes ad- 
jacent to the portal tracts (P) are normal (Hematoxylin and eosin stain, x 40.) (From Advances in  
Surgery. 1966, by permission of Year Book lledical Publishers. Inc.) 
and portal veins. There was edema of the portal connective tissue accompanied 
by fibroblastic proliferation. as well as infiltration by variable numbers of neu- 
trophilic polymorphonuclear leukocytes and a few mononuclear cells. Some 
centrilobular intracanalicular bile stasis was present in a few animals. Polymor- 
phonuclear infiltrates have also been produced in dog livers within f i ~ e  to 15 
days after the simple performance of cholecystoenterostomy in conjunction 
with common duct ligation. ', ?' 
WHOLE LIVER AUTOGRAFTS 
Technically liver autotransplantation is more difficult to perform than 
homotransplantation because the vessels to be anastomosed are shorter. Conse- 
quently, there are relativelj few reports on the structural alterations in long 
surviving hepatic autografts. 
Within the first two weeks the abnormalities have been variable. In four of 
the autografts examined in the n'orthn-estern laboratories seven to 15 days 
after operation there were essentially no  change^.^," On the other hand, 
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McBride and his associates studied seven such grafts for periods of as long as 14 
days and found the same changes that had been encountered in the sham 
operated livers. In addition, there was sometimes ascending suppurative chol- 
angitis. In a later study the Boston group"' found slightly increased amounts of 
portal fibrosis in two autografts in athich a biopsy was taken seven months 
after transplantation. 
A more ex tens i~e  study of canine hepatic autografts by Alican and Hardy,' 
in which biopsies were obtained at intervals of up to 17  months after transplan- 
tation, confirmed that the only abnormality was a mild degree of pericholangi- 
tis with acute inflammatory cells in the portal tracts. This change was thought 
to be due to the presence of the cholecystoduodenostomy Mononuclear cell 
infiltration and vascular narrowing were not found. 
Similar findings have been reported in porcine hepatic autografts.' 
UNTREATED CANINE HOMOGRAFTS 
Gross Features 
At autopsy the rejecting or rejected liver homografts usually are larger and 
heavier than normal. When sectioned the parenchyma bulges over the cut cap- 
sule. The surface has a nutmeg appearance like that seen in prolonged and 
severe cardiac failure. 1 4 .  2'. '? 
l ight Microscopy 
In the first 48 hours the central zones of the hepatic lobules become con- 
gested, a few of the hepatocytes adjacent to the central vein undergo necrosis, 
and the Kupffer cells enlarge. Macrophages. neutrophilic polymorphonuclear 
leukocytes. and occasional lymphocytes appear around the portal and central 
veins. These changes are nonspecific because they may also occur in the liver 
after sham operation and in hepatic autografts. 
From the third day after transplantation, changes characteristic of rejec- 
tion commence (Fig. 191). LIononuclear cells accumulate around and within 
the malls of the small portal and central veins, particularly the former (Figs. 
192 and 193). Approximatel? 40 per cent of these cells possess pyroninophilic 
cytoplasm, and occasionally a cell is seen in mitosis. The number of infiltrating 
cells steadily increases, and b? six days the infiltration is generally \ ery dense. 
As cells accumulate in the graft, the hepatocytes in the central and middle 
zones of the lobules undergo necrosis until on11 a thin rim gf living liver cells 
remains around the portal tracts. This zonal l i ler necrosis is associated, first. 
with distortion of the centrally located sinusoids and, later, with collapse of the 
central part of the lobular reticulin framenork. This leads to condensation of 
reticulin and some early fibrosis around the central \ eins in the longest survi- 
vors. The hypertrophied Kupffer cells contain bile pigment and hemosiderin 
Ficjzi1.e 191.  Untreated canine hepatic homograft a t  six days. Portal 1-eir,, (PI and  central vein 
(C)  are  surrounded by dense cellular infiltration. There is centrilobular necrosis with hemorrhage. 
The cytoplasm of the  surviving hepatocytes in  the  middle and  peripheral zones of the lobules con- 
tLlins abundant  lipid. (Hematoxylin and  eosin stain. x 30.1 (From A d ~ a n c e s  in  Surgery. 1966. by per- 
mission of Year Book Lledical Publishers. Inc.)  
F i q u r r  192. Portal tract of the untl.eated canine hepatic homocraft slio!rn in Figure 191. The  
portal l-ein is surrounded b!- inononuclear cells. Sonle of these cells call be seen in  the  \!all of the  
vessel. The hepatic artery is unaffected, (Hematoxylin and  eosin stain, x 300.)  
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F i g z l ~ r  193. Central rein. surrounded by mononuclear cells. from the untreated canine hepatic 
homograft shown in Figures 191 and 192. Soine of the cells are adhering to the endothelium and 
others are infiltrating the vein wall. (Hematoxylin and eosin stain. x 500.) (From Ad\-ances in Sur- 
gery. by permission of Year Book Medical Publishers, Inc.) 
and there is intrahepatic bile stasis. Fibrinoid necrosis is sometimes seen in the 
walls of the small hepatic arteries but this is not common, occurring in less 
than 25 per cent of the homografts." ':'-I5. ' 7 . H 3 2 6  
lmmunofluorescence 
In the first three days no immunoglobulins are found either in the infil- 
trating cells or coating any of the vascular or biliary channels. From the fourth 
day onward the cytoplasm of about 5 per cent of the infiltrating mononuclear 
cells "stains" positively for IgG. At about eight days. when rejection is usually 
complete, IgG and complement may appear in the walls of some of the small 
hepatic a r t e r i e ~ . ~  
Electron Microscopy 
Forty-eight hours after transplantation any lymphocytes in the graft are 
usually the small variety with few organelles in their scanty cytoplasm (Fig. 
194). After that time there is a progressive accumulation of large lymphoid 
cells with abundant cytoplasm that is full of polyribosomes but lacking in 
rough endoplasmic reticulum (Fig. 195). Many of these cells have large Golgi 
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F i g u r e  194. Canine hepatic homograft 48 hours after trallsplantation to a n  unmodified recipient. 
. small 1ymphoc)-te lies within the widened space of Disse. The cytoplasm is scanty and lacking in 
organelles. n=Nucleus: m=nlitochondrion. (Lead stain. x 11.000.) 
bodies. The large lymphoid cells squeeze through the cell junctions of the 
endothelium of the portal veins and accumulate in the subendothelial space 
before passing through the vascular basement membrane to enter the portal 
connective tissue (Fig. 196). 
The infiltrating lymphoid cells also accumulate in the space of Disse. Asso- 
ciated with this process the tenuous walls of many of the centrilobular sinus- 
oids appear to disrupt (Fig. 197) and fibrin accumulates in the \ enous suben- 
dothelial spaces (Fig. 198). The hepatocytes adjacent to the damaged sinusoids 
are injured, as shown by swelling and clumping of the mitochondria. loss of the 
rough endoplasmic reticulum. and shedding of cytoplasm. A few plasma cells 
with abundant rough endoplasmic reticulum (Fig. 199) are always present in  
the cellular infiltrate, but they only appear in appreciable numbers late in the 
course of rejection. llacrophages, with typical ultrastructure, are common in 
the portal tracts (Figs. 200 and 201). When there is cholestasis the bile canalic- 
uli lack microvilli and contain bile plugs (Fig. 202). Fibrinoid necrosis with 
deposition of IgG and complement is associated ultrastructurally with a homo- 
geneous, finely granular deposit between the endothelium and the internal 
elastic lamina of the affected arteries.' 
UNTREATED PORCINE HOMOGRAFTS 
In contrast to the beha\-ior of canine hepatic homografts. the rejection of 
liver transplants in pigs is a relati\-ely weak and slow process even when donor 
( T e x t  continzied on page 435 . )  
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F i g u r e  195. Canine hepatic homograft four days after transplantation. One small lymphoid cell 
(ly 1) lies in  a sinusoid ts). -4 second lyinphoid cell 11; 2)  is in  the  process of migrating from the 
sinusoid into the space of Disse :Dj xvhile a third lymphoid cell (11. 3' is in Disse's space between 
a hepatocyte :hep) and  the  sinusoidal endothelium (end).  The  third cell has  abundant cytoplasm that 
is full  of ribosomes. (Lead stain. x 7000.) 
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F i g u r e  196. Biopsy made four days after transplantation of a hepatic homograft in a n  untreated 
dog. Electroil micrograph sholr-ing a central hepatic 1-ein. L ~ m p h o c ~ t e s  I:-:, platelets p:. and  fibrin 
!f) lie beneath the endothelial lining e n d :  of the I essel. Fluid and cells ha\-e accuillulated in  the  
perivascular space, per=Peric>-te: m=macrophage: lu=lumen of vein. (Lead stain. x 2,250.) (By per- 
missiorl of Surgery 63 :638.  1968.) 
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Figr11.e 197.  Biops!- of caiiilie hepatic liolnograft four  days af ter  t rans l~lanta t ion  to ail unmodified 
recipient.  Electroil micrograph sho~ \ - ing  a centrilobular sinusoid.  The  endothelial l i i l i~ ig  (end)  i s  
ruptured  at  t he  poi~i ts  marked \\-it11 arroxrs. Tlie space of Disse is XI-ider than norlnal and  contains 
fluid (fl). X lyi~lphoid cell ;1>-: and t11-o er)-throcytes [ rbc)  a r e  present i n  the  l u m e n  Ilu: of the  sinusoid. 
The  adjacent  liepatoc>-tes . l ~ e p :  are  in jured .  a s  sho\\-ii b> SII-elliiig aiid clumpini:  of their  mito- 
chondria arid loss of rough endoplasmic re t iculum.  Lead s t a i n  x 6000. ; B y  permission of Surgerv 
63 :6.58. 1968.) 
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Figu i . r  198. Biops>- of untreated canine hepatic homoqraft four days after transplantation. Elec- 
tron micrograph sho\r.ing part of ~ v a l l  of a 1-ein ill a small portal tract. The \\-all contains I?-mphocytes 
(I)-), macrophages :mi .  and fibrin 'f:. l u=Lu~ne i l  of \-ein; end=endorhelial lining cells. (Lead stain, 
x 6000.) (By perlnissiorl of Surgery 63 :638.  1968.) 
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F i g r c ~ e  199. Untreated canine hepatic homoqraft 10 days after transplantation. A plasma cell (pc) 
with abundant rough endoplasmic reticulum is lea1-ing a sinusoid and iniqrating into the space of 
Disse which ahead?- contains 1ymphoc)-tes (ly). X Kupffer cell (K) is filled xrith fat droplets, lipo- 
fuscin and bile pigment. (Lead stain, x 6800.) 
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F i g u r e  200. Untreated canine hepatic homograft 10 da!-s after transplantation. .A rnacrophage 
lies in  the portal tract adjacent to the peripheral hepatocytes. n=Nucleus. (Lead stain. r 6000.) 
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Figzcre  201. Higher power view of cytoplasm of upper part of macrophage s h o ~ r n  in Figure 200. 
There are several lysosonles (I?-s). two of n-hich contain lipid and bile pigment, and seleral vacuoles 
(v). m=.l.litochondrion. (Lead stain, x 31.000.) 
Figzcre  202. LTntreated canine hepatic homograft se\.en d a y  after transplantation. X bile canalic- 
ulus lacks micro\-illi and its lumen is blocked by inspissated bJe.  (Lead stain. x 14.000.: 
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and recipient are of completely different breeds. When Cordier. Garnier, and 
their associates" studied two liver transplants that had survived for 35 and 51 
days. respectilely, they found only edema and a fern focal necroses, but no 
cellular infiltration or other stigmata of rejection, even though the donor and 
recipient were unrelated. 
A detailed description of the structural changes that occur in porcine hepat- 
ic homografts has been gi.i en by Hunt,"' sl ho studied 16 such livers. He found 
that in the first fen days after transplantation there n a s  onlj edema of the 
interlobular septa, but that at about the fourth day mononuclear cells began 
infiltrating the portal areas and the septa. The proportion of pyroninophilic cells 
in the infiltrate varied from 20 to 50 per cent in different grafts and in different 
areas of the same liver. Ultrastructurally these cells nere  large lymphoid cells 
with abundant free ribosomes and prominent Golgi bodies. Some of these "im- 
munocytes" were found in the space of Disse. others lay between hepatocytes, 
and a few e\ en appeared to be actually within hepatocytes. Eosinophils were 
also present in the infiltrate. The majority of the hepatocytes lacked glycogen 
and had dilated rough endoplasmic reticulum with loss of membrane-bound 
ribosomes. 
Focal necroses were present in all the livers studied by Hunt. particularly 
adjacent to the interlobular septa. but they m-ere never extensive. Centrizonal 
necrosis was rare. Intracanalicular bile plugs were scarce before eight days, but 
were present in a few of the longer surLlving livers. Arterial fibrinoid necrosis 
was not encountered. In the longest survivor a biopsy of the liver six months 
after transplantation revealed a commencing fibrosis with increased amounts 
of fibrous tissue in the interlobular septa and a few strands of collagen running 
into the substance of the lobules. 
Similar findings have been reported by Calne and his associates4 in nine 
liver homografts examined microscopically more than four days after trans- 
plantation. They found only slight mononuclear cell infiltration in the portal 
tracts and interlobular septa and, in some long-term survivors. an  increased 
amount of fibrous connectir e tissue in the portal tracts and interlobular septa 
and around the central 1 eins. In two animals there Itas slight fibroelastic in- 
timal thickening of some hepatic arteries. A variable degree of cholangitis was 
present in seven of the nine animals. 
In the Denver series of sel en porcine hepatic homotransplantations in 
which there was survival of six days or more (Table 14. Chapter Elesen), four 
animals died of rejection at eight. eight. 20. and 37 days, respecti\-ely. Micro- 
scopically, the portal tracts of all four grafts were infiltrated with mononuclear 
cells. 50 per cent of ~ s h i c h  possessed p>roninophilic cytoplasm. Similar cells 
were also present in small numbers around the central s-eins and adjacent to 
the sinusoids. A few of the lymphoid cells were in mitosis (Fig. 203). There was 
both foc;; and centr i~onal  necrosis of hepatocytes (Fig. 204). Intracanalicular 
cholestasis n a s  not found. but there were focal bile lakes. Centrilobular retic- 
ulin collapse n-as not a feature of these l i ~  ers. 
In the 20-day and 37-day s u n  i\ ors there was sllght reticulin increase in the 
portal tracts and interlobular septa. Biopsies of the homografts zn the two living 
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F i g u r e  203. Untreated porcine hepatic homoqraft 20 days after transplantation. The animal had 
become jaundiced (Experiment 7. Table 14. Chapter Eleven). X portal tract is densely infiltrated 
with nlononuclear cells that have basophilic cytoplasm: three of these cells are in mitosis (arrows). 
(Hematoxylin and eosin stain. x 600.) 
Figl1 i . r  204. Untreated porcine hepatic holnoqraft eight days after transplantation. The animal 
died of rejection 'Experiment S. Table 11. Chapter Elel-en # .  -4 hepatic lobule contains areas of 
centrizonal :cn) and focal necrosis 'fn: of lil-er cells. -4 moderately dense infiltrate of nlononuclear 
cells lies in the portal tract ( p ;  and interlobular septa 'is:. ,Hematoxylin and eosin stain, x 150.) 
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F i g z i i e  203. Biopsy of 
plantation (Experiment 
elastic stain. x 130.) 
untreated porcine hepatic homograft five and a half months after trans- 
4. Table 14. Chapter Eleven). The liver appears normal. cyan Gieson and 
pigs five and a half months after transplantation showed normal liver tissue 
(Fig. 205). The latter animals are still alive 15 months postoperatively. 
These findings indicate that although porcine liver homografts do undergo 
rejection, this is usually a much milder and more protracted process than in the 
untreated dog. This is particularly interesting since porcine renal or skin grafts 
are promptly rejected in a normal manner.4 Moreover. in the pig the presence 
of a liver transplant seems to delay the rejection of kidney or skin grafts done 
simultaneously.' The implications of these observations are discussed in Chap- 
ters Eleven and Twelve. 
TREATED CANINE HOMOGRAFTS 
Continuous Treatment wi th  Azathioprine 
At the beginning of the chapter the need was stressed for differentiating 
artifacts due to operation from the changes caused by unmodified rejection. In 
dogs treated with azathioprine, an additional difficulty in pathologic interpreta- 
tion was introduced by the fact that this drug can damage the canine liver. The 
biochemical manifestations of hepatotoxicity were described in Chapter 
Twelve in 18 othern-ise normal animals which were given therapeutic doses of 
azathioprine for 40 days and then sacrificed. There were histologic abnormali- 
438 / PATHOLOGY OF THE ORTHOTOPIC HOMOGRAFT AND HETEROGRAFT 
ties in 12 of the 18 livers.14, lb These included the presence of centrizonal hepato- 
cyte pallor or necrosis (seven dogs). bile thrombi in the central and midzonal 
canaliculi (five dogs), and intracytoplasmic fat accumulation in the hepatocytes 
of the midzone (two dogs). As was mentioned previously. some or all of these 
alterations can also be caused by rejection. However, the pharmacologic injury 
was relatively mild compared to that caused by immunologic repudiation, and it 
was never associated with mononuclear cell infiltration. 
Consequently most of the structural changes to be described now in azathio- 
prine-treated orthotopic liver recipients were ascribed to an immunologic eti- 
ology. A total of 116 dogs were studiedJ4 ?" from a few days to more than four 
years after operation. It was found that graft rejection was almost invariably 
delayed. The livers examined in the first seven days after transplantation gen- 
erally showed only those changes that are seen in autografts and in untreated 
dogs before the third day. Mononuclear cells with pyroninophilic cytoplasm 
were rare at this stage. 
However, rejection did develop in many of the treated animals in the period 
seven to 15 days after transplantation, as manifested by changes that usually 
occur by four to seven days in the unmodified recipient. The livers became 
swollen and congested. The outstanding microscopic features were dense cellu- 
lar infiltration (Fig. 206) and marked centrizonal and midzonal necrosis of 
hepatocytes (Fig. 207). Thirty to 40 per cent of the mononuclear cells possessed 
pyroninophilic cytoplasm and a few were in mitosis (Fig. 208). Centrilobular 
F i g u r e  206. Treated canine hepatic holnoqraft ~ v h i c h  11-a~ undergo in^ rejection ser-e!~ days af ter  
transplantation. The portal tract i i  densel>- illfiltrated ~ \ - i t h  mononuclear cells. T l ~ e  cell indicated 
by a n  arron- is s h o ~ ~  11 in greater detail i n  Figure 298. ~Hematozy l in  and eosin stain, i 230.) (From 
Advances in  Surgery. 1966. b?- permission of Year Book nledical Publishers.  Inc.)  
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Ficl i irc.  207. Canine hepatic hornoqraf't n-hich had been rejected by 15 days despite azathioprine 
treatment. There is x.r-idespread destruction of hepatocytes in the central and middle zones of the 
lobules. Only a rim of l i \er  cells remains around the small portal tract (arrow). \\-hi& is densely 
infiltrated with mononuclear cells. (Hematoxylin and eosin stain, x 40.) (By  permission of Surgery 
58:131. 1965.) 
F i c j r i l . i ~  206. Derails of cellular infiltrate in portal tract of hepatic homoqraft shoxx-n ill Fiqure 206. 
3Iail!- of' the cells are 1ar.e l!-ml~hold cells xi-it11 sel  era1 ~lucleoli and basophilic cx toplasm. One is 
in  mitosis (arrow). (Hematoxylin and eosin stain. x 600.) 
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collapse and condensation of the reticulin framework was usual (Fig. 209) and 
was often accompanied by bile stasis in the centrilobular bile canaliculi. 
Ultrastructural examination of three such treated homografts showed more 
plasma cells and plasma cell precursors among the large lymphoid cells in the 
cellular infiltrate than in untreated grafts. The vascular and sinusoidal changes 
were similar to those seen in the untreated grafts. The central bile canaliculi 
were dilated and lacked microvilli and were often blocked by masses of bile 
pigment (Fig. 210). The hepatocytes in the central and middle zones of the 
lobules first showed mitochondria1 and other changes indicating injury and 
then underwent necrosis. 
Immunofluorescence studies demonstrated that about 15 per cent of the 
infiltrating mononuclear cells contained IgG. This was seen about three times 
as frequently as in untreated grafts. The increased incidence may have 
reflected the presence of greater numbers of plasma cells in the infiltrate in the 
treated animals. In a few grafts IgG and complement were found in the walls of 
the small hepatic artery radicles. in some of the sinusoids as a delicate deposit, 
or as a linear deposit in the portal and central veins. 
From 15 days onward most of the grafts appeared to be undergoing repair 
following subsidence of the first wave of rejection. When animals died it was 
commonly due to pneumonia or other nonhepatic causes (see Chapter Twelve). 
The livers were either normal in size or a little shrunken and finely granular. 
The cut surface was often stained yellow and showed an accentuated lobular 
pattern. Microscopically, although some cellular infiltration was usually pres- 
ent around the portal and central veins, it was almost always scanty and few of 
F i g u r e  209. Treated canine hepatic homograft 15 to 20 d a y  after transplanta" - ' -trilobular 
loss of hepatocytes has been follolr-ed b?- collapse and condensation of retic central 
vein (arrow). P=Portal tract. (Reticulin stain, x 40.) (By  permission of Surgel, 36.131, 1965.) 
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F i g u r e  210. Treated canine hepatic 11omo::raft sel-en days after transpla!itation. Parts of four 
hepatoc>-tes are shon-n. Be t~reen  them there is an infilrratin? lynphoid cell (ly). .A bile callaliculus 
(arrow) contains inspissated bile. The space of Disse (D) is widened. (Lead stain, x 6300.) 
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the cells were pyroninophilic. Large lynlphoid cells were uncommon. The 
majority of cells were small lymphocytes, hemosiderin-laden macrophages, and 
plasma cells. The high iron content of the macrophages and of many Kupffer 
cells was apparently closely related to the increased red cell destruction that 
occurred in the first month after liver transplantation (Chapter Twelve). There 
was centrilobular atrophy. the hepatocytes often containing lipid droplets and 
excess lipofuscin. Intrahepatic cholestasis, maximal in the central zones, was 
present in  most of these livers (Fig. 21 1). 
The features of healing and regeneration after the first two weeks varied 
according to the magnitude of the initial injury. Death or atrophy of the centri- 
lobular hepatocytes was accompanied by collapse and condensation of the cen- 
tral part of the lobular reticulin framework. Linking of adjacent central veins 
by connective tissue bands was present in about half the specimens examined 
after 25 days. Increased connective tissue in the portal tracts was a less con- 
sistent feature, but when present, the portal and central scars were sometimes 
connected, leading to hepatic fibrosis (Fig. 212). Evidence of regeneration was 
usually obtained between 25 and 50 days, and occasionally thereafter. Hepato- 
cytes at the periphery of the liver lobules showed increased basophilia, oc- 
casional mitoses, and polyploidy indicative of proliferation. In a few of the 
livers there were many small bile ductules in the portal tracts. Regeneration 
nodules were present in about one third of the homografts after 50 days. These 
nodules were often associated with hepatic fibrosis and focal areas of hepato- 
cyte necrosis. constituting a cirrhosis of portal type. 
Similar findings have been described by other authors.'", 29 
Treatment with Azathioprine for Four Months, 
Followed by Withdrawal of Therapy 
Ten dogs had azathioprine therapy discontinued about four months after 
liver transplantation (see Table 15, Chapter Twelve). In no case did abrupt 
rejection occur. However, in two instances (Schime 9 and SS 4) there was 
progressive cellular infiltration. centrilobular atrophy of hepatocytes, and cen- 
tral fibrosis. The animals died 77 and 120 days later. respectively. 
Four other dogs (Sly 26. S"  18. I 10. and ICBAI 13) had an abnormal hepatic 
homograft at the time therapy was ~vi thdra~vn,  in that there were fibrosis and 
cellular infiltration. Three of the livers remained in much the same state with 
no appreciable histological deterioration for a further 31. 48. and 27 days. The 
fourth animal (S3' 18) had de\eloped cholangitls when the homograft was ex- 
amined 84 days later. but after this period the biliary tract infection died down. 
When the animal perished after another 133 days from a perforated duodenal 
ulcer. the homograft sho~ved less cellular infiltration and no rnore fibrosis than 
had been present at the time therapy was stopped. 
Of the four animals that s u r x i ~  ed for more than one >ear after cessation of 
treatment, the two that n-ere still ali\-e in April. 1969, had normal l i ~  ers at all 
times (Figs. 213 and 214). The homografts of the other two dogs (HHAI 2 and 
HHM 12) showed some fibrosis and cellular infiltration at the time therapy was 
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Fig1ir.e 21 1 .  Treated canine hepatic homograft 21 da?-s after transplantation. Parts of three atrophic 
centrilobular heparoc!-tes are  shon-11 hep 1 to 3 ) .  The c! toplasin oi the heparoc>-tes is colnpact and 
contain5 deposits of lipofusciil and bile pigment. The rough endoplasnlic reticulum is dilated. 
Several bile canaliculi are distended ~ ~ i t h  inspissated bile :arron-s . .Lead stain. x 3000.) 
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F i g u r e  212. Hepatic homograft at 32 days from a dog treated with azathioprine. The reticulin 
framework of the lobules has collapsed around the central \.eins. and bands of reticulin now con- 
nect the central veins to each other and to portal tracts. (Reticulin stain, x 20.) (Bq permission 
of Surgery 58 :131. 1965.) 
Fig1ir.e 213. Biopsy froin a canine heparic homograft taken 302 da!-s after transplanration. The 
dog receil-ed azathioprine for the first 120 days: the drug was then stopped. The lir-er appears normal. 
(Hematoxylin and eosin stain. x 40.) (By permission of Surgery 38:131. 1965.) 
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Fig2c1.e 214.  Electron micrograph fro111 canine hepatic homograft sho\vn in Fiyure 213. Parts of 
four hepatocytes are shon-n. The ultrastructure appears normal. n=l 'ucleus: nu=nucleolus: m= 
mitochondrion: bc=biliary canaliculus. Fine black dots are  glycogen granules. (Lead stain. x 6400.) 
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stopped. The cellular infiltration diminished over the ensuing 443 and 1041 
days, respectively, but the fibrosis progressed to severe cirrhosis and eventually 
killed the animals. 
Treatment with Heterologous Antilymphoid 
Globulin 
The contention that the abnormalities in the foregoing azathioprine experi- 
ments were reflections of rejection rather than of pharmacologic injury was 
supported by subsequent trials with ALS and ALG. The changes in  the 
homografts protected by antilymphocyte agents which were free of hepatotox- 
icityH were not significantly different from those in the animals treated with 
azathioprine. 
In 18 experiments with ALS or ALG,Li it was found that animals dying in 
the first three weeks after liver transplantation had centrizonal and, usually, 
midzonal necrosis of hepatocytes in the graft, infiltration of mononuclear cells 
around the portal tracts and central veins, and centrilobular cholestasis. The six 
homografts examined after three weeks showed variable degrees of centrilobu- 
lar hepatocyte atrophy, central reticulin condensatjon. hepatic fibrosis, and 
proliferation of bile ductules in the portal areas. Five of the six livers contained 
mononuclear cells, but in two grafts the numbers were low. In all the trans- 
plants pyroninophjlic cells were sparse and active rejection appeared to have 
ceased. 
Similar findings have been reported by Mikaeloff and his  colleague^.'^ 
TREATED PORCINE HOMOGRAFTS 
Of nine pigs that were treated with horse anti-pig lymphocyte globulin in 
Denver. seven survived for seven days or more (Table 14, Chapter Eleven). Six 
of these animals died of rejection at seven. seven, 13. 15. 23. and 28 days after 
transplantation. Pyroninophilic lymphoid cell infiltration was prominent in four 
of the homografts; in the other two livers lymphoid cells were less frequent, 
but centrizonal and focal necrosis of hepatocytes and bile lakes were common. 
Cholangitis was a complication in two of the pigs that died from rejection. The 
one long-term survivor had a histologically normal liver when a biopsy was 
taken five and a half months after transplantation. 
The ALG used in these experiments appeared to have had no beneficial 
effect. 
HUMAN HOMOGRAFTS 
There were 27 orthotopic liver homotransplantations performed in Denver 
between March. 1963, and March, 1969; 25 were primary procedures and the 
other two were retransplantations. By  April. 1969. two of the patients with first 
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transplants (OT 13 and 19) and the two patients with second grafts (OT 14 and 
16) were still alive and no biopsy had been taken of their grafts. Tissue obtained 
by needle biopsy, open operation, and autopsy was available from the other 23 
livers. The pathologic findings in a number of these cases have been reported 
before."'. 2 0 .  2,". 2. 5. 28 
Homografts Examined During the First 1 I Days 
After Transplantation 
Ten of the 27 Denver hepatic homografts became available at  autopsy 
during the first 11 postoperative days and were examined histologically. 
Massive Hepatic Injury Before Transplantation. The first hepatic homograft in 
the Denver series (OT 1) did not function and the recipient died within a few 
hours. This case is described in detail in Chapter Six. The liver transplant 
was ischemic at body temperature for 60 minutes and the total time from 
donor death to revascularization of the graft was 420 minutes. At autopsy the 
liver was swollen and pale. Microscopically there was massive necrosis of the 
hepatocytes, particularly in the central and middle zones of the lobules. 
Severe Hepatic Injury Before Transplantation. The homograft of another patient 
(OT 6) functioned poorly and the patient died after seven days. The donor was a 
73 year old man who had no detectable blood pressure for nine hours before 
death. After transplantation of the liver the recipient suffered repeated intra- 
peritoneal and gastrointestinal hemorrhages and he had to be surgically ex- 
plored twice (see Chapter Six). 
At autopsy the liver was swollen and pale; the capsule was coated with 
fibrin. Microscopically there was necrosis of all the hepatocytes in the central 
and middle zones of the liver lobules and of many of the hepatocytes in the 
peripheral zones. Only a thin rim of liver cells survived around the portal tracts. 
There was collapse and condensation of the central parts of the lobular retic- 
ulin. A few bile "thrombi" were present among the surviving hepatocytes. The 
portal tracts were lightly infiltrated with lymphoid cells, a few neutrophilic 
polymorphonuclear leukocytes and seleral eosinophils. None of the mono- 
nuclear cells had pyroninophilic cytoplasm. The portal and central veins, he- 
patic artery. and bile ducts were normal. 
The long period of inadequate perfusion in the donor was responsible for 
much of the hepatic injury in this graft: further injury undoubtedly occurred 
during the stormy postoperative course. There was no elidence of rejection of 
the liver. 
Hepatic Artery Occlusion. I11 three liver homografts the hepatic artery was 
occluded. This n a s  due to compression in taso instances and thrombosis in the 
third. 
In patient OT 20 the hepatic arterial supply mas compressed by the caudate 
lobe of a very large homograft (see Chapters Eight and Sine) .  Death followed 
15 hours later as the result of acute hepatic insufficlenc), n hich included an 
uncontrollable bleeding diathesis. At autopsy the lil er n-as swollen and pale. 
LMicroscopically many of the hepatocytes were necrotic and there were 
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moderately dense collections of small lymphocytes around the portal vein tribu- 
taries in several of the smaller portal tracts. 
Another child (OT 24) had complex congenital malformations of the upper 
abdominal viscera (Fig. 55. Chapter Eight) and a kinked hepatic artery (Fig. 56, 
Chapter Eight). She died of hepatic insufficiency after 11 days. At autopsy the 
swollen graft showed widespread severe necrosis of hepatocytes in the central 
and middle zones of the lobules. There were a few nonpyroninophilic mono- 
nuclear cells in the portal tracts. 
Hepatic artery thrombosis occurred in a one year old patient (OT 18; see 
Chapter Nine). Within an hour of completion of the operation the hepatic artery 
clotted at the site of the anastomosis and the transplant became cyanotic. Re- 
anastomosis was performed, but the vessel again clotted during the early post- 
operative period. The child died on the fourth day after transplantation. At the 
autopsy the liver was completely necrotic except for a single layer of surviving 
liver cells just beneath the capsule. 
In none of these three patients was there evidence that rejection played any 
part in  the failure of the graft. 
Portal Vein Thrombosis. One child (OT 21) died 12 hours after operation from 
this complication. Anomalies of both the recipient portal vein and hepatic ar- 
teries probably played an  important roie I - -  producing this complication (Fig. 
57B, Chapter Eight; Chapter Nine). At autopsy there was necrosis of the hepato- 
cytes in  the central and middle zones of the lobules. The surviving hepato- 
cytes contained fat droplets; there was no cellular infiltration of the liver. 
Bile Duct Obstruction. One patient (OT 22) died as the result of iatrogenic 
biliary obstruction. The cystic and common ducts of the homograft were fused, 
and at operation the common duct ligature occluded both lumina and prevented 
the passage of bile into the gallbladder (Fig. 62. Chapter Nine). The patient 
became jaundiced and died when exploration was attempted 10 days later. 
At autopsy the liver was swollen and green. 12/licroscopically the bile ducts 
in the portal tracts were dilated and filled with inspissated bile, and there were 
intracanalicular bile "thrombi." There was necrosis of the centrilobular hepato- 
cytes, and a few infiltrating polymorphonuclear leukocytes and nonpyronino- 
philic lymphocytes were present in the portal tracts. There was no evidence 
that rejection was occurring in this graft. 
Pulmonary Emboli Plus Poor Graft Function. Multiple pulmonary emboli seven 
and a half days (OT 3 )  and six and a half days (OT 4) after liver transplantation 
were contributory to the deaths of two patients. The peripheral clots may have 
been caused by the use of external bypasses and the administration of clot- 
producing agents in these patients (Chapters Nine and Ten). The transplanted 
livers did not provide good function (Chapter Six). 
At autopsy both grafts showed some atrophy of the hepatocytes and conges- 
tion of the sinusoids in the central zones of the lobules. A moderate number of 
infiltrating cells were present in the connective tissue of the portal tracts. Most 
of these cells were small lymphocytes. Several small hepatic artery branches 
showed focal areas of fibrinoid necrosis affecting the intima and media; a few 
others showed fibroelastic thickening of the intima.': In some of the smaller 
portal tracts there was proliferation of bile ductules.'-' 
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The arterial changes in these cases were thought to have been present 
before transplantation. The donor for OT 3 was aged 69 years and had died 
from a cerebrovascular accident: the donor for OT 4 was aged 73 years and had 
died from a coronary thrombosis. Both donors had suffered from hypertension. 
The cellular infiltrate was probably nonspecific. It lacked the large pvronino- 
philic mononuclear cells characteristic of rejection. 
Acute Rejection. One 11 month old patient (OT 7) apparently died from 
acute rejection. His liver transplant came from a one year old microencephalic 
girl who died 48 hours after aspirating a feed. The liver was not a good one 
because the donor was hypotensive for the last 14 hours of her life. The nor- 
mothermic ischemia time was 14 minutes and the total ischemia interval 371 
minutes (Table 6. Chapter Six). Immediately after operation the serum 
bilirubin fell from 10.9 mg to 4.7 mgIl00 ml; shortly afterward it began to rise 
again (Fig. 28, Chapter Six). The SGOT and SGPT rose to very high levels, 
ascites appeared at the end of the first week, and the patient became comatose 
and died 10 days after transplantation. 
At autopsy the liver was swollen and coated with fibrin. Near the surface 
there were focal areas of necrosis. Microscopically the portal tracts were 
densely infiltrated with large numbers of lymphoid cells and a few eosinophils 
(Fig. 215). About 30 per cent of the lymphoid cells possessed pyroninophilic 
cytoplasm. The infiltrating cells were particularly numerous around the portal 
vein tributaries and were present in the walls of these vessels. The hepatic 
Fi i j i i i . e  2 i 3 .  Human hepatic homograft OT 7 )  10 d a y  after transplantation. The lix-er shows 
acute rejection. The portal tract5 are densely infiltrated ~x-ith mononuclear cells with basophilic 
cytoplasm. There is hemorrl~agic necrosis of the midzonal hepatocytes rmn:. pv=Portal x-ein; bd= 
bile duct; ha=hepatic artery. (Hematoxylin and eosin stain, x 400.) 
450 / PATHOLOGY OF THE ORTHOTOPIC HOMOGRAFT AND HETEROGRAFT 
artery branches and bile ducts were normal; the lymphatics were dilated. There 
was complete hemorrhagic necrosis of the hepatocytes in the middle and cen- 
tral zones of the lobules, leaving only a thin rim of surviving. fat-containing 
liver cells around the portal tracts. The centrizonal and midzonal sinusoids 
were congested. There was a moderately dense infiltration of lymphoid cells 
around the central veins and within the walls of these vessels. The central 
parts of the lobular reticulin framework were collapsed, but there was no cho- 
lestasis and the Kupffer cells lacked hemosiderin. 
Although the severity and extent of the hepatic necrosis were undoubtedly 
partly due to the ischemia the homograft was subjected to before transplanta- 
tion, it is impossible to dismiss the massive infiltration with large pyronino- 
philic lymphoid cells as simply reaction to ischemic injury. Acute rejection 
undoubtedly contributed greatly to the early failure of this hepatic homograft. 
This is interesting because the donor differed from the recipient at two major 
histocompatibility antigens. HLA2 and HLA5. and was classified as a grade D 
match by Terasaki (Table 5. Chapter Three). 
Cholangitis. There were no examples of this complication in the 10 
specimens. 
Homografts Examined Three Weeks to 400 Days 
After Transplantation 
Tissue from 13 of the 27 Denver hepatic homografts became available for 
examination from three weeks to more than a year after transplantation. 
Acute Rejection. On the basis of the findings in untreated and treated canine 
liver homografts described earlier, the assumption was made that dense infil- 
tration of the portal tracts with large pyroninophilic lymphoid cells indicated an 
active rejection process. Open biopsies from three of the Denver hepatic 
homografts (OT 9,  10, and 8) taken eight, 27, and 30 days after transplantation 
all showed this change." In each patient there was good early liver function. 
However, the grafts became swollen. a fever developed, and ultimately large 
areas of the transplanted organs became necrotic (Chapter Fifteen). \17hen sur- 
gical exploration was carried out for the purpose of debridement and drainage 
of the gangrenous areas. viable pieces of tissue were also removed for his- 
tologic examination. 
The portal and central vein branches in the living portions of the 
homografts were surrounded and infiltrated by large numbers of mononuclear 
cells. Ten to 40 per cent of these cells had pyroninophilic cytoplasm and were 
large lymphoid cells with many free ribosomes in their cytoplasm. Some of the 
cells lay beneath the stripped up venous endothelium. A fen- were in the 
widened space of Disse. The sinusoidal endothelium was disrupted in many 
places (Figs. 216. 217. and 218). Several of the infiltrating cells contained IgG 
in their cytoplasm (Fig. 219). The centrilobular hepatocytes shoned loss of 
microvilli. mitochondria1 swelling, dilatation or disappearance of the rough 
endoplasmic reticulum, and loss of glycogen and membrane-attached ribosomes. 
Some centrilobular intracanalicular bile stasis was present in all three livers. 
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Flqu1.e 216 .  Human hepatic homograft ( O T  10) 27 da>-s after transplantation. The space of Disse 
'D) is n-idened b?- fluid and  contains %I!-cogen and cell fragments.  Two lymphoid cells 'I!-) lie beneath 
the sinusoidal endothelium. X Kupffer cell K) contains lipofuscin and  bile. Rbczerythrocyte in 
sinusoid: hep 1 and  E=hepatocytes. 'Lead stain.  i 6300.) 
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F i g u r e  21 7.  \'ie~v of lymphoid cells lying beneath stripped-up sinusoidal endothelium in human 
hepatic homograft (OT 10) shown in Figure 216. ly=Lymphoid cell: s=sinusoid: D=space of Disse. 
(Lead stain, x 5600.) 
The similarity between these changes in treated human hepatic 
homografts and those encountered in untreated canine liver homografts was 
striking. 
Repair Following Acute Rejection. Dogs that start to recover from rejection, 
either spontaneously or as a result of treatment with immunosuppressive 
drugs, characteristically lose the lymphoid cell infiltration and develop promi- 
nent centrilobular bile stasis. atrophy of the centrilobular hepatocytes, collapse 
and condensation of the centrilobular reticulin, and increased amounts of retic- 
ulin and collagen in the portal tracts.?-l 2h 
These changes were present in eight of the human hepatic homografts (OT 
2, 5, 8, 11. 12, 15. 23. and 25) examined at 22. 23. 100 (and 400). 6 .  105, 339, 
143, and 39 days. respectively, after transplantation. Each of these patients had 
developed some evidence of rejection during the first two postoperative months 
according to the diagnostic criteria outlined in Chapter Fourteen. All the pa- 
tients had some degree of hyperbilirubinemia at the time the specimens were 
obtained, even though the jaundice was not clinically detectable in patient OT 
8 when a biopsy of the liver was taken at 100 days. 
Microscopically plugging of the centrilobular and sometimes the midzonal 
bile canaliculi with inspissated bile was the most striking feature of these liver 
homografts. Ultrastructurally the microvilli of the canaliculi were reduced in 
number or absent and the bile plugs were in the form of aggregates of dense, 
needle-shaped bodies. Dilatation of the bile canaliculi was frequent. Material 
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Ftcj2ii.e 218.  Human hepatic homoqraft OT 8: 30 da!-s after transplantatioll. Three l!-mphoid 
cells (1y 1 to 3 )  are in  the process of leal-ing the sinusoid s to eiiter the enlarged space of Disse (D). 
end=Sinusoidal endothelium: K=Kupffer cell. (Lead stain. x 7500.) 
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F i g u r e  219. Human hepatic l~omoqraft 30 days after transplantation !OT 8). A frozen section 
has been treated ~ v i t h  goat-antihuman IgG and then 1-ien-ed by f l~~orescen t  microscopy. Several 
infiltrating mononuclear cells within the wall of a portal \ ein stain positively for IgG. ( x  300.) 
similar to that in the bile canaliculi was often deposited in hepatocytes and 
sometimes in the sinusoidal lining cells (Figs. 220 and 221). 
There was atrophy of cells in the central parts of the liver lobules. The 
atrophic hepatocytes exhibited a compact cytoplasm containing glycogen, en- 
larged mitochondria, scanty but dilated rough endoplasmic reticulum and sev- 
eral large microbodies. The hepatocytes were separated from one another, and 
bundles of collagen and reticulin fibers lay between the hepatocytes and in the 
spaces of Disse (Fig. 222). The canalicular borders of the hepatocytes were al- 
most free of microvilli. 
This excess connective tissue was clearly seen in sections examined by 
light microscopy. The central parts of the reticulin framework of the lobules 
were collapsed and there were more reticulin and collagen fibers than normal 
around the central veins (Fig. 223). Increased amounts of reticulin and 
collagen were also present in the portal tracts of five of the livers (OT 2, 5, 8, 
11, and 12). This portal fibrosis was accompanied by slender bands of reticulin 
and collagen that linked some portal tracts and central veins one to the other, 
and by similar bands that subdivided lobules and joined together some of the 
central and portal areas of fibrosis. In one homograft (OT 11) the hepatic fibro- 
sis had progressed to cirrhosis. with regeneration nodules and foci of hepato- 
cyte necrosis. 
In three of the eight liver homografts (OT 2. 5. and 8) there were still a 
small number of mononuclear cells lying in the tissues around the portal vein 
radicles in the portal triads. Fen of these cells were large pyroninophilic lym- 
phocytes: most ss ere small lymphocytes. 
In one graft (OT 23) there were small groups of plasma cells in the portal 
tracts. Immunofluorescent studies showed that these cells contained IgG in 
their cytoplasm (Fig. 224); few cells contained Ighl. Immunoglobulin G. fibrino- 
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F i g l i r e  220. Ceiltral part of a lix-er lobule f rom a hulnail  hepatic homooraft  :OT 8' 100 days a f t e r  
rransplailtation. The  hepatocytes are  atrophic nlld se l  era] conraill lipofuscin and  bile pigment.  
There is  intracanalicul,~r cholestasis !arroI!-s al though the  patient n-as not ox-ertly jaundiced at this 
t ime or for many  subsequent  moilths :see F i su re  164. Chapter  Sel-enteen;.  I I u c h  bile p igment  is 
present in Kupffer cells (K:. Lead stain.  820.: 
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F i g u r e  221. Higher polver \-iew of a bile canaliculus from hepatic homoyraft (OT 8) shown in 
Figure 220. The micro\-illi are flattened and the lumen obstructed by a mass of bile pigment. (Lead 
stain, x 12,000.) 
Figzc1.e 222. Higher pol\-er 1-iexr- of human hepatic homograft OT 8 s l i o ~ ~ n  in Figure 220. A thin 
band of collayeli subdix-ides a lobule. The characteristic periodicity of the fibers can just be seen. 
(Lead stain. x 12.330.) 
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F i g u r e  223. H u m a n  orthotopic liver hornograft (OT 5). There  is collapse of tlie supporting cen- 
trilobular reticulin where  hepatocytes h a r e  undergone necrosis and atrophy. P=Portal  tract. (Re- 
ticulin stain.  x 30.) (F rom Ad\-ances in  Surgery. 1966. by permission of Year Book AIedical Pub- 
lishers. Inc.) 
Fig7 
has 
.I gr 
ire 224. H u m a n  hepatic 11olllo:raft ' 0 T  25 39 days af ter  tra~lsplantation. A frozen section 
been treated ~ r i t h  fluoresceinated .,oar-antihuman IgG and then \ i e ~ ~ ? d  b>- ultraviolet light. 
,oup of mononuclear cells lie i n  a portal tract. Their c!-toplasm stains positil-el)- for IgG.  ( x  150.) 
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gen. and complement deposits were also found in the walls of the portal and 
central veins in this same liver (Figs. 225 and 226). Additional delicate linear 
deposits were present in the walls of the sinusoids and bile canaliculi. 
In another transplanted liver (OT 15) the bile ductules were surrounded by 
neutrophilic and some eosinophilic polymorphonuclear leukocytes, some 
macrophages, and a few small lymphocytes. The leukocytes were probably 
mainly due to cholangitis (see later section). 
Infiltrating cells were absent from the other three homografts (OT 11, 12 
and 23). 
Late Rejection wi th  Vascular Changes. In human and canine renal homografts 
episodes of rejection occurring months or years after transplantation are often 
associated with intimal thickening of the intrarenal arteries." Similar changes 
have now been seen in four human liver homografts (OT 9, 10. 14A, and 16A) 
which were examined at 133, 186, 107 (and 380), and 68 days after transplanta- 
tion. The arterial narrowing was accompanied in all instances by fibrosis and 
cholestasis. and in two patients by cirrhosis (OT 9 and 14). 
All the patients had passed through a phase of early rejection. In one pa- 
tient (OT 10) there was an "anicteric rejection" (Chapters Fourteen and Fif- 
teen) which began during the first postoperative month. The other three pa- 
tients had suffered the indolent and persistent variety of early rejection. Fol- 
lowing this the high blood bilirubin levels fell in three of the patients and there 
intervened a jaundice-free period of 27 days to five months before a second 
bout of icterus occurred; the other patient (OT 16) had no remission of jaundice 
(Chapter Fourteen). In all four patients the hepatic function ultimately became 
progressively more abnormal (see Chapter Seventeen). 
At the time of autopsy or retransplantation the four livers were shrunken 
Figz1i.e 223. H u ~ n a n  hepatic holllograft 'OT 25: 39 days after transplantation. Frozen section 
treated ~ r i t h  fluoresceinared qoar-antihuman I g G  and then examined under ultra\-ioler light. The 
wall of a portal vein stains positix-el>- for IgG. (x 300.) 
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Figure 226. Human hepatic homograft (OT 23) 39 da>-s after transplantation. Frozen section 
treated with fluoresceinated goat-antihuman fibrinogen and then xielj-ed under ultraviolet light. 
The walls of a central vein and several sinusoids stain positively for fibrinogen. (x 150.) 
and firmer than normal. Two of the grafts (OT 9 and 14A)  also showed a fine 
granularity of their surfaces and, on slicing, a cirrhotic pattern was apparent. 
Microscopically in each liver homograft many of the small branches and 
some of the large branches of the hepatic artery were narrowed or even com- 
pletely occluded by intimal thickening (Fig. 227). The changes were most 
widespread and severe in the grafts from patients OT 10 and 16. The thickened 
intima contained many large cells with abundant foamy cytoplasm that was 
full of neutral fat (Fig. 228). In many of the arteries the internal elastic lamina 
was ruptured (Fig. 229). In the homograft from patient OT 10 there was fibrous 
tissue in the thickened intima of many arteries. 
Immunofluorescent studies showed the presence of IgG and the C ' l q  frac- 
tion of complement in the walls of the narrowed hepatic arteries. The deposits 
were on both sides of the internal elastic lamina. 
Ultrastructurally the large foamy cells in the intimal wall consisted of al- 
tered and hypertrophied endothelial cells as well as some macrophages, all 
containing lipid deposits and other material in phagosomes. Deep to these cells 
were deposits of a finely granular homogeneous material compatible with anti- 
gen-antibody complex. 
The pattern of fibrous and reticulin increase that was also present in all 
four livers did not differ from that seen in the eight homografts that were 
described under the heading "Repair Following Acute Rejection." The cirrhosis 
in the two most badly scarred livers (OT 9 and 14A) was of the portal type (Fig. 
230). Broad bands of connecti\e tissue subdixided the lobules. Regeneration 
nodules were small and frequent and there was some small bile duct 
proliferation. 
Cellular infiltration was present in three of these grafts; in  OT 10 and 14 it 
Figure 227. Human hepatic homograft relnor ed 68 days after transplantation (OT 16). Persistent 
rejection follon-ed early \vithdral\-a1 of anti1ymphoc~-te globulin. In the portal tract a branch of the 
hepatic artery is greatly narro~ved by large intimal cells with foamy c!-toplasm. The internal elastic 
lamina of the vessel is rnarked n-it11 a n  arron-. (Elastic stain. x 300.)  ( B y  permission of Surg. Gynec. 
Obstet. 128:327.  1969.) 
Figzi1.r 228. H u m a i ~  hepatic homopraft remox-ed 186 days after rransplantatioi~ OT 10'. The portal 
tract contaiils excess fibrous tissue and is 11:htly inhitrated \~- i th  1:mphoid and plasma cells. A 
small hepatic arterT- branch is almost occluded b>- 1ar.e illriinal cells Tiit11 foam!- cytoplasm. (Elastic 
stain, x 300.) 
F i g l i r e  229. Same liver graft as in Figure 227, sho~r-int: a branch of the hepatjc artery in a port 
tract. The vessel is completely occluded by intimal thickening and the internal elastic lamina 
ruptured. (Elastic stain. x 300.) (By permission of Surg. Gynec. Obstet. 128:327. 1969.) 
F i g  lire 230. Hulnan hepatic holllozratt renlo~-ed at autops! four and a half months after trans- 
plantation (OT 9'. The normal lobular arc11itectul.e is interrupted b?- bands of fibrous tissue arrows) .  
producing a portal t!pe of cirrhoiis. Part of the ir:e:ulall;,- rerellerating l i ~  er is necrotic (nec). 
(Hematoxylin and eosin stain, n 180.) iB>- permission of Ann. Surg. 16a:392. 196S.j 
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was mild, but in OT 16 dense collections of large pyroninophilic lymphoid cells 
were present. Intracanalicular bile stasis was present in all four livers. but was 
particularly severe and accompanied by extensive bile pigmentation of hepato- 
cytes in the graft of patient OT 14. 
NO Evidence of Rejection. Only one of the human hepatic homografts (OT 17) 
examined showed no evidence of active or past rejection. This patient had good 
liver function and died after 35 days from pneumonia caused by Pseudomonas 
(see Chapter Sixteen). Her terminal bilirubin level was less than 1 mgIlOO ml. 
It is of interest that a violent and nearly fatal rejection had been diagnosed only 
a few weeks earlier (Fig. 126, Chapter Fourteen). 
At autopsy a few small lymphocytes and occasional macrophages were pres- 
ent in the portal tracts of the graft, but the numbers were within normal 
limits. There were no large pyroninophilic lymphoid cells. Collagen was absent. 
Immunofluorescence showed no immunoglobulin deposits. 
Cholangitis. As mentioned earlier, cholangitis has been a major complica- 
tion in some canine hepatic autografts and homografts, and in porcine 
homografts. In the 13  human hepatic homografts available for examination 
three weeks or longer after transplantation, it was present in only three (OT 8, 
14A. and 15) that were examined 400, 380, and 339 days postoperatively. 
Two of the three patients with cholangitis had developed obstruction to 
their biliary tract by metastatic carcinoma. In patient OT 8 a huge tumor mass 
in the right upper quadrant of the abdomen compressed the cholecystoduoden- 
ostomy (see Chapter Seventeen). In the second patient (OT 15) a large recur- 
rent carcinoma developed in the hilum of the liver and pressed upon and 
eroded the common hepatic duct. In both homografts the biliary radicles within 
the liver were dilated and contained a few stones and extensive sludge. In the 
third patient with cholangitis (OT 14A) the biliary duct system appeared unob- 
structed at the time the homograft was removed and replaced 380 days after its 
original insertion. 
Microscopically the large and small bile ducts and bile ductules were 
surrounded by neutrophilic and eosinophilic polymorphonuclear leukocytes, 
and some small lymphocytes. In many places in the three grafts the bile duct 
epithelium was necrotic. A granulomatous reaction was present around a few 
ducts (Fig. 231). 
Biliary Duct Obstruction Without Cholangitis. In another liver homograft (OT 
12) a kink at the junction of the cystic and common duct produced dilated 
intrahepatic biliary ducts filled with inspissated bile and soft stones, but 
without cholangitis. 
Metastasis of Tumor to Graft. Eleven hepatic homografts in the Denver series 
were transplanted into patients suffering from carcinoma of the liver. Four of 
the recipients survived for 143 days or longer. Of these four grafts, all became 
the seat of metastases (Chapter Seventeen). The invading tumors were all 
hepatomas. The secondary deposits were more anaplastic than the primary 
growths. 
Regional Hepatic Infarction. In seven patients undergoing rejection of their 
hepatic homografts iOT 8 to 12. 13 and 16). the results of serial liver scans 
using "q'l-technetium suggested that areas of the transplants had become 
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Fiqui.e 231. Cholangitis in a human hepatic homograf't more than one year after transplantation 
OT 14). The wall of the small bile duct is thickened (arrow) and infiltrated n-ith polymorphonuclear 
leukocytes. The biliary lumen contains poly~norphonuclear leukocytes and inspissated bile. The 
hepatic artery branch (ha) and portal vein ipx-) are normal. (Hematoxylin and eosin stain. x 300.) 
ischemic (Chapters Fourteen and Fifteen). The process appeared to reverse 
spontaneously in one case (OT 15)> and in another patient (OT 16) the 
homograft was replaced with a second organ. 
There were multiple small infarcts in the tissue removed from the five 
homografts (OT 8 to 12) in which frank gangrene had developed. Each of the 
necrotic areas was rimmed with abundant neutrophilic polymorphonuclenr leu- 
kocytes. many eosinophils, and some lymphoid cells. but no fibrous tissue. The 
necrotic centers of most, but not all, of the infarcts contained gram negative 
bacilli. 
As described in previous sections, the residual viable parenchyma in these 
five livers had evidence either of acute rejection (OT 8 to 10) or of repair 
follonring acute rejection (OT 11 and 12). In the latter two patients the 
homograft gangrene led to death within a few days. and the right hepatic artery 
was found at autopsy to be freshly thrombosed in the hilum: the terminal 
intrahepatic branches did not seem nearly so badly damaged by rejection as the 
veins. The three patients whose lives were prolonged by the debridement proce- 
dures iOT 8 to 10) had mononuclear cell infiltration and injury of the portal and 
central veins and sinusoidal lining in the viable parenchyma.'!'. '" but the small 
arteries Tvere then relatively unaffected. However, by the time of death many 
months later. old thrombosis of the common (OT 8) or right hepatic artery (OT 
9 and 10) was demonstrated. I n  the intervening period widespread narrowing 
of the patent intrahepatic arteries to the left lobe had occurred in patients OT 9 
and 10. 
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The homografts of the two recipients who apparently narrowly escaped the 
complication of partial hepatic gangrene were also examined. The liver which 
had suffered rapidly reversible ischemic changes in the second and third post- 
operative weeks (OT 15) contained neither infarcts nor arterial lesions at  au- 
topsy 11 months later. In contrast, the homograft which n7as removed and 
replaced after 68 days (OT 16) had multiple old and nev infarctions. Further- 
more, there was widespread arterial narrowing (Fig. 227). 
The pathogenesis of early necrosis in liver homografts was discussed in 
Chapters Fourteen and Fifteen. Although mechanical considerations were ap- 
parently important in determining the localization of the acute ischemic 
changes, an even more important underlying factor was probably a reduced 
blood flow secondary to damage by rejection of the veins and sinusoidal bed of 
the homografts. as has been demonstrated in dogs.X It has become clear that the 
resulting sudden hemodynamic alterations can be decisively reversed under 
the proper circumstances. Later, however, the development of arterial 
narrowing as the consequence of chronic rejection can be responsible for con- 
tinuous homograft ischemia. 
Correlation of Histopathologic Findings with the 
Results of Tissue Typing . 
With the small amount of histocompatibility data at  present available 
(Table 5. Chapter Three) no correlation between HLA group mismatches and 
the presence or absence of histologic changes is yet discernible. 
The liver homografts from the two patients (OT 8 and 16A) who showed no 
HLA group mismatches with their donors were densely infiltrated with lym- 
phoid cells. In one of the grafts (OT 16A) there was also severe arterial intimal 
thickening. 
Origin of Kupffer Cells and Endothelial Cells in 
Long-surviving Human Hepatic Homografts 
Using the technique first described by Barr et all it is possible to sex the 
nuclei of many cells. The nuclei of female cells contain a distinctive chromatin 
mass. 
Among the 23 Denver patients with liver homografts in whom samples of 
tissue from the transplant were a\-ailable for examination. there were nine 
instances (OT 5. 8. 12. 14. 17. 18. 20. 21. 24) in which a liver from a male donor 
was transplanted into a female recipient. A modification of Barr's method was 
used to determine the sex of the Kupffer cells and the hepatic arterial and 
portal venous endothelial cells in the graft. The modification was to examine 
azure 11-stained serial 0 . 5 , ~  thick sections from Epoxy-embedded tissue. 
The sex of the vascular endothelial cells remained male in all nine 
instances (Table 35). Hoxl-ever. the Kupffer cells became female and, therefore, 
of host origin in the three patients (OT 8. 12. 14) whose livers were examined 
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Table 35. Analysis of Sex of Cells" 
- - -- 
SEX CHASGE IN  GRAFT (MALE TO FEMALE) 
PATIENT O T  DAYS GRAFT 
NUMBER RESIDENCE Kupflei, Cells E~zdotlzelict l  Cells 
--
--
8 400 Yes No 
12 1 05 Yes No 
Yes 
No 
No 
N 0 
N 0 
No 
Analysis of the sex of the Kupffer and vascular endothelial cells in  nine patients in  whom 
orthotopic livers were transplanted from male donors to female recipients. 
400. 105, and 380 days. respectively. after transplantation (Table 35). The same 
sex transition had not occurred in the other six homografts that had been in 
residence for one half to 35 days (Table 35). 
Lymphoid Tissue Transplanted w i th  Graf t  
With each liver graft a number of donor lymph nodes and cellular aggrega- 
tions of lymphoid cells are transplanted. This lymphoid tissue was examined in 
12 of the 23 Denver human hepatic homografts. In each instance there were 
lymphoid follicles with prominent germinal centers and plenty of plasma cells 
in the medulla. These latter cells nlay have been the source of the donor type 
IgG that was found ill some of the patients after hepatic transplantation (see 
Chapter Eighteen). 
CHANGES IN HOST LYMPHOID TISSUES AFTER 
ORTHOTOPIC LIVER TRANSPLANTATION 
In dogs not treated n i th  immunosuppressive agents there is generalized 
enlargement of the lymph nodes. XIicroscopicall~ there is a proliferation of 
large lymphoid cells ni th  pyroninophilic cytoplasm around the postcapillary 
venules in the paracortical area of the nodes. These cells are larger than those 
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that invade the portal tracts of the graft but are otherwise morphologically very 
similar. 
In the first week after transplantation more and more of the large lymphoid 
cells accumulate in the paracortical zones of the lymph nodes. By seven to 10 
days, when most untreated animals die from hepatic failure, plasma cells are 
appearing in large numbers in the medulla and in the prominent germinal 
centers of lymphoid follicles in the superficial cortex. A similar proliferation of 
large pyroninophilic lymphoid cells occurs soon after liver transplantation in 
the periarteriolar sheaths in the white pulp of the spleen. Later, multitudes of 
plasma cells can be seen in the splenic red pulp. 
Those animals which are treated with azathioprine or antilymphocyte 
globulin, but which still reject the transplant, show lymphoid changes that may 
be delayed but that are essentially the same as those occurring in the untreated 
animal. Observations made at autopsy on patients with liver grafts suggest that 
a similar series of events transpires in the lymph nodes of man if the graft 
undergoes rejection. 
CHIMPANZEE TO HUMAN HETEROGRAFT 
In Chapter Nineteen the clinical course was described of a child who 
received an  orthotopic chimpanzee liver. At autopsy nine days after transplan- 
tation the graft was not swollen and all the vessels were patent. The only gross 
abnormalities were many small hemorrhagic foci scattered throughout the 
substance of the liver and a number of subcapsular focal necroses. 
Microscopically there was a dense infiltration of lymphoid cells in all the 
portal tracts (Fig. 232). About 30 per cent of these cells possessed pyronine- 
positive cytoplasm. Rare polymorphonuclear leukocytes were also present. A 
few lymphoid cells were seen around the central veins. The hepatocytes ad- 
jacent to the central veins were atrophic and there was marked centrilobular 
cholestasis with bile "thrombi" (Fig. 233).  The majority of the hepatocytes 
appeared normal. The lobular reticulin pattern was normal. Portal vein tribu- 
taries. hepatic artery branches, and small bile ducts were normal. 
In the hemorrhagic foci there was necrosis of the centrilobular hepatocytes 
with destruction of sinusoids and extravasation of blood. In the paler subcapsu- 
lar foci there was necrosis of the hepatocytes in the middle and central zones of 
the lobules but no central hemorrhage (Fig. 234). 
The histologic changes in this liver heterograft were very like those that 
occur in hepatic homografts. The lymphoid cell infiltration in the portal tracts 
was dense, but no more so than in the grafts from patients OT 7 to 10 (see 
Figure 215 for comparison) and in many treated canine hepatic homografts. 
There were no lesions of large blood vessels. Fibrinoid necrosis of arterial walls 
was conspicuouslp absent. It n-as difficult to believe that this child's death had 
been the direct result of hepatic failure produced by rejection. The analysis of 
the postoperati~e clinical events given in Chapter Nineteen tended to support 
the conclusion that considerable liver function n-as maintained until almost the 
endofl i fe .  K A  6 3 0 ~ f r d  / Y C y  
F i g u ~ r  232. Human orthotopic hepatic heterograf't nine days after transplantation. Sample from 
grossly normal part of chimpanzee lil-er. There is dense cellular infiltration in the portal tract, 
particularly around the portal vein (P\'). The peripheral and midzonal hepatocytes contain a few 
droplets of fat but are essentially normal. The central hepatocytes (arrou-) are atrophic. (Hematoxylin 
and eosin stain. x 80.) 
F1glii.e 233, Same chimpanzee ro man l i ~ e r  hererografr as in Figures 232 and 231. High power 
1-iew of central part of one of rhe 1i1-er lobules s h o ~ ~ - i ~ l g  inspissated bile in the callaliculi arrours). 
CV=central 1-ein. (Van Gieson and elastic stain: i 300.\ 
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468 / PATHOLOGY OF THE ORTHOTOPIC HOMOGRAFT AND HETEROGRAFT 
F i g l l r c  234. Sample from a subcapsul,lr necrotic focus of the chin~pallzee to Inan lix-er heterograft. 
Only a rim of hepatoc?-tes surx-ixe ilnmediate1~- adjacent to the portal tract (P) .  I lany of the mid- 
zonal and centrizonal hepatocytes are necrotic. (Hematoxylin and eosi11 stain, x 80.) 
CONCLUSIONS 
From these studies of orthotopic whole liver homografts in dogs, pigs, and 
man a fairly clear picture emerges of the sequence of pathologic events which 
occur when the recipient rejects the graft. As will be mentioned in connection 
with auxiliary liver transplantation (Chapters Twenty-one and Twenty-three), 
the same conclusions probably also apply in rats. 
In untreated members of all species there seems to be a quiescent phase of 
at least two or three days during which only rare small lymphocytes are found 
in the tissue spaces of the liver. Other changes can occur in the graft at this 
time. such as widening of the space of Disse and some damage to the centri- 
zonal hepatocytes. but such alterations are nonspecific and are commonly 
found in autografts. Honever. during this period, large pyroninophilic cells 
start proliferating in the paracortical zones of the host lymph nodes. 
About the third day after transplantation, lymphoid cells, many of them 
with pyroninophilic cytoplasm containing abundant free ribosomes. begin to 
leave the portal ~ e i n  tributaries in a random way throughout the graft. The 
venous endothelium becomes lifted an-a? from the basement membrane and 
fibrin collects in the subendothelial space. After passing through the vessel 
wall the lymphoc? tes accumulate in the portal tracts. Smaller numbers of simi- 
lar lymphoid cells immigrate through the walls of the central leins and 
through the endothelial lining of the sinusoids. These cells invade the space of 
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Disse and some squeeze between hepatocytes. Immunoglobulins are rare in the 
cytoplasm of these infiltrating cells (see also Chapter Twenty-three). 
Associated with the cellular infiltration, the walls of many of the sinusoids 
disintegrate. the blood flow through the liver begins to decrease. and some 
centrilobular hepatocytes die. As the centrilobular necrosis progresses to mid- 
zonal necrosis, the liver function becomes affected. Inspissated bile appears in 
surviving bile canaliculi, and lipid droplets accumulate in the hepatocytes 
around the portal tract. Shortly before the death of the recipient. foci of 
fibrinoid necrosis may occur in the walls of the small branches of the hepatic 
artery and these are associated with the appearance of IgG and complement in 
the intima and media. 
The reduction in blood flow which destroys the graft is probably the result 
of damage to the venous and sinusoidal parts of the ~asculature.  The lymphoid 
cells seem to produce this damage, but how is not known. Cell-bound antibody 
is suspected but has not yet been demonstrated. 
Lee and Edgington's experiments with rats (see Chapter Twenty-three) 
have shown that these events are accelerated with increased histocompatibility 
differences between donor and recipient; presumably this situation pertained 
in some of the human homotransplantations (as in Case OT 7) and also in the 
heterotransplantation. The changes are delayed and often attenuated either if 
the histocompatibility differences are slight or if the recipient is treated with 
immunosuppressive agents. The host response evoked by the liver may be 
inherently less vigorous or at least less lethal than that induced by a number of 
other grafted tissues. The strongest indication that this may be the case has 
come from the pig experiments cited earlier in this chapter and in Chapter 
Eleven. However, the same may be true in the dog (Chapter Twelve) and in 
other species as well. 
When rejection is minimal (as in pigs) or if it is modified by treatment (in 
dogs and humans), the destruction of hepatocytes stops, but there is often 
collapse of the central part of the lobular reticulin framemork. This e\ ent is 
frequently accompanied by the marked accumulation of inspissated bile in the 
centrilobular bile canaliculi. but whether the centrilobular changes cause the 
cholestasis is not known. An alternati\e possibility is that the bile stasis is 
secondary to the widespread loss or distortion of the canalicular microvilli 
which occurs at about the same time. 
Later. connecting bands of reticulin may be laid down between the central 
areas. subdividing the lobules. What triggers this progression to hepatic fibrosis 
in some grafts is unknown. In a few recipients a true cirrhosis may even even- 
tually be produced. 
Great intimal thickening with obstruction of the lumen occurs in many of 
the branches of the hepatic artery in some long-sur~i l ing human liver 
homografts. The accu~nulation of IgG and compleinent in the altered vessel 
wall raises the possibility that this damage is a late manifestation of rejection 
brought about by circulating antibod?. but this is at present pure speculation. 
Some of the hepatocyte damage in treated human grafts may h a ~ e  been 
due to the immunosuppressive drugs useci. particularl? azathioprine (see Chap- 
ter Twelve). Viral hepatitis may also have been responsible for a few of the 
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PART IV 
AUXILIARY 
TRANSPLANTATION 

Chapter Twenty-one 
METABOLIC CONSIDERATIONS 
IN ANIMALS 
There have been dozens of reports of heterotopic hepatic transplantation in  
dogs. The studies all had a clinical orientation since, at  first thought, the con- 
cept of using an  auxiliary hepatic homograft for the treatment of patients with 
benign liver disease has a special attractiveness. First, sacrifice of the 
remaining limited function of the failing recipient liver can be avoided. Thus, 
in the event of poor initial performance by the homograft due to i s c h t ~ i a  or to 
a severe but reversible rejection. it might be hoped that some assistance would 
be provided by the diseased host liver during a transition period. This would be 
predicted to be a particularly significant advantage in patients with biliary atre- 
sia, since the synthesizing functions of the liver are often retained until the 
terminal stages of this disease. Second. it was initially assumed that the place- 
ment of an  extra liver would be safer and technically less demanding than the 
orthotopic procedure. 
The appeal of auxiliary hepatic transplantation has lost a good deal of its 
3 
luster in view of some of the mechanical difficulties which have been encoun- 
tered (Chapter Twenty-two) and in light of the special physiologic problems to 
be discussed later which are posed by dual liver systems. Nevertheless, there 
may be a limited role (see Chapters One and Twenty-two) for carefully planned 
and executed auxiliary transplantations. 
THE PROBLEM OF GRAFT ATROPHY 
The first experiments with whole organ liver homografts were carried out 
in dogs by 1Velch." jq The operation as originally described, or slightly modified 
by later authors. insolved the transplantation of an extra canine liver in the 
right paravertebral gutter or pelvis of a nonrelated mongrel recipient. The hepat- 
ic arterial supply Isas derived from the aorta or iliac artery (Fig. 235). Venous 
inflow was reconstituted by anastomosing the distal iliac a ein or inferior vena 
cava to the homograft portal vein; outfloat was into the proximal iliac vein or 
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Figure 235. Auxiliary liver transplantation in  dogs by a modification of Welch's original technique. 
Note that the reconstituted portal blood s u p p l ~  IS from the dlstal inferior vena c a t a  Cholecysto- 
duodenostom) 1s performed (BT pellnlsslon of Ann Surg 160 41 1 1964 ) 
vena cava. \Velchi" n i th  Goodrichbnd those who followed3". 3 i  3* proved that 
such livers produced bile for several days after transplantation and then ceased 
to function. The organs had histopathologic evidence of rejection. This was to 
be expected since immunosuppressive therapy was not employed. 
It was 10 years after Welch's first publication before auxiliary transplanta- 
tion was attempted in immunosuppressed canine recipients. X curious and dis- 
quieting obser~ation was soon made:44"- It n a s  found that auxiliary 
homografts, inserted by a modification of Welch's technique into dogs being 
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treated with azathioprine, were much more severely damaged than orthotopi- 
cally placed livers. There m7ere moderate and sustained increases in the 
serum transaminases and alkaline phosphatases. However. the most striking 
event was rapid shrinkage of the extra organ, which was usually evldent within 
two weeks and which was very advanced at all times after one month (Fig. 
236). 
The gross appearance and lobar proportions of the no\\ diminutive 
homografts remained relatively unaltered except for size. The duct system did 
not participate in the shrinkage and often was more or less completely spared 
from rejection. Within the parenchyma there was a massive loss of hepatocytes 
from focal or widespread necrosis. reticulin collapse. and consequent crowding 
together of intrahepatic portal tracts. Later. Daloze et all showed that an 
inherent vascular insufficiency was not responsible for these changes. In their 
studies the total blood flow through auxiliary Welch homografts was about 
equal to that of the hosts' own livers. 
These small transplants were incapable of sustaining life. In four dogs, the 
host livers were removed four weeks after transplantation.14 All four animals 
died within 12 to 48 hours. At autopsy no explanation for death could be found, 
and it was concluded that the animals had died of hepatic insufficiency. Hem- 
orrhage such as that which invariably terminates experiments after simple 
total hepatectomy" had not occurred. 
F i g l ~ . r  236. The  auxi1iar)- ho~nogra f t  Criehr' and  the  recipient doe's  o~1-n  lix-er { lef t !  in a n  experi- 
men t  i n  ~ ~ h i c h  the  host and  transplanted oreails had oriqinall!- been about the  s ame  size. Tlle method 
of re\-ascularization 11-as a s  illustrated in Fieure  235. Postoperatil-e i m i ~ l u i ~ o s u p p ~ ~ e s s i o i l  was  wi th  
azathioprine,  S o r e  the  well preserx-ed bur dimensionall!- reduced general s t ruc ture  of the  homo- 
graft. The  gallbladder did nor shrink proportionatel!-. The  specimells x e r e  obtained 45 days a f t e r  
transplantation.  (By permission of Ann. Surg .  160:411. 1964.) 
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Three possible explanations were advanced to account for these findings.47 
The least likely was that immunosuppressive therapy, which is partly depen- 
dent on accurate day-to-day monitoring of homograft function, had been in- 
decisively delivered because of the inability to differentiate between the me- 
tabolism of the homograft and the host liver: this was later proved not to be the 
case. A second proposal was that the host's own liver "may have contributed 
substantially to the immunologic reaction [against the auxiliary homograft], a 
factor which would be eliminated in the orthotopic preparation." This proved 
not to be the essential explanation for the graft shrinkage. 
The third suggested possibility proved to be the correct one: "The abnormal 
revascularization may have contributed even though. . . dogs with portacaval 
transposition do not have loss of hepatic mass.:i Competition [of the homograft] 
with the dog's own liver for nutritional substrate may have been an unfavor- 
able ~ondit ion."~ '  Subsequent work has established beyond doubt that aux- 
iliary liver homografts which are placed in various ectopic locations can under- 
go involution by this mechanism. 
Competition and Graft  Atrophy 
Evidence of competition between coexisting livers was subsequently 
provided from our laboratories by Marchioro et al." In these experiments 
canine homografts were placed in the right paravertebral gutter in the usual 
way except that the portal vein of the homograft was connected to the superior 
mesenteric vein. Splanchnic flow through the auxiliary liver was then pro- 
moted by ligating the portal vein at the hilum of the host liver (Fig. 237B). 
The animals, which were treated with azathioprine, now usually had 
atrophy of their own livers but not of the homografts. In commenting on these 
results4' it was remarked: "Apparently, there is a competition between coexist- 
ing livers for some metabolite or other substance in the portal venous blood. 
That organ which has first access to the portal flow retains its functional and 
morphologic integrity. The other organ. whether it be the homograft or the 
autologous liver. undergoes atrophy predominantly affecting the centrizonular 
area." The validity of this point of Liew and the fact that the competitive rela- 
tionship can be unbalanced in ways other than by the presence or absence of 
splanchnic flow will now be considered. 
The Quant i tat ive Effect of Splanchnic Venous Blood. During the first half of the 
twentieth century conflicting opinions and evidence were presented concern- 
ing the influence of splanchnic venous blood on hepatic morphology and 
function. After Eck's initial observation that portal venous diversion in dogs did 
not result in deathqh the importance of splanchnic venous inflow to the liver 
was minimized. il'ithin a fen- years, however. Hahn." working with Pavlov, 
demonstrated that animals xvith this operation had liver atrophy. serious weight 
loss, and neurologic aberrations that could be triggered by protein ingestion. 
Since animals with Eck's fistula have a reduced total hepatic blood flo~v.l~3 1 5 . 4 9  
the unresolved question was n hether these adverse consequences were simply 
due to the quantitative flow change or whether they resulted from depriving 
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Figure 237. Marchioro's first experiment with auxiliary hepatic homotransplantation, which 
suggested competition between coexisting livers. A .  nlodification of' LI'elch-Goodrich technique; 
the portal blood flow to the transplant was from the systemic venous system. The homograft under- 
went rapid atrophy. B.  The portal venous inflow was obtained from the nonhepatic splanchnic bed. 
The host liver received only a n  arterial supply. With these changes. the homograft atrophy was 
prevented and in some experiments the shrinkage now involved host livers. (By permission of 
Surg. Gynec. Obstet. 121 :17, 1965.) 
the liver of some substance or substances present in high concentration in the 
intestinal venous effluent from which the portal system is normally supplied. 
The issue seemed to have been settled in 1953 with the observations on 
canine portacaval transposition by Child,' which were later confirmed and ex- 
tended by Silen4? and many others.lb 4X 1' With this operation the portal venous 
blood was diverted from the liver as n i th  an Eck's fistula but it was replaced by 
a systemic Lenous inflow from the inferior vena cava (Fig. 238): total hepatic 
blood flow was unchanged or increased.lh -"' and the illness caused by Eck's 
fistula was avoided. Furthermore. dogs with transposition were thought by 
Child3 to have a normal capacity for liver regeneration and by others to have 
normal hepatic function except for a reduced ability to eliminate an intravenous 
ammonia load.'? 
These findings indicated that the quantity of portal venous inflow is a vital 
element in the maintenance of hepatic integrity in normal dogs. The same 
conclusion applies equall? or even more so for heterotopic hepatic homografts 
as mill subsequently be made clear, especially In discussing hon to prevent 
atrophy of these auxiliary canine organs. For the moment it will only be pointed 
out that the research with portacaval transposition did not rule out the possi- 
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F i g u r e  238. The technique of portacal-a1 transposition as it has been carried out in  patients with 
glycogen storage disease. In canine experiments the safety of the operation is greatly increased if 
it is performed under total bod>- hypothennia. :By permission of Surgery 57:687 .  1965.) 
bility that the composition of splanchnic venous blood might be an important 
additional factor. 
With transposition, the blood which is initially bypassed around the hepatic 
tissue is processed through the mixing chambers of the heart and eventually 
delivered back to the liver in diluted form. In spite of this recirculating effect, 
severe deglycogeliation of hepatic tissue has been described". 4"tvthin six or 
eight weeks after transposition. suggesting that subtle metabolic changes had 
been produced and that the livers, although compatible with good health and 
long life, were not completely normal. 
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The Qualitative Effect of Splanchnic Venous Blood. The concept that the pres- 
ence of two livers altered the just described metabolite recirculation was im- 
plicit in Marchioro's interpretation of his results after auxiliary transplantation. 
He suggested that the organ which was perfused first by splanchnic blood 
extracted a disproportionate share of unspecified substances. and that the other 
liver atrophied because of its disadvantaged competitive situation." This view 
was soon supported by Thornford," Halgr i rnson , ' and  Tretbar."."" Thom- 
ford showed that the atrophy in Welch auxiliary homografts could be prevented 
in immunosuppressed recipients if the host livers were removed within a few 
days after transplantation, and Tretbar and Halgrimson demonstrated that the 
shrinkage could be reduced by diversion of portal blood away from the host 
liver. 
The value of various double liver techniques for making apparent this 
otherwise well masked physiologic effect of interliver competition could hardly 
be overemphasized. Hon~ever. the transplant preparations originally used had 
two serious flaws which prevented definitive conclusions about the exact 
pathogenesis of the atrophy. First. the total flows delivered to the two coexist- 
ing livers were often different. Second, there was by definition an inherent 
inequality of the two organs since the homograft was under immunologic at- 
tack despite host immunosuppression whereas the animal's own liver was not. 
Consequently. another experiment was undertaken which was designed to cir- 
cumvent both deficiencies. 
The preparation used was termed a "split transposition.""'":' In normal 
dogs either the right or left portal trunk was detached from the main portal 
vein and revascularized by anastomosing it to the suprarenal inferior vena cava 
(Fig. 239). Thus, the portal inflow of one fracticn of the liver came from the . 
hind quarter and kidneys. The portal perfusion for the other fraction came from 
the nonhepatic splanchnic bed. The total hepatic flow to the respective sides 
Figzl1.e 239. A11 experiment designed to sho~r -  the effect of splanchnic T-enous blood upon the 
liver (partial p o r t a c a ~ a l  transposition?. S o t e  that one portion of the lil-er received venous blood 
f rom the intestinal effluent. but  that the  other part derived its portal inflon- f rom the  inferior vena 
cava. (By permission of Surgery 61 :723,  1967.) 
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was Oxygen content in  the two sources of venous supply was 
not significantly different." The arterial supply and biliary tract drainage were 
not disturbed. 
Under these conditions the portion of livers receiving splanchnic venous 
flow thrived and often hypertrophied. whereas the fragment nourished with 
equal or even greater volumes of systemic venous blood atrophied (Fig. 240). 
Biochemical analyses of the two sides showed marked deglycogenation of the 
shrunken hepatic tissue.", '' a finding which supported the possibility that the 
peculiar "hepatotrophic" effect of splanchnic blood was due to metabolites 
such as sugar, which it contains in  high concentration after meals. However, 
measures of proteins and various enzymes (including phosphorylase, glucose-6- ' phosphatase, acid phosphatase, and phosphoglucomutase) were equal on both 
sides. 
The advantage (and hypertrophy) enjoyed by the tissue which was perfused 
with splanchnic blood and the disadvantage (and atrophy) of the other frag- 
ments were quickly confirmed in dogs by the studies of PriceH and SigelAo and 
their associates, who transplanted pieces of autologous liver to ectopic loca- 
tions, varying the methods of vascularization of the residual and transferred 
portions. More recently, Lee and Edgington'" have reported similar findings in  
Figz11.e 240. Marked atrophy af ter  partial t r a~ l spos i t i o~ l  to the  left ma in  portal t runk [Fig.  239B). 
The autopsy specimen was  obtained 73 da!-s af ter  operation. The  atrophic left  portion ~ v e i g h e d  32 gm. 
T h e  hypertrophied right fraction weighed 234 gm. B!: permission of Surgery G I  :723.  1967.) 
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rats. The application of these principles in auxiliary homotransplantation will 
be considered subsequently. 
Other Factors in the Competitive Balance. Factors other than the quality and 
quantity of blood supply can influence the outcome of such an experiment. 
This clinically significant fact was acknowledged in many of our early publica- 
tions by comments such as the following: "Whether substrate competition will 
prove to be of important clinical significance is not known. In the benign 
diseases for which liver transplantation might be contemplated, there would be 
pre-existing failure of the recipient patient's liver. so that it might be incapable 
of efficient metabolic extraction. Should this prove to be the case, the exact 
method of auxiliary homograft revascularization will be less ~r i t ica l . "~ '  
There are a variety of experimental ways in which liver tissue can be in- 
jured. One of the simplest is to ligate the duct system. It has been long known 
that when a lobar or segmental duct is occluded in rabbits." j4 cats.14 "' 
pigs," and monkeys,?" the hepatic tissue which it drains may ultimately 
atrophy, whereas the remaining undisturbed parenchyma undergoes hyper- 
trophy. Completion of the sequence of events is rapid in the rabbit, requir- 
ing only four to six weeks, and slower in the other animals, taking as long as 
12 to 15 months in some species. To account for this effect several of the 
authors cited above speculated about a reciprocal inechanism which has obvi- 
ous analogies to that proposed to explain the findings after "split 
transposition." 
The hypothesis was very clearly developed by Schalm et al,'4 who wrote in 
1956: "These observations would seem to support the theory that any relative 
difference in functional possibilities between both hepatic parts is associated 
with (differential) atrophy and hypertrophy. . . . If part of the liver is deprived of 
its possibility of bile drainage or its supply of portal blood, atrophy of this 
hepatic part occurs, associated with simultaneous hypertrophy of the other 
hepatic part which has retained its functions. It is likely that these phenomena 
always occur when one part is in a relatively more favorable functional condi- 
tion than the other. The rapidity of development of this phenomenon is deter- 
mined by the extent of the functional difference." Ten years later Schalm 
briefly reviewed this subject again, drawing attention to its relevance in aux- 
iliary t ran~planta t ion .~~ 
Host common duct ligation in dogs in conjunction with auxiliary transplan- 
tation was first reported by Hagihara and Absolon,"' originally as a means to 
permit better tracking of the bilirubin-clearing capacity of the extra liver. As an  
incidental finding they observed that the function of the homograft. at least in 
terms of bile excretion. was thereby prolonged. Later. Gliedman of New Y ~ r k , ~  
Faris in our laboratories,: and \ a n  der Heyde of Leyden Universityih-i" did the 
same thing for the purpose of favoring the auxiliary liver. The precise degree to 
which this objective was met was not analyzable in any of these experiments 
since other variables were present. including inequalities of both the kind and 
quantity of hepatic blood flon- to the two livers. and the unpredictable effect of 
immunologic repudiation on one of the two organs. Far more credible confirma- 
tion of the physiologic handicap imposed by biliary tract obstruction in a trans- 
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plant situation was later provided by the experiments of Price31 and Leela, 19, in 
which the element of rejection was eliminated by the employment of aut- 
ologous and or syngeneic grafts. 
In Lee's studies in rats he also noted that the combination of biliary ob- 
struction plus portal deprivation had a more profoundly injurious effect than 
either insult alone.'" The same conditions were probably present in the much 
earlier canine autotransplantations performed by Sigel. who free-grafted small 
pieces of hepatic tissue to defunctionalized loops of small intestine. The trans- 
plants underwent rapid shrinkage4' which, however, could be slowed by partial 
host hepatectomy or by Eck's f i~ tu l a .~"  
There is little reason to further belabor the point that one of two co-existing 
livers can be rendered relatively noncompetitive in many more ways than those 
mentioned above. One that so far has been mentioned only in passing is to 
submit it to the injury of immunologic rejection. The crucial importance of this 
factor in affecting the relation of a hepatic homograft to the host liver will be 
returned to later. 
In this and the preceding sections interliver competition has been con- 
sidered as a physiologic concept which was first fully appreciated in the course 
of research with ectopically placed homografts but which could then be most 
accurately studied outside the sometimes bewildering context of homotrans- 
plantation. The topic of competition was considered in detail because of the 
need to have a completely crystallized view of the problem before discussing 
the prevention of auxiliary hoinograft atrophy. In so doing, the first publica- 
tions on the subject were directly quoted more freely than usual because of the 
desire to clarify the terminology initially used by us in respect to that later 
employed by the research team at Leyden. Holland." ''r" The latter workers 
have used slightly different terms to describe the identical phenomenon. Since 
such semantic distinctions could be confusing, they will not be considered 
further. 
THE PREVENTION OF HOMOGRAFT ATROPHY 
The first step in minimizing or preventing auxiliary homograft atrophy in 
canine experiments is to avoid situations in which the transplanted liver is 
placed at an absolute physiologic disadvantage. as in M7elch's original opera- 
tion". "!' and in several modifications of this procedure,"'. 2 4 .  ". :"'. :". :'*. 4 4 ,  4; Fol- 
lowing Alarchioro's enunciation of this principle." many subsequent investiga- 
tors have attempted to restore the competitil-e balance or to tilt it in favor of the 
transplanted organ either by giving the homograft a quantitatively or qualita- 
tively superior blood supply.?. '  7 .  ". I!'. 5'. ';-?!I. 4". 5" 3:: by more or less defunc- 
tionalizing the host's o~1.n liver in a I-ariety of ways that have ranged from its 
complete removal through common duct ligation.]. 7 .  '. 1". '1. j 4 .  '3. 3 7 ,  3' or by a 
combination of these approaches. 
The second step is to appreciate fully that the homograft requires a better 
than equal environmental opportunity to counteract the immunologic duress 
which it alone must suffer if there is not a perfect histocompatibility match or 
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else totally effective immunosuppression. The problem was recognized by 
Marchioro2' and most dec is i~  ely studied by Halgrimson.'? The dogs in the latter 
investigation'? were subjected to Eck's fistula and treated with azathioprine. 
Auxiliary homografts mere placed in the right parasertebral gutter and 
provided with a double blood supply (Fig. 241). I n  se\ era1 instances the portal 
venous anastomosis clotted (Fig. 241B). leaving both organs coinparably ar- 
terialized. There was profound arid rapid shrinkage of the transplants. 
Unfortunately, the "lead" which is required for protection of a canine 
homograft, or indeed if an! advantage will be sufficient. is not analyzable 
in advance in any given experiment. The reasons are that histocompatibility 
matching cannot be accurate11 done betneen ino~gre l  dogs and that the 
efficiency of ~mmunosuppression ma) be variable froin case to case. Using 
azathioprine as the sole method of immunosuppression, the privilege extended 
to the homograft should ideally be of the magnitude of that pro1 ided by hlarchi- 
oro2? when he deprived the host liver of its portal flou and diverted the 
nonhepatic splanchnic venous blood through the homograft (Fig. 237B), 
thereby causing atrophy of the recipient's own organ and avoiding it nearly 
completely in the transplant. The penalty for a less complete approach, using 
F i g z l ~ . e  241. Experiinental  design of auxi1iar)- canine  homotransplantatioll of t he  lix-er. i n  conjunc-  
tion with host portacax-a1 slluilt. .A. tha t  the  homograft  received a double blood supp1~- .  t he  portal 
inflow being of systemic x-eilous oriqin. Except for t he  host  portacaval shun t ,  the  procedure was  
essentially that  described b!- \Yelch.' - '  Jloderare atrophy of both the  l ~ o m o e r a f t  a n d  host li\-er were  
obserl-ed. B .  In these dogs the  portal \-enous a n a s t o i ~ ~ o s i s  clotted: thus .  borh the  host l i \~el .al ld homo- 
graft receil-ed 0111~- a n  arterial blood suppl!-. Transl~lailr  arroph!- lvas profound. B! perinission of 
Arch. Surg.  93:107. 1966.) 
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this form of immunosuppression. was demonstrated by Halgrimsonl2 and Da- 
lozei in our laboratories and by Tretbar." Halgrimson and Tretbar performed an  
Eck's fistula on the host liver and revascularized the homografts as with por- 
tacaval transposition, thereby giving the auxiliary liver a double blood supply as 
opposed to an arterial supply alone for the autologous organ (Fig. 241A). The 
transplant atrophy was considerably reduced but not prevented after an aver- 
age follow-up of 58 days. 
In an  extension of this experiment Faris7 and van der Heydei7.j8 added 
ligation of the host common duct. There were apparently 11 dogs in van der 
Heyde's series that survived for at least three weeks, but only one that had lived 
for more than 46 days. Atrophy affected the transplant in only 3 (or 4) of the 11 
cases. The shrinkage that can occur even under these relatively favorable cir- 
cumstances was also remarked upon by Farisi and is illustrated in Figure 242. 
The ultimate criterion of success after auxiliary hepatic transplantation is 
the ability to have life sustained by the homograft after delayed removal of the 
host liver. This has rarely been achieved even for short periods and it has never 
been accomplished with really long survival. Three dogs in Marchioro's seriesL2 
had transplants of normal size in conjunction with atrophy of their own livers 
77, 61, and 73 days after the procedure shown in Figure 237B. Autologous 
hepatectomy was then performed. The animals lived for 49, 8, and 27 more 
days, respectively, although they had abnormal hepatic function (Fig. 243). To 
date, these experiments and those of Thomford" have been the only ones in  
which total recipient dependence upon auxiliary homografts has been com- 
patible with life for more than a few days. The hepatectomies in Thomford's 
animals were carried out seven days after transplantation. The longest subse- 
quent survival was seven and a half weeks. 
RELEVANCE TO CLINICAL TRIALS 
It is virtually certain that the principles outlined in this chapter apply in a 
general way to auxiliary hepatic transplantation in humans. What is not known, 
since there have not yet been any opportunities to study long-term human 
survivors after such operations, is to what degree chronic interliver competi- 
tion will occur in patients. All that can be said now is that the evidence of 
homograft atrophy has been suggestive but quite inconclusive in recipients 
observed for as long as 34 days (Chapters Twenty-two and Twenty-three). All 
these patients had Laennec's cirrhosis. On the other hand, it is conceivable that 
the host liver in victims of biliary atresia could be capable of promptly and seri- 
ously compromising the welfare of the new organ since the hepatic 
parenchymal function in such patients is often surprisingly well maintained 
until just before death. There have not yet been any clinical observations with 
which to rule out this possibility. 
Be that as it may, the host liver in all legitimate candidates for auxiliary 
transplantation will ha l e  been rendered relatively noncompetitive by the 
disease for ~vhich treatment is indicated, the question being only one of degree. 
Under these circumstances the advantage which must be created for the homo- 
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F i g u r e  242. Shrinkage of a canine auxiliary 
homograft that received a hepatic arterial supply 
as well as a n  inflow for its portal vein from systemic 
venous sources. The host liver was handicapped 
by ligation of its common duct and by the perform- 
ance of a n  Eck fistula. Despite these advantages, 
the transplant atrophied. suggesting that a high 
grade donor-recipient histoincompatibility had 
existed or that the immunosuppressi~-e treatment 
had been inefficient. See text for discussion of the 
role of rejection in affecting interliver competition. 
-4. Rose bengal "'I scan on day of transplantation 
demonstrates better uptake by the homograft than 
b?- the host liver. xh ich  has been depri'r-ed of its 
portal venous inflow and had its common duct li- 
-. 
l i r e  
- + gated. B.  Rose bengal " I  scan 21 days after trans- 
*" plantation illustrates negligible uptake of rose 
AU '98 bengal b!- the homograft. C. Gold scan. also 21 days 
2 1 DAYS POST TRANSPLANT after transplantation. demonstrates excellent up- 
C take of '"'Au by the atrophic homograft. despite its inability to concentrate rose bengal ' ' I .  This homo- 
graft. which weighed 463 gm when transplanted. was onl?- 80 gm at autopsy on the thirt!--second 
postoperative day. (By permission of Surg. Gynec. Obstet. 123:1261. 1966.) 
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Figure  243. The clinical course of a dog ~ r h i c h  received an auxiliar?. li\-er homograft by the tech- 
nique shown in Figure 237B. Note the abrupt hyperbilirubinemia that f'ollolved removal of the 
dog's 017-n li1-er on the seventy-sel-enth post-transplantation day. After autologous hepatectomy. the 
dog lived for 49 days xvith sole dependence upon the homograft. ultimatel!- dyini: as the result of 
wound dehiscence and evisceration lvhich follolved biopsy. The gain in  body weight \$-as due to 
ascites. (By permission of Surg. Gynec. Obstet. 121 :17. 1965.) 
graft by the surgical procedure would be predicted to be less, a point that was 
taken into consideration in planning the operations to be described in the next 
chapter. 
Another feature which may make the precise physiologic environment less 
critical in humans is the greater effecti\ eness with n hich complex and chronic 
immunosuppressi\ e treatment can be given to patients as compared to experi- 
mental animals for reasons described in Chapter Thirteen. 1-1s a consequence 
rejection. nhich is probably the most important of all the factors described 
earlier in inhibiting the colnpetitir e potential of an auxiliary homograft, can at 
least be minimized. The use of donor-recipient histocompatibility matching 
should have the same effect. 
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Chapter Twenty-two 
CLINICAL AUXILIARY 
TRANSPLANTATION 
This chapter will be concerned primarily with a total of nine auxiliary liver 
transplantations in man that have appeared in the world literature, four from 
our own centeri4. "" and five from other institutions.'~ " S  I " ,  '" I "  In all instances 
the attempts ultimately failed. the longest postoperative survival being only 34 
'I These documented efforts represent only a small fraction of the actual 
experience compiled to date. since it is known by personal communication, by 
newspaper reports, and by word of mouth that many other unsuccessful trials 
have been made. probably as many as 25. However: inasmuch as the latter 
cases cannot be carefully re\-iewed they will be referred to only in the event of 
some unique or especially interesting feature which has been verified by per- 
sonal contact with the responsible surgeon. 
INDICATIONS FOR OPERATION 
The first auxiliary hepatic transplantation in a human was performed on 
November 3. 1964. by Dr. Karel B. Absolon and his associates at the University 
of NIinnesota.' The patient was a 13  month old child with extrahepatic biliary 
atresia, the same diagnosis as in one of our recipients (AT 3). In the other 
formally reported cases the patients were adults with alcoholic or postnecrotic 
cirrhosis,& 14.  1 ! ~ 2 1  hepatitis."' 01: hepatoma.'" 
All the patients suffering from ncn-neoplastic liver disease (Table 36) were 
in very poor condition at the time of transplantation, and most were moribund. 
For example. the three adults with cirrhosis treated at our institutions were 
either stuporous or in frank hepatic coma. Their serum bilirubin concentrations 
were 27 to 38 mg per cent and the prothrombin times n-ere 20 to 23 per cent of 
normal (Table 36). One patient (AT 4) had been essentially anuric for several 
days with the poorly understood" .'. ';. I '  "hepatorenal syndrome" and required 
intensive hemodialysis before he could be taken to the operating room. Another 
had received an emergency portacal-a1 shunt three days prel-iouslj- because of 
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major hemorrhage from esophageal varices. All three had massive ascites as 
well as peripheral edema. Even the 16 month old child with biliary atresia was 
a bad risk since ascites formation and rapid clinical deterioration had started. 
Perusal of the reports from the other authors' ". '" "' suggests that the same 
unfavorable conditions pertained in their cases as well (Table 36). The limited 
and relatively nonspecific resuscitative measures that could be taken were dis- 
cussed in Chapter Four. 
THE DIFFERENT OPERATIONS 
Unlike the orthotopic procedure, which has a relatively fixed design, aux- 
iliary transplantation may be performed in several ways and with placement of 
the new organ in any part of the abdomen except the right upper quadrant. 
Before deciding on one of the variations, thought should be given to the condi- 
tion of drainage from the host's nonhepatic splanchnic venous bed. which is 
present at the beginning and which will eventually exist after completion of 
the procedure. There are physiologic reasons, discussed at length in the pre- 
ceding chapter. why such considerations may be important, particularly if the 
patient's diseased liver retains enough function so it is able to engage in com- 
petition with the homograft. 
Of even greater practical significance is the fact that the state of the 
splanchnic venous circulation can profoundly influence the difficulty of the 
transplantation according to the presence or absence of portal hypertension. 
This factor may even determine whether it is technically feasible to do the 
operation at all without an excessive risk of producing uncontrollable venous 
hemorrhage from high pressure intra-abdominal varices. At least in adults with 
end stage cirrhosis, it is probably highly desirable if only for the latter reason to 
decompress the portal system of the recipient, either before or at the same time 
as the transplantation, by one of the techniques to be described later. 
It would be reasonable to place the cases of clinical auxiliary transplanta- 
tion into categories according to the homograft location, the diseases treated, or 
other criteria. However, in view of the emphasis in the foregoing remarks and 
in those of the preceding chapter about the importance of tlie details of both 
the host and the transplant vascular systems, the classification used below 
will be based upon the homograft blood supply. 
Arterial Supply Only 
In one of our cases (AT 4) and in Absolon's patient1 only a hepatic arterial 
supply was restored. O u t f l o ~ ~  from the homograft was through its distal in- 
ferior vena cava which. in turn. was anastomosed to the host systemic venous 
system. The organs were placed in the left upper quadrant after splenectomy. 
In our recipient, it had been planned in addition to anastomose the distal 
splenic vein to the transplant portal vein for two reasons: the double objective 
was to nourish the new liver by perfusing its sinusoidal bed with splanchnic 
CLINICAL AUXILIARY TRANSPLANTATION / 495 
venous blood and to coincidentally provide by this route a means for decom- 
pression of the patient's portal hypertension. 
The effort to restore portal flow to the homograft failed. The recipient was 
a 48 year old male with Laennec's cirrhosis who was given the liver of a new- 
born anencephalic monster. The weights of the recipient and donor were 84.0 
and 3.1 kg, respectively. A splenectomy was performed through a thoracoab- 
dominal incision. The splenic artery was attached to the distal end of the in- 
fant's aorta, which had been removed in continuity with the celiac axis and 
hepatic artery (Fig. 244). The homograft portal vein was less than a millimeter 
in diameter and was ligated. Vascular outflow passed through the full length of 
the donor infrahepatic inferior vena cava, the distal end of which was anas- 
tomosed to one of the renal vein divisions in the recipient (Fig. 244); the supra- 
hepatic vena cava was closed by suture. 
Until this stage of the procedure. the severe portal hypertension secondary 
to the advanced cirrhosis had made it impossible to obtain adequate hemostasis 
' %  X ~ F ~ ~ ~ ' L  v ,J 
Figzcre 244. Auxiliary liver transplantation carried out in a 48 year old man with Laennec's cir- 
rhosis (AT 4). The homograft. ~vhich  was taken from a 3.1 kg. nelvborn anencephalic monster, 
weighed 80 gm. Its inter\-a1 of ischemia. all hypothermic. was 88 minutes. For technical reasons it 
Tvas possible only to pro\-ide an arterial blood supply, Note that the vena cava of the transplanted 
organ 'isas used as a hornol-ital prosthesis through ~ s h i c h  to perform a splenorenal shunt. It is prob- 
able that the extra flon- thereby directed througll the homograft \ - e m  ca1-a protected it from clotting, 
to which it might other~rise  ha\-e been prone if it transmitted onl?- the hepatic \-enous effluent. 
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of the operative wound. As a last resort it was decided to perform a splenorenal 
shunt through the homograft. This was accomplished by reopening the supra- 
hepatic vena cava of the transplant and anastomosing it to the enlarged recipi- 
ent splenic vein. The host splanchnic blood could then pass through the graft 
vena calra and directly into the left renal vein (Fig. 244). The venous bleeding 
ceased immediately, and the procedure was completed by anastomosing the 
gallbladder to the proximal jejunum through a window in the left mesocolon 
(Fig. 244). The operation required 14 hours and blood replacement of 8000 ml. 
The technique used by Absolon was different in several ways (Fig. 245). 
Host splanchnic decompression was not attempted. In addition, the connec- 
tions for the arterial supply and the venous outflow were to the external iliac 
vessels. Finally, the homograft portal vein and vena cava were anastomosed 
together (Fig. 245) "in order to decompress the transplant in case. . . prolonged 
ischemia. . . led to high resistance to blood inflow."' In retrospect the addition 
of this technical detail to the operation was probably unnecessary and, since it 
could promote shunting of the blood supply away from the sinusoidal bed, it 
may not have been advisable. 
Arterial  a n d  Systemic Venous Inf low 
Although it is desirable to provide a portal inflow from splanchnic venous 
sources (Chapter Twenty-one), this may be technically more difficult to achieve 
in people than in dogs because of species differences in anatomy. The human 
portal vein and its major tributaries are not only less accessible because of a 
more complete fusion of the colonic and duodenal mesenteries to the posterior 
body wall. but they are also less mobile even after being exposed. 
Consequently, a compromise procedure was performed in two of our pa- 
tients (Figs. 246 and 247) aged 50 and 47 years (AT 1 and 2). The auxiliary 
homografts xvere obtained from 79 and 12 year old donors of the same blood 
type, placed in the right paravertebral gutter. and rearterialized from the host 
aorta or hypogastric artery. Irenous blood from the lon-er extremities was used 
to perfuse the portal system of the new organ. In both patients standard por- 
tacaval anastomoses had been performed three days (AT 1) and one day (AT 2) 
previously. I:? the first recipient the preliminary shunt was for the control of a 
massive variceal hemorrhage, but in the second it was carried out with even- 
tual placement of an auxiliary organ in mind. After transplantation the hemo- 
dynamic conditions simulated those (Fig. 24111. Chapter Twenty-one) reported 
from our laboratories by Ha lg r im~on '~  and from the Cleveland Clinic by 
Tretbar.?? 
The techniques of these two human operations are shown in Figures 246 
and 247. They were the same in principle but differed in some details having to 
do with the level of homograft insertion and the exact source of the arterial and 
venous blood supply (compare Figures 246 and 247). In both instances outflow 
from the organ was through its suprahepatic 1-ena c a m  into the abdominal 
vena c a w  of the host. The graft infrahepatic vena cava was closed by suture. 
To make room for the new organ the cecum and ascending colon were reflected 
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F i g u r e  246. Auxiliary liver transplantation from a 79 year old cadaveric donor to a 50 year old 
recipient (AT 1) who was dying of Laennec's cirrhosis; both patients had A blood type. The donor had 
a cardiac arrest on Februar~-  20. 1965. which was treated with external and internal cardiac massage 
for 105 minutes. When a heart beat could not be restored, he was placed on hypothermia-inducing 
extracorporeal bypass for the next 110 minutes (see Chapter Five). during which time the liver was 
remo\-ed. It n.as revascularized 49 minutes later in the recipient, .-I. Incisions used for the two 
operations. B.  Stage I. An emergent!. end-to-side portacax-a1 shunt was carried out three days before 
the transplantation for the control of massive helnorrhage from esophageal x-arices. C .  Completed 
transplantation. Note that  re^-ascularization of the homograft is in principle the same as that after 
portacaval transpositions inasmuch as the portal flow comes from a s!-sternic x-enous source. In 
spite of the preliminar!- portacax-a1 shunt. large \-enous collaterals in the right retroperitoneal space 
made reflection of the ascending colon x-ery difficult. The  control of helnorrhage required 11 hours 
and necessitated the transfusion of 3000 ml blood. (By  permission of Arch. Surg 93:107, 1966.) 
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F i g u r e  247. The method of auxiliary liver transplantation used in a 47 year old patient (AT 2) on 
July 5, 1965; both donor and recipient had 0 blood type. The donor. a 12 year old boy. died from head 
trauma a few minutes after arrival a t  the hospital. Circulation was maintained for 45 minutes by 
external cardiac massage until tne liver could be cooled bl- intraportal infusion of a chilled electro- 
lyte solution. The subsequent hypothermic period required to remol-e the lil-er and revascularize it 
in  the recipient IT-as 1'20 minutes. A .  X segment of vena cava below the anastomosis has been 
removed, as well as all the right cominon iliac vein. The field is read?- for receipt of the hoinograft. 
B. The outfloy.\- of the new organ was directed into the transected inferior cava. The portal 
blood supply Tvas obtained from the external iliac 1-ein. The h>-pogastric arter?- easil?- reached the 
celiac axis for end-to-end anastomosis. The lil-er was small enough to readily fit behind the reflected 
cecum. The operation mas completed in five hours. with a blood loss of 2300 ml, S o t e  the Roux-en-Y 
cholecystojejunostoiny, (By  permission of Arch Surg. 93: 107. 1966.) 
upward and to the left. The openilig of the retroperitoneal plane might have 
been technically impossible had it not been for the prior relief of the portal 
hypertension. In spite of this advantage the fact that the venous collaterals had 
not yet undergone involution complicated the dissection, particularly in patient 
AT 1, who required intraoperative blood replacement of 5000 ml. 
After revascularization had been completed no effort was made to close the 
retroperitoneal space. Biliary drainage was with a Roux-en-Y cholecystojejunos- 
tomy after ligation of the homograft common duct. The abdominal incisions 
were closed without drainage. 
Arterial plus Splanchnic Venous Inflow 
' 
There have been five well documented attempts to divert both arterial and 
splanchnic venous blood through auxiliary homografts. Each of the recipients 
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died a short time later, although not because of any special problems caused by 
the method of portal revascularization. The least successful effort was in our 
in~t i tu t ion . '~ ,  The patient was a 16 month old child with extrahepatic biliary 
atresia into whose splenic fossa n7as transplanted the liver of a seven month old 
infant with Krabbe's disease. The technical difficulties encountered in this 
case have been published and need only be summarized here. First. the small 
size of the recipient splenic artery made it necessary to eventually use the host 
common iliac artery for end-to-end anastomosis to the transplant celiac axis 
(Fig. 248)' as originally described by Absolon.' Second, the retrograde flow from 
Figure  248. The technique used for attempted auxiliary transplantation in  patient AT 3. The 
donor's temperature was 24'C at  the time of death: the lix-er was further cooled by an infusion 
technique, removed and rel-ascularized in the recipient 152 minutes later. The homograft faced 
medially. permitting anastomosis of the host splenic vein and common iliac artery to the homograft 
portal vein and celiac axis, respecti!-el!-. 1-enous outflow was pro\-ided by anastomosing the graft 
abdominal vena cava to the 1-ena ca1.a of the host. S o t e  the angulation near the origin of the left 
common iliac artery. This n.as responsible for the technical failure of the transplant. (Bl- permission 
of Arch. Surg. 9 3 : l O i .  1966.) 
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the host splenic vein into the auxiliary organ was sluggish. since portal hyper- 
tension was not very severe; consequently, good portal perfusion could not 
have been expected. 
Finally, a serious technical accident occurred during operation. After revas- 
cularization the homograft was soft. pink and elaborated bile almost immediate- 
ly. However, when the abdominal incision was allowed to reapproximate to 
cover the overcrowded viscera, the host aorto-iliac junction became kinked 
(Fig. 248). The hepatic arterial supply promptly clotted. The arterial suture line 
was excised, thrombectomv was carried out. the anastomosis was reperformed, 
and the folding of the iliac arterv was relieved by ligation and division of the 
two most inferior left lumbar arteries. 
An arterial supply was partially restored, but there were multiple residual 
infarcts in the hepatic parenchyma. A liver scan with '""Au was obtained as 
soon as the wound was closed (Fig. 249). This showed no isotope concentration 
in the auxiliary liver. Consequently the homograft was immediately removed 
and the host iliac artery repaired by end-to-end anastomosis. The child had a 
cardiac arrest and died one hour later. Acute acidosis caused by metabolites 
F1ijlii.e 249. -1 l i ~  er scan obtalned ~mmediatel!- in the 16 month old child , A T  3 rrhose operation 
is shoxt-11 in Figure 248. The neqliqible uptake of " - . i ~ i  s ~ipparenr.  The superior portion of the  homo- 
graft occupies the bed of the excised spleen. (By permissio~l of Surg. Gynec. Obstet. 123:1261,  1966.) 
502 / CLINICAL AUXILIARY TRANSPLANTATION 
from the transplanted liver and possibly from the recipient's ischemic left 
lower extremity was suspected to have been responsible for the sudden death. 
Calne6 has also described a similar attempt at transplantation to the splenic 
fossa. The donor and recipient were both adults. The patient bled to death a few 
hours after operation. 
In  the three other cases reported by Cree.lh Sheil,'" and FonkalsrudIo the 
auxiliary livers were placed on the right side of the abdomen. Cree anas- 
tomosed the host inferior mesenteric vein to the graft portal vein. Sheil per- 
formed the operation shown in Figure 250. These two recipients died after 46 
and 76 hours, respectively. All the vascular anastomoses were patent. The prob- 
able reasons for the unfavorable course in these patients will be discussed 
later. Fonkalsrud"' employed essentially the same operation as Sheil for a 46 
year old man with hepatoma who still had good liver function. The hepatic 
artery, which was revascularized from the host renal artery after right nephrec- 
tomy, was found to be clotted at the time of autopsy 12 days later. The trans- 
planted organ was necrotic. 
SPECIFIC PROBLEMS 
The many difficulties that can be encountered during or immediately after 
operation are evident from the foregoing accounts. Some of the problems are 
not specific to auxiliary transplantation since they have also been noted after 
orthotopic operation. Included are bleeding, intravascular clotting, and acute 
life-threatening metabolic aberrations. However, there are also some special 
complications which may result from placing an  extra organ into the abdominal 
cavity. 
As already suggested, it is probable that the immediate technical failure 
from arterial thrombosis in one of our cases (AT 3 )  was related to this unique 
factor. Absolon also drew attention to the same aspect of the procedure. To 
make room for the homograft in the splenic fossa it was necessary in his case to 
remove the recipient's left kidney as well as the spleen. In spite of the added 
measure, a photograph of the child in the early postoperative period. published 
in the report of the case,' testified that the closure of the wounds had been with 
considerable tension. 
A more extreme example of intra-abdominal overcrowding was related to 
us by Dr. David Hume of Richmond. Virginia." In 1964, he attempted to place 
an  auxiliary homograft in the splenic fossa of a teen-aged girl after splenec- 
tomy; the donor mas an adult. After revascularizing the extra organ, it was 
impossible to close the incision until after the patient's own diseased liver had 
been removed. 
The existence of such great disparities between the space which is 
available and that which is needed undoubtedly predisposes to serious pulmo- 
nary complications. The same may be true even under more favorable anatomic 
conditions. The three patients in our series with Laennec's cirrhosis (AT 1,  2, 
and 4) had abdominal cavities that had been so stretched by massive ascites 
that adult organs could easily have been placed in each instance, although, in 
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F ~ g u r e  250 Auxlllar\ l lrel transplantatloll as  cartied out b~ A G R Shell of Australia from a 44 
year old n70man to a 45 rear  old man xilth Laennec's cirrhosis Note that the transplant n a s  given a 
double blood supplx and that the r enous coinponent xxas from the nonhepatic splanchnlc bed The 
technique mas almost identical to that d e ~  eloped In dogs b~ Bengoechea-Gonzalez Blllarr drainage 
mas 111th a Roux-en-k c h o l e c ~ s t o ~ e ~ u n o s r o l l l ~  L1nfortunatelr the patient dled 76 houls post- 
operatir elx There mas no el ldence of function from the honlograft 
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actuality, two of these auxiliary livers were obtained from one day (AT 4) and 
12 year old (AT 2) donors. Consequently it was not expected that diaphragmatic 
movement would be impaired. It is disquieting to note that all three patients 
had difficulty breathing postoperatively and that all had widespread pneumoni- 
tis at the time of their death three to five weeks later. 
For the indication of biliary atresia there has not been enough experience 
with auxiliary transplantation to arbitrarily dismiss such a therapeutic ap- 
proach. However, in view of the lethal pulmonary complications that have 
developed even under the favorable circumstances mentioned above, it is 
probable that children with atresia should usually be considered for orthotopic 
rather than for auxiliary transplantation. With the former procedure, removal of 
the bulky host liver (and preferably also the spleen) can permit rapid reversal of 
the respiratory embarrassment that is often present preoperatively. The most 
important reason is that the amount of tissue removed is invariably several 
times greater than that which is added. Another advantage of the replacement 
operation which should not be overlooked is that the abnormal vascular com- 
munications feeding pulmonary veno-arterial shunts are functionally almost 
immediately closed (Chapters Four and Nine). This prompt benefit could not be 
expected after auxiliary transplantation. 
One other extraordinary complication of clinical auxiliary hepatic trans- 
plantation has been described to us by Dr. Marvin Gliedman" of Brooklyn, New 
York. In his patient the extra liver was placed in the right paravertebral space 
by a modification of the technique shown in Figure 247. Within a few hours 
ascites began to form at such a rapid rate that more than a hundred liters of 
fluid were aspirated in the few days of postoperative life. At autopsy it was 
found that the intrahepatic and suprarenal vena cava of the recipient had been 
almost completely closed by compression from the diseased liver. The same 
problem has been encountered by Fonkalsrud."' 
In a later angiographic and autopsy study," Gliedman showed that this 
anatomic change is not uncommon in patients with Laennec's cirrhosis; 
furthermore, the same findings can be produced in dogs by causing liver injury 
in a variety of ways.'? The implication of these investigations is evident; if such 
an  abnormality TTere present. the outflow of the new liver would be placed 
below the site of an obstruction with all the techniques described in this chap- 
ter. Consequently Gliedman" has recommended that a venacavogram be con- 
sidered a mandatory step in the evaluation of any patient for auxiliary hepatic 
transplantation. 
IMMUNOSUPPRESSION 
The first tn-o patients who survived operation in our institutions (AT 1 and 
2) were treated with the double drug regimen of azathioprine and prednisone 
that was described earlier in the book. The average daily doses administered 
were summarized in Table 17, Chapter Thirteen. The complete courses of these 
patients have also been shown graphically in Figure 109, Chapter Thirteen, and 
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Figures 251 and 252. The attempts at therapy failed, both because of drug 
toxicity and because of the inability to control rejection. 
The third recipient who survived operation (AT 4) was treated with the 
triple drug protocol of azathioprine, prednisone. and ALG (Fig. 253). The 
development of thrombocytopenia after two weeks necessitated discontinuance 
of the immune globulin. The doses of azathioprine were very small (Fig. 253), 
averaging only 0.36 mg kg per day for the 24 days of post-transplantation life. It 
is not surprising that he was unable to support larger quantities since the 
presence of both hepatic and renal failure compromised the two most impor- 
tant pathways of detoxification of this drug (see Chapter Thirteen). Leukopenia 
was not produced at any time, despite which the patient developed multiple 
infectious complications (Chapter Sixteen). 
COURSE AND LIVER FUNCTION 
The survival after all reported attempts at auxiliary liver transplantation is 
given in Table 36. Absolon's patient' unquestionably obtained function from 
the new organ during 13 days of survival. even though the direction of tissue 
transfer was across a strong red cell group incompatibility (A to 0). The 
bilirubin fell from about 20 mg per cent to almost normal. coincident with the 
appearance of bile in the stools: prothrombin times were improved. 
In contrast there was no objective evidence of supplementary hepatic func- 
tion in the cases of Cree.") Calne." Sheil.'" and Fonkalsrud."' The bilirubin con- 
centrations in the sera of their recipients fell during operation, an effect which 
was probably explicable by the infusions of fluid and blood. Two of the patients 
with non-neoplastic liver diseaseH1 I "  were comatose before the procedures were 
begun and did not wake up afterward: Calne's recipient, who was rational 
before operation, did not recover from a n e ~ t h e s i a . ~  Refractory hypotension 
developed shortly after the three auxiliary organs were revascularized and this 
persisted until death 14. 46. and 76 hours later. respectively. Although hepato- 
cellular necrosis of the homografts was not a particularly prominent autopsy 
finding, it is probable that very serious ischemic injury had occurred during the 
last stages of donor death and in the course of the transplantation. As men- 
tioned earlier, the homograft underwent necrosis in Fonkalsrud's caselo be- 
cause of thrombosis of the hepatic artery. The patient survived for 12 days, 
probably because hepatic failure was not present preoperatively: the indication 
for operation was hepatoma. For reasons discussed in Chapter Seventeen, aux- 
iliary transplantation for hepatic malignancy will probably not be considered 
advisable in future cases. 
Patient AT 4 .  Organ damage from ischemia was probably not the explana- 
tion for failure to demonstrate a metabolic coiltribution by the homograft in the 
adult patient in our series who receil ed the l i ~  er of an anencephalic monster 
and n-ho was treated n-ith triple drug iinmunosuppressi~ e therapy. The donor 
was placed on a mechanical \elltilator immediately after birth, n a s  cooled to 
30" C before hepatectoin>. and was known to have had an effecti\ e circulation 
Text conti?zzied 071 page 508. 
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Figure 231.  The clinical course of a patient (AT 1) ~ r i t h  Laennec's cirrhosis  rho received a n  
auxiliary liver homograft: the operation is depicted in Figure 246. The preliminary portacal-a1 shunt 
controlled massive hemorrhage from esophageal varices. Note the e\-idence of function of the 
transplanted lil-er. with a fall in the serum bilirubin and a sustained improvement in the prothrombin 
time. The rejection that f o l l o ~ ~  ed was not IT-ell controlled. During the last several days of life there 
lvas profound leukopenia. The irradiation dosages were to the center of the homograft. (By permis- 
sion of Arch. Surg. 93:107. 1966.) 
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AT 2 47 y . o . 8  
68.5 + 62.6 kg. 
FQRTACAVAL SHUNT, 
SPLENECTOMY 
2 5 0 -  
SGOT 200 .  150. (S. - F: Units) 100. 
5 0 .  
ALKALI N E 20.  
PHOSPHATASE 15. 10. ( B. - L .  Units) 5. 
BILIRUBIN 
(mg/100 ml) 
TOTAL- C0NJ.- - - - 
0- 
SERUM PROTEIN 
(g/100 ml) 4. '. 
TOTAL- ALBUMIN - - - -  2. 
PROTHROMBIN TIME 
( % of normal) 
BUN 150. 
(mg/IOOml) 100. 
I 
~ - - - - - - - - - _ - _ _  - - -  
- . ------ - 
I 
---.. 
AUXILIARY 
LIVER 
TRANSPLANTATION ] DAYS 
0 
~ r )  
Figure  252. The course of the patient (AT 2) whose operation 1s depicted in  Figure 247. There was 
apparently good initial function which later deteriorated n-hen rejection was not controlled. Note 
the rapid det-elopment of azotemia late in the course. The gastroilltestinal bleeding which \?-as the 
immediate cause of death was due to widespread intestinal moniliasis: the exp1orator)- laparotomy 
was made in a n  effort to control the bleeding. The details of the immunosuppressioi used in this 
case as well as  the consequent effects upon the peripheral hematologic findings are shon-n graph- 
ically in Figure 109. Chapter Thirteen. Profound leukopenia de\-eloped during the fourth post- 
operative week. 
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BILIRUBIN 35 30 
(mg per 100ml) 2; 
- - - __ - - -  
_ _ _ _ - - - - - -  
TOTAL - 15 
CONJUGATED - - - - - -  10 5 
0 
PROTHROMBIN 40 
TlME 30 20 
( %1 10 
0 
SGOT - 
SGPT - - - - - - -  200 
( I .  u. 1 100 
DIALYSIS + o 
SERUM 15 
CREATlNlNE 10 5 (mg per 100 ml) 20g 
BUN 100 
(mg per 100 ml) 
0 
150 AZATHIOPRINE loo 
(mg 1 50 
0 PREDNISONE 100 
(mg)  200 
A LG 
AUXILIARY EXPIRED 
TRANSPLANTATION 
TlME IN DAYS 
Figzl1.e 253.  The course of a patient :.AT 4) 11-ith Laennec's cirrhosis and hepatorenal syndrome 
who received a newborn auxiliary homograft. The transient reduction of jaundice lras probably due 
to the blood transfusions during operation. The patient required emergent!. 11emodiall;sis before 
operation and at frequent intervals thereafter. Death on the t~t-enty-fourth da!- xras due to hepatic 
and renal failure and to pneumonitis. 
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until almost the moment of organ removal and hypothermic perfusion. The 
subsequent interval of cold ischemia was 88 minutes. 
Instead, the difficulty in detecting function of the auxiliary organ may have 
been the consequence both of its tiny size (80 gm) and its physiologic imma- 
turity. Newborn livers are well known to have striking limitations of function 
due at least in part to deficiencies of microsomal enzymes required for drug 
detoxification and excretion and for the metabolism of naturally occurring 
substrates, including bilirubin.: As specific examples. the activities of UDPG 
dehydrogenase and glucuronyl transferase, which are necessary for the conju- 
gation of bilirubin and other compounds, are notably reduced at birth.' ' 
The course of the patient is summarized in Figure 253. Before operation he 
was stuporous. Afterward and for the next few days he was perfectly oriented 
and cooperative. but this may have been due to the massive transfusions of 
fresh blood. Within a few days his clinical condition began to deteriorate slowly. 
The intermittent hemodialysis that had been commenced preoperatively was 
continued. since his own kidneys never resumed life-sustaining function. The 
immediate cause of death on the 24th postoperative day was pneumonitis, the 
underlying causes being hepatic and renal failure. He also had a severe infec- 
tion of his thoraco-abdominal wound. 
As with the clearing of sensorium, the changes in liver function tests could 
have been due to the intraoperative exchange transfusion. There was an  acute 
fall in the serum bilirubin (Fig. 253). Thereafter the jaundice gradually 
deepened to about its previous degree. There were slight variations in the other 
liver function tests, but these were neither great enough nor sufficiently sus- 
tained to ascribe them to the presence of the newT liver. The most suggestive 
finding was an improvement in the prothrombin time. which was maintained 
for slightly more than two weeks; at the same time other clotting factors (espe- 
cially V) also increased (Fig. 254). Total serum proteins were essentially unal- 
tered. In spite of the lack of unequivocal evidence for its function, the trans- 
plant was proved with liver scans to be viable throughout the entire post- 
operative period. The results of the scans will be returned to later. 
Patients AT I and 2 .  The other two recipients who survived auxiliary trans- 
plantation in our institution had adequate to excellent hepatic function during 
the first postoperative days (Figs. 251 and 252). The early transaminase 
changes were moderate. suggesting that a severe ischemic injury had not oc- 
curred. Both patients had prompt lowering of the pre-existing h!perbilirubine- 
mia. At about the same time. or shortly thereafter. they d e ~  eloped watery diar- 
rhea which was green and had an obviously high bile content. However, the 
most convincing changes were of the prothrombin times. which were badly 
depressed prior to operation, but 1% hich Fvere strikingly restored toward normal 
afterward. The total serum proteins \\ere less affected, either remaining at 
about the preoperative level (Fig. 251) or being slightly improled (Fig. 252) .  
The significance of the early protein measurements was obscured by the fact 
that albumin infusions were given to both patients during operation. 
Clinically there was a prompt clearing of sensorium from the preoperative 
stuporous or comatose state. The patients began to eat nithin a fen days and 
one (AT 2) took an adequate diet for more than three weeks. The latter recipient 
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Figure  254. Clotting factors in a 48 year old man with Laennec's cirrhosis (AT 4) who received 
the liver of a newborn anencephalic monster. The immediate improvements in the clotting Factors 
I1 (prothrombin) and V (accelerator globulin) were probably due to massive intraoperative trans- 
fusions. However, the increase in the coagulation factors from days 4 to 16 did not seem explicable 
on this basis. The research studies lvere carried out by Dr. Liberto Pechet. Note that Dr. Pechet's 
analyses of prothrombin activit). did not reveal exactly the same results as were obtained in the 
hematolog)- laboratories (compare ~ i t h  Figure 253 ) :  ho~r-ex-er. the general conclusions were the 
same. 
appeared to be quite healthy at first. The other man (AT I),  who had required a 
tracheostomy on the first postoperative day. was clinically very ill throughout 
the remainder of his life. 
The double drug therapy with azathioprine and prednisone did not prevent 
the onset of moderately severe rejection. ivithin a week the bilirubin concentra- 
tion began to increase secondarily more slowly in the first (Fig. 251) than in the 
second patient (Fig. 252). The latter recipient also had rises in the alkaline 
phosphatase to levels far exceeding those present before the transplantation 
(Fig. 252). The other measurements of liver function were not affected so early. 
It will be recalled (Chapter Fourteen) that the manifestations of homograft 
repudiation in cases of orthotopic homotransplantation have also often had an  
initial component strongly suggestive of biliary obstruction. 
Unfortunately the process was not reversed (Figs. 251 and 252) despite the 
administration of the immunosuppressis-e drugs in doses that proved to be 
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lethal. Eventually there was deterioration of all measures of liver function. 
Death was contributed to by recurrence of the hepatic failure. but was caused 
primarily by the complex of infections which was considered separately in 
Chapter Sixteen (see Table 21). Both patients had widespread pneumonitis. 
One (AT 2) ultimately bled to death from multiple gastrointestinal ulcerations, 
apparently caused by monilia (Fig. 153. Chapter Sixteen). Survival was for 
three (AT 1) and five (AT 2) weeks. 
Before the auxiliary transplantations both these patients had subnormal 
kidney function; although their blood urea nitrogens (BUN) were low, the cre- 
atinine clearances were less than 35 mllmin. After operation but before the 
beginning of the liver homograft rejection. urine excretion was well main- 
tained or even improved. With the onset of this process. renal function deterio- 
rated, most severely in patient AT 2, whose last BUN and serum creatinine 
were 156 and 9.0 mg per cent. respectively (Fig. 252).  
THE QUESTION OF ATROPHY 
In patient AT 1 there was minimal evidence at autopsy 22 days after opera- 
tion that atrophy had affected the auxiliary liver. The homograft was somewhat 
smaller (1400 gm) than normal adult size but it had the same gross appearance 
as at the time of its transplantation. Moreover, there were few histopathologic 
features to suggest that shrinkage had occurred (see Chapter Twenty-three). 
An attempt was made in the next case (AT 2) to measure the size of the 
auxiliary organ with serial liver scans. Two techniques were used.' With one, 
rose bengal "'1 was administered intravenously in a dose of 150 pc. Since the 
elimination of this isotope is through the hepatocytes, it could also be used as a 
crude test of the relative parenchymal function of the two coexisting livers. 
Alternatively. radioactive gold "'Wu, which is picked up by the reticuloendothe- 
lial system, was given. With the latter method the size and configuration of the 
liver can be assessed in analogous canine experiments long after the ability to 
define the organ with rose bengal has been lost." 
One day postoperatively in patient AT 2 a gold scan revealed intense con- 
centration in the homograft, but none In the cirrhotic autologous liver (Fig. 
255). On the eleventh postoperative day after most of the gold had cleared from 
the transplant, a rose bengal scan was performed and it also showed a greater 
concentration in the homograft: this examination was carried out after the 
clinical rejection had started. Rose bengal scans on the fourteenth. twenty-first 
and twenty-eighth days continued to show the homograft uptake to be greater 
than in the patient's own liver (Fig. 236). At no time did the ~ isua l ly  estimated 
ratio of the rose bengal specific activity seem to change in favor of one organ or 
the other, although ultimately the concentrating ability of both organs appeared 
to have diminished in parallel. On the thirty-second day a second gold scan 
again visualized the homograft exclusively, with no detectable activity found in 
the autologous liver (Fig. 235). With both kinds of scans there appeared to be a 
diminution in the size of the transplanted organ: however, the changes could 
have been due to the loss of isotope concentrating ability rather than a real 
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reduction in size. The impression of atrophy could not be supported with cer- 
tainty from the histopathologic studies of the homograft (Chapter Twenty- 
three). However, both hepatocyte loss and collapse of the supporting reticulin 
were features of the autopsy specimen. 
The third patient (AT 4) who survived the operative procedure of auxiliary 
transplantation at our institution also had several liver scans. The first one was 
with "'"Au on the first postoperati~ e day. For subsequent examinations "'"'-tech- 
netium was used." There was a progressive increase in the size of the 
homograft and a decrease in its concentration of isotope (Fig. 257). presumably 
as it was suffering a rejection. At autopsy the homograft was found to be 
swollen. Its weight was 370 gm compared to 80 gm 24 days previously; the 
edges were rounded. The histologic findings are described in Chapter Twenty- 
three. 
FUTURE PROSPECTS OF AUXILIARY 
TRANSPLANTATION 
Until now life has not been prolonged for more than a few days in any 
recipient by means of auxiliary liver transplantation. The disappointing results 
may be explained partly by the generally very poor condition of the patients 
treated, by overly toxic immunosuppression in most of the early cases, and by a 
high incidence of technical difficulties. Ho.ise~ er. it is probably more than co- 
incidence that the results with such operations in dogs have also been extremely 
disappointing (see Chapter Twenty-one). 
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Figure  256. Three rose bengal ('"I) scans in 
the same patient as in  Figure 255 .  The photo- 
graphic reproductions were with identical 
magnification techniques. .A. Eleven days post- 
operative. There is sharing, of isotope excre- 
tion by the host lil-er and the homograft. B, 
Twenty-one days postoperative. The concentra- 
tion of rose bengal is decreased in both livers. 
C. T~vent>-eight days postoperati~~e. The de- 
terioration has continued. The shado~r. cast b?- 
the holnograft is noxv distinctly smaller but. 
as in Figure 233, the change could represent 
a reduction in homograft function rather than 
real size loss. 
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Figure 257. Three scans in  Patient AT 4 
performed with !'!'"-technetium. The auxiliary 
transplant is in the splenic fossa on the right 
and a portion of the patient's own liver is in  
the upper left. The magnification is exactly the 
same for all three scans. The obvious differ- 
ences in technique. particularly on the last 
examination. were due to variables in  back- 
ground erase. Note that the transplanted organ 
retains its size and. if an!-thing. becomes bigger. A .  Four days post-transplantation: B ,  seven days 
post-transplantation: C .  19 days post-transplantation. 
Nevertheless. it may ultimately be found that auxiliary transplantation can 
be used with benefit for victims of non-neoplastic liver disease under the ap- 
propriate circumstances. Because of the space problems described earlier 
and in view of the frequency of pulmonary complications to which abdominal 
overcrowding may have contributed, it would seem prudent to give special 
thought to the relative size of the homograft which is available. Our present 
belief is that the organ would ideally come from a smaller donor and be placed 
in a recipient whose abdomen had been prepared by stretching with long- 
standing ascites. Such a perfect anatomic situation was present in one of our 
cases (AT 2). 
If the operation is not technically simple. many of its most important ad- 
vantages are lost. For this reason we would plan in future trials to do the 
compromise operation depicted in Figures 246 and 247, in which the homograft 
is revascularized as with portacaval transposition in the right lower abdomen; 
preoperative venacavograms would be highly desirable to establish the patency 
of outflow channels. Furthermore, we would probably think it mandatory for 
reasons discussed earlier to first perform a host portacaval shunt even if this 
meant storing the organ (Chapter Five) for several hours while the portal de- 
compression was accomplished. We 1%-ould no longer consider auxiliary trans- 
plantation to the splenic fossa since it seemed to be a more traumatic and 
technically demanding operation. 
The clinical obse r~  ations made so far about interliver competition and 
atrophy are by no means conclusive. Although homograft sh r i~kage  did not 
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occur at a rapid rate within the follow-up intervals of three to five weeks, there 
is still no assurance that this urould not have occurred later. In the patient with 
the longest survival (AT 2) a kind of competition could be monitored 
throughout the postoperative course. at least in terms of the division of rose 
bengal excretion. The proportions seized by the two livers did not change dras- 
tically but the size of the homograft, at least as measured by scans, seemed to 
gradually become smaller. To what extent a sharing of other metabolic pro- 
cesses might have influenced the long term welfare of either organ can only be 
speculated upon in the absence of more information. 
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Chapter Twenty-three 
PATHOLOGY OF THE AUXILIARY 
HOMOGRAFT 
by K .  A. Porter, ,W.D., D.Sc. 
As reviewed in Chapter Twenty-one, the fate of the auxiliary hepatic 
transplant is influenced to an extraordinary degree in animals by competition 
between the recipient's own liver and the homograft. Atrophy of one or the 
other coexisting livers may occur according to their relative physiologic advan- 
tages, including the quantity and quality of their blood supply and the state of 
their biliary drainage.  moreo over, the functional interrelationship of the organs 
can be unpredictably unbalanced in outbred animals by the magnitude of the 
immunologic attack upon the transplant. Under these circumstances it is nec- 
essary in examining an auxiliary homograft to differentiate the histo- 
pathologic changes that are secondary to a nonimmunologic etiology from those 
that are due to rejection. The distinction may be difficult in  any given case. 
THE MORPHOLOGIC CONSEQUENCES OF LIVER 
COMPETITION 
Consequently the most precise information about interliver competition 
has come from the study of preparations in which immunologic factors were 
avoided. In some of these experiments the blood supply of a portion of the 
canine liver avas altered in situ7 by the performance of "split transposition" 
(Chapter Twenty-one): in others. parts of the canine liver n-ere relocated as 
autografts." l" or partial lil-er isografts Tvere transplanted to ectopic sites in 
rats." 
In Marchioro's investigations7 of split transposition in se1-en dogs (Fig. 239, 
Chapter Twenty-one), the hepatic arterial supply and biliary drainage n-ere not 
disturbed. Both portions of the divided lil-er were thought to have received 
initially about the same quantity of venous-inflow to the portal vein: however, 
this was derived from the inferior vena cava on one side and from the normal 
516 
PATHOLOGY OF THE AUXILIARY HOMOGRAFT / 517 
splanchnic venous source on the other. The part of the liver receiving caval 
blood atrophied after 70 to 94 days in every case (Fig. 240, Chapter Twenty-one). 
Histologically it contained shrunken lobules with centrizonal atrophy. depletion 
of glycogen. and irregularity of cell size, shape. and staining. There were often 
central collapse. reticulin condensation, and sinusoidal irregularities. Capsular 
thickening. increased subcapsular lymphatics, centrizonal cholestasis, and an  
increased number of Kupffer cells were present in a few of the animals. The 
blood vessels and intrahepatic bile ducts lvere normal. Ultrastructurally many 
cells showed marked reduction of rough and smooth endoplasmic reticulum; 
the remaining cisterns were often dilated. Glycogen was scarce and there were 
moderate numbers of small fat vacuoles. In  some cells the electron density of 
the h>aloplasm was greatly reduced. Mitochondria were sparse. were often , 
vacuolated. and occasionally contained fibrillar inclusions. 
The liver tissue receiving splanchnic venous inflow was grossly hyper- 
trophied. Microscopically this portion of the liver appeared to have larger 
lobules and hepatocytes than were present in the pretransposition biopsy. There 
were also binucleate and trinucleate liver cells. mitoses, and proliferating bile 
ducts. Ultrastructurally the enlarged cells were essentially normal. although 
the profiles of endoplasmic reticulum were more irregularly arranged than 
usual. 
The other studies cited on page 516 in which portions of livers were revascu- 
larized in  heterotopic locations". " Ih have agreed about the value of 
providing a splanchnic venous inflow to the liver for the purpose of preventing 
transplant atrophy. In Lee and Edgington's investigations with rat i s o g r a f t ~ , ~  30 
per cent of the host liver was left in place. with an obstructed duct system but 
with an  intact splanchnic venous and arterial blood supply. The heterotopically 
placed partial hepatic isografts (30 per cent of a donor liver) also had bile duct 
obstruction. In some of their experiments in which the transplants were given 
only an  arterial inflow. an  injury pattern could be seen within the first day. The 
livers developed edema of the portal regions and space of Disse, and mild hydro- 
pic changes occurred in  the hepatocytes. By day three the pericholangiolar 
region had become infiltrated by polymorphonuclear leukocytes together with a 
few lymphocytes and monocytes. After day three bile duct proliferation in  the 
portal tracts became prominent. Subsequent atrophy was profound at the same 
time the host liver hypertrophied. In  contrast, when the host hepatic remnant 
was deportalized and the isograft given a normal double blood supply, a progres- 
sive gain in  the graft mass occurred which 11-as most rapid during the first 
seven days after transplantation and which was completed by day 21. 
The numerous other ways in  which interliver competition may be un- 
balanced in  fa1 or of one organ or other were described in Chapter Twenty-one. 
AUXILIARY LIVER HOMOGRAFTS I N  UNTREATED 
DOGS 
There haxe been several descrlptlons of the pathologic and immuno- 
pathologic changes that occur in whole auxihary liver transplants in unmodi- 
fied dogs.3 ' I ' I  1 2  1" 1; 
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A particularly careful study was made by the Mount Sinai group of New 
York City.j. '" l 2  In the first two days they found only some nonspecific centri- 
lobular ischemic necrosis and an  increase in prominence of the Kupffer cells. 
About the fourth day after transplantation lymphoid cells with basophilic cyto- 
plasm appeared in the portal tracts and these cells steadily increased in num- 
bers over the next seven days. Foci of necrosis of hepatocytes were first noted 
five days after transplantation. These were particularly common at the 
periphery of the lobules. and as they progressed the liver cells adjacent to the 
portal tracts disappeared. With graft destruction the composition of the cellular 
infiltrate changed and macrophages, polymorphonuclear leukocytes, and 
plasma cells began to predominate. Two livers removed at 20 days were 
shrunken and wrinkled. and the liver cells were entirely replaced by either 
pools of blood or infiltrating cells; the latter were mostly plasma cells. The 
arteries remained unchanged throughout; the veins were narrowed by 20 
days.lL 
Ultrastructurally many of the infiltrating mononuclear cells contained few 
profiles of rough endoplasmic reticulum but had numerous polyribosomes. 
These cells were found in the tissue spaces adjacent to and indenting the 
hepatocytes. The indented hepatocytes were smaller than normal and lacked 
surface microvilli. Macrophages and fibrin deposits were present in the spaces 
of Disse and the sinusoids were compressed by the large number of infiltrating 
cells.i 
Immunofluorescent studies revealed that in the first week after transplan- 
tation only a few of the infiltrating, pyroninophilic, mononuclear cells con- 
tained IgG and there was no binding of immunoglobulins or complement to the 
vessels and bile ducts. During the second week IgG was found in many more of 
the infiltrating cells and was now localized in the cytoplasm of the bile duct 
cells and in the intima and media of the vessels. Complement was fixed in vitro 
by the same structures."' 
When interpreting these findings, it must be borne in mind that all these 
transplants were deprived of portal vein blood and that this complicating 
element alone would be sufficient to cause necrosis of hepatocytes and 
shrinkage of the graft.8 
AUXILIARY LIVER HOMOGRAFTS IN  UNTREATED 
RATS 
Exactly the same reservation applies to the observations made by Lee and 
Edgington.They studied the sequence of the rejection of Sprague-Dawley to 
Lewis rat homografts. using one of the partial transplant models mentioned in 
the first section of this chapter in connection with their work with isografts. 
Both the host and auxiliary organs had bile duct obstruction. The recipient's 
own liver had a double blood supply. whereas the transplant was nourished only 
by an artery. 
During the first two days the homografts did not differ histologically from 
isografts. Then abruptly on day three a cellular infiltration appeared in the 
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portal zones. This infiltrate was quantitatively greater than that observed in the 
isografts and consisted predominantly of large lymphoid cells. Numerous mono- 
nuclear cells were found within portal venules and frequently appeared to be 
in intimate contact with the endothelial surface of these vessels. Rare lymphoid 
cells were found in the region of the central veins. The pericholangiolar infil- 
trate of polymorphonuclear leukocytes seen in the isografts was also found. In 
the next three days mitotic figures were frequent in the portal infiltrate. 
On day seven mononuclear cells appeared within the lobules in association 
with endothelial cells and the surface of hepatocytes. At the same time there 
was focal necrosis of hepatocytes. and mononuclear cells were frequently 
found in immediate contact with the injured liver cells. The number of mono- 
nuclear cells in the portal regions also diminished and portal edema increased. 
Arteritic lesions were not seen. The cellular infiltrate and hepatocellular injury, 
initiated on day seven, rapidly progressed and the graft was destroyed by day 10 
or 11. 
Immunofluorescence showed that at all stages only a few of the mono- 
nuclear cells contained IgG. A fine linear deposit of fibrin appeared along the 
sinusoids on day seven. 
When livers were transplanted from Brown-Norway strain rats to Lewis 
recipients the same events occurred but more rapidly. indicating that the 
degree of histocompatibility was a significant factor. 
AUXILIARY LIVER HOMOGRAFTS I N  TREATED DOGS 
When whole auxiliary livers are heterotopically transplanted to normal dogs 
that are receiving immunosuppressive treatment with azathioprine, it is found 
that the auxiliary grafts markedly diminish in size within a few weeks after 
ope ra t i~n . '~ .  l b  This fate is in contrast to that of orthotopic hepatic homografts in 
similarly treated animals (Chapter Twenty). The difference in behavior of the 
two types of homograft is not immunologic; shrinkage of the auxiliary 
homograft is due to competition with the unhandicapped host liver, as 
explained earlier in this chapter and in Chapter Twenty-one. If the situation is 
reversed so that the nonhepatic splanchnic blood flow is taken from the recipi- 
ent's own liver and directed through the homograft. the dog's own organ 
 shrink^.^ In the host liver the centrilobular hepatocytes undergo necrosis and 
there is collapse and condensation of the reticulin in the centers of the lobules 
(Figs. 258 and 259). 
When the homograft is given a physiologic advantage of this magnitude in 
the azathioprine-treated canine recipient. the pathologic features of modified 
rejection are not especially different from similarly immunosuppressed ortho- 
topic transplants (Chapter Twenty). Under these circumstances"he majority 
of the auxiliary livers become infiltrated by lymphoid cells around the small 
branches of the portal vein and around the central hepatic veins (Fig. 260)' but 
sequential biopsies show that the cellular infiltration tends to decrease with 
time. Later. centrilobular fibrosis (Fig. 261) and, to a much less extent. peripor- 
tal fibrosis occur. In the longest survivors these changes progress to the 
F i g u r e  258. Biopsy of host liver from a dog with an auxiliarJ- homoqraft. Thirty-five days pre- 
viously an operation had been performed on the animal. directing the splanchnic blood flow in a 
retrograde fashion through the homograft. The dog's o ~ r n  l i ler  Lras supplied only by the hepatic 
artery. There is necrosis of the centrilobular hepatocytes. PEportal tract: C=central vein (Hema- 
toxylin and eosin stain, x 63.)  
F i t  9 .  Biops!- of hcst lil-er from a do? ~v i th  an aus i l i a r~  l lomo~raf t .  Fjft!-one d a y  previously 
the splanchllic blood floxr had been dil-erted throueh th-e %raft and the dox's ox\-n lil-er as left with 
only a hepatic arterial suppi!. The li\-er sllolr s niarked collapse of tlie cenrrilobular reticulin (arrow). 
(Reticulin stain. x 90.) 
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Ficjlcre 260. Biops?- of' canine auxi1ial.y hepatic liolnoeraft that n-as provided with a splanchnic 
blood f l o ~ ~  at  the  t ime of' transplantation 33 da?-s pre\iousl>-. The portal tracrs (P) contain many in- 
filtratinq lymphoid cells. There is a n  accumulation of fibrous tissue around the central  vein (C) and  
this area is liqhtly infiltrated 17-it11 lyml~hocyres.  This doq's o ~ v n  1ix.e~ is shown in Fiqure 258. (Hema-  
toxylin and  eosin stain. x 65.) 
F i g 1 o . e  961. Eiops!- of canine duxiliar!- hepatic liomoo,raft char ~ 1 - a ~  pro1-ided ~ v i r h  a splanchnic 
blood flo~r.  at  the rime of transplanration 61 dd!-5 p~e~iousl ! - .  There is a dense accumulation of re- 
ticulin and collaqen fibers around 2nd IT-ithin the ~ v a l l  of the central  hepatic \-ein. P=porral tract. 
(Reticulin stain, x 65.) 
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development of fibrous and reticulin bands which link some of the affected 
central zones (Fig. 262). In association with this hepatic fibrosis there is 
marked accumulation of inspissated bile in the centrilobular canaliculi. 
Fibrinoid necrosis of the branches of the hepatic artery is sometimes seen, but 
not c ~ m m o n l y . ~ ~  Fibrous intimal thickening of either arteries or veins has not 
been described. 
The protection of auxiliary homografts from "competition atrophy" is not 
an  all or none effect (Chapter Twenty-one); if the transplant is favored but 
to a lesser extent than described above, atrophy may be reduced but not 
prevented under comparable conditions of immunosuppression. Then the 
pathologic changes may represent the consequences of rejection injury com- 
bined with those of nonimmunologic damage.' lh I i  
Another example of such a compromise procedure was reported by Van der 
Heyde et a1 in dogs treated with azathioprine.'" They transplanted the left lobe 
of the liver with only an  arterial supply and handicapped the host liver by 
depriving it of portal blood and by obstructing its bile drainage. Nine of the 11 
recipients died after three weeks to 46 days; two other animals were still alive 
after 35 days and three months, respectively. Only three (or four) of these 11 
transplanted liver fragments dropped from their pretransplantation weight 
during residence in the new hosts. The others either weighed the same or more 
at autopsy or else looked bigger at surgical re-exploration than at the time of the 
original transplantation. No details were given about the histologic changes in 
the grafts of the long survivors. 
F i g u r e  262 .  Cailiiie auxiliar). hepatic homograft 120 d a y  after transplantation. The %raft was 
provided ~ v i t h  a splanchnic blood flo~7-. .A band of reticulin fibers links t w o  central 1-eins. P=portal 
tract. (Reticulin stain. x 65.) 
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HUMAN AUXILIARY HOMOGRAFTS 
The four Denver recipients of auxiliary hepatic homografts died a few 
hours to 34 days after operation. The pathologic changes in three of these 
organs were previously reported.?, 
Graft Removed Five Hours After Transplantation 
The hepatic arterial supply to a transplant in a 16 month old child (AT 3) 
became thrombosed on the operating table. Although reanastomosis was per- 
formed, a liver scan with '"%u showed no isotope concentration in the liver; 
therefore. the graft was removed (Chapter Twenty-two). 
The liver contained many areas of hemorrhagic infarction. In the inter- 
vening liver there was necrosis of the central and midzonal hepatocytes with 
preservation of a thin rim of liver cells around the portal tracts. Several hepatic 
artery branches and portal vein tributaries were thrombosed. Hemorrhages 
were present in the portal tracts. but there was no cellular infiltration. 
Grafts Examined 22 to 34 Days After 
Transplantation 
Three auxiliary hepatic homografts were examined at 22, 24, and 34 days 
after transplantation. Two of the livers (AT 1 and 2) had a double blood supply 
restored, the portal inflow being from systemic venous sources; the third liver 
(AT 4) received only an arterial inflow. 
In the shortest survivor (AT 1) the portal tracts were densely infiltrated 
with mononuclear cells, between 5 and 10 per cerit of which were large lym- 
phocytes with pyroninophilic cytoplasm (Fig. 263). The portal tracts of the 
other two grafts (AT 2 and 4) contained very few lymphocytes. with several 
macrophages and eosinophils. Less than 5 per cent of the lymphoid cells had 
pyroninophilic cytoplasm. 
Intracanalicular bile stasis was a feature of all three homografts: it was 
associated with dilated bile ductules that contained casts of inspissated bile 
(Fig. 264). Atrophy of the centrilobular hepatocytes was also present. I t  was 
most severe in the longest survivor and was accompanied by collapse and con- 
densation of the central part of the lobular reticulin framework (Figs. 265 and 
266). Fat deposits were present in the midzonal and peripheral hepatocytes of 
two of the grafts (AT 2 and 4). In the graft that received only a hepatic arterial 
supply (AT 4) there was also necrosis of many of the hepatocytes in the central 
and middle zones of the lobules. There mas no hepatic fibrosis or cirrhosis. 
In the graft with marked cellular infiltration (AT 1) several of the smaller 
hepatic artery branches showed foci of fibrinoid necrosis in their walls, and in 
many of the larger arterial branches there n a s  fibroelastic intimal thickening 
and reduplication of the internal elastic lamina. The lesions in the larger 
branches were thought to have been present in the liver before transplantation; 
F i g u r ~  263. Human auxiliary hepatic hon~oqraft ( A T  1) 22 days after transplantation. High pom7er 
viem of a portal tract ~vhich  is infiltrated with mononuclear cells. (Hematox?-lin and eosin stain, 
x 600.) 
F i g u r e  264.  tiurnan auxiliar!- hepatic hollloeraft AT 1) 22 days after transplanratlon. The portal 
tract (P) is infiltrated by inollonuclear cells and sel era1 of the smaller bile ducts colltain casts of 
inspissated bile arroxl-s . There is cholejrasis ill the centrilohular bile ca~laliculi. excess of lipofuscin 
in the central hepatoc?-tes and atrophy of the lil-er ceils adjacent to the central \-ein iC'.  [Hema- 
toxylin and eosin stain. x 80. )  
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Figure  265. Humail auxiliary hepatic homograft (AT 2)  34 days after transplantation. The cen- 
trilobular hepatocytes are atrophic (arrow) and there are fat droplets i11 the liver cells in the middle 
and peripheral zones of the lobules. There is no cellular infiltration in  the portal tract (P). (Hema- 
toxylin and eosin stain. x 80.)  
Figure  266. The same humall auxilial.!- hepatic holnograft as slio~i-11 in Figure 265. There is col- 
lapse of the central part of the reticulin franlelr-ork of the li\-er lobules arroxx-'. P=portal tract. 
(Reticulin stain, x 80.) 
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the fibrinoid necrotic foci probably occurred after transplantation. The arteries 
and veins of the other two grafts were normal. Cytomegalic virus inclusions 
were present in many of the biliary duct epithelial cells in one of the livers (AT 
2) (Fig. 154, Chapter Sixteen). 
These findings suggest that only one of the grafts (AT 1) was undergoing 
active rejection. Because the cholestasis that was present in three of the grafts 
was accompanied by dilatation of the biliary ducts, it was suspected on histo- 
pathologic grounds that there had been an element of extrahepatic bile duct 
obstruction in all these livers. However, this had been carefully looked for by 
those performing the autopsies and it had not been found. 
CONCLUSIONS 
The experimental studies have shown that the features of auxiliary homo- 
graft rejection are not fundamentally different than in orthotopic trans- 
plants. They have also demonstrated that the auxiliary liver can be submitted to 
an  additional injury caused by its necessity to compete with the host liver, 
presumably for nutritional substances in the circulating blood. 
The degree to which the latter factor contributed to the morphologic alter- 
ations found in the three human auxiliary livers after 22 to 34 days could not be 
determined with any degree of certainty. Atrophic changes were found in all 
three of the transplants, most severely in the two organs that had been in place 
for the longest periods and that did not have much evidence of active rejection. 
These consisted of hepatocyte atrophy or loss, particularly in the centrilobular 
areas, and of reticulin collapse. Similar abnormalities have been seen in ortho- 
topic livers (Chapter Twenty), but not usually to this extent so early. Neverthe- 
less, the question of whether auxiliary homograft atrophy will be a special and 
troublesome problem in patients subjected to this kind of procedure cannot be 
decisively answered at the present time. 
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Chapter Twenty-four 
APPENDIX OF CASE MATERIAL AND 
BIBLIOGRAPHY 
The following pages list the liver transplantations at the Colorado General 
Hospital and the Denver Veterans Administration Hospital. Other data on these 
cases are summarized in the various chapters. In particular, the reader may 
wish to cross refer to the information about histocompatibility (Table 5. Chap- 
ter Three), the circumstances of donor death (Table 6. Chapter Six), the infec- 
tious disease complications (Tables 21 to 23. Chapter Sixteen), and the timing 
and character of early and late rejection (Table 26. Chapter Seventeen). 
In addition. all cases of liver transplantation are included which were for- 
mally reported before April 1.  1969, from other institutions. Many additional 
unreported attempts have been made. For a recent sylnposium held in Cam- 
bridge, England, Dr. Carl Groth of Stockholm was able to collect 24 and 12 
informal accounts of orthotopic and auxiliary operations, respectively, from 
centers other than the University of Colorado, in addition to the eight and nine 
cases tabulated from the formal literature in this chapter. The unpublished 
statistics have not been cornpiled because of the difficulty of assuring the 
accuracy of documentation. Nevertheless, it is worth noting that surlival of 
more than a month was achieved in a number of the unreported cases of ortho- 
topic liver replacement. including one each of Calne (Cambridge). Fortner 
(New York City). Garnier (Paris). Kestens (Loulain), and Najarian 
(Minneapolis). 
In the second part of the chapter an alphabetical bibliography is g i ~  en of all 
the publications about liver transplantation that have appeared in the world 
literature prior to April 1, 1969. 
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coagulation studies in ,  160-165 
liver injury in. 65  
massire. 66  
minor. 66 
moderate. 66-70 
liver rejection in. 176-184 
remission of. 229 
transplantation in. composite, liver in, 182 
hepatic blood flon following. 181 
portal re\ascularization follo~ving, variations in, 
182 
postoperati1 e course. 178 
survival from. 176- 178 
treated. hoinograft in. 437-446 
-auxiliar?-. 5 19 
untreated. homograft in, 424-427 
auxiliar5-, 5 17 
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Donor(s), liver. See Liver donor. 
organ. nonrelated. 245-247 
Donor hepatectomy, and liver preservation, 41-64 
aortic dissection in. 56 
emergency postmortem measures, 41  
ex \-ivo perfusion follo\ving. See Perfusion, e x  L ~ L O .  
final procedures. 56 
portal triad in. 54 
preliminary steps in. 49 
vena ca\-a in ,  49 
Doriden, degradation of. 87  
Ilrug therapy. double, 242-253 
deficiencies of. 248 
hepatic transplantation and,  
results from, 251-253 
histocompatibility and. 246 
in renal transplantation. See Renal t ransplanta-  
tion. rlouhle drnq ikerapg in.  
liver injury by. 88. 388 
triple, 253-273 
hepatic transplantation and. 266-273 
renal transplantation and. See Renal t ransplanta-  
tion. triple tlrlcq the7'fip?j in. 
Eck's fistula. 478 
Edema. following hepatic transplantation, 6 7  
Electrolytes, changes in. intraoperative, 102 
transplantation and. 91 
Embolus(i). air. postoperative. I51  
pulmonarl-, and poor graft function, 448 
postoperative. 134 
Endothelial cells in  long-sur\-iring homografts, 464 
Epontol, degradation of. 85 
Esophagitis follolving transplantation, 332 
Ethyl \-inyl ether. l i \er  and. 90 
Excretion, renal postoperat i~e,  157 
Extrahepatic organs, heterotransplantation of, 408-415 
Fibrinolysis, alterations in, in  homograft, 160 
Fistula. Eck's. 478 
Flaxedil. degradation of. 8 7  
Fluid balance, postoperative, 157 
Fluoromar. liver and. 90 
Fluoroxene, liver and. 90 
Fluothane, toxicity of. 89 
Foreign protein reaction, antilymphocyte globulin and 
serum and. 224 
Fungemia following transplantation, 339, 341 
Gallamine, degradation of. 8 7  
Gangrene. hepatic. See Hepcitic gci7zg~e7ze. 
Gastrointestinal tract. hemorrhage of, postoperative, 
154 
ulceration of. azathioprine and. 206 
postoperati!-e. 68,  154 
Gene frequencies. 24 
Globulin, antill-mphocyte. See .Aiztilg1xphocyte globu- 
li11. 
gamma A. postoperati! e l e ~  el of. 396 
gamma G ,  postoperati! e elemtion of. 396 
gamma S, postoperative le \  el of, 396 
Glutethimide. degradation of. 87  
Halothane. degradation of. 86 
toxicit! of. 89 
Hemagglutinatlon-inhibition test, lMartensson's, 399 
Hemochromatosis, 11  
Hemodialysis, preceding hepatic transplantation. 38 
Hemorrhage, gastrointestinal, postoperative. 154 
intra- and postoperati\-e, 144 
Hepatectomy, donor. See D011or lzepatecto1ny. 
recipient. See L i t e r  recipieizt. kepiitectonzy in.  
Hepatic artery. in homograft insertion, 130. See also 
Licer. 
occlusion of. 347 
right, prel-ention of' distortion. 327 
thrombosis of. 324 
thron~bosis of. 367 
late, 384 
Hepatic gangrene, acute  rejection and,  308-328 
relationship of. 314 
bacteriologic findings. 309 
etiology of'. mechanical considerations, 323 
liver rejection in patients without, 277-307 
persistent rejection and. 319 
regional. 462 
septic, pre\ ention of, 327 
subclinical rejection and. 315 
symptoms and signs. 309 
treatment of. surgical. 319-323 
Hepatic homograft. acceptance of. mechanism of, 229- 
232. See also Trci1ispl(liztation. 
adaptation of. 233 
adequatel) functioning, coagulation in, 167 
antigraft antibodies and,  232 
arterial s? stem of. 323 
as cause of' bacterernia in recipient, 345 
auxiliary. atrophy in,  473 
competition and, 478 
prevention. 484-486 
in hepatitis. 12 
canine, 65  
auxiliary. coagulation changes in, 164 
poorl) preserved. coagulation changes in, 162 
treated. 437-446 
azathioprine in. 437-442 
withdra\val of'. 442-446 
heterologous antilymphoid globulin in. 446 
untreated. 424.427 
well-preserved. coagulation changes in. 160 
cholangitis and. 390 
condition at  time of transplantation. Importance, 329 
de\-ascularization of. earl),  171 
examination of. 21 to 400 days after transplantation, 
450-465 
within 11 days of transplantation. 447-450 
extrahepatic obstruction and. 390 
human.  446-463 
injury of, in man,  70 
hopeless. 70 
massive. 70-76 
moderate. 77-79 
serious, 76 
insertion of. 123-142 
biliary drainage in,  136-140 
choledochocholedochostomy in, 136 
disadvantages of. 138 
closure follon-ing. 142 
hepatic arter:; in. 130 
infrahepatic ena cava in, 128 
liver fixat~on follon-ing. 140 
operati! e staging of. 140 
portal 1-ein in. 128 
suprahepatic vena cava in. 125-128 
ascular ano~ndlies and. 130 
irradiation of. 273 
imlnunosuppression and. 226 
long-surx-i\ing. Kupffer and endothelial cells in, 464 
lymphoid tissue transplanted ~ s i r h .  465 
metastasis to. 462 
modification of. 226 
pathology of, 422-471 
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Hepatic homograft (Continued)  
perfusion with RKA, pretransplant, 227 
poor function of, and pulmonary emboli, 448 
coagulation and,  167 
porcine. treated. 446 
untreated. 427-437 
reaction of recipient to. 203 
rejection of. acute. 279-306 
hyperacute. 278. 279 
size discrepancy in. 133-136 
Hepatic infarction, septic. syndrome of, 309-314 
Hepatic ischemia. consequences of, 65-80 
prex-ention of, 41 
cooling in. 42, 43 
Hepatic sepsis. in early cases, 332 
in intermediate cases, 339 
in later cases. 345 
Hepatic transplantation, actinomycin C and, 273 
anesthesia and intraoperative care in, 83-1 11 
antilymphoc! te globulin and,  l>mphopenia in. 270 
thrombocytopenia and. 272 
ascites following. 67 
candidacy for. 3 
canine. prolonged survival after, 198 
contraindications to, 3 
double drug therapy and,  249 
results from. 251-253 
edema follovring, 67 
gastrointestinal ulceration following, 6 8  
hemodialysis preceding, 38 
hemorrhage following, 66  
histocompatibility testing in. 27 
hyperbilirubinemia follo\ving, 68 
intraoperatiw blood transfusion in, 38 
platelet depression in. 269 
serum protein changes follo~ving, 67 
splenectom) in,  273 
transaminase increase following, 6 8  
triple drug therapy in. 266-273 
Hepatitis. auxiliary homografts and,  12 
x-iral, lix-er injury from. 388 
Hepatoma, as indication for transplantation, 4 
determination of operability in. 113 
primary, \ s ,  liver metastases, 8 
Heterograft(s). 412. See also Heterotransplantat ion.  
baboon to man.  410 
chimpanzee to man.  466 
pathology of, 422-471 
Heterotransplantation. animal. relel-ance to clinical, 
414 
baboon to man. 410 
immunologic studies in ,  41 1 
chimpanzee to man,  409 
immunologic studies in, 410 
clinical. 415-419 
immunosuppressive therapy following, 417 
operative procedures for. 416 
postoperative course. 418 
preoperative evaluation in, 415 
retrospective anal!-sis of, 419 
minor generic disparitl- and, 414 
Histocompat~Lility. animal, 485 
double drug therapy and,  246 
renal transplantation and,  26 
typing for. 18. 22-33 
errors in. sources of. 22 
false 1-alues in. 23  
in liver transplantation. 27 
HL-.A antigens in renal transplantation, 26 
HL-A system, alleles of. 24 
HL-A2 antigens. 25. 26 
homo graft,^:, hepatic. See Hepcitic homograft. 
renal, h!peracute rejection of. 278 
irradiation of, 244 
Homograft-recipient relationships, changing, 227-233 
Hormones. lit-er and,  92 
Host. See Reciple?lt. 
Hydrocarbons, degradation of, 8 5  
Hyperbaric oxygenation. following donor hepatectomy, 
6 3  
Hyperbilirubinemia, following hepatic transplantation, 
68 
Hypercarbia, lix-er and,  88  
Hypersensitivit)-, anti])-mphocytic globulin and,  255 
Hypertension. arterial, postoperatix-e. 154 
portal, in  liver recipient, 113 
postoperative. 92 
venous. acute. 92 
Hypoglycemia. intraoperatix-e. prevention of, 9 8  
Hypotension. controlled. liver and. 88  
transplantation and,  9 3  
Hypothermia. total body, 4 3  
Hypoxia. liver and. 88  
Immunochemical studies. special, 394-407 
Immunoglobulins, 396-406 
interreactions of', fractional. 397 
rheumatoid factors and,  402 
serum concentrations of. 396 
source of, 397 
studies of, significance of. 404 
Immunosuppression, adjustments in ,  late rejection 
and. 375 
antilymphocyte globulin and,  207-225 
antilymphocyte serum and. 207 
azathioprine In. See Azuthioprine. 
follo~ving transplantation. 327 
homograft irradiation and. 226 
in early cases, 331 
in intermediate cases, 331 
in later cases. 341 
in man,  242-276 
in transplantation. 193-241 
renal. 196 
irradiation in,  193 
6-mercaptopurine in, 203 
metastasis and. 8 .  372 
methionine in. 201 
prednisone and,  226 
susceptibility to infection and,  329 
transplantability of tumors and, 369 
tumor growth and. 369 
Inborn errors of metabolism, liver, 13  
Incision for transplantation, 113 
Incompatibility. red cell group, 277, 278 
Infarction, adrenal, postoperative, 131 
hepatic. septic. See Heputic gangrene.  
nonhepatic, in early cases. 331 
in intermediate cases, 336 
in later cases. 341 
susceptibility to, immunosuppression and,  329 
Intestines. injury to. intraoperative. 151 
Intrahepatic atresia. 9 
Intrax-enous therapy. intraoperative. 98 
postoperatix-e. 154 
Irradiation. bod!. promotion of tolerance by, 230 
total. in immunosuppression. 193 
homograft. 244. 273 
in~munosuppression and.  226 
Ischemia. hepatic, consequences of. 65-80 
prex-ention of. 41 
cooling in. 42. 43 
Jaundice, in  animals during rejection, 179 
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Kanamycin, following transplantation, 327 
Ketalar. degradation of. 8 5  
Kid!iey. See Renal. 
Kupffer cells in long-surviving homografts, 464 
Leukoagglutination test, incidence of nonreproduci- 
bility-, 23  
Lidocaine, degradation of, 8 7  
Liiel., acute failure of. 11. See also Hepatic. 
acute yellon- atrophy of. 12 
d 
after sham operation, 422 
atrophy of, auxiliary transplantation and,  311 
s.nd hypertrophy of. balance between. 483 
auailiarl- compet i t i~e  balance with natural liver, 483 
azathioprine degradation and. 252 
cadareric. cooling of. 4 3  
intraportal infusion of, 4 3  
carbon tetrachloride and,  88  
carcinoma of. primary. 4 
(:ompetition with auxiliary homograft, 478 
~norphologic consequences of, 516 
controlled hypotension and,  88 
donated, preserlation of, 62 
quality of. tests of. 19 
drug toxicity and. 388 
effect of anesthesia on, 87-90 
effect on anesthesia, 83.87 
fixation of, folloxving homograft insertion, 140 
iunction of, fpllo~ving auxiliary transplantation, 505- 
51 1 
llormones and, 91 
hypercarbia and,  88  
hypoxia and,  88 
in composite graft, 182 
injured. in  dogs. 65  
ischemia of. See Hepcitic ischemia. 
malfunction of, follolring transplantation, causes of, 
387 
metastases to, vs, hepatoma, 8 
nlobilization and remo\-a1 of, 119 
phosphorus and. 88 
preservation of, follonring donor hepatectomy, 41-64 
viral hepatitis and. 398 
Ljver disease. anemia :md, 94  
ascites and. 94 
cardiodynamic changes in, 93 
incidence of. 3 
non-neoplastic. 8-13 
respiratory changes in, 9 3  
Liver donor, 16-21 
age criterion. 18 
selection of, 16 
SGOT of, 19 
SGPT of. 19 
L,iver recipient. bacteremia in. homograft a s  cause of, 
345 
bacterial cultures from, 330 
postoperatix-e therapy and,  36 
cardiorespiratory system in. study of, 36 
determination of operability. 113 
early death in. 350 
emluation of. emergency, 35  
long distance. 34 
hepatectomy in. 113-125 
creation of b > ~ a s s  during. 122 
dissection of portal triad in. 115 
incision for. 113 
technique of. iexiations in. 125 
lvmphoid tissue5 of. changes in after transplantation, 
465 
operation in,  112.143 
portal hypertension in. 113 
Liver recipient (Continued) 
prolonged survival of. 350 
reaction to homograft, 203 
selection and preparation of, 34-38 
vascular anomalies in. 131 
Liver transplant. See Hepcltic hon~ogrnft.  
L>-mphocyte c)-totoxicity test, incidence of nonrepro- 
ducibility. 23  
Lymphoid tissue, host, changes in after transplantation, 
465 
transplanted with graft. 465 
Lymphopenia. antil>mphocyte globulin therapy and, 
263.270 
Malignant disease. hepatic, 4-8 
recurrence of, 350-373 
Martensson's hemagglutination-inhibition test, 399 
Mepivacaine, degradation of, 8 7  
6-Slercaptopurine, immunosuppression with, 203 
promotion of tolerance by, 230 
Metabolic diseases, transplantation and. 12 
Metastasis(es). as contraindication to transplantation, 4 
i-.nmunosuppressix-e therapy and. 8, 372 
liver, vs, hepatoma, 8 
to homograft. 462 
Methicillin, follobt-ing transplantation, 327, 330 
Methionine, in imn~unosuppression. 201 
Methoxyflurane. toxicity of, 89  
hlonitoring of vital signs, intraoperative, 94  
Muscle relaxants. 8 6  
Narcotics, degradation of, 8 5  
Nephritis. serum sickness, antilymphocyte globulin 
and serum and. 224. 225 
Nitrous oxide, lix-er and, 90 
Obstruction, bile duct, 448 
complete. postoperative. 148 
extrahepatic. 390 
Occlusion, arterial. nonthrombotic. postoperative, 148 
of hepatic arterl-. 447 
venous. effect on blood pressure. 101 
Operation, sham. liver following. 422 
2-Orthochlorophenyl. 2-methylamino cyclohexanone 
hydrochloride, degradation of. 85 
Orthotopic heterotransplantation. 408-421 
Orthotopic homotransplantation. 4. See also Hepat ic  
honsogrcift and Tr i i i~s~) l~ i l~ t ( i t io~z .  
case material. tabulation of. 330-532 
Oxygenation, hyperbaric, follo\iing donor hepatectomy, 
6 3  
Pancreatitis. postoperati\-e. 155 
Paracentesis, preceding liver transplantation, 36 
Paralysis. diaphragmatic, postoperative, 151 
Penthrane. toxicity of. 89 
Pentobarbital. lix-er and. 89 
Peptic ulcer regimen. postoperati\-e. 157 
Perfusion, ex 1-iro. follo~r-ing donor hepatectomy, blood 
for. 63 
limitations of method. 61 
preser! ation unit for. 59 
compression and depression in,  61 
final n-ashing in. 61 
f l o ~  in.  59 
Peritonitis follon-ing transplantation, 332 
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Phtnotypes. ccnveision of. 399 
detection of. 399 
gamma G globulin, 399 
Phosphoriis. liver and,  88  
: Pigc coagulation changes in, 165 
. -- .- 
I;,-er rejection in. 184-190 
remission of. 229 
treated. homogtafts in. 446 
untreated. homografts in. 427-437 
Piperocaine. degradation of, 87  
Platelets, depression clf, in  hepatic trar:splantation. 269 
Pneumonitis, fol lo~i ing transplantation, 332, 339, 342 
prevention 0:. 157 
Polymyxin, folion-ing transplantation, 327 
Portal trind, dissection of. 115 
in donor hepatectociy. 54 
Portal T ein. thron~bosis of. 446 
Potassium. scrun?. intraoperatil-e r,hanges in ,  104 
i'rednisone. 243, 244 
dosage r e g m e n .  249 
follou-iing tr:ir~s~lant;ition, 327 
imnIunosuppression and,  226 
Preser, ation of dunor liver, 62 
Priicchine, degradation of. 87  
P :~ca ine ,  degrad:itiun of. d 7  
Prr>par.id~d, drg1,ad:rtion of. 8 5  
ProtelL.(s), fureign. -.cnclio.~ to alitilymphocyte globulin 
and serum. 22-1 
nc~limmul~oglubulir~,  5ovrc.e of. 394 
s r ~ u n ~ ,  ch'tnges In follo\ring hepatic transplantation. 
F 7 
t. .aJ. :)f donor, 19 
PI.: ~.:irc~mbin time of donor. 19 
Pi-wdocholinc 4:  st. 'r,trao,~erati\.e. 104 
P ~ * l , n r * ~ l . ~ r  :mb,:il. jntl poor irait function, 448 
postop~?r:itive, 134 
Rdts, untrL,it.~d. altxlliary h ~ m o g r a f t s  in. 518 
Recipie~lt of !i\er. See Lizmer :el i p z e n t .  
13ec;pient-homcgrhft rel;ltio,~ships, changing, 227.233 
' ~ d  pel1 groui~.  com,~:~tibiiity of, 277, 278 
Rejection acute. 27Q-30C. 449, 450 
canine. I 76-i81- 
hepzt'c gangrelie and ?0:1-328 
rep ,~ i r  ,ollon.;r :. 452 
hype! icu.?. 277-V7Y 
In renal tmnsp la l~ tz~ lon ,  30
ill patien::, ivithout hfp. t ic  gangrene, 277-307 
in unmodifi-:I ani. ,.;is. 176-192 
indolent, 294-306 
1abora:ari studies in. 297 
ph)-sica: bigns of, 294 
prognosis l a .  3C5 
replantatiol? in ,  302 
reversibility of, 300 
treatment of. 298 
latz. 373-387 
bartereinia in. 258 
followin: pievious septic hepatic infarction, 380 
immunos~lppreqsion adjustments and, 375 
in prexiousl~ i:-,tact homografts, 
irrel-ersible. c qurse of. 379 
manifestations .t. 375 
time of onset. 373 
\ascular  changes v;ith. 438 
n;itigation or pr~!-?.ltlon of. 193-241 
~f l . s i s t en t .  hepat:c gmgrene  2nd. 316 
pc;cine. 184-190 
reniissiriq of. 228 
reverrdl of 219 
s p l e r ~ ~ c t o n ~ !  and,  7 3  
subcl!.iical. .LBO 263 
l?epar;c ganglene ;nd, 315 
Rejection i c o n t i n n e d )  
subclinical. iaborator:: stltdies in ,  280 
physical signs of. 280 
prognosis in, long-term. 283 
reversibilit:: of. 080 
treatment of, 280 
Rejection crisis. 283-294 
laborator). studies in ,  286 
liver scan in. 288 
physical signs of. 286 
prognosis in ,  long-term, 294 
reversibility of. 293 
treatment of. 292 
Relaxants. muscle. 86 
Remission of rejection, 258 
Renal excretion. postoperative, 157 
Renal homograftq. hyperacute rejection of, 278 
Renal transplantation, antilymphocyte globulin follow- 
ing. 216 
antilymphocyte serum fcllolving, 21 6 
cadaveric. 261 
doutle  drug therapy in,  242 
ancillary measures, 243 
deficiencics of. 248 
histocompatibility and,  246 
timing of. 243 
histocompatibility and,  26 
HL-A antigens in. 26 
homograft irradiation in, 214 
hyperacute rejection in. 30 , 
immunosuppression in, i9li 
intra-familial, triple drug t l~erapy in,  255 
nonrelatrd donor- in. 245.247 
ren~ispion of rejection in,  2518 
thoracic duct drainage in,  214 
triple drug therap?- in. 253-266 
first trials of. 253 
Respiration. postoperative prol)lems of, 153 ,  
Retrarlsplantation f~nsibility of, 384 
Revascularizatlcn. portal. x-aritciorls in. 182 
Rheumatoid factors. detection 3f. 203 
i:nmunoglobulin ~nierreac'io,is and. 402 
in renal transplantation. 465 
incidence of, 403 
RNA. homograft perfusion with, pretransplant, 227 
Scans, liver. iri rejectiori cr is :~,  288 
Sepsis. follo\ving transplan~a'lons. causes of, 324 
;)ulri~onary. postoperat]\ e. 1 5? 
uri!-.-lr> tracr, follo~vin: trarj:,jil.~n:.arlon. 332 , 
Serum, .~n t i lx -mpl~oc~te .  See .A71 il:j~i?;~l?ocyte s rum. 
concer,:ration of immunoglohuiins ir,, ,396 
Serum bilimhin test of donor, i 9  
Serum prot:.ins, changes in follo\sinq hepatic trans- 
plantation, 67 
SH antiken. hepatitis and ,  315 
Shock. i~ re re r s ib le ,  f o l l o ~ ~ n g  rraniplai tation, 92 
Splenecto r?-. 11: hepatic transplantation, 273 
rejection and. 273 
trdnsplaniation and. 141 
Stagilation. T-enous. 92 
Si:ccinylcholire. degradati-n of. 8 6  
Succin!-ldichol<!le. deyraiation of. 66 
Syndrome of septic hepanc infarcti::n. 309-314 
prel-ention of. 327 
Synergism. antill\-mphucyte globulin and,  220 
Test, alkaline phosphatase, of donor. 19 
leukoaggl~1tina1ion. incidence of nmr?producibilit!, 
2 3 
lymphocyte cytoioxi~ity, incidence ?f nonreproduci- 
bility. 23  
Test (Continued) 
Martensson's hemagglutination-inhibition, 399 
serum bilirubin. of donor, 19 
Tetracaine, degrcdation of, 87 
Thiopental. liver and. 89 
Thoracentesis. preceding lix-er transplantation. 36 
Thoracic duct. drainage of. in renal transplantation, 244 
Thromboc~topenia, antilymphocyte globulin therapy 
and. 264 
in hepatic transplantation. 272 
following transplantation, 160 
Thrombosis. arterial. lobar. postoperative, 148 
total. postoperatixe. 145-148 
of hepatic artery. 367 
late, 384 
right. 324 
of portal x ein, 448 
postoperative. 148 
Thymectoml-. antilymphocyte serum and, 222 
Tolerance, immu~lologic, specific, 229 
Transaminases. increase in, follocving hepatic trans- 
plantation. 68 
Transfusion, blood. intraoperat i~e.  in liver transplan- 
tation. 38 
Transplantation, acid-base balance and. 91. See also 
Hepittic 11un.rlqrccft. 
anhepatic stage of. metabolic :!Iterations during, 90 
dntibiotic therapy follo~ving. 327 
auxiliary. See A!( ~ z / ! n ~ ! j  trcifc\])l~intittion. 
1,acteremi'i i'ollorving, 332. 336, 342, 345 
blood group compatibility in. 17. 277. 278 
canine. anti1yniphoc)-te globulin follo~ving. 216-219 
antilymphoc? te seruin iolloxri~lg. 216-219 
carbohydrate metabolism and. 91 
care follolving. 136 
changes in host lynlphoid tissues following, 465 
cholangitis following. 462 
coagulation during and after. 166-171 
complications of. 100 
infectious. 329-347 
intra- and postoperative, 144-158 
composite. lirer in. 182 
contraindications to. 3 
rnerastasis as. 4 
electrolytes and. 91 
esophagitis folloxving, 332 
hemorrhage followinq, 66 
hepatic injury before. massive, 447 
sevcre. 447 
homclgrafts in, examination from 21 to 400 days, 450- 
465 
examinarion.\vithin 11 days. 447-450 
hypotension and. 93 
immunosupprc.ssio~; i11. 193-2.41, 327 
late results and complications. 348-393 
liver malfunctiori follo~ring, causes of, 387 
Transplantation ( C o n  tinlled) 
medical community cooperatiol; in, 1'7 
metabolic diseases and. 12 
nlonitoring of \-ital signs during, 94 
neritoniris fo1lo~vii:g. 332 
pneumon~ti?  follon.ing. 332. 339. 342 
pcrcine. bl-pass In. 186 
postoperative car?. 99 
renal. See Rr~in!  trci,zsp/antatio?z. 
sepsis follo\ving, causes of, 324 
urinar) tract. 332 
splenectomy and. 141 
surgical accidclits during, 348 
Tribromoethar~ol, degradation of, 87 
Trichlorocihan~l. degradation of, 86 
Trichloroethylene. degradation of, 8 3  
Trifluoreth>-lx I I I ~ ~  ether. liver and, 90 
Trilene. degradation of. 85 
Tubocurarine, deli,r:ldation of, 86 
Tumor(!,). malignant. growth of, immunosuppression 
and. 369 
new. spontanecus de\-elop~nent of, 370 
transplantibilit! of, imniunosuppression and, 369 
Ulceration. gastro~ntestinal, azathioprine and, 206 
folloxz-iz;g hepatic transplantation, 68 
postoperative. 134 
Urinar) tract sepsis, following transplan'xtion, 332 
Vein(s), portal, in homograft insertion, 128 
stagnation of blood in. 92 
Vena cava, in donor hepatectorny, 49 
infrahepatic, anas:or:losis of in hoirmgraft insertion, 
128 
suprahepatic. anastornos;, of follo.ving homograft 
insertion, 125128  
Ventilation. mechanical, postoperative, 151 
Vinamar. liver and. 90 
Vinethene. lix er and. 90 
Vital signs. monitoring of. intraoperative. 94 
Vitamin K, postoperati! e administration, 157 
Wilson's hepatolenticular degeneration, 11 
Xenograft, 412 
rejection of. 412 
mitigation of, 414 







